abs | rel | |
---|---|---|
Health | 1627 | 91.3% |
Medicine | 1465 | 82.2% |
Health sciences | 1430 | 80.2% |
Health care | 1420 | 79.6% |
Medical specialties | 1153 | 64.7% |
Clinical medicine | 1076 | 60.3% |
Risk | 678 | 38.0% |
Public health | 648 | 36.3% |
Human activities | 485 | 27.2% |
Disease | 477 | 26.8% |
Diseases and disorders | 463 | 26.0% |
Hospital | 437 | 24.5% |
Infection | 431 | 24.2% |
Patient | 395 | 22.2% |
Epidemiology | 386 | 21.6% |
Preventive healthcare | 373 | 20.9% |
Health economics | 343 | 19.2% |
Research | 330 | 18.5% |
Cancer | 294 | 16.5% |
Nursing | 293 | 16.4% |
Evidence-based medicine | 286 | 16.0% |
Clinical trial | 280 | 15.7% |
Medication | 248 | 13.9% |
Emergency department | 239 | 13.4% |
Randomized controlled trial | 239 | 13.4% |
Adherence (medicine) | 238 | 13.3% |
Chronic condition | 238 | 13.3% |
Medicare (United States) | 228 | 12.8% |
Medical diagnosis | 227 | 12.7% |
Biology | 222 | 12.5% |
Surgery | 219 | 12.3% |
Health policy | 214 | 12.0% |
Systematic review | 208 | 11.7% |
Cardiovascular disease | 198 | 11.1% |
Health professional | 193 | 10.8% |
Medicaid | 190 | 10.7% |
Therapy | 188 | 10.5% |
Screening (medicine) | 187 | 10.5% |
HIV/AIDS | 182 | 10.2% |
Health system | 182 | 10.2% |
Life sciences | 176 | 9.9% |
Mental health | 167 | 9.4% |
Infectious diseases | 165 | 9.3% |
Meta-analysis | 164 | 9.2% |
Caregiver | 159 | 8.9% |
Governance | 159 | 8.9% |
Patient safety | 159 | 8.9% |
Evaluation | 158 | 8.9% |
Medical humanities | 157 | 8.8% |
Immunology | 156 | 8.7% |
Vaccine | 155 | 8.7% |
Sensitivity and specificity | 154 | 8.6% |
Medical guideline | 151 | 8.5% |
Technology | 151 | 8.5% |
Childbirth | 147 | 8.2% |
Hypertension | 147 | 8.2% |
Electronic health record | 146 | 8.2% |
Heart | 145 | 8.1% |
Primary care | 144 | 8.1% |
Risk assessment | 142 | 8.0% |
Stroke | 141 | 7.9% |
Audit | 140 | 7.9% |
Myocardial infarction | 139 | 7.8% |
Sustainability | 137 | 7.7% |
Tuberculosis | 136 | 7.6% |
COVID-19 pandemic | 135 | 7.6% |
Coronary artery disease | 132 | 7.4% |
General practitioner | 128 | 7.2% |
Obesity | 128 | 7.2% |
Public sphere | 128 | 7.2% |
Antimicrobial resistance | 127 | 7.1% |
Pharmacy | 126 | 7.1% |
Virus | 120 | 6.7% |
Pregnancy | 117 | 6.6% |
Artificial intelligence | 115 | 6.4% |
Safety | 115 | 6.4% |
Science | 115 | 6.4% |
Physician | 112 | 6.3% |
Medical imaging | 111 | 6.2% |
Microbiology | 111 | 6.2% |
Cardiovascular system | 109 | 6.1% |
Health care quality | 108 | 6.1% |
Mental disorder | 108 | 6.1% |
Clinical commissioning group | 105 | 5.9% |
Cohort study | 105 | 5.9% |
Health informatics | 103 | 5.8% |
Innovation | 103 | 5.8% |
Hospital readmission | 101 | 5.7% |
Influenza | 101 | 5.7% |
Cardiology | 99 | 5.6% |
Employment | 94 | 5.3% |
Breast cancer | 93 | 5.2% |
Diabetes | 93 | 5.2% |
Major depressive disorder | 92 | 5.2% |
Risk management | 92 | 5.2% |
Blood pressure | 89 | 5.0% |
Confidence interval | 88 | 4.9% |
Information | 87 | 4.9% |
Physical therapy | 87 | 4.9% |
Self-care | 86 | 4.8% |
Branches of science | 85 | 4.8% |
Coronavirus disease 2019 | 84 | 4.7% |
Regulatory compliance | 84 | 4.7% |
Exercise | 83 | 4.7% |
Fee-for-service | 83 | 4.7% |
Telehealth | 82 | 4.6% |
Management of HIV/AIDS | 81 | 4.5% |
Medical treatments | 80 | 4.5% |
Comorbidity | 79 | 4.4% |
Social work | 79 | 4.4% |
Antibiotic | 78 | 4.4% |
Transmission (medicine) | 78 | 4.4% |
Sexually transmitted infection | 77 | 4.3% |
Hepatitis | 76 | 4.3% |
Social programs | 76 | 4.3% |
Statistics | 76 | 4.3% |
Business | 74 | 4.2% |
Managed care | 74 | 4.2% |
Type 2 diabetes | 74 | 4.2% |
Health equity | 72 | 4.0% |
Statin | 72 | 4.0% |
Education | 71 | 4.0% |
Management | 71 | 4.0% |
Cholesterol | 70 | 3.9% |
Emergency management | 70 | 3.9% |
Policy | 70 | 3.9% |
Adverse effect | 68 | 3.8% |
Dementia | 68 | 3.8% |
Genetics | 67 | 3.8% |
Low-density lipoprotein | 67 | 3.8% |
Data analysis | 66 | 3.7% |
Human reproduction | 66 | 3.7% |
Blinded experiment | 65 | 3.6% |
CT scan | 65 | 3.6% |
Government | 65 | 3.6% |
Public services | 65 | 3.6% |
Disability | 63 | 3.5% |
Heart failure | 63 | 3.5% |
Infection prevention and control | 63 | 3.5% |
Pneumonia | 63 | 3.5% |
Accountable care organization | 62 | 3.5% |
COVID-19 | 62 | 3.5% |
Food | 62 | 3.5% |
Privacy | 62 | 3.5% |
Quality-adjusted life year | 62 | 3.5% |
Drugs | 61 | 3.4% |
Health insurance | 61 | 3.4% |
Best practice | 60 | 3.4% |
Insurance | 60 | 3.4% |
Pandemic | 60 | 3.4% |
Biotechnology | 59 | 3.3% |
Cost-effectiveness analysis | 59 | 3.3% |
Intensive care unit | 59 | 3.3% |
Pharmacology | 59 | 3.3% |
Chemotherapy | 58 | 3.3% |
Gene | 58 | 3.3% |
Leadership | 58 | 3.3% |
Medical record | 58 | 3.3% |
Psychiatry | 58 | 3.3% |
High-density lipoprotein | 57 | 3.2% |
Occupational safety and health | 57 | 3.2% |
Radiology | 57 | 3.2% |
Neoplasms | 56 | 3.1% |
Prescription drug | 56 | 3.1% |
DNA sequencing | 55 | 3.1% |
Medical prescription | 55 | 3.1% |
Severe acute respiratory syndrome coronavirus 2 | 55 | 3.1% |
Colorectal cancer | 54 | 3.0% |
Glycated hemoglobin | 54 | 3.0% |
Vaccination | 54 | 3.0% |
Internal medicine | 53 | 3.0% |
Radiation therapy | 53 | 3.0% |
Receiver operating characteristic | 53 | 3.0% |
Surveillance | 53 | 3.0% |
Asthma | 52 | 2.9% |
Behavior | 52 | 2.9% |
Diagnosis of HIV/AIDS | 52 | 2.9% |
Venous thrombosis | 52 | 2.9% |
Biomarker | 51 | 2.9% |
Community health | 51 | 2.9% |
Dose (biochemistry) | 51 | 2.9% |
Personal protective equipment | 51 | 2.9% |
Anticoagulant | 50 | 2.8% |
Chronic kidney disease | 50 | 2.8% |
Economics of service industries | 50 | 2.8% |
HIV | 50 | 2.8% |
Poverty | 50 | 2.8% |
Tuberculosis management | 50 | 2.8% |
Magnetic resonance imaging | 49 | 2.7% |
Medical device | 49 | 2.7% |
Palliative care | 49 | 2.7% |
Pay for performance (healthcare) | 49 | 2.7% |
Population health | 49 | 2.7% |
Sepsis | 49 | 2.7% |
NHS foundation trust | 48 | 2.7% |
Chronic obstructive pulmonary disease | 47 | 2.6% |
Lung cancer | 47 | 2.6% |
Breastfeeding | 46 | 2.6% |
Clinical governance | 46 | 2.6% |
Machine learning | 46 | 2.6% |
Thrombosis | 46 | 2.6% |
Body mass index | 45 | 2.5% |
Cognition | 45 | 2.5% |
Medical test | 45 | 2.5% |
Angina | 44 | 2.5% |
Emergency | 44 | 2.5% |
Methicillin-resistant Staphylococcus aureus | 44 | 2.5% |
Nursing home care | 44 | 2.5% |
Patient Protection and Affordable Care Act | 44 | 2.5% |
Prostate cancer | 44 | 2.5% |
Substance abuse | 44 | 2.5% |
Cervical cancer | 43 | 2.4% |
Ethics | 43 | 2.4% |
Psychotherapy | 43 | 2.4% |
Health information technology | 42 | 2.4% |
Internal control | 42 | 2.4% |
Multi-drug-resistant tuberculosis | 42 | 2.4% |
Preterm birth | 42 | 2.4% |
Renal function | 42 | 2.4% |
Cancer screening | 41 | 2.3% |
Medical home | 41 | 2.3% |
Agriculture | 40 | 2.2% |
Angiology | 40 | 2.2% |
Atrial fibrillation | 40 | 2.2% |
Hypercholesterolemia | 40 | 2.2% |
Influenza pandemic | 40 | 2.2% |
Intensive care medicine | 40 | 2.2% |
Isolation (health care) | 40 | 2.2% |
Long-term care | 40 | 2.2% |
Percutaneous coronary intervention | 40 | 2.2% |
Quality assurance | 40 | 2.2% |
Sampling (statistics) | 40 | 2.2% |
Simulation | 40 | 2.2% |
Antiviral drug | 39 | 2.2% |
Atherosclerosis | 39 | 2.2% |
Non-communicable disease | 39 | 2.2% |
Osteoporosis | 39 | 2.2% |
Services sector of the economy | 39 | 2.2% |
Triage | 39 | 2.2% |
Decision-making | 38 | 2.1% |
Diabetes management | 38 | 2.1% |
Emergency medicine | 38 | 2.1% |
Immune system | 38 | 2.1% |
Immunodeficiency | 38 | 2.1% |
Malaria | 38 | 2.1% |
Maternal health | 38 | 2.1% |
Positive and negative predictive values | 38 | 2.1% |
Psychology | 38 | 2.1% |
Blood sugar level | 36 | 2.0% |
Circulatory system | 36 | 2.0% |
GeneXpert MTB/RIF | 36 | 2.0% |
Health Insurance Portability and Accountability Act | 36 | 2.0% |
Hospital-acquired infection | 36 | 2.0% |
Internal audit | 36 | 2.0% |
Nursing home | 36 | 2.0% |
Antihypertensive drug | 35 | 2.0% |
Audit committee | 35 | 2.0% |
Bias | 35 | 2.0% |
Creative Commons license | 35 | 2.0% |
Health promotion | 35 | 2.0% |
Service industries | 35 | 2.0% |
Shortness of breath | 35 | 2.0% |
Survey methodology | 35 | 2.0% |
Sustainable Development Goals | 35 | 2.0% |
Welfare | 35 | 2.0% |
Adjuvant therapy | 34 | 1.9% |
Aspirin | 34 | 1.9% |
Avian influenza | 34 | 1.9% |
Board of directors | 34 | 1.9% |
Brain | 34 | 1.9% |
Clinic | 34 | 1.9% |
Database | 34 | 1.9% |
Informed consent | 34 | 1.9% |
Pain | 34 | 1.9% |
Regression analysis | 34 | 1.9% |
Tobacco smoking | 34 | 1.9% |
Transient ischemic attack | 34 | 1.9% |
Chemistry | 33 | 1.9% |
Cognitive science | 33 | 1.9% |
Health insurance coverage in the United States | 33 | 1.9% |
Infection control | 33 | 1.9% |
Laboratory | 33 | 1.9% |
Men who have sex with men | 33 | 1.9% |
Robot | 33 | 1.9% |
Smoking cessation | 33 | 1.9% |
Social determinants of health | 33 | 1.9% |
Alzheimer's disease | 32 | 1.8% |
Antibody | 32 | 1.8% |
Biopsy | 32 | 1.8% |
Diabetes mellitus | 32 | 1.8% |
Dietary supplement | 32 | 1.8% |
Physical examination | 32 | 1.8% |
Point of care | 32 | 1.8% |
Politics | 32 | 1.8% |
Prevention of HIV/AIDS | 32 | 1.8% |
Sensitivity analysis | 32 | 1.8% |
Tax | 32 | 1.8% |
Air pollution | 31 | 1.7% |
Case management (US health system) | 31 | 1.7% |
Deep vein thrombosis | 31 | 1.7% |
Disease management (health) | 31 | 1.7% |
Expert | 31 | 1.7% |
Extensively drug-resistant tuberculosis | 31 | 1.7% |
Hepatitis C | 31 | 1.7% |
Human papillomavirus infection | 31 | 1.7% |
International Statistical Classification of Diseases and Related Health Problems | 31 | 1.7% |
Mammography | 31 | 1.7% |
Midwife | 31 | 1.7% |
Placebo | 31 | 1.7% |
Prediabetes | 31 | 1.7% |
RTT | 31 | 1.7% |
Safe sex | 31 | 1.7% |
COVID-19 vaccine | 30 | 1.7% |
Causes of death | 30 | 1.7% |
Goal | 30 | 1.7% |
Gonorrhea | 30 | 1.7% |
Human | 30 | 1.7% |
Immunization | 30 | 1.7% |
Influenza vaccine | 30 | 1.7% |
Medical statistics | 30 | 1.7% |
Medicare dual eligible | 30 | 1.7% |
Nervous system | 30 | 1.7% |
Organ transplantation | 30 | 1.7% |
Polymerase chain reaction | 30 | 1.7% |
Protein | 30 | 1.7% |
Community | 29 | 1.6% |
Economy | 29 | 1.6% |
Epidemic | 29 | 1.6% |
Food safety | 29 | 1.6% |
Genomics | 29 | 1.6% |
Health care in the United States | 29 | 1.6% |
Infant | 29 | 1.6% |
Interoperability | 29 | 1.6% |
Kidney failure | 29 | 1.6% |
MEDLINE | 29 | 1.6% |
Medical research | 29 | 1.6% |
Metastasis | 29 | 1.6% |
Pediatrics | 29 | 1.6% |
Qualitative research | 29 | 1.6% |
Shared decision-making in medicine | 29 | 1.6% |
Violence | 29 | 1.6% |
Warfarin | 29 | 1.6% |
Zoonosis | 29 | 1.6% |
Computer security | 28 | 1.6% |
Ebola virus disease | 28 | 1.6% |
Echocardiography | 28 | 1.6% |
Government budget balance | 28 | 1.6% |
Prediction | 28 | 1.6% |
Reporting bias | 28 | 1.6% |
Scientific method | 28 | 1.6% |
Analytics | 27 | 1.5% |
Bacteria | 27 | 1.5% |
Condom | 27 | 1.5% |
Diabetes mellitus type 2 | 27 | 1.5% |
Disease surveillance | 27 | 1.5% |
Electrocardiography | 27 | 1.5% |
Emergency medical services | 27 | 1.5% |
Genetic testing | 27 | 1.5% |
Homelessness | 27 | 1.5% |
Nanotechnology | 27 | 1.5% |
Post-exposure prophylaxis | 27 | 1.5% |
Recruitment | 27 | 1.5% |
Reproductive health | 27 | 1.5% |
Respiratory disease | 27 | 1.5% |
Social distancing | 27 | 1.5% |
Women's health | 27 | 1.5% |
Adolescence | 26 | 1.5% |
Birth defect | 26 | 1.5% |
Clinical audit | 26 | 1.5% |
Contract | 26 | 1.5% |
DNA | 26 | 1.5% |
Engineering | 26 | 1.5% |
Geriatrics | 26 | 1.5% |
Incremental cost-effectiveness ratio | 26 | 1.5% |
Inflammation | 26 | 1.5% |
Ischemia | 26 | 1.5% |
Mutation | 26 | 1.5% |
Ovarian cancer | 26 | 1.5% |
Prenatal development | 26 | 1.5% |
Robotics | 26 | 1.5% |
Saturated fat | 26 | 1.5% |
Toxicity | 26 | 1.5% |
Urology | 26 | 1.5% |
Beta blocker | 25 | 1.4% |
Budget | 25 | 1.4% |
Confounding | 25 | 1.4% |
Data | 25 | 1.4% |
Dieting | 25 | 1.4% |
Genetic engineering | 25 | 1.4% |
Hygiene | 25 | 1.4% |
Laparoscopy | 25 | 1.4% |
Maternal death | 25 | 1.4% |
Measles | 25 | 1.4% |
Neurology | 25 | 1.4% |
Vein | 25 | 1.4% |
Ageing | 24 | 1.3% |
Anesthesia | 24 | 1.3% |
Assay | 24 | 1.3% |
C-reactive protein | 24 | 1.3% |
Dual-energy X-ray absorptiometry | 24 | 1.3% |
End-of-life care | 24 | 1.3% |
Influenza A virus subtype H5N1 | 24 | 1.3% |
Mortality rate | 24 | 1.3% |
Nature | 24 | 1.3% |
Neuroscience | 24 | 1.3% |
Nutrition | 24 | 1.3% |
Pathology | 24 | 1.3% |
Patient participation | 24 | 1.3% |
Pension | 24 | 1.3% |
Performance indicator | 24 | 1.3% |
Pre-exposure prophylaxis | 24 | 1.3% |
Sexual health | 24 | 1.3% |
Sexual intercourse | 24 | 1.3% |
System | 24 | 1.3% |
Water | 24 | 1.3% |
Weight loss | 24 | 1.3% |
Bleeding | 23 | 1.3% |
Bone density | 23 | 1.3% |
Coronary artery bypass surgery | 23 | 1.3% |
Information privacy | 23 | 1.3% |
Menopause | 23 | 1.3% |
Personalized medicine | 23 | 1.3% |
Phases of clinical research | 23 | 1.3% |
Physical sciences | 23 | 1.3% |
Physiology | 23 | 1.3% |
ACE inhibitor | 22 | 1.2% |
Allergy | 22 | 1.2% |
Biosecurity | 22 | 1.2% |
Bone | 22 | 1.2% |
Current Procedural Terminology | 22 | 1.2% |
Dependent and independent variables | 22 | 1.2% |
Digital health | 22 | 1.2% |
Family medicine | 22 | 1.2% |
Fecal occult blood | 22 | 1.2% |
Foodborne illness | 22 | 1.2% |
Gene therapy | 22 | 1.2% |
Genome | 22 | 1.2% |
Health technology | 22 | 1.2% |
Healthcare industry | 22 | 1.2% |
Hepatitis B | 22 | 1.2% |
Intravenous therapy | 22 | 1.2% |
Medical error | 22 | 1.2% |
Miscarriage | 22 | 1.2% |
Obstetrics | 22 | 1.2% |
Organisms | 22 | 1.2% |
Outcomes research | 22 | 1.2% |
Social media | 22 | 1.2% |
Study heterogeneity | 22 | 1.2% |
Waste | 22 | 1.2% |
Acute coronary syndrome | 21 | 1.2% |
Biochemistry | 21 | 1.2% |
Capacity building | 21 | 1.2% |
Cardiothoracic surgery | 21 | 1.2% |
Cardiovascular diseases | 21 | 1.2% |
Clostridioides difficile infection | 21 | 1.2% |
Cochrane Library | 21 | 1.2% |
Colonoscopy | 21 | 1.2% |
Confidentiality | 21 | 1.2% |
Determinants of health | 21 | 1.2% |
Fraud | 21 | 1.2% |
Healthy diet | 21 | 1.2% |
Internet of things | 21 | 1.2% |
Leukemia | 21 | 1.2% |
Lung | 21 | 1.2% |
Lymphoma | 21 | 1.2% |
Medical Subject Headings | 21 | 1.2% |
Pharmaceutical sciences | 21 | 1.2% |
Pharmacist | 21 | 1.2% |
Prothrombin time | 21 | 1.2% |
Zidovudine | 21 | 1.2% |
Affordable Care Act | 20 | 1.1% |
Antiplatelet drug | 20 | 1.1% |
Automation | 20 | 1.1% |
Birth control | 20 | 1.1% |
Bone fracture | 20 | 1.1% |
Communication | 20 | 1.1% |
Culture | 20 | 1.1% |
Genome editing | 20 | 1.1% |
Hepatocellular carcinoma | 20 | 1.1% |
Hormone replacement therapy | 20 | 1.1% |
Kidney | 20 | 1.1% |
Lentiviruses | 20 | 1.1% |
Opioid | 20 | 1.1% |
Organ donation | 20 | 1.1% |
Pesticide | 20 | 1.1% |
Pharmacovigilance | 20 | 1.1% |
Schizophrenia | 20 | 1.1% |
Severe acute respiratory syndrome | 20 | 1.1% |
Stem cell | 20 | 1.1% |
Substance use disorder | 20 | 1.1% |
Synthetic biology | 20 | 1.1% |
Trust law | 20 | 1.1% |
Artificial cardiac pacemaker | 19 | 1.1% |
Biodiversity | 19 | 1.1% |
Bipolar disorder | 19 | 1.1% |
Blood transfusion | 19 | 1.1% |
Caesarean section | 19 | 1.1% |
Child | 19 | 1.1% |
Cirrhosis | 19 | 1.1% |
Cloud computing | 19 | 1.1% |
ELISA | 19 | 1.1% |
Hematopoietic stem cell transplantation | 19 | 1.1% |
Home care in the United States | 19 | 1.1% |
Incentive | 19 | 1.1% |
Influenza A virus subtype H1N1 | 19 | 1.1% |
Infrastructure | 19 | 1.1% |
Logistic regression | 19 | 1.1% |
Metabolic syndrome | 19 | 1.1% |
Millennium Development Goals | 19 | 1.1% |
Neonatal intensive care unit | 19 | 1.1% |
Neoplasm | 19 | 1.1% |
Office of Inspector General (United States) | 19 | 1.1% |
Psychological resilience | 19 | 1.1% |
Public health surveillance | 19 | 1.1% |
Publication bias | 19 | 1.1% |
Quarantine | 19 | 1.1% |
Standard deviation | 19 | 1.1% |
Surgical mask | 19 | 1.1% |
Toxicology | 19 | 1.1% |
Vertically transmitted infection | 19 | 1.1% |
Vitamin D | 19 | 1.1% |
Angiotensin II receptor blocker | 18 | 1.0% |
Attention | 18 | 1.0% |
Big data | 18 | 1.0% |
Bisphosphonate | 18 | 1.0% |
Brain–computer interface | 18 | 1.0% |
Cognitive behavioral therapy | 18 | 1.0% |
Consent | 18 | 1.0% |
DPT vaccine | 18 | 1.0% |
Dentistry | 18 | 1.0% |
Diagnosis-related group | 18 | 1.0% |
Ecology | 18 | 1.0% |
Economics | 18 | 1.0% |
Electroencephalography | 18 | 1.0% |
Fetus | 18 | 1.0% |
Finance | 18 | 1.0% |
Gynaecology | 18 | 1.0% |
Health data | 18 | 1.0% |
Health literacy | 18 | 1.0% |
Hyperglycemia | 18 | 1.0% |
Medical ultrasound | 18 | 1.0% |
Minimally invasive procedure | 18 | 1.0% |
Pressure ulcer | 18 | 1.0% |
Preventive medicine | 18 | 1.0% |
Prostate-specific antigen | 18 | 1.0% |
Quality of life | 18 | 1.0% |
Reliability engineering | 18 | 1.0% |
Signs and symptoms | 18 | 1.0% |
Supplemental Nutrition Assistance Program | 18 | 1.0% |
Urinary tract infection | 18 | 1.0% |
Validity (statistics) | 18 | 1.0% |
Whole genome sequencing | 18 | 1.0% |
Alcoholism | 17 | 1.0% |
Angiography | 17 | 1.0% |
Arrhythmia | 17 | 1.0% |
Atheroma | 17 | 1.0% |
Bioinformatics | 17 | 1.0% |
Cell (biology) | 17 | 1.0% |
Chlamydia infection | 17 | 1.0% |
Cost–utility analysis | 17 | 1.0% |
EHealth | 17 | 1.0% |
Evidence-based practice | 17 | 1.0% |
Framingham Risk Score | 17 | 1.0% |
Hand washing | 17 | 1.0% |
Human pregnancy | 17 | 1.0% |
Influenza A virus | 17 | 1.0% |
Internet | 17 | 1.0% |
Liver | 17 | 1.0% |
Metformin | 17 | 1.0% |
Midwifery | 17 | 1.0% |
Old age | 17 | 1.0% |
Pharmaceutical industry | 17 | 1.0% |
Positron emission tomography | 17 | 1.0% |
Smoking | 17 | 1.0% |
Syphilis | 17 | 1.0% |
Visual impairment | 17 | 1.0% |
Vitamin | 17 | 1.0% |
Antigen | 16 | 0.9% |
Autonomy | 16 | 0.9% |
Bioethics | 16 | 0.9% |
Biosafety | 16 | 0.9% |
Blood | 16 | 0.9% |
Bundled payment | 16 | 0.9% |
CD4 | 16 | 0.9% |
COVID-19 testing | 16 | 0.9% |
Cardiac surgery | 16 | 0.9% |
Case–control study | 16 | 0.9% |
Cervical screening | 16 | 0.9% |
Climate resilience | 16 | 0.9% |
Clinical decision support system | 16 | 0.9% |
Coronavirus | 16 | 0.9% |
Deep learning | 16 | 0.9% |
Diarrhea | 16 | 0.9% |
Economic growth | 16 | 0.9% |
Expense | 16 | 0.9% |
Experiment | 16 | 0.9% |
Financial statement | 16 | 0.9% |
Gene expression | 16 | 0.9% |
Global warming | 16 | 0.9% |
HER2/neu | 16 | 0.9% |
Hazard | 16 | 0.9% |
Health care industry | 16 | 0.9% |
Hip fracture | 16 | 0.9% |
Infant mortality | 16 | 0.9% |
Influenza-like illness | 16 | 0.9% |
Inspection | 16 | 0.9% |
Insulin | 16 | 0.9% |
Lipoprotein | 16 | 0.9% |
Medical history | 16 | 0.9% |
Molecular biology | 16 | 0.9% |
Nevirapine | 16 | 0.9% |
Pathogen | 16 | 0.9% |
Pre-eclampsia | 16 | 0.9% |
Psychological concepts | 16 | 0.9% |
Psychosis | 16 | 0.9% |
Rifampicin | 16 | 0.9% |
Robot-assisted surgery | 16 | 0.9% |
Rubella | 16 | 0.9% |
Sexually transmitted diseases and infections | 16 | 0.9% |
Simvastatin | 16 | 0.9% |
Spirometry | 16 | 0.9% |
Strategic planning | 16 | 0.9% |
Transitional care | 16 | 0.9% |
Traumatic brain injury | 16 | 0.9% |
Usability | 16 | 0.9% |
Vagina | 16 | 0.9% |
Valvular heart disease | 16 | 0.9% |
3D printing | 15 | 0.8% |
Anesthesiology | 15 | 0.8% |
Animal viral diseases | 15 | 0.8% |
Aortic stenosis | 15 | 0.8% |
BRCA mutation | 15 | 0.8% |
Breast cancer screening | 15 | 0.8% |
Breastfeeding and HIV | 15 | 0.8% |
Cardiac catheterization | 15 | 0.8% |
Cardioversion | 15 | 0.8% |
Dabigatran | 15 | 0.8% |
Data quality | 15 | 0.8% |
Death | 15 | 0.8% |
Disease burden | 15 | 0.8% |
Effect size | 15 | 0.8% |
Efficient energy use | 15 | 0.8% |
Environmental social science | 15 | 0.8% |
Fall prevention | 15 | 0.8% |
Federally Qualified Health Center | 15 | 0.8% |
Food and drink | 15 | 0.8% |
Frailty syndrome | 15 | 0.8% |
Gestational age | 15 | 0.8% |
Gestational diabetes | 15 | 0.8% |
Health Information Technology for Economic and Clinical Health Act | 15 | 0.8% |
Health technology in the United States | 15 | 0.8% |
Incidence (epidemiology) | 15 | 0.8% |
Kidney transplantation | 15 | 0.8% |
MMR vaccine | 15 | 0.8% |
Mind | 15 | 0.8% |
Natural reservoir | 15 | 0.8% |
Osteopenia | 15 | 0.8% |
Parameter | 15 | 0.8% |
Personal data | 15 | 0.8% |
Placebo-controlled study | 15 | 0.8% |
Primary health care | 15 | 0.8% |
Procurement | 15 | 0.8% |
Pulmonary embolism | 15 | 0.8% |
Recovery approach | 15 | 0.8% |
Specialty (medicine) | 15 | 0.8% |
Staphylococcus aureus | 15 | 0.8% |
Sustainability and transformation plan | 15 | 0.8% |
Training | 15 | 0.8% |
Type I and type II errors | 15 | 0.8% |
Anti-diabetic medication | 14 | 0.8% |
Antipsychotic | 14 | 0.8% |
Aortic valve | 14 | 0.8% |
Appropriations bill (United States) | 14 | 0.8% |
BCG vaccine | 14 | 0.8% |
Birth weight | 14 | 0.8% |
Capitation (healthcare) | 14 | 0.8% |
Cardiac stress test | 14 | 0.8% |
Cigarette | 14 | 0.8% |
Clinical pathology | 14 | 0.8% |
Clopidogrel | 14 | 0.8% |
Delirium | 14 | 0.8% |
Drug development | 14 | 0.8% |
Face masks during the COVID-19 pandemic | 14 | 0.8% |
Familial hypercholesterolemia | 14 | 0.8% |
Fat | 14 | 0.8% |
Fever | 14 | 0.8% |
Flu season | 14 | 0.8% |
Global health | 14 | 0.8% |
Gynaecologic disorders | 14 | 0.8% |
Hemodialysis | 14 | 0.8% |
Hyperlipidemia | 14 | 0.8% |
Hypoglycemia | 14 | 0.8% |
Immunotherapy | 14 | 0.8% |
Influenza A virus subtype H7N9 | 14 | 0.8% |
Kidney disease | 14 | 0.8% |
Lamivudine | 14 | 0.8% |
Law | 14 | 0.8% |
Medical specialty | 14 | 0.8% |
Medical tests | 14 | 0.8% |
Nephrology | 14 | 0.8% |
Neuron | 14 | 0.8% |
Pain management | 14 | 0.8% |
Paramedic | 14 | 0.8% |
Perception | 14 | 0.8% |
Peripheral neuropathy | 14 | 0.8% |
Physical fitness | 14 | 0.8% |
Postpartum period | 14 | 0.8% |
Prenatal testing | 14 | 0.8% |
Quality and Outcomes Framework | 14 | 0.8% |
Reference range | 14 | 0.8% |
Rivaroxaban | 14 | 0.8% |
Salary | 14 | 0.8% |
Statistical classification | 14 | 0.8% |
Transport | 14 | 0.8% |
Treatment of cancer | 14 | 0.8% |
Accounting | 13 | 0.7% |
Algorithm | 13 | 0.7% |
Allocation concealment | 13 | 0.7% |
Ambulance | 13 | 0.7% |
Animal diseases | 13 | 0.7% |
Antidepressant | 13 | 0.7% |
Asset | 13 | 0.7% |
Atrium (heart) | 13 | 0.7% |
CRISPR | 13 | 0.7% |
Cancer immunotherapy | 13 | 0.7% |
Carcinogen | 13 | 0.7% |
Cardiovascular physiology | 13 | 0.7% |
Case management (US healthcare system) | 13 | 0.7% |
Clinical endpoint | 13 | 0.7% |
Community mental health service | 13 | 0.7% |
Denosumab | 13 | 0.7% |
Diabetic retinopathy | 13 | 0.7% |
Diet (nutrition) | 13 | 0.7% |
Directly observed treatment, short-course | 13 | 0.7% |
Disability-adjusted life year | 13 | 0.7% |
Disorders of endocrine pancreas | 13 | 0.7% |
Endocrine system | 13 | 0.7% |
Epidemiology of HIV/AIDS | 13 | 0.7% |
Genetically modified organism | 13 | 0.7% |
Human diseases and disorders | 13 | 0.7% |
Information governance | 13 | 0.7% |
Information security | 13 | 0.7% |
MHealth | 13 | 0.7% |
Middle East respiratory syndrome | 13 | 0.7% |
Motherhood | 13 | 0.7% |
Natural environment | 13 | 0.7% |
Neuroimaging | 13 | 0.7% |
Nicotine replacement therapy | 13 | 0.7% |
Non-alcoholic fatty liver disease | 13 | 0.7% |
Non-executive director | 13 | 0.7% |
Organs (anatomy) | 13 | 0.7% |
Overdiagnosis | 13 | 0.7% |
Patient safety organization | 13 | 0.7% |
Prenatal care | 13 | 0.7% |
Prosthesis | 13 | 0.7% |
Public Health Emergency of International Concern | 13 | 0.7% |
Public policy | 13 | 0.7% |
Pyrazinamide | 13 | 0.7% |
Serology | 13 | 0.7% |
Standardization | 13 | 0.7% |
Type 1 diabetes | 13 | 0.7% |
Uncertainty | 13 | 0.7% |
Viral load | 13 | 0.7% |
WIC | 13 | 0.7% |
Zoledronic acid | 13 | 0.7% |
Accessibility | 12 | 0.7% |
Accuracy and precision | 12 | 0.7% |
Atorvastatin | 12 | 0.7% |
Attention deficit hyperactivity disorder | 12 | 0.7% |
Bank | 12 | 0.7% |
Bloodstream infections | 12 | 0.7% |
CHA2DS2–VASc score | 12 | 0.7% |
Chikungunya | 12 | 0.7% |
Climate change | 12 | 0.7% |
Combined oral contraceptive pill | 12 | 0.7% |
Committee | 12 | 0.7% |
Community health worker | 12 | 0.7% |
Correlation and dependence | 12 | 0.7% |
Cytopathology | 12 | 0.7% |
Da Vinci Surgical System | 12 | 0.7% |
Dialysis | 12 | 0.7% |
Disinfectant | 12 | 0.7% |
EPSDT | 12 | 0.7% |
Evolution | 12 | 0.7% |
Ezetimibe | 12 | 0.7% |
False positives and false negatives | 12 | 0.7% |
Family planning | 12 | 0.7% |
Five Year Forward View | 12 | 0.7% |
Fuel cell | 12 | 0.7% |
Functional magnetic resonance imaging | 12 | 0.7% |
General practice | 12 | 0.7% |
Genetic counseling | 12 | 0.7% |
Health human resources | 12 | 0.7% |
Hematology | 12 | 0.7% |
Hysterectomy | 12 | 0.7% |
Institutional review board | 12 | 0.7% |
Insulin (medication) | 12 | 0.7% |
Insulin resistance | 12 | 0.7% |
International Classification of Diseases | 12 | 0.7% |
Learning | 12 | 0.7% |
Male genital disorders | 12 | 0.7% |
Memory | 12 | 0.7% |
Meningitis | 12 | 0.7% |
Mobile app | 12 | 0.7% |
Monitoring (medicine) | 12 | 0.7% |
Multidrug-resistant tuberculosis | 12 | 0.7% |
Nicotine | 12 | 0.7% |
Organism | 12 | 0.7% |
Patient-reported outcome | 12 | 0.7% |
Pelvic inflammatory disease | 12 | 0.7% |
Percutaneous aortic valve replacement | 12 | 0.7% |
Peripheral artery disease | 12 | 0.7% |
Physics | 12 | 0.7% |
Precision medicine | 12 | 0.7% |
Quality management | 12 | 0.7% |
Quantitative research | 12 | 0.7% |
Quantitative structure–activity relationship | 12 | 0.7% |
Radiography | 12 | 0.7% |
Raloxifene | 12 | 0.7% |
Recovery model | 12 | 0.7% |
Recycling | 12 | 0.7% |
Relative risk | 12 | 0.7% |
Residency (medicine) | 12 | 0.7% |
Respirator | 12 | 0.7% |
Safeguarding | 12 | 0.7% |
Sex worker | 12 | 0.7% |
Single-nucleotide polymorphism | 12 | 0.7% |
Social Security (United States) | 12 | 0.7% |
Statistical process control | 12 | 0.7% |
Strategy | 12 | 0.7% |
Stress (biology) | 12 | 0.7% |
Substance dependence | 12 | 0.7% |
Symptom | 12 | 0.7% |
T cell | 12 | 0.7% |
Thorax (human anatomy) | 12 | 0.7% |
Tissues (biology) | 12 | 0.7% |
Variance | 12 | 0.7% |
Viral hemorrhagic fever | 12 | 0.7% |
Virtual reality | 12 | 0.7% |
Wearable technology | 12 | 0.7% |
Adverse event | 11 | 0.6% |
Amiodarone | 11 | 0.6% |
Analgesic | 11 | 0.6% |
Anaphylaxis | 11 | 0.6% |
Animal testing | 11 | 0.6% |
Aortic valve replacement | 11 | 0.6% |
BRCA1 | 11 | 0.6% |
Bevacizumab | 11 | 0.6% |
Biosensor | 11 | 0.6% |
Blood donation | 11 | 0.6% |
Breast milk | 11 | 0.6% |
Cardiac muscle | 11 | 0.6% |
Cardiopulmonary resuscitation | 11 | 0.6% |
Central venous catheter | 11 | 0.6% |
Chest radiograph | 11 | 0.6% |
Copyright | 11 | 0.6% |
Corporate governance | 11 | 0.6% |
Cost–benefit analysis | 11 | 0.6% |
Creatinine | 11 | 0.6% |
Dengue fever | 11 | 0.6% |
Development aid | 11 | 0.6% |
Down syndrome | 11 | 0.6% |
Emerging technologies | 11 | 0.6% |
Employee retention | 11 | 0.6% |
Endoscopy | 11 | 0.6% |
Epilepsy | 11 | 0.6% |
General Data Protection Regulation | 11 | 0.6% |
Genome-wide association study | 11 | 0.6% |
Glucose tolerance test | 11 | 0.6% |
Going concern | 11 | 0.6% |
Hearing loss | 11 | 0.6% |
Heart rate | 11 | 0.6% |
Hereditary nonpolyposis colorectal cancer | 11 | 0.6% |
Hierarchy of evidence | 11 | 0.6% |
Immunity (medical) | 11 | 0.6% |
Implantable cardioverter-defibrillator | 11 | 0.6% |
Intelligence | 11 | 0.6% |
Ionizing radiation | 11 | 0.6% |
Life | 11 | 0.6% |
Listeriosis | 11 | 0.6% |
MammaPrint | 11 | 0.6% |
Management of atrial fibrillation | 11 | 0.6% |
Mathematical optimization | 11 | 0.6% |
Medi-Cal | 11 | 0.6% |
Missing data | 11 | 0.6% |
Nanoparticle | 11 | 0.6% |
Needs assessment | 11 | 0.6% |
Neurotechnology | 11 | 0.6% |
Newborn screening | 11 | 0.6% |
Non-small-cell lung carcinoma | 11 | 0.6% |
Omega-3 fatty acid | 11 | 0.6% |
Ophthalmology | 11 | 0.6% |
P-value | 11 | 0.6% |
Pap test | 11 | 0.6% |
Parkinson's disease | 11 | 0.6% |
Particulates | 11 | 0.6% |
Platelet | 11 | 0.6% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 11 | 0.6% |
Registered nurse | 11 | 0.6% |
Regulation | 11 | 0.6% |
Rosuvastatin | 11 | 0.6% |
Sleep | 11 | 0.6% |
Sleep apnea | 11 | 0.6% |
Soil | 11 | 0.6% |
Supplemental Security Income | 11 | 0.6% |
Teriparatide | 11 | 0.6% |
Tissue engineering | 11 | 0.6% |
Transcranial magnetic stimulation | 11 | 0.6% |
Transmission-based precautions | 11 | 0.6% |
Unmanned aerial vehicle | 11 | 0.6% |
Urinary incontinence | 11 | 0.6% |
Ventricular fibrillation | 11 | 0.6% |
Western African Ebola virus epidemic | 11 | 0.6% |
Accountability | 10 | 0.6% |
Amniocentesis | 10 | 0.6% |
Antimalarial medication | 10 | 0.6% |
Antimicrobial | 10 | 0.6% |
Antimicrobial stewardship | 10 | 0.6% |
Apolipoprotein | 10 | 0.6% |
Arthritis | 10 | 0.6% |
Artificial objects | 10 | 0.6% |
Atrial septal defect | 10 | 0.6% |
Autism | 10 | 0.6% |
Biobank | 10 | 0.6% |
Biopharmaceutical | 10 | 0.6% |
Bioterrorism | 10 | 0.6% |
COVID-19 pandemic in the United Kingdom | 10 | 0.6% |
Cancer staging | 10 | 0.6% |
Cancer survivor | 10 | 0.6% |
Charitable organization | 10 | 0.6% |
Coagulation | 10 | 0.6% |
Computer network | 10 | 0.6% |
Contact tracing | 10 | 0.6% |
Control chart | 10 | 0.6% |
Cyberattack | 10 | 0.6% |
Dietitian | 10 | 0.6% |
Digoxin | 10 | 0.6% |
Ecosystem | 10 | 0.6% |
Electronic prescribing | 10 | 0.6% |
Emergency contraception | 10 | 0.6% |
Emergency medical technician | 10 | 0.6% |
Forecasting | 10 | 0.6% |
HPV vaccine | 10 | 0.6% |
Health maintenance organization | 10 | 0.6% |
Heart valve | 10 | 0.6% |
Hematuria | 10 | 0.6% |
Hormonal contraception | 10 | 0.6% |
Human sexuality | 10 | 0.6% |
Immigration | 10 | 0.6% |
Improving Access to Psychological Therapies | 10 | 0.6% |
Indication (medicine) | 10 | 0.6% |
Influenza A virus subtype H3N2 | 10 | 0.6% |
Information technology | 10 | 0.6% |
Intellectual property | 10 | 0.6% |
International Health Regulations | 10 | 0.6% |
Isoniazid | 10 | 0.6% |
Knowledge | 10 | 0.6% |
Likelihood function | 10 | 0.6% |
Low-carbon economy | 10 | 0.6% |
Lung cancer screening | 10 | 0.6% |
Malnutrition | 10 | 0.6% |
Mantoux test | 10 | 0.6% |
Medical school | 10 | 0.6% |
Medicare Advantage | 10 | 0.6% |
Medroxyprogesterone acetate | 10 | 0.6% |
Melanoma | 10 | 0.6% |
Nonsteroidal anti-inflammatory drug | 10 | 0.6% |
Nurse practitioner | 10 | 0.6% |
Performance appraisal | 10 | 0.6% |
Pharmacogenomics | 10 | 0.6% |
Photovoltaics | 10 | 0.6% |
Plant breeding | 10 | 0.6% |
Polio vaccine | 10 | 0.6% |
Prevalence | 10 | 0.6% |
Programmed cell death protein 1 | 10 | 0.6% |
Proteomics | 10 | 0.6% |
Real-time polymerase chain reaction | 10 | 0.6% |
Reliability (statistics) | 10 | 0.6% |
Reperfusion therapy | 10 | 0.6% |
Reverse-transcriptase inhibitor | 10 | 0.6% |
Sample size determination | 10 | 0.6% |
Sea | 10 | 0.6% |
Selective serotonin reuptake inhibitor | 10 | 0.6% |
Self-driving car | 10 | 0.6% |
Supply chain | 10 | 0.6% |
Tamoxifen | 10 | 0.6% |
Thrombocytopenia | 10 | 0.6% |
Traffic collision | 10 | 0.6% |
Unemployment | 10 | 0.6% |
Vaginitis | 10 | 0.6% |
Ventricle (heart) | 10 | 0.6% |
2009 flu pandemic | 9 | 0.5% |
Abdominal obesity | 9 | 0.5% |
Acute kidney injury | 9 | 0.5% |
Acute myeloid leukemia | 9 | 0.5% |
Antiarrhythmic agent | 9 | 0.5% |
Anxiety | 9 | 0.5% |
Apixaban | 9 | 0.5% |
Artificial neural network | 9 | 0.5% |
Autism spectrum | 9 | 0.5% |
Bladder cancer | 9 | 0.5% |
Blood plasma | 9 | 0.5% |
Blood-borne disease | 9 | 0.5% |
Body fluids | 9 | 0.5% |
Bovine spongiform encephalopathy | 9 | 0.5% |
Cancer prevention | 9 | 0.5% |
Candidiasis | 9 | 0.5% |
Carbon dioxide | 9 | 0.5% |
Carcinoma | 9 | 0.5% |
Cardiac arrest | 9 | 0.5% |
Cell potency | 9 | 0.5% |
Chickenpox | 9 | 0.5% |
Chief executive officer | 9 | 0.5% |
Chief financial officer | 9 | 0.5% |
Chlamydia | 9 | 0.5% |
Cogeneration | 9 | 0.5% |
Computing | 9 | 0.5% |
Conflict of interest | 9 | 0.5% |
Consciousness | 9 | 0.5% |
Cough | 9 | 0.5% |
DICOM | 9 | 0.5% |
Debt | 9 | 0.5% |
Depression (mood) | 9 | 0.5% |
Design | 9 | 0.5% |
Dexamethasone | 9 | 0.5% |
Doppler ultrasonography | 9 | 0.5% |
Early intervention in psychosis | 9 | 0.5% |
Earnings before interest, taxes, depreciation and amortization | 9 | 0.5% |
Emotion | 9 | 0.5% |
Endometrial cancer | 9 | 0.5% |
Errors and residuals | 9 | 0.5% |
Fertility | 9 | 0.5% |
Fish oil | 9 | 0.5% |
Food security | 9 | 0.5% |
Generic drug | 9 | 0.5% |
Greenhouse gas | 9 | 0.5% |
Heart arrhythmia | 9 | 0.5% |
Hepatitis B vaccine | 9 | 0.5% |
Home care | 9 | 0.5% |
Hypothesis | 9 | 0.5% |
Immunosuppressive drug | 9 | 0.5% |
Infertility | 9 | 0.5% |
Intention-to-treat analysis | 9 | 0.5% |
Interventional radiology | 9 | 0.5% |
Labor induction | 9 | 0.5% |
License | 9 | 0.5% |
Life expectancy | 9 | 0.5% |
Linear regression | 9 | 0.5% |
Logistics | 9 | 0.5% |
Mammalian pregnancy | 9 | 0.5% |
Maternal–fetal medicine | 9 | 0.5% |
Medical microbiology | 9 | 0.5% |
Medicinal chemistry | 9 | 0.5% |
Metabolism | 9 | 0.5% |
Microscopy | 9 | 0.5% |
Nivolumab | 9 | 0.5% |
Non-governmental organization | 9 | 0.5% |
Oseltamivir | 9 | 0.5% |
PCSK9 | 9 | 0.5% |
Passive smoking | 9 | 0.5% |
Personal genomics | 9 | 0.5% |
Plasmodium falciparum | 9 | 0.5% |
Plasmodium vivax | 9 | 0.5% |
Pneumococcal vaccine | 9 | 0.5% |
Polio | 9 | 0.5% |
Prison | 9 | 0.5% |
Problem solving | 9 | 0.5% |
Productivity | 9 | 0.5% |
Prostate cancer screening | 9 | 0.5% |
Prostatectomy | 9 | 0.5% |
Public hospital | 9 | 0.5% |
Quality of life (healthcare) | 9 | 0.5% |
RNA | 9 | 0.5% |
Regenerative medicine | 9 | 0.5% |
Research methods | 9 | 0.5% |
Respiratory droplet | 9 | 0.5% |
Reverse transcription polymerase chain reaction | 9 | 0.5% |
Rheumatoid arthritis | 9 | 0.5% |
Society | 9 | 0.5% |
Solar cell | 9 | 0.5% |
Sotalol | 9 | 0.5% |
Species | 9 | 0.5% |
Standard error | 9 | 0.5% |
Stavudine | 9 | 0.5% |
Stillbirth | 9 | 0.5% |
Stomach cancer | 9 | 0.5% |
Tetanus vaccine | 9 | 0.5% |
Thrombosis prevention | 9 | 0.5% |
Transmissible spongiform encephalopathy | 9 | 0.5% |
Troponin | 9 | 0.5% |
Universal health care | 9 | 0.5% |
Utilization management | 9 | 0.5% |
Varenicline | 9 | 0.5% |
Verification and validation | 9 | 0.5% |
Veterinary medicine | 9 | 0.5% |
Viral vector | 9 | 0.5% |
Virology | 9 | 0.5% |
Zika fever | 9 | 0.5% |
2019–20 coronavirus outbreak | 8 | 0.4% |
Abacavir | 8 | 0.4% |
Active surveillance of prostate cancer | 8 | 0.4% |
Addiction | 8 | 0.4% |
Adverse drug reaction | 8 | 0.4% |
Analysis | 8 | 0.4% |
Angioplasty | 8 | 0.4% |
Anticonvulsant | 8 | 0.4% |
Assessment of kidney function | 8 | 0.4% |
Assumption | 8 | 0.4% |
Bacterial vaginosis | 8 | 0.4% |
Balance sheet | 8 | 0.4% |
Bariatric surgery | 8 | 0.4% |
Behavioural sciences | 8 | 0.4% |
Benchmarking | 8 | 0.4% |
Biofuel | 8 | 0.4% |
Biomass | 8 | 0.4% |
Biomedicine | 8 | 0.4% |
Blood glucose monitoring | 8 | 0.4% |
Blood lipids | 8 | 0.4% |
Bronchodilator | 8 | 0.4% |
Bupropion | 8 | 0.4% |
CRISPR gene editing | 8 | 0.4% |
Cardiac rehabilitation | 8 | 0.4% |
Cardiotocography | 8 | 0.4% |
Cas9 | 8 | 0.4% |
Cattle | 8 | 0.4% |
Cerebrovascular disease | 8 | 0.4% |
Cervical intraepithelial neoplasia | 8 | 0.4% |
Children's Health Insurance Program | 8 | 0.4% |
Competence (human resources) | 8 | 0.4% |
Computer science | 8 | 0.4% |
Computer-aided diagnosis | 8 | 0.4% |
Congressional oversight | 8 | 0.4% |
Coronary catheterization | 8 | 0.4% |
Cystic fibrosis | 8 | 0.4% |
Defibrillation | 8 | 0.4% |
Diabetic ketoacidosis | 8 | 0.4% |
Do not resuscitate | 8 | 0.4% |
EQ-5D | 8 | 0.4% |
Ebola | 8 | 0.4% |
Eicosapentaenoic acid | 8 | 0.4% |
Electric vehicle | 8 | 0.4% |
Empowerment | 8 | 0.4% |
Epidermal growth factor receptor | 8 | 0.4% |
Epidural administration | 8 | 0.4% |
Eradication of infectious diseases | 8 | 0.4% |
Estrogen | 8 | 0.4% |
External auditor | 8 | 0.4% |
Fenofibrate | 8 | 0.4% |
Fluconazole | 8 | 0.4% |
Formulary (pharmacy) | 8 | 0.4% |
Good manufacturing practice | 8 | 0.4% |
Harm reduction | 8 | 0.4% |
Head and neck cancer | 8 | 0.4% |
Health care prices in the United States | 8 | 0.4% |
Healthcare | 8 | 0.4% |
Healthcare quality | 8 | 0.4% |
Heart failure with preserved ejection fraction | 8 | 0.4% |
Herpes simplex | 8 | 0.4% |
Human development | 8 | 0.4% |
Hydrogen | 8 | 0.4% |
Immunoglobulin G | 8 | 0.4% |
Intellectual disability | 8 | 0.4% |
Latent tuberculosis | 8 | 0.4% |
Licensed practical nurse | 8 | 0.4% |
Low birth weight | 8 | 0.4% |
Macular degeneration | 8 | 0.4% |
Market (economics) | 8 | 0.4% |
Maryland hospital payment system | 8 | 0.4% |
Median | 8 | 0.4% |
Medicare Sustainable Growth Rate | 8 | 0.4% |
Meningococcal disease | 8 | 0.4% |
Motivation | 8 | 0.4% |
Multiple myeloma | 8 | 0.4% |
N95 respirator | 8 | 0.4% |
Neisseria meningitidis | 8 | 0.4% |
Nephrectomy | 8 | 0.4% |
Neurodegeneration | 8 | 0.4% |
Neuroethics | 8 | 0.4% |
Neurostimulation | 8 | 0.4% |
Neutralizing antibody | 8 | 0.4% |
Obstetric ultrasonography | 8 | 0.4% |
Obstructive sleep apnea | 8 | 0.4% |
Occupational therapist | 8 | 0.4% |
Off-label use | 8 | 0.4% |
Opioid use disorder | 8 | 0.4% |
Osteoarthritis | 8 | 0.4% |
Patent | 8 | 0.4% |
Pembrolizumab | 8 | 0.4% |
Pharmacokinetics | 8 | 0.4% |
Philosophy | 8 | 0.4% |
Photonics | 8 | 0.4% |
Pneumococcal conjugate vaccine | 8 | 0.4% |
Pollution | 8 | 0.4% |
Posttraumatic stress disorder | 8 | 0.4% |
Prasugrel | 8 | 0.4% |
Prevention | 8 | 0.4% |
Primary care physician | 8 | 0.4% |
Procalcitonin | 8 | 0.4% |
Proteinuria | 8 | 0.4% |
Psychological trauma | 8 | 0.4% |
Psychosocial | 8 | 0.4% |
Radiographer | 8 | 0.4% |
Random forest | 8 | 0.4% |
Renewable energy | 8 | 0.4% |
Research and development | 8 | 0.4% |
Retirement | 8 | 0.4% |
Revenue | 8 | 0.4% |
Social science | 8 | 0.4% |
Social stigma | 8 | 0.4% |
Specification (technical standard) | 8 | 0.4% |
Statistical significance | 8 | 0.4% |
Systems biology | 8 | 0.4% |
Thought | 8 | 0.4% |
Thrombophilia | 8 | 0.4% |
Ticagrelor | 8 | 0.4% |
Training, validation, and test sets | 8 | 0.4% |
Trichomoniasis | 8 | 0.4% |
Turnover (employment) | 8 | 0.4% |
Unemployment benefits | 8 | 0.4% |
World Wide Web | 8 | 0.4% |
Youth | 8 | 0.4% |
Abortion | 7 | 0.4% |
Academic degree | 7 | 0.4% |
Anatomical terms of motion | 7 | 0.4% |
Anxiety disorder | 7 | 0.4% |
Atrial flutter | 7 | 0.4% |
Atypical pneumonias | 7 | 0.4% |
Auditor's report | 7 | 0.4% |
Augmented reality | 7 | 0.4% |
Autoimmunity | 7 | 0.4% |
Bacteremia | 7 | 0.4% |
Balance (ability) | 7 | 0.4% |
Biosimilar | 7 | 0.4% |
Bone marrow | 7 | 0.4% |
Booster dose | 7 | 0.4% |
Brain tumor | 7 | 0.4% |
Bronchiectasis | 7 | 0.4% |
Canagliflozin | 7 | 0.4% |
Carbon neutrality | 7 | 0.4% |
Cardiac magnetic resonance imaging | 7 | 0.4% |
Case study | 7 | 0.4% |
Cellular differentiation | 7 | 0.4% |
Cervix | 7 | 0.4% |
Chairperson | 7 | 0.4% |
Chemicals in medicine | 7 | 0.4% |
Childhood obesity | 7 | 0.4% |
Cholecystectomy | 7 | 0.4% |
Chronic lymphocytic leukemia | 7 | 0.4% |
Classification of ethnicity in the United Kingdom | 7 | 0.4% |
Computed tomography angiography | 7 | 0.4% |
Consensus decision-making | 7 | 0.4% |
Coronary circulation | 7 | 0.4% |
Cyberwarfare | 7 | 0.4% |
D-dimer | 7 | 0.4% |
Dashboard (business) | 7 | 0.4% |
Data sharing | 7 | 0.4% |
Diffuse large B-cell lymphoma | 7 | 0.4% |
Disproportionate share hospital | 7 | 0.4% |
Doctor of Philosophy | 7 | 0.4% |
Earned income tax credit | 7 | 0.4% |
Educational assessment | 7 | 0.4% |
Ejection fraction | 7 | 0.4% |
Electric battery | 7 | 0.4% |
Electronic benefit transfer | 7 | 0.4% |
Epigenetics | 7 | 0.4% |
Erlotinib | 7 | 0.4% |
Expanded Program on Immunization | 7 | 0.4% |
FFP standards | 7 | 0.4% |
Fibrate | 7 | 0.4% |
Focus group | 7 | 0.4% |
Fund accounting | 7 | 0.4% |
Genetic disorder | 7 | 0.4% |
Genotoxicity | 7 | 0.4% |
Global Outbreak Alert and Response Network | 7 | 0.4% |
Gross domestic product | 7 | 0.4% |
Hazard ratio | 7 | 0.4% |
Health and wellbeing board | 7 | 0.4% |
Health research | 7 | 0.4% |
Healthcare in Greater Manchester | 7 | 0.4% |
Herd immunity | 7 | 0.4% |
Human sexual activity | 7 | 0.4% |
ICD-10 | 7 | 0.4% |
Immunoglobulin therapy | 7 | 0.4% |
Implant (medicine) | 7 | 0.4% |
Indigenous Australians | 7 | 0.4% |
Inflation | 7 | 0.4% |
Interest | 7 | 0.4% |
Intrauterine device | 7 | 0.4% |
Lassa fever | 7 | 0.4% |
Legal guardian | 7 | 0.4% |
Liraglutide | 7 | 0.4% |
Low molecular weight heparin | 7 | 0.4% |
Low-molecular-weight heparin | 7 | 0.4% |
Lung nodule | 7 | 0.4% |
Major trauma | 7 | 0.4% |
Mean | 7 | 0.4% |
Mental health professional | 7 | 0.4% |
Metabolic disorders | 7 | 0.4% |
Metabolomics | 7 | 0.4% |
Middle East respiratory syndrome-related coronavirus | 7 | 0.4% |
Mitochondrion | 7 | 0.4% |
Model organism | 7 | 0.4% |
Molecular diagnostics | 7 | 0.4% |
Mosquito | 7 | 0.4% |
Motivational interviewing | 7 | 0.4% |
Mycobacterium bovis | 7 | 0.4% |
Mycoplasma | 7 | 0.4% |
Myocardial perfusion imaging | 7 | 0.4% |
Nanomaterials | 7 | 0.4% |
Neglected tropical diseases | 7 | 0.4% |
Neonicotinoid | 7 | 0.4% |
Neuromodulation (medicine) | 7 | 0.4% |
Neutropenia | 7 | 0.4% |
Nuchal scan | 7 | 0.4% |
Occupational therapy | 7 | 0.4% |
Odds ratio | 7 | 0.4% |
Open access | 7 | 0.4% |
Optics | 7 | 0.4% |
Organization | 7 | 0.4% |
Osteonecrosis of the jaw | 7 | 0.4% |
Outpatient surgery | 7 | 0.4% |
Payment by Results | 7 | 0.4% |
Perinatal mortality | 7 | 0.4% |
Pharmacy benefit management | 7 | 0.4% |
Physical activity | 7 | 0.4% |
Plant disease resistance | 7 | 0.4% |
Platelet transfusion | 7 | 0.4% |
Polyp (medicine) | 7 | 0.4% |
Polypharmacy | 7 | 0.4% |
Private finance initiative | 7 | 0.4% |
Propensity score matching | 7 | 0.4% |
Pulmonary fibrosis | 7 | 0.4% |
Pulmonology | 7 | 0.4% |
Quantitative computed tomography | 7 | 0.4% |
Race and ethnicity in the United States Census | 7 | 0.4% |
Reason | 7 | 0.4% |
Reference dose | 7 | 0.4% |
Remdesivir | 7 | 0.4% |
Respite care | 7 | 0.4% |
Retail | 7 | 0.4% |
Retinopathy | 7 | 0.4% |
Science and Technology Options Assessment | 7 | 0.4% |
Section 504 of the Rehabilitation Act | 7 | 0.4% |
Single-photon emission computed tomography | 7 | 0.4% |
Solar energy | 7 | 0.4% |
Solar power | 7 | 0.4% |
Strontium ranelate | 7 | 0.4% |
Sulfonylurea | 7 | 0.4% |
Survival analysis | 7 | 0.4% |
Swine influenza | 7 | 0.4% |
Temporary Assistance for Needy Families | 7 | 0.4% |
Tocilizumab | 7 | 0.4% |
Top-down and bottom-up design | 7 | 0.4% |
Transcranial direct-current stimulation | 7 | 0.4% |
Translational research | 7 | 0.4% |
Transparency (behavior) | 7 | 0.4% |
Trastuzumab | 7 | 0.4% |
Tropical medicine | 7 | 0.4% |
Tuberculosis diagnosis | 7 | 0.4% |
Ulcer (dermatology) | 7 | 0.4% |
United States Code | 7 | 0.4% |
Unnecessary health care | 7 | 0.4% |
Visual acuity | 7 | 0.4% |
Vital signs | 7 | 0.4% |
Wound | 7 | 0.4% |
Aboriginal Australians | 6 | 0.3% |
Abuse | 6 | 0.3% |
Activities of daily living | 6 | 0.3% |
Acute respiratory distress syndrome | 6 | 0.3% |
Adenoviridae | 6 | 0.3% |
Adipose tissue | 6 | 0.3% |
Airborne transmission | 6 | 0.3% |
Allergen | 6 | 0.3% |
Alternative medicine | 6 | 0.3% |
Anatomy | 6 | 0.3% |
Aorta | 6 | 0.3% |
Aortic insufficiency | 6 | 0.3% |
Apolipoprotein B | 6 | 0.3% |
Apprenticeship | 6 | 0.3% |
Artificial intelligence in healthcare | 6 | 0.3% |
Assisted reproductive technology | 6 | 0.3% |
Astronomy | 6 | 0.3% |
Atmosphere of Earth | 6 | 0.3% |
BRCA2 | 6 | 0.3% |
Basic reproduction number | 6 | 0.3% |
Benign tumor | 6 | 0.3% |
Benzodiazepine | 6 | 0.3% |
Beta-lactamase | 6 | 0.3% |
Biological warfare | 6 | 0.3% |
Biomedical waste | 6 | 0.3% |
Birth | 6 | 0.3% |
Blockchain | 6 | 0.3% |
Bone resorption | 6 | 0.3% |
Bootstrapping (statistics) | 6 | 0.3% |
Brain natriuretic peptide | 6 | 0.3% |
Bronchitis | 6 | 0.3% |
Cancer registry | 6 | 0.3% |
Cancer research | 6 | 0.3% |
Car | 6 | 0.3% |
Casirivimab/imdevimab | 6 | 0.3% |
Catheter | 6 | 0.3% |
Catheter ablation | 6 | 0.3% |
Charity care | 6 | 0.3% |
Child care | 6 | 0.3% |
Childhood | 6 | 0.3% |
Chimeric antigen receptor T cell | 6 | 0.3% |
Climate | 6 | 0.3% |
Clinical coder | 6 | 0.3% |
Clinical psychology | 6 | 0.3% |
Collaboration | 6 | 0.3% |
Computer | 6 | 0.3% |
Conservation biology | 6 | 0.3% |
Contrast (vision) | 6 | 0.3% |
Corporate social responsibility | 6 | 0.3% |
Curriculum | 6 | 0.3% |
DNA repair | 6 | 0.3% |
Decision tree learning | 6 | 0.3% |
Demographic and Health Surveys | 6 | 0.3% |
Demography | 6 | 0.3% |
Developing country | 6 | 0.3% |
Diabetes mellitus type 1 | 6 | 0.3% |
Diagnosis code | 6 | 0.3% |
Diagnosis of malaria | 6 | 0.3% |
Diastole | 6 | 0.3% |
Difference in differences | 6 | 0.3% |
Dignity | 6 | 0.3% |
Diltiazem | 6 | 0.3% |
Dronedarone | 6 | 0.3% |
Ductal carcinoma in situ | 6 | 0.3% |
Earth | 6 | 0.3% |
Elderly care | 6 | 0.3% |
Electrical grid | 6 | 0.3% |
Endocrinology | 6 | 0.3% |
Endovascular aneurysm repair | 6 | 0.3% |
Essential health benefits | 6 | 0.3% |
Estimator | 6 | 0.3% |
Exhaled nitric oxide | 6 | 0.3% |
Exposure assessment | 6 | 0.3% |
Eye care | 6 | 0.3% |
Flecainide | 6 | 0.3% |
Glomerular filtration rate | 6 | 0.3% |
HIV-positive people | 6 | 0.3% |
HIV/AIDS in Africa | 6 | 0.3% |
Headache | 6 | 0.3% |
Health Level 7 | 6 | 0.3% |
Health information exchange | 6 | 0.3% |
Health insurance in the United States | 6 | 0.3% |
Health risk assessment | 6 | 0.3% |
Heart diseases | 6 | 0.3% |
Hib vaccine | 6 | 0.3% |
Human eye | 6 | 0.3% |
Hypothermia | 6 | 0.3% |
Hypoxia (medical) | 6 | 0.3% |
Impact evaluation | 6 | 0.3% |
In vitro | 6 | 0.3% |
Insomnia | 6 | 0.3% |
Intrauterine growth restriction | 6 | 0.3% |
Learning disability | 6 | 0.3% |
Lipoprotein(a) | 6 | 0.3% |
Magnetoencephalography | 6 | 0.3% |
Materials science | 6 | 0.3% |
Matron | 6 | 0.3% |
Mechanical filter (respirator) | 6 | 0.3% |
Medical education | 6 | 0.3% |
Meningococcal vaccine | 6 | 0.3% |
MicroRNA | 6 | 0.3% |
Microbiota | 6 | 0.3% |
Monitoring and evaluation | 6 | 0.3% |
Mood disorder | 6 | 0.3% |
Mosquito-borne disease | 6 | 0.3% |
Multiple sclerosis | 6 | 0.3% |
Nausea | 6 | 0.3% |
Neisseria gonorrhoeae | 6 | 0.3% |
Neurofeedback | 6 | 0.3% |
Neuropathic pain | 6 | 0.3% |
Neurosurgery | 6 | 0.3% |
Oncology | 6 | 0.3% |
PD-L1 | 6 | 0.3% |
Pancreatic cancer | 6 | 0.3% |
Paracetamol | 6 | 0.3% |
Pediatric nursing | 6 | 0.3% |
Pericardium | 6 | 0.3% |
Personally identifiable information | 6 | 0.3% |
Pesticide residue | 6 | 0.3% |
Pfizer–BioNTech COVID-19 vaccine | 6 | 0.3% |
Phytosterol | 6 | 0.3% |
Plant | 6 | 0.3% |
Point-of-care testing | 6 | 0.3% |
Positive airway pressure | 6 | 0.3% |
Poultry | 6 | 0.3% |
Poverty threshold | 6 | 0.3% |
Power of a test | 6 | 0.3% |
Prednisone | 6 | 0.3% |
Proton-exchange membrane fuel cell | 6 | 0.3% |
Public health genomics | 6 | 0.3% |
Public–private partnership | 6 | 0.3% |
Pulse | 6 | 0.3% |
Pulse oximetry | 6 | 0.3% |
QT interval | 6 | 0.3% |
Quality | 6 | 0.3% |
Rabies | 6 | 0.3% |
Radiation protection | 6 | 0.3% |
Radiofrequency ablation | 6 | 0.3% |
Remote patient monitoring | 6 | 0.3% |
Respiratory therapist | 6 | 0.3% |
Retina | 6 | 0.3% |
Rheumatic fever | 6 | 0.3% |
Rheumatology | 6 | 0.3% |
Rights | 6 | 0.3% |
Science and technology | 6 | 0.3% |
Selective estrogen receptor modulator | 6 | 0.3% |
Severe acute respiratory syndrome coronavirus | 6 | 0.3% |
Shingles | 6 | 0.3% |
Shock (circulatory) | 6 | 0.3% |
Sigmoidoscopy | 6 | 0.3% |
Social exclusion | 6 | 0.3% |
Software | 6 | 0.3% |
Star | 6 | 0.3% |
Streptococcus agalactiae | 6 | 0.3% |
Systemic lupus erythematosus | 6 | 0.3% |
SystmOne | 6 | 0.3% |
Technological convergence | 6 | 0.3% |
Tenofovir disoproxil | 6 | 0.3% |
Tetanus | 6 | 0.3% |
Tobacco control | 6 | 0.3% |
Transcription (biology) | 6 | 0.3% |
Transcriptomics technologies | 6 | 0.3% |
Transplant rejection | 6 | 0.3% |
Trauma center | 6 | 0.3% |
United States budget sequestration in 2013 | 6 | 0.3% |
Unwarranted variation | 6 | 0.3% |
Vaccine adverse event | 6 | 0.3% |
Vaginal discharge | 6 | 0.3% |
Variant Creutzfeldt–Jakob disease | 6 | 0.3% |
Vector (epidemiology) | 6 | 0.3% |
Vertebral augmentation | 6 | 0.3% |
Veteran | 6 | 0.3% |
Virtual colonoscopy | 6 | 0.3% |
Vision | 6 | 0.3% |
Vitamin E | 6 | 0.3% |
West Nile fever | 6 | 0.3% |
Wi-Fi | 6 | 0.3% |
Woman | 6 | 0.3% |
3D bioprinting | 5 | 0.3% |
Aciclovir | 5 | 0.3% |
Adaptive immune system | 5 | 0.3% |
Adenoma | 5 | 0.3% |
Alanine transaminase | 5 | 0.3% |
Alcoholic drink | 5 | 0.3% |
Alirocumab | 5 | 0.3% |
Amoxicillin | 5 | 0.3% |
Amyotrophic lateral sclerosis | 5 | 0.3% |
Aneurysm | 5 | 0.3% |
Angiotensin-converting enzyme | 5 | 0.3% |
Aortic aneurysm | 5 | 0.3% |
Aortic dissection | 5 | 0.3% |
Artesunate | 5 | 0.3% |
Ascending cholangitis | 5 | 0.3% |
Assisted living | 5 | 0.3% |
Atezolizumab | 5 | 0.3% |
B cell | 5 | 0.3% |
Back pain | 5 | 0.3% |
Beta cell | 5 | 0.3% |
Biological engineering | 5 | 0.3% |
Biomarker (medicine) | 5 | 0.3% |
Biomimetics | 5 | 0.3% |
Biosafety level | 5 | 0.3% |
Blood culture | 5 | 0.3% |
Brachytherapy | 5 | 0.3% |
CE marking | 5 | 0.3% |
CT pulmonary angiogram | 5 | 0.3% |
Cannabis (drug) | 5 | 0.3% |
Carbohydrate | 5 | 0.3% |
Cardiac electrophysiology | 5 | 0.3% |
Cataract | 5 | 0.3% |
Cell membrane | 5 | 0.3% |
Cell signaling | 5 | 0.3% |
Census | 5 | 0.3% |
Cerebral cortex | 5 | 0.3% |
Certification | 5 | 0.3% |
Chlamydia trachomatis | 5 | 0.3% |
Clozapine | 5 | 0.3% |
Colposcopy | 5 | 0.3% |
Combustion | 5 | 0.3% |
Common cold | 5 | 0.3% |
Compartmental models in epidemiology | 5 | 0.3% |
Concussion | 5 | 0.3% |
Congenital heart defect | 5 | 0.3% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 5 | 0.3% |
Cross-validation (statistics) | 5 | 0.3% |
Discovery (law) | 5 | 0.3% |
Disseminated intravascular coagulation | 5 | 0.3% |
Distributed generation | 5 | 0.3% |
Docetaxel | 5 | 0.3% |
Drug discovery | 5 | 0.3% |
Dual diagnosis | 5 | 0.3% |
Econometrics | 5 | 0.3% |
Educational technology | 5 | 0.3% |
Efavirenz | 5 | 0.3% |
Elastography | 5 | 0.3% |
Electroconvulsive therapy | 5 | 0.3% |
Electronic cigarette | 5 | 0.3% |
Embolism | 5 | 0.3% |
Embryonic stem cell | 5 | 0.3% |
Emergence | 5 | 0.3% |
Employee Retirement Income Security Act of 1974 | 5 | 0.3% |
Endocrine pancreas | 5 | 0.3% |
Endocrine, nutritional and metabolic diseases | 5 | 0.3% |
Energy | 5 | 0.3% |
Energy development | 5 | 0.3% |
Environmental health | 5 | 0.3% |
Environmental remediation | 5 | 0.3% |
Equity (finance) | 5 | 0.3% |
Esophagus | 5 | 0.3% |
External beam radiotherapy | 5 | 0.3% |
Fatigue | 5 | 0.3% |
Fatty liver disease | 5 | 0.3% |
Febrile neutropenia | 5 | 0.3% |
Financial audit | 5 | 0.3% |
Fixed asset | 5 | 0.3% |
Fluvastatin | 5 | 0.3% |
Folate | 5 | 0.3% |
Fraud deterrence | 5 | 0.3% |
Fuel | 5 | 0.3% |
Fundraising | 5 | 0.3% |
Gastroenterology | 5 | 0.3% |
Gastrointestinal tract | 5 | 0.3% |
Gender | 5 | 0.3% |
Genital wart | 5 | 0.3% |
Glaucoma | 5 | 0.3% |
Glucose test | 5 | 0.3% |
Glycemic index | 5 | 0.3% |
Good laboratory practice | 5 | 0.3% |
Group B streptococcal infection | 5 | 0.3% |
Hand sanitizer | 5 | 0.3% |
Health and Social Care Act 2012 | 5 | 0.3% |
Health insurance marketplace | 5 | 0.3% |
Healthcare Effectiveness Data and Information Set | 5 | 0.3% |
Healthcare management | 5 | 0.3% |
Hearing aid | 5 | 0.3% |
Heparin | 5 | 0.3% |
Hispanic and Latino Americans | 5 | 0.3% |
Histopathology | 5 | 0.3% |
Human brain | 5 | 0.3% |
Human chorionic gonadotropin | 5 | 0.3% |
Human enhancement | 5 | 0.3% |
Human female reproductive system | 5 | 0.3% |
Human nature | 5 | 0.3% |
Human resource management | 5 | 0.3% |
Human rights | 5 | 0.3% |
Human subject research | 5 | 0.3% |
Human–computer interaction | 5 | 0.3% |
Hypertrophic cardiomyopathy | 5 | 0.3% |
Hypogammaglobulinemia | 5 | 0.3% |
Image segmentation | 5 | 0.3% |
In vitro fertilisation | 5 | 0.3% |
Incident management | 5 | 0.3% |
Injection (medicine) | 5 | 0.3% |
Intranet | 5 | 0.3% |
Invoice | 5 | 0.3% |
Issues in ethics | 5 | 0.3% |
Laparoscopic radical prostatectomy | 5 | 0.3% |
Levonorgestrel | 5 | 0.3% |
Licensure | 5 | 0.3% |
Likelihood ratios in diagnostic testing | 5 | 0.3% |
Listeria | 5 | 0.3% |
Listeria monocytogenes | 5 | 0.3% |
Lithium (medication) | 5 | 0.3% |
Liver biopsy | 5 | 0.3% |
Liver cancer | 5 | 0.3% |
Liver disease | 5 | 0.3% |
Liver function tests | 5 | 0.3% |
Liver transplantation | 5 | 0.3% |
Long QT syndrome | 5 | 0.3% |
Long-term effects of alcohol consumption | 5 | 0.3% |
Lymphadenectomy | 5 | 0.3% |
Lymphocyte | 5 | 0.3% |
MMRV vaccine | 5 | 0.3% |
Marketing | 5 | 0.3% |
Maturity onset diabetes of the young | 5 | 0.3% |
Medical emergencies | 5 | 0.3% |
Medical laboratory | 5 | 0.3% |
Medical physics | 5 | 0.3% |
Medicare fraud | 5 | 0.3% |
Mediterranean diet | 5 | 0.3% |
Mental Health Act 1983 | 5 | 0.3% |
Metagenomics | 5 | 0.3% |
Methylphenidate | 5 | 0.3% |
Metronidazole | 5 | 0.3% |
Microplastics | 5 | 0.3% |
Middle East respiratory syndrome–related coronavirus | 5 | 0.3% |
Milk | 5 | 0.3% |
Mitral valve | 5 | 0.3% |
Moderna COVID-19 vaccine | 5 | 0.3% |
Molecule | 5 | 0.3% |
Moon | 5 | 0.3% |
Multiple drug resistance | 5 | 0.3% |
Mycobacteria | 5 | 0.3% |
Mycobacterium tuberculosis | 5 | 0.3% |
Myelodysplastic syndrome | 5 | 0.3% |
NHS Connecting for Health | 5 | 0.3% |
National security | 5 | 0.3% |
Needlestick injury | 5 | 0.3% |
Neonatal infection | 5 | 0.3% |
Nerve | 5 | 0.3% |
Neural engineering | 5 | 0.3% |
Neuroenhancement | 5 | 0.3% |
Neuropsychology | 5 | 0.3% |
Non-pharmaceutical intervention (epidemiology) | 5 | 0.3% |
Nuclear medicine | 5 | 0.3% |
Nuclear power | 5 | 0.3% |
Nutrient | 5 | 0.3% |
Organic farming | 5 | 0.3% |
Orphan drug | 5 | 0.3% |
Orthotics | 5 | 0.3% |
Outbreak | 5 | 0.3% |
PHQ-9 | 5 | 0.3% |
Parasitism | 5 | 0.3% |
Partition coefficient | 5 | 0.3% |
Patient portal | 5 | 0.3% |
Peer support | 5 | 0.3% |
Periodontology | 5 | 0.3% |
Perioperative | 5 | 0.3% |
Pharmacogenetics | 5 | 0.3% |
Physiologically based pharmacokinetic modelling | 5 | 0.3% |
Plasmodium | 5 | 0.3% |
Pleural effusion | 5 | 0.3% |
Polymer | 5 | 0.3% |
Potassium | 5 | 0.3% |
Potato | 5 | 0.3% |
Pravastatin | 5 | 0.3% |
Pre- and post-test probability | 5 | 0.3% |
Prescription monitoring program | 5 | 0.3% |
Primary healthcare | 5 | 0.3% |
Program evaluation | 5 | 0.3% |
Project management | 5 | 0.3% |
Prosecutor | 5 | 0.3% |
Psychiatric and mental health nursing | 5 | 0.3% |
Psychiatric hospital | 5 | 0.3% |
Quantum dot | 5 | 0.3% |
Radiosurgery | 5 | 0.3% |
Rape | 5 | 0.3% |
Rare disease | 5 | 0.3% |
Real estate appraisal | 5 | 0.3% |
Regeneration (biology) | 5 | 0.3% |
Registration, Evaluation, Authorisation and Restriction of Chemicals | 5 | 0.3% |
Reinsurance | 5 | 0.3% |
Respirator fit test | 5 | 0.3% |
Respiratory system | 5 | 0.3% |
Ritonavir | 5 | 0.3% |
Rituximab | 5 | 0.3% |
Rulemaking | 5 | 0.3% |
SGLT2 inhibitor | 5 | 0.3% |
Satellite | 5 | 0.3% |
Screening, brief intervention and referral to treatment | 5 | 0.3% |
Security clearance | 5 | 0.3% |
Selection bias | 5 | 0.3% |
Septic shock | 5 | 0.3% |
Sequencing | 5 | 0.3% |
Severe combined immunodeficiency | 5 | 0.3% |
Sickle cell disease | 5 | 0.3% |
Sievert | 5 | 0.3% |
Simon Stevens | 5 | 0.3% |
Smoking ban | 5 | 0.3% |
Social Security number | 5 | 0.3% |
Social inequality | 5 | 0.3% |
Soft drink | 5 | 0.3% |
Software testing | 5 | 0.3% |
Solar System | 5 | 0.3% |
Statistical hypothesis testing | 5 | 0.3% |
Strength training | 5 | 0.3% |
Subsidy | 5 | 0.3% |
Sugar | 5 | 0.3% |
Suicide | 5 | 0.3% |
Supportive housing | 5 | 0.3% |
Surface epithelial-stromal tumor | 5 | 0.3% |
Sustainable development | 5 | 0.3% |
Symptoms of COVID-19 | 5 | 0.3% |
Syncope (medicine) | 5 | 0.3% |
Systole | 5 | 0.3% |
Tachycardia | 5 | 0.3% |
Team | 5 | 0.3% |
Telecommuting | 5 | 0.3% |
Thematic analysis | 5 | 0.3% |
Thiazide | 5 | 0.3% |
Thorax | 5 | 0.3% |
Tooth decay | 5 | 0.3% |
Torsades de pointes | 5 | 0.3% |
Toxic Substances Control Act of 1976 | 5 | 0.3% |
Tracheal intubation | 5 | 0.3% |
Traffic | 5 | 0.3% |
Transhumanism | 5 | 0.3% |
Trustee | 5 | 0.3% |
U.S. state | 5 | 0.3% |
Vaccines | 5 | 0.3% |
Ventilator | 5 | 0.3% |
Ventricular natriuretic peptide | 5 | 0.3% |
Viral respiratory tract infections | 5 | 0.3% |
Virtual community | 5 | 0.3% |
Vulnerability (computing) | 5 | 0.3% |
Waste management | 5 | 0.3% |
Web of Science | 5 | 0.3% |
West Nile virus | 5 | 0.3% |
White blood cell | 5 | 0.3% |
Whooping cough | 5 | 0.3% |
X-ray | 5 | 0.3% |
Abdomen | 4 | 0.2% |
Abscess | 4 | 0.2% |
Abstract (summary) | 4 | 0.2% |
Acute lymphoblastic leukemia | 4 | 0.2% |
Adalimumab | 4 | 0.2% |
Air traffic control | 4 | 0.2% |
Airborne diseases | 4 | 0.2% |
All-payer rate setting | 4 | 0.2% |
Americans with Disabilities Act of 1990 | 4 | 0.2% |
Ames test | 4 | 0.2% |
Amphotericin B | 4 | 0.2% |
Anal sex | 4 | 0.2% |
Analysis of variance | 4 | 0.2% |
Anemia | 4 | 0.2% |
Animal welfare | 4 | 0.2% |
Animals and humans | 4 | 0.2% |
Anopheles | 4 | 0.2% |
Anthracycline | 4 | 0.2% |
Anthrax | 4 | 0.2% |
Antifungal | 4 | 0.2% |
Applied and interdisciplinary physics | 4 | 0.2% |
Aquaculture | 4 | 0.2% |
Aromatase inhibitor | 4 | 0.2% |
Asepsis | 4 | 0.2% |
Atmosphere | 4 | 0.2% |
Attitude (psychology) | 4 | 0.2% |
Audiology | 4 | 0.2% |
Autoimmune disease | 4 | 0.2% |
Baby Friendly Hospital Initiative | 4 | 0.2% |
Bachelor of Science in Nursing | 4 | 0.2% |
Bacillus thuringiensis | 4 | 0.2% |
Background check | 4 | 0.2% |
Bacteriuria | 4 | 0.2% |
Biocide | 4 | 0.2% |
Biodefense | 4 | 0.2% |
Biomechanics | 4 | 0.2% |
Biomonitoring | 4 | 0.2% |
Botany | 4 | 0.2% |
Botulism | 4 | 0.2% |
Brain metastasis | 4 | 0.2% |
Brexit | 4 | 0.2% |
Business continuity planning | 4 | 0.2% |
Business intelligence | 4 | 0.2% |
CCR5 | 4 | 0.2% |
COVID-19 pandemic in Papua New Guinea | 4 | 0.2% |
Calcium channel blocker | 4 | 0.2% |
Cancer syndrome | 4 | 0.2% |
Carbon capture and storage | 4 | 0.2% |
Carbon footprint | 4 | 0.2% |
Carbon nanotube | 4 | 0.2% |
Carotid artery stenosis | 4 | 0.2% |
Catalysis | 4 | 0.2% |
Cell therapy | 4 | 0.2% |
Cell-free fetal DNA | 4 | 0.2% |
Cerebral palsy | 4 | 0.2% |
Cerebrospinal fluid | 4 | 0.2% |
Child Protective Services | 4 | 0.2% |
Child protection | 4 | 0.2% |
Choosing Wisely | 4 | 0.2% |
Chronic fatigue syndrome | 4 | 0.2% |
Chronic myelogenous leukemia | 4 | 0.2% |
Chronic pain | 4 | 0.2% |
Circumcision | 4 | 0.2% |
Citizenship | 4 | 0.2% |
Classified information in the United States | 4 | 0.2% |
Cloning | 4 | 0.2% |
Cloth face mask | 4 | 0.2% |
Coefficient of determination | 4 | 0.2% |
Cold chain | 4 | 0.2% |
Community-acquired pneumonia | 4 | 0.2% |
Complete blood count | 4 | 0.2% |
Computerized physician order entry | 4 | 0.2% |
Convolutional neural network | 4 | 0.2% |
Cornea | 4 | 0.2% |
Corruption | 4 | 0.2% |
Crizotinib | 4 | 0.2% |
Crowdsourcing | 4 | 0.2% |
Cryptococcosis | 4 | 0.2% |
Cystectomy | 4 | 0.2% |
Cystic fibrosis transmembrane conductance regulator | 4 | 0.2% |
Cystoscopy | 4 | 0.2% |
Cytochrome P450 | 4 | 0.2% |
Cytokine | 4 | 0.2% |
DNA methylation | 4 | 0.2% |
Deep brain stimulation | 4 | 0.2% |
Dental implant | 4 | 0.2% |
Developmental disability | 4 | 0.2% |
Diabetes medication | 4 | 0.2% |
Diagnostic and Statistical Manual of Mental Disorders | 4 | 0.2% |
Dietary fiber | 4 | 0.2% |
Diphtheria vaccine | 4 | 0.2% |
Docosahexaenoic acid | 4 | 0.2% |
Dog | 4 | 0.2% |
Dose–response relationship | 4 | 0.2% |
Dosimetry | 4 | 0.2% |
Doxorubicin | 4 | 0.2% |
Drink | 4 | 0.2% |
Driving | 4 | 0.2% |
Drug metabolism | 4 | 0.2% |
Drug overdose | 4 | 0.2% |
Dual-use technology | 4 | 0.2% |
Dummy variable (statistics) | 4 | 0.2% |
Dyslipidemia | 4 | 0.2% |
Eclampsia | 4 | 0.2% |
Electrocorticography | 4 | 0.2% |
Embolization | 4 | 0.2% |
Empagliflozin | 4 | 0.2% |
Encryption | 4 | 0.2% |
Endocrine disruptor | 4 | 0.2% |
Endometriosis | 4 | 0.2% |
Endothelium | 4 | 0.2% |
Energy storage | 4 | 0.2% |
Entrepreneurship | 4 | 0.2% |
Enzyme inhibitor | 4 | 0.2% |
Epileptic seizure | 4 | 0.2% |
Equal opportunity | 4 | 0.2% |
Escherichia coli | 4 | 0.2% |
Ethinylestradiol | 4 | 0.2% |
Exemestane | 4 | 0.2% |
Exoplanet | 4 | 0.2% |
FDA Food Safety Modernization Act | 4 | 0.2% |
Failure mode and effects analysis | 4 | 0.2% |
Federal Food, Drug, and Cosmetic Act | 4 | 0.2% |
Field Epidemiology Training Program | 4 | 0.2% |
Fine-needle aspiration | 4 | 0.2% |
Flavivirus | 4 | 0.2% |
Fluid replacement | 4 | 0.2% |
Foot | 4 | 0.2% |
Fraction (mathematics) | 4 | 0.2% |
Free will | 4 | 0.2% |
Fresh frozen plasma | 4 | 0.2% |
Friends and Family Test | 4 | 0.2% |
Fundus photography | 4 | 0.2% |
Funnel plot | 4 | 0.2% |
Furosemide | 4 | 0.2% |
Fused filament fabrication | 4 | 0.2% |
Gabapentin | 4 | 0.2% |
Gas | 4 | 0.2% |
Gastroesophageal reflux disease | 4 | 0.2% |
Gene expression profiling | 4 | 0.2% |
Genetic association | 4 | 0.2% |
Genetic marker | 4 | 0.2% |
Genetically modified crops | 4 | 0.2% |
Genetically modified food | 4 | 0.2% |
Gene–environment interaction | 4 | 0.2% |
Gentamicin | 4 | 0.2% |
Geographic information system | 4 | 0.2% |
Gerontological nursing | 4 | 0.2% |
Globalization | 4 | 0.2% |
Globally Harmonized System of Classification and Labelling of Chemicals | 4 | 0.2% |
Graft-versus-host disease | 4 | 0.2% |
Grievance (labour) | 4 | 0.2% |
HBsAg | 4 | 0.2% |
HIV and pregnancy | 4 | 0.2% |
Hazard analysis and critical control points | 4 | 0.2% |
He Jiankui | 4 | 0.2% |
Health in All Policies | 4 | 0.2% |
Health services research | 4 | 0.2% |
Hearing | 4 | 0.2% |
Hela Province | 4 | 0.2% |
Helicobacter pylori | 4 | 0.2% |
Hepatectomy | 4 | 0.2% |
Hepatitis B virus | 4 | 0.2% |
Hip replacement | 4 | 0.2% |
Histoplasmosis | 4 | 0.2% |
History | 4 | 0.2% |
Hives | 4 | 0.2% |
Homosexuality | 4 | 0.2% |
Hormonal therapy (oncology) | 4 | 0.2% |
Hospice care in the United States | 4 | 0.2% |
Human anatomy | 4 | 0.2% |
Human genome | 4 | 0.2% |
Human microbiome | 4 | 0.2% |
Human–robot interaction | 4 | 0.2% |
Hypertriglyceridemia | 4 | 0.2% |
Hypnotic | 4 | 0.2% |
Hypopnea | 4 | 0.2% |
Hypothyroidism | 4 | 0.2% |
Immune thrombocytopenic purpura | 4 | 0.2% |
Immunoglobulin E | 4 | 0.2% |
Inflammatory bowel disease | 4 | 0.2% |
Innate immune system | 4 | 0.2% |
Insulin analog | 4 | 0.2% |
Integrated circuit | 4 | 0.2% |
Inter-rater reliability | 4 | 0.2% |
Intermediate Care Facilities for Individuals with Mental Retardation | 4 | 0.2% |
International development | 4 | 0.2% |
Intraclass correlation | 4 | 0.2% |
Invasive species | 4 | 0.2% |
Johnson & Johnson COVID-19 vaccine | 4 | 0.2% |
Junior doctor | 4 | 0.2% |
KRAS | 4 | 0.2% |
Labour economics | 4 | 0.2% |
Laser | 4 | 0.2% |
Left atrial appendage occlusion | 4 | 0.2% |
Lenalidomide | 4 | 0.2% |
Levofloxacin | 4 | 0.2% |
Life-cycle assessment | 4 | 0.2% |
Linezolid | 4 | 0.2% |
Livestock | 4 | 0.2% |
Loan | 4 | 0.2% |
Local anesthetic | 4 | 0.2% |
Logic model | 4 | 0.2% |
Lower respiratory tract infection | 4 | 0.2% |
Lymphogranuloma venereum | 4 | 0.2% |
Machine | 4 | 0.2% |
Macula of retina | 4 | 0.2% |
Management of COVID-19 | 4 | 0.2% |
Management of hypertension | 4 | 0.2% |
Mania | 4 | 0.2% |
Matter | 4 | 0.2% |
Meat | 4 | 0.2% |
Mechanical ventilation | 4 | 0.2% |
Median lethal dose | 4 | 0.2% |
Medical equipment | 4 | 0.2% |
Medical ethics | 4 | 0.2% |
Medical genetics | 4 | 0.2% |
Medicare Part D | 4 | 0.2% |
Mergers and acquisitions | 4 | 0.2% |
Metadata | 4 | 0.2% |
Metered-dose inhaler | 4 | 0.2% |
Methodology | 4 | 0.2% |
Methylprednisolone | 4 | 0.2% |
Microscope | 4 | 0.2% |
Middle East respiratory syndrome coronavirus | 4 | 0.2% |
Minimum Data Set | 4 | 0.2% |
Mitochondrial DNA | 4 | 0.2% |
Multiomics | 4 | 0.2% |
Multiple birth | 4 | 0.2% |
Mumps | 4 | 0.2% |
Musculoskeletal system | 4 | 0.2% |
Mutagen | 4 | 0.2% |
NHS primary care trust | 4 | 0.2% |
NHS targets | 4 | 0.2% |
National Health Interview Survey | 4 | 0.2% |
National Lung Screening Trial | 4 | 0.2% |
Needle exchange programme | 4 | 0.2% |
Neonatal alloimmune thrombocytopenia | 4 | 0.2% |
Neurological disorder | 4 | 0.2% |
Neuroprosthetics | 4 | 0.2% |
Niacin | 4 | 0.2% |
Nuclear proliferation | 4 | 0.2% |
Nucleic acid sequence | 4 | 0.2% |
Number needed to treat | 4 | 0.2% |
Ocean | 4 | 0.2% |
Odor | 4 | 0.2% |
Open science | 4 | 0.2% |
Ordinary least squares | 4 | 0.2% |
Orthopedic surgery | 4 | 0.2% |
Over-the-counter drug | 4 | 0.2% |
Overactive bladder | 4 | 0.2% |
Oxaliplatin | 4 | 0.2% |
Oxygen therapy | 4 | 0.2% |
Pancreatitis | 4 | 0.2% |
Pandemics | 4 | 0.2% |
Parathyroid hormone | 4 | 0.2% |
Peer review | 4 | 0.2% |
Percentile | 4 | 0.2% |
Pericardiocentesis | 4 | 0.2% |
Peritoneal dialysis | 4 | 0.2% |
Phenotype | 4 | 0.2% |
Phenylketonuria | 4 | 0.2% |
Photosynthesis | 4 | 0.2% |
Picture archiving and communication system | 4 | 0.2% |
Pioglitazone | 4 | 0.2% |
Placenta | 4 | 0.2% |
Plateletpheresis | 4 | 0.2% |
Pneumothorax | 4 | 0.2% |
Point of sale | 4 | 0.2% |
Polio eradication | 4 | 0.2% |
Poliomyelitis | 4 | 0.2% |
Poliovirus | 4 | 0.2% |
Polysomnography | 4 | 0.2% |
Power (statistics) | 4 | 0.2% |
Powered exoskeleton | 4 | 0.2% |
Prednisolone | 4 | 0.2% |
Primaquine | 4 | 0.2% |
Primary immunodeficiency | 4 | 0.2% |
Probability | 4 | 0.2% |
Probiotic | 4 | 0.2% |
Profession | 4 | 0.2% |
Protocol (science) | 4 | 0.2% |
Puberty | 4 | 0.2% |
Public engagement | 4 | 0.2% |
Pulmonary function testing | 4 | 0.2% |
Q fever | 4 | 0.2% |
QuantiFERON | 4 | 0.2% |
Quinolone antibiotic | 4 | 0.2% |
RNA interference | 4 | 0.2% |
ROS1 | 4 | 0.2% |
Race (human categorization) | 4 | 0.2% |
Rail transport | 4 | 0.2% |
Raw milk | 4 | 0.2% |
Regulatory Flexibility Act | 4 | 0.2% |
Regulatory science | 4 | 0.2% |
Residential treatment center | 4 | 0.2% |
Revised National Tuberculosis Control Program | 4 | 0.2% |
Road traffic safety | 4 | 0.2% |
Robust statistics | 4 | 0.2% |
Rock (geology) | 4 | 0.2% |
Rosiglitazone | 4 | 0.2% |
SARS-CoV-2 | 4 | 0.2% |
Salt | 4 | 0.2% |
Sarbecovirus | 4 | 0.2% |
Scientific control | 4 | 0.2% |
Selective laser sintering | 4 | 0.2% |
Sensor | 4 | 0.2% |
Sheep | 4 | 0.2% |
Single-payer healthcare | 4 | 0.2% |
Sintering | 4 | 0.2% |
Sinusitis | 4 | 0.2% |
Sleep disorder | 4 | 0.2% |
Smallpox | 4 | 0.2% |
Snellen chart | 4 | 0.2% |
Social institutions | 4 | 0.2% |
Social support | 4 | 0.2% |
Socioeconomic status | 4 | 0.2% |
Sociotechnical system | 4 | 0.2% |
Sofosbuvir | 4 | 0.2% |
Source control (respiratory disease) | 4 | 0.2% |
Spasticity | 4 | 0.2% |
Spinal cord | 4 | 0.2% |
Stanol ester | 4 | 0.2% |
Sternum | 4 | 0.2% |
Stratified sampling | 4 | 0.2% |
Sudden infant death syndrome | 4 | 0.2% |
Summary Care Record | 4 | 0.2% |
Superficial vein thrombosis | 4 | 0.2% |
Support-vector machine | 4 | 0.2% |
Surety | 4 | 0.2% |
Surgical procedures and techniques | 4 | 0.2% |
Sweetened beverage | 4 | 0.2% |
Synapse | 4 | 0.2% |
T helper cell | 4 | 0.2% |
Technological singularity | 4 | 0.2% |
Telemedicine | 4 | 0.2% |
Telepharmacy | 4 | 0.2% |
Test (assessment) | 4 | 0.2% |
Thrombus | 4 | 0.2% |
Thyroid hormones | 4 | 0.2% |
Tissue plasminogen activator | 4 | 0.2% |
Toxin | 4 | 0.2% |
Tracheotomy | 4 | 0.2% |
Trade Adjustment Assistance | 4 | 0.2% |
Translational medicine | 4 | 0.2% |
Treatment as prevention | 4 | 0.2% |
Trichomonas vaginalis | 4 | 0.2% |
Triglyceride | 4 | 0.2% |
Triple test | 4 | 0.2% |
Trust (social science) | 4 | 0.2% |
Unintended pregnancy | 4 | 0.2% |
United States federal budget | 4 | 0.2% |
Unlicensed assistive personnel | 4 | 0.2% |
Urgent care center | 4 | 0.2% |
Urinary system | 4 | 0.2% |
User interface | 4 | 0.2% |
Valproate | 4 | 0.2% |
Value (ethics) | 4 | 0.2% |
Vancomycin-resistant Enterococcus | 4 | 0.2% |
Variants of SARS-CoV-2 | 4 | 0.2% |
Vector control | 4 | 0.2% |
Vegetable | 4 | 0.2% |
Ventricular tachycardia | 4 | 0.2% |
Venture capital | 4 | 0.2% |
Verapamil | 4 | 0.2% |
Vertebral column | 4 | 0.2% |
Visual perception | 4 | 0.2% |
Vitamin D deficiency | 4 | 0.2% |
Volatile organic compound | 4 | 0.2% |
Volcano | 4 | 0.2% |
Well-being | 4 | 0.2% |
Whole grain | 4 | 0.2% |
Workforce development | 4 | 0.2% |
Working memory | 4 | 0.2% |
Zanamivir | 4 | 0.2% |
Zika virus | 4 | 0.2% |
100,000 Genomes Project | 3 | 0.2% |
2009 swine flu pandemic | 3 | 0.2% |
3D scanning | 3 | 0.2% |
5G | 3 | 0.2% |
Abdominal aortic aneurysm | 3 | 0.2% |
Acromegaly | 3 | 0.2% |
Acupuncture | 3 | 0.2% |
Acute promyelocytic leukemia | 3 | 0.2% |
Adoption | 3 | 0.2% |
Advertising | 3 | 0.2% |
Aflibercept | 3 | 0.2% |
Africa | 3 | 0.2% |
Agenda for Change | 3 | 0.2% |
Aggression | 3 | 0.2% |
Agreement on the Application of Sanitary and Phytosanitary Measures | 3 | 0.2% |
Aid | 3 | 0.2% |
Allied health professions | 3 | 0.2% |
Alpha-fetoprotein | 3 | 0.2% |
American Health Care Act of 2017 | 3 | 0.2% |
Aminoglycoside | 3 | 0.2% |
Ampicillin | 3 | 0.2% |
Amplicon | 3 | 0.2% |
Amputation | 3 | 0.2% |
Amyloid beta | 3 | 0.2% |
Anabolic steroid | 3 | 0.2% |
Anaerobic digestion | 3 | 0.2% |
Anatomical terms of location | 3 | 0.2% |
Animal anatomy | 3 | 0.2% |
Animal slaughter | 3 | 0.2% |
Anthropology | 3 | 0.2% |
Antibiotic prophylaxis | 3 | 0.2% |
Antineoplastic and immunomodulating drugs | 3 | 0.2% |
Antineoplastic drugs | 3 | 0.2% |
Antioxidant | 3 | 0.2% |
Antiphospholipid syndrome | 3 | 0.2% |
Antiserum | 3 | 0.2% |
Apoptosis | 3 | 0.2% |
Appendicitis | 3 | 0.2% |
Application software | 3 | 0.2% |
Applied ethics | 3 | 0.2% |
Arbovirus | 3 | 0.2% |
Argument | 3 | 0.2% |
Artemisinin | 3 | 0.2% |
Artery | 3 | 0.2% |
Artificial general intelligence | 3 | 0.2% |
Atopy | 3 | 0.2% |
Atrophic vaginitis | 3 | 0.2% |
Attachment theory | 3 | 0.2% |
Australians | 3 | 0.2% |
Automated external defibrillator | 3 | 0.2% |
Autophagy | 3 | 0.2% |
Average treatment effect | 3 | 0.2% |
Axon | 3 | 0.2% |
Azithromycin | 3 | 0.2% |
Baricitinib | 3 | 0.2% |
Barley yellow dwarf | 3 | 0.2% |
Bayesian inference | 3 | 0.2% |
Bedaquiline | 3 | 0.2% |
Behaviour therapy | 3 | 0.2% |
Bias of an estimator | 3 | 0.2% |
Bilirubin | 3 | 0.2% |
Biogas | 3 | 0.2% |
Biological pest control | 3 | 0.2% |
Biomedical engineering | 3 | 0.2% |
Biosafety cabinet | 3 | 0.2% |
Blood cell | 3 | 0.2% |
Blood film | 3 | 0.2% |
Blood type | 3 | 0.2% |
Botulinum toxin | 3 | 0.2% |
Brain damage | 3 | 0.2% |
Brand | 3 | 0.2% |
Breakthrough infection | 3 | 0.2% |
Breast cancer classification | 3 | 0.2% |
Breast imaging | 3 | 0.2% |
Breathing | 3 | 0.2% |
Buprenorphine/naloxone | 3 | 0.2% |
Business ethics | 3 | 0.2% |
Business process | 3 | 0.2% |
CA-125 | 3 | 0.2% |
CAD/CAM dentistry | 3 | 0.2% |
CBRN defense | 3 | 0.2% |
COVID-19 pandemic in the United States | 3 | 0.2% |
Campylobacter | 3 | 0.2% |
Cancer treatments | 3 | 0.2% |
Cannabidiol | 3 | 0.2% |
Carbapenem | 3 | 0.2% |
Carbapenem-resistant enterobacteriaceae | 3 | 0.2% |
Carbon | 3 | 0.2% |
Carcinogenesis | 3 | 0.2% |
Cardiac imaging | 3 | 0.2% |
Cardiac muscle cell | 3 | 0.2% |
Cardiac resynchronization therapy | 3 | 0.2% |
Cataract surgery | 3 | 0.2% |
Causality | 3 | 0.2% |
Cell growth | 3 | 0.2% |
Census in Australia | 3 | 0.2% |
Central nervous system | 3 | 0.2% |
Cephalosporin | 3 | 0.2% |
Cerebral shunt | 3 | 0.2% |
Cetuximab | 3 | 0.2% |
Chagas disease | 3 | 0.2% |
Chancroid | 3 | 0.2% |
Change management | 3 | 0.2% |
Chemical substance | 3 | 0.2% |
Chemical weapon | 3 | 0.2% |
Child mortality | 3 | 0.2% |
Chlorine dioxide | 3 | 0.2% |
Chloroquine | 3 | 0.2% |
Chlortalidone | 3 | 0.2% |
Cholecalciferol | 3 | 0.2% |
Chorioamnionitis | 3 | 0.2% |
Chronic care | 3 | 0.2% |
Cigar | 3 | 0.2% |
Ciprofloxacin | 3 | 0.2% |
Circadian rhythm | 3 | 0.2% |
Circulating tumor DNA | 3 | 0.2% |
Circumcision and HIV | 3 | 0.2% |
Classified information | 3 | 0.2% |
Climate change mitigation | 3 | 0.2% |
Clinical research | 3 | 0.2% |
Clinical urine tests | 3 | 0.2% |
Clostridioides difficile (bacteria) | 3 | 0.2% |
Clothing | 3 | 0.2% |
Co-receptor | 3 | 0.2% |
Cognitive liberty | 3 | 0.2% |
Common variable immunodeficiency | 3 | 0.2% |
Competition | 3 | 0.2% |
Complication (medicine) | 3 | 0.2% |
Composite material | 3 | 0.2% |
Comprehensive geriatric assessment | 3 | 0.2% |
Computer vision | 3 | 0.2% |
Concepts in metaphysics | 3 | 0.2% |
Condensed matter physics | 3 | 0.2% |
Continuing healthcare | 3 | 0.2% |
Convention on Biological Diversity | 3 | 0.2% |
Coronary CT calcium scan | 3 | 0.2% |
Corticosteroid | 3 | 0.2% |
Cosmetics | 3 | 0.2% |
Cotinine | 3 | 0.2% |
Credit | 3 | 0.2% |
Cryoablation | 3 | 0.2% |
Cryptography | 3 | 0.2% |
Culex | 3 | 0.2% |
Current liability | 3 | 0.2% |
Cyborg | 3 | 0.2% |
Cyclooxygenase | 3 | 0.2% |
Cystatin C | 3 | 0.2% |
Cytotoxic T cell | 3 | 0.2% |
DNA vaccination | 3 | 0.2% |
Dapagliflozin | 3 | 0.2% |
Daratumumab | 3 | 0.2% |
Data Protection Act 1998 | 3 | 0.2% |
Deficit spending | 3 | 0.2% |
Delphi method | 3 | 0.2% |
Dendritic cell | 3 | 0.2% |
Designer baby | 3 | 0.2% |
Diabetic nephropathy | 3 | 0.2% |
Diazepam | 3 | 0.2% |
Didanosine | 3 | 0.2% |
Diffusion of innovations | 3 | 0.2% |
Digestive system | 3 | 0.2% |
Digital divide | 3 | 0.2% |
Disease registry | 3 | 0.2% |
Dividend | 3 | 0.2% |
Domestic violence | 3 | 0.2% |
Dr Foster Intelligence | 3 | 0.2% |
Drug | 3 | 0.2% |
Drug design | 3 | 0.2% |
Drug injection | 3 | 0.2% |
Drug resistance | 3 | 0.2% |
Duchenne muscular dystrophy | 3 | 0.2% |
Dysmenorrhea | 3 | 0.2% |
Economic model | 3 | 0.2% |
Ectopic pregnancy | 3 | 0.2% |
Electricity generation | 3 | 0.2% |
Emergency Use Authorization | 3 | 0.2% |
Emerging infectious disease | 3 | 0.2% |
Emtricitabine | 3 | 0.2% |
Endometrium | 3 | 0.2% |
Endoscopic mucosal resection | 3 | 0.2% |
Enga Province | 3 | 0.2% |
Engineering controls | 3 | 0.2% |
Enterprise content management | 3 | 0.2% |
Environmental factor | 3 | 0.2% |
Epigenomics | 3 | 0.2% |
Erythropoietin | 3 | 0.2% |
Esophageal cancer | 3 | 0.2% |
Estradiol (medication) | 3 | 0.2% |
Evaluation methods | 3 | 0.2% |
Executive functions | 3 | 0.2% |
Exhaust gas | 3 | 0.2% |
Exome sequencing | 3 | 0.2% |
Exposure (photography) | 3 | 0.2% |
Extracellular matrix | 3 | 0.2% |
Extracorporeal membrane oxygenation | 3 | 0.2% |
Federal Information Security Management Act of 2002 | 3 | 0.2% |
Federal Information Technology Acquisition Reform Act | 3 | 0.2% |
Federal Insecticide, Fungicide, and Rodenticide Act | 3 | 0.2% |
Fibre-reinforced plastic | 3 | 0.2% |
File Transfer Protocol | 3 | 0.2% |
Fire | 3 | 0.2% |
Fiscal year | 3 | 0.2% |
Fixed effects model | 3 | 0.2% |
Flucytosine | 3 | 0.2% |
Follicular lymphoma | 3 | 0.2% |
Food defense | 3 | 0.2% |
Foot-and-mouth disease | 3 | 0.2% |
Forest plot | 3 | 0.2% |
Fractional flow reserve | 3 | 0.2% |
Frozen section procedure | 3 | 0.2% |
Functional near-infrared spectroscopy | 3 | 0.2% |
Fungicide | 3 | 0.2% |
Gardasil | 3 | 0.2% |
Gasification | 3 | 0.2% |
Gastroenteritis | 3 | 0.2% |
General anaesthesia | 3 | 0.2% |
General medical services | 3 | 0.2% |
Genotype | 3 | 0.2% |
Gestational trophoblastic disease | 3 | 0.2% |
Glioblastoma | 3 | 0.2% |
Global catastrophic risk | 3 | 0.2% |
Glucagon-like peptide-1 | 3 | 0.2% |
Glyphosate | 3 | 0.2% |
Google Scholar | 3 | 0.2% |
Government aid programs | 3 | 0.2% |
Great Society programs | 3 | 0.2% |
Green building | 3 | 0.2% |
Greenland ice sheet | 3 | 0.2% |
Group A streptococcal infection | 3 | 0.2% |
Guido Imbens | 3 | 0.2% |
HAS-BLED | 3 | 0.2% |
Habitat | 3 | 0.2% |
Hand dryer | 3 | 0.2% |
Haptic technology | 3 | 0.2% |
Head injury | 3 | 0.2% |
Health care fraud | 3 | 0.2% |
Health care management | 3 | 0.2% |
Health education | 3 | 0.2% |
Health technology assessment | 3 | 0.2% |
Healthcare in Cheshire | 3 | 0.2% |
Healthcare in the Netherlands | 3 | 0.2% |
Healthcare reform in the United States | 3 | 0.2% |
Healthcare shortage area | 3 | 0.2% |
Heat | 3 | 0.2% |
Hepatitis A | 3 | 0.2% |
Hepatitis C virus | 3 | 0.2% |
Hepatology | 3 | 0.2% |
Heroin | 3 | 0.2% |
Holter monitor | 3 | 0.2% |
Hospital-acquired condition | 3 | 0.2% |
Hospital-acquired pneumonia | 3 | 0.2% |
Human cytomegalovirus | 3 | 0.2% |
Human decontamination | 3 | 0.2% |
Human germline engineering | 3 | 0.2% |
Human migration | 3 | 0.2% |
Human nutrition | 3 | 0.2% |
Human respiratory syncytial virus | 3 | 0.2% |
Humanitarian aid | 3 | 0.2% |
Hyperkalemia | 3 | 0.2% |
Hypodermic needle | 3 | 0.2% |
ISO 9000 | 3 | 0.2% |
Ibandronic acid | 3 | 0.2% |
Immersion (virtual reality) | 3 | 0.2% |
Immunohistochemistry | 3 | 0.2% |
Implementation | 3 | 0.2% |
Individualized Education Program | 3 | 0.2% |
Induced pluripotent stem cell | 3 | 0.2% |
Infliximab | 3 | 0.2% |
Influenza A virus subtype H5N8 | 3 | 0.2% |
Informal economy | 3 | 0.2% |
Information system | 3 | 0.2% |
Infrared | 3 | 0.2% |
Inhaler | 3 | 0.2% |
Inquiry | 3 | 0.2% |
Institution | 3 | 0.2% |
Insulin pump | 3 | 0.2% |
Integrated care system | 3 | 0.2% |
Intelligence quotient | 3 | 0.2% |
Interdisciplinarity | 3 | 0.2% |
Interferon | 3 | 0.2% |
Intima-media thickness | 3 | 0.2% |
Intracranial hemorrhage | 3 | 0.2% |
Intracranial pressure | 3 | 0.2% |
Intramuscular injection | 3 | 0.2% |
Intravitreal administration | 3 | 0.2% |
Inventory | 3 | 0.2% |
Jaundice | 3 | 0.2% |
Knee replacement | 3 | 0.2% |
LOINC | 3 | 0.2% |
Laser coagulation | 3 | 0.2% |
Lasso (statistics) | 3 | 0.2% |
Lead poisoning | 3 | 0.2% |
Leishmaniasis | 3 | 0.2% |
Light therapy | 3 | 0.2% |
Lineage B.1.1.7 | 3 | 0.2% |
Linear no-threshold model | 3 | 0.2% |
Lipids | 3 | 0.2% |
Literacy | 3 | 0.2% |
Logistic function | 3 | 0.2% |
Loneliness | 3 | 0.2% |
Loop diuretic | 3 | 0.2% |
Low back pain | 3 | 0.2% |
Low-carbohydrate diet | 3 | 0.2% |
Lumbar puncture | 3 | 0.2% |
Lupus | 3 | 0.2% |
Lutein | 3 | 0.2% |
Lyme disease | 3 | 0.2% |
Lymphatic system | 3 | 0.2% |
Macrophage | 3 | 0.2% |
Management of acute coronary syndrome | 3 | 0.2% |
Manufacturing | 3 | 0.2% |
Marburg virus disease | 3 | 0.2% |
Mars | 3 | 0.2% |
Mass media | 3 | 0.2% |
Mass-casualty incident | 3 | 0.2% |
Mathematical model | 3 | 0.2% |
Mechanical engineering | 3 | 0.2% |
Medical and health organizations | 3 | 0.2% |
Medical cannabis | 3 | 0.2% |
Medical director | 3 | 0.2% |
Medical privacy | 3 | 0.2% |
Medical sign | 3 | 0.2% |
Medicare and Medicaid (United States) | 3 | 0.2% |
Menstrual cycle | 3 | 0.2% |
Mesenchymal stem cell | 3 | 0.2% |
Mesothelioma | 3 | 0.2% |
Messenger RNA | 3 | 0.2% |
Mestranol | 3 | 0.2% |
Metastatic breast cancer | 3 | 0.2% |
Methods of detecting exoplanets | 3 | 0.2% |
Microbicides for sexually transmitted diseases | 3 | 0.2% |
Microsatellite instability | 3 | 0.2% |
Mid-level practitioner | 3 | 0.2% |
Midazolam | 3 | 0.2% |
Mifepristone | 3 | 0.2% |
Migraine | 3 | 0.2% |
Minimally invasive procedures | 3 | 0.2% |
Misinformation | 3 | 0.2% |
Misoprostol | 3 | 0.2% |
Mitral insufficiency | 3 | 0.2% |
Modafinil | 3 | 0.2% |
Molecular machine | 3 | 0.2% |
Monoamine oxidase inhibitor | 3 | 0.2% |
Monoclonal antibody | 3 | 0.2% |
Morphine | 3 | 0.2% |
Multisystem inflammatory syndrome in children | 3 | 0.2% |
Mycobacterium | 3 | 0.2% |
Myzus persicae | 3 | 0.2% |
NHS 111 | 3 | 0.2% |
Nanomedicine | 3 | 0.2% |
Natalizumab | 3 | 0.2% |
National Federation of Independent Business v. Sebelius | 3 | 0.2% |
Natural gas | 3 | 0.2% |
Natural killer cell | 3 | 0.2% |
Natural selection | 3 | 0.2% |
Near-sightedness | 3 | 0.2% |
Nebulizer | 3 | 0.2% |
Neonatal sepsis | 3 | 0.2% |
Neural tube defect | 3 | 0.2% |
Neuromarketing | 3 | 0.2% |
Neuroplasticity | 3 | 0.2% |
Neurotransmitter | 3 | 0.2% |
Nightmare | 3 | 0.2% |
Non-invasive ventilation | 3 | 0.2% |
Norovirus | 3 | 0.2% |
Null hypothesis | 3 | 0.2% |
Oceanography | 3 | 0.2% |
Omalizumab | 3 | 0.2% |
Omics | 3 | 0.2% |
Ondansetron | 3 | 0.2% |
Oophorectomy | 3 | 0.2% |
Open data | 3 | 0.2% |
Opiate | 3 | 0.2% |
Oral cancer | 3 | 0.2% |
Oral sex | 3 | 0.2% |
Oregon Medicaid health experiment | 3 | 0.2% |
Organ (anatomy) | 3 | 0.2% |
Organoid | 3 | 0.2% |
Orthomyxoviridae | 3 | 0.2% |
Otitis media | 3 | 0.2% |
Outlier | 3 | 0.2% |
Outsourcing | 3 | 0.2% |
Ovarian cyst | 3 | 0.2% |
Ovary | 3 | 0.2% |
Ownership | 3 | 0.2% |
Oxford–AstraZeneca COVID-19 vaccine | 3 | 0.2% |
P53 | 3 | 0.2% |
Packaging and labeling | 3 | 0.2% |
Palbociclib | 3 | 0.2% |
Palpitations | 3 | 0.2% |
Pancreas | 3 | 0.2% |
Pancreatic islets | 3 | 0.2% |
Paper | 3 | 0.2% |
Paradigm | 3 | 0.2% |
Parenting | 3 | 0.2% |
Paresthesia | 3 | 0.2% |
Partnership | 3 | 0.2% |
Pathology of pregnancy, childbirth and the puerperium | 3 | 0.2% |
Patient choice | 3 | 0.2% |
Payroll tax | 3 | 0.2% |
Pectus excavatum | 3 | 0.2% |
Penicillin | 3 | 0.2% |
Per diem | 3 | 0.2% |
Perioperative mortality | 3 | 0.2% |
Personal Responsibility and Work Opportunity Act | 3 | 0.2% |
Pest (organism) | 3 | 0.2% |
Pet | 3 | 0.2% |
Pharmaceutical Benefits Scheme | 3 | 0.2% |
Pharmaceutics | 3 | 0.2% |
Pharyngitis | 3 | 0.2% |
Physician assistant | 3 | 0.2% |
Phytoplankton | 3 | 0.2% |
Placental abruption | 3 | 0.2% |
Planet | 3 | 0.2% |
Planetary habitability | 3 | 0.2% |
Planetary science | 3 | 0.2% |
Plants | 3 | 0.2% |
Plasmon | 3 | 0.2% |
Pneumocystis pneumonia | 3 | 0.2% |
Poliomyelitis eradication | 3 | 0.2% |
Pollinator | 3 | 0.2% |
Population | 3 | 0.2% |
Portal hypertension | 3 | 0.2% |
Post-thrombotic syndrome | 3 | 0.2% |
Potato leafroll virus | 3 | 0.2% |
Potato mop-top virus | 3 | 0.2% |
Potato virus Y | 3 | 0.2% |
Powdery scab | 3 | 0.2% |
Powered air-purifying respirator | 3 | 0.2% |
Precautionary principle | 3 | 0.2% |
Pregabalin | 3 | 0.2% |
Preimplantation genetic diagnosis | 3 | 0.2% |
Premium tax credit | 3 | 0.2% |
Present value | 3 | 0.2% |
President of the United States | 3 | 0.2% |
Primary biliary cholangitis | 3 | 0.2% |
Primer (molecular biology) | 3 | 0.2% |
Prion | 3 | 0.2% |
Prior authorization | 3 | 0.2% |
Privacy law | 3 | 0.2% |
Probability distribution | 3 | 0.2% |
Progestogen-only pill | 3 | 0.2% |
Progress | 3 | 0.2% |
Projectional radiography | 3 | 0.2% |
Propranolol | 3 | 0.2% |
Prostitution | 3 | 0.2% |
Provinces and territories of Canada | 3 | 0.2% |
Pseudoaneurysm | 3 | 0.2% |
Psychoactive drug | 3 | 0.2% |
Ptosis (eyelid) | 3 | 0.2% |
Public health insurance option | 3 | 0.2% |
Pyelonephritis | 3 | 0.2% |
QRISK | 3 | 0.2% |
Quantum computing | 3 | 0.2% |
Quantum mechanics | 3 | 0.2% |
Rabies vaccine | 3 | 0.2% |
Radar | 3 | 0.2% |
Radioactive contamination | 3 | 0.2% |
Raltegravir | 3 | 0.2% |
Ranibizumab | 3 | 0.2% |
Readability | 3 | 0.2% |
Red blood cell | 3 | 0.2% |
Rehabilitation Act of 1973 | 3 | 0.2% |
Remote surgery | 3 | 0.2% |
Renal cell carcinoma | 3 | 0.2% |
Renin | 3 | 0.2% |
Reproduction | 3 | 0.2% |
Reproduction in mammals | 3 | 0.2% |
Reproductive rights | 3 | 0.2% |
Reuse | 3 | 0.2% |
Rice | 3 | 0.2% |
Rural health | 3 | 0.2% |
Rural health clinic | 3 | 0.2% |
SARS-CoV-2 Beta variant | 3 | 0.2% |
SARS-CoV-2 Delta variant | 3 | 0.2% |
SBAR | 3 | 0.2% |
SOFA score | 3 | 0.2% |
SWOT analysis | 3 | 0.2% |
Safety culture | 3 | 0.2% |
Saving | 3 | 0.2% |
Saxagliptin | 3 | 0.2% |
Scanning laser ophthalmoscopy | 3 | 0.2% |
Scenario analysis | 3 | 0.2% |
Schengen Area | 3 | 0.2% |
Science, technology, engineering, and mathematics | 3 | 0.2% |
Scientific Advice Mechanism | 3 | 0.2% |
Seafood | 3 | 0.2% |
Section 8 (housing) | 3 | 0.2% |
Select agent | 3 | 0.2% |
Self-insurance | 3 | 0.2% |
Self-report study | 3 | 0.2% |
Semiconductor | 3 | 0.2% |
Serosorting | 3 | 0.2% |
Sexuality | 3 | 0.2% |
Signal transduction | 3 | 0.2% |
Skin cancer | 3 | 0.2% |
Social policy | 3 | 0.2% |
Social protection | 3 | 0.2% |
Soil-borne wheat mosaic virus | 3 | 0.2% |
Solid | 3 | 0.2% |
Sorafenib | 3 | 0.2% |
Space exploration | 3 | 0.2% |
Spinal anaesthesia | 3 | 0.2% |
Spinal fusion | 3 | 0.2% |
Staining | 3 | 0.2% |
Stakeholder (corporate) | 3 | 0.2% |
Statistical model | 3 | 0.2% |
Stereolithography | 3 | 0.2% |
Stereotactic surgery | 3 | 0.2% |
Stool guaiac test | 3 | 0.2% |
Strategic management | 3 | 0.2% |
Streptococcus | 3 | 0.2% |
Subacute sclerosing panencephalitis | 3 | 0.2% |
Suicide prevention | 3 | 0.2% |
Superfund | 3 | 0.2% |
Surrogate endpoint | 3 | 0.2% |
Swarm behaviour | 3 | 0.2% |
Systemic inflammatory response syndrome | 3 | 0.2% |
TNF inhibitor | 3 | 0.2% |
Talent management | 3 | 0.2% |
Technology roadmap | 3 | 0.2% |
Teenage pregnancy | 3 | 0.2% |
Telecare | 3 | 0.2% |
Telecommunication | 3 | 0.2% |
Terminal illness | 3 | 0.2% |
Tetraplegia | 3 | 0.2% |
Text mining | 3 | 0.2% |
Theory | 3 | 0.2% |
Time | 3 | 0.2% |
Tirofiban | 3 | 0.2% |
Tobacco rattle virus | 3 | 0.2% |
Toilet | 3 | 0.2% |
Toll-like receptor | 3 | 0.2% |
Tomato brown rugose fruit virus | 3 | 0.2% |
Tomography | 3 | 0.2% |
Tourism | 3 | 0.2% |
Toxicodynamics | 3 | 0.2% |
Trans fat | 3 | 0.2% |
Transfusion-related acute lung injury | 3 | 0.2% |
Transmission of COVID-19 | 3 | 0.2% |
Tricyclic antidepressant | 3 | 0.2% |
Tuberculosis in relation to HIV | 3 | 0.2% |
Tumor microenvironment | 3 | 0.2% |
Tumor necrosis factor alpha | 3 | 0.2% |
Typhoid fever | 3 | 0.2% |
Tyrosine kinase | 3 | 0.2% |
Umbilical cord | 3 | 0.2% |
Unit of alcohol | 3 | 0.2% |
Universal precautions | 3 | 0.2% |
University | 3 | 0.2% |
Urine test strip | 3 | 0.2% |
Urological conditions | 3 | 0.2% |
Uterine prolapse | 3 | 0.2% |
Utility | 3 | 0.2% |
Vaccination schedule | 3 | 0.2% |
Vaccine-preventable diseases | 3 | 0.2% |
Vaccines for Children Program | 3 | 0.2% |
Vaginal yeast infection | 3 | 0.2% |
Valsartan | 3 | 0.2% |
Vehicle | 3 | 0.2% |
Venipuncture | 3 | 0.2% |
Venlafaxine | 3 | 0.2% |
Ventilation (architecture) | 3 | 0.2% |
Ventilator-associated pneumonia | 3 | 0.2% |
Ventricular assist device | 3 | 0.2% |
Veterinarian | 3 | 0.2% |
VigiBase | 3 | 0.2% |
Violence against women | 3 | 0.2% |
Viral diseases | 3 | 0.2% |
Viral replication | 3 | 0.2% |
Virtual wards | 3 | 0.2% |
Volunteering | 3 | 0.2% |
WHO Framework Convention on Tobacco Control | 3 | 0.2% |
Wafer (electronics) | 3 | 0.2% |
Wart | 3 | 0.2% |
Weapon | 3 | 0.2% |
Weather forecasting | 3 | 0.2% |
Weight management | 3 | 0.2% |
Wheat streak mosaic virus | 3 | 0.2% |
Wheeze | 3 | 0.2% |
Wildfire | 3 | 0.2% |
Workplace wellness | 3 | 0.2% |
Zygosity | 3 | 0.2% |
2019–20 coronavirus pandemic | 2 | 0.1% |
3D computer graphics | 2 | 0.1% |
3D modeling | 2 | 0.1% |
3D printing processes | 2 | 0.1% |
ABC (medicine) | 2 | 0.1% |
ABVD | 2 | 0.1% |
ADME | 2 | 0.1% |
Abaloparatide | 2 | 0.1% |
Absorbed dose | 2 | 0.1% |
Absorption (pharmacology) | 2 | 0.1% |
Accounts receivable | 2 | 0.1% |
Acetylcysteine | 2 | 0.1% |
Acinetobacter | 2 | 0.1% |
Action plan | 2 | 0.1% |
Actuarial science | 2 | 0.1% |
Acute toxicity | 2 | 0.1% |
Adaptive behavior | 2 | 0.1% |
Added sugar | 2 | 0.1% |
Adjustable gastric band | 2 | 0.1% |
Administrative Procedure Act (United States) | 2 | 0.1% |
Advance healthcare directive | 2 | 0.1% |
Advanced practice nurse | 2 | 0.1% |
Adverse selection | 2 | 0.1% |
Aedes | 2 | 0.1% |
Aedes aegypti | 2 | 0.1% |
Aerobic exercise | 2 | 0.1% |
Aerosol | 2 | 0.1% |
African Americans | 2 | 0.1% |
Airborne disease | 2 | 0.1% |
Airline | 2 | 0.1% |
Airport | 2 | 0.1% |
Aldosterone | 2 | 0.1% |
Algae fuel | 2 | 0.1% |
Algal bloom | 2 | 0.1% |
Alien (law) | 2 | 0.1% |
Allele | 2 | 0.1% |
Allelopathy | 2 | 0.1% |
Allergic rhinitis | 2 | 0.1% |
Alpha-Linolenic acid | 2 | 0.1% |
Alternatives to animal testing | 2 | 0.1% |
Amblyopia | 2 | 0.1% |
Ambulatory blood pressure | 2 | 0.1% |
Ammunition | 2 | 0.1% |
Amos Tversky | 2 | 0.1% |
Amyloidosis | 2 | 0.1% |
Analytical chemistry | 2 | 0.1% |
Anaplastic lymphoma kinase | 2 | 0.1% |
Anastrozole | 2 | 0.1% |
Anatomical Therapeutic Chemical Classification System | 2 | 0.1% |
Andrea Palm | 2 | 0.1% |
Aneuploidy | 2 | 0.1% |
Angiotensin | 2 | 0.1% |
Animal bacterial diseases | 2 | 0.1% |
Animal bite | 2 | 0.1% |
Animal husbandry | 2 | 0.1% |
Animal virology | 2 | 0.1% |
Ankle–brachial pressure index | 2 | 0.1% |
Antarctica | 2 | 0.1% |
Antenna (radio) | 2 | 0.1% |
Anthropometry | 2 | 0.1% |
Anti-Müllerian hormone | 2 | 0.1% |
Anti-inflammatory | 2 | 0.1% |
Anti-lock braking system | 2 | 0.1% |
Anti-nuclear antibody | 2 | 0.1% |
Antibiotic sensitivity | 2 | 0.1% |
Antibiotics | 2 | 0.1% |
Antigen-presenting cell | 2 | 0.1% |
Antiretroviral drugs | 2 | 0.1% |
Antivenom | 2 | 0.1% |
Anti–vascular endothelial growth factor therapy | 2 | 0.1% |
Apheresis | 2 | 0.1% |
Appeal | 2 | 0.1% |
Appendectomy | 2 | 0.1% |
Appetite | 2 | 0.1% |
Application programming interface | 2 | 0.1% |
Applications of artificial intelligence | 2 | 0.1% |
Applied behavior analysis | 2 | 0.1% |
Applied mathematics | 2 | 0.1% |
Appropriation (law) | 2 | 0.1% |
Appropriation bill | 2 | 0.1% |
AquAdvantage salmon | 2 | 0.1% |
ArcGIS | 2 | 0.1% |
Aripiprazole | 2 | 0.1% |
Arms control | 2 | 0.1% |
Arthroscopy | 2 | 0.1% |
Artificial gene synthesis | 2 | 0.1% |
Artificial kidney | 2 | 0.1% |
Asbestos | 2 | 0.1% |
Aspergillosis | 2 | 0.1% |
Assistive technology | 2 | 0.1% |
Astigmatism | 2 | 0.1% |
Astrophysics | 2 | 0.1% |
Athetosis | 2 | 0.1% |
Atomic force microscopy | 2 | 0.1% |
Attenuated vaccine | 2 | 0.1% |
Authentication | 2 | 0.1% |
Autism therapies | 2 | 0.1% |
Autoimmune hepatitis | 2 | 0.1% |
Autologous chondrocyte implantation | 2 | 0.1% |
Automotive safety | 2 | 0.1% |
BadgerCare | 2 | 0.1% |
Balanced budget amendment | 2 | 0.1% |
Bareback (sex) | 2 | 0.1% |
Basal-cell carcinoma | 2 | 0.1% |
Baseline (budgeting) | 2 | 0.1% |
Basic life support | 2 | 0.1% |
Bee | 2 | 0.1% |
Beehive | 2 | 0.1% |
Behavior change method | 2 | 0.1% |
Belmont Report | 2 | 0.1% |
Bempedoic acid | 2 | 0.1% |
Bendamustine | 2 | 0.1% |
Benign prostatic hyperplasia | 2 | 0.1% |
Beta distribution | 2 | 0.1% |
Bethesda system | 2 | 0.1% |
Better Care Fund | 2 | 0.1% |
Bibliometrics | 2 | 0.1% |
Bicycle | 2 | 0.1% |
BioWatch | 2 | 0.1% |
Bioavailability | 2 | 0.1% |
Biochemical cascade | 2 | 0.1% |
Bioconcentration | 2 | 0.1% |
Bioequivalence | 2 | 0.1% |
Biofilm | 2 | 0.1% |
Biological dispersal | 2 | 0.1% |
Biological globalization | 2 | 0.1% |
Biometrics | 2 | 0.1% |
Biosignature | 2 | 0.1% |
Birthing center | 2 | 0.1% |
Bivalirudin | 2 | 0.1% |
Blastocyst | 2 | 0.1% |
Bleach | 2 | 0.1% |
Blepharoplasty | 2 | 0.1% |
Blood bank | 2 | 0.1% |
Blood lead level | 2 | 0.1% |
Blood pressure measurement | 2 | 0.1% |
Blood vessel | 2 | 0.1% |
BlueTrace | 2 | 0.1% |
Bluetongue disease | 2 | 0.1% |
Bluetooth | 2 | 0.1% |
Board certification | 2 | 0.1% |
Bond (finance) | 2 | 0.1% |
Bone metastasis | 2 | 0.1% |
Border | 2 | 0.1% |
Border control | 2 | 0.1% |
Borderline personality disorder | 2 | 0.1% |
Borrelia | 2 | 0.1% |
Bradycardia | 2 | 0.1% |
Breakthrough therapy | 2 | 0.1% |
Breast self-examination | 2 | 0.1% |
Brexit withdrawal agreement | 2 | 0.1% |
Broad-spectrum antibiotic | 2 | 0.1% |
Bruce Botelho | 2 | 0.1% |
Bruce Keogh | 2 | 0.1% |
Brucella | 2 | 0.1% |
Budesonide | 2 | 0.1% |
Budesonide/formoterol | 2 | 0.1% |
Built environment | 2 | 0.1% |
Buprenorphine | 2 | 0.1% |
Burroughs MCP | 2 | 0.1% |
CD135 | 2 | 0.1% |
CD19 | 2 | 0.1% |
CHOP | 2 | 0.1% |
COVID-19 apps | 2 | 0.1% |
COVID-19 vaccination in the United Kingdom | 2 | 0.1% |
COX-2 inhibitor | 2 | 0.1% |
CRC Energy Efficiency Scheme | 2 | 0.1% |
Calcitriol | 2 | 0.1% |
Calcium supplement | 2 | 0.1% |
Calibration | 2 | 0.1% |
Cancer pain | 2 | 0.1% |
Candida (fungus) | 2 | 0.1% |
Candida albicans | 2 | 0.1% |
Cannabinoid | 2 | 0.1% |
Carboplatin | 2 | 0.1% |
Carcinoembryonic antigen | 2 | 0.1% |
Cardiac marker | 2 | 0.1% |
Cardiac monitoring | 2 | 0.1% |
Cardiogenic shock | 2 | 0.1% |
Cardiopulmonary bypass | 2 | 0.1% |
Cardiopulmonary rehabilitation | 2 | 0.1% |
Cargo | 2 | 0.1% |
Carotid endarterectomy | 2 | 0.1% |
Carotid stenting | 2 | 0.1% |
Cartilage | 2 | 0.1% |
Case mix | 2 | 0.1% |
Cash flow statement | 2 | 0.1% |
Caspofungin | 2 | 0.1% |
Cefiderocol | 2 | 0.1% |
Ceftriaxone | 2 | 0.1% |
Cell biology | 2 | 0.1% |
Cell culture | 2 | 0.1% |
Cellular network | 2 | 0.1% |
Cellulitis | 2 | 0.1% |
Central nervous system disorders | 2 | 0.1% |
Cereal | 2 | 0.1% |
Ceritinib | 2 | 0.1% |
Cervicitis | 2 | 0.1% |
Chart | 2 | 0.1% |
Cheese | 2 | 0.1% |
Chemical element | 2 | 0.1% |
Chest pain | 2 | 0.1% |
Chief operating officer | 2 | 0.1% |
Chief risk officer | 2 | 0.1% |
Child development | 2 | 0.1% |
Childhood cancer | 2 | 0.1% |
Chlorhexidine | 2 | 0.1% |
Cholecystitis | 2 | 0.1% |
Choroidal neovascularization | 2 | 0.1% |
Chromatin | 2 | 0.1% |
Chronic care management | 2 | 0.1% |
Chronic myelomonocytic leukemia | 2 | 0.1% |
Chronic wasting disease | 2 | 0.1% |
Citalopram | 2 | 0.1% |
Clinical engineering | 2 | 0.1% |
Clinical pharmacy | 2 | 0.1% |
Clotrimazole | 2 | 0.1% |
Coal | 2 | 0.1% |
Coccidioidomycosis | 2 | 0.1% |
Code of Federal Regulations | 2 | 0.1% |
Cohen's kappa | 2 | 0.1% |
Coma | 2 | 0.1% |
Communication protocol | 2 | 0.1% |
Competition (economics) | 2 | 0.1% |
Complement system | 2 | 0.1% |
Complementary DNA | 2 | 0.1% |
Complex traits | 2 | 0.1% |
Complexity | 2 | 0.1% |
Computer-aided design | 2 | 0.1% |
Conjoint analysis | 2 | 0.1% |
Consolidated Omnibus Budget Reconciliation Act of 1985 | 2 | 0.1% |
Contact lens | 2 | 0.1% |
Continuing medical education | 2 | 0.1% |
Continuous positive airway pressure | 2 | 0.1% |
Coral reef | 2 | 0.1% |
CoronaVac | 2 | 0.1% |
Coronary CT angiography | 2 | 0.1% |
Corporation | 2 | 0.1% |
Corps | 2 | 0.1% |
Corrective and preventive action | 2 | 0.1% |
Cosmic dust | 2 | 0.1% |
Counseling psychology | 2 | 0.1% |
Counter-terrorism | 2 | 0.1% |
CpG site | 2 | 0.1% |
Creatine kinase | 2 | 0.1% |
Creutzfeldt–Jakob disease | 2 | 0.1% |
Crimean–Congo hemorrhagic fever | 2 | 0.1% |
Criminal record | 2 | 0.1% |
Crisis | 2 | 0.1% |
Crohn's disease | 2 | 0.1% |
Crop rotation | 2 | 0.1% |
Cross-sectional study | 2 | 0.1% |
Cryopreservation | 2 | 0.1% |
Cure | 2 | 0.1% |
Cushing's disease | 2 | 0.1% |
Customer relationship management | 2 | 0.1% |
Customer satisfaction | 2 | 0.1% |
Cyclin-dependent kinase | 2 | 0.1% |
Cycling | 2 | 0.1% |
Cyclophosphamide | 2 | 0.1% |
DNA microarray | 2 | 0.1% |
DNA profiling | 2 | 0.1% |
DNA replication | 2 | 0.1% |
Daclizumab | 2 | 0.1% |
Daniel Kahneman | 2 | 0.1% |
Dark matter | 2 | 0.1% |
Dasatinib | 2 | 0.1% |
Data center | 2 | 0.1% |
Data visualization | 2 | 0.1% |
Decentralization | 2 | 0.1% |
Declaration of Helsinki | 2 | 0.1% |
Deferred adjudication | 2 | 0.1% |
Deformation (mechanics) | 2 | 0.1% |
Dendrite | 2 | 0.1% |
Dengue vaccine | 2 | 0.1% |
Dense breast tissue | 2 | 0.1% |
Dental assistant | 2 | 0.1% |
Dental public health | 2 | 0.1% |
Dental therapist | 2 | 0.1% |
Deployment of COVID-19 vaccines | 2 | 0.1% |
Deprescribing | 2 | 0.1% |
Dermatitis | 2 | 0.1% |
Desertification | 2 | 0.1% |
Dessert | 2 | 0.1% |
Diabetic foot | 2 | 0.1% |
Diabetic foot ulcer | 2 | 0.1% |
Diabetic neuropathy | 2 | 0.1% |
Dieldrin | 2 | 0.1% |
Digital data | 2 | 0.1% |
Digital pathology | 2 | 0.1% |
Diphtheria | 2 | 0.1% |
Disaster recovery and business continuity auditing | 2 | 0.1% |
Discrete choice | 2 | 0.1% |
Discrete trial training | 2 | 0.1% |
Disease outbreak | 2 | 0.1% |
Disease outbreaks | 2 | 0.1% |
District nurse | 2 | 0.1% |
Do-it-yourself biology | 2 | 0.1% |
Docking (molecular) | 2 | 0.1% |
Doctor of Medicine | 2 | 0.1% |
Domperidone | 2 | 0.1% |
Donabedian model | 2 | 0.1% |
Donepezil | 2 | 0.1% |
Dopamine | 2 | 0.1% |
Doxycycline | 2 | 0.1% |
Drinking water | 2 | 0.1% |
Dronabinol | 2 | 0.1% |
Drug test | 2 | 0.1% |
Drug-induced QT prolongation | 2 | 0.1% |
Drugs acting on the nervous system | 2 | 0.1% |
Dynamo theory | 2 | 0.1% |
Earthquake | 2 | 0.1% |
East Riding of Yorkshire | 2 | 0.1% |
Eastern equine encephalitis | 2 | 0.1% |
Eating | 2 | 0.1% |
Ebola vaccine | 2 | 0.1% |
Echinocandin | 2 | 0.1% |
Economic development | 2 | 0.1% |
Economic inequality | 2 | 0.1% |
Effects of global warming | 2 | 0.1% |
Egg allergy | 2 | 0.1% |
Electromyography | 2 | 0.1% |
Electronic data interchange | 2 | 0.1% |
Electronic waste | 2 | 0.1% |
Electronics | 2 | 0.1% |
Embodied cognition | 2 | 0.1% |
Embolic stroke of undetermined source | 2 | 0.1% |
Emergency medical services in the United Kingdom | 2 | 0.1% |
Empiricism | 2 | 0.1% |
Encephalitis | 2 | 0.1% |
Endophthalmitis | 2 | 0.1% |
Endoscopic submucosal dissection | 2 | 0.1% |
Energy management | 2 | 0.1% |
Enterococcus | 2 | 0.1% |
Enterovirus-associated diseases | 2 | 0.1% |
Environmental governance | 2 | 0.1% |
Environmental protection | 2 | 0.1% |
Enzyme | 2 | 0.1% |
Epidemics | 2 | 0.1% |
Epithelium | 2 | 0.1% |
Eptifibatide | 2 | 0.1% |
Equalization payments | 2 | 0.1% |
Esophagogastroduodenoscopy | 2 | 0.1% |
Estrogen (medication) | 2 | 0.1% |
Estrogen receptor | 2 | 0.1% |
Ethology | 2 | 0.1% |
Etomidate | 2 | 0.1% |
Etonogestrel | 2 | 0.1% |
Eugenics | 2 | 0.1% |
Eur-Lex | 2 | 0.1% |
European Green Deal | 2 | 0.1% |
European Neighbourhood Policy | 2 | 0.1% |
Evaluation of binary classifiers | 2 | 0.1% |
Everolimus | 2 | 0.1% |
Evidence | 2 | 0.1% |
Evidence-based policy | 2 | 0.1% |
Exenatide | 2 | 0.1% |
Exercise prescription | 2 | 0.1% |
Exercise-induced bronchoconstriction | 2 | 0.1% |
Exhalation | 2 | 0.1% |
Exocrine system | 2 | 0.1% |
Externality | 2 | 0.1% |
Eye protection | 2 | 0.1% |
Ezetimibe/simvastatin | 2 | 0.1% |
FDA warning letter | 2 | 0.1% |
FRAX | 2 | 0.1% |
Facial recognition system | 2 | 0.1% |
Facilitator | 2 | 0.1% |
Factor H | 2 | 0.1% |
Factor V Leiden | 2 | 0.1% |
Factor X | 2 | 0.1% |
Fake news | 2 | 0.1% |
False Claims Act | 2 | 0.1% |
Familial adenomatous polyposis | 2 | 0.1% |
Family caregivers | 2 | 0.1% |
Fecal incontinence | 2 | 0.1% |
Fee | 2 | 0.1% |
Female condom | 2 | 0.1% |
Fentanyl | 2 | 0.1% |
Fertilizer | 2 | 0.1% |
Fetal movement | 2 | 0.1% |
Fibrinogen | 2 | 0.1% |
Field epidemiology | 2 | 0.1% |
First Nations | 2 | 0.1% |
Fish farming | 2 | 0.1% |
Fishing | 2 | 0.1% |
Flood | 2 | 0.1% |
Flowchart | 2 | 0.1% |
Fludeoxyglucose (18F) | 2 | 0.1% |
Fluoride varnish | 2 | 0.1% |
Fluoxetine | 2 | 0.1% |
Follicle-stimulating hormone | 2 | 0.1% |
Food Distribution Program on Indian Reservations | 2 | 0.1% |
Food allergy | 2 | 0.1% |
Food choice | 2 | 0.1% |
Food fortification | 2 | 0.1% |
Food intolerance | 2 | 0.1% |
Food marketing | 2 | 0.1% |
Foods | 2 | 0.1% |
Forestry | 2 | 0.1% |
Fraction | 2 | 0.1% |
Free clinic | 2 | 0.1% |
Freedom of Information Act (United States) | 2 | 0.1% |
Function (mathematics) | 2 | 0.1% |
Fungus | 2 | 0.1% |
GISAID | 2 | 0.1% |
Gas detector | 2 | 0.1% |
Gastric bypass surgery | 2 | 0.1% |
Gastrointestinal bleeding | 2 | 0.1% |
Gaza Strip | 2 | 0.1% |
Gefitinib | 2 | 0.1% |
Gel | 2 | 0.1% |
Gender equality | 2 | 0.1% |
Gene delivery | 2 | 0.1% |
Gene drive | 2 | 0.1% |
Gene expression profiling in cancer | 2 | 0.1% |
Gene signature | 2 | 0.1% |
Gene silencing | 2 | 0.1% |
Genealogy | 2 | 0.1% |
Generalized linear model | 2 | 0.1% |
Genetic code | 2 | 0.1% |
Genital herpes | 2 | 0.1% |
Geology | 2 | 0.1% |
Gerontology | 2 | 0.1% |
Gestational hypertension | 2 | 0.1% |
Glands | 2 | 0.1% |
Glasses | 2 | 0.1% |
Glucose | 2 | 0.1% |
Glycomics | 2 | 0.1% |
Goat | 2 | 0.1% |
Gout | 2 | 0.1% |
Granulocyte colony-stimulating factor | 2 | 0.1% |
Green card | 2 | 0.1% |
Grid computing | 2 | 0.1% |
Grocery store | 2 | 0.1% |
Group home | 2 | 0.1% |
Gut flora | 2 | 0.1% |
H-index | 2 | 0.1% |
HIV/AIDS research | 2 | 0.1% |
HTTPS | 2 | 0.1% |
Haematopoiesis | 2 | 0.1% |
Haemophilia | 2 | 0.1% |
Health and Social Care Network | 2 | 0.1% |
Health claim | 2 | 0.1% |
Health disasters | 2 | 0.1% |
Health law | 2 | 0.1% |
Health reimbursement account | 2 | 0.1% |
Health savings account | 2 | 0.1% |
Health security | 2 | 0.1% |
Health visitor | 2 | 0.1% |
Healthcare Cost and Utilization Project | 2 | 0.1% |
Heart-type fatty acid binding protein | 2 | 0.1% |
Heartburn | 2 | 0.1% |
Hematopoietic stem cell | 2 | 0.1% |
Hemofiltration | 2 | 0.1% |
Hemoglobin | 2 | 0.1% |
Hemolytic disease of the newborn | 2 | 0.1% |
Henipavirus | 2 | 0.1% |
Hepatotoxicity | 2 | 0.1% |
Herbal medicine | 2 | 0.1% |
High-grade serous carcinoma | 2 | 0.1% |
High-risk pregnancy | 2 | 0.1% |
Hip | 2 | 0.1% |
Hodgkin's lymphoma | 2 | 0.1% |
Honey bee | 2 | 0.1% |
Hormesis | 2 | 0.1% |
Hormone | 2 | 0.1% |
Hospice | 2 | 0.1% |
Hospital accreditation | 2 | 0.1% |
Household | 2 | 0.1% |
Housing First | 2 | 0.1% |
Human Development Index | 2 | 0.1% |
Human betaherpesvirus 5 | 2 | 0.1% |
Human cloning | 2 | 0.1% |
Human gastrointestinal microbiota | 2 | 0.1% |
Human leukocyte antigen | 2 | 0.1% |
Human orthopneumovirus | 2 | 0.1% |
Human resources | 2 | 0.1% |
Human services | 2 | 0.1% |
Humidity | 2 | 0.1% |
Humoral immunity | 2 | 0.1% |
Hunger | 2 | 0.1% |
Hurricane Katrina | 2 | 0.1% |
Hydrogen storage | 2 | 0.1% |
Hydronephrosis | 2 | 0.1% |
Hydroxychloroquine | 2 | 0.1% |
Hyperparathyroidism | 2 | 0.1% |
Hyperprolactinaemia | 2 | 0.1% |
Hyperthyroidism | 2 | 0.1% |
Hypokalemia | 2 | 0.1% |
Hypotension | 2 | 0.1% |
Hypoxemia | 2 | 0.1% |
IRS tax forms | 2 | 0.1% |
ISO 22000 | 2 | 0.1% |
Iatrogenesis | 2 | 0.1% |
Ibrutinib | 2 | 0.1% |
Ibuprofen | 2 | 0.1% |
Ice | 2 | 0.1% |
Idiopathic pulmonary fibrosis | 2 | 0.1% |
Imaging | 2 | 0.1% |
Immunoassay | 2 | 0.1% |
Immunoglobulin M | 2 | 0.1% |
Immunosuppression | 2 | 0.1% |
Impact factor | 2 | 0.1% |
Imputation (statistics) | 2 | 0.1% |
Inclusion (education) | 2 | 0.1% |
Income | 2 | 0.1% |
Incretin | 2 | 0.1% |
Index Medicus | 2 | 0.1% |
Indigestion | 2 | 0.1% |
Infant formula | 2 | 0.1% |
Infectious mononucleosis | 2 | 0.1% |
Infective endocarditis | 2 | 0.1% |
Inferior vena cava filter | 2 | 0.1% |
Inflammatory cytokine | 2 | 0.1% |
Influenza research | 2 | 0.1% |
Information and communications technology | 2 | 0.1% |
Injuries | 2 | 0.1% |
Insect | 2 | 0.1% |
Insect-borne diseases | 2 | 0.1% |
Insecticide | 2 | 0.1% |
Insulin aspart | 2 | 0.1% |
Insulin degludec | 2 | 0.1% |
Insulin glargine | 2 | 0.1% |
Integrated disease surveillance program | 2 | 0.1% |
Integrity | 2 | 0.1% |
Intensive farming | 2 | 0.1% |
Intention | 2 | 0.1% |
Interdisciplinary subfields | 2 | 0.1% |
Interest rate | 2 | 0.1% |
Interleukin-1 family | 2 | 0.1% |
Internal validity | 2 | 0.1% |
International humanitarian law | 2 | 0.1% |
Internet access | 2 | 0.1% |
Interstitial cystitis | 2 | 0.1% |
Intracytoplasmic sperm injection | 2 | 0.1% |
Intraocular lens | 2 | 0.1% |
Invasive carcinoma of no special type | 2 | 0.1% |
Investment | 2 | 0.1% |
Iodine deficiency | 2 | 0.1% |
Ipilimumab | 2 | 0.1% |
Iron overload | 2 | 0.1% |
Isotope | 2 | 0.1% |
Ivabradine | 2 | 0.1% |
Janssen COVID-19 vaccine | 2 | 0.1% |
Janus kinase | 2 | 0.1% |
Jože Plečnik | 2 | 0.1% |
Judgment (law) | 2 | 0.1% |
Junk food | 2 | 0.1% |
Jupiter | 2 | 0.1% |
Juvenile idiopathic arthritis | 2 | 0.1% |
KIT (gene) | 2 | 0.1% |
Kangaroo care | 2 | 0.1% |
Kaplan–Meier estimator | 2 | 0.1% |
Kaposi's sarcoma | 2 | 0.1% |
Kaposi's sarcoma-associated herpesvirus | 2 | 0.1% |
Kernicterus | 2 | 0.1% |
Kinase | 2 | 0.1% |
Kinder Surprise | 2 | 0.1% |
Knee | 2 | 0.1% |
Lab-on-a-chip | 2 | 0.1% |
Laboratory Response Network | 2 | 0.1% |
Lactobacillus | 2 | 0.1% |
Language interpretation | 2 | 0.1% |
Large for gestational age | 2 | 0.1% |
Lawsuit | 2 | 0.1% |
Leaf | 2 | 0.1% |
Legionella | 2 | 0.1% |
Legionnaires' disease | 2 | 0.1% |
Lentigo maligna | 2 | 0.1% |
Leprosy | 2 | 0.1% |
Levothyroxine | 2 | 0.1% |
Liability insurance | 2 | 0.1% |
Lidocaine | 2 | 0.1% |
Life history theory | 2 | 0.1% |
Likert scale | 2 | 0.1% |
Limited liability company | 2 | 0.1% |
Lineage B.1.351 | 2 | 0.1% |
Lisinopril | 2 | 0.1% |
Lixisenatide | 2 | 0.1% |
Li–Fraumeni syndrome | 2 | 0.1% |
Ljubljana | 2 | 0.1% |
Lobular carcinoma in situ | 2 | 0.1% |
Local average treatment effect | 2 | 0.1% |
Long COVID | 2 | 0.1% |
Long non-coding RNA | 2 | 0.1% |
Long-term effects of alcohol | 2 | 0.1% |
Loss function | 2 | 0.1% |
Lovastatin | 2 | 0.1% |
Lower gastrointestinal series | 2 | 0.1% |
Lymph node | 2 | 0.1% |
Lymphatic vessel | 2 | 0.1% |
MRI contrast agent | 2 | 0.1% |
MRNA vaccine | 2 | 0.1% |
Macular telangiectasia | 2 | 0.1% |
Magnesium deficiency | 2 | 0.1% |
Magnetic resonance angiography | 2 | 0.1% |
Malignancy | 2 | 0.1% |
Malware | 2 | 0.1% |
Mammalian sexuality | 2 | 0.1% |
Management of depression | 2 | 0.1% |
Mandibular advancement splint | 2 | 0.1% |
Marburg virus | 2 | 0.1% |
Marriage | 2 | 0.1% |
Mass drug administration | 2 | 0.1% |
Mass spectrometry | 2 | 0.1% |
Mastectomy | 2 | 0.1% |
Materials | 2 | 0.1% |
Mathematics | 2 | 0.1% |
Maximum likelihood estimation | 2 | 0.1% |
Maximum residue limit | 2 | 0.1% |
Mechanics | 2 | 0.1% |
MedDRA | 2 | 0.1% |
Media (communication) | 2 | 0.1% |
Medical abortion | 2 | 0.1% |
Medical emergency | 2 | 0.1% |
Medical equipment management | 2 | 0.1% |
Medical procedures | 2 | 0.1% |
Medical technology | 2 | 0.1% |
Medicalization | 2 | 0.1% |
Mediterranean Sea | 2 | 0.1% |
Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2 | 0.1% |
Mefloquine | 2 | 0.1% |
Megakaryocyte | 2 | 0.1% |
Melanocytic nevus | 2 | 0.1% |
Membrane | 2 | 0.1% |
Menstruation | 2 | 0.1% |
Mental states | 2 | 0.1% |
Mentorship | 2 | 0.1% |
Menu | 2 | 0.1% |
Meta-regression | 2 | 0.1% |
Metabolic engineering | 2 | 0.1% |
Metabolic pathway | 2 | 0.1% |
Metal detector | 2 | 0.1% |
Metamaterial | 2 | 0.1% |
Metastatic liver disease | 2 | 0.1% |
Methylenetetrahydrofolate reductase | 2 | 0.1% |
Metoprolol | 2 | 0.1% |
Microalbuminuria | 2 | 0.1% |
Microgrid | 2 | 0.1% |
Micronucleus | 2 | 0.1% |
Microorganism | 2 | 0.1% |
Microscope slide | 2 | 0.1% |
Microsimulation | 2 | 0.1% |
Microwave ablation | 2 | 0.1% |
Miliary tuberculosis | 2 | 0.1% |
Milky Way | 2 | 0.1% |
Minimum wage | 2 | 0.1% |
Mitigating factor | 2 | 0.1% |
Mitochondrial disease | 2 | 0.1% |
Mitochondrial replacement therapy | 2 | 0.1% |
MitraClip | 2 | 0.1% |
Mitral valve replacement | 2 | 0.1% |
Mobile phone | 2 | 0.1% |
Mobility aid | 2 | 0.1% |
Monocyte | 2 | 0.1% |
Monounsaturated fat | 2 | 0.1% |
Moral hazard | 2 | 0.1% |
Mosquito control | 2 | 0.1% |
Mother | 2 | 0.1% |
Mouse | 2 | 0.1% |
Mucositis | 2 | 0.1% |
Multilocus sequence typing | 2 | 0.1% |
Multiple-criteria decision analysis | 2 | 0.1% |
Myc | 2 | 0.1% |
Myelofibrosis | 2 | 0.1% |
Myocarditis | 2 | 0.1% |
N-terminal prohormone of brain natriuretic peptide | 2 | 0.1% |
NHS Direct | 2 | 0.1% |
NHS Test and Trace | 2 | 0.1% |
NIOSH air filtration rating | 2 | 0.1% |
Nabiximols | 2 | 0.1% |
Nandrolone | 2 | 0.1% |
Nanotoxicology | 2 | 0.1% |
Nanowire | 2 | 0.1% |
National Flood Insurance Program | 2 | 0.1% |
National School Lunch Act | 2 | 0.1% |
National coverage determination | 2 | 0.1% |
Native Americans in the United States | 2 | 0.1% |
Needle and syringe programmes | 2 | 0.1% |
Neonatal jaundice | 2 | 0.1% |
Neonatology | 2 | 0.1% |
Neovascularization | 2 | 0.1% |
Neurological disorders | 2 | 0.1% |
Neuromorphic engineering | 2 | 0.1% |
Neutrophil | 2 | 0.1% |
Nevus | 2 | 0.1% |
Nilotinib | 2 | 0.1% |
Nobel Prize in Chemistry | 2 | 0.1% |
Noise pollution | 2 | 0.1% |
Non-Hodgkin lymphoma | 2 | 0.1% |
Norethisterone | 2 | 0.1% |
Normal distribution | 2 | 0.1% |
Notary public | 2 | 0.1% |
Notifiable disease | 2 | 0.1% |
Notified body | 2 | 0.1% |
Novel food | 2 | 0.1% |
Nuclear reactor | 2 | 0.1% |
Nuclear weapon | 2 | 0.1% |
Nucleic acid | 2 | 0.1% |
Nuremberg Code | 2 | 0.1% |
Nursing in the United Kingdom | 2 | 0.1% |
Nutrients | 2 | 0.1% |
OIE/FAO Network of Expertise on Animal Influenza | 2 | 0.1% |
Obeticholic acid | 2 | 0.1% |
Obsessive–compulsive disorder | 2 | 0.1% |
Occam's razor | 2 | 0.1% |
Occupational Safety and Health Act (United States) | 2 | 0.1% |
Ocean acidification | 2 | 0.1% |
Olanzapine | 2 | 0.1% |
Omega-3 acid ethyl esters | 2 | 0.1% |
Ongoing events | 2 | 0.1% |
Open innovation | 2 | 0.1% |
Operating surplus | 2 | 0.1% |
Opioid overdose | 2 | 0.1% |
Optical microscope | 2 | 0.1% |
Optogenetics | 2 | 0.1% |
Orbit | 2 | 0.1% |
Orbit (anatomy) | 2 | 0.1% |
Organic compounds | 2 | 0.1% |
Organization development | 2 | 0.1% |
Orthohantavirus | 2 | 0.1% |
Osimertinib | 2 | 0.1% |
Otoacoustic emission | 2 | 0.1% |
Overfitting | 2 | 0.1% |
Oxidative stress | 2 | 0.1% |
Oxygen saturation (medicine) | 2 | 0.1% |
Ozone depletion | 2 | 0.1% |
PDCA | 2 | 0.1% |
2 | 0.1% | |
PET-CT | 2 | 0.1% |
PH | 2 | 0.1% |
Paclitaxel | 2 | 0.1% |
Pandemic H1N1/09 virus | 2 | 0.1% |
Panitumumab | 2 | 0.1% |
Paroxetine | 2 | 0.1% |
Particle physics | 2 | 0.1% |
Partner notification | 2 | 0.1% |
Patient education | 2 | 0.1% |
Patient navigators | 2 | 0.1% |
Patient-controlled analgesia | 2 | 0.1% |
Payment | 2 | 0.1% |
Pegaptanib | 2 | 0.1% |
Pelvic examination | 2 | 0.1% |
Pelvis | 2 | 0.1% |
Pemphigus | 2 | 0.1% |
Pentavalent vaccine | 2 | 0.1% |
Peptic ulcer disease | 2 | 0.1% |
Percentage | 2 | 0.1% |
Performance improvement | 2 | 0.1% |
Perfusion | 2 | 0.1% |
Pericarditis | 2 | 0.1% |
Perioperative nursing | 2 | 0.1% |
Peripherally inserted central catheter | 2 | 0.1% |
Peritoneum | 2 | 0.1% |
Perovskite (structure) | 2 | 0.1% |
Personal identity | 2 | 0.1% |
Pertuzumab | 2 | 0.1% |
Pervasive developmental disorder | 2 | 0.1% |
Pervasive developmental disorder not otherwise specified | 2 | 0.1% |
Phagocyte | 2 | 0.1% |
Pharmacodynamics | 2 | 0.1% |
Phencyclidine | 2 | 0.1% |
Phenotypic trait | 2 | 0.1% |
Philippine national identity card | 2 | 0.1% |
Photovoltaic system | 2 | 0.1% |
Physical restraint | 2 | 0.1% |
Physical security | 2 | 0.1% |
Physician Orders for Life-Sustaining Treatment | 2 | 0.1% |
Piperacillin | 2 | 0.1% |
Piperaquine | 2 | 0.1% |
Planetary core | 2 | 0.1% |
Plant pathology | 2 | 0.1% |
Plasma (physics) | 2 | 0.1% |
Plasmid | 2 | 0.1% |
Plasmodium malariae | 2 | 0.1% |
Plea bargain | 2 | 0.1% |
Pledge of Allegiance | 2 | 0.1% |
Podiatrist | 2 | 0.1% |
Podiatry | 2 | 0.1% |
Post-transplant lymphoproliferative disorder | 2 | 0.1% |
Post-traumatic amnesia | 2 | 0.1% |
Post-traumatic stress disorder | 2 | 0.1% |
Postgraduate education | 2 | 0.1% |
Postoperative nausea and vomiting | 2 | 0.1% |
Postpartum bleeding | 2 | 0.1% |
Powder bed and inkjet head 3D printing | 2 | 0.1% |
Power station | 2 | 0.1% |
Precision agriculture | 2 | 0.1% |
Predictive analytics | 2 | 0.1% |
Predictive modelling | 2 | 0.1% |
Premature ventricular contraction | 2 | 0.1% |
Price | 2 | 0.1% |
Pricing | 2 | 0.1% |
Primary sclerosing cholangitis | 2 | 0.1% |
Prince George's County, Maryland | 2 | 0.1% |
Procedural sedation and analgesia | 2 | 0.1% |
Professional degrees of public health | 2 | 0.1% |
Prognosis | 2 | 0.1% |
Program optimization | 2 | 0.1% |
Project Bioshield Act | 2 | 0.1% |
Promoter (genetics) | 2 | 0.1% |
Proof of concept | 2 | 0.1% |
Propfan | 2 | 0.1% |
Prostate biopsy | 2 | 0.1% |
Protected health information | 2 | 0.1% |
Protein kinase | 2 | 0.1% |
Prothrombin G20210A | 2 | 0.1% |
Protocell | 2 | 0.1% |
Proton therapy | 2 | 0.1% |
Protozoal diseases | 2 | 0.1% |
Pseudomonas | 2 | 0.1% |
Pseudomonas aeruginosa | 2 | 0.1% |
Psoriasis | 2 | 0.1% |
Psoriatic arthritis | 2 | 0.1% |
Psychiatric rehabilitation | 2 | 0.1% |
Psychologist | 2 | 0.1% |
Psychometrics | 2 | 0.1% |
Public broadcasting | 2 | 0.1% |
Public health informatics | 2 | 0.1% |
Pulse wave velocity | 2 | 0.1% |
Pump | 2 | 0.1% |
Quality management system | 2 | 0.1% |
Quantitative trait locus | 2 | 0.1% |
Quantum entanglement | 2 | 0.1% |
Quantum simulator | 2 | 0.1% |
Quetiapine | 2 | 0.1% |
Quinidine | 2 | 0.1% |
RANKL | 2 | 0.1% |
RNA-Seq | 2 | 0.1% |
Rabies virus | 2 | 0.1% |
Radiation | 2 | 0.1% |
Radio | 2 | 0.1% |
Radiobiology | 2 | 0.1% |
Radiopharmaceutical | 2 | 0.1% |
Radon | 2 | 0.1% |
Ramucirumab | 2 | 0.1% |
Randomness | 2 | 0.1% |
Reactive oxygen species | 2 | 0.1% |
Real world evidence | 2 | 0.1% |
Rechargeable battery | 2 | 0.1% |
Reconciliation (United States Congress) | 2 | 0.1% |
Record linkage | 2 | 0.1% |
Records management | 2 | 0.1% |
Refractive surgery | 2 | 0.1% |
Regularization (mathematics) | 2 | 0.1% |
Regulation of pesticides in the European Union | 2 | 0.1% |
Regulation of therapeutic goods | 2 | 0.1% |
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations | 2 | 0.1% |
Representativeness heuristic | 2 | 0.1% |
Reproducibility | 2 | 0.1% |
Reputation | 2 | 0.1% |
Residential care | 2 | 0.1% |
Residential segregation in the United States | 2 | 0.1% |
Resource | 2 | 0.1% |
Respiratory diseases | 2 | 0.1% |
Respiratory syncytial virus | 2 | 0.1% |
Respiratory tract infection | 2 | 0.1% |
Response rate (survey) | 2 | 0.1% |
Resting state fMRI | 2 | 0.1% |
Retinoblastoma | 2 | 0.1% |
Retinopathy of prematurity | 2 | 0.1% |
Retrovirus | 2 | 0.1% |
Reverse osmosis | 2 | 0.1% |
Reverse transcriptase | 2 | 0.1% |
Revised Cardiac Risk Index | 2 | 0.1% |
Rhabdomyolysis | 2 | 0.1% |
Rhinitis | 2 | 0.1% |
Rhinovirus | 2 | 0.1% |
Rifapentine | 2 | 0.1% |
Rift Valley fever | 2 | 0.1% |
Risk appetite | 2 | 0.1% |
Risperidone | 2 | 0.1% |
Road | 2 | 0.1% |
Robert Guthrie | 2 | 0.1% |
Root | 2 | 0.1% |
Rover (space exploration) | 2 | 0.1% |
Ryan White | 2 | 0.1% |
SARS-CoV-2 Alpha variant | 2 | 0.1% |
Salbutamol | 2 | 0.1% |
Sales | 2 | 0.1% |
Salmonella | 2 | 0.1% |
Salmonellosis | 2 | 0.1% |
Sanitation | 2 | 0.1% |
Sanitization (classified information) | 2 | 0.1% |
Sarcoma | 2 | 0.1% |
Satellite navigation | 2 | 0.1% |
Saturn | 2 | 0.1% |
Scanning electron microscope | 2 | 0.1% |
School meal | 2 | 0.1% |
School meal programs in the United States | 2 | 0.1% |
Scientific community | 2 | 0.1% |
Scientific modelling | 2 | 0.1% |
Scott Walker (politician) | 2 | 0.1% |
Seat belt | 2 | 0.1% |
Sedation | 2 | 0.1% |
Selective internal radiation therapy | 2 | 0.1% |
Self-assembly | 2 | 0.1% |
Self-contained breathing apparatus | 2 | 0.1% |
Self-employment | 2 | 0.1% |
Self-harm | 2 | 0.1% |
Semiconductor device fabrication | 2 | 0.1% |
Senescence | 2 | 0.1% |
Sequence alignment | 2 | 0.1% |
Sequential analysis | 2 | 0.1% |
Seroconversion | 2 | 0.1% |
Sertraline | 2 | 0.1% |
Sexology | 2 | 0.1% |
Sexual anatomy | 2 | 0.1% |
Sexual emotions | 2 | 0.1% |
Sexual violence | 2 | 0.1% |
Ship | 2 | 0.1% |
Shoulder | 2 | 0.1% |
Sick leave | 2 | 0.1% |
Sideroblastic anemia | 2 | 0.1% |
Sinopharm BIBP COVID-19 vaccine | 2 | 0.1% |
Sirolimus | 2 | 0.1% |
Situation awareness | 2 | 0.1% |
Skin condition | 2 | 0.1% |
Skull fracture | 2 | 0.1% |
Slum | 2 | 0.1% |
Sláintecare | 2 | 0.1% |
Small for gestational age | 2 | 0.1% |
Small satellite | 2 | 0.1% |
Small-cell carcinoma | 2 | 0.1% |
Smart city | 2 | 0.1% |
Smart grid | 2 | 0.1% |
Smartphone | 2 | 0.1% |
Snakebite | 2 | 0.1% |
Snowball sampling | 2 | 0.1% |
Social Security Act | 2 | 0.1% |
Social Security Disability Insurance | 2 | 0.1% |
Social competence | 2 | 0.1% |
Social discount rate | 2 | 0.1% |
Social isolation | 2 | 0.1% |
Social networking service | 2 | 0.1% |
Social responsibility | 2 | 0.1% |
Social robot | 2 | 0.1% |
Social services | 2 | 0.1% |
Sodium channel blocker | 2 | 0.1% |
Sodium hypochlorite | 2 | 0.1% |
Software development | 2 | 0.1% |
Software verification and validation | 2 | 0.1% |
Solar thermal energy | 2 | 0.1% |
Somatic cell nuclear transfer | 2 | 0.1% |
Spanish flu | 2 | 0.1% |
Speaker of the United States House of Representatives | 2 | 0.1% |
Special agent | 2 | 0.1% |
Species complex | 2 | 0.1% |
Spermicide | 2 | 0.1% |
Spice | 2 | 0.1% |
Spironolactone | 2 | 0.1% |
Spreadsheet | 2 | 0.1% |
Standard score | 2 | 0.1% |
Staphylococcus | 2 | 0.1% |
Star cluster | 2 | 0.1% |
Startup company | 2 | 0.1% |
Statistical area (United States) | 2 | 0.1% |
Statistical methods | 2 | 0.1% |
Statute of limitations | 2 | 0.1% |
Sterilization (medicine) | 2 | 0.1% |
Stichting | 2 | 0.1% |
Stimulant | 2 | 0.1% |
Streptococcus pneumoniae | 2 | 0.1% |
Stress hyperglycemia | 2 | 0.1% |
Student financial aid (United States) | 2 | 0.1% |
Student's t-test | 2 | 0.1% |
Subarachnoid hemorrhage | 2 | 0.1% |
Subcutaneous injection | 2 | 0.1% |
Subdural hematoma | 2 | 0.1% |
Substance-related disorders | 2 | 0.1% |
Sun | 2 | 0.1% |
Sunset provision | 2 | 0.1% |
Superconductivity | 2 | 0.1% |
Superficial thrombophlebitis | 2 | 0.1% |
Supermarket | 2 | 0.1% |
Supplier-induced demand | 2 | 0.1% |
Supply chain management | 2 | 0.1% |
Supraventricular tachycardia | 2 | 0.1% |
Surrogacy | 2 | 0.1% |
Survival rate | 2 | 0.1% |
Sustainable Development Goal 3 | 2 | 0.1% |
Synaptic plasticity | 2 | 0.1% |
Syndemic | 2 | 0.1% |
Synergy | 2 | 0.1% |
Synthetic-aperture radar | 2 | 0.1% |
TCN Protocol | 2 | 0.1% |
TLR4 | 2 | 0.1% |
Targeted temperature management | 2 | 0.1% |
Tax credit | 2 | 0.1% |
Teacher | 2 | 0.1% |
Technetium-99m | 2 | 0.1% |
Technology assessment | 2 | 0.1% |
Tedros Adhanom | 2 | 0.1% |
Teledermatology | 2 | 0.1% |
Telenursing | 2 | 0.1% |
Telerobotics | 2 | 0.1% |
Terrestrial planet | 2 | 0.1% |
Terrorism | 2 | 0.1% |
Testicular cancer | 2 | 0.1% |
Testosterone | 2 | 0.1% |
Tetrahydrocannabinol | 2 | 0.1% |
Textile | 2 | 0.1% |
Thalidomide | 2 | 0.1% |
Thermal power station | 2 | 0.1% |
Thin film | 2 | 0.1% |
Thoracotomy | 2 | 0.1% |
Thrombin | 2 | 0.1% |
Thromboelastography | 2 | 0.1% |
Thromboelastometry | 2 | 0.1% |
Thrombolysis | 2 | 0.1% |
Thrombopoietin | 2 | 0.1% |
Thyroid | 2 | 0.1% |
Thyroid-stimulating hormone | 2 | 0.1% |
Time series | 2 | 0.1% |
Tisagenlecleucel | 2 | 0.1% |
Titan (moon) | 2 | 0.1% |
Title X | 2 | 0.1% |
Tony Knowles (politician) | 2 | 0.1% |
Tourette syndrome | 2 | 0.1% |
Toxoplasmosis | 2 | 0.1% |
Train | 2 | 0.1% |
Transatlantic Trade and Investment Partnership | 2 | 0.1% |
Transcatheter arterial chemoembolization | 2 | 0.1% |
Transcription activator-like effector nuclease | 2 | 0.1% |
Transcutaneous electrical nerve stimulation | 2 | 0.1% |
Transfection | 2 | 0.1% |
Transfusion medicine | 2 | 0.1% |
Transmission and infection of H5N1 | 2 | 0.1% |
Transposable element | 2 | 0.1% |
Transtheoretical model | 2 | 0.1% |
Trauma types | 2 | 0.1% |
Traumatology | 2 | 0.1% |
Treaty | 2 | 0.1% |
Triiodothyronine | 2 | 0.1% |
Trimethoprim/sulfamethoxazole | 2 | 0.1% |
Triple-negative breast cancer | 2 | 0.1% |
Tropical disease | 2 | 0.1% |
Tropical diseases | 2 | 0.1% |
Truck driver | 2 | 0.1% |
Trump administration family separation policy | 2 | 0.1% |
Tumors of the hematopoietic and lymphoid tissues | 2 | 0.1% |
Twin | 2 | 0.1% |
Twin-to-twin transfusion syndrome | 2 | 0.1% |
Ulipristal acetate | 2 | 0.1% |
Ultracold atom | 2 | 0.1% |
Ultrashort pulse | 2 | 0.1% |
Ultrasound | 2 | 0.1% |
Ultraviolet | 2 | 0.1% |
Unexploded ordnance | 2 | 0.1% |
United Nations System | 2 | 0.1% |
United States budget process | 2 | 0.1% |
United States congressional committee | 2 | 0.1% |
United States elder law | 2 | 0.1% |
Universe | 2 | 0.1% |
Unstructured data | 2 | 0.1% |
Ureter | 2 | 0.1% |
Urethra | 2 | 0.1% |
Urinary bladder | 2 | 0.1% |
Urination | 2 | 0.1% |
Ursodeoxycholic acid | 2 | 0.1% |
Use case | 2 | 0.1% |
Uterine fibroid | 2 | 0.1% |
Uterus | 2 | 0.1% |
VKORC1 | 2 | 0.1% |
Vaccine hesitancy | 2 | 0.1% |
Vacuum aspiration | 2 | 0.1% |
Vaginal flora | 2 | 0.1% |
Vaginal lubrication | 2 | 0.1% |
Vancomycin | 2 | 0.1% |
Varicella vaccine | 2 | 0.1% |
Varicose veins | 2 | 0.1% |
Vascular surgery | 2 | 0.1% |
Ventricular hypertrophy | 2 | 0.1% |
Vertebra | 2 | 0.1% |
Very low-density lipoprotein | 2 | 0.1% |
Viral infections of the central nervous system | 2 | 0.1% |
Virus-like particle | 2 | 0.1% |
Viruses | 2 | 0.1% |
Vitamin C | 2 | 0.1% |
Vocal cord dysfunction | 2 | 0.1% |
Vocational education | 2 | 0.1% |
Volume expander | 2 | 0.1% |
Voting | 2 | 0.1% |
WASH | 2 | 0.1% |
War | 2 | 0.1% |
Water fluoridation | 2 | 0.1% |
Water footprint | 2 | 0.1% |
Water pollution | 2 | 0.1% |
Watson (computer) | 2 | 0.1% |
Website | 2 | 0.1% |
Weed | 2 | 0.1% |
Whistleblower | 2 | 0.1% |
White Americans | 2 | 0.1% |
Wind | 2 | 0.1% |
Wind power | 2 | 0.1% |
Wind turbine | 2 | 0.1% |
Wireless | 2 | 0.1% |
Wnt signaling pathway | 2 | 0.1% |
Wolff–Parkinson–White syndrome | 2 | 0.1% |
Women | 2 | 0.1% |
Workers' compensation | 2 | 0.1% |
Working capital | 2 | 0.1% |
Working group | 2 | 0.1% |
World energy consumption | 2 | 0.1% |
Xenobiology | 2 | 0.1% |
Years of potential life lost | 2 | 0.1% |
Yeast | 2 | 0.1% |
Yellow fever | 2 | 0.1% |
Zeaxanthin | 2 | 0.1% |
Zebrafish | 2 | 0.1% |
Zinc finger nuclease | 2 | 0.1% |
100 metres | 1 | 0.1% |
10199 Chariklo | 1 | 0.1% |
2,3,7,8-Tetrachlorodibenzodioxin | 1 | 0.1% |
2009 flu pandemic in the United Kingdom | 1 | 0.1% |
2009 flu pandemic vaccine | 1 | 0.1% |
2016 United States wireless spectrum auction | 1 | 0.1% |
486958 Arrokoth | 1 | 0.1% |
68W | 1 | 0.1% |
A Cooperative Strategy for 21st Century Seapower | 1 | 0.1% |
ACN-PCN method | 1 | 0.1% |
ALARP | 1 | 0.1% |
APACHE II | 1 | 0.1% |
API | 1 | 0.1% |
ASA physical status classification system | 1 | 0.1% |
ATM serine/threonine kinase | 1 | 0.1% |
Ab initio quantum chemistry methods | 1 | 0.1% |
Abbreviated New Drug Application | 1 | 0.1% |
Aberrations of the eye | 1 | 0.1% |
Abidjan | 1 | 0.1% |
Abiogenesis | 1 | 0.1% |
Abiotic stress | 1 | 0.1% |
Abiraterone acetate | 1 | 0.1% |
Abrupt climate change | 1 | 0.1% |
Absorption (skin) | 1 | 0.1% |
Abu Bakr al-Baghdadi | 1 | 0.1% |
Abu Dhabi | 1 | 0.1% |
Academic publishing | 1 | 0.1% |
Academy (English school) | 1 | 0.1% |
Acanthamoeba keratitis | 1 | 0.1% |
Access to COVID-19 Tools Accelerator | 1 | 0.1% |
Accidents | 1 | 0.1% |
Accounts payable | 1 | 0.1% |
Accretion (astrophysics) | 1 | 0.1% |
Accretion disk | 1 | 0.1% |
Acetabular labrum | 1 | 0.1% |
Acetylcholine | 1 | 0.1% |
Acetylcholinesterase | 1 | 0.1% |
Aclidinium bromide | 1 | 0.1% |
Acrylamide | 1 | 0.1% |
Actigraphy | 1 | 0.1% |
Action at a distance | 1 | 0.1% |
Action potential | 1 | 0.1% |
Active ageing | 1 | 0.1% |
Active galactic nucleus | 1 | 0.1% |
Active ingredient | 1 | 0.1% |
Active mobility | 1 | 0.1% |
Actuary | 1 | 0.1% |
Acupressure | 1 | 0.1% |
Acute exacerbation of chronic obstructive pulmonary disease | 1 | 0.1% |
Acute prostatitis | 1 | 0.1% |
Acute radiation syndrome | 1 | 0.1% |
Adaptive clinical trial | 1 | 0.1% |
Adeno-associated virus | 1 | 0.1% |
Adenocarcinoma | 1 | 0.1% |
Adenosine | 1 | 0.1% |
Adhesive | 1 | 0.1% |
Adipocyte | 1 | 0.1% |
Adiponectin | 1 | 0.1% |
Adjudication | 1 | 0.1% |
Adjuvant | 1 | 0.1% |
Administrative License Suspension | 1 | 0.1% |
Administrative divisions of Cambodia | 1 | 0.1% |
Administrative law | 1 | 0.1% |
Adolescent health | 1 | 0.1% |
Aducanumab | 1 | 0.1% |
Adult daycare center | 1 | 0.1% |
Adult neurogenesis | 1 | 0.1% |
Advanced life support | 1 | 0.1% |
Advanced practice registered nurse | 1 | 0.1% |
Advanced trauma life support | 1 | 0.1% |
Adverse Childhood Experiences Study | 1 | 0.1% |
Adverse childhood experiences | 1 | 0.1% |
Advertising to children | 1 | 0.1% |
Aedes albopictus | 1 | 0.1% |
Aegis Combat System | 1 | 0.1% |
Affordable housing | 1 | 0.1% |
Aflatoxin M1 | 1 | 0.1% |
African clawed frog | 1 | 0.1% |
African trypanosomiasis | 1 | 0.1% |
Agarose gel electrophoresis | 1 | 0.1% |
Agenda (meeting) | 1 | 0.1% |
Agrobacterium tumefaciens | 1 | 0.1% |
Agronomy | 1 | 0.1% |
Ailments of unknown cause | 1 | 0.1% |
Air conditioning | 1 | 0.1% |
Air medical services | 1 | 0.1% |
Air quality index | 1 | 0.1% |
Aircraft | 1 | 0.1% |
Airway management | 1 | 0.1% |
Alagille syndrome | 1 | 0.1% |
Albedo | 1 | 0.1% |
Albert Einstein | 1 | 0.1% |
Albumin | 1 | 0.1% |
Alcohol | 1 | 0.1% |
Alcohol abuse | 1 | 0.1% |
Alcohol advertising | 1 | 0.1% |
Alcohol and cancer | 1 | 0.1% |
Alcohol and pregnancy | 1 | 0.1% |
Alcohol intoxication | 1 | 0.1% |
Alcoholic liver disease | 1 | 0.1% |
Alectinib | 1 | 0.1% |
Alemtuzumab | 1 | 0.1% |
Algorithmic trading | 1 | 0.1% |
Alkaline phosphatase | 1 | 0.1% |
Allen Brain Atlas | 1 | 0.1% |
Allergen immunotherapy | 1 | 0.1% |
Allergic bronchopulmonary aspergillosis | 1 | 0.1% |
Allergology | 1 | 0.1% |
Allopurinol | 1 | 0.1% |
Alma Ata Declaration | 1 | 0.1% |
Alma Karlin | 1 | 0.1% |
Alpha wave | 1 | 0.1% |
Alpha-mannosidosis | 1 | 0.1% |
AlphaGo | 1 | 0.1% |
Alteplase | 1 | 0.1% |
Alternating current | 1 | 0.1% |
Alzheimer's disease biomarkers | 1 | 0.1% |
Amazon rainforest | 1 | 0.1% |
Ambulatory care | 1 | 0.1% |
Amenorrhea | 1 | 0.1% |
American Recovery and Reinvestment Act of 2009 | 1 | 0.1% |
Amikacin | 1 | 0.1% |
Amlodipine | 1 | 0.1% |
Amnesia | 1 | 0.1% |
Amodiaquine | 1 | 0.1% |
Amoebiasis | 1 | 0.1% |
Amphetamine | 1 | 0.1% |
Ampicillin/sulbactam | 1 | 0.1% |
Amplifier | 1 | 0.1% |
Amplitude | 1 | 0.1% |
Amyloid precursor protein | 1 | 0.1% |
Amyloid-beta precursor protein | 1 | 0.1% |
Anaerobic infection | 1 | 0.1% |
Anakinra | 1 | 0.1% |
Anal fissure | 1 | 0.1% |
Anaplastic oligodendroglioma | 1 | 0.1% |
Ancient DNA | 1 | 0.1% |
Andrew R. Wheeler | 1 | 0.1% |
Andrew Wakefield | 1 | 0.1% |
Androgen | 1 | 0.1% |
Androgen deprivation therapy | 1 | 0.1% |
André the Giant | 1 | 0.1% |
Anecortave acetate | 1 | 0.1% |
Anesthetic | 1 | 0.1% |
Angiogenesis | 1 | 0.1% |
Animal disease model | 1 | 0.1% |
Animal physiology | 1 | 0.1% |
Animals | 1 | 0.1% |
Anismus | 1 | 0.1% |
Ankle | 1 | 0.1% |
Ankyloglossia | 1 | 0.1% |
Annotated Code of Maryland | 1 | 0.1% |
Annual report | 1 | 0.1% |
Anomaly scan | 1 | 0.1% |
Anonymous birth | 1 | 0.1% |
Anosmia | 1 | 0.1% |
Anovulation | 1 | 0.1% |
Antagonistic pleiotropy hypothesis | 1 | 0.1% |
Antenatal steroid | 1 | 0.1% |
Anterior chamber of eyeball | 1 | 0.1% |
Anterior cruciate ligament | 1 | 0.1% |
Anterior cruciate ligament injury | 1 | 0.1% |
Anterograde amnesia | 1 | 0.1% |
Anthony Fauci | 1 | 0.1% |
Anthropogenic hazard | 1 | 0.1% |
Anthropometry of the upper arm | 1 | 0.1% |
Anti-NMDA receptor encephalitis | 1 | 0.1% |
Anti-dsDNA antibodies | 1 | 0.1% |
Anti-obesity medication | 1 | 0.1% |
Anti-social behaviour | 1 | 0.1% |
Anti-thymocyte globulin | 1 | 0.1% |
Antibody-drug conjugate | 1 | 0.1% |
Anticholinergic | 1 | 0.1% |
Anticipatory governance | 1 | 0.1% |
Antideficiency Act | 1 | 0.1% |
Antihistamine | 1 | 0.1% |
Antileukotriene | 1 | 0.1% |
Antimineralocorticoid | 1 | 0.1% |
Antiplatelet drugs | 1 | 0.1% |
Antithrombotic agents | 1 | 0.1% |
Anxiolytic | 1 | 0.1% |
Apiary | 1 | 0.1% |
Apitherapy | 1 | 0.1% |
Apnea | 1 | 0.1% |
Apolipoprotein A1 | 1 | 0.1% |
Apolipoprotein E | 1 | 0.1% |
Apolipoprotein L1 | 1 | 0.1% |
Apoptosis-inducing factor | 1 | 0.1% |
Apremilast | 1 | 0.1% |
Aqueous humour | 1 | 0.1% |
Arab world | 1 | 0.1% |
Arabidopsis thaliana | 1 | 0.1% |
Arabs | 1 | 0.1% |
Arcenciel | 1 | 0.1% |
Archaeology | 1 | 0.1% |
Arctic | 1 | 0.1% |
Arctic Ocean | 1 | 0.1% |
Arctic ecology | 1 | 0.1% |
Area Health Education Centers Program | 1 | 0.1% |
Areca nut | 1 | 0.1% |
Argonaute | 1 | 0.1% |
Arm | 1 | 0.1% |
Armed Forces Health Longitudinal Technology Application | 1 | 0.1% |
Aromatic compounds | 1 | 0.1% |
Arsenic | 1 | 0.1% |
Arsenic trioxide | 1 | 0.1% |
Art | 1 | 0.1% |
Arteriovenous malformation | 1 | 0.1% |
Arthrogram | 1 | 0.1% |
Arthur Eddington | 1 | 0.1% |
Article processing charge | 1 | 0.1% |
Artificial heart valve | 1 | 0.1% |
Asbestos-related diseases | 1 | 0.1% |
Asbestosis | 1 | 0.1% |
Ascending aorta | 1 | 0.1% |
Ascites | 1 | 0.1% |
Asenapine | 1 | 0.1% |
Asia | 1 | 0.1% |
Asian Americans | 1 | 0.1% |
Asperger syndrome | 1 | 0.1% |
Assertive community treatment | 1 | 0.1% |
Association for Molecular Pathology v. Myriad Genetics, Inc. | 1 | 0.1% |
Association mapping | 1 | 0.1% |
Assurance services | 1 | 0.1% |
Asteroid | 1 | 0.1% |
Asteroseismology | 1 | 0.1% |
Astrobiology | 1 | 0.1% |
Astrocyte | 1 | 0.1% |
Astrocytoma | 1 | 0.1% |
Astronomical objects | 1 | 0.1% |
Astrophysical jet | 1 | 0.1% |
Asystole | 1 | 0.1% |
Atelectasis | 1 | 0.1% |
Athletic heart syndrome | 1 | 0.1% |
Atlantic Ocean | 1 | 0.1% |
Atom | 1 | 0.1% |
Atomic nucleus | 1 | 0.1% |
Atomic number | 1 | 0.1% |
Atopic dermatitis | 1 | 0.1% |
Atrial natriuretic peptide | 1 | 0.1% |
Attentional control | 1 | 0.1% |
Atypical pneumonia | 1 | 0.1% |
Auckland | 1 | 0.1% |
Aurora | 1 | 0.1% |
Australian Organ Donor Register | 1 | 0.1% |
AutoPulse | 1 | 0.1% |
Autoantibody | 1 | 0.1% |
Autocorrelation | 1 | 0.1% |
Autoimmune hemolytic anemia | 1 | 0.1% |
Automated driving system | 1 | 0.1% |
Automated guided vehicle | 1 | 0.1% |
Automatic identification system | 1 | 0.1% |
Autonomic nervous system | 1 | 0.1% |
Autonomous underwater vehicle | 1 | 0.1% |
Autopsy | 1 | 0.1% |
Avascular necrosis | 1 | 0.1% |
Avelumab | 1 | 0.1% |
Aviation safety | 1 | 0.1% |
Awareness | 1 | 0.1% |
Axicabtagene ciloleucel | 1 | 0.1% |
Ayurveda | 1 | 0.1% |
Azacitidine | 1 | 0.1% |
Azaspiracid | 1 | 0.1% |
Azathioprine | 1 | 0.1% |
Azo dye | 1 | 0.1% |
Aztreonam | 1 | 0.1% |
B1 cell | 1 | 0.1% |
BK virus | 1 | 0.1% |
Bachelor of Medicine, Bachelor of Surgery | 1 | 0.1% |
Bacillus anthracis | 1 | 0.1% |
Bacillus cereus | 1 | 0.1% |
Back-illuminated sensor | 1 | 0.1% |
Background radiation | 1 | 0.1% |
Bacterial adhesin | 1 | 0.1% |
Bacterial diseases | 1 | 0.1% |
Bacteriology | 1 | 0.1% |
Bacteriophage | 1 | 0.1% |
Bacterioplankton | 1 | 0.1% |
Badger culling in the United Kingdom | 1 | 0.1% |
Bag valve mask | 1 | 0.1% |
Balanced Budget Act of 1997 | 1 | 0.1% |
Balanced scorecard | 1 | 0.1% |
Band gap | 1 | 0.1% |
Barbiturate | 1 | 0.1% |
Barents Sea | 1 | 0.1% |
Bariatrics | 1 | 0.1% |
Barley | 1 | 0.1% |
Baroreflex | 1 | 0.1% |
Barrett's esophagus | 1 | 0.1% |
Basal metabolic rate | 1 | 0.1% |
Base pair | 1 | 0.1% |
Baseball | 1 | 0.1% |
Basmati | 1 | 0.1% |
Bat | 1 | 0.1% |
Battle of Ia Drang | 1 | 0.1% |
Battlespace | 1 | 0.1% |
Bayesian statistics | 1 | 0.1% |
Bayh–Dole Act | 1 | 0.1% |
Bayley Scales of Infant Development | 1 | 0.1% |
Bazedoxifene | 1 | 0.1% |
Beaked whale | 1 | 0.1% |
Bedford | 1 | 0.1% |
Bedfordshire | 1 | 0.1% |
Beech | 1 | 0.1% |
Beef cattle | 1 | 0.1% |
Beekeeper | 1 | 0.1% |
Beekeeping | 1 | 0.1% |
Beetle | 1 | 0.1% |
Behaviorism | 1 | 0.1% |
Belief | 1 | 0.1% |
Bellman equation | 1 | 0.1% |
Bempedoic acid/ezetimibe | 1 | 0.1% |
Benjamin List | 1 | 0.1% |
Benjamin Netanyahu | 1 | 0.1% |
Benzatropine | 1 | 0.1% |
Benznidazole | 1 | 0.1% |
Bernard Lown | 1 | 0.1% |
Beta thalassemia | 1 | 0.1% |
Beta-Carotene | 1 | 0.1% |
Beta-Sitosterol | 1 | 0.1% |
Beta-catenin | 1 | 0.1% |
Beta-galactosidase | 1 | 0.1% |
Beta-secretase 1 | 1 | 0.1% |
Beta2-adrenergic agonist | 1 | 0.1% |
Bicuspid aortic valve | 1 | 0.1% |
Bile duct | 1 | 0.1% |
Bill (law) | 1 | 0.1% |
Bill Clinton | 1 | 0.1% |
Billericay | 1 | 0.1% |
Binge drinking | 1 | 0.1% |
Binimetinib | 1 | 0.1% |
Binomial distribution | 1 | 0.1% |
BioBrick | 1 | 0.1% |
Bioaccumulation | 1 | 0.1% |
Biobased economy | 1 | 0.1% |
Biochar | 1 | 0.1% |
Biochemistry methods | 1 | 0.1% |
Biodegradation | 1 | 0.1% |
Bioenergy | 1 | 0.1% |
Biofeedback | 1 | 0.1% |
Biofouling | 1 | 0.1% |
Biological Weapons Convention | 1 | 0.1% |
Biological techniques and tools | 1 | 0.1% |
Bionics | 1 | 0.1% |
Biophysics | 1 | 0.1% |
Bioproducts | 1 | 0.1% |
Bioprospecting | 1 | 0.1% |
Biopsychosocial model | 1 | 0.1% |
Bioreactor | 1 | 0.1% |
Biorefinery | 1 | 0.1% |
Biosynthesis | 1 | 0.1% |
Biotic stress | 1 | 0.1% |
Bird migration | 1 | 0.1% |
Bird vocalization | 1 | 0.1% |
Birds | 1 | 0.1% |
Birth rate | 1 | 0.1% |
Bisphenol A | 1 | 0.1% |
Bisulfite sequencing | 1 | 0.1% |
BitTorrent | 1 | 0.1% |
Black Death | 1 | 0.1% |
Black hole | 1 | 0.1% |
Blame | 1 | 0.1% |
Blast injury | 1 | 0.1% |
Blastoma | 1 | 0.1% |
Blinatumomab | 1 | 0.1% |
Blood alcohol content | 1 | 0.1% |
Blood disorders | 1 | 0.1% |
Blood substitute | 1 | 0.1% |
Blue Brain Project | 1 | 0.1% |
Blumeria graminis | 1 | 0.1% |
Blunt trauma | 1 | 0.1% |
Body composition | 1 | 0.1% |
Body integrity dysphoria | 1 | 0.1% |
Boiler | 1 | 0.1% |
Boldenone | 1 | 0.1% |
Bomb | 1 | 0.1% |
Bombyx mori | 1 | 0.1% |
Bone cyst | 1 | 0.1% |
Bone health | 1 | 0.1% |
Borna disease | 1 | 0.1% |
Borough of Halton | 1 | 0.1% |
Bortezomib | 1 | 0.1% |
Bottled water | 1 | 0.1% |
Bounce message | 1 | 0.1% |
Boundary Waters Canoe Area Wilderness | 1 | 0.1% |
Bourbon virus | 1 | 0.1% |
Bovine leukemia virus | 1 | 0.1% |
Brachial plexus | 1 | 0.1% |
Brain abscess | 1 | 0.1% |
Brain death | 1 | 0.1% |
Brain implant | 1 | 0.1% |
Brain ischemia | 1 | 0.1% |
Brain mapping | 1 | 0.1% |
BrainGate | 1 | 0.1% |
Brainstorming | 1 | 0.1% |
Brassica | 1 | 0.1% |
Breach of contract | 1 | 0.1% |
Breast implant | 1 | 0.1% |
Breast reconstruction | 1 | 0.1% |
Breathability | 1 | 0.1% |
Breathalyzer | 1 | 0.1% |
Breed | 1 | 0.1% |
Brentuximab vedotin | 1 | 0.1% |
Bribery | 1 | 0.1% |
Bribery Act 2010 | 1 | 0.1% |
Brick and mortar | 1 | 0.1% |
Brigatinib | 1 | 0.1% |
Brilacidin | 1 | 0.1% |
Brisbane Diamantina Health Partners | 1 | 0.1% |
British National Formulary | 1 | 0.1% |
Broadcasting | 1 | 0.1% |
Broccoli | 1 | 0.1% |
Broiler industry | 1 | 0.1% |
Bronchiolitis | 1 | 0.1% |
Bronchoscopy | 1 | 0.1% |
Brugada syndrome | 1 | 0.1% |
Bruno Siciliano (engineer) | 1 | 0.1% |
Bt cotton | 1 | 0.1% |
Bubonic plague | 1 | 0.1% |
Buckling | 1 | 0.1% |
Buckminsterfullerene | 1 | 0.1% |
Building-integrated photovoltaics | 1 | 0.1% |
Bulimia nervosa | 1 | 0.1% |
Bullous pemphigoid | 1 | 0.1% |
Bullying | 1 | 0.1% |
Bumetanide | 1 | 0.1% |
Bunker gear | 1 | 0.1% |
Bunyavirales | 1 | 0.1% |
Burden of proof (law) | 1 | 0.1% |
Burkholderia | 1 | 0.1% |
Burkholderia mallei | 1 | 0.1% |
Burkholderia pseudomallei | 1 | 0.1% |
Burn | 1 | 0.1% |
Business model | 1 | 0.1% |
CD20 | 1 | 0.1% |
CD4+ T cells and antitumor immunity | 1 | 0.1% |
CD86 | 1 | 0.1% |
CHEK2 | 1 | 0.1% |
CMA-ES | 1 | 0.1% |
COLD-PCR | 1 | 0.1% |
CONTEST | 1 | 0.1% |
COVID-19 Surveillance | 1 | 0.1% |
COVID-19 drug development | 1 | 0.1% |
COVID-19 in pregnancy | 1 | 0.1% |
COVID-19 misinformation | 1 | 0.1% |
COVID-19 pandemic in France | 1 | 0.1% |
COVID-19 pandemic in Iceland | 1 | 0.1% |
COVID-19 pandemic in New Jersey | 1 | 0.1% |
COVID-19 pandemic in New Zealand | 1 | 0.1% |
COVID-19 pandemic in Pakistan | 1 | 0.1% |
COVID-19 pandemic in Scotland | 1 | 0.1% |
COVID-19 pandemic in Ukraine | 1 | 0.1% |
COX-3 | 1 | 0.1% |
CRISPR/Cpf1 | 1 | 0.1% |
CYP3A4 | 1 | 0.1% |
Ca2+/calmodulin-dependent protein kinase II | 1 | 0.1% |
Cachexia | 1 | 0.1% |
Cadmium | 1 | 0.1% |
Caenorhabditis elegans | 1 | 0.1% |
Calcitonin | 1 | 0.1% |
Calcium | 1 | 0.1% |
California County Routes in zone G | 1 | 0.1% |
Calorie restriction | 1 | 0.1% |
Camera | 1 | 0.1% |
Campylobacter jejuni | 1 | 0.1% |
Canakinumab | 1 | 0.1% |
Cancer Drugs Fund | 1 | 0.1% |
Cancer biomarker | 1 | 0.1% |
Cancer rehabilitation | 1 | 0.1% |
Cancer-associated fibroblast | 1 | 0.1% |
Cancer-related fatigue | 1 | 0.1% |
Candesartan | 1 | 0.1% |
Candida glabrata | 1 | 0.1% |
Cangrelor | 1 | 0.1% |
Canola oil | 1 | 0.1% |
Canon PowerShot G | 1 | 0.1% |
Capability Maturity Model Integration | 1 | 0.1% |
Capacity (law) | 1 | 0.1% |
Capsule endoscopy | 1 | 0.1% |
Carbamazepine | 1 | 0.1% |
Carbon cycle | 1 | 0.1% |
Carbon fiber reinforced polymer | 1 | 0.1% |
Carbon tax | 1 | 0.1% |
Carboxyhemoglobin | 1 | 0.1% |
Cardiac amyloidosis | 1 | 0.1% |
Cardiac cycle | 1 | 0.1% |
Cardiac fibrosis | 1 | 0.1% |
Cardiac tamponade | 1 | 0.1% |
Cardiomegaly | 1 | 0.1% |
Cardiomyopathy | 1 | 0.1% |
Carfilzomib | 1 | 0.1% |
Caring for people with dementia | 1 | 0.1% |
Carlos Finlay | 1 | 0.1% |
Carrion crow | 1 | 0.1% |
Cas12a | 1 | 0.1% |
Cat | 1 | 0.1% |
Catalytic converter | 1 | 0.1% |
Cataplexy | 1 | 0.1% |
Categorical variable | 1 | 0.1% |
Cathode | 1 | 0.1% |
Causes of cancer | 1 | 0.1% |
Cecil County, Maryland | 1 | 0.1% |
Cefaclor | 1 | 0.1% |
Cefazolin | 1 | 0.1% |
Cefotaxime | 1 | 0.1% |
Ceftazidime | 1 | 0.1% |
Celecoxib | 1 | 0.1% |
Cell adhesion | 1 | 0.1% |
Cell cycle | 1 | 0.1% |
Cell nucleus | 1 | 0.1% |
Cell-mediated immunity | 1 | 0.1% |
Cellular respiration | 1 | 0.1% |
Cellular senescence | 1 | 0.1% |
Central Asia | 1 | 0.1% |
Central limit theorem | 1 | 0.1% |
Central processing unit | 1 | 0.1% |
Centre of Biological Research (Spain) | 1 | 0.1% |
Cerebral hypoxia | 1 | 0.1% |
Cerebral organoid | 1 | 0.1% |
Certified Nurse‐Midwife | 1 | 0.1% |
Certified Registered Nurse Anesthetist | 1 | 0.1% |
Certified reference materials | 1 | 0.1% |
Cervical cerclage | 1 | 0.1% |
ChIP-sequencing | 1 | 0.1% |
Chain of custody | 1 | 0.1% |
Chaka Fattah | 1 | 0.1% |
Chalazion | 1 | 0.1% |
Charge-coupled device | 1 | 0.1% |
Charitable trust | 1 | 0.1% |
Charity (practice) | 1 | 0.1% |
Checkpoint inhibitor | 1 | 0.1% |
Chemical Weapons Convention | 1 | 0.1% |
Chemical equilibrium | 1 | 0.1% |
Chemical product engineering | 1 | 0.1% |
Chemical reaction | 1 | 0.1% |
Chemical substances | 1 | 0.1% |
Chemical synapse | 1 | 0.1% |
Chemical warfare | 1 | 0.1% |
Chemotherapy-induced nausea and vomiting | 1 | 0.1% |
Chemotherapy-induced peripheral neuropathy | 1 | 0.1% |
Cheshire | 1 | 0.1% |
Chest tube | 1 | 0.1% |
Chi-squared test | 1 | 0.1% |
Chicken | 1 | 0.1% |
Chief information officer | 1 | 0.1% |
Child abuse | 1 | 0.1% |
Child custody | 1 | 0.1% |
Child neglect | 1 | 0.1% |
Child sexual abuse | 1 | 0.1% |
Child support | 1 | 0.1% |
Childhood immunizations in the United States | 1 | 0.1% |
Childhood leukemia | 1 | 0.1% |
Childlessness | 1 | 0.1% |
Children Act 1989 | 1 | 0.1% |
Children with Special Healthcare Needs in the United States | 1 | 0.1% |
Children's rights | 1 | 0.1% |
Chiller | 1 | 0.1% |
Chimbu Province | 1 | 0.1% |
Chimeric antigen receptor | 1 | 0.1% |
Chirality (chemistry) | 1 | 0.1% |
Chloride | 1 | 0.1% |
Chlorine-releasing compounds | 1 | 0.1% |
Chloroplast | 1 | 0.1% |
Chlorpyrifos | 1 | 0.1% |
Chocolate | 1 | 0.1% |
Choice | 1 | 0.1% |
Choice modelling | 1 | 0.1% |
Choking | 1 | 0.1% |
Cholera | 1 | 0.1% |
Cholera vaccine | 1 | 0.1% |
Cholestasis | 1 | 0.1% |
Cholinesterase | 1 | 0.1% |
Choosing Wisely Canada | 1 | 0.1% |
Chromosomal crossover | 1 | 0.1% |
Chronic inflammatory demyelinating polyneuropathy | 1 | 0.1% |
Chronic thromboembolic pulmonary hypertension | 1 | 0.1% |
Chronotype | 1 | 0.1% |
Chrysotile | 1 | 0.1% |
Chuck Schumer | 1 | 0.1% |
Chylomicron | 1 | 0.1% |
Circular RNA | 1 | 0.1% |
Circular economy | 1 | 0.1% |
Circumstellar habitable zone | 1 | 0.1% |
Cisplatin | 1 | 0.1% |
Citizen science | 1 | 0.1% |
Citizenship of the United States | 1 | 0.1% |
City | 1 | 0.1% |
Clathrate hydrate | 1 | 0.1% |
Clavicle fracture | 1 | 0.1% |
Claytronics | 1 | 0.1% |
Clean Air Act (United States) | 1 | 0.1% |
Clean Air Act of 1963 | 1 | 0.1% |
Cleaning agent | 1 | 0.1% |
Clerk of the United States House of Representatives | 1 | 0.1% |
Climate change feedback | 1 | 0.1% |
Climate engineering | 1 | 0.1% |
Climatology | 1 | 0.1% |
Clindamycin | 1 | 0.1% |
Clinical clerkship | 1 | 0.1% |
Clinical nurse specialist | 1 | 0.1% |
Clinical pathway | 1 | 0.1% |
ClinicalTrials.gov | 1 | 0.1% |
Clorazepate | 1 | 0.1% |
Closed-circuit television | 1 | 0.1% |
Closed-head injury | 1 | 0.1% |
Clostridial infections | 1 | 0.1% |
Clostridium difficile infection | 1 | 0.1% |
Cloud | 1 | 0.1% |
Cloud robotics | 1 | 0.1% |
Cluster analysis | 1 | 0.1% |
Cluster munition | 1 | 0.1% |
Co-stimulation | 1 | 0.1% |
Coalworker's pneumoconiosis | 1 | 0.1% |
Cochlea | 1 | 0.1% |
Cochlear implant | 1 | 0.1% |
Code of Virginia | 1 | 0.1% |
Codeine | 1 | 0.1% |
Coefficient of performance | 1 | 0.1% |
Coefficient of variation | 1 | 0.1% |
Coenzyme A | 1 | 0.1% |
Coenzyme Q10 | 1 | 0.1% |
Cofiring | 1 | 0.1% |
Cognitive bias | 1 | 0.1% |
Cognitive disorders | 1 | 0.1% |
Cognitive rehabilitation therapy | 1 | 0.1% |
Cognitive reserve | 1 | 0.1% |
Coitus interruptus | 1 | 0.1% |
Colchester Community Stadium | 1 | 0.1% |
Colesevelam | 1 | 0.1% |
Colestyramine | 1 | 0.1% |
Collaboratory | 1 | 0.1% |
Collision avoidance system | 1 | 0.1% |
Colorectal polyp | 1 | 0.1% |
Combat medic | 1 | 0.1% |
Combat stress reaction | 1 | 0.1% |
Combination therapy | 1 | 0.1% |
Combined hormonal contraception | 1 | 0.1% |
Comet assay | 1 | 0.1% |
Common Foreign and Security Policy | 1 | 0.1% |
Common bile duct stone | 1 | 0.1% |
Common carotid artery | 1 | 0.1% |
Community integration | 1 | 0.1% |
Commuting | 1 | 0.1% |
Compact Muon Solenoid | 1 | 0.1% |
Compact fluorescent lamp | 1 | 0.1% |
Compact of Free Association | 1 | 0.1% |
Company (military unit) | 1 | 0.1% |
Company secretary | 1 | 0.1% |
Comparative genomic hybridization | 1 | 0.1% |
Competition law | 1 | 0.1% |
Complaint | 1 | 0.1% |
Complementarity (molecular biology) | 1 | 0.1% |
Compliance (psychology) | 1 | 0.1% |
Complications of diabetes | 1 | 0.1% |
Compounding | 1 | 0.1% |
Comprehensive Soldier and Family Fitness | 1 | 0.1% |
Comprehensive medication management | 1 | 0.1% |
Compression stockings | 1 | 0.1% |
Computational chemistry | 1 | 0.1% |
Computational phylogenetics | 1 | 0.1% |
Computer file | 1 | 0.1% |
Computer hardware | 1 | 0.1% |
Computer-assisted surgery | 1 | 0.1% |
Concentrated solar power | 1 | 0.1% |
Concept | 1 | 0.1% |
Conceptual model | 1 | 0.1% |
Concrete | 1 | 0.1% |
Condition monitoring | 1 | 0.1% |
Confectionery | 1 | 0.1% |
Confidential Information Protection and Statistical Efficiency Act | 1 | 0.1% |
Conflict resolution | 1 | 0.1% |
Confocal microscopy | 1 | 0.1% |
Congenital cytomegalovirus infection | 1 | 0.1% |
Congenital hypothyroidism | 1 | 0.1% |
Congenital iodine deficiency syndrome | 1 | 0.1% |
Congenital pulmonary airway malformation | 1 | 0.1% |
Congenital syphilis | 1 | 0.1% |
Congressional Budget and Impoundment Control Act of 1974 | 1 | 0.1% |
Congressional Record | 1 | 0.1% |
Conjugate vaccine | 1 | 0.1% |
Conjugated estrogens | 1 | 0.1% |
Conjunctivitis | 1 | 0.1% |
Conspiracy theory | 1 | 0.1% |
Constipation | 1 | 0.1% |
Constraint-induced movement therapy | 1 | 0.1% |
Construction | 1 | 0.1% |
Consultant (medicine) | 1 | 0.1% |
Consumer price index | 1 | 0.1% |
Contact (law) | 1 | 0.1% |
Content analysis | 1 | 0.1% |
Contig | 1 | 0.1% |
Continuing resolution | 1 | 0.1% |
Continuous glucose monitor | 1 | 0.1% |
Continuum mechanics | 1 | 0.1% |
Contractual term | 1 | 0.1% |
Contrast-enhanced ultrasound | 1 | 0.1% |
Control (management) | 1 | 0.1% |
Control of Substances Hazardous to Health Regulations 2002 | 1 | 0.1% |
Controlled Substances Act | 1 | 0.1% |
Controlled ovarian hyperstimulation | 1 | 0.1% |
Convulsion | 1 | 0.1% |
Coombs test | 1 | 0.1% |
Copanlisib | 1 | 0.1% |
Copayment | 1 | 0.1% |
Copeptin | 1 | 0.1% |
Coping (psychology) | 1 | 0.1% |
Copolymer | 1 | 0.1% |
Copper IUDs | 1 | 0.1% |
Corneal pachymetry | 1 | 0.1% |
Corneal transplantation | 1 | 0.1% |
Coronagraph | 1 | 0.1% |
Coronary artery anomaly | 1 | 0.1% |
Coronary care unit | 1 | 0.1% |
Coronary stent | 1 | 0.1% |
Coronaviridae | 1 | 0.1% |
Coronavirus spike protein | 1 | 0.1% |
Coronavirus-associated diseases | 1 | 0.1% |
Coroner | 1 | 0.1% |
Correlation | 1 | 0.1% |
Cortical implant | 1 | 0.1% |
Corynebacterineae | 1 | 0.1% |
Cosmology | 1 | 0.1% |
Cost | 1 | 0.1% |
Cost estimate | 1 | 0.1% |
Cost-shifting | 1 | 0.1% |
Cotton | 1 | 0.1% |
Country of origin | 1 | 0.1% |
County Durham | 1 | 0.1% |
Courier | 1 | 0.1% |
Cracking (chemistry) | 1 | 0.1% |
Craig Venter | 1 | 0.1% |
Credential | 1 | 0.1% |
Credentialing | 1 | 0.1% |
Crenezumab | 1 | 0.1% |
Crime | 1 | 0.1% |
Criminalization | 1 | 0.1% |
Crisis management | 1 | 0.1% |
Cross-reactivity | 1 | 0.1% |
Crossing the Quality Chasm | 1 | 0.1% |
Crossover study | 1 | 0.1% |
Croup | 1 | 0.1% |
Crown (dentistry) | 1 | 0.1% |
Crown-rump length | 1 | 0.1% |
Crush syndrome | 1 | 0.1% |
Crust (geology) | 1 | 0.1% |
Cryptosporidiosis | 1 | 0.1% |
Crystallin | 1 | 0.1% |
Cultured meat | 1 | 0.1% |
Current events | 1 | 0.1% |
Cushing's syndrome | 1 | 0.1% |
Custirsen | 1 | 0.1% |
Customer experience | 1 | 0.1% |
Customs | 1 | 0.1% |
Cutaneous leishmaniasis | 1 | 0.1% |
Cybercrime | 1 | 0.1% |
Cyst | 1 | 0.1% |
Cystoisospora belli | 1 | 0.1% |
Cytogenetics | 1 | 0.1% |
Cytokinesis | 1 | 0.1% |
Cytoskeleton | 1 | 0.1% |
DASH diet | 1 | 0.1% |
DMARC | 1 | 0.1% |
DNA annotation | 1 | 0.1% |
DNA database | 1 | 0.1% |
DNA vaccine | 1 | 0.1% |
DTaP-IPV/Hib vaccine | 1 | 0.1% |
Dairy | 1 | 0.1% |
Dairy cattle | 1 | 0.1% |
Damages | 1 | 0.1% |
Dangerous goods | 1 | 0.1% |
Dansgaard–Oeschger event | 1 | 0.1% |
Darbepoetin alfa | 1 | 0.1% |
Dark energy | 1 | 0.1% |
Dark matter halo | 1 | 0.1% |
Darunavir | 1 | 0.1% |
Data anonymization | 1 | 0.1% |
Data mining | 1 | 0.1% |
Data re-identification | 1 | 0.1% |
David Baltimore | 1 | 0.1% |
De-escalation | 1 | 0.1% |
De-identification | 1 | 0.1% |
Deaf culture | 1 | 0.1% |
Deafblindness | 1 | 0.1% |
Debridement | 1 | 0.1% |
Debridement (dental) | 1 | 0.1% |
Debriefing | 1 | 0.1% |
Deception | 1 | 0.1% |
Declarative programming | 1 | 0.1% |
Decomposition | 1 | 0.1% |
Decompression sickness | 1 | 0.1% |
Decriminalizing sex work | 1 | 0.1% |
Deep sea mining | 1 | 0.1% |
Deepfake | 1 | 0.1% |
Deepwater Horizon oil spill | 1 | 0.1% |
Defecation | 1 | 0.1% |
Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury | 1 | 0.1% |
Defensive medicine | 1 | 0.1% |
Deferasirox | 1 | 0.1% |
Deferiprone | 1 | 0.1% |
Deferred Action for Childhood Arrivals | 1 | 0.1% |
Defined benefit pension plan | 1 | 0.1% |
Defined daily dose | 1 | 0.1% |
Definition | 1 | 0.1% |
Deforestation | 1 | 0.1% |
Deformation (engineering) | 1 | 0.1% |
Dehumidifier | 1 | 0.1% |
Dehydration | 1 | 0.1% |
Dehydroepiandrosterone | 1 | 0.1% |
Delivery (commerce) | 1 | 0.1% |
Delivery drone | 1 | 0.1% |
Demand | 1 | 0.1% |
Demand response | 1 | 0.1% |
Demcizumab | 1 | 0.1% |
Dementia with Lewy bodies | 1 | 0.1% |
Demographic dividend | 1 | 0.1% |
Demographic transition | 1 | 0.1% |
Demyelinating disease | 1 | 0.1% |
Dendrimer | 1 | 0.1% |
Dendritic spine | 1 | 0.1% |
Dengue virus | 1 | 0.1% |
Density | 1 | 0.1% |
Dental restoration | 1 | 0.1% |
Dental sealant | 1 | 0.1% |
Dentist | 1 | 0.1% |
Department of Motor Vehicles | 1 | 0.1% |
Dependency ratio | 1 | 0.1% |
Deposit account | 1 | 0.1% |
Depreciation | 1 | 0.1% |
Deradicalization | 1 | 0.1% |
Dermatology | 1 | 0.1% |
Dermatology Life Quality Index | 1 | 0.1% |
Dermatomyositis | 1 | 0.1% |
Dermatophytosis | 1 | 0.1% |
Dermatoscopy | 1 | 0.1% |
Desalination | 1 | 0.1% |
Desktop virtualization | 1 | 0.1% |
Desmopressin | 1 | 0.1% |
Desmoteplase | 1 | 0.1% |
Desogestrel | 1 | 0.1% |
Detection limit | 1 | 0.1% |
Detective quantum efficiency | 1 | 0.1% |
Deuterium | 1 | 0.1% |
Development of the nervous system | 1 | 0.1% |
Developmental biology | 1 | 0.1% |
Developmental psychology | 1 | 0.1% |
Diabetic cardiomyopathy | 1 | 0.1% |
Diabetic hypoglycemia | 1 | 0.1% |
Diagnosis | 1 | 0.1% |
Diagnosis of schizophrenia | 1 | 0.1% |
Dialect | 1 | 0.1% |
Diastereomer | 1 | 0.1% |
Diclofenac | 1 | 0.1% |
Dietary Reference Intake | 1 | 0.1% |
Digestive diseases | 1 | 0.1% |
Digital Revolution | 1 | 0.1% |
Digital electronics | 1 | 0.1% |
Digital library | 1 | 0.1% |
Digital polymerase chain reaction | 1 | 0.1% |
Digital radiography | 1 | 0.1% |
Digital twin | 1 | 0.1% |
Digitization | 1 | 0.1% |
Dihydrotestosterone | 1 | 0.1% |
Dioscorea alata | 1 | 0.1% |
Dioxins and dioxin-like compounds | 1 | 0.1% |
Diplomacy | 1 | 0.1% |
Direct-to-consumer advertising | 1 | 0.1% |
Directed evolution | 1 | 0.1% |
Directivity | 1 | 0.1% |
Director general | 1 | 0.1% |
Dirty bomb | 1 | 0.1% |
Disaster response | 1 | 0.1% |
Disasters | 1 | 0.1% |
Discounting | 1 | 0.1% |
Discourse | 1 | 0.1% |
Discrimination | 1 | 0.1% |
Disease-modifying antirheumatic drug | 1 | 0.1% |
Diseases of poverty | 1 | 0.1% |
Disinformation | 1 | 0.1% |
Dislocated shoulder | 1 | 0.1% |
Disopyramide | 1 | 0.1% |
Dispatcher | 1 | 0.1% |
Distal radius fracture | 1 | 0.1% |
Diuretic | 1 | 0.1% |
Diwata-1 | 1 | 0.1% |
Diwata-2 | 1 | 0.1% |
Doctor of Osteopathic Medicine | 1 | 0.1% |
Doctor–patient relationship | 1 | 0.1% |
Dofetilide | 1 | 0.1% |
Dolly (sheep) | 1 | 0.1% |
Dolutegravir | 1 | 0.1% |
DomainKeys Identified Mail | 1 | 0.1% |
Dominance (genetics) | 1 | 0.1% |
Donald Trump | 1 | 0.1% |
Door-to-balloon | 1 | 0.1% |
Dosimeter | 1 | 0.1% |
Doxepin | 1 | 0.1% |
Dragonfly (spacecraft) | 1 | 0.1% |
Draize test | 1 | 0.1% |
Dravet syndrome | 1 | 0.1% |
Dried blood spot | 1 | 0.1% |
Driving under the influence | 1 | 0.1% |
Droperidol | 1 | 0.1% |
Drosophila melanogaster | 1 | 0.1% |
Drought | 1 | 0.1% |
Drought tolerance | 1 | 0.1% |
Drug brand names | 1 | 0.1% |
Drug education | 1 | 0.1% |
Drug eruption | 1 | 0.1% |
Drug liberalization | 1 | 0.1% |
Drug nomenclature | 1 | 0.1% |
Drug reaction with eosinophilia and systemic symptoms | 1 | 0.1% |
Drug tolerance | 1 | 0.1% |
Drug user | 1 | 0.1% |
Drug withdrawal | 1 | 0.1% |
Drug-eluting stent | 1 | 0.1% |
Drunk drivers | 1 | 0.1% |
Drunk driving in the United States | 1 | 0.1% |
Drusen | 1 | 0.1% |
Duloxetine | 1 | 0.1% |
Dumpling | 1 | 0.1% |
Duodenum | 1 | 0.1% |
Dura mater | 1 | 0.1% |
Duty of candour | 1 | 0.1% |
Dynamic stochastic general equilibrium | 1 | 0.1% |
Dysentery | 1 | 0.1% |
Dysglycemia | 1 | 0.1% |
Dyspareunia | 1 | 0.1% |
Dysphagia | 1 | 0.1% |
Dysplastic nevus | 1 | 0.1% |
Dysprosium | 1 | 0.1% |
Dystonia | 1 | 0.1% |
E-commerce | 1 | 0.1% |
E-procurement | 1 | 0.1% |
E-services | 1 | 0.1% |
ECTS grading scale | 1 | 0.1% |
EConsult | 1 | 0.1% |
Eagle River, Anchorage | 1 | 0.1% |
Ear | 1 | 0.1% |
Early childhood intervention | 1 | 0.1% |
Early-onset Alzheimer's disease | 1 | 0.1% |
Earth analog | 1 | 0.1% |
Earth sciences | 1 | 0.1% |
Earth's magnetic field | 1 | 0.1% |
Eating disorder | 1 | 0.1% |
Ebola virus | 1 | 0.1% |
Ebola virus epidemic in Liberia | 1 | 0.1% |
Echinococcus multilocularis | 1 | 0.1% |
Echo chamber (media) | 1 | 0.1% |
Ecological design | 1 | 0.1% |
Ecological resilience | 1 | 0.1% |
Ecological stability | 1 | 0.1% |
Ecological succession | 1 | 0.1% |
Economic equilibrium | 1 | 0.1% |
Economics of climate change mitigation | 1 | 0.1% |
Ecosystem management | 1 | 0.1% |
Ecosystem services | 1 | 0.1% |
Edema | 1 | 0.1% |
Edge computing | 1 | 0.1% |
Edoxaban | 1 | 0.1% |
Efavirenz/emtricitabine/tenofovir | 1 | 0.1% |
Efficacy | 1 | 0.1% |
Eicosanoid | 1 | 0.1% |
El Niño–Southern Oscillation | 1 | 0.1% |
Elaine Marley | 1 | 0.1% |
Elasticity (physics) | 1 | 0.1% |
Elastomeric respirator | 1 | 0.1% |
Elbow | 1 | 0.1% |
Elective surgery | 1 | 0.1% |
Electric power transmission | 1 | 0.1% |
Electrical conduction system of the heart | 1 | 0.1% |
Electricity | 1 | 0.1% |
Electroblotting | 1 | 0.1% |
Electrochemistry | 1 | 0.1% |
Electrolysis | 1 | 0.1% |
Electromagnetic interference | 1 | 0.1% |
Electromagnetic metasurface | 1 | 0.1% |
Electromagnetic radiation | 1 | 0.1% |
Electromagnetic spectrum | 1 | 0.1% |
Electron microscope | 1 | 0.1% |
Electronic circuit | 1 | 0.1% |
Electronic design automation | 1 | 0.1% |
Electronic warfare | 1 | 0.1% |
Electrophysiology | 1 | 0.1% |
Electroporation | 1 | 0.1% |
Elimination diet | 1 | 0.1% |
Embedded system | 1 | 0.1% |
Embryo | 1 | 0.1% |
Embryo transfer | 1 | 0.1% |
Embryoid body | 1 | 0.1% |
Emergency Medical Treatment and Active Labor Act | 1 | 0.1% |
Emic and etic | 1 | 0.1% |
Emotional eating | 1 | 0.1% |
Emotional self-regulation | 1 | 0.1% |
Emphysema | 1 | 0.1% |
Empirical Bayes method | 1 | 0.1% |
Employee benefits | 1 | 0.1% |
Employee engagement | 1 | 0.1% |
Emtricitabine/tenofovir | 1 | 0.1% |
Emulsion | 1 | 0.1% |
Enantiomer | 1 | 0.1% |
Encephalopathy | 1 | 0.1% |
End Stage Renal Disease Program | 1 | 0.1% |
End user | 1 | 0.1% |
Endangered species | 1 | 0.1% |
Endocrine diseases | 1 | 0.1% |
Endocytosis | 1 | 0.1% |
Endogeneity (econometrics) | 1 | 0.1% |
Endophyte | 1 | 0.1% |
Endoplasmic reticulum | 1 | 0.1% |
Endoscopic retrograde cholangiopancreatography | 1 | 0.1% |
Enema | 1 | 0.1% |
Energy conservation | 1 | 0.1% |
Energy harvesting | 1 | 0.1% |
Energy industry | 1 | 0.1% |
Energy poverty and cooking | 1 | 0.1% |
Engine | 1 | 0.1% |
Engineer | 1 | 0.1% |
Enoxaparin sodium | 1 | 0.1% |
Entamoeba | 1 | 0.1% |
Entecavir | 1 | 0.1% |
Enterococcus faecalis | 1 | 0.1% |
Enterovirus | 1 | 0.1% |
Enterovirus 71 | 1 | 0.1% |
Entrectinib | 1 | 0.1% |
Entropy | 1 | 0.1% |
Enuresis | 1 | 0.1% |
Envelope glycoprotein GP120 | 1 | 0.1% |
Environmental enrichment | 1 | 0.1% |
Environmental impact assessment | 1 | 0.1% |
Environmental justice | 1 | 0.1% |
Environmental monitoring | 1 | 0.1% |
Environmental policy | 1 | 0.1% |
Environmental resource management | 1 | 0.1% |
Environmental science | 1 | 0.1% |
Envisat | 1 | 0.1% |
Ependymoma | 1 | 0.1% |
Epididymis | 1 | 0.1% |
Epigenetic clock | 1 | 0.1% |
Epigraphy | 1 | 0.1% |
Epistasis | 1 | 0.1% |
Epistemology | 1 | 0.1% |
Eplerenone | 1 | 0.1% |
Epstein–Barr virus | 1 | 0.1% |
Equation | 1 | 0.1% |
Equianalgesic | 1 | 0.1% |
Erectile dysfunction | 1 | 0.1% |
Ergocalciferol | 1 | 0.1% |
Error | 1 | 0.1% |
Erythrocyte sedimentation rate | 1 | 0.1% |
Escitalopram | 1 | 0.1% |
Esophageal achalasia | 1 | 0.1% |
Esophageal varices | 1 | 0.1% |
Essential fatty acid | 1 | 0.1% |
Essential hypertension | 1 | 0.1% |
Essex | 1 | 0.1% |
Estimand | 1 | 0.1% |
Estradiol | 1 | 0.1% |
Estriol | 1 | 0.1% |
Estrogen receptor alpha | 1 | 0.1% |
Estrogen receptor beta | 1 | 0.1% |
Estrous cycle | 1 | 0.1% |
Etanercept | 1 | 0.1% |
Eteplirsen | 1 | 0.1% |
Ethanol | 1 | 0.1% |
Ethionamide | 1 | 0.1% |
Ethyl eicosapentaenoic acid | 1 | 0.1% |
Etiquette | 1 | 0.1% |
Etoricoxib | 1 | 0.1% |
Eurasian beaver | 1 | 0.1% |
Euripides | 1 | 0.1% |
Europe | 1 | 0.1% |
European Health Insurance Card | 1 | 0.1% |
European Nucleotide Archive | 1 | 0.1% |
European Patent Convention | 1 | 0.1% |
European emission standards | 1 | 0.1% |
European polecat | 1 | 0.1% |
Eusociality | 1 | 0.1% |
Eutrophication | 1 | 0.1% |
Evaporative cooler | 1 | 0.1% |
Eviction | 1 | 0.1% |
Evolution of ageing | 1 | 0.1% |
Evolution of influenza | 1 | 0.1% |
Excavation (archaeology) | 1 | 0.1% |
Excessive daytime sleepiness | 1 | 0.1% |
Exclusion of the null hypothesis | 1 | 0.1% |
Executive Order 12866 | 1 | 0.1% |
Executive Order 13813 | 1 | 0.1% |
Executive dysfunction | 1 | 0.1% |
Executive order | 1 | 0.1% |
Exercise-induced pulmonary hemorrhage | 1 | 0.1% |
ExoMars | 1 | 0.1% |
Exophthalmos | 1 | 0.1% |
Exosome (vesicle) | 1 | 0.1% |
Exotic pet | 1 | 0.1% |
Expected utility hypothesis | 1 | 0.1% |
Expenditures in the United States federal budget | 1 | 0.1% |
Experience | 1 | 0.1% |
Exploration of the Moon | 1 | 0.1% |
Explosion | 1 | 0.1% |
Explosive | 1 | 0.1% |
Exponential distribution | 1 | 0.1% |
Exposure Notification | 1 | 0.1% |
Exposure therapy | 1 | 0.1% |
Expressed emotion | 1 | 0.1% |
External cephalic version | 1 | 0.1% |
External validity | 1 | 0.1% |
Extinction | 1 | 0.1% |
Extract, transform, load | 1 | 0.1% |
Eye | 1 | 0.1% |
Eye chart | 1 | 0.1% |
Eye neoplasm | 1 | 0.1% |
Eye surgery | 1 | 0.1% |
Eyelid | 1 | 0.1% |
FMR1 | 1 | 0.1% |
Face shield | 1 | 0.1% |
Facial trauma | 1 | 0.1% |
Factor VIII | 1 | 0.1% |
Factor analysis | 1 | 0.1% |
Fair Labor Standards Act of 1938 | 1 | 0.1% |
Fallopian tube | 1 | 0.1% |
Falls in older adults | 1 | 0.1% |
False advertising | 1 | 0.1% |
False alarm | 1 | 0.1% |
Fare | 1 | 0.1% |
Farm | 1 | 0.1% |
Fascia | 1 | 0.1% |
Fashion | 1 | 0.1% |
Fast food | 1 | 0.1% |
Fast food restaurant | 1 | 0.1% |
Fatty acid | 1 | 0.1% |
Fault tree analysis | 1 | 0.1% |
Fax | 1 | 0.1% |
Feasibility study | 1 | 0.1% |
Febrile seizure | 1 | 0.1% |
Federal Employees Health Benefits Program | 1 | 0.1% |
Feed-in tariff | 1 | 0.1% |
Feeding tube | 1 | 0.1% |
Feeling | 1 | 0.1% |
Felicia Cosman | 1 | 0.1% |
Fellatio | 1 | 0.1% |
Fellow | 1 | 0.1% |
Feminism | 1 | 0.1% |
Femoral artery | 1 | 0.1% |
Femoral fracture | 1 | 0.1% |
Femoroacetabular impingement | 1 | 0.1% |
Ferret | 1 | 0.1% |
Ferry | 1 | 0.1% |
Fertilisation | 1 | 0.1% |
Fertility preservation | 1 | 0.1% |
Fetal alcohol spectrum disorder | 1 | 0.1% |
Fiber laser | 1 | 0.1% |
Fiber-optic communication | 1 | 0.1% |
Fibrin | 1 | 0.1% |
Fibrinolysis | 1 | 0.1% |
FibroTest | 1 | 0.1% |
Fibroadenoma | 1 | 0.1% |
Fibrocystic breast changes | 1 | 0.1% |
Fidaxomicin | 1 | 0.1% |
Field triage | 1 | 0.1% |
Fifth disease | 1 | 0.1% |
Filariasis | 1 | 0.1% |
File format | 1 | 0.1% |
FileZilla | 1 | 0.1% |
Filtering facepiece respirator | 1 | 0.1% |
FinFET | 1 | 0.1% |
Financial crisis of 2007–2008 | 1 | 0.1% |
Financial risk | 1 | 0.1% |
Financial transaction | 1 | 0.1% |
Financialization | 1 | 0.1% |
Finasteride | 1 | 0.1% |
Finite element method | 1 | 0.1% |
Finite strain theory | 1 | 0.1% |
Fire department | 1 | 0.1% |
Firefighter | 1 | 0.1% |
Firefighting | 1 | 0.1% |
Fish meal | 1 | 0.1% |
Fish slaughter | 1 | 0.1% |
Fisheries management | 1 | 0.1% |
Fishing trawler | 1 | 0.1% |
Fixation (histology) | 1 | 0.1% |
Flag | 1 | 0.1% |
Flag of Slovenia | 1 | 0.1% |
Flavonoid | 1 | 0.1% |
Flexibility (anatomy) | 1 | 0.1% |
Flextime | 1 | 0.1% |
Flight surgeon | 1 | 0.1% |
Flooring | 1 | 0.1% |
Flow battery | 1 | 0.1% |
Flower | 1 | 0.1% |
Fludarabine | 1 | 0.1% |
Fluid dynamics | 1 | 0.1% |
Fluorescence in situ hybridization | 1 | 0.1% |
Fluorescence microscope | 1 | 0.1% |
Fluorescent lamp | 1 | 0.1% |
Fluoride therapy | 1 | 0.1% |
Fluorophore | 1 | 0.1% |
Flurazepam | 1 | 0.1% |
Fluticasone propionate | 1 | 0.1% |
Flynn effect | 1 | 0.1% |
Focal segmental glomerulosclerosis | 1 | 0.1% |
Fondaparinux | 1 | 0.1% |
Food and Drug Administration Amendments Act of 2007 | 1 | 0.1% |
Food energy | 1 | 0.1% |
Food extrusion | 1 | 0.1% |
Food frequency questionnaire | 1 | 0.1% |
Food industry | 1 | 0.1% |
Food politics | 1 | 0.1% |
Food safety in China | 1 | 0.1% |
Food safety-risk analysis | 1 | 0.1% |
Food system | 1 | 0.1% |
Food waste | 1 | 0.1% |
Food web | 1 | 0.1% |
Foodservice | 1 | 0.1% |
Forearm | 1 | 0.1% |
Forensic science | 1 | 0.1% |
Forest | 1 | 0.1% |
Forgery | 1 | 0.1% |
Formal verification | 1 | 0.1% |
Formaldehyde | 1 | 0.1% |
Formation and evolution of the Solar System | 1 | 0.1% |
Forward genetics | 1 | 0.1% |
Fosfomycin | 1 | 0.1% |
Fossil fuel | 1 | 0.1% |
Foster care | 1 | 0.1% |
Fourth Industrial Revolution | 1 | 0.1% |
Fraction of inspired oxygen | 1 | 0.1% |
Fracture | 1 | 0.1% |
Fracture mechanics | 1 | 0.1% |
Fracture toughness | 1 | 0.1% |
Fragile X syndrome | 1 | 0.1% |
Fran Ulmer | 1 | 0.1% |
France Prešeren | 1 | 0.1% |
Francis Collins | 1 | 0.1% |
Francis Crick | 1 | 0.1% |
Francisco Javier de Balmis | 1 | 0.1% |
Franklin Stahl | 1 | 0.1% |
Free flap breast reconstruction | 1 | 0.1% |
Freedom of Information Act 2000 | 1 | 0.1% |
Freezing | 1 | 0.1% |
Frequentist inference | 1 | 0.1% |
Fructosamine | 1 | 0.1% |
Fruit | 1 | 0.1% |
Fucus vesiculosus | 1 | 0.1% |
Fuel cell vehicle | 1 | 0.1% |
Fuel economy in automobiles | 1 | 0.1% |
Fullerene | 1 | 0.1% |
Fulvestrant | 1 | 0.1% |
Functional electrical stimulation | 1 | 0.1% |
Functional groups | 1 | 0.1% |
Functional neurological symptom disorder | 1 | 0.1% |
Funding of science | 1 | 0.1% |
Fusidic acid | 1 | 0.1% |
Futures studies | 1 | 0.1% |
Förster resonance energy transfer | 1 | 0.1% |
G2 phase | 1 | 0.1% |
GLUT1 | 1 | 0.1% |
GOES-16 | 1 | 0.1% |
GSK-3 | 1 | 0.1% |
Gadolinium | 1 | 0.1% |
Gain of function research | 1 | 0.1% |
Gait analysis | 1 | 0.1% |
Galactic halo | 1 | 0.1% |
Galactose-1-phosphate uridylyltransferase deficiency | 1 | 0.1% |
Galactosemia | 1 | 0.1% |
Galanin | 1 | 0.1% |
Galaxy | 1 | 0.1% |
Galilean moons | 1 | 0.1% |
Galileo (satellite navigation) | 1 | 0.1% |
Galileo (spacecraft) | 1 | 0.1% |
Gallbladder | 1 | 0.1% |
Gallium arsenide | 1 | 0.1% |
Gallium nitride | 1 | 0.1% |
Gallstone | 1 | 0.1% |
Gametocyte | 1 | 0.1% |
Ganciclovir | 1 | 0.1% |
Gangrene | 1 | 0.1% |
Gardner's syndrome | 1 | 0.1% |
Gas chromatography | 1 | 0.1% |
Gas to liquids | 1 | 0.1% |
Gasoline | 1 | 0.1% |
Geisteswissenschaft | 1 | 0.1% |
Gel electrophoresis | 1 | 0.1% |
Gemcitabine | 1 | 0.1% |
Gene duplication | 1 | 0.1% |
Gene gun | 1 | 0.1% |
Gene knockdown | 1 | 0.1% |
Gene regulatory network | 1 | 0.1% |
General Schedule (US civil service pay scale) | 1 | 0.1% |
General circulation model | 1 | 0.1% |
General relativity | 1 | 0.1% |
General surgery | 1 | 0.1% |
Generalized anxiety disorder | 1 | 0.1% |
Generation IV reactor | 1 | 0.1% |
Genetic analysis | 1 | 0.1% |
Genetic carrier | 1 | 0.1% |
Genetic diversity | 1 | 0.1% |
Genetic heterogeneity | 1 | 0.1% |
Genetic linkage | 1 | 0.1% |
Genetic recombination | 1 | 0.1% |
Genetic resources | 1 | 0.1% |
Genetically modified tomato | 1 | 0.1% |
Geneva Protocol | 1 | 0.1% |
Geography | 1 | 0.1% |
Geomagnetic reversal | 1 | 0.1% |
Geothermal energy | 1 | 0.1% |
Geriatric psychiatry | 1 | 0.1% |
Germline | 1 | 0.1% |
Germline mutation | 1 | 0.1% |
Gestrinone | 1 | 0.1% |
Giant-cell arteritis | 1 | 0.1% |
Gibbs free energy | 1 | 0.1% |
Gilbert's syndrome | 1 | 0.1% |
Glasgow Coma Scale | 1 | 0.1% |
Glia | 1 | 0.1% |
Gliflozin | 1 | 0.1% |
Glioma | 1 | 0.1% |
Global Burden of Disease Study | 1 | 0.1% |
Global Food Safety Initiative | 1 | 0.1% |
Global Influenza Surveillance and Response System | 1 | 0.1% |
Global governance | 1 | 0.1% |
Global security law | 1 | 0.1% |
Globular cluster | 1 | 0.1% |
Glomerulonephritis | 1 | 0.1% |
Glomerulus (kidney) | 1 | 0.1% |
Glove | 1 | 0.1% |
Glucocorticoid | 1 | 0.1% |
Glucose meter | 1 | 0.1% |
Glucose-6-phosphate dehydrogenase | 1 | 0.1% |
Glucose-6-phosphate dehydrogenase deficiency | 1 | 0.1% |
Glut1 deficiency | 1 | 0.1% |
Glutamate carboxypeptidase II | 1 | 0.1% |
Glutamate dehydrogenase | 1 | 0.1% |
Glutaric aciduria type 1 | 1 | 0.1% |
Glutathione | 1 | 0.1% |
Glycan | 1 | 0.1% |
Glycogen storage disease type II | 1 | 0.1% |
Glycome | 1 | 0.1% |
Glycosylation | 1 | 0.1% |
God | 1 | 0.1% |
Goitre | 1 | 0.1% |
Goldwater–Nichols Act | 1 | 0.1% |
Good governance | 1 | 0.1% |
Government agencies of the United Kingdom | 1 | 0.1% |
Government spending | 1 | 0.1% |
Gp41 | 1 | 0.1% |
Grandparent | 1 | 0.1% |
Granuloma inguinale | 1 | 0.1% |
Granzyme | 1 | 0.1% |
Graphene | 1 | 0.1% |
Graphical user interface | 1 | 0.1% |
Graphics processing unit | 1 | 0.1% |
Graves' disease | 1 | 0.1% |
Graves' ophthalmopathy | 1 | 0.1% |
Gravity | 1 | 0.1% |
Gray (unit) | 1 | 0.1% |
Gray goo | 1 | 0.1% |
Great Recession | 1 | 0.1% |
Great Society | 1 | 0.1% |
Greater trochanteric pain syndrome | 1 | 0.1% |
Green Revolution | 1 | 0.1% |
Green chemistry | 1 | 0.1% |
Green infrastructure | 1 | 0.1% |
Greenhouse effect | 1 | 0.1% |
Gregory Abowd | 1 | 0.1% |
Grid cell | 1 | 0.1% |
Ground-glass opacity | 1 | 0.1% |
Group purchasing organization | 1 | 0.1% |
Growth hormone | 1 | 0.1% |
Guide RNA | 1 | 0.1% |
Gulf War syndrome | 1 | 0.1% |
Gums | 1 | 0.1% |
Gun violence | 1 | 0.1% |
Gunshot wound | 1 | 0.1% |
Gut microbiota | 1 | 0.1% |
Gynoid | 1 | 0.1% |
H3K56ac | 1 | 0.1% |
HAL (robot) | 1 | 0.1% |
HARPS-N | 1 | 0.1% |
HBB | 1 | 0.1% |
HELLP syndrome | 1 | 0.1% |
HEPA | 1 | 0.1% |
HERG | 1 | 0.1% |
HIV tropism | 1 | 0.1% |
HIV vaccine | 1 | 0.1% |
HIV/AIDS in the United States | 1 | 0.1% |
HPV-positive oropharyngeal cancer | 1 | 0.1% |
HVAC | 1 | 0.1% |
Hadfield, Derbyshire | 1 | 0.1% |
Haemaphysalis longicornis | 1 | 0.1% |
Haemophilia B | 1 | 0.1% |
Hafnium | 1 | 0.1% |
Hair cell | 1 | 0.1% |
Halton (UK Parliament constituency) | 1 | 0.1% |
Hand | 1 | 0.1% |
Hans Kluge | 1 | 0.1% |
Haplotype | 1 | 0.1% |
Harassment | 1 | 0.1% |
Harmful algal bloom | 1 | 0.1% |
Hartree–Fock method | 1 | 0.1% |
Hash function | 1 | 0.1% |
Haumea | 1 | 0.1% |
Hawker centre | 1 | 0.1% |
Hay | 1 | 0.1% |
Head-mounted display | 1 | 0.1% |
Healing | 1 | 0.1% |
Health at Every Size | 1 | 0.1% |
Health belief model | 1 | 0.1% |
Health care brands | 1 | 0.1% |
Health care in France | 1 | 0.1% |
Health care reforms proposed during the Obama administration | 1 | 0.1% |
Health effects of sunlight exposure | 1 | 0.1% |
Health effects of tobacco | 1 | 0.1% |
Health forecasting | 1 | 0.1% |
Health insurance mandate | 1 | 0.1% |
Health issues in pregnancy | 1 | 0.1% |
Healthcare in Canada | 1 | 0.1% |
Healthcare in Italy | 1 | 0.1% |
Healthcare in Norfolk | 1 | 0.1% |
Healthcare reform | 1 | 0.1% |
Heart murmur | 1 | 0.1% |
Heart rate variability | 1 | 0.1% |
Heat exchanger | 1 | 0.1% |
Heat pump | 1 | 0.1% |
Heat wave | 1 | 0.1% |
Heated humidified high-flow therapy | 1 | 0.1% |
Heating, ventilation, and air conditioning | 1 | 0.1% |
Heaven | 1 | 0.1% |
Heavy water | 1 | 0.1% |
Helicobacter | 1 | 0.1% |
Helicopter | 1 | 0.1% |
Helminthiasis | 1 | 0.1% |
Help desk | 1 | 0.1% |
Hemiparesis | 1 | 0.1% |
Hemodynamics | 1 | 0.1% |
Hemoglobinopathy | 1 | 0.1% |
Hemophagocytic lymphohistiocytosis | 1 | 0.1% |
Hemorrhoid | 1 | 0.1% |
Hemosiderosis | 1 | 0.1% |
Hemostasis | 1 | 0.1% |
Hemothorax | 1 | 0.1% |
Henry Kissinger | 1 | 0.1% |
Heparin-induced thrombocytopenia | 1 | 0.1% |
Hepatic arterial infusion | 1 | 0.1% |
Hepatic encephalopathy | 1 | 0.1% |
Hepatic stellate cell | 1 | 0.1% |
Hepatitis E | 1 | 0.1% |
Hepatocyte | 1 | 0.1% |
Herbicide | 1 | 0.1% |
Herbivore | 1 | 0.1% |
Heredity | 1 | 0.1% |
Hernia | 1 | 0.1% |
Hershey–Chase experiment | 1 | 0.1% |
Heteroscedasticity | 1 | 0.1% |
Heterosexuality | 1 | 0.1% |
Heuristics in judgment and decision-making | 1 | 0.1% |
High production volume chemicals | 1 | 0.1% |
High-intensity focused ultrasound | 1 | 0.1% |
High-intensity interval training | 1 | 0.1% |
High-nutrient, low-chlorophyll regions | 1 | 0.1% |
High-performance plastics | 1 | 0.1% |
High-resolution transmission electron microscopy | 1 | 0.1% |
High-throughput screening | 1 | 0.1% |
Hindsight bias | 1 | 0.1% |
Hip arthroscopy | 1 | 0.1% |
Hip dislocation | 1 | 0.1% |
Hip pain | 1 | 0.1% |
Hispanic paradox | 1 | 0.1% |
Histamine | 1 | 0.1% |
Histocompatibility | 1 | 0.1% |
Histogram | 1 | 0.1% |
Histology | 1 | 0.1% |
Histone | 1 | 0.1% |
History of cancer chemotherapy | 1 | 0.1% |
Hodgkin lymphoma | 1 | 0.1% |
Holocene | 1 | 0.1% |
Holography | 1 | 0.1% |
Home hemodialysis | 1 | 0.1% |
Homo sapiens | 1 | 0.1% |
Homogeneous charge compression ignition | 1 | 0.1% |
Homoscedasticity | 1 | 0.1% |
Honey | 1 | 0.1% |
Honiara | 1 | 0.1% |
Hookah | 1 | 0.1% |
Hormonal IUDs | 1 | 0.1% |
Horse | 1 | 0.1% |
Horse trainer | 1 | 0.1% |
Host (biology) | 1 | 0.1% |
Hot flash | 1 | 0.1% |
House mouse | 1 | 0.1% |
Household income in the United States | 1 | 0.1% |
Housekeeping | 1 | 0.1% |
Huanan Seafood Wholesale Market | 1 | 0.1% |
Human Development Report | 1 | 0.1% |
Human T-lymphotropic virus | 1 | 0.1% |
Human body temperature | 1 | 0.1% |
Human capital | 1 | 0.1% |
Human development (economics) | 1 | 0.1% |
Human evolution | 1 | 0.1% |
Human gender and sexuality | 1 | 0.1% |
Human impact on the environment | 1 | 0.1% |
Human leg | 1 | 0.1% |
Human life stages | 1 | 0.1% |
Human metapneumovirus | 1 | 0.1% |
Human mission to Mars | 1 | 0.1% |
Human parainfluenza viruses | 1 | 0.1% |
Human sex ratio | 1 | 0.1% |
Human spaceflight | 1 | 0.1% |
Human tooth | 1 | 0.1% |
Human trafficking | 1 | 0.1% |
Humanities | 1 | 0.1% |
Humanoid robot | 1 | 0.1% |
Humerus | 1 | 0.1% |
Hunger (physiology) | 1 | 0.1% |
Hurricane Maria | 1 | 0.1% |
Hurricane Rita | 1 | 0.1% |
Hybridization probe | 1 | 0.1% |
Hydralazine | 1 | 0.1% |
Hydrazine | 1 | 0.1% |
Hydrocephalus | 1 | 0.1% |
Hydrogen production | 1 | 0.1% |
Hydrogen vehicle | 1 | 0.1% |
Hydrology | 1 | 0.1% |
Hydrops fetalis | 1 | 0.1% |
Hydrothermal vent | 1 | 0.1% |
Hydroxyethyl starch | 1 | 0.1% |
Hyperalgesia | 1 | 0.1% |
Hypercapnia | 1 | 0.1% |
Hyperemesis gravidarum | 1 | 0.1% |
Hyperhidrosis | 1 | 0.1% |
Hyperinsulinemia | 1 | 0.1% |
Hyperkinetic disorder | 1 | 0.1% |
Hyperoxia | 1 | 0.1% |
Hyperparameter optimization | 1 | 0.1% |
Hypersomnia | 1 | 0.1% |
Hyperspectral imaging | 1 | 0.1% |
Hypertelorism | 1 | 0.1% |
Hypertensive disease of pregnancy | 1 | 0.1% |
Hyperthermia | 1 | 0.1% |
Hyperthermia therapy | 1 | 0.1% |
Hyperuricemia | 1 | 0.1% |
Hypocalcemia | 1 | 0.1% |
Hypokinesia | 1 | 0.1% |
Hypopituitarism | 1 | 0.1% |
Hypothalamus | 1 | 0.1% |
Hypovolemic shock | 1 | 0.1% |
IFRS 9 | 1 | 0.1% |
IL17A | 1 | 0.1% |
IR35 | 1 | 0.1% |
ISM band | 1 | 0.1% |
ISO/IEC 27001 | 1 | 0.1% |
ITIL | 1 | 0.1% |
IUCLID | 1 | 0.1% |
Ice age | 1 | 0.1% |
Ice core | 1 | 0.1% |
Ice sheet | 1 | 0.1% |
Icodextrin | 1 | 0.1% |
Identifier | 1 | 0.1% |
Identity document | 1 | 0.1% |
Identity management | 1 | 0.1% |
Ideology | 1 | 0.1% |
Idiopathic hypersomnia | 1 | 0.1% |
Iditarod Trail Sled Dog Race | 1 | 0.1% |
Igneous rock | 1 | 0.1% |
Ignition interlock device | 1 | 0.1% |
Illicit cigarette trade | 1 | 0.1% |
Image noise | 1 | 0.1% |
Image resolution | 1 | 0.1% |
Image scanner | 1 | 0.1% |
Image sensor | 1 | 0.1% |
Image-guided surgery | 1 | 0.1% |
Imaging biomarker | 1 | 0.1% |
Imatinib | 1 | 0.1% |
Immune response | 1 | 0.1% |
Immune tolerance | 1 | 0.1% |
Immunization during pregnancy | 1 | 0.1% |
Immunocontraception | 1 | 0.1% |
Immunoelectrophoresis | 1 | 0.1% |
Immunoglobulin A | 1 | 0.1% |
Immunologic adjuvant | 1 | 0.1% |
Immunoprecipitation | 1 | 0.1% |
Immunosenescence | 1 | 0.1% |
Impetigo | 1 | 0.1% |
Impulsivity | 1 | 0.1% |
In silico | 1 | 0.1% |
Incandescent light bulb | 1 | 0.1% |
Incident Command System | 1 | 0.1% |
Incidental imaging finding | 1 | 0.1% |
Income tax | 1 | 0.1% |
Incubation period | 1 | 0.1% |
Indefinite leave to remain | 1 | 0.1% |
Index (economics) | 1 | 0.1% |
Index case | 1 | 0.1% |
Indiana vesiculovirus | 1 | 0.1% |
Indigenous health in Australia | 1 | 0.1% |
Indigenous peoples of Polynesia | 1 | 0.1% |
Indinavir | 1 | 0.1% |
Indo-Fijians | 1 | 0.1% |
Indole-3-carbinol | 1 | 0.1% |
Indoor air quality | 1 | 0.1% |
Indoor residual spraying | 1 | 0.1% |
Indoor tanning | 1 | 0.1% |
Industrial espionage | 1 | 0.1% |
Industrial policy | 1 | 0.1% |
Industrial robot | 1 | 0.1% |
Industries | 1 | 0.1% |
Infancy | 1 | 0.1% |
Infant bed | 1 | 0.1% |
Inferior vena cava | 1 | 0.1% |
Influenza A virus subtype H7N7 | 1 | 0.1% |
Influenza A virus subtype H9N2 | 1 | 0.1% |
Influenza prevention | 1 | 0.1% |
Influenza treatment | 1 | 0.1% |
Infodemic | 1 | 0.1% |
Infographic | 1 | 0.1% |
Information Sharing Environment | 1 | 0.1% |
Information science | 1 | 0.1% |
Information security management | 1 | 0.1% |
Information sensitivity | 1 | 0.1% |
Infusion pump | 1 | 0.1% |
Inhibitory postsynaptic potential | 1 | 0.1% |
Inpatient care | 1 | 0.1% |
Inquest | 1 | 0.1% |
Insight | 1 | 0.1% |
Instrumental variables estimation | 1 | 0.1% |
Insulin lispro | 1 | 0.1% |
Integrated Management of Childhood Illness | 1 | 0.1% |
Integrated pest management | 1 | 0.1% |
Intendix | 1 | 0.1% |
Intensive insulin therapy | 1 | 0.1% |
Interactome | 1 | 0.1% |
Interagency Coordinating Committee on the Validation of Alternative Methods | 1 | 0.1% |
Interferon gamma | 1 | 0.1% |
Interleukin | 1 | 0.1% |
Interleukin 15 | 1 | 0.1% |
Interleukin 17 | 1 | 0.1% |
Interleukin 2 | 1 | 0.1% |
Interleukin 6 | 1 | 0.1% |
Intermediate Care Facilities for Individuals with Intellectual Disabilities | 1 | 0.1% |
Intermittent preventive therapy | 1 | 0.1% |
Internal Revenue Code | 1 | 0.1% |
International Classification of Diseases for Oncology | 1 | 0.1% |
International Prognostic Index | 1 | 0.1% |
International law | 1 | 0.1% |
Internet of Military Things | 1 | 0.1% |
Internet privacy | 1 | 0.1% |
Internship | 1 | 0.1% |
Interstitial lung disease | 1 | 0.1% |
Interval training | 1 | 0.1% |
Intervertebral disc | 1 | 0.1% |
Interview | 1 | 0.1% |
Intraductal papillary mucinous neoplasm | 1 | 0.1% |
Intraocular pressure | 1 | 0.1% |
Intrauterine hypoxia | 1 | 0.1% |
Intravenous pyelogram | 1 | 0.1% |
Intraventricular hemorrhage | 1 | 0.1% |
Introduced species | 1 | 0.1% |
Investigations into the origin of COVID-19 | 1 | 0.1% |
Invitation to tender | 1 | 0.1% |
Io (moon) | 1 | 0.1% |
Iodised salt | 1 | 0.1% |
Iris recognition | 1 | 0.1% |
Iron | 1 | 0.1% |
Iron-deficiency anemia | 1 | 0.1% |
Irrigation | 1 | 0.1% |
Irritable bowel syndrome | 1 | 0.1% |
Isaac Asimov | 1 | 0.1% |
Islam | 1 | 0.1% |
Islet cell transplantation | 1 | 0.1% |
Isosporiasis | 1 | 0.1% |
Israeli settlement | 1 | 0.1% |
Itraconazole | 1 | 0.1% |
Ivacaftor | 1 | 0.1% |
Ivermectin | 1 | 0.1% |
Iwi | 1 | 0.1% |
JLENS | 1 | 0.1% |
Jacques Monod | 1 | 0.1% |
James Palmer (mayor) | 1 | 0.1% |
James Watson | 1 | 0.1% |
Janez Janša | 1 | 0.1% |
Japanese encephalitis | 1 | 0.1% |
Jejunum | 1 | 0.1% |
Jennifer Doudna | 1 | 0.1% |
Jerusalem | 1 | 0.1% |
Jews | 1 | 0.1% |
Job satisfaction | 1 | 0.1% |
John Bourn | 1 | 0.1% |
John F. Kennedy | 1 | 0.1% |
John J. Zhang | 1 | 0.1% |
Join (SQL) | 1 | 0.1% |
Joint Monitoring Programme for Water Supply and Sanitation | 1 | 0.1% |
Joint dislocation | 1 | 0.1% |
Jonathan D. Moreno | 1 | 0.1% |
Josephson effect | 1 | 0.1% |
Judaism | 1 | 0.1% |
Julie Gerberding | 1 | 0.1% |
Jupiter Icy Moons Explorer | 1 | 0.1% |
Juvenile dermatomyositis | 1 | 0.1% |
Jürgen Habermas | 1 | 0.1% |
K-nearest neighbors algorithm | 1 | 0.1% |
Kegel exercise | 1 | 0.1% |
Keloid | 1 | 0.1% |
Kennel cough | 1 | 0.1% |
Ketamine | 1 | 0.1% |
Kevin Warwick | 1 | 0.1% |
Ki-67 (protein) | 1 | 0.1% |
Kidney stone disease | 1 | 0.1% |
Kilowatt-hour | 1 | 0.1% |
Kings Cross, London | 1 | 0.1% |
Kingston upon Hull | 1 | 0.1% |
KiwiSaver | 1 | 0.1% |
Klamath River | 1 | 0.1% |
Klebsiella pneumoniae | 1 | 0.1% |
Klinefelter syndrome | 1 | 0.1% |
Knitted fabric | 1 | 0.1% |
Knutsford (UK Parliament constituency) | 1 | 0.1% |
Kosciuszko Institute | 1 | 0.1% |
Kosterlitz–Thouless transition | 1 | 0.1% |
Kris Faafoi | 1 | 0.1% |
Kt/V | 1 | 0.1% |
Kuala Lumpur International Airport | 1 | 0.1% |
Kuiper belt | 1 | 0.1% |
L-form bacteria | 1 | 0.1% |
LGBT community | 1 | 0.1% |
Labor | 1 | 0.1% |
Laboratories | 1 | 0.1% |
Laboratory diagnosis of viral infections | 1 | 0.1% |
Laboratory information management system | 1 | 0.1% |
Laboratory rat | 1 | 0.1% |
Laboratory techniques | 1 | 0.1% |
Lactate dehydrogenase | 1 | 0.1% |
Lactobacillus acidophilus | 1 | 0.1% |
Lactobacillus fermentum | 1 | 0.1% |
Lactobacillus rhamnosus | 1 | 0.1% |
Lake | 1 | 0.1% |
Lambert–Eaton myasthenic syndrome | 1 | 0.1% |
Laminoplasty | 1 | 0.1% |
Lamotrigine | 1 | 0.1% |
Landlord | 1 | 0.1% |
Landscape | 1 | 0.1% |
Language | 1 | 0.1% |
Laparotomy | 1 | 0.1% |
Lapatinib | 1 | 0.1% |
Laptop | 1 | 0.1% |
Large Hadron Collider | 1 | 0.1% |
Laryngeal cancer | 1 | 0.1% |
Lasting power of attorney | 1 | 0.1% |
Lateral flow test | 1 | 0.1% |
Laura Lechuga | 1 | 0.1% |
Law of Canada | 1 | 0.1% |
Law of the United States | 1 | 0.1% |
Lawyer | 1 | 0.1% |
Laxative | 1 | 0.1% |
Layoff | 1 | 0.1% |
Le Fort fracture of skull | 1 | 0.1% |
LeChuck | 1 | 0.1% |
Leaching (agriculture) | 1 | 0.1% |
Leaf spot | 1 | 0.1% |
Lease | 1 | 0.1% |
Leasehold estate | 1 | 0.1% |
Legal remedy | 1 | 0.1% |
Legislation | 1 | 0.1% |
Legislative branch of the United States government | 1 | 0.1% |
Lennox–Gastaut syndrome | 1 | 0.1% |
Lens (anatomy) | 1 | 0.1% |
Lentiviral vector in gene therapy | 1 | 0.1% |
Lentivirus | 1 | 0.1% |
Lenvatinib | 1 | 0.1% |
Leptospirosis | 1 | 0.1% |
Lethal autonomous weapon | 1 | 0.1% |
Lethal dose | 1 | 0.1% |
Leukorrhea | 1 | 0.1% |
Leukotriene | 1 | 0.1% |
Level crossing | 1 | 0.1% |
Liaison psychiatry | 1 | 0.1% |
Liberty | 1 | 0.1% |
Licensed behavior analyst | 1 | 0.1% |
Licensed professional counselor | 1 | 0.1% |
Life insurance | 1 | 0.1% |
Life on Titan | 1 | 0.1% |
Life satisfaction | 1 | 0.1% |
Life sciences industry | 1 | 0.1% |
Life support system | 1 | 0.1% |
Ligand (biochemistry) | 1 | 0.1% |
Light | 1 | 0.1% |
Light-emitting diode | 1 | 0.1% |
Light-water reactor | 1 | 0.1% |
Lighting | 1 | 0.1% |
Lignocellulosic biomass | 1 | 0.1% |
Limited English proficiency | 1 | 0.1% |
Limited liability partnership | 1 | 0.1% |
Limited partnership | 1 | 0.1% |
Lineage P.1 | 1 | 0.1% |
Linear particle accelerator | 1 | 0.1% |
Linear time-invariant system | 1 | 0.1% |
Linguistics | 1 | 0.1% |
Linkage disequilibrium | 1 | 0.1% |
Linus Pauling | 1 | 0.1% |
Lipid | 1 | 0.1% |
Lipid bilayer | 1 | 0.1% |
Lipid disorders | 1 | 0.1% |
Lipidomics | 1 | 0.1% |
Lipizzan | 1 | 0.1% |
Lipopolysaccharide | 1 | 0.1% |
Liquor | 1 | 0.1% |
Lisdexamfetamine | 1 | 0.1% |
Lithium | 1 | 0.1% |
Lithium-ion battery | 1 | 0.1% |
Lithium–air battery | 1 | 0.1% |
Live-in caregiver | 1 | 0.1% |
Living wage | 1 | 0.1% |
Lobotomy | 1 | 0.1% |
Locum | 1 | 0.1% |
Lojze Peterle | 1 | 0.1% |
London Borough of Camden | 1 | 0.1% |
Long interspersed nuclear element | 1 | 0.1% |
Long-acting beta-adrenoceptor agonist | 1 | 0.1% |
Long-acting reversible contraception | 1 | 0.1% |
Long-term care insurance in Germany | 1 | 0.1% |
Long-term potentiation | 1 | 0.1% |
Longevity | 1 | 0.1% |
Lopinavir/ritonavir | 1 | 0.1% |
Loratadine | 1 | 0.1% |
Lorazepam | 1 | 0.1% |
Low-Income Housing Tax Credit | 1 | 0.1% |
Low-threshold treatment programs | 1 | 0.1% |
Lujo mammarenavirus | 1 | 0.1% |
Lumbar vertebrae | 1 | 0.1% |
Lumen (unit) | 1 | 0.1% |
Lumpectomy | 1 | 0.1% |
Lunar magma ocean | 1 | 0.1% |
Lunar rover | 1 | 0.1% |
Lunasin | 1 | 0.1% |
Lung disorders | 1 | 0.1% |
Luteinizing hormone | 1 | 0.1% |
Luton | 1 | 0.1% |
Lymphadenopathy | 1 | 0.1% |
Lymphatic filariasis | 1 | 0.1% |
Lymphedema | 1 | 0.1% |
Lysergic acid diethylamide | 1 | 0.1% |
Lysosomal storage disease | 1 | 0.1% |
Lysosome | 1 | 0.1% |
Lyssavirus | 1 | 0.1% |
László Lovász | 1 | 0.1% |
MALT lymphoma | 1 | 0.1% |
MLH1 | 1 | 0.1% |
MMR vaccine and autism | 1 | 0.1% |
MOX fuel | 1 | 0.1% |
MRNA-1273 | 1 | 0.1% |
MSH2 | 1 | 0.1% |
MSH6 | 1 | 0.1% |
MTOR | 1 | 0.1% |
MTOR inhibitors | 1 | 0.1% |
MUC1 | 1 | 0.1% |
Macclesfield (UK Parliament constituency) | 1 | 0.1% |
Machining | 1 | 0.1% |
Macroeconomics | 1 | 0.1% |
Macrogol | 1 | 0.1% |
Macromolecules | 1 | 0.1% |
Maghreb | 1 | 0.1% |
Magma | 1 | 0.1% |
Magnesium | 1 | 0.1% |
Magnesium diboride | 1 | 0.1% |
Magnetometer | 1 | 0.1% |
Magnetosphere | 1 | 0.1% |
Magnetosphere of Jupiter | 1 | 0.1% |
1 | 0.1% | |
Maize | 1 | 0.1% |
Major histocompatibility complex | 1 | 0.1% |
Malaria antigen detection tests | 1 | 0.1% |
Malaria vaccine | 1 | 0.1% |
Malcolm B. Frost | 1 | 0.1% |
Mammal female reproductive system | 1 | 0.1% |
Mammaplasty | 1 | 0.1% |
Mammary tumor | 1 | 0.1% |
Management of dehydration | 1 | 0.1% |
Management of obesity | 1 | 0.1% |
Management of schizophrenia | 1 | 0.1% |
Mandible | 1 | 0.1% |
Mandibular fracture | 1 | 0.1% |
Mani Menon | 1 | 0.1% |
Mantle cell lymphoma | 1 | 0.1% |
Manus Island | 1 | 0.1% |
Marfan syndrome | 1 | 0.1% |
Marine protected area | 1 | 0.1% |
Mariposa County, California | 1 | 0.1% |
Mark and recapture | 1 | 0.1% |
Marker-assisted selection | 1 | 0.1% |
Market segmentation | 1 | 0.1% |
Marketing authorisation | 1 | 0.1% |
Marketing research | 1 | 0.1% |
Mastocytosis | 1 | 0.1% |
Mastopexy | 1 | 0.1% |
Matariki | 1 | 0.1% |
Matched filter | 1 | 0.1% |
Maternal mortality in the United States | 1 | 0.1% |
Mathematical and quantitative methods (economics) | 1 | 0.1% |
Matthew Meselson | 1 | 0.1% |
Max Delbrück | 1 | 0.1% |
Maxilla | 1 | 0.1% |
Mayor of London | 1 | 0.1% |
McDonald criteria | 1 | 0.1% |
McGeorge Bundy | 1 | 0.1% |
Meal | 1 | 0.1% |
Mechatronics | 1 | 0.1% |
Mediastinitis | 1 | 0.1% |
Mediastinum | 1 | 0.1% |
Mediation | 1 | 0.1% |
Medical Priority Dispatch System | 1 | 0.1% |
Medical assistant | 1 | 0.1% |
Medical classification | 1 | 0.1% |
Medical eligibility criteria for contraceptive use | 1 | 0.1% |
Medical laboratory scientist | 1 | 0.1% |
Medical license | 1 | 0.1% |
Medical malpractice | 1 | 0.1% |
Medical prevention | 1 | 0.1% |
Medical simulation | 1 | 0.1% |
Medical ventilator | 1 | 0.1% |
Medically unexplained physical symptoms | 1 | 0.1% |
Medicare Part D coverage gap | 1 | 0.1% |
Medulloblastoma | 1 | 0.1% |
Meige's syndrome | 1 | 0.1% |
Meiosis | 1 | 0.1% |
Melatonin | 1 | 0.1% |
Melioidosis | 1 | 0.1% |
Melting point | 1 | 0.1% |
Membrane bioreactor | 1 | 0.1% |
Membrane-active molecules | 1 | 0.1% |
Memorandum of understanding | 1 | 0.1% |
Memory B cell | 1 | 0.1% |
Memory T cell | 1 | 0.1% |
Men's health | 1 | 0.1% |
Meningioma | 1 | 0.1% |
Mental Health Parity Act | 1 | 0.1% |
Mental distress | 1 | 0.1% |
Mental health counselor | 1 | 0.1% |
Mental health literacy | 1 | 0.1% |
Mental status examination | 1 | 0.1% |
Meralgia paraesthetica | 1 | 0.1% |
Meso-zeaxanthin | 1 | 0.1% |
Metabolic equivalent of task | 1 | 0.1% |
Metabolome | 1 | 0.1% |
Metal | 1 | 0.1% |
Metal foam | 1 | 0.1% |
Metaproteomics | 1 | 0.1% |
Metastasectomy | 1 | 0.1% |
Meteoroid | 1 | 0.1% |
Meteorology | 1 | 0.1% |
Methadone | 1 | 0.1% |
Methamphetamine | 1 | 0.1% |
Methane | 1 | 0.1% |
Methicillin | 1 | 0.1% |
Methods of birth control | 1 | 0.1% |
Methotrexate | 1 | 0.1% |
Methylnaltrexone | 1 | 0.1% |
Methyltestosterone | 1 | 0.1% |
Metoclopramide | 1 | 0.1% |
Metolazone | 1 | 0.1% |
Metropolitan area | 1 | 0.1% |
Metropolitan statistical area | 1 | 0.1% |
Michael Barratt (astronaut) | 1 | 0.1% |
Michael Osterholm | 1 | 0.1% |
Microcephaly | 1 | 0.1% |
Microelectromechanical systems | 1 | 0.1% |
Microfluidics | 1 | 0.1% |
Microglia | 1 | 0.1% |
Micronucleus test | 1 | 0.1% |
Micronutrient | 1 | 0.1% |
Microprocessor | 1 | 0.1% |
Microsatellite | 1 | 0.1% |
Microsporidia | 1 | 0.1% |
Microstate (statistical mechanics) | 1 | 0.1% |
Microtia | 1 | 0.1% |
Microvascular angina | 1 | 0.1% |
Microwave | 1 | 0.1% |
Midostaurin | 1 | 0.1% |
Milan Spasić | 1 | 0.1% |
Mild cognitive impairment | 1 | 0.1% |
Military robot | 1 | 0.1% |
Military science | 1 | 0.1% |
Milk allergy | 1 | 0.1% |
Mindfulness-based cognitive therapy | 1 | 0.1% |
Mineral dust | 1 | 0.1% |
Minimal genome | 1 | 0.1% |
Minimaze procedure | 1 | 0.1% |
Minimum inhibitory concentration | 1 | 0.1% |
Mining | 1 | 0.1% |
Minneapolis–Saint Paul International Airport | 1 | 0.1% |
MinnesotaCare | 1 | 0.1% |
Minutes | 1 | 0.1% |
Mirtazapine | 1 | 0.1% |
Mitophagy | 1 | 0.1% |
Mitosis | 1 | 0.1% |
Mitral regurgitation | 1 | 0.1% |
Mitral stenosis | 1 | 0.1% |
Mitral valve annuloplasty | 1 | 0.1% |
Mitral valve repair | 1 | 0.1% |
Mitral valve stenosis | 1 | 0.1% |
Mixed-member proportional representation | 1 | 0.1% |
Mobile device | 1 | 0.1% |
Moclobemide | 1 | 0.1% |
Model for End-Stage Liver Disease | 1 | 0.1% |
Modern Slavery Act 2015 | 1 | 0.1% |
Mold | 1 | 0.1% |
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid | 1 | 0.1% |
Molecular binding | 1 | 0.1% |
Molecular cloning | 1 | 0.1% |
Molecular imaging | 1 | 0.1% |
Molecular marker | 1 | 0.1% |
Molecular phylogenetics | 1 | 0.1% |
Money | 1 | 0.1% |
Monoclonal B-cell lymphocytosis | 1 | 0.1% |
Monoclonal antibody therapy | 1 | 0.1% |
Monopoly | 1 | 0.1% |
Mood stabilizer | 1 | 0.1% |
Moral injury | 1 | 0.1% |
Morality | 1 | 0.1% |
Morobe Province | 1 | 0.1% |
Mortgage loan | 1 | 0.1% |
Moss | 1 | 0.1% |
Motion sickness | 1 | 0.1% |
Motor skill | 1 | 0.1% |
Motorcycle | 1 | 0.1% |
Mountaineering | 1 | 0.1% |
Mouth | 1 | 0.1% |
Moving average | 1 | 0.1% |
Mucus | 1 | 0.1% |
Multi-factor authentication | 1 | 0.1% |
Multicast | 1 | 0.1% |
Multiculturalism | 1 | 0.1% |
Multidimensional signal processing | 1 | 0.1% |
Multifocal motor neuropathy | 1 | 0.1% |
Multilateralism | 1 | 0.1% |
Multilevel model | 1 | 0.1% |
Multimethodology | 1 | 0.1% |
Multinomial logistic regression | 1 | 0.1% |
Multiple comparisons problem | 1 | 0.1% |
Multistakeholder governance | 1 | 0.1% |
Multistakeholder governance model | 1 | 0.1% |
Municipal Police (France) | 1 | 0.1% |
Muon | 1 | 0.1% |
Muriel Bowser | 1 | 0.1% |
Muromonab-CD3 | 1 | 0.1% |
Muscarinic antagonist | 1 | 0.1% |
Muscle | 1 | 0.1% |
Muscular dystrophy | 1 | 0.1% |
Museum | 1 | 0.1% |
Music | 1 | 0.1% |
Music Tech Fest | 1 | 0.1% |
Musicians from Florida | 1 | 0.1% |
Mustelidae | 1 | 0.1% |
Myasthenia gravis | 1 | 0.1% |
Mycophenolic acid | 1 | 0.1% |
Mycoplasma genitalium | 1 | 0.1% |
Mycoplasma pneumoniae | 1 | 0.1% |
Mycotoxin | 1 | 0.1% |
Myeloma protein | 1 | 0.1% |
Myeloproliferative neoplasm | 1 | 0.1% |
Myogenesis | 1 | 0.1% |
Myrosinase | 1 | 0.1% |
Māori | 1 | 0.1% |
Māori music | 1 | 0.1% |
Māori people | 1 | 0.1% |
NEEMO | 1 | 0.1% |
NHS Long Term Plan | 1 | 0.1% |
NHS dentistry | 1 | 0.1% |
NHS health check | 1 | 0.1% |
NHS trust | 1 | 0.1% |
Nail biting | 1 | 0.1% |
Naive T cell | 1 | 0.1% |
Naldemedine | 1 | 0.1% |
Naloxone | 1 | 0.1% |
Naltrexone | 1 | 0.1% |
Nanocapsule | 1 | 0.1% |
Nanocarriers | 1 | 0.1% |
Nanochemistry | 1 | 0.1% |
Nanodiamond | 1 | 0.1% |
Nanoelectronics | 1 | 0.1% |
Nanolithography | 1 | 0.1% |
Nanometrology | 1 | 0.1% |
Naproxen | 1 | 0.1% |
Narcolepsy | 1 | 0.1% |
Narrative | 1 | 0.1% |
Nasolacrimal duct obstruction | 1 | 0.1% |
Nasopharynx cancer | 1 | 0.1% |
National Ambient Air Quality Standards | 1 | 0.1% |
National Immunization Technical Advisory Group | 1 | 0.1% |
National Insurance | 1 | 0.1% |
National TB Elimination Program (India) | 1 | 0.1% |
National debt of the United States | 1 | 0.1% |
National health insurance | 1 | 0.1% |
Natural disaster | 1 | 0.1% |
Natural gas storage | 1 | 0.1% |
Natural killer T cell | 1 | 0.1% |
Natural language processing | 1 | 0.1% |
Natural product | 1 | 0.1% |
Natural resource management | 1 | 0.1% |
Natural rubber | 1 | 0.1% |
Natural science | 1 | 0.1% |
Naturalization | 1 | 0.1% |
Nature versus nurture | 1 | 0.1% |
Nature-based solutions | 1 | 0.1% |
Navigation | 1 | 0.1% |
Naypyidaw | 1 | 0.1% |
Near-infrared spectroscopy | 1 | 0.1% |
Nebular hypothesis | 1 | 0.1% |
Necrosis | 1 | 0.1% |
Necrotizing enterocolitis | 1 | 0.1% |
Necrotizing fasciitis | 1 | 0.1% |
Negative room pressure | 1 | 0.1% |
Negotiation | 1 | 0.1% |
Nelfinavir | 1 | 0.1% |
Neonatal diabetes mellitus | 1 | 0.1% |
Neonatal hypoglycemia | 1 | 0.1% |
Neonatal seizure | 1 | 0.1% |
Neonatal tetanus | 1 | 0.1% |
Nephrotic syndrome | 1 | 0.1% |
Neptune | 1 | 0.1% |
Nerve compression syndrome | 1 | 0.1% |
Nerve conduction study | 1 | 0.1% |
Nerve guidance conduit | 1 | 0.1% |
Neural circuit | 1 | 0.1% |
Neural coding | 1 | 0.1% |
Neural dust | 1 | 0.1% |
Neural oscillation | 1 | 0.1% |
Neuralgia | 1 | 0.1% |
Neuroeconomics | 1 | 0.1% |
Neuroendocrine tumor | 1 | 0.1% |
Neuroergonomics | 1 | 0.1% |
Neurolaw | 1 | 0.1% |
Neuromyelitis optica | 1 | 0.1% |
Neuropathic arthropathy | 1 | 0.1% |
Neuropathology | 1 | 0.1% |
Neuropsychological test | 1 | 0.1% |
Neuropsychopharmacology | 1 | 0.1% |
Neuroregeneration | 1 | 0.1% |
Neurotrauma | 1 | 0.1% |
Neurotrophin | 1 | 0.1% |
Neutron | 1 | 0.1% |
New Britain | 1 | 0.1% |
New Drug Application | 1 | 0.1% |
News | 1 | 0.1% |
Next of kin | 1 | 0.1% |
Nick Bostrom | 1 | 0.1% |
Nicotinamide adenine dinucleotide | 1 | 0.1% |
Nicotine dependence | 1 | 0.1% |
Nidovirales | 1 | 0.1% |
Nifedipine | 1 | 0.1% |
Nifurtimox | 1 | 0.1% |
Nintedanib | 1 | 0.1% |
Nipple | 1 | 0.1% |
Niraparib | 1 | 0.1% |
Nirmatrelvir | 1 | 0.1% |
Nitrogen | 1 | 0.1% |
Nitrogen dioxide | 1 | 0.1% |
Nobel Prize in Physiology or Medicine | 1 | 0.1% |
Nociceptor | 1 | 0.1% |
Noctilucent cloud | 1 | 0.1% |
Noise | 1 | 0.1% |
Non-Hispanic whites | 1 | 0.1% |
Non-coding DNA | 1 | 0.1% |
Non-commissioned officer | 1 | 0.1% |
Non-heart-beating donation | 1 | 0.1% |
Non-tariff barriers to trade | 1 | 0.1% |
Nondestructive testing | 1 | 0.1% |
Nonoxynol-9 | 1 | 0.1% |
Nonprofit organization | 1 | 0.1% |
Nontuberculous mycobacteria | 1 | 0.1% |
Nootropic | 1 | 0.1% |
Nordic countries | 1 | 0.1% |
Norethisterone enanthate | 1 | 0.1% |
Norgestimate | 1 | 0.1% |
Normal pressure hydrocephalus | 1 | 0.1% |
Northumberland | 1 | 0.1% |
Nortriptyline | 1 | 0.1% |
Norwegian language | 1 | 0.1% |
Nosema apis | 1 | 0.1% |
Nosema ceranae | 1 | 0.1% |
Nuclear and radiation accidents and incidents | 1 | 0.1% |
Nuclear fuel | 1 | 0.1% |
Nuclear fusion | 1 | 0.1% |
Nuclear pharmacy | 1 | 0.1% |
Nuclear safety and security | 1 | 0.1% |
Nucleic acid double helix | 1 | 0.1% |
Nucleic acid test | 1 | 0.1% |
Nucleic acid thermodynamics | 1 | 0.1% |
Nucleic acids | 1 | 0.1% |
Nucleosome | 1 | 0.1% |
Nucleotides | 1 | 0.1% |
Nudge theory | 1 | 0.1% |
Numeracy | 1 | 0.1% |
Numerical | 1 | 0.1% |
Nursing shortage | 1 | 0.1% |
Nutri-Score | 1 | 0.1% |
Nutrient sensing | 1 | 0.1% |
Nutrition education | 1 | 0.1% |
Nutrition facts label | 1 | 0.1% |
Nutritionist | 1 | 0.1% |
Nylon | 1 | 0.1% |
Nystatin | 1 | 0.1% |
OGT (gene) | 1 | 0.1% |
OLED | 1 | 0.1% |
Oath of office | 1 | 0.1% |
Obesity and the environment | 1 | 0.1% |
Obesity in Australia | 1 | 0.1% |
Objective structured clinical examination | 1 | 0.1% |
Observation | 1 | 0.1% |
Observer-expectancy effect | 1 | 0.1% |
Obstetric labor complication | 1 | 0.1% |
Obstructive lung disease | 1 | 0.1% |
Occult fracture | 1 | 0.1% |
Occultation | 1 | 0.1% |
Occupational burnout | 1 | 0.1% |
Occupational disease | 1 | 0.1% |
Occupational stress | 1 | 0.1% |
Octreotide | 1 | 0.1% |
Ocular tonometry | 1 | 0.1% |
Oculoplastics | 1 | 0.1% |
Off-target genome editing | 1 | 0.1% |
Offshore wind power | 1 | 0.1% |
Okara (food) | 1 | 0.1% |
Olaparib | 1 | 0.1% |
Older Americans Act | 1 | 0.1% |
Olfaction | 1 | 0.1% |
Oligoastrocytoma | 1 | 0.1% |
Oligodendroglioma | 1 | 0.1% |
Oligonucleotide | 1 | 0.1% |
Olive oil | 1 | 0.1% |
Omacetaxine mepesuccinate | 1 | 0.1% |
Ombudsman | 1 | 0.1% |
Omeprazole | 1 | 0.1% |
On-the-job training | 1 | 0.1% |
Onboarding | 1 | 0.1% |
Onchocerciasis | 1 | 0.1% |
Oncology Care Model | 1 | 0.1% |
Oncolytic adenovirus | 1 | 0.1% |
Oncolytic virus | 1 | 0.1% |
Oncovirus | 1 | 0.1% |
Online advertising | 1 | 0.1% |
Online analytical processing | 1 | 0.1% |
Online community | 1 | 0.1% |
Online shopping | 1 | 0.1% |
Online transaction processing | 1 | 0.1% |
Ontology | 1 | 0.1% |
Oocyte | 1 | 0.1% |
Open source | 1 | 0.1% |
Operant conditioning | 1 | 0.1% |
Operating margin | 1 | 0.1% |
Operation of computed tomography | 1 | 0.1% |
Operationalization | 1 | 0.1% |
Operations research | 1 | 0.1% |
Opioid epidemic | 1 | 0.1% |
Opioid epidemic in the United States | 1 | 0.1% |
Opportunity cost | 1 | 0.1% |
Opsoclonus myoclonus syndrome | 1 | 0.1% |
Optic disc | 1 | 0.1% |
Optic nerve | 1 | 0.1% |
Optic neuropathy | 1 | 0.1% |
Optical amplifier | 1 | 0.1% |
Optical coherence tomography | 1 | 0.1% |
Optical fiber | 1 | 0.1% |
Optical tweezers | 1 | 0.1% |
Optimism | 1 | 0.1% |
Optimism bias | 1 | 0.1% |
Optometry | 1 | 0.1% |
OraQuick | 1 | 0.1% |
Oral hygiene | 1 | 0.1% |
Oral rehydration therapy | 1 | 0.1% |
Orbital blowout fracture | 1 | 0.1% |
Oregon Health Plan | 1 | 0.1% |
Organ (biology) | 1 | 0.1% |
Organ donation in Australia | 1 | 0.1% |
Organ procurement | 1 | 0.1% |
Organ-on-a-chip | 1 | 0.1% |
Organic electronics | 1 | 0.1% |
Organic food | 1 | 0.1% |
Organic solar cell | 1 | 0.1% |
Organic, including symptomatic, mental disorders | 1 | 0.1% |
Organizational culture | 1 | 0.1% |
Organizational structure | 1 | 0.1% |
Organocatalysis | 1 | 0.1% |
Organophosphate | 1 | 0.1% |
Orlistat | 1 | 0.1% |
Orphan Drug Act of 1983 | 1 | 0.1% |
Orthodontics | 1 | 0.1% |
Osilodrostat | 1 | 0.1% |
Osmosis | 1 | 0.1% |
Ospemifene | 1 | 0.1% |
Osteoclast | 1 | 0.1% |
Osteocyte | 1 | 0.1% |
Osteopathy | 1 | 0.1% |
Osteotomy | 1 | 0.1% |
Ostreopsis | 1 | 0.1% |
Ostrinia furnacalis | 1 | 0.1% |
Otorhinolaryngology | 1 | 0.1% |
Ototoxicity | 1 | 0.1% |
Outer space | 1 | 0.1% |
Outpatient clinic (hospital department) | 1 | 0.1% |
Ovarian follicle | 1 | 0.1% |
Ovarian hyperstimulation syndrome | 1 | 0.1% |
Ovarian reserve | 1 | 0.1% |
Overdispersion | 1 | 0.1% |
Overhead (business) | 1 | 0.1% |
Overview and Scrutiny | 1 | 0.1% |
Overweight | 1 | 0.1% |
Ovulation | 1 | 0.1% |
Ovulation induction | 1 | 0.1% |
Oxazepam | 1 | 0.1% |
Oxybutynin | 1 | 0.1% |
P-glycoprotein | 1 | 0.1% |
P2Y12 | 1 | 0.1% |
PANDAS | 1 | 0.1% |
PD-1 and PD-L1 inhibitors | 1 | 0.1% |
PMS2 | 1 | 0.1% |
PRISM (surveillance program) | 1 | 0.1% |
PRNP | 1 | 0.1% |
PSEN1 | 1 | 0.1% |
PSMD4 | 1 | 0.1% |
PTEN (gene) | 1 | 0.1% |
PUVA therapy | 1 | 0.1% |
Packed red blood cells | 1 | 0.1% |
Paleoclimatology | 1 | 0.1% |
Palestinian territories | 1 | 0.1% |
Paliperidone | 1 | 0.1% |
Palivizumab | 1 | 0.1% |
Pancreatic mucinous cystic neoplasm | 1 | 0.1% |
Pancreaticoduodenectomy | 1 | 0.1% |
Pandemic and All-Hazards Preparedness Act | 1 | 0.1% |
Pandemrix | 1 | 0.1% |
Panton–Valentine leukocidin | 1 | 0.1% |
Paper towel | 1 | 0.1% |
Papillomaviridae | 1 | 0.1% |
Parasomnia | 1 | 0.1% |
Paratrooper | 1 | 0.1% |
Paratyphoid fever | 1 | 0.1% |
Parent | 1 | 0.1% |
Parental leave | 1 | 0.1% |
Parenteral nutrition | 1 | 0.1% |
Paro (robot) | 1 | 0.1% |
Paromomycin | 1 | 0.1% |
Parthenium argentatum | 1 | 0.1% |
Particle accelerator | 1 | 0.1% |
Party leaders of the United States House of Representatives | 1 | 0.1% |
Passive ventilation | 1 | 0.1% |
Password | 1 | 0.1% |
Patau syndrome | 1 | 0.1% |
Patent ductus arteriosus | 1 | 0.1% |
Pathogenic Escherichia coli | 1 | 0.1% |
Patient-centered outcomes | 1 | 0.1% |
Patiromer | 1 | 0.1% |
Paul Ridker | 1 | 0.1% |
Paula Vennells | 1 | 0.1% |
Pay-per-click | 1 | 0.1% |
Payment Card Industry Data Security Standard | 1 | 0.1% |
Peanut allergy | 1 | 0.1% |
Pearson correlation coefficient | 1 | 0.1% |
Pediatric intensive care unit | 1 | 0.1% |
Peer pressure | 1 | 0.1% |
Peer-to-peer | 1 | 0.1% |
Pelvic floor | 1 | 0.1% |
Pelvic floor dysfunction | 1 | 0.1% |
Pemetrexed | 1 | 0.1% |
Pemphigoid | 1 | 0.1% |
Penetrating trauma | 1 | 0.1% |
Penile cancer | 1 | 0.1% |
Pentose phosphate pathway | 1 | 0.1% |
Per- and polyfluoroalkyl substances | 1 | 0.1% |
Peramivir | 1 | 0.1% |
Percutaneous endoscopic gastrostomy | 1 | 0.1% |
Percutaneous tibial nerve stimulation | 1 | 0.1% |
Perennial plant | 1 | 0.1% |
Performance measurement | 1 | 0.1% |
Pericardial heart valves | 1 | 0.1% |
Periodic limb movement disorder | 1 | 0.1% |
Periodontal disease | 1 | 0.1% |
Peripheral nervous system | 1 | 0.1% |
Periventricular leukomalacia | 1 | 0.1% |
Perovskite solar cell | 1 | 0.1% |
Peroxisome proliferator-activated receptor | 1 | 0.1% |
Peroxisome proliferator-activated receptor gamma | 1 | 0.1% |
Perseverance (rover) | 1 | 0.1% |
Personal computer | 1 | 0.1% |
Personal exemption | 1 | 0.1% |
Personal health record | 1 | 0.1% |
Personal trainer | 1 | 0.1% |
Personality disorder | 1 | 0.1% |
Pertussis vaccine | 1 | 0.1% |
Pest control | 1 | 0.1% |
Pesticide resistance | 1 | 0.1% |
Peter C. Gøtzsche | 1 | 0.1% |
Peterborough | 1 | 0.1% |
Phacoemulsification | 1 | 0.1% |
Phage therapy | 1 | 0.1% |
Phagocytosis | 1 | 0.1% |
Phantom limb | 1 | 0.1% |
Pharmaceutical formulation | 1 | 0.1% |
Pharmacopoeia | 1 | 0.1% |
Pharmacy (shop) | 1 | 0.1% |
Pharmacy management system | 1 | 0.1% |
Pharmacy technician | 1 | 0.1% |
Phenobarbital | 1 | 0.1% |
Phenomenology (philosophy) | 1 | 0.1% |
Phenytoin | 1 | 0.1% |
Philanthropy | 1 | 0.1% |
Philip Auerswald | 1 | 0.1% |
Philip Hunt, Baron Hunt of Kings Heath | 1 | 0.1% |
Philosophy of science | 1 | 0.1% |
Phosphoinositide 3-kinase | 1 | 0.1% |
Phosphorus | 1 | 0.1% |
Photography | 1 | 0.1% |
Photolithography | 1 | 0.1% |
Photoluminescence | 1 | 0.1% |
Photomask | 1 | 0.1% |
Photopolymer | 1 | 0.1% |
Phthalate | 1 | 0.1% |
Phylogenetic tree | 1 | 0.1% |
Physical and logical qubits | 1 | 0.1% |
Physical chemistry | 1 | 0.1% |
Physical cosmology | 1 | 0.1% |
Physical medicine and rehabilitation | 1 | 0.1% |
Physician self-referral | 1 | 0.1% |
Physician supply | 1 | 0.1% |
Phytophthora cinnamomi | 1 | 0.1% |
Phytophthora infestans | 1 | 0.1% |
Phytophthora kernoviae | 1 | 0.1% |
Phytophthora ramorum | 1 | 0.1% |
Piezoelectricity | 1 | 0.1% |
Pirfenidone | 1 | 0.1% |
Piriformis syndrome | 1 | 0.1% |
Pitolisant | 1 | 0.1% |
Pituitary adenoma | 1 | 0.1% |
Pixantrone | 1 | 0.1% |
Pixel | 1 | 0.1% |
Plain language | 1 | 0.1% |
Plain tobacco packaging | 1 | 0.1% |
Planetary protection | 1 | 0.1% |
Planetary system | 1 | 0.1% |
Planets beyond Neptune | 1 | 0.1% |
Plankton | 1 | 0.1% |
Planning | 1 | 0.1% |
Plant litter | 1 | 0.1% |
Plant tissue culture | 1 | 0.1% |
Plant-based diet | 1 | 0.1% |
Plasma cell | 1 | 0.1% |
Plasmacytoma | 1 | 0.1% |
Plasmapheresis | 1 | 0.1% |
Plasmodium knowlesi | 1 | 0.1% |
Plasmodium ovale | 1 | 0.1% |
Plastic | 1 | 0.1% |
Plastic surgery | 1 | 0.1% |
Plate tectonics | 1 | 0.1% |
Pleural empyema | 1 | 0.1% |
Plug-in hybrid | 1 | 0.1% |
Pluto | 1 | 0.1% |
Poaching | 1 | 0.1% |
Poisson distribution | 1 | 0.1% |
Police National Computer | 1 | 0.1% |
Police officer | 1 | 0.1% |
Political corruption | 1 | 0.1% |
Political science | 1 | 0.1% |
Pollination | 1 | 0.1% |
Pollinator decline | 1 | 0.1% |
Polychlorinated dibenzodioxins | 1 | 0.1% |
Polyclonal B cell response | 1 | 0.1% |
Polyclonal antibodies | 1 | 0.1% |
Polycystic ovary syndrome | 1 | 0.1% |
Polycythemia vera | 1 | 0.1% |
Polyether ether ketone | 1 | 0.1% |
Polyethylene terephthalate | 1 | 0.1% |
Polylactic acid | 1 | 0.1% |
Polymerization | 1 | 0.1% |
Polynesian New Zealander | 1 | 0.1% |
Polypill | 1 | 0.1% |
Polystyrene sulfonate | 1 | 0.1% |
Population genetics | 1 | 0.1% |
Population pyramid | 1 | 0.1% |
Populism | 1 | 0.1% |
Porcine circovirus | 1 | 0.1% |
Pork | 1 | 0.1% |
Positron emission tomography–magnetic resonance imaging | 1 | 0.1% |
Post-transcriptional regulation | 1 | 0.1% |
Post-traumatic growth | 1 | 0.1% |
Post-traumatic seizure | 1 | 0.1% |
Postdoctoral researcher | 1 | 0.1% |
Postherpetic neuralgia | 1 | 0.1% |
Posthuman | 1 | 0.1% |
Posthumanism | 1 | 0.1% |
Postpartum infections | 1 | 0.1% |
Postterm pregnancy | 1 | 0.1% |
Potassium binder | 1 | 0.1% |
Potassium chloride | 1 | 0.1% |
Potassium iodide | 1 | 0.1% |
Potassium-sparing diuretic | 1 | 0.1% |
Poultry diseases | 1 | 0.1% |
Poultry farming | 1 | 0.1% |
Pound (mass) | 1 | 0.1% |
Poverty in the United States | 1 | 0.1% |
Poverty reduction | 1 | 0.1% |
Powassan virus | 1 | 0.1% |
Powdery mildew | 1 | 0.1% |
Power of attorney | 1 | 0.1% |
Poxviridae | 1 | 0.1% |
Practice-based commissioning | 1 | 0.1% |
Praseodymium | 1 | 0.1% |
Pre-clinical development | 1 | 0.1% |
Pre-existing condition | 1 | 0.1% |
Pre-preg | 1 | 0.1% |
Prebiotic (nutrition) | 1 | 0.1% |
Precision and recall | 1 | 0.1% |
Preclinical development | 1 | 0.1% |
Prelabor rupture of membranes | 1 | 0.1% |
Premature ovarian failure | 1 | 0.1% |
Premature rupture of membranes | 1 | 0.1% |
President pro tempore of the United States Senate | 1 | 0.1% |
Pretomanid | 1 | 0.1% |
Prevalence of tobacco use | 1 | 0.1% |
Primary care network | 1 | 0.1% |
Prior probability | 1 | 0.1% |
Prisoner | 1 | 0.1% |
Privacy Act of 1974 | 1 | 0.1% |
Privacy engineering | 1 | 0.1% |
Privacy policy | 1 | 0.1% |
Privacy-enhancing technologies | 1 | 0.1% |
Probation | 1 | 0.1% |
Problem gambling | 1 | 0.1% |
Procainamide | 1 | 0.1% |
Process modeling | 1 | 0.1% |
Product lifecycle | 1 | 0.1% |
Production function | 1 | 0.1% |
Professional certification | 1 | 0.1% |
Professionalization | 1 | 0.1% |
Progestin | 1 | 0.1% |
Programmable matter | 1 | 0.1% |
Programmer | 1 | 0.1% |
Progressive familial intrahepatic cholestasis | 1 | 0.1% |
Progressive multifocal leukoencephalopathy | 1 | 0.1% |
Progressive tax | 1 | 0.1% |
Proguanil | 1 | 0.1% |
Prolactinoma | 1 | 0.1% |
Prolapse | 1 | 0.1% |
Proliferative index | 1 | 0.1% |
Prolotherapy | 1 | 0.1% |
Propafenone | 1 | 0.1% |
Property | 1 | 0.1% |
Property tax | 1 | 0.1% |
Property tax in the United States | 1 | 0.1% |
Prophylactic salpingectomy | 1 | 0.1% |
Propofol | 1 | 0.1% |
Proportional hazards model | 1 | 0.1% |
Prosocial behavior | 1 | 0.1% |
Prospective payment system | 1 | 0.1% |
Prostaglandin-endoperoxide synthase 2 | 1 | 0.1% |
Prostate | 1 | 0.1% |
Prostate disorders | 1 | 0.1% |
Prostatitis | 1 | 0.1% |
Proteasome | 1 | 0.1% |
Protected area | 1 | 0.1% |
Protein C | 1 | 0.1% |
Protein complex | 1 | 0.1% |
Protein folding | 1 | 0.1% |
Proteome | 1 | 0.1% |
Proteostasis | 1 | 0.1% |
Proton | 1 | 0.1% |
Proton-pump inhibitor | 1 | 0.1% |
Provenance | 1 | 0.1% |
Provisioning (telecommunications) | 1 | 0.1% |
Proxy (climate) | 1 | 0.1% |
Prucol | 1 | 0.1% |
Pseudo-nitzschia | 1 | 0.1% |
Pseudoexfoliation syndrome | 1 | 0.1% |
Pseudonymization | 1 | 0.1% |
Psychiatric history | 1 | 0.1% |
Psychiatrist | 1 | 0.1% |
Psycho-oncology | 1 | 0.1% |
Psychoactive drugs | 1 | 0.1% |
Psychological evaluation | 1 | 0.1% |
Public Health Information Network | 1 | 0.1% |
Public Health Security and Bioterrorism Preparedness and Response Act | 1 | 0.1% |
Public finance | 1 | 0.1% |
Public good (economics) | 1 | 0.1% |
Public health nursing | 1 | 0.1% |
Public participation (decision making) | 1 | 0.1% |
Public toilet | 1 | 0.1% |
Public transport | 1 | 0.1% |
Public-key cryptography | 1 | 0.1% |
Pulmonary alveolus | 1 | 0.1% |
Pulmonary edema | 1 | 0.1% |
Pulmonary hypertension | 1 | 0.1% |
Pulmonary rehabilitation | 1 | 0.1% |
Pulmonary sequestration | 1 | 0.1% |
Pulp (paper) | 1 | 0.1% |
Pulse pressure | 1 | 0.1% |
Pyridoxine/doxylamine | 1 | 0.1% |
Quality (business) | 1 | 0.1% |
Quality Improvement Organizations (QIOs) in Medicare | 1 | 0.1% |
Quantifier (logic) | 1 | 0.1% |
Quantum algorithm | 1 | 0.1% |
Quantum annealing | 1 | 0.1% |
Quantum chemistry | 1 | 0.1% |
Quantum error correction | 1 | 0.1% |
Quantum key distribution | 1 | 0.1% |
Quantum machine learning | 1 | 0.1% |
Quantum memory | 1 | 0.1% |
Quantum superposition | 1 | 0.1% |
Quantum supremacy | 1 | 0.1% |
Quasar | 1 | 0.1% |
Quasi-experiment | 1 | 0.1% |
Qubit | 1 | 0.1% |
Question | 1 | 0.1% |
Quinine | 1 | 0.1% |
Quitline | 1 | 0.1% |
Quorum | 1 | 0.1% |
RDX | 1 | 0.1% |
RET proto-oncogene | 1 | 0.1% |
RHOA | 1 | 0.1% |
RICE (medicine) | 1 | 0.1% |
RTS,S | 1 | 0.1% |
Rabbit haemorrhagic disease | 1 | 0.1% |
Rabies in animals | 1 | 0.1% |
Race and ethnicity in the United States census | 1 | 0.1% |
Radiation hardening | 1 | 0.1% |
Radical polymerization | 1 | 0.1% |
Radio spectrum | 1 | 0.1% |
Radio-frequency identification | 1 | 0.1% |
Radioactive decay | 1 | 0.1% |
Radioallergosorbent test | 1 | 0.1% |
Radiomics | 1 | 0.1% |
Radionuclide | 1 | 0.1% |
Radius (bone) | 1 | 0.1% |
Ragweed | 1 | 0.1% |
Rain | 1 | 0.1% |
Rainforest | 1 | 0.1% |
Raman spectroscopy | 1 | 0.1% |
Random checkpoint | 1 | 0.1% |
Rangi Mātāmua | 1 | 0.1% |
Rapid eye movement sleep | 1 | 0.1% |
Rapid eye movement sleep behavior disorder | 1 | 0.1% |
Rare-earth element | 1 | 0.1% |
Rat | 1 | 0.1% |
Rate of return | 1 | 0.1% |
Ratio | 1 | 0.1% |
Rationality | 1 | 0.1% |
Rationalization (economics) | 1 | 0.1% |
Read code | 1 | 0.1% |
Real-time computing | 1 | 0.1% |
Receptor (biochemistry) | 1 | 0.1% |
Receptor antagonist | 1 | 0.1% |
Receptor tyrosine kinase | 1 | 0.1% |
Reciprocity (social and political philosophy) | 1 | 0.1% |
Recombinant DNA | 1 | 0.1% |
Rectal prolapse | 1 | 0.1% |
Rectocele | 1 | 0.1% |
Rectum | 1 | 0.1% |
Redlining | 1 | 0.1% |
Reference Daily Intake | 1 | 0.1% |
Refrigerator | 1 | 0.1% |
Refugee | 1 | 0.1% |
Refugee children | 1 | 0.1% |
Regional policy of the European Union | 1 | 0.1% |
Regulation of nanotechnology | 1 | 0.1% |
Regulatory T cell | 1 | 0.1% |
Regulatory affairs | 1 | 0.1% |
Regulatory impact analysis | 1 | 0.1% |
Regulatory risk differentiation | 1 | 0.1% |
Regurgitation (circulation) | 1 | 0.1% |
Reinforcement | 1 | 0.1% |
Reinforcement learning | 1 | 0.1% |
Rekrei | 1 | 0.1% |
Relapse | 1 | 0.1% |
Relational database | 1 | 0.1% |
Relational database management system | 1 | 0.1% |
Relative atomic mass | 1 | 0.1% |
Relevance | 1 | 0.1% |
Religious Freedom Restoration Act | 1 | 0.1% |
Remand (detention) | 1 | 0.1% |
Remifentanil | 1 | 0.1% |
Remote dispensing | 1 | 0.1% |
Remote sensing | 1 | 0.1% |
Remote work | 1 | 0.1% |
Renal sympathetic denervation | 1 | 0.1% |
Renting | 1 | 0.1% |
Reorganization plan of United States Army | 1 | 0.1% |
Repeal | 1 | 0.1% |
Reperfusion injury | 1 | 0.1% |
Representative Concentration Pathway | 1 | 0.1% |
Representative elementary volume | 1 | 0.1% |
Reproductive medicine | 1 | 0.1% |
Reprogramming | 1 | 0.1% |
Republic | 1 | 0.1% |
Request for proposal | 1 | 0.1% |
Resampling (statistics) | 1 | 0.1% |
Research Excellence Framework | 1 | 0.1% |
Resident Coordinator | 1 | 0.1% |
Resource-based relative value scale | 1 | 0.1% |
Respiration | 1 | 0.1% |
Respiratory failure | 1 | 0.1% |
Respiratory tract | 1 | 0.1% |
Responsive web design | 1 | 0.1% |
Retail Price Index | 1 | 0.1% |
Retinal implant | 1 | 0.1% |
Retrograde amnesia | 1 | 0.1% |
Retroviridae | 1 | 0.1% |
Return on investment | 1 | 0.1% |
Reuptake inhibitor | 1 | 0.1% |
Revalidation | 1 | 0.1% |
Revaluation of fixed assets | 1 | 0.1% |
Reverse mortgage | 1 | 0.1% |
Revolution in Military Affairs | 1 | 0.1% |
Reward system | 1 | 0.1% |
Reye syndrome | 1 | 0.1% |
Rhetoric | 1 | 0.1% |
Rhinorrhea | 1 | 0.1% |
Rhytidectomy | 1 | 0.1% |
Ribavirin | 1 | 0.1% |
Ribociclib | 1 | 0.1% |
Ribose 5-phosphate | 1 | 0.1% |
Richard Nixon | 1 | 0.1% |
Richter magnitude scale | 1 | 0.1% |
Richter's transformation | 1 | 0.1% |
Ricin | 1 | 0.1% |
Rifamycin | 1 | 0.1% |
Rights of nature | 1 | 0.1% |
Ring system | 1 | 0.1% |
Risk ratio | 1 | 0.1% |
Risk–benefit ratio | 1 | 0.1% |
Rivastigmine | 1 | 0.1% |
Road slipperiness | 1 | 0.1% |
Road surface | 1 | 0.1% |
Robert Mueller | 1 | 0.1% |
Robonaut | 1 | 0.1% |
Robot ethics | 1 | 0.1% |
Robotic vacuum cleaner | 1 | 0.1% |
Rocket propellant | 1 | 0.1% |
Romosozumab | 1 | 0.1% |
Root-mean-square deviation | 1 | 0.1% |
Rosalind Franklin | 1 | 0.1% |
Roseola | 1 | 0.1% |
Rotator cuff | 1 | 0.1% |
Rotavirus | 1 | 0.1% |
Rotavirus vaccine | 1 | 0.1% |
Rotorcraft | 1 | 0.1% |
Route of administration | 1 | 0.1% |
Royal Borough of Kensington and Chelsea | 1 | 0.1% |
RuBisCO | 1 | 0.1% |
Rubella vaccine | 1 | 0.1% |
Rubidium | 1 | 0.1% |
Rumor | 1 | 0.1% |
Runcorn | 1 | 0.1% |
Rural area | 1 | 0.1% |
Russian language | 1 | 0.1% |
Ruxolitinib | 1 | 0.1% |
Ryan White CARE Act | 1 | 0.1% |
Ryanodine receptor 2 | 1 | 0.1% |
SARS-CoV-2 Omicron variant | 1 | 0.1% |
SCADA | 1 | 0.1% |
SGK1 | 1 | 0.1% |
SMS | 1 | 0.1% |
SNOMED CT | 1 | 0.1% |
Saccade | 1 | 0.1% |
Saccharomyces cerevisiae | 1 | 0.1% |
Sacrum | 1 | 0.1% |
Sacubitril/valsartan | 1 | 0.1% |
Safe to Sleep | 1 | 0.1% |
Safety data sheet | 1 | 0.1% |
Safety management systems | 1 | 0.1% |
Safety net hospital | 1 | 0.1% |
Safety stock | 1 | 0.1% |
Saline (medicine) | 1 | 0.1% |
Saliva testing | 1 | 0.1% |
Salmeterol | 1 | 0.1% |
Sample (statistics) | 1 | 0.1% |
Sample-return mission | 1 | 0.1% |
Sanger sequencing | 1 | 0.1% |
Santa Clara County, California | 1 | 0.1% |
Santiago Ramón y Cajal | 1 | 0.1% |
Saquinavir | 1 | 0.1% |
Sarcopenia | 1 | 0.1% |
Savannah River Site | 1 | 0.1% |
Saxitoxin | 1 | 0.1% |
Scabies | 1 | 0.1% |
Scalability | 1 | 0.1% |
Scanning probe microscopy | 1 | 0.1% |
Scanning tunneling microscope | 1 | 0.1% |
Scar | 1 | 0.1% |
Scarlet fever | 1 | 0.1% |
Scatter plot | 1 | 0.1% |
Schistosomiasis | 1 | 0.1% |
Schizoaffective disorder | 1 | 0.1% |
School Breakfast Program | 1 | 0.1% |
School voucher | 1 | 0.1% |
Science fiction | 1 | 0.1% |
Science policy | 1 | 0.1% |
Scientific techniques | 1 | 0.1% |
Scientific visualization | 1 | 0.1% |
Scientist | 1 | 0.1% |
Scientometrics | 1 | 0.1% |
Scintigraphy | 1 | 0.1% |
Sclerostin | 1 | 0.1% |
Scrapie | 1 | 0.1% |
Scrub typhus | 1 | 0.1% |
Scrubs (clothing) | 1 | 0.1% |
Sea ice | 1 | 0.1% |
Sea level rise | 1 | 0.1% |
Seamount | 1 | 0.1% |
Seasonal energy efficiency ratio | 1 | 0.1% |
Seasonality | 1 | 0.1% |
Section 508 Amendment to the Rehabilitation Act of 1973 | 1 | 0.1% |
Secukinumab | 1 | 0.1% |
Secure copy | 1 | 0.1% |
Securitization | 1 | 0.1% |
Security hacker | 1 | 0.1% |
Security token | 1 | 0.1% |
Sedative | 1 | 0.1% |
Sedentary lifestyle | 1 | 0.1% |
Seismology | 1 | 0.1% |
Seizure | 1 | 0.1% |
Selective laser melting | 1 | 0.1% |
Selenium | 1 | 0.1% |
Self-administration | 1 | 0.1% |
Self-assembled monolayer | 1 | 0.1% |
Self-assessment | 1 | 0.1% |
Self-control | 1 | 0.1% |
Self-determination theory | 1 | 0.1% |
Self-disclosure | 1 | 0.1% |
Self-esteem | 1 | 0.1% |
Self-funded health care | 1 | 0.1% |
Self-healing material | 1 | 0.1% |
Semaglutide | 1 | 0.1% |
Semen | 1 | 0.1% |
Semen analysis | 1 | 0.1% |
Sender Policy Framework | 1 | 0.1% |
Sense | 1 | 0.1% |
Sense (molecular biology) | 1 | 0.1% |
Senses | 1 | 0.1% |
Sensorineural hearing loss | 1 | 0.1% |
Sensory neuron | 1 | 0.1% |
Sensory substitution | 1 | 0.1% |
Sentence (linguistics) | 1 | 0.1% |
Sentiment analysis | 1 | 0.1% |
Sentinel event | 1 | 0.1% |
Separation anxiety disorder | 1 | 0.1% |
Sequence motif | 1 | 0.1% |
Sequential Intercept Model | 1 | 0.1% |
Sergej Mašera | 1 | 0.1% |
Serious Mental Illness | 1 | 0.1% |
Serious mental illness | 1 | 0.1% |
Serum amyloid A1 | 1 | 0.1% |
Serum free light-chain measurement | 1 | 0.1% |
Severe acute respiratory syndrome coronavirus 1 | 1 | 0.1% |
Severe acute respiratory syndrome–related coronavirus | 1 | 0.1% |
Severe weather | 1 | 0.1% |
Sex and drugs | 1 | 0.1% |
Sex differences in humans | 1 | 0.1% |
Sex robot | 1 | 0.1% |
Sex-selective abortion | 1 | 0.1% |
Sexual orientation | 1 | 0.1% |
Sexual reproduction | 1 | 0.1% |
Sham surgery | 1 | 0.1% |
Shanty town | 1 | 0.1% |
Sharps waste | 1 | 0.1% |
Sheffield | 1 | 0.1% |
Shelf life | 1 | 0.1% |
Sheriffs in the United States | 1 | 0.1% |
Sherry Turkle | 1 | 0.1% |
Shift work | 1 | 0.1% |
Shigatoxigenic and verotoxigenic Escherichia coli | 1 | 0.1% |
Shortages related to the COVID-19 pandemic | 1 | 0.1% |
Shoulder impingement syndrome | 1 | 0.1% |
Sibling | 1 | 0.1% |
Sidewalk | 1 | 0.1% |
Sign language | 1 | 0.1% |
Signal-to-noise ratio | 1 | 0.1% |
Silicon | 1 | 0.1% |
Silicon on insulator | 1 | 0.1% |
Silk | 1 | 0.1% |
Simeprevir | 1 | 0.1% |
Simian immunodeficiency virus | 1 | 0.1% |
Single cell sequencing | 1 | 0.1% |
Single sign-on | 1 | 0.1% |
Single-cell transcriptomics | 1 | 0.1% |
Single-port laparoscopy | 1 | 0.1% |
Sinoatrial node | 1 | 0.1% |
Sisterhood method | 1 | 0.1% |
Sitosterolemia | 1 | 0.1% |
Sjögren syndrome | 1 | 0.1% |
Skeletal system | 1 | 0.1% |
Skin allergy test | 1 | 0.1% |
Skin grafting | 1 | 0.1% |
Skull | 1 | 0.1% |
Slavery in the 21st century | 1 | 0.1% |
Sleep and breathing | 1 | 0.1% |
Sleep deprivation | 1 | 0.1% |
Sleep medicine | 1 | 0.1% |
Slit lamp | 1 | 0.1% |
Slovene language | 1 | 0.1% |
Slow-wave sleep | 1 | 0.1% |
Small Business Innovation Research | 1 | 0.1% |
Small and medium-sized enterprises | 1 | 0.1% |
Small interfering RNA | 1 | 0.1% |
Small intestine | 1 | 0.1% |
Small modular reactor | 1 | 0.1% |
Smoke | 1 | 0.1% |
Smoke detector | 1 | 0.1% |
Smokeless tobacco | 1 | 0.1% |
Smoking and pregnancy | 1 | 0.1% |
Snow | 1 | 0.1% |
Snow science | 1 | 0.1% |
Social care in England | 1 | 0.1% |
Social group | 1 | 0.1% |
Social impact bond | 1 | 0.1% |
Social influence | 1 | 0.1% |
Social innovation | 1 | 0.1% |
Social justice | 1 | 0.1% |
Social marketing | 1 | 0.1% |
Social norm | 1 | 0.1% |
Social stigma of obesity | 1 | 0.1% |
Social stratification | 1 | 0.1% |
Social vulnerability | 1 | 0.1% |
Societal collapse | 1 | 0.1% |
Socio-ecological system | 1 | 0.1% |
Sociology | 1 | 0.1% |
Sodium | 1 | 0.1% |
Soft tissue | 1 | 0.1% |
Software-defined networking | 1 | 0.1% |
Soil pH | 1 | 0.1% |
Solanaceae | 1 | 0.1% |
Solanezumab | 1 | 0.1% |
Solar activity and climate | 1 | 0.1% |
Solar cell efficiency | 1 | 0.1% |
Solar panel | 1 | 0.1% |
Solar thermal collector | 1 | 0.1% |
Solar tracker | 1 | 0.1% |
Solid oxide fuel cell | 1 | 0.1% |
Solitary confinement | 1 | 0.1% |
Somatic symptom disorder | 1 | 0.1% |
Somatization | 1 | 0.1% |
Somatosensory system | 1 | 0.1% |
Somerset County, Maryland | 1 | 0.1% |
Sonar | 1 | 0.1% |
South London | 1 | 0.1% |
South Yorkshire | 1 | 0.1% |
Southeast Asia | 1 | 0.1% |
Southern United States | 1 | 0.1% |
Soy allergy | 1 | 0.1% |
Space Shuttle | 1 | 0.1% |
Space science | 1 | 0.1% |
Space weather | 1 | 0.1% |
Space-based solar power | 1 | 0.1% |
Spaceflight | 1 | 0.1% |
Spasmodic torticollis | 1 | 0.1% |
Spastic cerebral palsy | 1 | 0.1% |
Special education | 1 | 0.1% |
Specialty Society Relative Value Scale Update Committee | 1 | 0.1% |
Specific performance | 1 | 0.1% |
Spectroscopy | 1 | 0.1% |
Spectrum disorder | 1 | 0.1% |
Speech recognition | 1 | 0.1% |
Speech–language pathology | 1 | 0.1% |
Spent nuclear fuel | 1 | 0.1% |
Spermatozoon | 1 | 0.1% |
Sphygmomanometer | 1 | 0.1% |
Spina bifida | 1 | 0.1% |
Spinal disc herniation | 1 | 0.1% |
Spinal muscular atrophy | 1 | 0.1% |
Spo11 | 1 | 0.1% |
Spontaneous bacterial peritonitis | 1 | 0.1% |
Sport of athletics | 1 | 0.1% |
Sprain | 1 | 0.1% |
Sprained ankle | 1 | 0.1% |
Sputum | 1 | 0.1% |
Squamous cell carcinoma | 1 | 0.1% |
Standard Model | 1 | 0.1% |
Standard drink | 1 | 0.1% |
Standard of care | 1 | 0.1% |
Standardized mortality ratio | 1 | 0.1% |
Stanozolol | 1 | 0.1% |
Staphylococcus saprophyticus | 1 | 0.1% |
Star formation | 1 | 0.1% |
Stargardt disease | 1 | 0.1% |
Stark Law | 1 | 0.1% |
State of emergency | 1 | 0.1% |
States and territories of Australia | 1 | 0.1% |
Stationary process | 1 | 0.1% |
Statistical analysis | 1 | 0.1% |
Statistical physics | 1 | 0.1% |
Statistical theory | 1 | 0.1% |
Steam cracking | 1 | 0.1% |
Stellar astronomy | 1 | 0.1% |
Stem cell factor | 1 | 0.1% |
Stem-cell therapy | 1 | 0.1% |
Stenotrophomonas maltophilia | 1 | 0.1% |
Stepfamily | 1 | 0.1% |
Stereoisomerism | 1 | 0.1% |
Stevens–Johnson syndrome | 1 | 0.1% |
Stomach | 1 | 0.1% |
Stool test | 1 | 0.1% |
Stormwater | 1 | 0.1% |
Strabismus | 1 | 0.1% |
Strain (injury) | 1 | 0.1% |
Strategic National Stockpile | 1 | 0.1% |
Strategic health authority | 1 | 0.1% |
Strategic leadership | 1 | 0.1% |
Strategy implementation | 1 | 0.1% |
Strategy map | 1 | 0.1% |
Streaming media | 1 | 0.1% |
Street fundraising | 1 | 0.1% |
Streptococcus pyogenes | 1 | 0.1% |
Streptomycin | 1 | 0.1% |
Stress (mechanics) | 1 | 0.1% |
Stress incontinence | 1 | 0.1% |
Striatum | 1 | 0.1% |
Strigolactone | 1 | 0.1% |
Stroke recovery | 1 | 0.1% |
Structure formation | 1 | 0.1% |
Student-centered learning | 1 | 0.1% |
Stunted growth | 1 | 0.1% |
Subclavian artery | 1 | 0.1% |
Substance abuse prevention | 1 | 0.1% |
Substantia nigra | 1 | 0.1% |
Succinate dehydrogenase | 1 | 0.1% |
Sucrose | 1 | 0.1% |
Sudden unexpected death in epilepsy | 1 | 0.1% |
Sugarcane | 1 | 0.1% |
Sugary drink tax | 1 | 0.1% |
Suicidal ideation | 1 | 0.1% |
Sun tanning | 1 | 0.1% |
Sunitinib | 1 | 0.1% |
Super-Earth | 1 | 0.1% |
Supercapacitor | 1 | 0.1% |
Supercomputer | 1 | 0.1% |
Supercritical fluid | 1 | 0.1% |
Supercritical water reactor | 1 | 0.1% |
Superlens | 1 | 0.1% |
Supermassive black hole | 1 | 0.1% |
Supernatural | 1 | 0.1% |
Supernova | 1 | 0.1% |
Supervised learning | 1 | 0.1% |
Supported employment | 1 | 0.1% |
Suprachiasmatic nucleus | 1 | 0.1% |
Supraspinatus muscle | 1 | 0.1% |
Surface science | 1 | 0.1% |
Surface-enhanced Raman spectroscopy | 1 | 0.1% |
Surfactant protein B | 1 | 0.1% |
Surgical specialties | 1 | 0.1% |
Survey (archaeology) | 1 | 0.1% |
Surveying | 1 | 0.1% |
Sussex | 1 | 0.1% |
Sustainable Development Goal 12 | 1 | 0.1% |
Sustainable Development Goal 7 | 1 | 0.1% |
Sustainable city | 1 | 0.1% |
Sustainable energy | 1 | 0.1% |
Sustainable fashion | 1 | 0.1% |
Symbol | 1 | 0.1% |
Sympathetic nervous system | 1 | 0.1% |
Symptoms and signs | 1 | 0.1% |
Symptoms and signs: General | 1 | 0.1% |
Synthetic membrane | 1 | 0.1% |
System on a chip | 1 | 0.1% |
Systematics | 1 | 0.1% |
Systems engineering | 1 | 0.1% |
T-statistic | 1 | 0.1% |
TAL effector | 1 | 0.1% |
TCF7L2 | 1 | 0.1% |
TIMI | 1 | 0.1% |
TNM staging system | 1 | 0.1% |
TNT | 1 | 0.1% |
TRAPPIST-1 | 1 | 0.1% |
TRIPS Agreement | 1 | 0.1% |
Tablet (pharmacy) | 1 | 0.1% |
Tabubil | 1 | 0.1% |
Tacrolimus | 1 | 0.1% |
Tafamidis | 1 | 0.1% |
Tag (metadata) | 1 | 0.1% |
Tag SNP | 1 | 0.1% |
Takotsubo cardiomyopathy | 1 | 0.1% |
Talimogene laherparepvec | 1 | 0.1% |
Tangata whenua | 1 | 0.1% |
Tank | 1 | 0.1% |
TaqMan | 1 | 0.1% |
Tariff | 1 | 0.1% |
Tattoo | 1 | 0.1% |
Tau protein | 1 | 0.1% |
Tax assessment | 1 | 0.1% |
Tax deduction | 1 | 0.1% |
Tax return (United States) | 1 | 0.1% |
Taxation in the United States | 1 | 0.1% |
Taxpayer | 1 | 0.1% |
Technological paradigm | 1 | 0.1% |
Technology transfer | 1 | 0.1% |
Telehomecare | 1 | 0.1% |
Telepathology | 1 | 0.1% |
Telepsychiatry | 1 | 0.1% |
Teleradiology | 1 | 0.1% |
Telescope | 1 | 0.1% |
Telmisartan | 1 | 0.1% |
Telomere | 1 | 0.1% |
Temazepam | 1 | 0.1% |
Temozolomide | 1 | 0.1% |
Temporary work | 1 | 0.1% |
Temporomandibular joint | 1 | 0.1% |
Temporomandibular joint dysfunction | 1 | 0.1% |
Tendinopathy | 1 | 0.1% |
Tendon | 1 | 0.1% |
Terminator (genetics) | 1 | 0.1% |
Testosterone (medication) | 1 | 0.1% |
Tetralogy of Fallot | 1 | 0.1% |
Tf–idf | 1 | 0.1% |
Thalassemia | 1 | 0.1% |
The Double Helix | 1 | 0.1% |
The European Semester | 1 | 0.1% |
The Hallmarks of Cancer | 1 | 0.1% |
The Midlands | 1 | 0.1% |
The New England Journal of Medicine | 1 | 0.1% |
Theiler's disease | 1 | 0.1% |
Theoretical physics | 1 | 0.1% |
Theory of planned behavior | 1 | 0.1% |
Theory of relativity | 1 | 0.1% |
Thermal management (electronics) | 1 | 0.1% |
Thermodynamic equilibrium | 1 | 0.1% |
Thermosetting polymer | 1 | 0.1% |
Thermosphere | 1 | 0.1% |
Thesis | 1 | 0.1% |
Thiamine deficiency | 1 | 0.1% |
Thiomersal | 1 | 0.1% |
Thoracentesis | 1 | 0.1% |
Thoracic diaphragm | 1 | 0.1% |
Threat (computer) | 1 | 0.1% |
Threshold limit value | 1 | 0.1% |
Through-silicon via | 1 | 0.1% |
Thumb | 1 | 0.1% |
Thymoglobulin | 1 | 0.1% |
Thymus | 1 | 0.1% |
Thyroid disease | 1 | 0.1% |
Thyroid nodule | 1 | 0.1% |
Tibia | 1 | 0.1% |
Tibolone | 1 | 0.1% |
Tick | 1 | 0.1% |
Ticlopidine | 1 | 0.1% |
Tigecycline | 1 | 0.1% |
Till Roenneberg | 1 | 0.1% |
Timeline of the SARS outbreak | 1 | 0.1% |
Tinnitus | 1 | 0.1% |
Tiotropium bromide | 1 | 0.1% |
Tipping points in the climate system | 1 | 0.1% |
Tissue Doppler echocardiography | 1 | 0.1% |
Titanium dioxide | 1 | 0.1% |
Tobacco | 1 | 0.1% |
Tobacco Master Settlement Agreement | 1 | 0.1% |
Toe | 1 | 0.1% |
Tofacitinib | 1 | 0.1% |
Toleration | 1 | 0.1% |
Tom Petty | 1 | 0.1% |
Tomosynthesis | 1 | 0.1% |
Tooth enamel | 1 | 0.1% |
Toothpaste | 1 | 0.1% |
Tort | 1 | 0.1% |
Tort reform | 1 | 0.1% |
Torticollis | 1 | 0.1% |
Total fertility rate | 1 | 0.1% |
Total quality management | 1 | 0.1% |
Tourniquet | 1 | 0.1% |
Toxic equivalency factor | 1 | 0.1% |
Toxic shock syndrome | 1 | 0.1% |
Toxicogenomics | 1 | 0.1% |
Toxicokinetics | 1 | 0.1% |
Tozinameran | 1 | 0.1% |
Trabecula | 1 | 0.1% |
Traceability | 1 | 0.1% |
Traction force microscopy | 1 | 0.1% |
Trade facilitation | 1 | 0.1% |
Trade-off | 1 | 0.1% |
Traditional Chinese medicine | 1 | 0.1% |
Traditional knowledge | 1 | 0.1% |
Traditional medicine | 1 | 0.1% |
Trafford | 1 | 0.1% |
Tramadol | 1 | 0.1% |
Trans-Neptunian object | 1 | 0.1% |
Transcriptome | 1 | 0.1% |
Transdisciplinarity | 1 | 0.1% |
Transesophageal echocardiogram | 1 | 0.1% |
Transformation (genetics) | 1 | 0.1% |
Transitional justice | 1 | 0.1% |
Translation | 1 | 0.1% |
Translation (biology) | 1 | 0.1% |
Transmission (mechanics) | 1 | 0.1% |
Transmission electron microscopy | 1 | 0.1% |
Transmitter | 1 | 0.1% |
Transposition of the great vessels | 1 | 0.1% |
Transthyretin | 1 | 0.1% |
Transverse mode | 1 | 0.1% |
Trapped ion quantum computer | 1 | 0.1% |
Trawling | 1 | 0.1% |
Treatment | 1 | 0.1% |
Treatment and control groups | 1 | 0.1% |
Treatment and management of COVID-19 | 1 | 0.1% |
Treatment of bipolar disorder | 1 | 0.1% |
Treatment of lung cancer | 1 | 0.1% |
Treatment-resistant depression | 1 | 0.1% |
Treaty of Lisbon | 1 | 0.1% |
Treaty on the Non-Proliferation of Nuclear Weapons | 1 | 0.1% |
Tree | 1 | 0.1% |
Tree of life (biology) | 1 | 0.1% |
Tremor | 1 | 0.1% |
Treponema pallidum | 1 | 0.1% |
Tretinoin | 1 | 0.1% |
Triatoma protracta | 1 | 0.1% |
Triatominae | 1 | 0.1% |
Trichloroethylene | 1 | 0.1% |
Tricuspid insufficiency | 1 | 0.1% |
Tricuspid valve | 1 | 0.1% |
Triglav | 1 | 0.1% |
Tropical cyclone | 1 | 0.1% |
Tropical rainforest | 1 | 0.1% |
Trucking industry in the United States | 1 | 0.1% |
Truenat | 1 | 0.1% |
Trust (emotion) | 1 | 0.1% |
Truth | 1 | 0.1% |
Trypanosoma | 1 | 0.1% |
Trypanosoma cruzi | 1 | 0.1% |
Trypanosoma lewisi | 1 | 0.1% |
Tsetse fly | 1 | 0.1% |
Tsunami | 1 | 0.1% |
Tuberculin | 1 | 0.1% |
Tubo-ovarian abscess | 1 | 0.1% |
Tuition payments | 1 | 0.1% |
Tumour heterogeneity | 1 | 0.1% |
Tundra | 1 | 0.1% |
Turbine | 1 | 0.1% |
Turner syndrome | 1 | 0.1% |
Two-photon excitation microscopy | 1 | 0.1% |
Tympanostomy tube | 1 | 0.1% |
Type 26 frigate | 1 | 0.1% |
Type Ia supernova | 1 | 0.1% |
Type three secretion system | 1 | 0.1% |
U.S. Route 60 in Arizona | 1 | 0.1% |
Ultimatum game | 1 | 0.1% |
Unanimous consent | 1 | 0.1% |
Uncanny valley | 1 | 0.1% |
Understanding | 1 | 0.1% |
Underweight | 1 | 0.1% |
Underwriting | 1 | 0.1% |
Unfolded protein response | 1 | 0.1% |
Uniform distribution (continuous) | 1 | 0.1% |
United Nations Security Council Resolution 478 | 1 | 0.1% |
United States biological defense program | 1 | 0.1% |
United States federal government continuity of operations | 1 | 0.1% |
United States federal probation and supervised release | 1 | 0.1% |
Universal neonatal hearing screening | 1 | 0.1% |
Unsafe abortion | 1 | 0.1% |
Unsaturated fat | 1 | 0.1% |
Unstable angina | 1 | 0.1% |
Unsupervised learning | 1 | 0.1% |
Upper Carniola | 1 | 0.1% |
Upper gastrointestinal series | 1 | 0.1% |
Upwelling | 1 | 0.1% |
Uracil-DNA glycosylase | 1 | 0.1% |
Urban agriculture | 1 | 0.1% |
Urbanization | 1 | 0.1% |
Urethritis | 1 | 0.1% |
Urgent care centers | 1 | 0.1% |
Uric acid | 1 | 0.1% |
Urinary cast | 1 | 0.1% |
Urinary retention | 1 | 0.1% |
Urine | 1 | 0.1% |
Urogynecology | 1 | 0.1% |
Usability testing | 1 | 0.1% |
Ustekinumab | 1 | 0.1% |
Uttlesford | 1 | 0.1% |
Uveitis | 1 | 0.1% |
VO2 max | 1 | 0.1% |
Vaccine Adverse Event Reporting System | 1 | 0.1% |
Vaccine Information Statement | 1 | 0.1% |
Vaccine efficacy | 1 | 0.1% |
Vaccinia | 1 | 0.1% |
Vaginal bleeding | 1 | 0.1% |
Vaginal ring | 1 | 0.1% |
Vagus nerve stimulation | 1 | 0.1% |
Valley Metro Rail | 1 | 0.1% |
Valuation (finance) | 1 | 0.1% |
Value chain | 1 | 0.1% |
Value-Based Insurance Design | 1 | 0.1% |
Vandetanib | 1 | 0.1% |
Vaporized hydrogen peroxide | 1 | 0.1% |
Vascular dementia | 1 | 0.1% |
Vascular endothelial growth factor | 1 | 0.1% |
Vasospasm | 1 | 0.1% |
Vector (molecular biology) | 1 | 0.1% |
Veganism | 1 | 0.1% |
Vegetarianism | 1 | 0.1% |
Vehicle emission standard | 1 | 0.1% |
Vehicular automation | 1 | 0.1% |
Venereal Disease Research Laboratory test | 1 | 0.1% |
Venetoclax | 1 | 0.1% |
Venezuelan equine encephalitis virus | 1 | 0.1% |
Venous access | 1 | 0.1% |
Ventricular escape beat | 1 | 0.1% |
Vesicle (biology and chemistry) | 1 | 0.1% |
Veterinary physician | 1 | 0.1% |
Vibrio | 1 | 0.1% |
Video game | 1 | 0.1% |
Video-assisted thoracoscopic surgery | 1 | 0.1% |
Vienna Convention on the Law of Treaties | 1 | 0.1% |
Vineyard | 1 | 0.1% |
Viral evolution | 1 | 0.1% |
Viral load monitoring for HIV | 1 | 0.1% |
Viral vector vaccine | 1 | 0.1% |
Virtua | 1 | 0.1% |
Virtual assistant | 1 | 0.1% |
Virtual private network | 1 | 0.1% |
Virtual reality headset | 1 | 0.1% |
Virtualization | 1 | 0.1% |
Virus latency | 1 | 0.1% |
Virus quantification | 1 | 0.1% |
Visceral leishmaniasis | 1 | 0.1% |
Vision (spirituality) | 1 | 0.1% |
Visual field test | 1 | 0.1% |
Visual prosthesis | 1 | 0.1% |
Visual system | 1 | 0.1% |
Vital statistics (government records) | 1 | 0.1% |
Vitamin A | 1 | 0.1% |
Vitamin B12 | 1 | 0.1% |
Viticulture | 1 | 0.1% |
Volume | 1 | 0.1% |
Vomiting | 1 | 0.1% |
Vulnerable plaque | 1 | 0.1% |
Waist–hip ratio | 1 | 0.1% |
Waitangi Day | 1 | 0.1% |
Waitematā Harbour | 1 | 0.1% |
Wakame | 1 | 0.1% |
Warrington | 1 | 0.1% |
Wastewater treatment | 1 | 0.1% |
Water on Mars | 1 | 0.1% |
Water purification | 1 | 0.1% |
Water quality | 1 | 0.1% |
Water resource management | 1 | 0.1% |
Water vapor | 1 | 0.1% |
Wave function collapse | 1 | 0.1% |
Waveguide | 1 | 0.1% |
Weakness | 1 | 0.1% |
Weapon of mass destruction | 1 | 0.1% |
Wearable computer | 1 | 0.1% |
Weather | 1 | 0.1% |
Weather satellite | 1 | 0.1% |
Weather station | 1 | 0.1% |
Weathering | 1 | 0.1% |
Web Content Accessibility Guidelines | 1 | 0.1% |
Web conferencing | 1 | 0.1% |
Weddell Sea | 1 | 0.1% |
Weighted arithmetic mean | 1 | 0.1% |
Welfare economics | 1 | 0.1% |
West Bank | 1 | 0.1% |
Western blot | 1 | 0.1% |
Western honey bee | 1 | 0.1% |
Wet market | 1 | 0.1% |
Wheat | 1 | 0.1% |
White coat hypertension | 1 | 0.1% |
White dwarf | 1 | 0.1% |
White people | 1 | 0.1% |
Whitehall Study | 1 | 0.1% |
Whole blood | 1 | 0.1% |
Wildfire suppression | 1 | 0.1% |
Wildlife trade | 1 | 0.1% |
Window | 1 | 0.1% |
Winter service vehicle | 1 | 0.1% |
Winterbourne View hospital abuse | 1 | 0.1% |
Wireless power transfer | 1 | 0.1% |
Wireless sensor network | 1 | 0.1% |
Wissenschaft | 1 | 0.1% |
Witness | 1 | 0.1% |
Wood | 1 | 0.1% |
Working conditions | 1 | 0.1% |
Working poor | 1 | 0.1% |
Workplace | 1 | 0.1% |
World Water Forum | 1 | 0.1% |
World population | 1 | 0.1% |
World view | 1 | 0.1% |
Wound healing | 1 | 0.1% |
Wrist | 1 | 0.1% |
Wristband | 1 | 0.1% |
X-linked agammaglobulinemia | 1 | 0.1% |
X-linked severe combined immunodeficiency | 1 | 0.1% |
X-ray binary | 1 | 0.1% |
XML | 1 | 0.1% |
XML schema | 1 | 0.1% |
XYY syndrome | 1 | 0.1% |
Xanthomonas oryzae pv. oryzae | 1 | 0.1% |
Xenopus | 1 | 0.1% |
Yam (vegetable) | 1 | 0.1% |
Yellow rain | 1 | 0.1% |
Yogurt | 1 | 0.1% |
York | 1 | 0.1% |
Youth smoking | 1 | 0.1% |
Zdravljica | 1 | 0.1% |
Zero-emissions vehicle | 1 | 0.1% |
Zero-energy building | 1 | 0.1% |
Zileuton | 1 | 0.1% |
Zinc | 1 | 0.1% |
Zolpidem | 1 | 0.1% |
Zoning | 1 | 0.1% |
Zoster vaccine | 1 | 0.1% |
Zygomatic bone | 1 | 0.1% |
Zymoseptoria tritici | 1 | 0.1% |
Β-lactam antibiotic | 1 | 0.1% |
ΔF508 | 1 | 0.1% |
abs | rel | |
---|---|---|
Decision-making | 1 | 100.0% |
Economics of service industries | 1 | 100.0% |
Evidence-based medicine | 1 | 100.0% |
Health | 1 | 100.0% |
Health care | 1 | 100.0% |
Health care quality | 1 | 100.0% |
Health economics | 1 | 100.0% |
Health sciences | 1 | 100.0% |
Human activities | 1 | 100.0% |
Medical guideline | 1 | 100.0% |
Medicine | 1 | 100.0% |
Patient | 1 | 100.0% |
Patient participation | 1 | 100.0% |
Physician | 1 | 100.0% |
Quality | 1 | 100.0% |
Science | 1 | 100.0% |
Single-payer healthcare | 1 | 100.0% |
abs | rel | |
---|---|---|
Adherence (medicine) | 1 | 100.0% |
Angina | 1 | 100.0% |
Back pain | 1 | 100.0% |
Clinical medicine | 1 | 100.0% |
Clinical trial | 1 | 100.0% |
Comorbidity | 1 | 100.0% |
Coronary artery disease | 1 | 100.0% |
Coronary care unit | 1 | 100.0% |
Diseases and disorders | 1 | 100.0% |
Emergency department | 1 | 100.0% |
Emergency medicine | 1 | 100.0% |
Evidence-based medicine | 1 | 100.0% |
Health | 1 | 100.0% |
Health care | 1 | 100.0% |
Health sciences | 1 | 100.0% |
Health services research | 1 | 100.0% |
Hospital | 1 | 100.0% |
Hospital readmission | 1 | 100.0% |
Intensive care unit | 1 | 100.0% |
Low back pain | 1 | 100.0% |
Medical guideline | 1 | 100.0% |
Medical specialties | 1 | 100.0% |
Medicine | 1 | 100.0% |
Myocardial infarction | 1 | 100.0% |
Pain | 1 | 100.0% |
Patient | 1 | 100.0% |
Physician | 1 | 100.0% |
Preventive healthcare | 1 | 100.0% |
Reliability engineering | 1 | 100.0% |
Research | 1 | 100.0% |
Risk | 1 | 100.0% |
Triage | 1 | 100.0% |
abs | rel | |
---|---|---|
Adolescence | 1 | 100.0% |
Asian Americans | 1 | 100.0% |
Birth rate | 1 | 100.0% |
Birth weight | 1 | 100.0% |
Birthing center | 1 | 100.0% |
Childbirth | 1 | 100.0% |
Doctor of Osteopathic Medicine | 1 | 100.0% |
Environmental social science | 1 | 100.0% |
Fertility | 1 | 100.0% |
Gestational age | 1 | 100.0% |
Health | 1 | 100.0% |
Health care | 1 | 100.0% |
Health sciences | 1 | 100.0% |
Hispanic and Latino Americans | 1 | 100.0% |
Human development | 1 | 100.0% |
Human pregnancy | 1 | 100.0% |
Human reproduction | 1 | 100.0% |
Large for gestational age | 1 | 100.0% |
Mammalian pregnancy | 1 | 100.0% |
Maternal health | 1 | 100.0% |
Medical specialties | 1 | 100.0% |
Midwife | 1 | 100.0% |
Mother | 1 | 100.0% |
Motherhood | 1 | 100.0% |
Multiple birth | 1 | 100.0% |
Non-Hispanic whites | 1 | 100.0% |
Pound (mass) | 1 | 100.0% |
Pregnancy | 1 | 100.0% |
Prenatal care | 1 | 100.0% |
Prenatal development | 1 | 100.0% |
Preterm birth | 1 | 100.0% |
Public health | 1 | 100.0% |
Race and ethnicity in the United States Census | 1 | 100.0% |
Teenage pregnancy | 1 | 100.0% |
Twin | 1 | 100.0% |
Women's health | 1 | 100.0% |
abs | rel | |
---|---|---|
Health | 2 | 100.0% |
Health care | 2 | 100.0% |
Health sciences | 2 | 100.0% |
Medical specialties | 2 | 100.0% |
Medicine | 2 | 100.0% |
Risk | 2 | 100.0% |
Antibiotic | 1 | 50.0% |
Antimicrobial resistance | 1 | 50.0% |
Caregiver | 1 | 50.0% |
Chronic condition | 1 | 50.0% |
Ciprofloxacin | 1 | 50.0% |
Clinical medicine | 1 | 50.0% |
Clinical trial | 1 | 50.0% |
Community-acquired pneumonia | 1 | 50.0% |
Comorbidity | 1 | 50.0% |
Cost-effectiveness analysis | 1 | 50.0% |
Dementia | 1 | 50.0% |
Disease | 1 | 50.0% |
Drugs | 1 | 50.0% |
Evaluation | 1 | 50.0% |
Geriatrics | 1 | 50.0% |
Hospital | 1 | 50.0% |
Levofloxacin | 1 | 50.0% |
Lower respiratory tract infection | 1 | 50.0% |
MEDLINE | 1 | 50.0% |
Major depressive disorder | 1 | 50.0% |
Medical diagnosis | 1 | 50.0% |
Medication | 1 | 50.0% |
Meta-analysis | 1 | 50.0% |
Mycoplasma pneumoniae | 1 | 50.0% |
Nursing | 1 | 50.0% |
Nursing home care | 1 | 50.0% |
Patient | 1 | 50.0% |
Physical restraint | 1 | 50.0% |
Physical therapy | 1 | 50.0% |
Pneumonia | 1 | 50.0% |
Pressure ulcer | 1 | 50.0% |
Psychology | 1 | 50.0% |
Public health | 1 | 50.0% |
Quinolone antibiotic | 1 | 50.0% |
Safety | 1 | 50.0% |
Sensitivity analysis | 1 | 50.0% |
Shortness of breath | 1 | 50.0% |
Streptococcus pneumoniae | 1 | 50.0% |
Therapy | 1 | 50.0% |
abs | rel | |
---|---|---|
Health | 6 | 85.7% |
Health care | 6 | 85.7% |
Medicine | 6 | 85.7% |
Health sciences | 5 | 71.4% |
Hospital | 4 | 57.1% |
Medicaid | 4 | 57.1% |
Medical specialties | 4 | 57.1% |
Nursing | 3 | 42.9% |
Substance abuse | 3 | 42.9% |
Case management (US health system) | 2 | 28.6% |
Clinical medicine | 2 | 28.6% |
Disease | 2 | 28.6% |
Human activities | 2 | 28.6% |
Medicare (United States) | 2 | 28.6% |
Nursing home care | 2 | 28.6% |
Patient | 2 | 28.6% |
Physician | 2 | 28.6% |
Preventive healthcare | 2 | 28.6% |
Public health | 2 | 28.6% |
Risk | 2 | 28.6% |
Substance dependence | 2 | 28.6% |
Surgery | 2 | 28.6% |
Accuracy and precision | 1 | 14.3% |
Adherence (medicine) | 1 | 14.3% |
Adverse effect | 1 | 14.3% |
Alcoholism | 1 | 14.3% |
Anabolic steroid | 1 | 14.3% |
Androgen | 1 | 14.3% |
Aspirin | 1 | 14.3% |
Asthma | 1 | 14.3% |
Audit | 1 | 14.3% |
Board of directors | 1 | 14.3% |
Bootstrapping (statistics) | 1 | 14.3% |
Bruce Botelho | 1 | 14.3% |
Budget | 1 | 14.3% |
Cancer | 1 | 14.3% |
Capitation (healthcare) | 1 | 14.3% |
Cardiothoracic surgery | 1 | 14.3% |
Clinic | 1 | 14.3% |
Confidence interval | 1 | 14.3% |
Contract | 1 | 14.3% |
Copayment | 1 | 14.3% |
Da Vinci Surgical System | 1 | 14.3% |
Data analysis | 1 | 14.3% |
Database | 1 | 14.3% |
Dementia | 1 | 14.3% |
Dihydrotestosterone | 1 | 14.3% |
Drug tolerance | 1 | 14.3% |
EPSDT | 1 | 14.3% |
Economics of service industries | 1 | 14.3% |
Emergency department | 1 | 14.3% |
Employment | 1 | 14.3% |
Errors and residuals | 1 | 14.3% |
Estimator | 1 | 14.3% |
Estrogen | 1 | 14.3% |
Fee-for-service | 1 | 14.3% |
General practitioner | 1 | 14.3% |
Government | 1 | 14.3% |
Health economics | 1 | 14.3% |
Health insurance | 1 | 14.3% |
Health insurance coverage in the United States | 1 | 14.3% |
Health maintenance organization | 1 | 14.3% |
Health policy | 1 | 14.3% |
Home care in the United States | 1 | 14.3% |
Hypothalamus | 1 | 14.3% |
Iditarod Trail Sled Dog Race | 1 | 14.3% |
Insurance | 1 | 14.3% |
Laparoscopy | 1 | 14.3% |
Long-term care | 1 | 14.3% |
Managed care | 1 | 14.3% |
Medical diagnosis | 1 | 14.3% |
Medical prescription | 1 | 14.3% |
Medical procedures | 1 | 14.3% |
Medical record | 1 | 14.3% |
Medical technology | 1 | 14.3% |
Medical treatments | 1 | 14.3% |
Medication | 1 | 14.3% |
Menstrual cycle | 1 | 14.3% |
Mental health | 1 | 14.3% |
Methyltestosterone | 1 | 14.3% |
Minimum Data Set | 1 | 14.3% |
Morphine | 1 | 14.3% |
Mortality rate | 1 | 14.3% |
Nandrolone | 1 | 14.3% |
Operant conditioning | 1 | 14.3% |
Pearson correlation coefficient | 1 | 14.3% |
Per diem | 1 | 14.3% |
Pharmacology | 1 | 14.3% |
Pharmacy | 1 | 14.3% |
Placebo-controlled study | 1 | 14.3% |
Politics | 1 | 14.3% |
Prostate cancer | 1 | 14.3% |
Prostate-specific antigen | 1 | 14.3% |
Psychiatry | 1 | 14.3% |
Psychoactive drug | 1 | 14.3% |
Psychological trauma | 1 | 14.3% |
Psychology | 1 | 14.3% |
Public sphere | 1 | 14.3% |
Radiology | 1 | 14.3% |
Reinforcement | 1 | 14.3% |
Remote surgery | 1 | 14.3% |
Respiratory therapist | 1 | 14.3% |
Reye syndrome | 1 | 14.3% |
Robot-assisted surgery | 1 | 14.3% |
Sample size determination | 1 | 14.3% |
Sampling (statistics) | 1 | 14.3% |
Section 504 of the Rehabilitation Act | 1 | 14.3% |
Self-administration | 1 | 14.3% |
Self-care | 1 | 14.3% |
Somatic symptom disorder | 1 | 14.3% |
Somatization | 1 | 14.3% |
Standard error | 1 | 14.3% |
Superfund | 1 | 14.3% |
Surgical procedures and techniques | 1 | 14.3% |
Survey methodology | 1 | 14.3% |
Systematic review | 1 | 14.3% |
Technology | 1 | 14.3% |
Telehealth | 1 | 14.3% |
Testosterone | 1 | 14.3% |
Tony Knowles (politician) | 1 | 14.3% |
Trichloroethylene | 1 | 14.3% |
U.S. state | 1 | 14.3% |
Variance | 1 | 14.3% |
Welfare | 1 | 14.3% |
abs | rel | |
---|---|---|
Health | 13 | 100.0% |
Health care | 11 | 84.6% |
Medicine | 11 | 84.6% |
Health sciences | 10 | 76.9% |
Clinical medicine | 9 | 69.2% |
Medical specialties | 9 | 69.2% |
Public health | 9 | 69.2% |
Disease | 7 | 53.8% |
Epidemiology | 7 | 53.8% |
Human activities | 6 | 46.2% |
Diseases and disorders | 5 | 38.5% |
Infection | 5 | 38.5% |
Emergency department | 4 | 30.8% |
Health policy | 4 | 30.8% |
Hospital | 4 | 30.8% |
Immunology | 4 | 30.8% |
Infectious diseases | 4 | 30.8% |
Medical humanities | 4 | 30.8% |
Microbiology | 4 | 30.8% |
Preventive healthcare | 4 | 30.8% |
Public sphere | 4 | 30.8% |
Bioterrorism | 3 | 23.1% |
HIV/AIDS | 3 | 23.1% |
Medicaid | 3 | 23.1% |
Medical diagnosis | 3 | 23.1% |
Medicare (United States) | 3 | 23.1% |
Patient | 3 | 23.1% |
Surveillance | 3 | 23.1% |
Antimicrobial resistance | 2 | 15.4% |
Blood sugar level | 2 | 15.4% |
Candidiasis | 2 | 15.4% |
Cardiovascular system | 2 | 15.4% |
Chlamydia infection | 2 | 15.4% |
Coronary artery disease | 2 | 15.4% |
Coronavirus | 2 | 15.4% |
Disability | 2 | 15.4% |
Disease surveillance | 2 | 15.4% |
Electronic health record | 2 | 15.4% |
Emergency | 2 | 15.4% |
Emergency management | 2 | 15.4% |
Employment | 2 | 15.4% |
Evaluation | 2 | 15.4% |
Gonorrhea | 2 | 15.4% |
Health economics | 2 | 15.4% |
Health informatics | 2 | 15.4% |
Human reproduction | 2 | 15.4% |
Insurance | 2 | 15.4% |
Long-term care | 2 | 15.4% |
Low-density lipoprotein | 2 | 15.4% |
Nursing | 2 | 15.4% |
Nursing home care | 2 | 15.4% |
Obesity | 2 | 15.4% |
Pandemic | 2 | 15.4% |
Pelvic inflammatory disease | 2 | 15.4% |
Polymerase chain reaction | 2 | 15.4% |
Public health surveillance | 2 | 15.4% |
Reproductive health | 2 | 15.4% |
Research | 2 | 15.4% |
Risk | 2 | 15.4% |
Sensitivity and specificity | 2 | 15.4% |
Severe acute respiratory syndrome | 2 | 15.4% |
Technology | 2 | 15.4% |
Vaccine | 2 | 15.4% |
Virus | 2 | 15.4% |
Abdominal obesity | 1 | 7.7% |
Aciclovir | 1 | 7.7% |
Adherence (medicine) | 1 | 7.7% |
Adverse selection | 1 | 7.7% |
Ageing | 1 | 7.7% |
Airline | 1 | 7.7% |
Alcoholism | 1 | 7.7% |
Anthropometry | 1 | 7.7% |
Antiviral drug | 1 | 7.7% |
Apolipoprotein | 1 | 7.7% |
Apolipoprotein B | 1 | 7.7% |
Atherosclerosis | 1 | 7.7% |
Atorvastatin | 1 | 7.7% |
Azithromycin | 1 | 7.7% |
Bacterial vaginosis | 1 | 7.7% |
Behavior | 1 | 7.7% |
Biological warfare | 1 | 7.7% |
Biology | 1 | 7.7% |
Bovine spongiform encephalopathy | 1 | 7.7% |
Bruce Botelho | 1 | 7.7% |
COVID-19 pandemic | 1 | 7.7% |
CT scan | 1 | 7.7% |
Capitation (healthcare) | 1 | 7.7% |
Cardiology | 1 | 7.7% |
Cardiovascular disease | 1 | 7.7% |
Caregiver | 1 | 7.7% |
Case management (US health system) | 1 | 7.7% |
Cervicitis | 1 | 7.7% |
Child care | 1 | 7.7% |
Child protection | 1 | 7.7% |
Childbirth | 1 | 7.7% |
Chlamydia trachomatis | 1 | 7.7% |
Cholesterol | 1 | 7.7% |
Chronic condition | 1 | 7.7% |
Chronic kidney disease | 1 | 7.7% |
Chronic wasting disease | 1 | 7.7% |
Clinical trial | 1 | 7.7% |
Community mental health service | 1 | 7.7% |
Comorbidity | 1 | 7.7% |
Computer network | 1 | 7.7% |
Computer vision | 1 | 7.7% |
Coronary CT calcium scan | 1 | 7.7% |
Coronavirus disease 2019 | 1 | 7.7% |
Cyberattack | 1 | 7.7% |
Data analysis | 1 | 7.7% |
Diabetes | 1 | 7.7% |
Diabetes management | 1 | 7.7% |
Diabetes mellitus | 1 | 7.7% |
Diabetes mellitus type 1 | 1 | 7.7% |
Diabetes mellitus type 2 | 1 | 7.7% |
Disease management (health) | 1 | 7.7% |
Disinfectant | 1 | 7.7% |
Drinking water | 1 | 7.7% |
Drugs | 1 | 7.7% |
Ectopic pregnancy | 1 | 7.7% |
Education | 1 | 7.7% |
Elderly care | 1 | 7.7% |
Endocrinology | 1 | 7.7% |
Epidemic | 1 | 7.7% |
Ezetimibe | 1 | 7.7% |
False positives and false negatives | 1 | 7.7% |
Family caregivers | 1 | 7.7% |
Fare | 1 | 7.7% |
Fee-for-service | 1 | 7.7% |
Fluconazole | 1 | 7.7% |
Food safety | 1 | 7.7% |
Foodborne illness | 1 | 7.7% |
Fran Ulmer | 1 | 7.7% |
Genital wart | 1 | 7.7% |
Geographic information system | 1 | 7.7% |
Geriatrics | 1 | 7.7% |
Glycated hemoglobin | 1 | 7.7% |
Government | 1 | 7.7% |
Grandparent | 1 | 7.7% |
Granuloma inguinale | 1 | 7.7% |
Gregory Abowd | 1 | 7.7% |
Gynaecologic disorders | 1 | 7.7% |
Gynaecology | 1 | 7.7% |
Hand sanitizer | 1 | 7.7% |
Health Insurance Portability and Accountability Act | 1 | 7.7% |
Health insurance | 1 | 7.7% |
Health maintenance organization | 1 | 7.7% |
Health professional | 1 | 7.7% |
Health system | 1 | 7.7% |
Herpes simplex | 1 | 7.7% |
High-density lipoprotein | 1 | 7.7% |
Home care in the United States | 1 | 7.7% |
Human female reproductive system | 1 | 7.7% |
Hypercholesterolemia | 1 | 7.7% |
Hypertension | 1 | 7.7% |
Imaging | 1 | 7.7% |
Infection control | 1 | 7.7% |
Infection prevention and control | 1 | 7.7% |
Inflation | 1 | 7.7% |
Influenza | 1 | 7.7% |
Influenza pandemic | 1 | 7.7% |
Influenza vaccine | 1 | 7.7% |
Influenza-like illness | 1 | 7.7% |
Information | 1 | 7.7% |
Information security | 1 | 7.7% |
Internet | 1 | 7.7% |
Interoperability | 1 | 7.7% |
Isolation (health care) | 1 | 7.7% |
Issues in ethics | 1 | 7.7% |
Julie Gerberding | 1 | 7.7% |
Laboratory | 1 | 7.7% |
Lawyer | 1 | 7.7% |
Life sciences | 1 | 7.7% |
Lipoprotein | 1 | 7.7% |
Lipoprotein(a) | 1 | 7.7% |
Lymphogranuloma venereum | 1 | 7.7% |
Male genital disorders | 1 | 7.7% |
Managed care | 1 | 7.7% |
Management | 1 | 7.7% |
Maternal death | 1 | 7.7% |
Mediation | 1 | 7.7% |
Medical equipment | 1 | 7.7% |
Medical guideline | 1 | 7.7% |
Medical imaging | 1 | 7.7% |
Medical physics | 1 | 7.7% |
Medical record | 1 | 7.7% |
Medical test | 1 | 7.7% |
Medical tests | 1 | 7.7% |
Medication | 1 | 7.7% |
Mental disorder | 1 | 7.7% |
Mental health | 1 | 7.7% |
Metabolic disorders | 1 | 7.7% |
Metabolic syndrome | 1 | 7.7% |
Metformin | 1 | 7.7% |
Metronidazole | 1 | 7.7% |
Michael Osterholm | 1 | 7.7% |
Minneapolis–Saint Paul International Airport | 1 | 7.7% |
Multidimensional signal processing | 1 | 7.7% |
Nutrition | 1 | 7.7% |
Nystatin | 1 | 7.7% |
Operation of computed tomography | 1 | 7.7% |
Oral sex | 1 | 7.7% |
Pension | 1 | 7.7% |
Per diem | 1 | 7.7% |
Pharmacy | 1 | 7.7% |
Physician | 1 | 7.7% |
Pneumonia | 1 | 7.7% |
Positive and negative predictive values | 1 | 7.7% |
Pregnancy | 1 | 7.7% |
Primary care | 1 | 7.7% |
Psychiatry | 1 | 7.7% |
Public health informatics | 1 | 7.7% |
Quality of life | 1 | 7.7% |
Quality-adjusted life year | 1 | 7.7% |
Quarantine | 1 | 7.7% |
RTT | 1 | 7.7% |
Radio-frequency identification | 1 | 7.7% |
Radiology | 1 | 7.7% |
Respite care | 1 | 7.7% |
Risk assessment | 1 | 7.7% |
Science | 1 | 7.7% |
Screening (medicine) | 1 | 7.7% |
Self-care | 1 | 7.7% |
Severe acute respiratory syndrome coronavirus 2 | 1 | 7.7% |
Sexual health | 1 | 7.7% |
Sexual intercourse | 1 | 7.7% |
Sexually transmitted infection | 1 | 7.7% |
Simulation | 1 | 7.7% |
Simvastatin | 1 | 7.7% |
Sisterhood method | 1 | 7.7% |
Smallpox | 1 | 7.7% |
Social work | 1 | 7.7% |
Standardization | 1 | 7.7% |
Statin | 1 | 7.7% |
Substance abuse | 1 | 7.7% |
Syphilis | 1 | 7.7% |
Tax | 1 | 7.7% |
Taxpayer | 1 | 7.7% |
Telecommunication | 1 | 7.7% |
Telehealth | 1 | 7.7% |
Timeline of the SARS outbreak | 1 | 7.7% |
Tony Knowles (politician) | 1 | 7.7% |
Transmissible spongiform encephalopathy | 1 | 7.7% |
Transmission (medicine) | 1 | 7.7% |
Transport | 1 | 7.7% |
Type 2 diabetes | 1 | 7.7% |
Vaccinia | 1 | 7.7% |
Vagina | 1 | 7.7% |
Vaginitis | 1 | 7.7% |
Variant Creutzfeldt–Jakob disease | 1 | 7.7% |
Virtual private network | 1 | 7.7% |
Welfare | 1 | 7.7% |
Women's health | 1 | 7.7% |
Workforce development | 1 | 7.7% |
abs | rel | |
---|---|---|
Health | 7 | 100.0% |
Clinical medicine | 6 | 85.7% |
Health sciences | 6 | 85.7% |
Medical specialties | 6 | 85.7% |
Medicine | 6 | 85.7% |
Health care | 4 | 57.1% |
Infection | 4 | 57.1% |
Preventive healthcare | 4 | 57.1% |
Public health | 4 | 57.1% |
Risk | 4 | 57.1% |
Cancer | 3 | 42.9% |
Cardiovascular disease | 3 | 42.9% |
Disease | 3 | 42.9% |
HIV/AIDS | 3 | 42.9% |
Research | 3 | 42.9% |
Antimicrobial resistance | 2 | 28.6% |
Biology | 2 | 28.6% |
Chronic condition | 2 | 28.6% |
Coronary artery disease | 2 | 28.6% |
Diseases and disorders | 2 | 28.6% |
Evaluation | 2 | 28.6% |
HIV | 2 | 28.6% |
Hormone replacement therapy | 2 | 28.6% |
Life sciences | 2 | 28.6% |
Management of HIV/AIDS | 2 | 28.6% |
Medical imaging | 2 | 28.6% |
Obesity | 2 | 28.6% |
Pre-eclampsia | 2 | 28.6% |
Pregnancy | 2 | 28.6% |
Risk management | 2 | 28.6% |
Stroke | 2 | 28.6% |
Surgery | 2 | 28.6% |
Type 2 diabetes | 2 | 28.6% |
Zidovudine | 2 | 28.6% |
ACE inhibitor | 1 | 14.3% |
Alcohol and pregnancy | 1 | 14.3% |
Amblyopia | 1 | 14.3% |
Ambulatory blood pressure | 1 | 14.3% |
Ammunition | 1 | 14.3% |
Angina | 1 | 14.3% |
Angiology | 1 | 14.3% |
Angiotensin | 1 | 14.3% |
Angiotensin II receptor blocker | 1 | 14.3% |
Angiotensin-converting enzyme | 1 | 14.3% |
Antihypertensive drug | 1 | 14.3% |
Aspirin | 1 | 14.3% |
Asset | 1 | 14.3% |
Asthma | 1 | 14.3% |
Audit | 1 | 14.3% |
BRCA mutation | 1 | 14.3% |
BRCA1 | 1 | 14.3% |
BRCA2 | 1 | 14.3% |
Balance sheet | 1 | 14.3% |
Behavior | 1 | 14.3% |
Beta blocker | 1 | 14.3% |
Bioinformatics | 1 | 14.3% |
Biosensor | 1 | 14.3% |
Blood plasma | 1 | 14.3% |
Blood pressure | 1 | 14.3% |
Blood pressure measurement | 1 | 14.3% |
Bomb | 1 | 14.3% |
Brain | 1 | 14.3% |
Breast cancer | 1 | 14.3% |
Breastfeeding | 1 | 14.3% |
Budget | 1 | 14.3% |
CD4 | 1 | 14.3% |
Caesarean section | 1 | 14.3% |
Calcium channel blocker | 1 | 14.3% |
Cardiovascular system | 1 | 14.3% |
Cash flow statement | 1 | 14.3% |
Cataract | 1 | 14.3% |
Childbirth | 1 | 14.3% |
Chlortalidone | 1 | 14.3% |
Cholesterol | 1 | 14.3% |
Clinic | 1 | 14.3% |
Clinical governance | 1 | 14.3% |
Clinical trial | 1 | 14.3% |
Cluster munition | 1 | 14.3% |
Condom | 1 | 14.3% |
Cornea | 1 | 14.3% |
Crystallin | 1 | 14.3% |
Current liability | 1 | 14.3% |
Cystic fibrosis | 1 | 14.3% |
Cystic fibrosis transmembrane conductance regulator | 1 | 14.3% |
DASH diet | 1 | 14.3% |
Decision-making | 1 | 14.3% |
Density | 1 | 14.3% |
Depreciation | 1 | 14.3% |
Diabetic retinopathy | 1 | 14.3% |
Diagnosis of HIV/AIDS | 1 | 14.3% |
Diuretic | 1 | 14.3% |
Dividend | 1 | 14.3% |
Dose (biochemistry) | 1 | 14.3% |
Dose–response relationship | 1 | 14.3% |
Drug injection | 1 | 14.3% |
Drugs | 1 | 14.3% |
Eclampsia | 1 | 14.3% |
Ecology | 1 | 14.3% |
Electromagnetic interference | 1 | 14.3% |
Emergency department | 1 | 14.3% |
Environmental remediation | 1 | 14.3% |
Epidemiology | 1 | 14.3% |
Epidemiology of HIV/AIDS | 1 | 14.3% |
Equity (finance) | 1 | 14.3% |
Evidence-based medicine | 1 | 14.3% |
Exercise | 1 | 14.3% |
Expense | 1 | 14.3% |
Explosion | 1 | 14.3% |
Explosive | 1 | 14.3% |
Exposure assessment | 1 | 14.3% |
FMR1 | 1 | 14.3% |
Fault tree analysis | 1 | 14.3% |
Finance | 1 | 14.3% |
Financial statement | 1 | 14.3% |
Fixed asset | 1 | 14.3% |
Fragile X syndrome | 1 | 14.3% |
Functional magnetic resonance imaging | 1 | 14.3% |
Gene | 1 | 14.3% |
Genetic carrier | 1 | 14.3% |
Genetic counseling | 1 | 14.3% |
Genetic testing | 1 | 14.3% |
Genetics | 1 | 14.3% |
Gene–environment interaction | 1 | 14.3% |
Genome | 1 | 14.3% |
Glaucoma | 1 | 14.3% |
Governance | 1 | 14.3% |
Government budget balance | 1 | 14.3% |
Gynaecology | 1 | 14.3% |
HIV/AIDS in Africa | 1 | 14.3% |
Hand washing | 1 | 14.3% |
Harm reduction | 1 | 14.3% |
Hazard | 1 | 14.3% |
Health economics | 1 | 14.3% |
Health equity | 1 | 14.3% |
Health policy | 1 | 14.3% |
Hospital | 1 | 14.3% |
Human reproduction | 1 | 14.3% |
Hygiene | 1 | 14.3% |
Hypertension | 1 | 14.3% |
Immune system | 1 | 14.3% |
Infant mortality | 1 | 14.3% |
Infection prevention and control | 1 | 14.3% |
Infectious diseases | 1 | 14.3% |
Influenza | 1 | 14.3% |
Information | 1 | 14.3% |
Insurance | 1 | 14.3% |
Intensive care medicine | 1 | 14.3% |
Intensive care unit | 1 | 14.3% |
Internal control | 1 | 14.3% |
Interstitial cystitis | 1 | 14.3% |
Kidney failure | 1 | 14.3% |
Lamivudine | 1 | 14.3% |
Lens (anatomy) | 1 | 14.3% |
Low-density lipoprotein | 1 | 14.3% |
Macular degeneration | 1 | 14.3% |
Magnetic resonance imaging | 1 | 14.3% |
Magnetometer | 1 | 14.3% |
Malaria | 1 | 14.3% |
Mammography | 1 | 14.3% |
Management of hypertension | 1 | 14.3% |
Medical humanities | 1 | 14.3% |
Medical prescription | 1 | 14.3% |
Medical record | 1 | 14.3% |
Medical research | 1 | 14.3% |
Medium-chain acyl-coenzyme A dehydrogenase deficiency | 1 | 14.3% |
Men who have sex with men | 1 | 14.3% |
Mental disorder | 1 | 14.3% |
Metal detector | 1 | 14.3% |
Methicillin-resistant Staphylococcus aureus | 1 | 14.3% |
Microbicides for sexually transmitted diseases | 1 | 14.3% |
Minimally invasive procedure | 1 | 14.3% |
Mutation | 1 | 14.3% |
Myocardial infarction | 1 | 14.3% |
NHS foundation trust | 1 | 14.3% |
NHS primary care trust | 1 | 14.3% |
Nanomedicine | 1 | 14.3% |
Near-sightedness | 1 | 14.3% |
Negotiation | 1 | 14.3% |
Neurology | 1 | 14.3% |
Nevirapine | 1 | 14.3% |
Newborn screening | 1 | 14.3% |
Nuclear power | 1 | 14.3% |
Nuclear weapon | 1 | 14.3% |
Nursing | 1 | 14.3% |
Occupational safety and health | 1 | 14.3% |
Oophorectomy | 1 | 14.3% |
Operating surplus | 1 | 14.3% |
Outpatient surgery | 1 | 14.3% |
Ovarian cancer | 1 | 14.3% |
Palliative care | 1 | 14.3% |
Patient | 1 | 14.3% |
Patient safety | 1 | 14.3% |
Pharmacogenomics | 1 | 14.3% |
Pharmacy | 1 | 14.3% |
Potassium-sparing diuretic | 1 | 14.3% |
Poverty | 1 | 14.3% |
Prenatal development | 1 | 14.3% |
Prescription drug | 1 | 14.3% |
Preterm birth | 1 | 14.3% |
Prevention of HIV/AIDS | 1 | 14.3% |
Private finance initiative | 1 | 14.3% |
Probability | 1 | 14.3% |
Prostitution | 1 | 14.3% |
Proteomics | 1 | 14.3% |
Public health genomics | 1 | 14.3% |
RDX | 1 | 14.3% |
RTT | 1 | 14.3% |
Radioactive decay | 1 | 14.3% |
Rate of return | 1 | 14.3% |
Real estate appraisal | 1 | 14.3% |
Receiver operating characteristic | 1 | 14.3% |
Reference dose | 1 | 14.3% |
Regulatory risk differentiation | 1 | 14.3% |
Reliability engineering | 1 | 14.3% |
Renin | 1 | 14.3% |
Retina | 1 | 14.3% |
Retinopathy | 1 | 14.3% |
Retinopathy of prematurity | 1 | 14.3% |
Retrovirus | 1 | 14.3% |
Revaluation of fixed assets | 1 | 14.3% |
Risk assessment | 1 | 14.3% |
Royal Borough of Kensington and Chelsea | 1 | 14.3% |
Safe sex | 1 | 14.3% |
Safety | 1 | 14.3% |
Sampling (statistics) | 1 | 14.3% |
Saturated fat | 1 | 14.3% |
Schizophrenia | 1 | 14.3% |
Science | 1 | 14.3% |
Screening (medicine) | 1 | 14.3% |
Sexual intercourse | 1 | 14.3% |
Sexually transmitted infection | 1 | 14.3% |
Simian immunodeficiency virus | 1 | 14.3% |
Single-nucleotide polymorphism | 1 | 14.3% |
Social work | 1 | 14.3% |
Soil | 1 | 14.3% |
Spironolactone | 1 | 14.3% |
Statin | 1 | 14.3% |
Statistics | 1 | 14.3% |
Stillbirth | 1 | 14.3% |
Strabismus | 1 | 14.3% |
Strategic health authority | 1 | 14.3% |
Sudden infant death syndrome | 1 | 14.3% |
Superfund | 1 | 14.3% |
T helper cell | 1 | 14.3% |
TNT | 1 | 14.3% |
Thiazide | 1 | 14.3% |
Tissue engineering | 1 | 14.3% |
Toxicity | 1 | 14.3% |
Transcription (biology) | 1 | 14.3% |
Transient ischemic attack | 1 | 14.3% |
Transmission (medicine) | 1 | 14.3% |
Tuberculosis | 1 | 14.3% |
Uncertainty | 1 | 14.3% |
Unexploded ordnance | 1 | 14.3% |
Urinary tract infection | 1 | 14.3% |
Valuation (finance) | 1 | 14.3% |
Vertically transmitted infection | 1 | 14.3% |
Virus | 1 | 14.3% |
Visual impairment | 1 | 14.3% |
Water | 1 | 14.3% |
Weight loss | 1 | 14.3% |
White coat hypertension | 1 | 14.3% |
abs | rel | |
---|---|---|
Health | 7 | 87.5% |
Health care | 7 | 87.5% |
Medicine | 7 | 87.5% |
Health sciences | 6 | 75.0% |
Clinical medicine | 4 | 50.0% |
Hospital | 4 | 50.0% |
Human activities | 4 | 50.0% |
Medical specialties | 4 | 50.0% |
Patient | 4 | 50.0% |
Public health | 4 | 50.0% |
Disease | 3 | 37.5% |
Health economics | 3 | 37.5% |
Medication | 3 | 37.5% |
Nursing | 3 | 37.5% |
Pharmacy | 3 | 37.5% |
Research | 3 | 37.5% |
Risk | 3 | 37.5% |
Surgery | 3 | 37.5% |
Caregiver | 2 | 25.0% |
Diseases and disorders | 2 | 25.0% |
Epidemiology | 2 | 25.0% |
Governance | 2 | 25.0% |
Health professional | 2 | 25.0% |
Managed care | 2 | 25.0% |
Medical diagnosis | 2 | 25.0% |
Physician | 2 | 25.0% |
Preventive healthcare | 2 | 25.0% |
Accessibility | 1 | 12.5% |
Adalimumab | 1 | 12.5% |
Adherence (medicine) | 1 | 12.5% |
Adverse drug reaction | 1 | 12.5% |
Ambulance | 1 | 12.5% |
Ammunition | 1 | 12.5% |
Anesthesia | 1 | 12.5% |
Arthritis | 1 | 12.5% |
Audit | 1 | 12.5% |
BCG vaccine | 1 | 12.5% |
Bioterrorism | 1 | 12.5% |
Blame | 1 | 12.5% |
Blood transfusion | 1 | 12.5% |
Cardiovascular disease | 1 | 12.5% |
Cardiovascular system | 1 | 12.5% |
Case management (US health system) | 1 | 12.5% |
Childbirth | 1 | 12.5% |
Cholesterol | 1 | 12.5% |
Clinic | 1 | 12.5% |
Clinical audit | 1 | 12.5% |
Clinical governance | 1 | 12.5% |
Clinical nurse specialist | 1 | 12.5% |
Cohort study | 1 | 12.5% |
Community | 1 | 12.5% |
Community health | 1 | 12.5% |
Competition | 1 | 12.5% |
Computer security | 1 | 12.5% |
Confidentiality | 1 | 12.5% |
Coronary artery disease | 1 | 12.5% |
Debriefing | 1 | 12.5% |
Dementia | 1 | 12.5% |
Diagnosis-related group | 1 | 12.5% |
Disease management (health) | 1 | 12.5% |
Electronic health record | 1 | 12.5% |
Emergency department | 1 | 12.5% |
Emergency medical services | 1 | 12.5% |
Emergency medical services in the United Kingdom | 1 | 12.5% |
Environmental remediation | 1 | 12.5% |
Etanercept | 1 | 12.5% |
Evaluation | 1 | 12.5% |
Excavation (archaeology) | 1 | 12.5% |
Exercise | 1 | 12.5% |
Fall prevention | 1 | 12.5% |
Family medicine | 1 | 12.5% |
File Transfer Protocol | 1 | 12.5% |
FileZilla | 1 | 12.5% |
Foodborne illness | 1 | 12.5% |
Gastroenteritis | 1 | 12.5% |
General medical services | 1 | 12.5% |
General practitioner | 1 | 12.5% |
Geriatrics | 1 | 12.5% |
Gerontological nursing | 1 | 12.5% |
Graft-versus-host disease | 1 | 12.5% |
Health Level 7 | 1 | 12.5% |
Health care in the United States | 1 | 12.5% |
Health care quality | 1 | 12.5% |
Health informatics | 1 | 12.5% |
Health insurance coverage in the United States | 1 | 12.5% |
Health maintenance organization | 1 | 12.5% |
Health promotion | 1 | 12.5% |
Hepatitis | 1 | 12.5% |
High-density lipoprotein | 1 | 12.5% |
Hospital readmission | 1 | 12.5% |
Hypercholesterolemia | 1 | 12.5% |
Immunology | 1 | 12.5% |
Incentive | 1 | 12.5% |
Infection | 1 | 12.5% |
Infliximab | 1 | 12.5% |
Influenza | 1 | 12.5% |
Innovation | 1 | 12.5% |
International Statistical Classification of Diseases and Related Health Problems | 1 | 12.5% |
Interoperability | 1 | 12.5% |
Isoniazid | 1 | 12.5% |
John Bourn | 1 | 12.5% |
Leadership | 1 | 12.5% |
Learning | 1 | 12.5% |
Long-term care | 1 | 12.5% |
Mantoux test | 1 | 12.5% |
Market (economics) | 1 | 12.5% |
Maternal death | 1 | 12.5% |
Medicaid | 1 | 12.5% |
Medical device | 1 | 12.5% |
Medical error | 1 | 12.5% |
Medical guideline | 1 | 12.5% |
Medical malpractice | 1 | 12.5% |
Medical prescription | 1 | 12.5% |
Medical specialty | 1 | 12.5% |
Medical treatments | 1 | 12.5% |
Medicare (United States) | 1 | 12.5% |
Mental disorder | 1 | 12.5% |
Meta-analysis | 1 | 12.5% |
Metal detector | 1 | 12.5% |
Monopoly | 1 | 12.5% |
Myocardial infarction | 1 | 12.5% |
NHS Connecting for Health | 1 | 12.5% |
NHS Direct | 1 | 12.5% |
NHS foundation trust | 1 | 12.5% |
NHS primary care trust | 1 | 12.5% |
Nursing home care | 1 | 12.5% |
Obesity | 1 | 12.5% |
Occupational therapist | 1 | 12.5% |
Occupational therapy | 1 | 12.5% |
Orthopedic surgery | 1 | 12.5% |
Osteoporosis | 1 | 12.5% |
Outpatient surgery | 1 | 12.5% |
Patient participation | 1 | 12.5% |
Patient safety | 1 | 12.5% |
Payment by Results | 1 | 12.5% |
Physical fitness | 1 | 12.5% |
Physical therapy | 1 | 12.5% |
Physician self-referral | 1 | 12.5% |
Pneumonia | 1 | 12.5% |
Practice-based commissioning | 1 | 12.5% |
Prescription drug | 1 | 12.5% |
Primary care | 1 | 12.5% |
Provinces and territories of Canada | 1 | 12.5% |
Public Health Information Network | 1 | 12.5% |
Public health informatics | 1 | 12.5% |
Public health surveillance | 1 | 12.5% |
Pyrazinamide | 1 | 12.5% |
Randomized controlled trial | 1 | 12.5% |
Regulatory compliance | 1 | 12.5% |
Rheumatoid arthritis | 1 | 12.5% |
Risk management | 1 | 12.5% |
Safety | 1 | 12.5% |
Safety culture | 1 | 12.5% |
Self-care | 1 | 12.5% |
Sensitivity analysis | 1 | 12.5% |
Sensitivity and specificity | 1 | 12.5% |
Simvastatin | 1 | 12.5% |
Social work | 1 | 12.5% |
Soil | 1 | 12.5% |
Specialty (medicine) | 1 | 12.5% |
Stark Law | 1 | 12.5% |
Statin | 1 | 12.5% |
Strength training | 1 | 12.5% |
Surveillance | 1 | 12.5% |
TNF inhibitor | 1 | 12.5% |
Tax | 1 | 12.5% |
Team | 1 | 12.5% |
Training | 1 | 12.5% |
Tuberculin | 1 | 12.5% |
Tuberculosis | 1 | 12.5% |
Tumor necrosis factor alpha | 1 | 12.5% |
Unexploded ordnance | 1 | 12.5% |
Whooping cough | 1 | 12.5% |
abs | rel | |
---|---|---|
Health | 14 | 100.0% |
Health sciences | 13 | 92.9% |
Health care | 11 | 78.6% |
Medicine | 11 | 78.6% |
Clinical medicine | 9 | 64.3% |
Medical specialties | 9 | 64.3% |
Diseases and disorders | 8 | 57.1% |
Public health | 8 | 57.1% |
Epidemiology | 6 | 42.9% |
Disease | 5 | 35.7% |
HIV/AIDS | 5 | 35.7% |
Human activities | 5 | 35.7% |
Infection | 5 | 35.7% |
Preventive healthcare | 5 | 35.7% |
Tuberculosis | 5 | 35.7% |
Cardiovascular disease | 4 | 28.6% |
Coronary artery disease | 4 | 28.6% |
Infectious diseases | 4 | 28.6% |
Influenza | 4 | 28.6% |
Management of HIV/AIDS | 4 | 28.6% |
Risk | 4 | 28.6% |
Screening (medicine) | 4 | 28.6% |
Sexually transmitted infection | 4 | 28.6% |
Therapy | 4 | 28.6% |
Vaccine | 4 | 28.6% |
Antimicrobial resistance | 3 | 21.4% |
Avian influenza | 3 | 21.4% |
Breastfeeding and HIV | 3 | 21.4% |
Chlamydia infection | 3 | 21.4% |
Cholesterol | 3 | 21.4% |
Chronic condition | 3 | 21.4% |
Exercise | 3 | 21.4% |
Heart | 3 | 21.4% |
Hospital | 3 | 21.4% |
Hypertension | 3 | 21.4% |
Immunology | 3 | 21.4% |
Influenza pandemic | 3 | 21.4% |
Information | 3 | 21.4% |
Microbiology | 3 | 21.4% |
Obesity | 3 | 21.4% |
Adherence (medicine) | 2 | 14.3% |
Adverse effect | 2 | 14.3% |
Antiviral drug | 2 | 14.3% |
Biology | 2 | 14.3% |
Birth defect | 2 | 14.3% |
Blood pressure | 2 | 14.3% |
Body mass index | 2 | 14.3% |
Cardiac stress test | 2 | 14.3% |
Cardiology | 2 | 14.3% |
Cardiovascular system | 2 | 14.3% |
Cervical cancer | 2 | 14.3% |
Clinical trial | 2 | 14.3% |
Diabetes | 2 | 14.3% |
Diagnosis of HIV/AIDS | 2 | 14.3% |
Disease surveillance | 2 | 14.3% |
Drugs | 2 | 14.3% |
Economy | 2 | 14.3% |
Epidemic | 2 | 14.3% |
Evaluation | 2 | 14.3% |
Evidence-based medicine | 2 | 14.3% |
Health economics | 2 | 14.3% |
Health promotion | 2 | 14.3% |
Heart failure | 2 | 14.3% |
Hepatitis | 2 | 14.3% |
High-density lipoprotein | 2 | 14.3% |
Human reproduction | 2 | 14.3% |
Hyperlipidemia | 2 | 14.3% |
Influenza A virus subtype H5N1 | 2 | 14.3% |
Lymphogranuloma venereum | 2 | 14.3% |
Medical guideline | 2 | 14.3% |
Medical humanities | 2 | 14.3% |
Medication | 2 | 14.3% |
Myocardial infarction | 2 | 14.3% |
Pandemic | 2 | 14.3% |
Patient | 2 | 14.3% |
Pension | 2 | 14.3% |
Pharmacology | 2 | 14.3% |
Prevention of HIV/AIDS | 2 | 14.3% |
Program evaluation | 2 | 14.3% |
Public sphere | 2 | 14.3% |
RTT | 2 | 14.3% |
Research | 2 | 14.3% |
Sepsis | 2 | 14.3% |
Statin | 2 | 14.3% |
Surveillance | 2 | 14.3% |
Survey methodology | 2 | 14.3% |
Syphilis | 2 | 14.3% |
Technology | 2 | 14.3% |
Vaccination | 2 | 14.3% |
Virus | 2 | 14.3% |
ACE inhibitor | 1 | 7.1% |
Abacavir | 1 | 7.1% |
Abdominal obesity | 1 | 7.1% |
Adolescence | 1 | 7.1% |
Alien (law) | 1 | 7.1% |
Alzheimer's disease | 1 | 7.1% |
Amiodarone | 1 | 7.1% |
Antiarrhythmic agent | 1 | 7.1% |
Antibiotic | 1 | 7.1% |
Antihypertensive drug | 1 | 7.1% |
Apolipoprotein | 1 | 7.1% |
Apolipoprotein B | 1 | 7.1% |
Arrhythmia | 1 | 7.1% |
Asthma | 1 | 7.1% |
Atheroma | 1 | 7.1% |
Atherosclerosis | 1 | 7.1% |
Atorvastatin | 1 | 7.1% |
Atrial fibrillation | 1 | 7.1% |
Atrium (heart) | 1 | 7.1% |
Attitude (psychology) | 1 | 7.1% |
Bacteria | 1 | 7.1% |
Bacterial adhesin | 1 | 7.1% |
Bacterial vaginosis | 1 | 7.1% |
Behavior | 1 | 7.1% |
Beta-lactamase | 1 | 7.1% |
Biological warfare | 1 | 7.1% |
Biosecurity | 1 | 7.1% |
Birth control | 1 | 7.1% |
Blood lipids | 1 | 7.1% |
Blood sugar level | 1 | 7.1% |
Bluetongue disease | 1 | 7.1% |
Botulism | 1 | 7.1% |
Branches of science | 1 | 7.1% |
Breast cancer | 1 | 7.1% |
Budget | 1 | 7.1% |
Business | 1 | 7.1% |
C-reactive protein | 1 | 7.1% |
CBRN defense | 1 | 7.1% |
Cancer | 1 | 7.1% |
Cancer screening | 1 | 7.1% |
Cancer survivor | 1 | 7.1% |
Candida (fungus) | 1 | 7.1% |
Candida albicans | 1 | 7.1% |
Candidiasis | 1 | 7.1% |
Cardiovascular diseases | 1 | 7.1% |
Cardiovascular physiology | 1 | 7.1% |
Cardioversion | 1 | 7.1% |
Cervical intraepithelial neoplasia | 1 | 7.1% |
Childbirth | 1 | 7.1% |
Choice modelling | 1 | 7.1% |
Cigarette | 1 | 7.1% |
Citizenship | 1 | 7.1% |
Clinical governance | 1 | 7.1% |
Clinical pathology | 1 | 7.1% |
Community | 1 | 7.1% |
Condom | 1 | 7.1% |
Confidence interval | 1 | 7.1% |
Coronavirus | 1 | 7.1% |
Cost estimate | 1 | 7.1% |
Cost-effectiveness analysis | 1 | 7.1% |
Cost–benefit analysis | 1 | 7.1% |
Counter-terrorism | 1 | 7.1% |
Cytokine | 1 | 7.1% |
DNA sequencing | 1 | 7.1% |
DPT vaccine | 1 | 7.1% |
Decision-making | 1 | 7.1% |
Declarative programming | 1 | 7.1% |
Demand | 1 | 7.1% |
Diabetes management | 1 | 7.1% |
Diabetes mellitus | 1 | 7.1% |
Didanosine | 1 | 7.1% |
Dieting | 1 | 7.1% |
Diffusion of innovations | 1 | 7.1% |
Discounting | 1 | 7.1% |
Discrete choice | 1 | 7.1% |
Disinfectant | 1 | 7.1% |
Disopyramide | 1 | 7.1% |
Disproportionate share hospital | 1 | 7.1% |
Dofetilide | 1 | 7.1% |
Dose (biochemistry) | 1 | 7.1% |
Dosimeter | 1 | 7.1% |
Dosimetry | 1 | 7.1% |
Drug resistance | 1 | 7.1% |
Earned income tax credit | 1 | 7.1% |
Echocardiography | 1 | 7.1% |
Educational assessment | 1 | 7.1% |
Efavirenz | 1 | 7.1% |
Electrocardiography | 1 | 7.1% |
Emergency management | 1 | 7.1% |
Employment | 1 | 7.1% |
Escherichia coli | 1 | 7.1% |
Estrogen | 1 | 7.1% |
Experiment | 1 | 7.1% |
Ezetimibe | 1 | 7.1% |
Family planning | 1 | 7.1% |
Fenofibrate | 1 | 7.1% |
Fibrate | 1 | 7.1% |
Flecainide | 1 | 7.1% |
Fluconazole | 1 | 7.1% |
Fluvastatin | 1 | 7.1% |
Foot-and-mouth disease | 1 | 7.1% |
Forecasting | 1 | 7.1% |
General practitioner | 1 | 7.1% |
Global health | 1 | 7.1% |
Glycated hemoglobin | 1 | 7.1% |
Goal | 1 | 7.1% |
Gonorrhea | 1 | 7.1% |
Governance | 1 | 7.1% |
Government | 1 | 7.1% |
Government budget balance | 1 | 7.1% |
Green card | 1 | 7.1% |
Gynaecology | 1 | 7.1% |
Health Level 7 | 1 | 7.1% |
Health informatics | 1 | 7.1% |
Health insurance | 1 | 7.1% |
Health insurance coverage in the United States | 1 | 7.1% |
Health insurance in the United States | 1 | 7.1% |
Health policy | 1 | 7.1% |
Health professional | 1 | 7.1% |
Heart diseases | 1 | 7.1% |
Hepatitis A | 1 | 7.1% |
Hepatitis B | 1 | 7.1% |
Hepatitis C | 1 | 7.1% |
Hospital-acquired infection | 1 | 7.1% |
Human | 1 | 7.1% |
Human cytomegalovirus | 1 | 7.1% |
Human female reproductive system | 1 | 7.1% |
Human papillomavirus infection | 1 | 7.1% |
Hurricane Katrina | 1 | 7.1% |
Hypercholesterolemia | 1 | 7.1% |
Hypertriglyceridemia | 1 | 7.1% |
Immune system | 1 | 7.1% |
Immunization | 1 | 7.1% |
Immunoglobulin G | 1 | 7.1% |
Indication (medicine) | 1 | 7.1% |
Indinavir | 1 | 7.1% |
Influenza A virus | 1 | 7.1% |
Influenza vaccine | 1 | 7.1% |
Information technology | 1 | 7.1% |
Insurance | 1 | 7.1% |
Internal medicine | 1 | 7.1% |
Kaposi's sarcoma | 1 | 7.1% |
Kaposi's sarcoma-associated herpesvirus | 1 | 7.1% |
Knowledge | 1 | 7.1% |
Laboratory | 1 | 7.1% |
Labour economics | 1 | 7.1% |
Lactobacillus | 1 | 7.1% |
Lamivudine | 1 | 7.1% |
Likelihood function | 1 | 7.1% |
Lipoprotein | 1 | 7.1% |
Lipoprotein(a) | 1 | 7.1% |
Listeria monocytogenes | 1 | 7.1% |
Listeriosis | 1 | 7.1% |
Logic model | 1 | 7.1% |
Logistic regression | 1 | 7.1% |
Logistics | 1 | 7.1% |
Long QT syndrome | 1 | 7.1% |
Lopinavir/ritonavir | 1 | 7.1% |
Lovastatin | 1 | 7.1% |
Low-density lipoprotein | 1 | 7.1% |
Mammal female reproductive system | 1 | 7.1% |
Managed care | 1 | 7.1% |
Management | 1 | 7.1% |
Medicaid | 1 | 7.1% |
Medical diagnosis | 1 | 7.1% |
Medical treatments | 1 | 7.1% |
Medicare (United States) | 1 | 7.1% |
Meningococcal disease | 1 | 7.1% |
Metabolic disorders | 1 | 7.1% |
Metabolic syndrome | 1 | 7.1% |
Miscarriage | 1 | 7.1% |
Molecular diagnostics | 1 | 7.1% |
Mortality rate | 1 | 7.1% |
Multinomial logistic regression | 1 | 7.1% |
Mycoplasma genitalium | 1 | 7.1% |
NHS Connecting for Health | 1 | 7.1% |
NHS foundation trust | 1 | 7.1% |
Natural reservoir | 1 | 7.1% |
Naturalization | 1 | 7.1% |
Neisseria meningitidis | 1 | 7.1% |
Neural tube defect | 1 | 7.1% |
Nevirapine | 1 | 7.1% |
Newborn screening | 1 | 7.1% |
Niacin | 1 | 7.1% |
Nursing | 1 | 7.1% |
Occupational safety and health | 1 | 7.1% |
Opportunity cost | 1 | 7.1% |
Outcomes research | 1 | 7.1% |
Pathogen | 1 | 7.1% |
Pathogenic Escherichia coli | 1 | 7.1% |
Patient choice | 1 | 7.1% |
Payment by Results | 1 | 7.1% |
Pediatrics | 1 | 7.1% |
Pelvic inflammatory disease | 1 | 7.1% |
Performance measurement | 1 | 7.1% |
Peripheral artery disease | 1 | 7.1% |
Physiology | 1 | 7.1% |
Phytophthora cinnamomi | 1 | 7.1% |
Phytophthora kernoviae | 1 | 7.1% |
Phytophthora ramorum | 1 | 7.1% |
Placenta | 1 | 7.1% |
Plant pathology | 1 | 7.1% |
Policy | 1 | 7.1% |
Post-exposure prophylaxis | 1 | 7.1% |
Pravastatin | 1 | 7.1% |
Prediabetes | 1 | 7.1% |
Pregnancy | 1 | 7.1% |
Present value | 1 | 7.1% |
Preterm birth | 1 | 7.1% |
Private finance initiative | 1 | 7.1% |
Procainamide | 1 | 7.1% |
Procurement | 1 | 7.1% |
Propafenone | 1 | 7.1% |
Public policy | 1 | 7.1% |
QT interval | 1 | 7.1% |
Quality-adjusted life year | 1 | 7.1% |
QuantiFERON | 1 | 7.1% |
Quantifier (logic) | 1 | 7.1% |
Quinidine | 1 | 7.1% |
Reliability (statistics) | 1 | 7.1% |
Renal function | 1 | 7.1% |
Resampling (statistics) | 1 | 7.1% |
Reverse-transcriptase inhibitor | 1 | 7.1% |
Ritonavir | 1 | 7.1% |
Rosuvastatin | 1 | 7.1% |
SNOMED CT | 1 | 7.1% |
Safe sex | 1 | 7.1% |
Safety stock | 1 | 7.1% |
Saliva testing | 1 | 7.1% |
Saquinavir | 1 | 7.1% |
Saturated fat | 1 | 7.1% |
Self-contained breathing apparatus | 1 | 7.1% |
Sensitivity analysis | 1 | 7.1% |
Sequencing | 1 | 7.1% |
Services sector of the economy | 1 | 7.1% |
Severe acute respiratory syndrome | 1 | 7.1% |
Simulation | 1 | 7.1% |
Simvastatin | 1 | 7.1% |
Smoking ban | 1 | 7.1% |
Smoking cessation | 1 | 7.1% |
Social Security number | 1 | 7.1% |
Social discount rate | 1 | 7.1% |
Soft drink | 1 | 7.1% |
Sotalol | 1 | 7.1% |
Spreadsheet | 1 | 7.1% |
Staphylococcus saprophyticus | 1 | 7.1% |
Statistics | 1 | 7.1% |
Stavudine | 1 | 7.1% |
Strategy | 1 | 7.1% |
Streptococcus agalactiae | 1 | 7.1% |
Stroke | 1 | 7.1% |
Subsidy | 1 | 7.1% |
Supplemental Security Income | 1 | 7.1% |
Supply chain | 1 | 7.1% |
Supply chain management | 1 | 7.1% |
TLR4 | 1 | 7.1% |
Tablet (pharmacy) | 1 | 7.1% |
Tax deduction | 1 | 7.1% |
Tenofovir disoproxil | 1 | 7.1% |
Tobacco smoking | 1 | 7.1% |
Toll-like receptor | 1 | 7.1% |
Torsades de pointes | 1 | 7.1% |
Toxin | 1 | 7.1% |
Toxoplasmosis | 1 | 7.1% |
Transmission (medicine) | 1 | 7.1% |
Transmission and infection of H5N1 | 1 | 7.1% |
Transtheoretical model | 1 | 7.1% |
Type 2 diabetes | 1 | 7.1% |
Ultrasound | 1 | 7.1% |
Unemployment | 1 | 7.1% |
Unemployment benefits | 1 | 7.1% |
Urinary tract infection | 1 | 7.1% |
Utility | 1 | 7.1% |
Vagina | 1 | 7.1% |
Vaginal flora | 1 | 7.1% |
Vaginal yeast infection | 1 | 7.1% |
Validity (statistics) | 1 | 7.1% |
Ventricular fibrillation | 1 | 7.1% |
Welfare | 1 | 7.1% |
Youth | 1 | 7.1% |
Zidovudine | 1 | 7.1% |
Zoonosis | 1 | 7.1% |
abs | rel | |
---|---|---|
Health | 19 | 82.6% |
Health sciences | 19 | 82.6% |
Medicine | 19 | 82.6% |
Clinical medicine | 17 | 73.9% |
Medical specialties | 17 | 73.9% |
Health care | 14 | 60.9% |
Diseases and disorders | 8 | 34.8% |
Preventive healthcare | 7 | 30.4% |
Risk | 7 | 30.4% |
Cardiovascular system | 6 | 26.1% |
Disease | 6 | 26.1% |
Human activities | 6 | 26.1% |
Infection | 6 | 26.1% |
Public health | 6 | 26.1% |
Angiology | 5 | 21.7% |
Anticoagulant | 5 | 21.7% |
Atrial fibrillation | 5 | 21.7% |
Cardiology | 5 | 21.7% |
Cardiovascular diseases | 5 | 21.7% |
Cardioversion | 5 | 21.7% |
Circulatory system | 5 | 21.7% |
Epidemiology | 5 | 21.7% |
Health economics | 5 | 21.7% |
Heart | 5 | 21.7% |
Heart failure | 5 | 21.7% |
Internal medicine | 5 | 21.7% |
Physiology | 5 | 21.7% |
RTT | 5 | 21.7% |
Research | 5 | 21.7% |
Ventricular fibrillation | 5 | 21.7% |
Atrium (heart) | 4 | 17.4% |
Beta blocker | 4 | 17.4% |
Cancer | 4 | 17.4% |
Cardiovascular physiology | 4 | 17.4% |
Chronic condition | 4 | 17.4% |
Coronary artery disease | 4 | 17.4% |
Digoxin | 4 | 17.4% |
Heart diseases | 4 | 17.4% |
Heart rate | 4 | 17.4% |
Hospital | 4 | 17.4% |
Management of atrial fibrillation | 4 | 17.4% |
Medication | 4 | 17.4% |
Stroke | 4 | 17.4% |
Amiodarone | 3 | 13.0% |
Antiarrhythmic agent | 3 | 13.0% |
Arrhythmia | 3 | 13.0% |
Cardiac electrophysiology | 3 | 13.0% |
Cardiovascular disease | 3 | 13.0% |
Clinical trial | 3 | 13.0% |
Evaluation | 3 | 13.0% |
Evidence-based medicine | 3 | 13.0% |
Flecainide | 3 | 13.0% |
Health policy | 3 | 13.0% |
Medical humanities | 3 | 13.0% |
Randomized controlled trial | 3 | 13.0% |
Science | 3 | 13.0% |
Systematic review | 3 | 13.0% |
Warfarin | 3 | 13.0% |
Agriculture | 2 | 8.7% |
Aspirin | 2 | 8.7% |
Atrial flutter | 2 | 8.7% |
Bioethics | 2 | 8.7% |
Biology | 2 | 8.7% |
Biotechnology | 2 | 8.7% |
Bioterrorism | 2 | 8.7% |
Breast cancer | 2 | 8.7% |
Calcium channel blocker | 2 | 8.7% |
Cardiac surgery | 2 | 8.7% |
Cardiopulmonary bypass | 2 | 8.7% |
Caregiver | 2 | 8.7% |
Chemistry | 2 | 8.7% |
Clinical engineering | 2 | 8.7% |
Colorectal cancer | 2 | 8.7% |
Diltiazem | 2 | 8.7% |
Genetics | 2 | 8.7% |
HIV/AIDS | 2 | 8.7% |
Health insurance | 2 | 8.7% |
Human reproduction | 2 | 8.7% |
Immunology | 2 | 8.7% |
Infectious diseases | 2 | 8.7% |
Influenza | 2 | 8.7% |
Insurance | 2 | 8.7% |
Life sciences | 2 | 8.7% |
Major depressive disorder | 2 | 8.7% |
Mental disorder | 2 | 8.7% |
Meta-analysis | 2 | 8.7% |
Nanotechnology | 2 | 8.7% |
Occupational safety and health | 2 | 8.7% |
Patent | 2 | 8.7% |
Patient | 2 | 8.7% |
Percutaneous coronary intervention | 2 | 8.7% |
Physician | 2 | 8.7% |
Primary care | 2 | 8.7% |
Protein | 2 | 8.7% |
Prothrombin time | 2 | 8.7% |
Public health genomics | 2 | 8.7% |
Risk assessment | 2 | 8.7% |
Risk management | 2 | 8.7% |
Screening (medicine) | 2 | 8.7% |
Selective serotonin reuptake inhibitor | 2 | 8.7% |
Sensitivity and specificity | 2 | 8.7% |
Sexually transmitted infection | 2 | 8.7% |
Sodium channel blocker | 2 | 8.7% |
Sotalol | 2 | 8.7% |
Technology | 2 | 8.7% |
Transient ischemic attack | 2 | 8.7% |
Tuberculosis | 2 | 8.7% |
Vaccine | 2 | 8.7% |
Validity (statistics) | 2 | 8.7% |
Valvular heart disease | 2 | 8.7% |
Venous thrombosis | 2 | 8.7% |
Accounting | 1 | 4.3% |
Accuracy and precision | 1 | 4.3% |
Aciclovir | 1 | 4.3% |
Active ingredient | 1 | 4.3% |
Acute kidney injury | 1 | 4.3% |
Acute radiation syndrome | 1 | 4.3% |
Adherence (medicine) | 1 | 4.3% |
Adolescence | 1 | 4.3% |
Alien (law) | 1 | 4.3% |
Allergen | 1 | 4.3% |
Allergology | 1 | 4.3% |
Allergy | 1 | 4.3% |
Anaphylaxis | 1 | 4.3% |
Anthrax | 1 | 4.3% |
Anthropogenic hazard | 1 | 4.3% |
Antibiotic | 1 | 4.3% |
Antidepressant | 1 | 4.3% |
Antimicrobial resistance | 1 | 4.3% |
Antiplatelet drug | 1 | 4.3% |
Anxiety | 1 | 4.3% |
Applied and interdisciplinary physics | 1 | 4.3% |
Appropriations bill (United States) | 1 | 4.3% |
Atomic force microscopy | 1 | 4.3% |
Atopic dermatitis | 1 | 4.3% |
Atopy | 1 | 4.3% |
Audit | 1 | 4.3% |
Audit committee | 1 | 4.3% |
Auditor's report | 1 | 4.3% |
Autism | 1 | 4.3% |
Autonomy | 1 | 4.3% |
Avian influenza | 1 | 4.3% |
Azithromycin | 1 | 4.3% |
BRCA mutation | 1 | 4.3% |
Bacillus thuringiensis | 1 | 4.3% |
Bacteria | 1 | 4.3% |
Basmati | 1 | 4.3% |
Biodiversity | 1 | 4.3% |
Bioinformatics | 1 | 4.3% |
Biomedical engineering | 1 | 4.3% |
Biomedicine | 1 | 4.3% |
Birth defect | 1 | 4.3% |
Bleeding | 1 | 4.3% |
Bradycardia | 1 | 4.3% |
Branches of science | 1 | 4.3% |
Breastfeeding | 1 | 4.3% |
Breed | 1 | 4.3% |
Buckminsterfullerene | 1 | 4.3% |
Business | 1 | 4.3% |
Caenorhabditis elegans | 1 | 4.3% |
Candidiasis | 1 | 4.3% |
Carbon | 1 | 4.3% |
Carbon nanotube | 1 | 4.3% |
Cardiopulmonary resuscitation | 1 | 4.3% |
Cell (biology) | 1 | 4.3% |
Certification | 1 | 4.3% |
Cervicitis | 1 | 4.3% |
Chemotherapy | 1 | 4.3% |
Child | 1 | 4.3% |
Chlamydia infection | 1 | 4.3% |
Chlamydia trachomatis | 1 | 4.3% |
Chronic kidney disease | 1 | 4.3% |
Chronic obstructive pulmonary disease | 1 | 4.3% |
Citizenship | 1 | 4.3% |
Citizenship of the United States | 1 | 4.3% |
Climate change | 1 | 4.3% |
Clinical governance | 1 | 4.3% |
Cloning | 1 | 4.3% |
Clopidogrel | 1 | 4.3% |
Cogeneration | 1 | 4.3% |
Community health | 1 | 4.3% |
Competition (economics) | 1 | 4.3% |
Competition law | 1 | 4.3% |
Conservation biology | 1 | 4.3% |
Convention on Biological Diversity | 1 | 4.3% |
Coronary artery bypass surgery | 1 | 4.3% |
Cost-effectiveness analysis | 1 | 4.3% |
Cyberattack | 1 | 4.3% |
DNA | 1 | 4.3% |
DNA profiling | 1 | 4.3% |
DNA sequencing | 1 | 4.3% |
Data anonymization | 1 | 4.3% |
Defibrillation | 1 | 4.3% |
Depression (mood) | 1 | 4.3% |
Dermatitis | 1 | 4.3% |
Developmental psychology | 1 | 4.3% |
Diabetes | 1 | 4.3% |
Diagnosis of HIV/AIDS | 1 | 4.3% |
Dialysis | 1 | 4.3% |
Dirty bomb | 1 | 4.3% |
Disability | 1 | 4.3% |
Disaster response | 1 | 4.3% |
Disease surveillance | 1 | 4.3% |
Disproportionate share hospital | 1 | 4.3% |
Doctor of Philosophy | 1 | 4.3% |
Dolly (sheep) | 1 | 4.3% |
Dose (biochemistry) | 1 | 4.3% |
Dosimetry | 1 | 4.3% |
Drugs | 1 | 4.3% |
EPSDT | 1 | 4.3% |
Earthquake | 1 | 4.3% |
Echocardiography | 1 | 4.3% |
Economy | 1 | 4.3% |
Ectopic pregnancy | 1 | 4.3% |
Education | 1 | 4.3% |
Educational assessment | 1 | 4.3% |
Electrocardiography | 1 | 4.3% |
Electron microscope | 1 | 4.3% |
Elimination diet | 1 | 4.3% |
Emergency department | 1 | 4.3% |
Emergency management | 1 | 4.3% |
Emergency medical services | 1 | 4.3% |
Emergency medical technician | 1 | 4.3% |
Emergency medicine | 1 | 4.3% |
Emerging technologies | 1 | 4.3% |
Employment | 1 | 4.3% |
Encryption | 1 | 4.3% |
Endangered species | 1 | 4.3% |
Engineering | 1 | 4.3% |
Epidemic | 1 | 4.3% |
Ethics | 1 | 4.3% |
Evolution | 1 | 4.3% |
Extensively drug-resistant tuberculosis | 1 | 4.3% |
Extinction | 1 | 4.3% |
Fallopian tube | 1 | 4.3% |
Familial adenomatous polyposis | 1 | 4.3% |
Fee-for-service | 1 | 4.3% |
Financial audit | 1 | 4.3% |
Financial statement | 1 | 4.3% |
Flood | 1 | 4.3% |
Fluconazole | 1 | 4.3% |
Folate | 1 | 4.3% |
Food allergy | 1 | 4.3% |
Food and drink | 1 | 4.3% |
Food intolerance | 1 | 4.3% |
Food security | 1 | 4.3% |
Fullerene | 1 | 4.3% |
Funnel plot | 1 | 4.3% |
Gene | 1 | 4.3% |
Genealogy | 1 | 4.3% |
Genetic engineering | 1 | 4.3% |
Genetic resources | 1 | 4.3% |
Genetic testing | 1 | 4.3% |
Genetically modified crops | 1 | 4.3% |
Genetically modified organism | 1 | 4.3% |
Gene–environment interaction | 1 | 4.3% |
Genome | 1 | 4.3% |
Genomics | 1 | 4.3% |
Genotype | 1 | 4.3% |
Global health | 1 | 4.3% |
Globalization | 1 | 4.3% |
Goal | 1 | 4.3% |
Gonorrhea | 1 | 4.3% |
Governance | 1 | 4.3% |
Government | 1 | 4.3% |
Government aid programs | 1 | 4.3% |
Green card | 1 | 4.3% |
Gynaecology | 1 | 4.3% |
HEPA | 1 | 4.3% |
Hazard | 1 | 4.3% |
Health insurance coverage in the United States | 1 | 4.3% |
Health insurance in the United States | 1 | 4.3% |
Health professional | 1 | 4.3% |
Health promotion | 1 | 4.3% |
Hemodialysis | 1 | 4.3% |
Hemofiltration | 1 | 4.3% |
Hepatitis | 1 | 4.3% |
Hepatitis B | 1 | 4.3% |
Hepatitis B vaccine | 1 | 4.3% |
Hereditary nonpolyposis colorectal cancer | 1 | 4.3% |
High-resolution transmission electron microscopy | 1 | 4.3% |
History | 1 | 4.3% |
Hospice care in the United States | 1 | 4.3% |
Human cloning | 1 | 4.3% |
Human decontamination | 1 | 4.3% |
Human female reproductive system | 1 | 4.3% |
Hypertension | 1 | 4.3% |
Hypothermia | 1 | 4.3% |
Immunoglobulin E | 1 | 4.3% |
Impact factor | 1 | 4.3% |
Incident Command System | 1 | 4.3% |
Incident management | 1 | 4.3% |
Infertility | 1 | 4.3% |
Influenza A virus subtype H5N1 | 1 | 4.3% |
Influenza pandemic | 1 | 4.3% |
Influenza vaccine | 1 | 4.3% |
Information | 1 | 4.3% |
Innovation | 1 | 4.3% |
Intellectual property | 1 | 4.3% |
Intensive care medicine | 1 | 4.3% |
Intensive care unit | 1 | 4.3% |
Internal audit | 1 | 4.3% |
Internal control | 1 | 4.3% |
Ionizing radiation | 1 | 4.3% |
Ischemia | 1 | 4.3% |
Isolation (health care) | 1 | 4.3% |
Kidney | 1 | 4.3% |
Kidney failure | 1 | 4.3% |
Knowledge | 1 | 4.3% |
Lead poisoning | 1 | 4.3% |
Life expectancy | 1 | 4.3% |
Li–Fraumeni syndrome | 1 | 4.3% |
Long QT syndrome | 1 | 4.3% |
Maize | 1 | 4.3% |
Major trauma | 1 | 4.3% |
Managed care | 1 | 4.3% |
Management | 1 | 4.3% |
Manufacturing | 1 | 4.3% |
Mass-casualty incident | 1 | 4.3% |
Materials | 1 | 4.3% |
Materials science | 1 | 4.3% |
Measles | 1 | 4.3% |
Medicaid | 1 | 4.3% |
Medical diagnosis | 1 | 4.3% |
Medical history | 1 | 4.3% |
Medical prescription | 1 | 4.3% |
Medical record | 1 | 4.3% |
Medical treatments | 1 | 4.3% |
Medicare (United States) | 1 | 4.3% |
Meningococcal disease | 1 | 4.3% |
Mental health | 1 | 4.3% |
Mergers and acquisitions | 1 | 4.3% |
Methicillin-resistant Staphylococcus aureus | 1 | 4.3% |
Methylenetetrahydrofolate reductase | 1 | 4.3% |
Metronidazole | 1 | 4.3% |
Microbiology | 1 | 4.3% |
Microscope | 1 | 4.3% |
Milk | 1 | 4.3% |
Milk allergy | 1 | 4.3% |
Molecule | 1 | 4.3% |
Myocardial infarction | 1 | 4.3% |
NHS foundation trust | 1 | 4.3% |
Nanoelectronics | 1 | 4.3% |
Nanomaterials | 1 | 4.3% |
Nanometrology | 1 | 4.3% |
Nanoparticle | 1 | 4.3% |
Nanowire | 1 | 4.3% |
Natural disaster | 1 | 4.3% |
Natural environment | 1 | 4.3% |
Neisseria meningitidis | 1 | 4.3% |
Nephrology | 1 | 4.3% |
Newborn screening | 1 | 4.3% |
Non-executive director | 1 | 4.3% |
Nontuberculous mycobacteria | 1 | 4.3% |
Nursing | 1 | 4.3% |
Oncology | 1 | 4.3% |
Optical tweezers | 1 | 4.3% |
Organic farming | 1 | 4.3% |
Organisms | 1 | 4.3% |
Ovarian cancer | 1 | 4.3% |
Paper | 1 | 4.3% |
Peanut allergy | 1 | 4.3% |
Pediatrics | 1 | 4.3% |
Pelvic inflammatory disease | 1 | 4.3% |
Personal protective equipment | 1 | 4.3% |
Pharmacy | 1 | 4.3% |
Phenotype | 1 | 4.3% |
Photolithography | 1 | 4.3% |
Physical sciences | 1 | 4.3% |
Physical therapy | 1 | 4.3% |
Plant breeding | 1 | 4.3% |
Posttraumatic stress disorder | 1 | 4.3% |
Poverty | 1 | 4.3% |
Precautionary principle | 1 | 4.3% |
Progress | 1 | 4.3% |
Prostate cancer | 1 | 4.3% |
Proteomics | 1 | 4.3% |
Prucol | 1 | 4.3% |
Psychiatry | 1 | 4.3% |
Psychological trauma | 1 | 4.3% |
Psychology | 1 | 4.3% |
Public sphere | 1 | 4.3% |
Publication bias | 1 | 4.3% |
Quality-adjusted life year | 1 | 4.3% |
Quantum dot | 1 | 4.3% |
Quarantine | 1 | 4.3% |
Quinidine | 1 | 4.3% |
Radiation | 1 | 4.3% |
Radiation therapy | 1 | 4.3% |
Radioactive contamination | 1 | 4.3% |
Radioallergosorbent test | 1 | 4.3% |
Radiobiology | 1 | 4.3% |
Recovery approach | 1 | 4.3% |
Research and development | 1 | 4.3% |
Respirator | 1 | 4.3% |
Rice | 1 | 4.3% |
Richter magnitude scale | 1 | 4.3% |
Safety | 1 | 4.3% |
Scanning electron microscope | 1 | 4.3% |
Scanning probe microscopy | 1 | 4.3% |
Scanning tunneling microscope | 1 | 4.3% |
Self-assembly | 1 | 4.3% |
Self-employment | 1 | 4.3% |
Separation anxiety disorder | 1 | 4.3% |
Services sector of the economy | 1 | 4.3% |
Severe combined immunodeficiency | 1 | 4.3% |
Severe weather | 1 | 4.3% |
Shock (circulatory) | 1 | 4.3% |
Single-nucleotide polymorphism | 1 | 4.3% |
Skin allergy test | 1 | 4.3% |
Social Security number | 1 | 4.3% |
Social work | 1 | 4.3% |
Soy allergy | 1 | 4.3% |
Species | 1 | 4.3% |
Statistics | 1 | 4.3% |
Supplemental Security Income | 1 | 4.3% |
Surgery | 1 | 4.3% |
Syphilis | 1 | 4.3% |
System | 1 | 4.3% |
Tachycardia | 1 | 4.3% |
Therapy | 1 | 4.3% |
Thin film | 1 | 4.3% |
Thrombosis prevention | 1 | 4.3% |
Top-down and bottom-up design | 1 | 4.3% |
Torsades de pointes | 1 | 4.3% |
Tracheal intubation | 1 | 4.3% |
Transmission electron microscopy | 1 | 4.3% |
Triage | 1 | 4.3% |
Tropical cyclone | 1 | 4.3% |
Trust law | 1 | 4.3% |
Tsunami | 1 | 4.3% |
Tuberculosis management | 1 | 4.3% |
Unemployment benefits | 1 | 4.3% |
University | 1 | 4.3% |
VKORC1 | 1 | 4.3% |
Vaccination | 1 | 4.3% |
Vagina | 1 | 4.3% |
Vaginitis | 1 | 4.3% |
Value (ethics) | 1 | 4.3% |
Ventricular assist device | 1 | 4.3% |
Verapamil | 1 | 4.3% |
Virus | 1 | 4.3% |
Vital signs | 1 | 4.3% |
Water | 1 | 4.3% |
Welfare | 1 | 4.3% |
Wildfire | 1 | 4.3% |
Wind | 1 | 4.3% |
Wolff–Parkinson–White syndrome | 1 | 4.3% |
Women's health | 1 | 4.3% |
abs | rel | |
---|---|---|
Health | 16 | 84.2% |
Health sciences | 15 | 78.9% |
Medicine | 14 | 73.7% |
Health care | 11 | 57.9% |
Medical specialties | 11 | 57.9% |
Clinical medicine | 10 | 52.6% |
Public health | 10 | 52.6% |
Human activities | 7 | 36.8% |
Risk | 5 | 26.3% |
Disease | 4 | 21.1% |
Diseases and disorders | 4 | 21.1% |
Epidemiology | 4 | 21.1% |
Infection | 4 | 21.1% |
Medication | 4 | 21.1% |
Pharmacy | 4 | 21.1% |
Safety | 4 | 21.1% |
Angiology | 3 | 15.8% |
Biology | 3 | 15.8% |
Cardiology | 3 | 15.8% |
Cardiovascular system | 3 | 15.8% |
Clinical trial | 3 | 15.8% |
Evaluation | 3 | 15.8% |
HIV/AIDS | 3 | 15.8% |
Health care quality | 3 | 15.8% |
Health economics | 3 | 15.8% |
Heart | 3 | 15.8% |
Hospital | 3 | 15.8% |
Immunology | 3 | 15.8% |
Internal medicine | 3 | 15.8% |
Medicare (United States) | 3 | 15.8% |
Patient safety | 3 | 15.8% |
Research | 3 | 15.8% |
Risk management | 3 | 15.8% |
Sexually transmitted infection | 3 | 15.8% |
Adverse effect | 2 | 10.5% |
Angina | 2 | 10.5% |
Blood transfusion | 2 | 10.5% |
Cardiovascular diseases | 2 | 10.5% |
Childbirth | 2 | 10.5% |
Chronic condition | 2 | 10.5% |
Condom | 2 | 10.5% |
Coronary artery disease | 2 | 10.5% |
Death | 2 | 10.5% |
Diagnosis of HIV/AIDS | 2 | 10.5% |
Diarrhea | 2 | 10.5% |
Employment | 2 | 10.5% |
Federal Food, Drug, and Cosmetic Act | 2 | 10.5% |
Food | 2 | 10.5% |
Food safety | 2 | 10.5% |
Generic drug | 2 | 10.5% |
Health policy | 2 | 10.5% |
Health professional | 2 | 10.5% |
Infectious diseases | 2 | 10.5% |
Influenza | 2 | 10.5% |
Influenza pandemic | 2 | 10.5% |
Life sciences | 2 | 10.5% |
Medical error | 2 | 10.5% |
Medical humanities | 2 | 10.5% |
Medical record | 2 | 10.5% |
Methicillin-resistant Staphylococcus aureus | 2 | 10.5% |
Microbiology | 2 | 10.5% |
Myocardial infarction | 2 | 10.5% |
Nursing | 2 | 10.5% |
Patient | 2 | 10.5% |
Patient safety organization | 2 | 10.5% |
Physician | 2 | 10.5% |
Pneumonia | 2 | 10.5% |
Prescription drug | 2 | 10.5% |
Prevention of HIV/AIDS | 2 | 10.5% |
Preventive healthcare | 2 | 10.5% |
Public sphere | 2 | 10.5% |
Safe sex | 2 | 10.5% |
Science | 2 | 10.5% |
Sexual intercourse | 2 | 10.5% |
Surgery | 2 | 10.5% |
Systematic review | 2 | 10.5% |
Verification and validation | 2 | 10.5% |
Abbreviated New Drug Application | 1 | 5.3% |
Abortion | 1 | 5.3% |
Acute coronary syndrome | 1 | 5.3% |
Adherence (medicine) | 1 | 5.3% |
Adverse event | 1 | 5.3% |
Anabolic steroid | 1 | 5.3% |
Anesthesia | 1 | 5.3% |
Anthrax | 1 | 5.3% |
Aortic insufficiency | 1 | 5.3% |
Aortic stenosis | 1 | 5.3% |
Aortic valve | 1 | 5.3% |
Aortic valve replacement | 1 | 5.3% |
Appeal | 1 | 5.3% |
Appropriations bill (United States) | 1 | 5.3% |
Artificial intelligence | 1 | 5.3% |
Asthma | 1 | 5.3% |
Atrium (heart) | 1 | 5.3% |
Avian influenza | 1 | 5.3% |
Background check | 1 | 5.3% |
Bill Clinton | 1 | 5.3% |
Bionics | 1 | 5.3% |
Biotechnology | 1 | 5.3% |
Birthing center | 1 | 5.3% |
Bisphenol A | 1 | 5.3% |
Blood donation | 1 | 5.3% |
Blood substitute | 1 | 5.3% |
Boldenone | 1 | 5.3% |
Bone | 1 | 5.3% |
Bone density | 1 | 5.3% |
Booster dose | 1 | 5.3% |
Botulism | 1 | 5.3% |
Breast milk | 1 | 5.3% |
Breastfeeding | 1 | 5.3% |
Breastfeeding and HIV | 1 | 5.3% |
Bundled payment | 1 | 5.3% |
CE marking | 1 | 5.3% |
Capitation (healthcare) | 1 | 5.3% |
Cardiac marker | 1 | 5.3% |
Cardiothoracic surgery | 1 | 5.3% |
Cardiovascular disease | 1 | 5.3% |
Causality | 1 | 5.3% |
Cholesterol | 1 | 5.3% |
Chronic obstructive pulmonary disease | 1 | 5.3% |
Circulatory system | 1 | 5.3% |
Coccidioidomycosis | 1 | 5.3% |
Cognition | 1 | 5.3% |
Cognitive science | 1 | 5.3% |
Community | 1 | 5.3% |
Comorbidity | 1 | 5.3% |
Complete blood count | 1 | 5.3% |
Complication (medicine) | 1 | 5.3% |
Compounding | 1 | 5.3% |
Congenital heart defect | 1 | 5.3% |
Consent | 1 | 5.3% |
Continuing resolution | 1 | 5.3% |
Copyright | 1 | 5.3% |
Counseling psychology | 1 | 5.3% |
Credit | 1 | 5.3% |
Criminal record | 1 | 5.3% |
Culture | 1 | 5.3% |
DPT vaccine | 1 | 5.3% |
DTaP-IPV/Hib vaccine | 1 | 5.3% |
Data | 1 | 5.3% |
Data analysis | 1 | 5.3% |
Decision-making | 1 | 5.3% |
Deep vein thrombosis | 1 | 5.3% |
Definition | 1 | 5.3% |
Diagnosis-related group | 1 | 5.3% |
Diastole | 1 | 5.3% |
Disability | 1 | 5.3% |
Discourse | 1 | 5.3% |
Dose (biochemistry) | 1 | 5.3% |
Drug | 1 | 5.3% |
Drugs | 1 | 5.3% |
Economics of service industries | 1 | 5.3% |
Education | 1 | 5.3% |
Electronic health record | 1 | 5.3% |
Emergence | 1 | 5.3% |
Emergency department | 1 | 5.3% |
Encephalitis | 1 | 5.3% |
Endocrine system | 1 | 5.3% |
Endocrinology | 1 | 5.3% |
Endovascular aneurysm repair | 1 | 5.3% |
Error | 1 | 5.3% |
Erythropoietin | 1 | 5.3% |
Ethics | 1 | 5.3% |
Evidence-based medicine | 1 | 5.3% |
Exercise-induced pulmonary hemorrhage | 1 | 5.3% |
Expert | 1 | 5.3% |
FDA warning letter | 1 | 5.3% |
Failure mode and effects analysis | 1 | 5.3% |
Familial hypercholesterolemia | 1 | 5.3% |
Family planning | 1 | 5.3% |
Fee-for-service | 1 | 5.3% |
Food and Drug Administration Amendments Act of 2007 | 1 | 5.3% |
Food defense | 1 | 5.3% |
Foodborne illness | 1 | 5.3% |
Furosemide | 1 | 5.3% |
Geisteswissenschaft | 1 | 5.3% |
Good manufacturing practice | 1 | 5.3% |
Governance | 1 | 5.3% |
Government | 1 | 5.3% |
HIV | 1 | 5.3% |
Hay | 1 | 5.3% |
Health care industry | 1 | 5.3% |
Health information technology | 1 | 5.3% |
Health maintenance organization | 1 | 5.3% |
Health system | 1 | 5.3% |
Health technology in the United States | 1 | 5.3% |
Healthcare reform in the United States | 1 | 5.3% |
Heart valve | 1 | 5.3% |
Heparin | 1 | 5.3% |
Hib vaccine | 1 | 5.3% |
Hindsight bias | 1 | 5.3% |
Home care | 1 | 5.3% |
Hormone replacement therapy | 1 | 5.3% |
Horse trainer | 1 | 5.3% |
Hospital-acquired infection | 1 | 5.3% |
Hospital-acquired pneumonia | 1 | 5.3% |
Human | 1 | 5.3% |
Human reproduction | 1 | 5.3% |
Human rights | 1 | 5.3% |
Hypercholesterolemia | 1 | 5.3% |
Hypertension | 1 | 5.3% |
Hypodermic needle | 1 | 5.3% |
Hypoxia (medical) | 1 | 5.3% |
Iatrogenesis | 1 | 5.3% |
Immunization | 1 | 5.3% |
Infant | 1 | 5.3% |
Infant formula | 1 | 5.3% |
Infection control | 1 | 5.3% |
Influenza A virus | 1 | 5.3% |
Influenza A virus subtype H1N1 | 1 | 5.3% |
Influenza A virus subtype H3N2 | 1 | 5.3% |
Influenza A virus subtype H5N1 | 1 | 5.3% |
Influenza treatment | 1 | 5.3% |
Influenza-like illness | 1 | 5.3% |
Injection (medicine) | 1 | 5.3% |
Innovation | 1 | 5.3% |
Inspection | 1 | 5.3% |
Insurance | 1 | 5.3% |
Intelligence | 1 | 5.3% |
Intensive care medicine | 1 | 5.3% |
Intensive care unit | 1 | 5.3% |
Intention | 1 | 5.3% |
Internal control | 1 | 5.3% |
International Statistical Classification of Diseases and Related Health Problems | 1 | 5.3% |
Intramuscular injection | 1 | 5.3% |
Ischemia | 1 | 5.3% |
Jürgen Habermas | 1 | 5.3% |
Listeriosis | 1 | 5.3% |
MEDLINE | 1 | 5.3% |
Magnetic resonance imaging | 1 | 5.3% |
Malaria | 1 | 5.3% |
Managed care | 1 | 5.3% |
Management | 1 | 5.3% |
Medical Subject Headings | 1 | 5.3% |
Medical device | 1 | 5.3% |
Medical diagnosis | 1 | 5.3% |
Medical home | 1 | 5.3% |
Medical prescription | 1 | 5.3% |
Medicare Sustainable Growth Rate | 1 | 5.3% |
Men who have sex with men | 1 | 5.3% |
Menopause | 1 | 5.3% |
Metabolic disorders | 1 | 5.3% |
Musculoskeletal system | 1 | 5.3% |
Nandrolone | 1 | 5.3% |
Nanotechnology | 1 | 5.3% |
Natural reservoir | 1 | 5.3% |
Natural science | 1 | 5.3% |
Nature | 1 | 5.3% |
Neuroenhancement | 1 | 5.3% |
Neuroethics | 1 | 5.3% |
Neuroscience | 1 | 5.3% |
Non-governmental organization | 1 | 5.3% |
Norovirus | 1 | 5.3% |
Number needed to treat | 1 | 5.3% |
Nursing home care | 1 | 5.3% |
Organic farming | 1 | 5.3% |
Organization | 1 | 5.3% |
Osteoporosis | 1 | 5.3% |
Parent | 1 | 5.3% |
Pay for performance (healthcare) | 1 | 5.3% |
Pediatrics | 1 | 5.3% |
Percutaneous aortic valve replacement | 1 | 5.3% |
Pericardial heart valves | 1 | 5.3% |
Pharmaceutical sciences | 1 | 5.3% |
Pharmacology | 1 | 5.3% |
Pharmacovigilance | 1 | 5.3% |
Philosophy | 1 | 5.3% |
Philosophy of science | 1 | 5.3% |
Physics | 1 | 5.3% |
Pneumococcal conjugate vaccine | 1 | 5.3% |
Pneumococcal vaccine | 1 | 5.3% |
Point of care | 1 | 5.3% |
Point-of-care testing | 1 | 5.3% |
Policy | 1 | 5.3% |
Polio vaccine | 1 | 5.3% |
Politics | 1 | 5.3% |
Positive and negative predictive values | 1 | 5.3% |
Pregnancy | 1 | 5.3% |
Pressure ulcer | 1 | 5.3% |
Preventive medicine | 1 | 5.3% |
Protocol (science) | 1 | 5.3% |
Psychotherapy | 1 | 5.3% |
Public health surveillance | 1 | 5.3% |
Pulmonary embolism | 1 | 5.3% |
Qualitative research | 1 | 5.3% |
Question | 1 | 5.3% |
Randomized controlled trial | 1 | 5.3% |
Regulatory compliance | 1 | 5.3% |
Reinsurance | 1 | 5.3% |
Reliability (statistics) | 1 | 5.3% |
Residency (medicine) | 1 | 5.3% |
Resource-based relative value scale | 1 | 5.3% |
Rift Valley fever | 1 | 5.3% |
Risk assessment | 1 | 5.3% |
Robotics | 1 | 5.3% |
Rotavirus vaccine | 1 | 5.3% |
Science and technology | 1 | 5.3% |
Science fiction | 1 | 5.3% |
Self-disclosure | 1 | 5.3% |
Sensitivity and specificity | 1 | 5.3% |
Sepsis | 1 | 5.3% |
Sex worker | 1 | 5.3% |
Social science | 1 | 5.3% |
Stanozolol | 1 | 5.3% |
Staphylococcus aureus | 1 | 5.3% |
Statin | 1 | 5.3% |
Statistical classification | 1 | 5.3% |
Stem cell | 1 | 5.3% |
Subcutaneous injection | 1 | 5.3% |
Surveillance | 1 | 5.3% |
Swine influenza | 1 | 5.3% |
Synergy | 1 | 5.3% |
Synthetic biology | 1 | 5.3% |
System | 1 | 5.3% |
Teacher | 1 | 5.3% |
Technology assessment | 1 | 5.3% |
Tetralogy of Fallot | 1 | 5.3% |
Thiamine deficiency | 1 | 5.3% |
Thorax (human anatomy) | 1 | 5.3% |
Thrombosis | 1 | 5.3% |
Tobacco smoking | 1 | 5.3% |
Toxic shock syndrome | 1 | 5.3% |
Transdisciplinarity | 1 | 5.3% |
Transhumanism | 1 | 5.3% |
Treaty of Lisbon | 1 | 5.3% |
Trimethoprim/sulfamethoxazole | 1 | 5.3% |
Troponin | 1 | 5.3% |
Truck driver | 1 | 5.3% |
Trust law | 1 | 5.3% |
Trustee | 1 | 5.3% |
Tuberculosis | 1 | 5.3% |
Ulcer (dermatology) | 1 | 5.3% |
Unstable angina | 1 | 5.3% |
Vaccination | 1 | 5.3% |
Vaccine | 1 | 5.3% |
Vaccines | 1 | 5.3% |
Valvular heart disease | 1 | 5.3% |
Vehicle emission standard | 1 | 5.3% |
Vein | 1 | 5.3% |
Venous thrombosis | 1 | 5.3% |
Ventilator-associated pneumonia | 1 | 5.3% |
Ventricle (heart) | 1 | 5.3% |
Vibrio | 1 | 5.3% |
Virus | 1 | 5.3% |
Vision (spirituality) | 1 | 5.3% |
Waste | 1 | 5.3% |
Wissenschaft | 1 | 5.3% |
Working group | 1 | 5.3% |
World view | 1 | 5.3% |
Wound | 1 | 5.3% |
Zoonosis | 1 | 5.3% |
abs | rel | |
---|---|---|
Health | 25 | 92.6% |
Health sciences | 24 | 88.9% |
Medicine | 24 | 88.9% |
Health care | 22 | 81.5% |
Medical specialties | 22 | 81.5% |
Clinical medicine | 20 | 74.1% |
Public health | 12 | 44.4% |
Disease | 9 | 33.3% |
Diseases and disorders | 8 | 29.6% |
Epidemiology | 8 | 29.6% |
Human activities | 7 | 25.9% |
Hospital | 6 | 22.2% |
Medication | 6 | 22.2% |
Patient | 6 | 22.2% |
Preventive healthcare | 6 | 22.2% |
Risk | 6 | 22.2% |
Vaccine | 6 | 22.2% |
Cardiovascular disease | 5 | 18.5% |
Chronic condition | 5 | 18.5% |
Emergency department | 5 | 18.5% |
Influenza | 5 | 18.5% |
Nursing | 5 | 18.5% |
Research | 5 | 18.5% |
Screening (medicine) | 5 | 18.5% |
Biology | 4 | 14.8% |
Cancer | 4 | 14.8% |
Cardiovascular system | 4 | 14.8% |
Coronary artery disease | 4 | 14.8% |
Exercise | 4 | 14.8% |
Heart | 4 | 14.8% |
High-density lipoprotein | 4 | 14.8% |
Hypertension | 4 | 14.8% |
Infectious diseases | 4 | 14.8% |
Influenza pandemic | 4 | 14.8% |
Life sciences | 4 | 14.8% |
Medical treatments | 4 | 14.8% |
Myocardial infarction | 4 | 14.8% |
Stroke | 4 | 14.8% |
Adherence (medicine) | 3 | 11.1% |
Antiviral drug | 3 | 11.1% |
Avian influenza | 3 | 11.1% |
Cardiology | 3 | 11.1% |
Cholesterol | 3 | 11.1% |
Clinical trial | 3 | 11.1% |
Cost-effectiveness analysis | 3 | 11.1% |
HIV/AIDS | 3 | 11.1% |
Health economics | 3 | 11.1% |
Health policy | 3 | 11.1% |
Health professional | 3 | 11.1% |
Immunology | 3 | 11.1% |
Infection | 3 | 11.1% |
Influenza A virus subtype H5N1 | 3 | 11.1% |
Internal medicine | 3 | 11.1% |
Low-density lipoprotein | 3 | 11.1% |
Medical humanities | 3 | 11.1% |
Microbiology | 3 | 11.1% |
Obesity | 3 | 11.1% |
Oseltamivir | 3 | 11.1% |
Pharmacy | 3 | 11.1% |
Physician | 3 | 11.1% |
Public sphere | 3 | 11.1% |
Saturated fat | 3 | 11.1% |
Simulation | 3 | 11.1% |
Statin | 3 | 11.1% |
Surgery | 3 | 11.1% |
Abdominal obesity | 2 | 7.4% |
Anticoagulant | 2 | 7.4% |
Antihypertensive drug | 2 | 7.4% |
Antimicrobial resistance | 2 | 7.4% |
Apolipoprotein B | 2 | 7.4% |
Atrial fibrillation | 2 | 7.4% |
Biotechnology | 2 | 7.4% |
Body mass index | 2 | 7.4% |
C-reactive protein | 2 | 7.4% |
CHA2DS2–VASc score | 2 | 7.4% |
Cancer screening | 2 | 7.4% |
Cardiovascular diseases | 2 | 7.4% |
Childbirth | 2 | 7.4% |
Cognition | 2 | 7.4% |
Cognitive science | 2 | 7.4% |
Colonoscopy | 2 | 7.4% |
Colorectal cancer | 2 | 7.4% |
Culture | 2 | 7.4% |
Diabetes | 2 | 7.4% |
Disease surveillance | 2 | 7.4% |
Drugs | 2 | 7.4% |
Electrocardiography | 2 | 7.4% |
Electronic health record | 2 | 7.4% |
Ethics | 2 | 7.4% |
Evidence-based medicine | 2 | 7.4% |
Family medicine | 2 | 7.4% |
Fat | 2 | 7.4% |
Fecal occult blood | 2 | 7.4% |
Framingham Risk Score | 2 | 7.4% |
General practitioner | 2 | 7.4% |
Heart failure | 2 | 7.4% |
Human | 2 | 7.4% |
Hypercholesterolemia | 2 | 7.4% |
Influenza vaccine | 2 | 7.4% |
Information | 2 | 7.4% |
Lipoprotein | 2 | 7.4% |
Medical prescription | 2 | 7.4% |
Medical record | 2 | 7.4% |
Medicare (United States) | 2 | 7.4% |
Mental disorder | 2 | 7.4% |
Mental health | 2 | 7.4% |
Metabolic syndrome | 2 | 7.4% |
Pandemic | 2 | 7.4% |
Patient safety | 2 | 7.4% |
Pharmacology | 2 | 7.4% |
Polyp (medicine) | 2 | 7.4% |
Pregnancy | 2 | 7.4% |
Prescription drug | 2 | 7.4% |
Primary care | 2 | 7.4% |
Psychological concepts | 2 | 7.4% |
Psychology | 2 | 7.4% |
Randomized controlled trial | 2 | 7.4% |
Renal function | 2 | 7.4% |
Science | 2 | 7.4% |
Sensitivity analysis | 2 | 7.4% |
Sensitivity and specificity | 2 | 7.4% |
Sexually transmitted infection | 2 | 7.4% |
Statistics | 2 | 7.4% |
Stool guaiac test | 2 | 7.4% |
Systematic review | 2 | 7.4% |
Technology | 2 | 7.4% |
Therapy | 2 | 7.4% |
Virus | 2 | 7.4% |
Vitamin D | 2 | 7.4% |
Zanamivir | 2 | 7.4% |
2009 flu pandemic | 1 | 3.7% |
2009 flu pandemic vaccine | 1 | 3.7% |
68W | 1 | 3.7% |
A Cooperative Strategy for 21st Century Seapower | 1 | 3.7% |
Abortion | 1 | 3.7% |
Accounts receivable | 1 | 3.7% |
Addiction | 1 | 3.7% |
Adenoma | 1 | 3.7% |
Adiponectin | 1 | 3.7% |
Adjuvant therapy | 1 | 3.7% |
Adoption | 1 | 3.7% |
Adverse effect | 1 | 3.7% |
Adverse event | 1 | 3.7% |
Allergy | 1 | 3.7% |
Alzheimer's disease | 1 | 3.7% |
Amphetamine | 1 | 3.7% |
Angioplasty | 1 | 3.7% |
Anti-diabetic medication | 1 | 3.7% |
Antibiotic | 1 | 3.7% |
Antibody | 1 | 3.7% |
Antidepressant | 1 | 3.7% |
Antigen | 1 | 3.7% |
Antiplatelet drug | 1 | 3.7% |
Apolipoprotein | 1 | 3.7% |
Applied and interdisciplinary physics | 1 | 3.7% |
Areca nut | 1 | 3.7% |
Armed Forces Health Longitudinal Technology Application | 1 | 3.7% |
Asset | 1 | 3.7% |
Asthma | 1 | 3.7% |
Atheroma | 1 | 3.7% |
Atherosclerosis | 1 | 3.7% |
Atorvastatin | 1 | 3.7% |
Attention | 1 | 3.7% |
Attention deficit hyperactivity disorder | 1 | 3.7% |
B cell | 1 | 3.7% |
Bacteria | 1 | 3.7% |
Balance sheet | 1 | 3.7% |
Balanced scorecard | 1 | 3.7% |
Bariatric surgery | 1 | 3.7% |
Behavior | 1 | 3.7% |
Beta blocker | 1 | 3.7% |
Biodefense | 1 | 3.7% |
Biomarker | 1 | 3.7% |
Birth weight | 1 | 3.7% |
Blastocyst | 1 | 3.7% |
Brain | 1 | 3.7% |
Brain implant | 1 | 3.7% |
Brain natriuretic peptide | 1 | 3.7% |
Brain–computer interface | 1 | 3.7% |
Breast cancer | 1 | 3.7% |
Business | 1 | 3.7% |
CD20 | 1 | 3.7% |
COVID-19 pandemic | 1 | 3.7% |
CT scan | 1 | 3.7% |
Cardiac catheterization | 1 | 3.7% |
Cardiac stress test | 1 | 3.7% |
Cardiogenic shock | 1 | 3.7% |
Cardiopulmonary resuscitation | 1 | 3.7% |
Cardiothoracic surgery | 1 | 3.7% |
Central venous catheter | 1 | 3.7% |
Chemotherapy | 1 | 3.7% |
Cholecystectomy | 1 | 3.7% |
Chronic kidney disease | 1 | 3.7% |
Chronic obstructive pulmonary disease | 1 | 3.7% |
Cigarette | 1 | 3.7% |
Circulatory system | 1 | 3.7% |
Clinic | 1 | 3.7% |
Clinical commissioning group | 1 | 3.7% |
Cohort study | 1 | 3.7% |
Combat medic | 1 | 3.7% |
Combat stress reaction | 1 | 3.7% |
Communication | 1 | 3.7% |
Comprehensive Soldier and Family Fitness | 1 | 3.7% |
Concussion | 1 | 3.7% |
Consciousness | 1 | 3.7% |
Consensus decision-making | 1 | 3.7% |
Coronary artery bypass surgery | 1 | 3.7% |
Coronary stent | 1 | 3.7% |
Corps | 1 | 3.7% |
Correlation and dependence | 1 | 3.7% |
Cost–benefit analysis | 1 | 3.7% |
Cost–utility analysis | 1 | 3.7% |
Creatinine | 1 | 3.7% |
Crossing the Quality Chasm | 1 | 3.7% |
Current Procedural Terminology | 1 | 3.7% |
Cyborg | 1 | 3.7% |
Cystatin C | 1 | 3.7% |
Cytokine | 1 | 3.7% |
DICOM | 1 | 3.7% |
DNA methylation | 1 | 3.7% |
DNA microarray | 1 | 3.7% |
DNA vaccination | 1 | 3.7% |
DPT vaccine | 1 | 3.7% |
Da Vinci Surgical System | 1 | 3.7% |
Death | 1 | 3.7% |
Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury | 1 | 3.7% |
Dentist | 1 | 3.7% |
Detective quantum efficiency | 1 | 3.7% |
Determinants of health | 1 | 3.7% |
Diabetes management | 1 | 3.7% |
Diabetes mellitus | 1 | 3.7% |
Diabetes mellitus type 2 | 1 | 3.7% |
Diet (nutrition) | 1 | 3.7% |
Dietary fiber | 1 | 3.7% |
Dieting | 1 | 3.7% |
Digital radiography | 1 | 3.7% |
Disease management (health) | 1 | 3.7% |
Door-to-balloon | 1 | 3.7% |
Economy | 1 | 3.7% |
Electroencephalography | 1 | 3.7% |
Electromagnetic radiation | 1 | 3.7% |
Electronic prescribing | 1 | 3.7% |
Emergence | 1 | 3.7% |
Emergency | 1 | 3.7% |
Emergency management | 1 | 3.7% |
Emergency medical services | 1 | 3.7% |
Emotion | 1 | 3.7% |
Empiricism | 1 | 3.7% |
Epigenetics | 1 | 3.7% |
Errors and residuals | 1 | 3.7% |
Estrogen | 1 | 3.7% |
Evidence-based practice | 1 | 3.7% |
Expert | 1 | 3.7% |
Exposure (photography) | 1 | 3.7% |
Ezetimibe | 1 | 3.7% |
Fenofibrate | 1 | 3.7% |
Fetus | 1 | 3.7% |
Fibrate | 1 | 3.7% |
Flu season | 1 | 3.7% |
Fluvastatin | 1 | 3.7% |
Free will | 1 | 3.7% |
Functional magnetic resonance imaging | 1 | 3.7% |
Gastroenterology | 1 | 3.7% |
Gene | 1 | 3.7% |
Genetic disorder | 1 | 3.7% |
Gene–environment interaction | 1 | 3.7% |
Glucose tolerance test | 1 | 3.7% |
Glycated hemoglobin | 1 | 3.7% |
Goal | 1 | 3.7% |
Government budget balance | 1 | 3.7% |
HIV | 1 | 3.7% |
Health care in the United States | 1 | 3.7% |
Health care quality | 1 | 3.7% |
Health equity | 1 | 3.7% |
Health insurance coverage in the United States | 1 | 3.7% |
Health promotion | 1 | 3.7% |
Health system | 1 | 3.7% |
Health technology | 1 | 3.7% |
Health technology assessment | 1 | 3.7% |
Healthy diet | 1 | 3.7% |
Home care in the United States | 1 | 3.7% |
Human brain | 1 | 3.7% |
Human enhancement | 1 | 3.7% |
Human nutrition | 1 | 3.7% |
Humanitarian aid | 1 | 3.7% |
Hyperglycemia | 1 | 3.7% |
Hyperlipidemia | 1 | 3.7% |
Hypertriglyceridemia | 1 | 3.7% |
Hysterectomy | 1 | 3.7% |
Ideology | 1 | 3.7% |
Image noise | 1 | 3.7% |
Image segmentation | 1 | 3.7% |
Imaging | 1 | 3.7% |
Immune system | 1 | 3.7% |
Immune tolerance | 1 | 3.7% |
Immunization | 1 | 3.7% |
Incremental cost-effectiveness ratio | 1 | 3.7% |
Infection control | 1 | 3.7% |
Inflammation | 1 | 3.7% |
Inflammatory cytokine | 1 | 3.7% |
Influenza A virus subtype H1N1 | 1 | 3.7% |
Influenza A virus subtype H3N2 | 1 | 3.7% |
Innate immune system | 1 | 3.7% |
Insulin resistance | 1 | 3.7% |
Interferon | 1 | 3.7% |
Kidney disease | 1 | 3.7% |
Knowledge | 1 | 3.7% |
Laboratory | 1 | 3.7% |
Labour economics | 1 | 3.7% |
Laparoscopic radical prostatectomy | 1 | 3.7% |
Laparoscopy | 1 | 3.7% |
Liberty | 1 | 3.7% |
Linear regression | 1 | 3.7% |
Lipoprotein(a) | 1 | 3.7% |
Long-term care | 1 | 3.7% |
Lymphoma | 1 | 3.7% |
MEDLINE | 1 | 3.7% |
MMR vaccine | 1 | 3.7% |
MMRV vaccine | 1 | 3.7% |
Machine | 1 | 3.7% |
Macrophage | 1 | 3.7% |
Major depressive disorder | 1 | 3.7% |
Major trauma | 1 | 3.7% |
MammaPrint | 1 | 3.7% |
Management | 1 | 3.7% |
Mania | 1 | 3.7% |
Maternal death | 1 | 3.7% |
Maturity onset diabetes of the young | 1 | 3.7% |
Mean | 1 | 3.7% |
Medicaid | 1 | 3.7% |
Medical education | 1 | 3.7% |
Medical error | 1 | 3.7% |
Medical guideline | 1 | 3.7% |
Medical history | 1 | 3.7% |
Medical home | 1 | 3.7% |
Medical procedures | 1 | 3.7% |
Medical specialty | 1 | 3.7% |
Medical tests | 1 | 3.7% |
Medicalization | 1 | 3.7% |
Memory | 1 | 3.7% |
Methicillin-resistant Staphylococcus aureus | 1 | 3.7% |
Methylphenidate | 1 | 3.7% |
Microglia | 1 | 3.7% |
Mid-level practitioner | 1 | 3.7% |
Mind | 1 | 3.7% |
Minimally invasive procedures | 1 | 3.7% |
Modafinil | 1 | 3.7% |
Model organism | 1 | 3.7% |
Molecular biology | 1 | 3.7% |
Monoclonal antibody | 1 | 3.7% |
Nanotechnology | 1 | 3.7% |
Neisseria gonorrhoeae | 1 | 3.7% |
Nephrectomy | 1 | 3.7% |
Neuroenhancement | 1 | 3.7% |
Neuroscience | 1 | 3.7% |
Neurotechnology | 1 | 3.7% |
Niacin | 1 | 3.7% |
Non-commissioned officer | 1 | 3.7% |
Non-pharmaceutical intervention (epidemiology) | 1 | 3.7% |
Nursing home care | 1 | 3.7% |
Nutrition | 1 | 3.7% |
Optics | 1 | 3.7% |
Osteoporosis | 1 | 3.7% |
Outbreak | 1 | 3.7% |
Outpatient surgery | 1 | 3.7% |
Parkinson's disease | 1 | 3.7% |
Patient safety organization | 1 | 3.7% |
Perception | 1 | 3.7% |
Percutaneous coronary intervention | 1 | 3.7% |
Peripheral artery disease | 1 | 3.7% |
Peroxisome proliferator-activated receptor | 1 | 3.7% |
Peroxisome proliferator-activated receptor gamma | 1 | 3.7% |
Personal identity | 1 | 3.7% |
Pharmaceutical sciences | 1 | 3.7% |
Philosophy | 1 | 3.7% |
Physical fitness | 1 | 3.7% |
Physical therapy | 1 | 3.7% |
Pixel | 1 | 3.7% |
Placenta | 1 | 3.7% |
Plasmid | 1 | 3.7% |
Pneumonia | 1 | 3.7% |
Politics | 1 | 3.7% |
Polymerase chain reaction | 1 | 3.7% |
Post-exposure prophylaxis | 1 | 3.7% |
Post-traumatic growth | 1 | 3.7% |
Post-traumatic stress disorder | 1 | 3.7% |
Posthuman | 1 | 3.7% |
Posthumanism | 1 | 3.7% |
Pravastatin | 1 | 3.7% |
Prediabetes | 1 | 3.7% |
Pressure ulcer | 1 | 3.7% |
Prion | 1 | 3.7% |
Prison | 1 | 3.7% |
Projectional radiography | 1 | 3.7% |
Prostatectomy | 1 | 3.7% |
Prosthesis | 1 | 3.7% |
Psychiatry | 1 | 3.7% |
Psychological resilience | 1 | 3.7% |
Psychological trauma | 1 | 3.7% |
Puberty | 1 | 3.7% |
Quality of life (healthcare) | 1 | 3.7% |
Quality-adjusted life year | 1 | 3.7% |
Rabies | 1 | 3.7% |
Rabies vaccine | 1 | 3.7% |
Radiation | 1 | 3.7% |
Radiography | 1 | 3.7% |
Radiology | 1 | 3.7% |
Reason | 1 | 3.7% |
Recovery approach | 1 | 3.7% |
Regenerative medicine | 1 | 3.7% |
Regression analysis | 1 | 3.7% |
Reorganization plan of United States Army | 1 | 3.7% |
Reperfusion therapy | 1 | 3.7% |
Residency (medicine) | 1 | 3.7% |
Revalidation | 1 | 3.7% |
Reverse transcription polymerase chain reaction | 1 | 3.7% |
Rhinovirus | 1 | 3.7% |
Rights | 1 | 3.7% |
Risk assessment | 1 | 3.7% |
Rituximab | 1 | 3.7% |
Robot-assisted surgery | 1 | 3.7% |
Rosuvastatin | 1 | 3.7% |
Safety | 1 | 3.7% |
Science and Technology Options Assessment | 1 | 3.7% |
Scientific method | 1 | 3.7% |
Self-care | 1 | 3.7% |
Sentinel event | 1 | 3.7% |
Sepsis | 1 | 3.7% |
Serology | 1 | 3.7% |
Sheep | 1 | 3.7% |
Shock (circulatory) | 1 | 3.7% |
Sigmoidoscopy | 1 | 3.7% |
Signal-to-noise ratio | 1 | 3.7% |
Simvastatin | 1 | 3.7% |
Sleep deprivation | 1 | 3.7% |
Smoking cessation | 1 | 3.7% |
Social distancing | 1 | 3.7% |
Social programs | 1 | 3.7% |
Society | 1 | 3.7% |
Specialty Society Relative Value Scale Update Committee | 1 | 3.7% |
Species | 1 | 3.7% |
Standard error | 1 | 3.7% |
Standard score | 1 | 3.7% |
Strategy map | 1 | 3.7% |
Stress (biology) | 1 | 3.7% |
Suicide prevention | 1 | 3.7% |
Surgical procedures and techniques | 1 | 3.7% |
Surrogate endpoint | 1 | 3.7% |
Sustainability and transformation plan | 1 | 3.7% |
Swine influenza | 1 | 3.7% |
Symbol | 1 | 3.7% |
Synthetic biology | 1 | 3.7% |
T cell | 1 | 3.7% |
TCF7L2 | 1 | 3.7% |
Tamoxifen | 1 | 3.7% |
Thought | 1 | 3.7% |
Tobacco smoking | 1 | 3.7% |
Transcranial magnetic stimulation | 1 | 3.7% |
Transhumanism | 1 | 3.7% |
Transient ischemic attack | 1 | 3.7% |
Translational medicine | 1 | 3.7% |
Translational research | 1 | 3.7% |
Trauma center | 1 | 3.7% |
Traumatic brain injury | 1 | 3.7% |
Triage | 1 | 3.7% |
Triglyceride | 1 | 3.7% |
Tuberculosis | 1 | 3.7% |
Tumor microenvironment | 1 | 3.7% |
Type 1 diabetes | 1 | 3.7% |
Type 2 diabetes | 1 | 3.7% |
Urinary incontinence | 1 | 3.7% |
Urology | 1 | 3.7% |
Vaccination | 1 | 3.7% |
Vaccines for Children Program | 1 | 3.7% |
Validity (statistics) | 1 | 3.7% |
Venous thrombosis | 1 | 3.7% |
Ventricular fibrillation | 1 | 3.7% |
Veteran | 1 | 3.7% |
Virtual colonoscopy | 1 | 3.7% |
Vitamin | 1 | 3.7% |
Vitamin C | 1 | 3.7% |
WIC | 1 | 3.7% |
Warfarin | 1 | 3.7% |
Working capital | 1 | 3.7% |
X-ray | 1 | 3.7% |
abs | rel | |
---|---|---|
Health | 29 | 90.6% |
Medicine | 28 | 87.5% |
Health sciences | 26 | 81.2% |
Medical specialties | 25 | 78.1% |
Health care | 24 | 75.0% |
Clinical medicine | 22 | 68.8% |
Public health | 13 | 40.6% |
Disease | 12 | 37.5% |
Biology | 11 | 34.4% |
Epidemiology | 11 | 34.4% |
Research | 10 | 31.2% |
Clinical trial | 9 | 28.1% |
Evidence-based medicine | 9 | 28.1% |
Preventive healthcare | 9 | 28.1% |
Risk | 9 | 28.1% |
Diseases and disorders | 8 | 25.0% |
Adherence (medicine) | 7 | 21.9% |
Cancer | 7 | 21.9% |
Genetic testing | 7 | 21.9% |
Randomized controlled trial | 7 | 21.9% |
Science | 7 | 21.9% |
Gene | 6 | 18.8% |
Genetics | 6 | 18.8% |
Human activities | 6 | 18.8% |
Life sciences | 6 | 18.8% |
Medical diagnosis | 6 | 18.8% |
Evaluation | 5 | 15.6% |
Heart | 5 | 15.6% |
Major depressive disorder | 5 | 15.6% |
Personal genomics | 5 | 15.6% |
Screening (medicine) | 5 | 15.6% |
Self-care | 5 | 15.6% |
Sensitivity and specificity | 5 | 15.6% |
Behavior | 4 | 12.5% |
Cardiovascular disease | 4 | 12.5% |
Chronic condition | 4 | 12.5% |
Evidence-based practice | 4 | 12.5% |
Genetic association | 4 | 12.5% |
Genome-wide association study | 4 | 12.5% |
HIV/AIDS | 4 | 12.5% |
Health economics | 4 | 12.5% |
Hepatitis | 4 | 12.5% |
Influenza | 4 | 12.5% |
Information | 4 | 12.5% |
Medication | 4 | 12.5% |
Meta-analysis | 4 | 12.5% |
Mutation | 4 | 12.5% |
Myocardial infarction | 4 | 12.5% |
Obesity | 4 | 12.5% |
Pharmacogenomics | 4 | 12.5% |
Risk assessment | 4 | 12.5% |
Validity (statistics) | 4 | 12.5% |
Warfarin | 4 | 12.5% |
Caregiver | 3 | 9.4% |
Chronic obstructive pulmonary disease | 3 | 9.4% |
Comorbidity | 3 | 9.4% |
Disease surveillance | 3 | 9.4% |
Health policy | 3 | 9.4% |
Infection | 3 | 9.4% |
Infectious diseases | 3 | 9.4% |
Influenza A virus subtype H1N1 | 3 | 9.4% |
Influenza pandemic | 3 | 9.4% |
Medical history | 3 | 9.4% |
Medical humanities | 3 | 9.4% |
Medical treatments | 3 | 9.4% |
Medicare (United States) | 3 | 9.4% |
Outcomes research | 3 | 9.4% |
Pain | 3 | 9.4% |
Pharmacogenetics | 3 | 9.4% |
Pharmacology | 3 | 9.4% |
Physical examination | 3 | 9.4% |
Pneumonia | 3 | 9.4% |
Privacy | 3 | 9.4% |
Public sphere | 3 | 9.4% |
Receiver operating characteristic | 3 | 9.4% |
Scientific method | 3 | 9.4% |
Sexually transmitted infection | 3 | 9.4% |
Shortness of breath | 3 | 9.4% |
Spirometry | 3 | 9.4% |
Surgery | 3 | 9.4% |
Therapy | 3 | 9.4% |
Vaccine | 3 | 9.4% |
Virus | 3 | 9.4% |
Adverse effect | 2 | 6.2% |
Allergen | 2 | 6.2% |
Allergic rhinitis | 2 | 6.2% |
Allergy | 2 | 6.2% |
Analgesic | 2 | 6.2% |
Antiviral drug | 2 | 6.2% |
Asthma | 2 | 6.2% |
Avian influenza | 2 | 6.2% |
Biosecurity | 2 | 6.2% |
Breast cancer | 2 | 6.2% |
Bronchodilator | 2 | 6.2% |
Cardiovascular system | 2 | 6.2% |
Chemistry | 2 | 6.2% |
Chest radiograph | 2 | 6.2% |
Childbirth | 2 | 6.2% |
Chlamydia infection | 2 | 6.2% |
Colorectal cancer | 2 | 6.2% |
Confidentiality | 2 | 6.2% |
Consent | 2 | 6.2% |
Coronary artery disease | 2 | 6.2% |
Cough | 2 | 6.2% |
Database | 2 | 6.2% |
Emergency department | 2 | 6.2% |
Ethics | 2 | 6.2% |
Exercise-induced bronchoconstriction | 2 | 6.2% |
Field Epidemiology Training Program | 2 | 6.2% |
Gastroesophageal reflux disease | 2 | 6.2% |
Genetic counseling | 2 | 6.2% |
Gonorrhea | 2 | 6.2% |
Government | 2 | 6.2% |
Heartburn | 2 | 6.2% |
Hospital | 2 | 6.2% |
Human reproduction | 2 | 6.2% |
Hypertension | 2 | 6.2% |
Immunology | 2 | 6.2% |
Influenza A virus | 2 | 6.2% |
Influenza A virus subtype H5N1 | 2 | 6.2% |
Influenza vaccine | 2 | 6.2% |
Influenza-like illness | 2 | 6.2% |
Informed consent | 2 | 6.2% |
Insurance | 2 | 6.2% |
Lung | 2 | 6.2% |
Medicaid | 2 | 6.2% |
Medical guideline | 2 | 6.2% |
Medical record | 2 | 6.2% |
Medical research | 2 | 6.2% |
Medicinal chemistry | 2 | 6.2% |
Microbiology | 2 | 6.2% |
Nursing | 2 | 6.2% |
Obstructive sleep apnea | 2 | 6.2% |
Patient | 2 | 6.2% |
Personal data | 2 | 6.2% |
Pharmaceutical sciences | 2 | 6.2% |
Physical sciences | 2 | 6.2% |
Pregnancy | 2 | 6.2% |
Psychiatry | 2 | 6.2% |
Psychotherapy | 2 | 6.2% |
Pulmonary function testing | 2 | 6.2% |
Pulmonology | 2 | 6.2% |
Quantitative structure–activity relationship | 2 | 6.2% |
Registered nurse | 2 | 6.2% |
Rhinitis | 2 | 6.2% |
Safety | 2 | 6.2% |
Sinusitis | 2 | 6.2% |
Sleep apnea | 2 | 6.2% |
Stroke | 2 | 6.2% |
Surveillance | 2 | 6.2% |
Tuberculosis | 2 | 6.2% |
Vocal cord dysfunction | 2 | 6.2% |
Wheeze | 2 | 6.2% |
2009 flu pandemic | 1 | 3.1% |
ADME | 1 | 3.1% |
Abortion | 1 | 3.1% |
Absorption (pharmacology) | 1 | 3.1% |
Acupuncture | 1 | 3.1% |
Acute myeloid leukemia | 1 | 3.1% |
Acute toxicity | 1 | 3.1% |
Ageing | 1 | 3.1% |
Agriculture | 1 | 3.1% |
Air pollution | 1 | 3.1% |
Air quality index | 1 | 3.1% |
Alcoholism | 1 | 3.1% |
Allergic bronchopulmonary aspergillosis | 1 | 3.1% |
Alternative medicine | 1 | 3.1% |
Alzheimer's disease | 1 | 3.1% |
Anatomical terms of motion | 1 | 3.1% |
Anesthesia | 1 | 3.1% |
Anesthesiology | 1 | 3.1% |
Angina | 1 | 3.1% |
Angiology | 1 | 3.1% |
Animal bacterial diseases | 1 | 3.1% |
Animal testing | 1 | 3.1% |
Annotated Code of Maryland | 1 | 3.1% |
Anonymous birth | 1 | 3.1% |
Antibiotic | 1 | 3.1% |
Anticonvulsant | 1 | 3.1% |
Antileukotriene | 1 | 3.1% |
Antimicrobial resistance | 1 | 3.1% |
Antiphospholipid syndrome | 1 | 3.1% |
Aortic stenosis | 1 | 3.1% |
Aortic valve | 1 | 3.1% |
Aortic valve replacement | 1 | 3.1% |
Applied ethics | 1 | 3.1% |
Artificial cardiac pacemaker | 1 | 3.1% |
Atopy | 1 | 3.1% |
Atrial fibrillation | 1 | 3.1% |
Attention | 1 | 3.1% |
Automated external defibrillator | 1 | 3.1% |
Autonomy | 1 | 3.1% |
BRCA mutation | 1 | 3.1% |
Bariatric surgery | 1 | 3.1% |
Best practice | 1 | 3.1% |
Beta2-adrenergic agonist | 1 | 3.1% |
Bioavailability | 1 | 3.1% |
Biobank | 1 | 3.1% |
Biochemistry | 1 | 3.1% |
Bioethics | 1 | 3.1% |
Biosafety | 1 | 3.1% |
Biotechnology | 1 | 3.1% |
Birth control | 1 | 3.1% |
Blinded experiment | 1 | 3.1% |
Blood pressure | 1 | 3.1% |
Bone marrow | 1 | 3.1% |
Branches of science | 1 | 3.1% |
Breastfeeding | 1 | 3.1% |
Bronchitis | 1 | 3.1% |
Cancer syndrome | 1 | 3.1% |
Carbon dioxide | 1 | 3.1% |
Carboxyhemoglobin | 1 | 3.1% |
Cardiac arrest | 1 | 3.1% |
Cardiac resynchronization therapy | 1 | 3.1% |
Cardiology | 1 | 3.1% |
Cardiopulmonary resuscitation | 1 | 3.1% |
Case management (US health system) | 1 | 3.1% |
Case–control study | 1 | 3.1% |
Cell membrane | 1 | 3.1% |
Cervical cancer | 1 | 3.1% |
Chemical weapon | 1 | 3.1% |
Chemicals in medicine | 1 | 3.1% |
Chemotherapy | 1 | 3.1% |
Chest pain | 1 | 3.1% |
Chronic myelomonocytic leukemia | 1 | 3.1% |
Circulatory system | 1 | 3.1% |
Cirrhosis | 1 | 3.1% |
Cognitive behavioral therapy | 1 | 3.1% |
Cohort study | 1 | 3.1% |
Combined oral contraceptive pill | 1 | 3.1% |
Combustion | 1 | 3.1% |
Community | 1 | 3.1% |
Community health | 1 | 3.1% |
Condom | 1 | 3.1% |
Continuing medical education | 1 | 3.1% |
Contrast (vision) | 1 | 3.1% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 1 | 3.1% |
Coronavirus disease 2019 | 1 | 3.1% |
Cross-validation (statistics) | 1 | 3.1% |
Cystic fibrosis | 1 | 3.1% |
Cystic fibrosis transmembrane conductance regulator | 1 | 3.1% |
Cytochrome P450 | 1 | 3.1% |
DNA database | 1 | 3.1% |
DNA profiling | 1 | 3.1% |
DNA sequencing | 1 | 3.1% |
DPT vaccine | 1 | 3.1% |
Data | 1 | 3.1% |
Data Protection Act 1998 | 1 | 3.1% |
Data re-identification | 1 | 3.1% |
Deep vein thrombosis | 1 | 3.1% |
Defibrillation | 1 | 3.1% |
Delirium | 1 | 3.1% |
Dementia | 1 | 3.1% |
Diabetes | 1 | 3.1% |
Diabetes mellitus | 1 | 3.1% |
Diagnosis of HIV/AIDS | 1 | 3.1% |
Dietary supplement | 1 | 3.1% |
Dignity | 1 | 3.1% |
Direct-to-consumer advertising | 1 | 3.1% |
Disability | 1 | 3.1% |
Disease management (health) | 1 | 3.1% |
Down syndrome | 1 | 3.1% |
Driving | 1 | 3.1% |
Drug | 1 | 3.1% |
Drug design | 1 | 3.1% |
Drug discovery | 1 | 3.1% |
Drug metabolism | 1 | 3.1% |
Drugs | 1 | 3.1% |
Electronic health record | 1 | 3.1% |
Emergency contraception | 1 | 3.1% |
Employment | 1 | 3.1% |
Endometrial cancer | 1 | 3.1% |
Epidural administration | 1 | 3.1% |
Eradication of infectious diseases | 1 | 3.1% |
Etomidate | 1 | 3.1% |
Executive dysfunction | 1 | 3.1% |
Exercise | 1 | 3.1% |
Exhaled nitric oxide | 1 | 3.1% |
Eye chart | 1 | 3.1% |
Factor V Leiden | 1 | 3.1% |
False advertising | 1 | 3.1% |
Flu season | 1 | 3.1% |
Food | 1 | 3.1% |
Food safety | 1 | 3.1% |
Foodborne illness | 1 | 3.1% |
Forensic science | 1 | 3.1% |
Fraud | 1 | 3.1% |
Fungicide | 1 | 3.1% |
Genetic marker | 1 | 3.1% |
Gestational trophoblastic disease | 1 | 3.1% |
Glaucoma | 1 | 3.1% |
Global Outbreak Alert and Response Network | 1 | 3.1% |
Goal | 1 | 3.1% |
Gulf War syndrome | 1 | 3.1% |
Headache | 1 | 3.1% |
Health claim | 1 | 3.1% |
Health equity | 1 | 3.1% |
Health informatics | 1 | 3.1% |
Health insurance | 1 | 3.1% |
Health insurance coverage in the United States | 1 | 3.1% |
Health professional | 1 | 3.1% |
Health research | 1 | 3.1% |
Health system | 1 | 3.1% |
Heart arrhythmia | 1 | 3.1% |
Heart failure | 1 | 3.1% |
Heart rate | 1 | 3.1% |
Hematopoietic stem cell transplantation | 1 | 3.1% |
Hepatocellular carcinoma | 1 | 3.1% |
Home care in the United States | 1 | 3.1% |
Hormonal contraception | 1 | 3.1% |
Human rights | 1 | 3.1% |
Hypoglycemia | 1 | 3.1% |
ISM band | 1 | 3.1% |
Identifier | 1 | 3.1% |
Immunization | 1 | 3.1% |
Implantable cardioverter-defibrillator | 1 | 3.1% |
Infant | 1 | 3.1% |
Infection control | 1 | 3.1% |
Inflammatory bowel disease | 1 | 3.1% |
Influenza A virus subtype H3N2 | 1 | 3.1% |
Information privacy | 1 | 3.1% |
Institutional review board | 1 | 3.1% |
Intensive care medicine | 1 | 3.1% |
Intensive care unit | 1 | 3.1% |
Internal control | 1 | 3.1% |
Internal medicine | 1 | 3.1% |
Internal validity | 1 | 3.1% |
International Health Regulations | 1 | 3.1% |
Intracranial pressure | 1 | 3.1% |
Ischemia | 1 | 3.1% |
Isoniazid | 1 | 3.1% |
Laboratory | 1 | 3.1% |
Lamotrigine | 1 | 3.1% |
Lethal dose | 1 | 3.1% |
Leukemia | 1 | 3.1% |
Leukotriene | 1 | 3.1% |
Levonorgestrel | 1 | 3.1% |
Licensed practical nurse | 1 | 3.1% |
Logic model | 1 | 3.1% |
MMR vaccine | 1 | 3.1% |
Management of HIV/AIDS | 1 | 3.1% |
Maternal health | 1 | 3.1% |
Measles | 1 | 3.1% |
Median lethal dose | 1 | 3.1% |
Medical device | 1 | 3.1% |
Medical error | 1 | 3.1% |
Medical ethics | 1 | 3.1% |
Medical statistics | 1 | 3.1% |
Medroxyprogesterone acetate | 1 | 3.1% |
Memory | 1 | 3.1% |
Menopause | 1 | 3.1% |
Mental disorder | 1 | 3.1% |
Mental health | 1 | 3.1% |
Metered-dose inhaler | 1 | 3.1% |
Mid-level practitioner | 1 | 3.1% |
Miscarriage | 1 | 3.1% |
Monitoring and evaluation | 1 | 3.1% |
Mycobacteria | 1 | 3.1% |
Myelodysplastic syndrome | 1 | 3.1% |
National Ambient Air Quality Standards | 1 | 3.1% |
Nebulizer | 1 | 3.1% |
Neoplasms | 1 | 3.1% |
Nervous system | 1 | 3.1% |
Neurology | 1 | 3.1% |
Newborn screening | 1 | 3.1% |
Nursing home care | 1 | 3.1% |
OIE/FAO Network of Expertise on Animal Influenza | 1 | 3.1% |
Occupational safety and health | 1 | 3.1% |
Old age | 1 | 3.1% |
Omalizumab | 1 | 3.1% |
Opioid | 1 | 3.1% |
Organ donation | 1 | 3.1% |
Orthotics | 1 | 3.1% |
Oseltamivir | 1 | 3.1% |
Pain management | 1 | 3.1% |
Pandemic | 1 | 3.1% |
Partition coefficient | 1 | 3.1% |
Patient Protection and Affordable Care Act | 1 | 3.1% |
Patient-controlled analgesia | 1 | 3.1% |
Pelvic inflammatory disease | 1 | 3.1% |
Percutaneous aortic valve replacement | 1 | 3.1% |
Percutaneous endoscopic gastrostomy | 1 | 3.1% |
Performance indicator | 1 | 3.1% |
Personalized medicine | 1 | 3.1% |
Pharmaceutics | 1 | 3.1% |
Pharmacokinetics | 1 | 3.1% |
Pharmacy | 1 | 3.1% |
Physical therapy | 1 | 3.1% |
Physician | 1 | 3.1% |
Physiologically based pharmacokinetic modelling | 1 | 3.1% |
Placebo | 1 | 3.1% |
Placebo-controlled study | 1 | 3.1% |
Pneumococcal conjugate vaccine | 1 | 3.1% |
Pneumococcal vaccine | 1 | 3.1% |
Point of care | 1 | 3.1% |
Politics | 1 | 3.1% |
Positive airway pressure | 1 | 3.1% |
Potato | 1 | 3.1% |
Preimplantation genetic diagnosis | 1 | 3.1% |
Prenatal testing | 1 | 3.1% |
Prevention of HIV/AIDS | 1 | 3.1% |
Prior authorization | 1 | 3.1% |
Privacy law | 1 | 3.1% |
Procedural sedation and analgesia | 1 | 3.1% |
Prosthesis | 1 | 3.1% |
Protein | 1 | 3.1% |
Proteinuria | 1 | 3.1% |
Prothrombin G20210A | 1 | 3.1% |
Pyrazinamide | 1 | 3.1% |
RTT | 1 | 3.1% |
Race (human categorization) | 1 | 3.1% |
Radio spectrum | 1 | 3.1% |
Records management | 1 | 3.1% |
Reference dose | 1 | 3.1% |
Regulatory compliance | 1 | 3.1% |
Remifentanil | 1 | 3.1% |
Repeal | 1 | 3.1% |
Reproductive health | 1 | 3.1% |
Rifampicin | 1 | 3.1% |
Rights | 1 | 3.1% |
Road traffic safety | 1 | 3.1% |
Scientific control | 1 | 3.1% |
Sedation | 1 | 3.1% |
Service industries | 1 | 3.1% |
Sexual health | 1 | 3.1% |
Sham surgery | 1 | 3.1% |
Sideroblastic anemia | 1 | 3.1% |
Single-nucleotide polymorphism | 1 | 3.1% |
Sleep disorder | 1 | 3.1% |
Snellen chart | 1 | 3.1% |
Social institutions | 1 | 3.1% |
Specialty (medicine) | 1 | 3.1% |
Stress (biology) | 1 | 3.1% |
Substance abuse | 1 | 3.1% |
Superfund | 1 | 3.1% |
Support-vector machine | 1 | 3.1% |
Syncope (medicine) | 1 | 3.1% |
Syndemic | 1 | 3.1% |
Syphilis | 1 | 3.1% |
Systemic lupus erythematosus | 1 | 3.1% |
Technology | 1 | 3.1% |
Telecommunication | 1 | 3.1% |
Telehealth | 1 | 3.1% |
Test (assessment) | 1 | 3.1% |
Thorax (human anatomy) | 1 | 3.1% |
Thrombophilia | 1 | 3.1% |
Thrombosis | 1 | 3.1% |
Toxicity | 1 | 3.1% |
Toxicology | 1 | 3.1% |
Traditional Chinese medicine | 1 | 3.1% |
Traffic collision | 1 | 3.1% |
Training, validation, and test sets | 1 | 3.1% |
Transmission (medicine) | 1 | 3.1% |
Transmission and infection of H5N1 | 1 | 3.1% |
Traumatic brain injury | 1 | 3.1% |
Tuberculosis management | 1 | 3.1% |
Type 2 diabetes | 1 | 3.1% |
Vaccination | 1 | 3.1% |
Vaccine-preventable diseases | 1 | 3.1% |
Vaccines for Children Program | 1 | 3.1% |
Valvular heart disease | 1 | 3.1% |
Venous thrombosis | 1 | 3.1% |
Ventricular tachycardia | 1 | 3.1% |
Veteran | 1 | 3.1% |
Visual acuity | 1 | 3.1% |
Visual impairment | 1 | 3.1% |
Vital signs | 1 | 3.1% |
Weight loss | 1 | 3.1% |
Wireless | 1 | 3.1% |
Women's health | 1 | 3.1% |
Working memory | 1 | 3.1% |
World Wide Web | 1 | 3.1% |
Zileuton | 1 | 3.1% |
ΔF508 | 1 | 3.1% |
abs | rel | |
---|---|---|
Health | 42 | 87.5% |
Health sciences | 39 | 81.2% |
Medicine | 37 | 77.1% |
Health care | 35 | 72.9% |
Medical specialties | 28 | 58.3% |
Risk | 27 | 56.2% |
Clinical medicine | 26 | 54.2% |
Public health | 17 | 35.4% |
Human activities | 16 | 33.3% |
Biology | 15 | 31.2% |
Epidemiology | 15 | 31.2% |
Disease | 14 | 29.2% |
Research | 14 | 29.2% |
Diseases and disorders | 13 | 27.1% |
Patient | 11 | 22.9% |
Preventive healthcare | 11 | 22.9% |
Cancer | 10 | 20.8% |
Evidence-based medicine | 10 | 20.8% |
Infection | 10 | 20.8% |
Hospital | 9 | 18.8% |
Science | 9 | 18.8% |
Stroke | 9 | 18.8% |
Medical guideline | 8 | 16.7% |
Nursing | 8 | 16.7% |
Obesity | 8 | 16.7% |
Risk assessment | 8 | 16.7% |
Cardiovascular disease | 7 | 14.6% |
Dietary supplement | 7 | 14.6% |
Emergency department | 7 | 14.6% |
Evaluation | 7 | 14.6% |
Health economics | 7 | 14.6% |
Randomized controlled trial | 7 | 14.6% |
Surgery | 7 | 14.6% |
Sustainability | 7 | 14.6% |
Systematic review | 7 | 14.6% |
Technology | 7 | 14.6% |
Vaccine | 7 | 14.6% |
Adherence (medicine) | 6 | 12.5% |
Breast cancer | 6 | 12.5% |
Clinical trial | 6 | 12.5% |
Gene | 6 | 12.5% |
Genetics | 6 | 12.5% |
Health policy | 6 | 12.5% |
Influenza | 6 | 12.5% |
Life sciences | 6 | 12.5% |
Medical humanities | 6 | 12.5% |
Medication | 6 | 12.5% |
Myocardial infarction | 6 | 12.5% |
Patient safety | 6 | 12.5% |
Screening (medicine) | 6 | 12.5% |
Sensitivity and specificity | 6 | 12.5% |
Virus | 6 | 12.5% |
Adjuvant therapy | 5 | 10.4% |
Audit | 5 | 10.4% |
Chemistry | 5 | 10.4% |
Cholesterol | 5 | 10.4% |
Chronic condition | 5 | 10.4% |
Coronary artery disease | 5 | 10.4% |
Database | 5 | 10.4% |
Health care quality | 5 | 10.4% |
Health professional | 5 | 10.4% |
Medical imaging | 5 | 10.4% |
NHS foundation trust | 5 | 10.4% |
Biochemistry | 4 | 8.3% |
Biotechnology | 4 | 8.3% |
Body mass index | 4 | 8.3% |
CT scan | 4 | 8.3% |
Cardiovascular system | 4 | 8.3% |
Childbirth | 4 | 8.3% |
Cognition | 4 | 8.3% |
Diabetes | 4 | 8.3% |
Evidence-based practice | 4 | 8.3% |
Exercise | 4 | 8.3% |
Governance | 4 | 8.3% |
HIV/AIDS | 4 | 8.3% |
Heart | 4 | 8.3% |
Hierarchy of evidence | 4 | 8.3% |
High-density lipoprotein | 4 | 8.3% |
Hypertension | 4 | 8.3% |
Infectious diseases | 4 | 8.3% |
Information | 4 | 8.3% |
Nanotechnology | 4 | 8.3% |
Pharmacy | 4 | 8.3% |
Physical therapy | 4 | 8.3% |
Radiation therapy | 4 | 8.3% |
Safety | 4 | 8.3% |
Saturated fat | 4 | 8.3% |
Therapy | 4 | 8.3% |
Toxicity | 4 | 8.3% |
Toxicology | 4 | 8.3% |
Transmission (medicine) | 4 | 8.3% |
Type 2 diabetes | 4 | 8.3% |
Weight loss | 4 | 8.3% |
ACE inhibitor | 3 | 6.2% |
Agriculture | 3 | 6.2% |
Air traffic control | 3 | 6.2% |
Artificial intelligence | 3 | 6.2% |
Aspirin | 3 | 6.2% |
Beta blocker | 3 | 6.2% |
Bevacizumab | 3 | 6.2% |
Blood pressure | 3 | 6.2% |
Brain | 3 | 6.2% |
Branches of science | 3 | 6.2% |
Cardiology | 3 | 6.2% |
Caregiver | 3 | 6.2% |
Cell (biology) | 3 | 6.2% |
Chemotherapy | 3 | 6.2% |
Clinical governance | 3 | 6.2% |
Colorectal cancer | 3 | 6.2% |
DNA | 3 | 6.2% |
DNA sequencing | 3 | 6.2% |
Diabetes mellitus | 3 | 6.2% |
Eicosapentaenoic acid | 3 | 6.2% |
Evolution | 3 | 6.2% |
Expert | 3 | 6.2% |
Fish oil | 3 | 6.2% |
Food | 3 | 6.2% |
General practitioner | 3 | 6.2% |
Genetic counseling | 3 | 6.2% |
Genetic testing | 3 | 6.2% |
Genetically modified organism | 3 | 6.2% |
Genomics | 3 | 6.2% |
Immunology | 3 | 6.2% |
Innovation | 3 | 6.2% |
Laboratory | 3 | 6.2% |
MMR vaccine | 3 | 6.2% |
Measles | 3 | 6.2% |
Median lethal dose | 3 | 6.2% |
Medical diagnosis | 3 | 6.2% |
Medical treatments | 3 | 6.2% |
Meningococcal disease | 3 | 6.2% |
Meta-analysis | 3 | 6.2% |
Microbiology | 3 | 6.2% |
Mutation | 3 | 6.2% |
Neoplasm | 3 | 6.2% |
Neoplasms | 3 | 6.2% |
Omega-3 fatty acid | 3 | 6.2% |
Ovarian cancer | 3 | 6.2% |
Pesticide | 3 | 6.2% |
Pesticide residue | 3 | 6.2% |
Pharmacology | 3 | 6.2% |
Physical sciences | 3 | 6.2% |
Pre-eclampsia | 3 | 6.2% |
Prediabetes | 3 | 6.2% |
Quantitative structure–activity relationship | 3 | 6.2% |
Radiology | 3 | 6.2% |
Regulatory compliance | 3 | 6.2% |
Risk management | 3 | 6.2% |
Robot | 3 | 6.2% |
Scientific method | 3 | 6.2% |
Statin | 3 | 6.2% |
Surveillance | 3 | 6.2% |
System | 3 | 6.2% |
Water | 3 | 6.2% |
Acute coronary syndrome | 2 | 4.2% |
Airport | 2 | 4.2% |
Ames test | 2 | 4.2% |
Angiotensin II receptor blocker | 2 | 4.2% |
Anthrax | 2 | 4.2% |
Antihypertensive drug | 2 | 4.2% |
Antiviral drug | 2 | 4.2% |
Asset | 2 | 4.2% |
Assumption | 2 | 4.2% |
Asthma | 2 | 4.2% |
Atherosclerosis | 2 | 4.2% |
Atrial fibrillation | 2 | 4.2% |
Attention | 2 | 4.2% |
BRCA mutation | 2 | 4.2% |
Bacteria | 2 | 4.2% |
Balance sheet | 2 | 4.2% |
Biodiversity | 2 | 4.2% |
Bioinformatics | 2 | 4.2% |
Biomarker | 2 | 4.2% |
Biosafety | 2 | 4.2% |
Biosecurity | 2 | 4.2% |
Bisphosphonate | 2 | 4.2% |
Bone | 2 | 4.2% |
Business | 2 | 4.2% |
C-reactive protein | 2 | 4.2% |
Cancer syndrome | 2 | 4.2% |
Carbon dioxide | 2 | 4.2% |
Carcinogen | 2 | 4.2% |
Cell membrane | 2 | 4.2% |
Clinical audit | 2 | 4.2% |
Comorbidity | 2 | 4.2% |
Computer science | 2 | 4.2% |
Culture | 2 | 4.2% |
Dabigatran | 2 | 4.2% |
Dengue fever | 2 | 4.2% |
Denosumab | 2 | 4.2% |
Design | 2 | 4.2% |
Diabetes mellitus type 2 | 2 | 4.2% |
Diarrhea | 2 | 4.2% |
Dieting | 2 | 4.2% |
Dietitian | 2 | 4.2% |
Drugs | 2 | 4.2% |
Dual-energy X-ray absorptiometry | 2 | 4.2% |
Ecology | 2 | 4.2% |
Efficient energy use | 2 | 4.2% |
Electrical grid | 2 | 4.2% |
Electronic health record | 2 | 4.2% |
Electronics | 2 | 4.2% |
Embodied cognition | 2 | 4.2% |
Employment | 2 | 4.2% |
Engineering | 2 | 4.2% |
Epidemic | 2 | 4.2% |
Ethics | 2 | 4.2% |
Exemestane | 2 | 4.2% |
Family medicine | 2 | 4.2% |
Fetus | 2 | 4.2% |
Food safety | 2 | 4.2% |
Framingham Risk Score | 2 | 4.2% |
Fuel cell | 2 | 4.2% |
Genotoxicity | 2 | 4.2% |
Global warming | 2 | 4.2% |
Goal | 2 | 4.2% |
Government budget balance | 2 | 4.2% |
Greenhouse gas | 2 | 4.2% |
Health equity | 2 | 4.2% |
Health informatics | 2 | 4.2% |
Healthy diet | 2 | 4.2% |
Heart failure | 2 | 4.2% |
Hispanic and Latino Americans | 2 | 4.2% |
History | 2 | 4.2% |
Hospital readmission | 2 | 4.2% |
Immune system | 2 | 4.2% |
Infection prevention and control | 2 | 4.2% |
Influenza pandemic | 2 | 4.2% |
Inquiry | 2 | 4.2% |
Inspection | 2 | 4.2% |
Internet | 2 | 4.2% |
Laser | 2 | 4.2% |
Leadership | 2 | 4.2% |
Life | 2 | 4.2% |
Listeriosis | 2 | 4.2% |
Low-density lipoprotein | 2 | 4.2% |
Magnetic resonance imaging | 2 | 4.2% |
Major depressive disorder | 2 | 4.2% |
Management | 2 | 4.2% |
Maximum residue limit | 2 | 4.2% |
Medical and health organizations | 2 | 4.2% |
Medical device | 2 | 4.2% |
Medical test | 2 | 4.2% |
Mental health | 2 | 4.2% |
Metabolic syndrome | 2 | 4.2% |
Metabolism | 2 | 4.2% |
Metastasis | 2 | 4.2% |
Methicillin-resistant Staphylococcus aureus | 2 | 4.2% |
Mutagen | 2 | 4.2% |
Natural environment | 2 | 4.2% |
Nature | 2 | 4.2% |
Neisseria meningitidis | 2 | 4.2% |
Nuclear proliferation | 2 | 4.2% |
Nursing home care | 2 | 4.2% |
Obstetrics | 2 | 4.2% |
Organism | 2 | 4.2% |
Organisms | 2 | 4.2% |
Osteoporosis | 2 | 4.2% |
Palliative care | 2 | 4.2% |
Pandemic | 2 | 4.2% |
Pay for performance (healthcare) | 2 | 4.2% |
Performance appraisal | 2 | 4.2% |
Photovoltaics | 2 | 4.2% |
Physician | 2 | 4.2% |
Point of care | 2 | 4.2% |
Policy | 2 | 4.2% |
Pollution | 2 | 4.2% |
Prediction | 2 | 4.2% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 2 | 4.2% |
Pregnancy | 2 | 4.2% |
Primary care | 2 | 4.2% |
Privacy | 2 | 4.2% |
Prostate cancer | 2 | 4.2% |
Proton-exchange membrane fuel cell | 2 | 4.2% |
Quality | 2 | 4.2% |
Quality-adjusted life year | 2 | 4.2% |
Radiation protection | 2 | 4.2% |
Reference dose | 2 | 4.2% |
Reference range | 2 | 4.2% |
Research methods | 2 | 4.2% |
Reverse transcription polymerase chain reaction | 2 | 4.2% |
Robotics | 2 | 4.2% |
Rubella | 2 | 4.2% |
SBAR | 2 | 4.2% |
Sea | 2 | 4.2% |
Social science | 2 | 4.2% |
Solar cell | 2 | 4.2% |
Stem cell | 2 | 4.2% |
Subacute sclerosing panencephalitis | 2 | 4.2% |
Systems biology | 2 | 4.2% |
Tamoxifen | 2 | 4.2% |
Teriparatide | 2 | 4.2% |
Testicular cancer | 2 | 4.2% |
Thiazide | 2 | 4.2% |
Transient ischemic attack | 2 | 4.2% |
Tuberculosis | 2 | 4.2% |
Uncertainty | 2 | 4.2% |
Usability | 2 | 4.2% |
Validity (statistics) | 2 | 4.2% |
Viral hemorrhagic fever | 2 | 4.2% |
Vitamin D | 2 | 4.2% |
Waste | 2 | 4.2% |
Whole grain | 2 | 4.2% |
Zoledronic acid | 2 | 4.2% |
2009 swine flu pandemic | 1 | 2.1% |
ALARP | 1 | 2.1% |
Absorbed dose | 1 | 2.1% |
Accountability | 1 | 2.1% |
Accuracy and precision | 1 | 2.1% |
Acute toxicity | 1 | 2.1% |
Adenoviridae | 1 | 2.1% |
Adverse effect | 1 | 2.1% |
Aedes aegypti | 1 | 2.1% |
Aedes albopictus | 1 | 2.1% |
Ageing | 1 | 2.1% |
Air pollution | 1 | 2.1% |
Allergy | 1 | 2.1% |
Amazon rainforest | 1 | 2.1% |
Analytics | 1 | 2.1% |
Anastrozole | 1 | 2.1% |
Angina | 1 | 2.1% |
Angiography | 1 | 2.1% |
Angiology | 1 | 2.1% |
Angiotensin-converting enzyme | 1 | 2.1% |
Animal husbandry | 1 | 2.1% |
Animal testing | 1 | 2.1% |
Anti-diabetic medication | 1 | 2.1% |
Antibiotic | 1 | 2.1% |
Antibody | 1 | 2.1% |
Antimalarial medication | 1 | 2.1% |
Antimicrobial resistance | 1 | 2.1% |
Antioxidant | 1 | 2.1% |
Antiplatelet drug | 1 | 2.1% |
Antiplatelet drugs | 1 | 2.1% |
Antithrombotic agents | 1 | 2.1% |
Anti–vascular endothelial growth factor therapy | 1 | 2.1% |
Arbovirus | 1 | 2.1% |
Argument | 1 | 2.1% |
Aromatase inhibitor | 1 | 2.1% |
Artesunate | 1 | 2.1% |
Artificial objects | 1 | 2.1% |
Assay | 1 | 2.1% |
Astrobiology | 1 | 2.1% |
Atomic force microscopy | 1 | 2.1% |
Audit committee | 1 | 2.1% |
Automated external defibrillator | 1 | 2.1% |
Avian influenza | 1 | 2.1% |
Aviation safety | 1 | 2.1% |
BRCA1 | 1 | 2.1% |
BRCA2 | 1 | 2.1% |
Baby Friendly Hospital Initiative | 1 | 2.1% |
Bariatric surgery | 1 | 2.1% |
Base pair | 1 | 2.1% |
Baseball | 1 | 2.1% |
Beaked whale | 1 | 2.1% |
Behavior | 1 | 2.1% |
Best practice | 1 | 2.1% |
BioBrick | 1 | 2.1% |
Biobank | 1 | 2.1% |
Biofuel | 1 | 2.1% |
Biological engineering | 1 | 2.1% |
Biological warfare | 1 | 2.1% |
Biomass | 1 | 2.1% |
Biomechanics | 1 | 2.1% |
Biomedicine | 1 | 2.1% |
Biometrics | 1 | 2.1% |
Biomimetics | 1 | 2.1% |
Biopsy | 1 | 2.1% |
Biosensor | 1 | 2.1% |
Biosynthesis | 1 | 2.1% |
Bird migration | 1 | 2.1% |
Birth defect | 1 | 2.1% |
Bladder cancer | 1 | 2.1% |
Bleeding | 1 | 2.1% |
Blood lipids | 1 | 2.1% |
Blood sugar level | 1 | 2.1% |
Bloodstream infections | 1 | 2.1% |
Boiler | 1 | 2.1% |
Bone density | 1 | 2.1% |
Bone metastasis | 1 | 2.1% |
Bone resorption | 1 | 2.1% |
Bunyavirales | 1 | 2.1% |
Business intelligence | 1 | 2.1% |
CA-125 | 1 | 2.1% |
Caesarean section | 1 | 2.1% |
Cancer survivor | 1 | 2.1% |
Cangrelor | 1 | 2.1% |
Capacity building | 1 | 2.1% |
Carbohydrate | 1 | 2.1% |
Carbon | 1 | 2.1% |
Carbon capture and storage | 1 | 2.1% |
Cardiac arrest | 1 | 2.1% |
Cardiac rehabilitation | 1 | 2.1% |
Cardiopulmonary resuscitation | 1 | 2.1% |
Cardiovascular diseases | 1 | 2.1% |
Carrion crow | 1 | 2.1% |
Cash flow statement | 1 | 2.1% |
Cataract | 1 | 2.1% |
Cattle | 1 | 2.1% |
Cell growth | 1 | 2.1% |
Centre of Biological Research (Spain) | 1 | 2.1% |
Cereal | 1 | 2.1% |
ChIP-sequencing | 1 | 2.1% |
Chikungunya | 1 | 2.1% |
Chloroquine | 1 | 2.1% |
Cholecalciferol | 1 | 2.1% |
Choroidal neovascularization | 1 | 2.1% |
Chromatin | 1 | 2.1% |
Chromosomal crossover | 1 | 2.1% |
Chronic kidney disease | 1 | 2.1% |
Chronic obstructive pulmonary disease | 1 | 2.1% |
Clinic | 1 | 2.1% |
Clinical coder | 1 | 2.1% |
Clinical commissioning group | 1 | 2.1% |
Cloning | 1 | 2.1% |
Clopidogrel | 1 | 2.1% |
Clostridioides difficile (bacteria) | 1 | 2.1% |
Clostridioides difficile infection | 1 | 2.1% |
Coal | 1 | 2.1% |
Cogeneration | 1 | 2.1% |
Cognitive science | 1 | 2.1% |
Colonoscopy | 1 | 2.1% |
Community | 1 | 2.1% |
Community health | 1 | 2.1% |
Complement system | 1 | 2.1% |
Composite material | 1 | 2.1% |
Computed tomography angiography | 1 | 2.1% |
Computer network | 1 | 2.1% |
Concept | 1 | 2.1% |
Confidence interval | 1 | 2.1% |
Contact tracing | 1 | 2.1% |
Contrast (vision) | 1 | 2.1% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 1 | 2.1% |
Copolymer | 1 | 2.1% |
Coronavirus disease 2019 | 1 | 2.1% |
Cost-effectiveness analysis | 1 | 2.1% |
Cost–benefit analysis | 1 | 2.1% |
Counter-terrorism | 1 | 2.1% |
Craig Venter | 1 | 2.1% |
Crimean–Congo hemorrhagic fever | 1 | 2.1% |
Crown-rump length | 1 | 2.1% |
Culex | 1 | 2.1% |
Current liability | 1 | 2.1% |
Curriculum | 1 | 2.1% |
Customer relationship management | 1 | 2.1% |
Cutaneous leishmaniasis | 1 | 2.1% |
DNA repair | 1 | 2.1% |
DNA vaccination | 1 | 2.1% |
DPT vaccine | 1 | 2.1% |
Dairy | 1 | 2.1% |
Data | 1 | 2.1% |
Data analysis | 1 | 2.1% |
Data sharing | 1 | 2.1% |
David Baltimore | 1 | 2.1% |
Death | 1 | 2.1% |
Debt | 1 | 2.1% |
Decision-making | 1 | 2.1% |
Dengue vaccine | 1 | 2.1% |
Dengue virus | 1 | 2.1% |
Determinants of health | 1 | 2.1% |
Diabetes management | 1 | 2.1% |
Dietary fiber | 1 | 2.1% |
Diffusion of innovations | 1 | 2.1% |
Director general | 1 | 2.1% |
Disability | 1 | 2.1% |
Disease surveillance | 1 | 2.1% |
Distributed generation | 1 | 2.1% |
Dividend | 1 | 2.1% |
Do not resuscitate | 1 | 2.1% |
Do-it-yourself biology | 1 | 2.1% |
Down syndrome | 1 | 2.1% |
Doxycycline | 1 | 2.1% |
Drosophila melanogaster | 1 | 2.1% |
Drusen | 1 | 2.1% |
ELISA | 1 | 2.1% |
Earth | 1 | 2.1% |
Ebola virus disease | 1 | 2.1% |
Echocardiography | 1 | 2.1% |
Economic model | 1 | 2.1% |
Economics of climate change mitigation | 1 | 2.1% |
Ecosystem | 1 | 2.1% |
Education | 1 | 2.1% |
Effects of global warming | 1 | 2.1% |
Embryo transfer | 1 | 2.1% |
Empiricism | 1 | 2.1% |
Empowerment | 1 | 2.1% |
End-of-life care | 1 | 2.1% |
Endothelium | 1 | 2.1% |
Energy | 1 | 2.1% |
Energy management | 1 | 2.1% |
Environmental impact assessment | 1 | 2.1% |
Epigenetics | 1 | 2.1% |
Epilepsy | 1 | 2.1% |
Epistemology | 1 | 2.1% |
Equity (finance) | 1 | 2.1% |
Errors and residuals | 1 | 2.1% |
Ethanol | 1 | 2.1% |
Ethology | 1 | 2.1% |
Exhaust gas | 1 | 2.1% |
Expense | 1 | 2.1% |
Exposure assessment | 1 | 2.1% |
Extensively drug-resistant tuberculosis | 1 | 2.1% |
Eye care | 1 | 2.1% |
Factor H | 1 | 2.1% |
False positives and false negatives | 1 | 2.1% |
Fertilisation | 1 | 2.1% |
Fiber laser | 1 | 2.1% |
Financial statement | 1 | 2.1% |
Fixation (histology) | 1 | 2.1% |
Flu season | 1 | 2.1% |
Folate | 1 | 2.1% |
Fruit | 1 | 2.1% |
Fucus vesiculosus | 1 | 2.1% |
Fundus photography | 1 | 2.1% |
GSK-3 | 1 | 2.1% |
Gallium nitride | 1 | 2.1% |
Gasoline | 1 | 2.1% |
General medical services | 1 | 2.1% |
Genetic code | 1 | 2.1% |
Genetic diversity | 1 | 2.1% |
Genetic engineering | 1 | 2.1% |
Genetic recombination | 1 | 2.1% |
Genetically modified food | 1 | 2.1% |
Genome | 1 | 2.1% |
Geography | 1 | 2.1% |
Gestational age | 1 | 2.1% |
Gestational diabetes | 1 | 2.1% |
Global health | 1 | 2.1% |
Glucose test | 1 | 2.1% |
Glucose tolerance test | 1 | 2.1% |
Glycated hemoglobin | 1 | 2.1% |
Glycemic index | 1 | 2.1% |
Glycosylation | 1 | 2.1% |
God | 1 | 2.1% |
Gonorrhea | 1 | 2.1% |
Good laboratory practice | 1 | 2.1% |
Government agencies of the United Kingdom | 1 | 2.1% |
Grid computing | 1 | 2.1% |
H3K56ac | 1 | 2.1% |
HER2/neu | 1 | 2.1% |
HIV | 1 | 2.1% |
HIV vaccine | 1 | 2.1% |
Headache | 1 | 2.1% |
Health care industry | 1 | 2.1% |
Health care management | 1 | 2.1% |
Health human resources | 1 | 2.1% |
Health insurance coverage in the United States | 1 | 2.1% |
Health literacy | 1 | 2.1% |
Health system | 1 | 2.1% |
Healthcare in the Netherlands | 1 | 2.1% |
Healthcare management | 1 | 2.1% |
Healthcare quality | 1 | 2.1% |
Hearing loss | 1 | 2.1% |
Hematopoietic stem cell | 1 | 2.1% |
Hematopoietic stem cell transplantation | 1 | 2.1% |
Hematuria | 1 | 2.1% |
Hepatitis | 1 | 2.1% |
Hepatitis B vaccine | 1 | 2.1% |
Hereditary nonpolyposis colorectal cancer | 1 | 2.1% |
High production volume chemicals | 1 | 2.1% |
Hip fracture | 1 | 2.1% |
Hispanic paradox | 1 | 2.1% |
Histone | 1 | 2.1% |
Homelessness | 1 | 2.1% |
Honey bee | 1 | 2.1% |
Hormonal therapy (oncology) | 1 | 2.1% |
Hormone replacement therapy | 1 | 2.1% |
Hospital-acquired infection | 1 | 2.1% |
Human | 1 | 2.1% |
Human eye | 1 | 2.1% |
Human gastrointestinal microbiota | 1 | 2.1% |
Human impact on the environment | 1 | 2.1% |
Human migration | 1 | 2.1% |
Human papillomavirus infection | 1 | 2.1% |
Human pregnancy | 1 | 2.1% |
Human reproduction | 1 | 2.1% |
Human–robot interaction | 1 | 2.1% |
Hydrogen | 1 | 2.1% |
Hypercholesterolemia | 1 | 2.1% |
Hyperglycemia | 1 | 2.1% |
Immunization | 1 | 2.1% |
Immunohistochemistry | 1 | 2.1% |
In vitro fertilisation | 1 | 2.1% |
Incremental cost-effectiveness ratio | 1 | 2.1% |
Index case | 1 | 2.1% |
Infant mortality | 1 | 2.1% |
Inflammation | 1 | 2.1% |
Influenza A virus subtype H1N1 | 1 | 2.1% |
Influenza A virus subtype H3N2 | 1 | 2.1% |
Influenza A virus subtype H5N1 | 1 | 2.1% |
Influenza prevention | 1 | 2.1% |
Influenza vaccine | 1 | 2.1% |
Information governance | 1 | 2.1% |
Information security | 1 | 2.1% |
Information technology | 1 | 2.1% |
Infusion pump | 1 | 2.1% |
Institutional review board | 1 | 2.1% |
Insulin resistance | 1 | 2.1% |
Intellectual property | 1 | 2.1% |
Intelligence | 1 | 2.1% |
Interdisciplinarity | 1 | 2.1% |
Internal control | 1 | 2.1% |
Internal medicine | 1 | 2.1% |
Interoperability | 1 | 2.1% |
Intima-media thickness | 1 | 2.1% |
Intracytoplasmic sperm injection | 1 | 2.1% |
Intravenous therapy | 1 | 2.1% |
Intravitreal administration | 1 | 2.1% |
Ionizing radiation | 1 | 2.1% |
Iron | 1 | 2.1% |
Japanese encephalitis | 1 | 2.1% |
Ki-67 (protein) | 1 | 2.1% |
Laparoscopy | 1 | 2.1% |
Laser coagulation | 1 | 2.1% |
Lassa fever | 1 | 2.1% |
Law | 1 | 2.1% |
Learning | 1 | 2.1% |
Leishmaniasis | 1 | 2.1% |
Life expectancy | 1 | 2.1% |
Lignocellulosic biomass | 1 | 2.1% |
Linear no-threshold model | 1 | 2.1% |
Lipid | 1 | 2.1% |
Liraglutide | 1 | 2.1% |
Literacy | 1 | 2.1% |
Long interspersed nuclear element | 1 | 2.1% |
Long-term care | 1 | 2.1% |
Lujo mammarenavirus | 1 | 2.1% |
Lumbar vertebrae | 1 | 2.1% |
Lung cancer | 1 | 2.1% |
Lutein | 1 | 2.1% |
Lymphadenectomy | 1 | 2.1% |
MEDLINE | 1 | 2.1% |
Macula of retina | 1 | 2.1% |
Macular degeneration | 1 | 2.1% |
Macular telangiectasia | 1 | 2.1% |
Major trauma | 1 | 2.1% |
Malaria | 1 | 2.1% |
Malaria vaccine | 1 | 2.1% |
Mammalian pregnancy | 1 | 2.1% |
Management of acute coronary syndrome | 1 | 2.1% |
Marburg virus | 1 | 2.1% |
Marburg virus disease | 1 | 2.1% |
Marketing | 1 | 2.1% |
Materials science | 1 | 2.1% |
Maternal health | 1 | 2.1% |
Maternal–fetal medicine | 1 | 2.1% |
Matter | 1 | 2.1% |
Mechanical engineering | 1 | 2.1% |
Medicaid | 1 | 2.1% |
Medical error | 1 | 2.1% |
Medical genetics | 1 | 2.1% |
Medical physics | 1 | 2.1% |
Medical prescription | 1 | 2.1% |
Medical record | 1 | 2.1% |
Medical ultrasound | 1 | 2.1% |
Medicare (United States) | 1 | 2.1% |
Mediterranean Sea | 1 | 2.1% |
Meiosis | 1 | 2.1% |
Meningitis | 1 | 2.1% |
Meningococcal vaccine | 1 | 2.1% |
Menopause | 1 | 2.1% |
Mesenchymal stem cell | 1 | 2.1% |
Metabolic engineering | 1 | 2.1% |
Metastatic breast cancer | 1 | 2.1% |
Metformin | 1 | 2.1% |
Microscope | 1 | 2.1% |
Microscopy | 1 | 2.1% |
Midwife | 1 | 2.1% |
Midwifery | 1 | 2.1% |
Mind | 1 | 2.1% |
Minimal genome | 1 | 2.1% |
Missing data | 1 | 2.1% |
Mitosis | 1 | 2.1% |
Molecular biology | 1 | 2.1% |
Monitoring and evaluation | 1 | 2.1% |
Mosquito | 1 | 2.1% |
Mosquito-borne disease | 1 | 2.1% |
Motherhood | 1 | 2.1% |
Multiple birth | 1 | 2.1% |
Natural gas | 1 | 2.1% |
Natural killer cell | 1 | 2.1% |
Natural product | 1 | 2.1% |
Natural reservoir | 1 | 2.1% |
Natural rubber | 1 | 2.1% |
Natural selection | 1 | 2.1% |
Needs assessment | 1 | 2.1% |
Neonatal intensive care unit | 1 | 2.1% |
Neovascularization | 1 | 2.1% |
Nephrectomy | 1 | 2.1% |
Neural engineering | 1 | 2.1% |
Neurodegeneration | 1 | 2.1% |
Neurology | 1 | 2.1% |
Neuron | 1 | 2.1% |
Neutrophil | 1 | 2.1% |
Newborn screening | 1 | 2.1% |
Noise pollution | 1 | 2.1% |
Nondestructive testing | 1 | 2.1% |
Nosema apis | 1 | 2.1% |
Nosema ceranae | 1 | 2.1% |
Nuclear power | 1 | 2.1% |
Nucleic acid sequence | 1 | 2.1% |
Nucleosome | 1 | 2.1% |
Nutrition | 1 | 2.1% |
Nutritionist | 1 | 2.1% |
Obstetric ultrasonography | 1 | 2.1% |
Occupational safety and health | 1 | 2.1% |
Ocean | 1 | 2.1% |
Ocean acidification | 1 | 2.1% |
Oceanography | 1 | 2.1% |
Old age | 1 | 2.1% |
Ontology | 1 | 2.1% |
Ophthalmology | 1 | 2.1% |
Optics | 1 | 2.1% |
Organ transplantation | 1 | 2.1% |
Orthohantavirus | 1 | 2.1% |
Osteonecrosis of the jaw | 1 | 2.1% |
Osteopenia | 1 | 2.1% |
Outcomes research | 1 | 2.1% |
Oxaliplatin | 1 | 2.1% |
PSMD4 | 1 | 2.1% |
Paradigm | 1 | 2.1% |
Paromomycin | 1 | 2.1% |
Parthenium argentatum | 1 | 2.1% |
Particulates | 1 | 2.1% |
Patent | 1 | 2.1% |
Patient Protection and Affordable Care Act | 1 | 2.1% |
Patient safety organization | 1 | 2.1% |
Pegaptanib | 1 | 2.1% |
Pension | 1 | 2.1% |
Perception | 1 | 2.1% |
Percutaneous coronary intervention | 1 | 2.1% |
Perioperative mortality | 1 | 2.1% |
Personalized medicine | 1 | 2.1% |
Pharmacogenomics | 1 | 2.1% |
Photonics | 1 | 2.1% |
Physical activity | 1 | 2.1% |
Physics | 1 | 2.1% |
Phytoplankton | 1 | 2.1% |
Pioglitazone | 1 | 2.1% |
Plant breeding | 1 | 2.1% |
Plasmodium | 1 | 2.1% |
Plasmodium falciparum | 1 | 2.1% |
Plasmodium vivax | 1 | 2.1% |
Pneumonia | 1 | 2.1% |
Polymer | 1 | 2.1% |
Polymerase chain reaction | 1 | 2.1% |
Polymerization | 1 | 2.1% |
Population health | 1 | 2.1% |
Positron emission tomography | 1 | 2.1% |
Post-exposure prophylaxis | 1 | 2.1% |
Poultry | 1 | 2.1% |
Poxviridae | 1 | 2.1% |
Prasugrel | 1 | 2.1% |
Premature rupture of membranes | 1 | 2.1% |
Prenatal care | 1 | 2.1% |
Prenatal development | 1 | 2.1% |
Prescription drug | 1 | 2.1% |
Pressure ulcer | 1 | 2.1% |
Preterm birth | 1 | 2.1% |
Primaquine | 1 | 2.1% |
Probiotic | 1 | 2.1% |
Problem solving | 1 | 2.1% |
Procurement | 1 | 2.1% |
Product lifecycle | 1 | 2.1% |
Proliferative index | 1 | 2.1% |
Property | 1 | 2.1% |
Prosthesis | 1 | 2.1% |
Proteasome | 1 | 2.1% |
Protein | 1 | 2.1% |
Protocell | 1 | 2.1% |
Protocol (science) | 1 | 2.1% |
Provenance | 1 | 2.1% |
Provinces and territories of Canada | 1 | 2.1% |
Psychiatry | 1 | 2.1% |
Psychology | 1 | 2.1% |
Public health genomics | 1 | 2.1% |
Public sphere | 1 | 2.1% |
Quality and Outcomes Framework | 1 | 2.1% |
Quantitative computed tomography | 1 | 2.1% |
Quantitative research | 1 | 2.1% |
Quantum dot | 1 | 2.1% |
RTS,S | 1 | 2.1% |
Race and ethnicity in the United States Census | 1 | 2.1% |
Radical polymerization | 1 | 2.1% |
Rail transport | 1 | 2.1% |
Raloxifene | 1 | 2.1% |
Ranibizumab | 1 | 2.1% |
Rare disease | 1 | 2.1% |
Real estate appraisal | 1 | 2.1% |
Real-time polymerase chain reaction | 1 | 2.1% |
Reason | 1 | 2.1% |
Receptor (biochemistry) | 1 | 2.1% |
Recycling | 1 | 2.1% |
Red blood cell | 1 | 2.1% |
Regression analysis | 1 | 2.1% |
Renal cell carcinoma | 1 | 2.1% |
Reperfusion therapy | 1 | 2.1% |
Reproduction | 1 | 2.1% |
Research and development | 1 | 2.1% |
Retail Price Index | 1 | 2.1% |
Retina | 1 | 2.1% |
Rhetoric | 1 | 2.1% |
Rift Valley fever | 1 | 2.1% |
Road | 1 | 2.1% |
Root-mean-square deviation | 1 | 2.1% |
Rosiglitazone | 1 | 2.1% |
Saccade | 1 | 2.1% |
Saccharomyces cerevisiae | 1 | 2.1% |
Safeguarding | 1 | 2.1% |
Safety management systems | 1 | 2.1% |
Santiago Ramón y Cajal | 1 | 2.1% |
Scanning laser ophthalmoscopy | 1 | 2.1% |
Science and Technology Options Assessment | 1 | 2.1% |
Science and technology | 1 | 2.1% |
Scientific control | 1 | 2.1% |
Scientist | 1 | 2.1% |
Scrub typhus | 1 | 2.1% |
Seat belt | 1 | 2.1% |
Section 8 (housing) | 1 | 2.1% |
Selective estrogen receptor modulator | 1 | 2.1% |
Self-care | 1 | 2.1% |
Sensor | 1 | 2.1% |
Services sector of the economy | 1 | 2.1% |
Severe acute respiratory syndrome | 1 | 2.1% |
Severe acute respiratory syndrome coronavirus | 1 | 2.1% |
Sexually transmitted infection | 1 | 2.1% |
Sheep | 1 | 2.1% |
Sibling | 1 | 2.1% |
Sievert | 1 | 2.1% |
Signal transduction | 1 | 2.1% |
Silicon on insulator | 1 | 2.1% |
Simulation | 1 | 2.1% |
Smallpox | 1 | 2.1% |
Smoking cessation | 1 | 2.1% |
Social marketing | 1 | 2.1% |
Socioeconomic status | 1 | 2.1% |
Software development | 1 | 2.1% |
Solar energy | 1 | 2.1% |
Sonar | 1 | 2.1% |
Species | 1 | 2.1% |
Spo11 | 1 | 2.1% |
Staining | 1 | 2.1% |
Stakeholder (corporate) | 1 | 2.1% |
Standard deviation | 1 | 2.1% |
Staphylococcus aureus | 1 | 2.1% |
Stress (biology) | 1 | 2.1% |
Strontium ranelate | 1 | 2.1% |
Subarachnoid hemorrhage | 1 | 2.1% |
Sugarcane | 1 | 2.1% |
Supportive housing | 1 | 2.1% |
Surface epithelial-stromal tumor | 1 | 2.1% |
Surgical mask | 1 | 2.1% |
Survey methodology | 1 | 2.1% |
Swarm behaviour | 1 | 2.1% |
Swine influenza | 1 | 2.1% |
Symptom | 1 | 2.1% |
Synthetic biology | 1 | 2.1% |
Syphilis | 1 | 2.1% |
Telehealth | 1 | 2.1% |
Telehomecare | 1 | 2.1% |
Telemedicine | 1 | 2.1% |
Terrorism | 1 | 2.1% |
Theory | 1 | 2.1% |
Ticagrelor | 1 | 2.1% |
Time | 1 | 2.1% |
Toll-like receptor | 1 | 2.1% |
Top-down and bottom-up design | 1 | 2.1% |
Tourniquet | 1 | 2.1% |
Traffic | 1 | 2.1% |
Transitional care | 1 | 2.1% |
Translational medicine | 1 | 2.1% |
Translational research | 1 | 2.1% |
Transport | 1 | 2.1% |
Transposable element | 1 | 2.1% |
Trauma center | 1 | 2.1% |
Triage | 1 | 2.1% |
Twin | 1 | 2.1% |
Typhoid fever | 1 | 2.1% |
Ulcer (dermatology) | 1 | 2.1% |
Ultrashort pulse | 1 | 2.1% |
Universal health care | 1 | 2.1% |
Urology | 1 | 2.1% |
Usability testing | 1 | 2.1% |
Vaccination | 1 | 2.1% |
Vasospasm | 1 | 2.1% |
Vector (epidemiology) | 1 | 2.1% |
Vegetable | 1 | 2.1% |
Venous thrombosis | 1 | 2.1% |
Vertebral augmentation | 1 | 2.1% |
Veteran | 1 | 2.1% |
Violence | 1 | 2.1% |
Vision | 1 | 2.1% |
Visual acuity | 1 | 2.1% |
Visual impairment | 1 | 2.1% |
Visual system | 1 | 2.1% |
Vitamin | 1 | 2.1% |
Vitamin E | 1 | 2.1% |
Volatile organic compound | 1 | 2.1% |
Warfarin | 1 | 2.1% |
Waste management | 1 | 2.1% |
Water footprint | 1 | 2.1% |
Weddell Sea | 1 | 2.1% |
Weight management | 1 | 2.1% |
West Nile fever | 1 | 2.1% |
West Nile virus | 1 | 2.1% |
Western honey bee | 1 | 2.1% |
Whole genome sequencing | 1 | 2.1% |
Women's health | 1 | 2.1% |
World Wide Web | 1 | 2.1% |
X-ray | 1 | 2.1% |
Xenobiology | 1 | 2.1% |
Yeast | 1 | 2.1% |
Yellow fever | 1 | 2.1% |
Zeaxanthin | 1 | 2.1% |
Zoonosis | 1 | 2.1% |
abs | rel | |
---|---|---|
Medicine | 77 | 92.8% |
Health | 76 | 91.6% |
Health sciences | 71 | 85.5% |
Medical specialties | 69 | 83.1% |
Health care | 66 | 79.5% |
Clinical medicine | 63 | 75.9% |
Public health | 40 | 48.2% |
Diseases and disorders | 33 | 39.8% |
Risk | 29 | 34.9% |
Infection | 28 | 33.7% |
Preventive healthcare | 27 | 32.5% |
Disease | 24 | 28.9% |
Epidemiology | 24 | 28.9% |
Health economics | 20 | 24.1% |
HIV/AIDS | 18 | 21.7% |
Health professional | 17 | 20.5% |
Human activities | 17 | 20.5% |
Health policy | 16 | 19.3% |
Evidence-based medicine | 15 | 18.1% |
Infectious diseases | 15 | 18.1% |
Medical humanities | 15 | 18.1% |
Research | 15 | 18.1% |
Adherence (medicine) | 14 | 16.9% |
Biology | 14 | 16.9% |
Immunology | 14 | 16.9% |
Myocardial infarction | 14 | 16.9% |
Antimicrobial resistance | 13 | 15.7% |
Cancer | 13 | 15.7% |
Patient | 13 | 15.7% |
Sensitivity and specificity | 13 | 15.7% |
Tuberculosis | 13 | 15.7% |
Cardiovascular disease | 12 | 14.5% |
Coronary artery disease | 12 | 14.5% |
Hospital | 12 | 14.5% |
Hypertension | 12 | 14.5% |
Medical diagnosis | 12 | 14.5% |
Chronic condition | 11 | 13.3% |
Microbiology | 11 | 13.3% |
Randomized controlled trial | 11 | 13.3% |
Sexually transmitted infection | 11 | 13.3% |
Surgery | 11 | 13.3% |
Systematic review | 11 | 13.3% |
Therapy | 11 | 13.3% |
Heart | 10 | 12.0% |
Life sciences | 10 | 12.0% |
Management of HIV/AIDS | 10 | 12.0% |
Public sphere | 10 | 12.0% |
Cardiovascular system | 9 | 10.8% |
Evaluation | 9 | 10.8% |
Human reproduction | 9 | 10.8% |
Pneumonia | 9 | 10.8% |
Pregnancy | 9 | 10.8% |
Stroke | 9 | 10.8% |
Antibiotic | 8 | 9.6% |
Health system | 8 | 9.6% |
Obesity | 8 | 9.6% |
Blood pressure | 7 | 8.4% |
Cardiology | 7 | 8.4% |
Low-density lipoprotein | 7 | 8.4% |
Medical guideline | 7 | 8.4% |
Medicare (United States) | 7 | 8.4% |
Medication | 7 | 8.4% |
Meta-analysis | 7 | 8.4% |
Nursing | 7 | 8.4% |
Percutaneous coronary intervention | 7 | 8.4% |
Screening (medicine) | 7 | 8.4% |
Self-care | 7 | 8.4% |
Sexual health | 7 | 8.4% |
Technology | 7 | 8.4% |
Childbirth | 6 | 7.2% |
Cholesterol | 6 | 7.2% |
Clinical trial | 6 | 7.2% |
Diagnosis of HIV/AIDS | 6 | 7.2% |
Emergency department | 6 | 7.2% |
Exercise | 6 | 7.2% |
Gonorrhea | 6 | 7.2% |
Women's health | 6 | 7.2% |
Breast cancer | 5 | 6.0% |
CT scan | 5 | 6.0% |
Caregiver | 5 | 6.0% |
Diabetes | 5 | 6.0% |
Disability | 5 | 6.0% |
Drugs | 5 | 6.0% |
High-density lipoprotein | 5 | 6.0% |
Hypercholesterolemia | 5 | 6.0% |
Immunodeficiency | 5 | 6.0% |
Medicaid | 5 | 6.0% |
Patient safety | 5 | 6.0% |
RTT | 5 | 6.0% |
Risk assessment | 5 | 6.0% |
Social programs | 5 | 6.0% |
Statin | 5 | 6.0% |
Transmission (medicine) | 5 | 6.0% |
Tropical medicine | 5 | 6.0% |
Vaccine | 5 | 6.0% |
Acute coronary syndrome | 4 | 4.8% |
Adverse effect | 4 | 4.8% |
Antibody | 4 | 4.8% |
Anticoagulant | 4 | 4.8% |
Antihypertensive drug | 4 | 4.8% |
Asthma | 4 | 4.8% |
Biotechnology | 4 | 4.8% |
C-reactive protein | 4 | 4.8% |
Cervical cancer | 4 | 4.8% |
Chronic obstructive pulmonary disease | 4 | 4.8% |
Clinical pathology | 4 | 4.8% |
Comorbidity | 4 | 4.8% |
Confidence interval | 4 | 4.8% |
DNA | 4 | 4.8% |
Diabetes mellitus type 2 | 4 | 4.8% |
Electronic health record | 4 | 4.8% |
Fertility | 4 | 4.8% |
Glycated hemoglobin | 4 | 4.8% |
Governance | 4 | 4.8% |
HIV | 4 | 4.8% |
Health informatics | 4 | 4.8% |
Health insurance coverage in the United States | 4 | 4.8% |
Information | 4 | 4.8% |
Lentiviruses | 4 | 4.8% |
Malaria | 4 | 4.8% |
Medical statistics | 4 | 4.8% |
Nature | 4 | 4.8% |
Nutrition | 4 | 4.8% |
Pharmacology | 4 | 4.8% |
Pharmacy | 4 | 4.8% |
Physician | 4 | 4.8% |
Policy | 4 | 4.8% |
Primary care | 4 | 4.8% |
Public services | 4 | 4.8% |
Quality-adjusted life year | 4 | 4.8% |
Reproductive health | 4 | 4.8% |
Safe sex | 4 | 4.8% |
Safety | 4 | 4.8% |
Science | 4 | 4.8% |
Sepsis | 4 | 4.8% |
Stem cell | 4 | 4.8% |
Survey methodology | 4 | 4.8% |
Sustainability | 4 | 4.8% |
Tuberculosis management | 4 | 4.8% |
Urology | 4 | 4.8% |
Angina | 3 | 3.6% |
Angioplasty | 3 | 3.6% |
Animal viral diseases | 3 | 3.6% |
Antimalarial medication | 3 | 3.6% |
Audit | 3 | 3.6% |
Best practice | 3 | 3.6% |
Birth control | 3 | 3.6% |
Birth defect | 3 | 3.6% |
Blinded experiment | 3 | 3.6% |
Blood sugar level | 3 | 3.6% |
Blood transfusion | 3 | 3.6% |
Branches of science | 3 | 3.6% |
Cell potency | 3 | 3.6% |
Chemotherapy | 3 | 3.6% |
Chlamydia infection | 3 | 3.6% |
Clinical decision support system | 3 | 3.6% |
Cognition | 3 | 3.6% |
Cohort study | 3 | 3.6% |
Colorectal cancer | 3 | 3.6% |
Condom | 3 | 3.6% |
Cost-effectiveness analysis | 3 | 3.6% |
Data analysis | 3 | 3.6% |
Diabetes management | 3 | 3.6% |
Diabetes mellitus | 3 | 3.6% |
Diagnosis of malaria | 3 | 3.6% |
Diarrhea | 3 | 3.6% |
Dieting | 3 | 3.6% |
Directly observed treatment, short-course | 3 | 3.6% |
ELISA | 3 | 3.6% |
Education | 3 | 3.6% |
Emergency contraception | 3 | 3.6% |
Engineering | 3 | 3.6% |
Ethics | 3 | 3.6% |
Family planning | 3 | 3.6% |
Fever | 3 | 3.6% |
Food | 3 | 3.6% |
Gene therapy | 3 | 3.6% |
Genetic engineering | 3 | 3.6% |
Genetic testing | 3 | 3.6% |
Gynaecologic disorders | 3 | 3.6% |
Health information technology | 3 | 3.6% |
Health promotion | 3 | 3.6% |
Heart failure | 3 | 3.6% |
Hepatitis | 3 | 3.6% |
Herpes simplex | 3 | 3.6% |
Hormonal contraception | 3 | 3.6% |
Hospital-acquired infection | 3 | 3.6% |
Human sexuality | 3 | 3.6% |
Infant | 3 | 3.6% |
Infection control | 3 | 3.6% |
Infertility | 3 | 3.6% |
Informed consent | 3 | 3.6% |
Insulin | 3 | 3.6% |
Internal medicine | 3 | 3.6% |
Internet | 3 | 3.6% |
Male genital disorders | 3 | 3.6% |
Management | 3 | 3.6% |
Medical record | 3 | 3.6% |
Medical research | 3 | 3.6% |
Medical test | 3 | 3.6% |
Medical treatments | 3 | 3.6% |
Methicillin-resistant Staphylococcus aureus | 3 | 3.6% |
Miscarriage | 3 | 3.6% |
Molecular biology | 3 | 3.6% |
Neisseria gonorrhoeae | 3 | 3.6% |
Neurology | 3 | 3.6% |
Non-communicable disease | 3 | 3.6% |
Nursing home care | 3 | 3.6% |
Occupational safety and health | 3 | 3.6% |
Physical sciences | 3 | 3.6% |
Plasmodium falciparum | 3 | 3.6% |
Plasmodium vivax | 3 | 3.6% |
Polymerase chain reaction | 3 | 3.6% |
Prediabetes | 3 | 3.6% |
Prevention of HIV/AIDS | 3 | 3.6% |
Procalcitonin | 3 | 3.6% |
Radiation therapy | 3 | 3.6% |
Rape | 3 | 3.6% |
Regenerative medicine | 3 | 3.6% |
Reporting bias | 3 | 3.6% |
Saturated fat | 3 | 3.6% |
Sexual intercourse | 3 | 3.6% |
Sexually transmitted diseases and infections | 3 | 3.6% |
Staphylococcus aureus | 3 | 3.6% |
Synthetic biology | 3 | 3.6% |
Syphilis | 3 | 3.6% |
System | 3 | 3.6% |
Telehealth | 3 | 3.6% |
Trichomoniasis | 3 | 3.6% |
Type 2 diabetes | 3 | 3.6% |
Zidovudine | 3 | 3.6% |
Abortion | 2 | 2.4% |
Adipose tissue | 2 | 2.4% |
Agriculture | 2 | 2.4% |
Angiology | 2 | 2.4% |
Angiotensin II receptor blocker | 2 | 2.4% |
Animals and humans | 2 | 2.4% |
Antiplatelet drug | 2 | 2.4% |
Aortic insufficiency | 2 | 2.4% |
Aortic stenosis | 2 | 2.4% |
Aortic valve | 2 | 2.4% |
Aortic valve replacement | 2 | 2.4% |
Apolipoprotein | 2 | 2.4% |
Artesunate | 2 | 2.4% |
Artificial intelligence | 2 | 2.4% |
Asepsis | 2 | 2.4% |
Aspirin | 2 | 2.4% |
Atherosclerosis | 2 | 2.4% |
Atrial fibrillation | 2 | 2.4% |
Atrium (heart) | 2 | 2.4% |
Attention | 2 | 2.4% |
Bacteremia | 2 | 2.4% |
Bacteria | 2 | 2.4% |
Bacterial vaginosis | 2 | 2.4% |
Balance (ability) | 2 | 2.4% |
Behavior | 2 | 2.4% |
Benzodiazepine | 2 | 2.4% |
Biobank | 2 | 2.4% |
Biodiversity | 2 | 2.4% |
Bioethics | 2 | 2.4% |
Biological engineering | 2 | 2.4% |
Biomarker | 2 | 2.4% |
Biomedicine | 2 | 2.4% |
Biomimetics | 2 | 2.4% |
Biopharmaceutical | 2 | 2.4% |
Biopsy | 2 | 2.4% |
Biosecurity | 2 | 2.4% |
Blood donation | 2 | 2.4% |
Blood lipids | 2 | 2.4% |
Blood-borne disease | 2 | 2.4% |
Brain | 2 | 2.4% |
Breastfeeding | 2 | 2.4% |
Bronchitis | 2 | 2.4% |
Caesarean section | 2 | 2.4% |
Cancer prevention | 2 | 2.4% |
Cancer registry | 2 | 2.4% |
Cardiac catheterization | 2 | 2.4% |
Cardiac muscle | 2 | 2.4% |
Cardiothoracic surgery | 2 | 2.4% |
Causes of death | 2 | 2.4% |
Cell (biology) | 2 | 2.4% |
Central nervous system disorders | 2 | 2.4% |
Chemistry | 2 | 2.4% |
Chickenpox | 2 | 2.4% |
Chlamydia trachomatis | 2 | 2.4% |
Cholecystectomy | 2 | 2.4% |
Circulatory system | 2 | 2.4% |
Climate | 2 | 2.4% |
Clinic | 2 | 2.4% |
Clinical commissioning group | 2 | 2.4% |
Clopidogrel | 2 | 2.4% |
Cloud computing | 2 | 2.4% |
Cognitive science | 2 | 2.4% |
Combined oral contraceptive pill | 2 | 2.4% |
Computing | 2 | 2.4% |
Concussion | 2 | 2.4% |
Consciousness | 2 | 2.4% |
Coronary artery bypass surgery | 2 | 2.4% |
Culture | 2 | 2.4% |
Cystectomy | 2 | 2.4% |
DNA sequencing | 2 | 2.4% |
Da Vinci Surgical System | 2 | 2.4% |
Depression (mood) | 2 | 2.4% |
Determinants of health | 2 | 2.4% |
Dietary supplement | 2 | 2.4% |
Disease management (health) | 2 | 2.4% |
Echocardiography | 2 | 2.4% |
Electrocardiography | 2 | 2.4% |
Embryonic stem cell | 2 | 2.4% |
Environmental social science | 2 | 2.4% |
Epileptic seizure | 2 | 2.4% |
Expert | 2 | 2.4% |
Fee-for-service | 2 | 2.4% |
Foot-and-mouth disease | 2 | 2.4% |
Gene | 2 | 2.4% |
General practitioner | 2 | 2.4% |
Genetics | 2 | 2.4% |
Genome | 2 | 2.4% |
Genomics | 2 | 2.4% |
Gestational diabetes | 2 | 2.4% |
Glucose tolerance test | 2 | 2.4% |
Government | 2 | 2.4% |
HIV/AIDS in Africa | 2 | 2.4% |
Hand washing | 2 | 2.4% |
Head injury | 2 | 2.4% |
Health Insurance Portability and Accountability Act | 2 | 2.4% |
Health care quality | 2 | 2.4% |
Health insurance | 2 | 2.4% |
Health technology in the United States | 2 | 2.4% |
Healthy diet | 2 | 2.4% |
Hepatitis A | 2 | 2.4% |
Hepatocellular carcinoma | 2 | 2.4% |
Human | 2 | 2.4% |
Human chorionic gonadotropin | 2 | 2.4% |
Human diseases and disorders | 2 | 2.4% |
Human papillomavirus infection | 2 | 2.4% |
Human sexual activity | 2 | 2.4% |
Hygiene | 2 | 2.4% |
Hyperglycemia | 2 | 2.4% |
Hysterectomy | 2 | 2.4% |
Immune system | 2 | 2.4% |
Incremental cost-effectiveness ratio | 2 | 2.4% |
Infection prevention and control | 2 | 2.4% |
Inflammation | 2 | 2.4% |
Influenza | 2 | 2.4% |
Information privacy | 2 | 2.4% |
Injuries | 2 | 2.4% |
Integrity | 2 | 2.4% |
Intellectual property | 2 | 2.4% |
Intelligence | 2 | 2.4% |
International Statistical Classification of Diseases and Related Health Problems | 2 | 2.4% |
Internet of things | 2 | 2.4% |
Isolation (health care) | 2 | 2.4% |
Laboratory | 2 | 2.4% |
Lamivudine | 2 | 2.4% |
Laparoscopy | 2 | 2.4% |
Law | 2 | 2.4% |
Leukemia | 2 | 2.4% |
Life | 2 | 2.4% |
Lipoprotein | 2 | 2.4% |
Lymphoma | 2 | 2.4% |
Major depressive disorder | 2 | 2.4% |
Maternal health | 2 | 2.4% |
Measles | 2 | 2.4% |
Medical device | 2 | 2.4% |
Medical prescription | 2 | 2.4% |
Medicare dual eligible | 2 | 2.4% |
Men who have sex with men | 2 | 2.4% |
Meningitis | 2 | 2.4% |
Mental disorder | 2 | 2.4% |
Metabolic syndrome | 2 | 2.4% |
Microscopy | 2 | 2.4% |
Midwife | 2 | 2.4% |
Mifepristone | 2 | 2.4% |
Mind | 2 | 2.4% |
Minimally invasive procedure | 2 | 2.4% |
Multi-drug-resistant tuberculosis | 2 | 2.4% |
NHS foundation trust | 2 | 2.4% |
National Health Interview Survey | 2 | 2.4% |
Nephrectomy | 2 | 2.4% |
Nervous system | 2 | 2.4% |
Neural engineering | 2 | 2.4% |
Neurofeedback | 2 | 2.4% |
Neurological disorders | 2 | 2.4% |
Neuromodulation (medicine) | 2 | 2.4% |
Neutropenia | 2 | 2.4% |
Nevirapine | 2 | 2.4% |
Obstetrics | 2 | 2.4% |
Office of Inspector General (United States) | 2 | 2.4% |
Organ donation | 2 | 2.4% |
Organ transplantation | 2 | 2.4% |
Organism | 2 | 2.4% |
Osteoporosis | 2 | 2.4% |
Ovarian cancer | 2 | 2.4% |
Palliative care | 2 | 2.4% |
Parasitism | 2 | 2.4% |
Pelvic inflammatory disease | 2 | 2.4% |
Percutaneous aortic valve replacement | 2 | 2.4% |
Personal genomics | 2 | 2.4% |
Personal protective equipment | 2 | 2.4% |
Physical therapy | 2 | 2.4% |
Plasmodium | 2 | 2.4% |
Positive and negative predictive values | 2 | 2.4% |
Post-exposure prophylaxis | 2 | 2.4% |
Post-traumatic amnesia | 2 | 2.4% |
Postpartum period | 2 | 2.4% |
Prasugrel | 2 | 2.4% |
Prenatal development | 2 | 2.4% |
Prenatal testing | 2 | 2.4% |
Preterm birth | 2 | 2.4% |
Primary care physician | 2 | 2.4% |
Primary healthcare | 2 | 2.4% |
Privacy | 2 | 2.4% |
Prostate cancer | 2 | 2.4% |
Prostatectomy | 2 | 2.4% |
Protein | 2 | 2.4% |
Psychology | 2 | 2.4% |
Quality of life | 2 | 2.4% |
Receiver operating characteristic | 2 | 2.4% |
Regulation | 2 | 2.4% |
Regulatory compliance | 2 | 2.4% |
Remote patient monitoring | 2 | 2.4% |
Reperfusion therapy | 2 | 2.4% |
Respiratory droplet | 2 | 2.4% |
Robot | 2 | 2.4% |
Robot-assisted surgery | 2 | 2.4% |
Science and Technology Options Assessment | 2 | 2.4% |
Sequencing | 2 | 2.4% |
Sheep | 2 | 2.4% |
Simulation | 2 | 2.4% |
Social stigma | 2 | 2.4% |
Sociotechnical system | 2 | 2.4% |
Specialty (medicine) | 2 | 2.4% |
Standardization | 2 | 2.4% |
Surgical mask | 2 | 2.4% |
Surveillance | 2 | 2.4% |
Tamoxifen | 2 | 2.4% |
Technological convergence | 2 | 2.4% |
Technological singularity | 2 | 2.4% |
Telepharmacy | 2 | 2.4% |
Thrombosis | 2 | 2.4% |
Ticagrelor | 2 | 2.4% |
Tobacco smoking | 2 | 2.4% |
Top-down and bottom-up design | 2 | 2.4% |
Transcranial magnetic stimulation | 2 | 2.4% |
Transmission-based precautions | 2 | 2.4% |
Trauma types | 2 | 2.4% |
Traumatic brain injury | 2 | 2.4% |
Traumatology | 2 | 2.4% |
Trichomonas vaginalis | 2 | 2.4% |
Unintended pregnancy | 2 | 2.4% |
Vaccination | 2 | 2.4% |
Vagina | 2 | 2.4% |
Vaginal discharge | 2 | 2.4% |
Vaginitis | 2 | 2.4% |
Valvular heart disease | 2 | 2.4% |
Vancomycin-resistant Enterococcus | 2 | 2.4% |
Vein | 2 | 2.4% |
Vertically transmitted infection | 2 | 2.4% |
Veterinarian | 2 | 2.4% |
Veterinary medicine | 2 | 2.4% |
Virus | 2 | 2.4% |
Weight loss | 2 | 2.4% |
Whole genome sequencing | 2 | 2.4% |
2009 flu pandemic | 1 | 1.2% |
ABVD | 1 | 1.2% |
ACE inhibitor | 1 | 1.2% |
ADME | 1 | 1.2% |
ATM serine/threonine kinase | 1 | 1.2% |
Abdominal obesity | 1 | 1.2% |
Absorption (pharmacology) | 1 | 1.2% |
Accidents | 1 | 1.2% |
Accretion (astrophysics) | 1 | 1.2% |
Accretion disk | 1 | 1.2% |
Aciclovir | 1 | 1.2% |
Active galactic nucleus | 1 | 1.2% |
Acute myeloid leukemia | 1 | 1.2% |
Acute promyelocytic leukemia | 1 | 1.2% |
Adaptive immune system | 1 | 1.2% |
Adjustable gastric band | 1 | 1.2% |
Adjuvant therapy | 1 | 1.2% |
Adolescence | 1 | 1.2% |
Adoption | 1 | 1.2% |
African Americans | 1 | 1.2% |
Air pollution | 1 | 1.2% |
Airborne disease | 1 | 1.2% |
Airborne transmission | 1 | 1.2% |
Allergy | 1 | 1.2% |
Allocation concealment | 1 | 1.2% |
Alpha-fetoprotein | 1 | 1.2% |
Alternative medicine | 1 | 1.2% |
Alzheimer's disease | 1 | 1.2% |
Amiodarone | 1 | 1.2% |
Amnesia | 1 | 1.2% |
Amniocentesis | 1 | 1.2% |
Amodiaquine | 1 | 1.2% |
Amplifier | 1 | 1.2% |
Amyloid beta | 1 | 1.2% |
Anal sex | 1 | 1.2% |
Anaphylaxis | 1 | 1.2% |
Anaplastic oligodendroglioma | 1 | 1.2% |
Aneurysm | 1 | 1.2% |
Animal anatomy | 1 | 1.2% |
Animal diseases | 1 | 1.2% |
Antarctica | 1 | 1.2% |
Anterograde amnesia | 1 | 1.2% |
Anthracycline | 1 | 1.2% |
Anthropometry | 1 | 1.2% |
Antibiotic prophylaxis | 1 | 1.2% |
Antidepressant | 1 | 1.2% |
Antigen | 1 | 1.2% |
Antineoplastic and immunomodulating drugs | 1 | 1.2% |
Antineoplastic drugs | 1 | 1.2% |
Aorta | 1 | 1.2% |
Aortic aneurysm | 1 | 1.2% |
Aortic dissection | 1 | 1.2% |
Aromatase inhibitor | 1 | 1.2% |
Artemisinin | 1 | 1.2% |
Artery | 1 | 1.2% |
Ascending aorta | 1 | 1.2% |
Asteroid | 1 | 1.2% |
Astrocytoma | 1 | 1.2% |
Astronomy | 1 | 1.2% |
Astrophysical jet | 1 | 1.2% |
Atom | 1 | 1.2% |
Atomic nucleus | 1 | 1.2% |
Atomic number | 1 | 1.2% |
Atrial septal defect | 1 | 1.2% |
Attention deficit hyperactivity disorder | 1 | 1.2% |
Attitude (psychology) | 1 | 1.2% |
Authentication | 1 | 1.2% |
Avian influenza | 1 | 1.2% |
B cell | 1 | 1.2% |
BRCA mutation | 1 | 1.2% |
BRCA1 | 1 | 1.2% |
Baby Friendly Hospital Initiative | 1 | 1.2% |
Background radiation | 1 | 1.2% |
Bareback (sex) | 1 | 1.2% |
Bariatric surgery | 1 | 1.2% |
Benznidazole | 1 | 1.2% |
Beta blocker | 1 | 1.2% |
Beta cell | 1 | 1.2% |
Bevacizumab | 1 | 1.2% |
Bias | 1 | 1.2% |
Bicuspid aortic valve | 1 | 1.2% |
Bioavailability | 1 | 1.2% |
Biochemistry | 1 | 1.2% |
Biomechanics | 1 | 1.2% |
Bisphosphonate | 1 | 1.2% |
Bivalirudin | 1 | 1.2% |
Black hole | 1 | 1.2% |
Bleeding | 1 | 1.2% |
Blood cell | 1 | 1.2% |
Blood glucose monitoring | 1 | 1.2% |
Blood plasma | 1 | 1.2% |
Blood pressure measurement | 1 | 1.2% |
Blunt trauma | 1 | 1.2% |
Body mass index | 1 | 1.2% |
Bone | 1 | 1.2% |
Bone density | 1 | 1.2% |
Bone fracture | 1 | 1.2% |
Bone marrow | 1 | 1.2% |
Bone resorption | 1 | 1.2% |
Brain damage | 1 | 1.2% |
Brain natriuretic peptide | 1 | 1.2% |
Brain tumor | 1 | 1.2% |
Breast milk | 1 | 1.2% |
Breastfeeding and HIV | 1 | 1.2% |
CD4 | 1 | 1.2% |
Calcitonin | 1 | 1.2% |
Calcitriol | 1 | 1.2% |
Cancer pain | 1 | 1.2% |
Cancer staging | 1 | 1.2% |
Cancer treatments | 1 | 1.2% |
Candidiasis | 1 | 1.2% |
Capacity building | 1 | 1.2% |
Car | 1 | 1.2% |
Carbohydrate | 1 | 1.2% |
Carbon dioxide | 1 | 1.2% |
Carbon nanotube | 1 | 1.2% |
Carboplatin | 1 | 1.2% |
Carcinogen | 1 | 1.2% |
Carcinoma | 1 | 1.2% |
Cardiac cycle | 1 | 1.2% |
Cardiac muscle cell | 1 | 1.2% |
Cardiac stress test | 1 | 1.2% |
Cardiac surgery | 1 | 1.2% |
Cardiovascular diseases | 1 | 1.2% |
Cardiovascular physiology | 1 | 1.2% |
Cardioversion | 1 | 1.2% |
Case management (US health system) | 1 | 1.2% |
Catalysis | 1 | 1.2% |
Catalytic converter | 1 | 1.2% |
Catheter | 1 | 1.2% |
Catheter ablation | 1 | 1.2% |
Cell cycle | 1 | 1.2% |
Cell membrane | 1 | 1.2% |
Cellular differentiation | 1 | 1.2% |
Central nervous system | 1 | 1.2% |
Central venous catheter | 1 | 1.2% |
Cervical screening | 1 | 1.2% |
Cervix | 1 | 1.2% |
Cetuximab | 1 | 1.2% |
Chagas disease | 1 | 1.2% |
Chancroid | 1 | 1.2% |
Chief executive officer | 1 | 1.2% |
Child care | 1 | 1.2% |
Childlessness | 1 | 1.2% |
Children's Health Insurance Program | 1 | 1.2% |
Chlamydia | 1 | 1.2% |
Chlorhexidine | 1 | 1.2% |
Chloroquine | 1 | 1.2% |
Chronic kidney disease | 1 | 1.2% |
Chronic myelogenous leukemia | 1 | 1.2% |
Cirrhosis | 1 | 1.2% |
Climate change | 1 | 1.2% |
Climate change mitigation | 1 | 1.2% |
Climate engineering | 1 | 1.2% |
Clinical audit | 1 | 1.2% |
Closed-head injury | 1 | 1.2% |
Clostridioides difficile infection | 1 | 1.2% |
Coccidioidomycosis | 1 | 1.2% |
Coitus interruptus | 1 | 1.2% |
Coma | 1 | 1.2% |
Combustion | 1 | 1.2% |
Communication | 1 | 1.2% |
Community | 1 | 1.2% |
Community health | 1 | 1.2% |
Community health worker | 1 | 1.2% |
Community mental health service | 1 | 1.2% |
Community-acquired pneumonia | 1 | 1.2% |
Compact Muon Solenoid | 1 | 1.2% |
Computer security | 1 | 1.2% |
Computer-aided design | 1 | 1.2% |
Confidentiality | 1 | 1.2% |
Conflict of interest | 1 | 1.2% |
Confounding | 1 | 1.2% |
Congenital syphilis | 1 | 1.2% |
Contract | 1 | 1.2% |
Contrast-enhanced ultrasound | 1 | 1.2% |
Copper IUDs | 1 | 1.2% |
Coral reef | 1 | 1.2% |
Coronary catheterization | 1 | 1.2% |
Cost–utility analysis | 1 | 1.2% |
Cough | 1 | 1.2% |
Creatinine | 1 | 1.2% |
Cross-validation (statistics) | 1 | 1.2% |
Cryoablation | 1 | 1.2% |
Cryptococcosis | 1 | 1.2% |
Cryptography | 1 | 1.2% |
Cryptosporidiosis | 1 | 1.2% |
Cybercrime | 1 | 1.2% |
Cystoisospora belli | 1 | 1.2% |
Cytochrome P450 | 1 | 1.2% |
Cytoskeleton | 1 | 1.2% |
Cytotoxic T cell | 1 | 1.2% |
DPT vaccine | 1 | 1.2% |
Dabigatran | 1 | 1.2% |
Decision-making | 1 | 1.2% |
Delirium | 1 | 1.2% |
Dementia | 1 | 1.2% |
Demographic and Health Surveys | 1 | 1.2% |
Dendritic cell | 1 | 1.2% |
Denosumab | 1 | 1.2% |
Desertification | 1 | 1.2% |
Developing country | 1 | 1.2% |
Diabetes mellitus type 1 | 1 | 1.2% |
Diabetic ketoacidosis | 1 | 1.2% |
Diabetic retinopathy | 1 | 1.2% |
Diagnosis-related group | 1 | 1.2% |
Diagnostic and Statistical Manual of Mental Disorders | 1 | 1.2% |
Diastole | 1 | 1.2% |
Diet (nutrition) | 1 | 1.2% |
Discrimination | 1 | 1.2% |
Disease burden | 1 | 1.2% |
Disorders of endocrine pancreas | 1 | 1.2% |
Docetaxel | 1 | 1.2% |
Domestic violence | 1 | 1.2% |
Doppler ultrasonography | 1 | 1.2% |
Dose (biochemistry) | 1 | 1.2% |
Down syndrome | 1 | 1.2% |
Doxorubicin | 1 | 1.2% |
Doxycycline | 1 | 1.2% |
Drug design | 1 | 1.2% |
Drug discovery | 1 | 1.2% |
Drug metabolism | 1 | 1.2% |
Dual-energy X-ray absorptiometry | 1 | 1.2% |
EPSDT | 1 | 1.2% |
Earthquake | 1 | 1.2% |
Ecological design | 1 | 1.2% |
Economic growth | 1 | 1.2% |
Economics | 1 | 1.2% |
Economics of service industries | 1 | 1.2% |
Ecosystem | 1 | 1.2% |
Efavirenz | 1 | 1.2% |
Effect size | 1 | 1.2% |
Effects of global warming | 1 | 1.2% |
Efficient energy use | 1 | 1.2% |
Ejection fraction | 1 | 1.2% |
Electric battery | 1 | 1.2% |
Electric vehicle | 1 | 1.2% |
Electrical conduction system of the heart | 1 | 1.2% |
Electrical grid | 1 | 1.2% |
Electromagnetic spectrum | 1 | 1.2% |
Electronic waste | 1 | 1.2% |
Embedded system | 1 | 1.2% |
Emergence | 1 | 1.2% |
Emergency | 1 | 1.2% |
Emergency management | 1 | 1.2% |
Emergency medicine | 1 | 1.2% |
Employment | 1 | 1.2% |
Encryption | 1 | 1.2% |
Endocrine system | 1 | 1.2% |
Endocrine, nutritional and metabolic diseases | 1 | 1.2% |
Endogeneity (econometrics) | 1 | 1.2% |
Endometrial cancer | 1 | 1.2% |
Endometrium | 1 | 1.2% |
Endothelium | 1 | 1.2% |
Endovascular aneurysm repair | 1 | 1.2% |
Energy storage | 1 | 1.2% |
Engine | 1 | 1.2% |
Enterovirus-associated diseases | 1 | 1.2% |
Envelope glycoprotein GP120 | 1 | 1.2% |
Ependymoma | 1 | 1.2% |
Epidermal growth factor receptor | 1 | 1.2% |
Epidural administration | 1 | 1.2% |
Epilepsy | 1 | 1.2% |
Eptifibatide | 1 | 1.2% |
Eradication of infectious diseases | 1 | 1.2% |
Estriol | 1 | 1.2% |
Ethionamide | 1 | 1.2% |
Evidence-based policy | 1 | 1.2% |
Evidence-based practice | 1 | 1.2% |
Exocrine system | 1 | 1.2% |
Experiment | 1 | 1.2% |
Fall prevention | 1 | 1.2% |
False Claims Act | 1 | 1.2% |
Familial hypercholesterolemia | 1 | 1.2% |
Family medicine | 1 | 1.2% |
Fat | 1 | 1.2% |
Febrile neutropenia | 1 | 1.2% |
Federally Qualified Health Center | 1 | 1.2% |
Fellatio | 1 | 1.2% |
Female condom | 1 | 1.2% |
Fenofibrate | 1 | 1.2% |
Fertility preservation | 1 | 1.2% |
Fiber-optic communication | 1 | 1.2% |
Fibre-reinforced plastic | 1 | 1.2% |
Flood | 1 | 1.2% |
Flu season | 1 | 1.2% |
Fludarabine | 1 | 1.2% |
Folate | 1 | 1.2% |
Food and drink | 1 | 1.2% |
Food fortification | 1 | 1.2% |
Formulary (pharmacy) | 1 | 1.2% |
Frailty syndrome | 1 | 1.2% |
Framingham Risk Score | 1 | 1.2% |
Fraud | 1 | 1.2% |
Fuel | 1 | 1.2% |
Fuel cell | 1 | 1.2% |
Functional neurological symptom disorder | 1 | 1.2% |
Galaxy | 1 | 1.2% |
Galileo (satellite navigation) | 1 | 1.2% |
Gametocyte | 1 | 1.2% |
Gastric bypass surgery | 1 | 1.2% |
Gastroenteritis | 1 | 1.2% |
Gefitinib | 1 | 1.2% |
Gene delivery | 1 | 1.2% |
Genetic counseling | 1 | 1.2% |
Genetically modified organism | 1 | 1.2% |
Genital herpes | 1 | 1.2% |
Genital wart | 1 | 1.2% |
Gentamicin | 1 | 1.2% |
Geriatrics | 1 | 1.2% |
Gestational age | 1 | 1.2% |
Gestrinone | 1 | 1.2% |
Glasgow Coma Scale | 1 | 1.2% |
Glioblastoma | 1 | 1.2% |
Global warming | 1 | 1.2% |
Glucose test | 1 | 1.2% |
Goal | 1 | 1.2% |
Gp41 | 1 | 1.2% |
Greenland ice sheet | 1 | 1.2% |
Grid computing | 1 | 1.2% |
Grievance (labour) | 1 | 1.2% |
Gross domestic product | 1 | 1.2% |
Group B streptococcal infection | 1 | 1.2% |
Gynaecology | 1 | 1.2% |
HER2/neu | 1 | 1.2% |
HIV and pregnancy | 1 | 1.2% |
HTTPS | 1 | 1.2% |
Hand sanitizer | 1 | 1.2% |
Hazard ratio | 1 | 1.2% |
Head and neck cancer | 1 | 1.2% |
Headache | 1 | 1.2% |
Health Information Technology for Economic and Clinical Health Act | 1 | 1.2% |
Health and Social Care Act 2012 | 1 | 1.2% |
Health care in the United States | 1 | 1.2% |
Health education | 1 | 1.2% |
Health equity | 1 | 1.2% |
Health human resources | 1 | 1.2% |
Health literacy | 1 | 1.2% |
Health technology | 1 | 1.2% |
Health technology assessment | 1 | 1.2% |
Heart arrhythmia | 1 | 1.2% |
Heart murmur | 1 | 1.2% |
Heart rate | 1 | 1.2% |
Heart valve | 1 | 1.2% |
Hematopoietic stem cell transplantation | 1 | 1.2% |
Hemodialysis | 1 | 1.2% |
Hepatology | 1 | 1.2% |
Herd immunity | 1 | 1.2% |
Hereditary nonpolyposis colorectal cancer | 1 | 1.2% |
Hierarchy of evidence | 1 | 1.2% |
Histoplasmosis | 1 | 1.2% |
History of cancer chemotherapy | 1 | 1.2% |
Hodgkin lymphoma | 1 | 1.2% |
Homogeneous charge compression ignition | 1 | 1.2% |
Homosexuality | 1 | 1.2% |
Hormonal therapy (oncology) | 1 | 1.2% |
Hormone replacement therapy | 1 | 1.2% |
Hospital-acquired pneumonia | 1 | 1.2% |
Human anatomy | 1 | 1.2% |
Human cytomegalovirus | 1 | 1.2% |
Human female reproductive system | 1 | 1.2% |
Human pregnancy | 1 | 1.2% |
Human rights | 1 | 1.2% |
Human subject research | 1 | 1.2% |
Humoral immunity | 1 | 1.2% |
Hydrogen | 1 | 1.2% |
Hydrogen storage | 1 | 1.2% |
Hydrogen vehicle | 1 | 1.2% |
Hyperparathyroidism | 1 | 1.2% |
Hypertriglyceridemia | 1 | 1.2% |
Hypnotic | 1 | 1.2% |
Hypoglycemia | 1 | 1.2% |
Hypokalemia | 1 | 1.2% |
Hypothyroidism | 1 | 1.2% |
Ice sheet | 1 | 1.2% |
Immunization | 1 | 1.2% |
Immunocontraception | 1 | 1.2% |
Incentive | 1 | 1.2% |
Incidence (epidemiology) | 1 | 1.2% |
Incident management | 1 | 1.2% |
Indoor air quality | 1 | 1.2% |
Induced pluripotent stem cell | 1 | 1.2% |
Infant formula | 1 | 1.2% |
Influenza A virus subtype H1N1 | 1 | 1.2% |
Influenza A virus subtype H3N2 | 1 | 1.2% |
Influenza A virus subtype H5N1 | 1 | 1.2% |
Influenza pandemic | 1 | 1.2% |
Influenza research | 1 | 1.2% |
Influenza vaccine | 1 | 1.2% |
Innovation | 1 | 1.2% |
Insect-borne diseases | 1 | 1.2% |
Institution | 1 | 1.2% |
Insulin pump | 1 | 1.2% |
Insulin resistance | 1 | 1.2% |
Integrated circuit | 1 | 1.2% |
Intensive care medicine | 1 | 1.2% |
Intensive care unit | 1 | 1.2% |
Inter-rater reliability | 1 | 1.2% |
Interdisciplinarity | 1 | 1.2% |
Interest | 1 | 1.2% |
Intermediate Care Facilities for Individuals with Mental Retardation | 1 | 1.2% |
Interventional radiology | 1 | 1.2% |
Intraclass correlation | 1 | 1.2% |
Intracranial hemorrhage | 1 | 1.2% |
Intrauterine device | 1 | 1.2% |
Intravenous therapy | 1 | 1.2% |
Ischemia | 1 | 1.2% |
Isoniazid | 1 | 1.2% |
Isosporiasis | 1 | 1.2% |
Isotope | 1 | 1.2% |
KRAS | 1 | 1.2% |
Kaposi's sarcoma | 1 | 1.2% |
Knowledge | 1 | 1.2% |
Kuiper belt | 1 | 1.2% |
Labor induction | 1 | 1.2% |
Laparoscopic radical prostatectomy | 1 | 1.2% |
Lapatinib | 1 | 1.2% |
Large Hadron Collider | 1 | 1.2% |
Leadership | 1 | 1.2% |
Lenalidomide | 1 | 1.2% |
Leukorrhea | 1 | 1.2% |
Levonorgestrel | 1 | 1.2% |
Levothyroxine | 1 | 1.2% |
Life-cycle assessment | 1 | 1.2% |
Light | 1 | 1.2% |
Liver | 1 | 1.2% |
Liver cancer | 1 | 1.2% |
Low birth weight | 1 | 1.2% |
Low-carbohydrate diet | 1 | 1.2% |
Lower respiratory tract infection | 1 | 1.2% |
Lung | 1 | 1.2% |
Lung cancer | 1 | 1.2% |
Lymph node | 1 | 1.2% |
Lymphatic system | 1 | 1.2% |
Lymphocyte | 1 | 1.2% |
MEDLINE | 1 | 1.2% |
MMR vaccine | 1 | 1.2% |
MRI contrast agent | 1 | 1.2% |
Macrophage | 1 | 1.2% |
Macula of retina | 1 | 1.2% |
Macular degeneration | 1 | 1.2% |
Magnesium deficiency | 1 | 1.2% |
Magnesium diboride | 1 | 1.2% |
Magnetic resonance imaging | 1 | 1.2% |
Malaria antigen detection tests | 1 | 1.2% |
Malnutrition | 1 | 1.2% |
Malware | 1 | 1.2% |
Mammalian sexuality | 1 | 1.2% |
Mammography | 1 | 1.2% |
Managed care | 1 | 1.2% |
Management of acute coronary syndrome | 1 | 1.2% |
Management of atrial fibrillation | 1 | 1.2% |
Management of hypertension | 1 | 1.2% |
Marfan syndrome | 1 | 1.2% |
Market (economics) | 1 | 1.2% |
Mass drug administration | 1 | 1.2% |
Maternal death | 1 | 1.2% |
Medical abortion | 1 | 1.2% |
Medical and health organizations | 1 | 1.2% |
Medical emergencies | 1 | 1.2% |
Medical equipment | 1 | 1.2% |
Medical equipment management | 1 | 1.2% |
Medical history | 1 | 1.2% |
Medical imaging | 1 | 1.2% |
Medical physics | 1 | 1.2% |
Medical specialty | 1 | 1.2% |
Medical tests | 1 | 1.2% |
Medical ultrasound | 1 | 1.2% |
Medicinal chemistry | 1 | 1.2% |
Medroxyprogesterone acetate | 1 | 1.2% |
Medulloblastoma | 1 | 1.2% |
Mefloquine | 1 | 1.2% |
Memory | 1 | 1.2% |
Menopause | 1 | 1.2% |
Menstrual cycle | 1 | 1.2% |
Mental health | 1 | 1.2% |
Mental health professional | 1 | 1.2% |
Mental status examination | 1 | 1.2% |
Meso-zeaxanthin | 1 | 1.2% |
Metabolic disorders | 1 | 1.2% |
Metamaterial | 1 | 1.2% |
Metastasis | 1 | 1.2% |
Metformin | 1 | 1.2% |
Methylenetetrahydrofolate reductase | 1 | 1.2% |
Microelectromechanical systems | 1 | 1.2% |
Microorganism | 1 | 1.2% |
Microprocessor | 1 | 1.2% |
Midwifery | 1 | 1.2% |
Milky Way | 1 | 1.2% |
Misoprostol | 1 | 1.2% |
Mitral insufficiency | 1 | 1.2% |
Mitral valve | 1 | 1.2% |
Mitral valve annuloplasty | 1 | 1.2% |
Mitral valve stenosis | 1 | 1.2% |
Monocyte | 1 | 1.2% |
Mortality rate | 1 | 1.2% |
Mucositis | 1 | 1.2% |
Multiple myeloma | 1 | 1.2% |
Muon | 1 | 1.2% |
Mycobacterium | 1 | 1.2% |
Mycoplasma | 1 | 1.2% |
Myelodysplastic syndrome | 1 | 1.2% |
Myeloma protein | 1 | 1.2% |
Myocardial perfusion imaging | 1 | 1.2% |
N95 respirator | 1 | 1.2% |
Nanotechnology | 1 | 1.2% |
National coverage determination | 1 | 1.2% |
Natural killer T cell | 1 | 1.2% |
Natural reservoir | 1 | 1.2% |
Nausea | 1 | 1.2% |
Needlestick injury | 1 | 1.2% |
Needs assessment | 1 | 1.2% |
Negative room pressure | 1 | 1.2% |
Neglected tropical diseases | 1 | 1.2% |
Neonatal infection | 1 | 1.2% |
Neonatal sepsis | 1 | 1.2% |
Neoplasms | 1 | 1.2% |
Neural tube defect | 1 | 1.2% |
Neurodegeneration | 1 | 1.2% |
Neurosurgery | 1 | 1.2% |
Neurotrauma | 1 | 1.2% |
Neutron | 1 | 1.2% |
Niacin | 1 | 1.2% |
Nicotine | 1 | 1.2% |
Nifurtimox | 1 | 1.2% |
Non-governmental organization | 1 | 1.2% |
Nonoxynol-9 | 1 | 1.2% |
Nuchal scan | 1 | 1.2% |
Number needed to treat | 1 | 1.2% |
Nurse practitioner | 1 | 1.2% |
Obstetric ultrasonography | 1 | 1.2% |
Occupational stress | 1 | 1.2% |
Oligoastrocytoma | 1 | 1.2% |
Oligodendroglioma | 1 | 1.2% |
Open access | 1 | 1.2% |
Open data | 1 | 1.2% |
Opioid | 1 | 1.2% |
Optical amplifier | 1 | 1.2% |
Optics | 1 | 1.2% |
Organic electronics | 1 | 1.2% |
Organs (anatomy) | 1 | 1.2% |
Orthopedic surgery | 1 | 1.2% |
Osteopenia | 1 | 1.2% |
Outbreak | 1 | 1.2% |
Outcomes research | 1 | 1.2% |
Outlier | 1 | 1.2% |
Outpatient surgery | 1 | 1.2% |
P2Y12 | 1 | 1.2% |
P53 | 1 | 1.2% |
Paclitaxel | 1 | 1.2% |
Pain | 1 | 1.2% |
Pain management | 1 | 1.2% |
Pancreatic cancer | 1 | 1.2% |
Pancreatic islets | 1 | 1.2% |
Paradigm | 1 | 1.2% |
Parathyroid hormone | 1 | 1.2% |
Particle accelerator | 1 | 1.2% |
Particle physics | 1 | 1.2% |
Partition coefficient | 1 | 1.2% |
Patent | 1 | 1.2% |
Pathology | 1 | 1.2% |
Payment Card Industry Data Security Standard | 1 | 1.2% |
Pediatrics | 1 | 1.2% |
Pelvic examination | 1 | 1.2% |
Perception | 1 | 1.2% |
Performance indicator | 1 | 1.2% |
Peripheral neuropathy | 1 | 1.2% |
Peripherally inserted central catheter | 1 | 1.2% |
Personalized medicine | 1 | 1.2% |
Phagocyte | 1 | 1.2% |
Phagocytosis | 1 | 1.2% |
Pharmaceutical formulation | 1 | 1.2% |
Pharmaceutical sciences | 1 | 1.2% |
Pharmaceutics | 1 | 1.2% |
Pharmacokinetics | 1 | 1.2% |
Phases of clinical research | 1 | 1.2% |
Photovoltaic system | 1 | 1.2% |
Photovoltaics | 1 | 1.2% |
Physical fitness | 1 | 1.2% |
Physician assistant | 1 | 1.2% |
Physics | 1 | 1.2% |
Physiologically based pharmacokinetic modelling | 1 | 1.2% |
Physiology | 1 | 1.2% |
Planet | 1 | 1.2% |
Plant breeding | 1 | 1.2% |
Plasma cell | 1 | 1.2% |
Plasmacytoma | 1 | 1.2% |
Plasmid | 1 | 1.2% |
Pneumocystis pneumonia | 1 | 1.2% |
Point of care | 1 | 1.2% |
Polio vaccine | 1 | 1.2% |
Poliomyelitis | 1 | 1.2% |
Poliomyelitis eradication | 1 | 1.2% |
Population | 1 | 1.2% |
Post-traumatic seizure | 1 | 1.2% |
Potassium | 1 | 1.2% |
Poverty | 1 | 1.2% |
Pre-eclampsia | 1 | 1.2% |
Prenatal care | 1 | 1.2% |
Prescription drug | 1 | 1.2% |
Prevalence | 1 | 1.2% |
Prevention | 1 | 1.2% |
Preventive medicine | 1 | 1.2% |
Pricing | 1 | 1.2% |
Primaquine | 1 | 1.2% |
Procurement | 1 | 1.2% |
Productivity | 1 | 1.2% |
Program evaluation | 1 | 1.2% |
Progressive multifocal leukoencephalopathy | 1 | 1.2% |
Proguanil | 1 | 1.2% |
Proton | 1 | 1.2% |
Proton-exchange membrane fuel cell | 1 | 1.2% |
Protozoal diseases | 1 | 1.2% |
Psychometrics | 1 | 1.2% |
Psychosis | 1 | 1.2% |
Psychotherapy | 1 | 1.2% |
Public engagement | 1 | 1.2% |
Public good (economics) | 1 | 1.2% |
Public health genomics | 1 | 1.2% |
Public health surveillance | 1 | 1.2% |
Public policy | 1 | 1.2% |
Public-key cryptography | 1 | 1.2% |
Public–private partnership | 1 | 1.2% |
Pulmonary hypertension | 1 | 1.2% |
Pyrazinamide | 1 | 1.2% |
QRISK | 1 | 1.2% |
Quality and Outcomes Framework | 1 | 1.2% |
Quality assurance | 1 | 1.2% |
Quality management | 1 | 1.2% |
Quality of life (healthcare) | 1 | 1.2% |
Quantitative computed tomography | 1 | 1.2% |
Quantitative structure–activity relationship | 1 | 1.2% |
Quantum mechanics | 1 | 1.2% |
Quasar | 1 | 1.2% |
Quinine | 1 | 1.2% |
RANKL | 1 | 1.2% |
RNA | 1 | 1.2% |
Race and ethnicity in the United States Census | 1 | 1.2% |
Radiofrequency ablation | 1 | 1.2% |
Radiology | 1 | 1.2% |
Rain | 1 | 1.2% |
Raloxifene | 1 | 1.2% |
Real-time polymerase chain reaction | 1 | 1.2% |
Reason | 1 | 1.2% |
Rectal prolapse | 1 | 1.2% |
Recycling | 1 | 1.2% |
Red blood cell | 1 | 1.2% |
Regeneration (biology) | 1 | 1.2% |
Relative risk | 1 | 1.2% |
Reliability (statistics) | 1 | 1.2% |
Reprogramming | 1 | 1.2% |
Respiratory disease | 1 | 1.2% |
Respiratory therapist | 1 | 1.2% |
Respiratory tract infection | 1 | 1.2% |
Retirement | 1 | 1.2% |
Retrograde amnesia | 1 | 1.2% |
Retrovirus | 1 | 1.2% |
Reverse-transcriptase inhibitor | 1 | 1.2% |
Rheumatic fever | 1 | 1.2% |
Rifampicin | 1 | 1.2% |
Risk management | 1 | 1.2% |
Ritonavir | 1 | 1.2% |
Rubella | 1 | 1.2% |
Rubella vaccine | 1 | 1.2% |
SMS | 1 | 1.2% |
Sampling (statistics) | 1 | 1.2% |
Sarcoma | 1 | 1.2% |
Satellite navigation | 1 | 1.2% |
Scatter plot | 1 | 1.2% |
Science and technology | 1 | 1.2% |
Science policy | 1 | 1.2% |
Scientific control | 1 | 1.2% |
Sea level rise | 1 | 1.2% |
Sedative | 1 | 1.2% |
Selective estrogen receptor modulator | 1 | 1.2% |
Septic shock | 1 | 1.2% |
Serology | 1 | 1.2% |
Services sector of the economy | 1 | 1.2% |
Severe acute respiratory syndrome | 1 | 1.2% |
Sex differences in humans | 1 | 1.2% |
Sexology | 1 | 1.2% |
Sexual emotions | 1 | 1.2% |
Sexual orientation | 1 | 1.2% |
Sexual violence | 1 | 1.2% |
Sexuality | 1 | 1.2% |
Shared decision-making in medicine | 1 | 1.2% |
Shingles | 1 | 1.2% |
Sievert | 1 | 1.2% |
Sinoatrial node | 1 | 1.2% |
Skull fracture | 1 | 1.2% |
Small-cell carcinoma | 1 | 1.2% |
Smartphone | 1 | 1.2% |
Smoking | 1 | 1.2% |
Smoking cessation | 1 | 1.2% |
Social work | 1 | 1.2% |
Soil | 1 | 1.2% |
Solar System | 1 | 1.2% |
Solar cell | 1 | 1.2% |
Solar energy | 1 | 1.2% |
Solar power | 1 | 1.2% |
Somatic cell nuclear transfer | 1 | 1.2% |
Spermatozoon | 1 | 1.2% |
Spermicide | 1 | 1.2% |
Sphygmomanometer | 1 | 1.2% |
Standard Model | 1 | 1.2% |
Stanol ester | 1 | 1.2% |
Star | 1 | 1.2% |
Statistics | 1 | 1.2% |
Stavudine | 1 | 1.2% |
Sterilization (medicine) | 1 | 1.2% |
Stormwater | 1 | 1.2% |
Strategy | 1 | 1.2% |
Streptococcus | 1 | 1.2% |
Streptococcus agalactiae | 1 | 1.2% |
Striatum | 1 | 1.2% |
Strontium ranelate | 1 | 1.2% |
Study heterogeneity | 1 | 1.2% |
Subdural hematoma | 1 | 1.2% |
Substance abuse | 1 | 1.2% |
Sun | 1 | 1.2% |
Supercapacitor | 1 | 1.2% |
Superconductivity | 1 | 1.2% |
Supermassive black hole | 1 | 1.2% |
Supernova | 1 | 1.2% |
Support-vector machine | 1 | 1.2% |
Surface epithelial-stromal tumor | 1 | 1.2% |
Surgical specialties | 1 | 1.2% |
Systole | 1 | 1.2% |
T cell | 1 | 1.2% |
T helper cell | 1 | 1.2% |
Technological paradigm | 1 | 1.2% |
Temozolomide | 1 | 1.2% |
Teriparatide | 1 | 1.2% |
Tetanus | 1 | 1.2% |
Tetanus vaccine | 1 | 1.2% |
Thin film | 1 | 1.2% |
Thorax (human anatomy) | 1 | 1.2% |
Thymus | 1 | 1.2% |
Tissue engineering | 1 | 1.2% |
Titan (moon) | 1 | 1.2% |
Toxoplasmosis | 1 | 1.2% |
Training, validation, and test sets | 1 | 1.2% |
Trans fat | 1 | 1.2% |
Transient ischemic attack | 1 | 1.2% |
Trastuzumab | 1 | 1.2% |
Triage | 1 | 1.2% |
Triatominae | 1 | 1.2% |
Tricuspid insufficiency | 1 | 1.2% |
Tricuspid valve | 1 | 1.2% |
Triple test | 1 | 1.2% |
Tropical diseases | 1 | 1.2% |
Troponin | 1 | 1.2% |
Trypanosoma | 1 | 1.2% |
Trypanosoma cruzi | 1 | 1.2% |
Trypanosoma lewisi | 1 | 1.2% |
Type 1 diabetes | 1 | 1.2% |
Type Ia supernova | 1 | 1.2% |
Uncertainty | 1 | 1.2% |
United States federal budget | 1 | 1.2% |
Universal health care | 1 | 1.2% |
Universal precautions | 1 | 1.2% |
Unsafe abortion | 1 | 1.2% |
Urinary incontinence | 1 | 1.2% |
Urological conditions | 1 | 1.2% |
Uterine prolapse | 1 | 1.2% |
Uterus | 1 | 1.2% |
Vacuum aspiration | 1 | 1.2% |
Validity (statistics) | 1 | 1.2% |
Value (ethics) | 1 | 1.2% |
Vector (epidemiology) | 1 | 1.2% |
Vehicle | 1 | 1.2% |
Venous access | 1 | 1.2% |
Venous thrombosis | 1 | 1.2% |
Ventilator-associated pneumonia | 1 | 1.2% |
Ventricle (heart) | 1 | 1.2% |
Violence | 1 | 1.2% |
Violence against women | 1 | 1.2% |
Viral infections of the central nervous system | 1 | 1.2% |
Viral load | 1 | 1.2% |
Viral respiratory tract infections | 1 | 1.2% |
Virology | 1 | 1.2% |
Virtual wards | 1 | 1.2% |
Vitamin D | 1 | 1.2% |
Wart | 1 | 1.2% |
Welfare | 1 | 1.2% |
Western blot | 1 | 1.2% |
White Americans | 1 | 1.2% |
White blood cell | 1 | 1.2% |
White dwarf | 1 | 1.2% |
Whitehall Study | 1 | 1.2% |
Woman | 1 | 1.2% |
Wound | 1 | 1.2% |
X-ray | 1 | 1.2% |
X-ray binary | 1 | 1.2% |
York | 1 | 1.2% |
Zoledronic acid | 1 | 1.2% |
abs | rel | |
---|---|---|
Health | 57 | 89.1% |
Medicine | 47 | 73.4% |
Health sciences | 46 | 71.9% |
Health care | 45 | 70.3% |
Medical specialties | 41 | 64.1% |
Clinical medicine | 39 | 60.9% |
Risk | 20 | 31.2% |
Public health | 19 | 29.7% |
Hospital | 18 | 28.1% |
Disease | 17 | 26.6% |
Human activities | 17 | 26.6% |
Health economics | 16 | 25.0% |
Patient | 16 | 25.0% |
Infection | 15 | 23.4% |
Cancer | 14 | 21.9% |
Emergency department | 13 | 20.3% |
Preventive healthcare | 13 | 20.3% |
Research | 13 | 20.3% |
Diseases and disorders | 12 | 18.8% |
Medicare (United States) | 12 | 18.8% |
Nursing | 12 | 18.8% |
Epidemiology | 11 | 17.2% |
Audit | 10 | 15.6% |
Evidence-based medicine | 10 | 15.6% |
Health system | 10 | 15.6% |
Medical guideline | 10 | 15.6% |
Surgery | 10 | 15.6% |
Biology | 9 | 14.1% |
Health professional | 9 | 14.1% |
Medicaid | 9 | 14.1% |
Patient safety | 9 | 14.1% |
Screening (medicine) | 9 | 14.1% |
Chronic condition | 8 | 12.5% |
Clinical trial | 8 | 12.5% |
Cohort study | 8 | 12.5% |
Physician | 8 | 12.5% |
Randomized controlled trial | 8 | 12.5% |
Clinical commissioning group | 7 | 10.9% |
General practitioner | 7 | 10.9% |
Health policy | 7 | 10.9% |
Heart | 7 | 10.9% |
Hospital readmission | 7 | 10.9% |
Meta-analysis | 7 | 10.9% |
Primary care | 7 | 10.9% |
Adherence (medicine) | 6 | 9.4% |
Caregiver | 6 | 9.4% |
Childbirth | 6 | 9.4% |
Community health | 6 | 9.4% |
Government | 6 | 9.4% |
Health care quality | 6 | 9.4% |
Medical diagnosis | 6 | 9.4% |
Medication | 6 | 9.4% |
Mental health | 6 | 9.4% |
Psychiatry | 6 | 9.4% |
Systematic review | 6 | 9.4% |
Therapy | 6 | 9.4% |
Tuberculosis | 6 | 9.4% |
Best practice | 5 | 7.8% |
Cancer screening | 5 | 7.8% |
Cardiology | 5 | 7.8% |
Cardiovascular disease | 5 | 7.8% |
Clinic | 5 | 7.8% |
Dementia | 5 | 7.8% |
Disability | 5 | 7.8% |
Employment | 5 | 7.8% |
Governance | 5 | 7.8% |
HIV/AIDS | 5 | 7.8% |
Health informatics | 5 | 7.8% |
Infectious diseases | 5 | 7.8% |
Insurance | 5 | 7.8% |
Mental disorder | 5 | 7.8% |
Myocardial infarction | 5 | 7.8% |
Pain | 5 | 7.8% |
Patient Protection and Affordable Care Act | 5 | 7.8% |
Policy | 5 | 7.8% |
Public sphere | 5 | 7.8% |
Statistics | 5 | 7.8% |
Tax | 5 | 7.8% |
Antimicrobial resistance | 4 | 6.2% |
Bias | 4 | 6.2% |
Biomarker | 4 | 6.2% |
Cardiovascular system | 4 | 6.2% |
Colorectal cancer | 4 | 6.2% |
Coronary artery disease | 4 | 6.2% |
Emergency medicine | 4 | 6.2% |
GeneXpert MTB/RIF | 4 | 6.2% |
Information | 4 | 6.2% |
Internal medicine | 4 | 6.2% |
Life sciences | 4 | 6.2% |
Medical humanities | 4 | 6.2% |
Microbiology | 4 | 6.2% |
Palliative care | 4 | 6.2% |
Pharmacy | 4 | 6.2% |
Pregnancy | 4 | 6.2% |
Safety | 4 | 6.2% |
Sampling (statistics) | 4 | 6.2% |
Sensitivity and specificity | 4 | 6.2% |
Substance abuse | 4 | 6.2% |
Adverse effect | 3 | 4.7% |
Angiology | 3 | 4.7% |
Angiotensin II receptor blocker | 3 | 4.7% |
Asthma | 3 | 4.7% |
Audit committee | 3 | 4.7% |
Blinded experiment | 3 | 4.7% |
Brain | 3 | 4.7% |
Breast cancer | 3 | 4.7% |
Cardiovascular physiology | 3 | 4.7% |
Case management (US health system) | 3 | 4.7% |
Children's Health Insurance Program | 3 | 4.7% |
Clinical audit | 3 | 4.7% |
Clinical governance | 3 | 4.7% |
Comorbidity | 3 | 4.7% |
Confidence interval | 3 | 4.7% |
Correlation and dependence | 3 | 4.7% |
EPSDT | 3 | 4.7% |
Earned income tax credit | 3 | 4.7% |
Electronic health record | 3 | 4.7% |
Emergency management | 3 | 4.7% |
Evaluation | 3 | 4.7% |
Exercise | 3 | 4.7% |
Fee-for-service | 3 | 4.7% |
Fraud | 3 | 4.7% |
HIV | 3 | 4.7% |
Health Insurance Portability and Accountability Act | 3 | 4.7% |
Health equity | 3 | 4.7% |
Health insurance | 3 | 4.7% |
Health insurance coverage in the United States | 3 | 4.7% |
Heart failure | 3 | 4.7% |
Hepatitis C | 3 | 4.7% |
Human reproduction | 3 | 4.7% |
Hypertension | 3 | 4.7% |
Immunology | 3 | 4.7% |
Internal audit | 3 | 4.7% |
Internet | 3 | 4.7% |
Kidney | 3 | 4.7% |
Law | 3 | 4.7% |
Malaria | 3 | 4.7% |
Medical home | 3 | 4.7% |
Medical imaging | 3 | 4.7% |
Medical treatments | 3 | 4.7% |
Medicare dual eligible | 3 | 4.7% |
Methicillin-resistant Staphylococcus aureus | 3 | 4.7% |
Multi-drug-resistant tuberculosis | 3 | 4.7% |
NHS 111 | 3 | 4.7% |
NHS foundation trust | 3 | 4.7% |
Nervous system | 3 | 4.7% |
Nursing home | 3 | 4.7% |
Organ donation | 3 | 4.7% |
Parkinson's disease | 3 | 4.7% |
Physical therapy | 3 | 4.7% |
Politics | 3 | 4.7% |
Poverty | 3 | 4.7% |
Prostate cancer | 3 | 4.7% |
Receiver operating characteristic | 3 | 4.7% |
Risk assessment | 3 | 4.7% |
Risk management | 3 | 4.7% |
Robot | 3 | 4.7% |
Sexually transmitted infection | 3 | 4.7% |
Social Security (United States) | 3 | 4.7% |
Social Security number | 3 | 4.7% |
Social work | 3 | 4.7% |
Survey methodology | 3 | 4.7% |
Technology | 3 | 4.7% |
Telehealth | 3 | 4.7% |
Triage | 3 | 4.7% |
ACE inhibitor | 2 | 3.1% |
Accessibility | 2 | 3.1% |
Acute coronary syndrome | 2 | 3.1% |
Acute kidney injury | 2 | 3.1% |
Agriculture | 2 | 3.1% |
Analgesic | 2 | 3.1% |
Angina | 2 | 3.1% |
Animal viral diseases | 2 | 3.1% |
Antiplatelet drug | 2 | 3.1% |
Arrhythmia | 2 | 3.1% |
Artificial cardiac pacemaker | 2 | 3.1% |
Artificial intelligence | 2 | 3.1% |
Aspirin | 2 | 3.1% |
Autonomy | 2 | 3.1% |
Behavior | 2 | 3.1% |
Biobank | 2 | 3.1% |
Biosecurity | 2 | 3.1% |
Biotechnology | 2 | 3.1% |
Blood donation | 2 | 3.1% |
Blood pressure | 2 | 3.1% |
Bloodstream infections | 2 | 3.1% |
Board of directors | 2 | 3.1% |
Brain natriuretic peptide | 2 | 3.1% |
Brain–computer interface | 2 | 3.1% |
Business | 2 | 3.1% |
Caesarean section | 2 | 3.1% |
Cancer prevention | 2 | 3.1% |
Cancer survivor | 2 | 3.1% |
Cardiovascular diseases | 2 | 3.1% |
Cholesterol | 2 | 3.1% |
Chronic kidney disease | 2 | 3.1% |
Circulatory system | 2 | 3.1% |
Clinical pathology | 2 | 3.1% |
Clopidogrel | 2 | 3.1% |
Clostridioides difficile infection | 2 | 3.1% |
Cochrane Library | 2 | 3.1% |
Cognitive science | 2 | 3.1% |
Colonoscopy | 2 | 3.1% |
Confounding | 2 | 3.1% |
DNA sequencing | 2 | 3.1% |
Dashboard (business) | 2 | 3.1% |
Deep vein thrombosis | 2 | 3.1% |
Dentistry | 2 | 3.1% |
Diabetes | 2 | 3.1% |
Diagnosis of HIV/AIDS | 2 | 3.1% |
Directly observed treatment, short-course | 2 | 3.1% |
Disease management (health) | 2 | 3.1% |
District nurse | 2 | 3.1% |
Dr Foster Intelligence | 2 | 3.1% |
ELISA | 2 | 3.1% |
Ecology | 2 | 3.1% |
Education | 2 | 3.1% |
Electroencephalography | 2 | 3.1% |
Ethics | 2 | 3.1% |
Expert | 2 | 3.1% |
Extensively drug-resistant tuberculosis | 2 | 3.1% |
Fecal occult blood | 2 | 3.1% |
Federally Qualified Health Center | 2 | 3.1% |
Flavivirus | 2 | 3.1% |
Fluoride varnish | 2 | 3.1% |
Gene | 2 | 3.1% |
Genetic testing | 2 | 3.1% |
Genetics | 2 | 3.1% |
Genomics | 2 | 3.1% |
Glycated hemoglobin | 2 | 3.1% |
Gynaecologic disorders | 2 | 3.1% |
Health and wellbeing board | 2 | 3.1% |
Health insurance marketplace | 2 | 3.1% |
Health literacy | 2 | 3.1% |
Health promotion | 2 | 3.1% |
Healthcare shortage area | 2 | 3.1% |
Hepatitis | 2 | 3.1% |
High-density lipoprotein | 2 | 3.1% |
Hyperthyroidism | 2 | 3.1% |
Immunodeficiency | 2 | 3.1% |
Infection prevention and control | 2 | 3.1% |
Inflammation | 2 | 3.1% |
Inflammatory bowel disease | 2 | 3.1% |
Influenza | 2 | 3.1% |
Informed consent | 2 | 3.1% |
Innovation | 2 | 3.1% |
Intensive care medicine | 2 | 3.1% |
Intensive care unit | 2 | 3.1% |
Internal control | 2 | 3.1% |
Kidney failure | 2 | 3.1% |
Knee replacement | 2 | 3.1% |
Labor induction | 2 | 3.1% |
Lentiviruses | 2 | 3.1% |
Low-carbon economy | 2 | 3.1% |
Low-density lipoprotein | 2 | 3.1% |
Lung cancer | 2 | 3.1% |
Major depressive disorder | 2 | 3.1% |
Male genital disorders | 2 | 3.1% |
Mammography | 2 | 3.1% |
Managed care | 2 | 3.1% |
Management of HIV/AIDS | 2 | 3.1% |
Medical device | 2 | 3.1% |
Medical record | 2 | 3.1% |
Medical research | 2 | 3.1% |
Medical test | 2 | 3.1% |
Medicare Part D | 2 | 3.1% |
Medicare fraud | 2 | 3.1% |
Millennium Development Goals | 2 | 3.1% |
Mind | 2 | 3.1% |
Motivational interviewing | 2 | 3.1% |
Nature | 2 | 3.1% |
Neonatal intensive care unit | 2 | 3.1% |
Neoplasms | 2 | 3.1% |
Neurology | 2 | 3.1% |
Neuroscience | 2 | 3.1% |
Neurosurgery | 2 | 3.1% |
Nonsteroidal anti-inflammatory drug | 2 | 3.1% |
Nursing home care | 2 | 3.1% |
Obesity | 2 | 3.1% |
Occupational safety and health | 2 | 3.1% |
Odds ratio | 2 | 3.1% |
Office of Inspector General (United States) | 2 | 3.1% |
Organ transplantation | 2 | 3.1% |
Pain management | 2 | 3.1% |
Paracetamol | 2 | 3.1% |
Parameter | 2 | 3.1% |
Pathology | 2 | 3.1% |
Percutaneous coronary intervention | 2 | 3.1% |
Performance indicator | 2 | 3.1% |
Periodontology | 2 | 3.1% |
Peripheral neuropathy | 2 | 3.1% |
Physiology | 2 | 3.1% |
Positive and negative predictive values | 2 | 3.1% |
Poverty threshold | 2 | 3.1% |
Premium tax credit | 2 | 3.1% |
Pressure ulcer | 2 | 3.1% |
Prison | 2 | 3.1% |
Prostate-specific antigen | 2 | 3.1% |
Psychological concepts | 2 | 3.1% |
Psychology | 2 | 3.1% |
Psychotherapy | 2 | 3.1% |
Public hospital | 2 | 3.1% |
Public policy | 2 | 3.1% |
Quality assurance | 2 | 3.1% |
Recovery model | 2 | 3.1% |
Regulatory compliance | 2 | 3.1% |
Renal function | 2 | 3.1% |
Reporting bias | 2 | 3.1% |
Respiratory disease | 2 | 3.1% |
Robotics | 2 | 3.1% |
Science | 2 | 3.1% |
Self-care | 2 | 3.1% |
Sensitivity analysis | 2 | 3.1% |
Sexual health | 2 | 3.1% |
Sexually transmitted diseases and infections | 2 | 3.1% |
Social institutions | 2 | 3.1% |
Standardization | 2 | 3.1% |
Staphylococcus aureus | 2 | 3.1% |
Statin | 2 | 3.1% |
Stratified sampling | 2 | 3.1% |
Stroke | 2 | 3.1% |
Supplemental Security Income | 2 | 3.1% |
Surveillance | 2 | 3.1% |
Sustainability | 2 | 3.1% |
Tax credit | 2 | 3.1% |
Tobacco smoking | 2 | 3.1% |
Tooth decay | 2 | 3.1% |
Transitional care | 2 | 3.1% |
Transmission (medicine) | 2 | 3.1% |
Trust law | 2 | 3.1% |
Tuberculosis in relation to HIV | 2 | 3.1% |
Tuberculosis management | 2 | 3.1% |
United States budget sequestration in 2013 | 2 | 3.1% |
Vaccine | 2 | 3.1% |
Variance | 2 | 3.1% |
Vein | 2 | 3.1% |
Venous thrombosis | 2 | 3.1% |
Water fluoridation | 2 | 3.1% |
Welfare | 2 | 3.1% |
West Nile fever | 2 | 3.1% |
West Nile virus | 2 | 3.1% |
Whole genome sequencing | 2 | 3.1% |
Abacavir | 1 | 1.6% |
Accountable care organization | 1 | 1.6% |
Accounting | 1 | 1.6% |
Acetylcysteine | 1 | 1.6% |
Acromegaly | 1 | 1.6% |
Action potential | 1 | 1.6% |
Actuarial science | 1 | 1.6% |
Actuary | 1 | 1.6% |
Acupuncture | 1 | 1.6% |
Addiction | 1 | 1.6% |
Administrative law | 1 | 1.6% |
Adolescence | 1 | 1.6% |
Adoption | 1 | 1.6% |
Adult neurogenesis | 1 | 1.6% |
Adverse event | 1 | 1.6% |
Affordable Care Act | 1 | 1.6% |
Air pollution | 1 | 1.6% |
Aldosterone | 1 | 1.6% |
Algae fuel | 1 | 1.6% |
Allocation concealment | 1 | 1.6% |
Alternative medicine | 1 | 1.6% |
Alzheimer's disease | 1 | 1.6% |
Ambulance | 1 | 1.6% |
Amiodarone | 1 | 1.6% |
Amphotericin B | 1 | 1.6% |
Analytics | 1 | 1.6% |
Anemia | 1 | 1.6% |
Anesthesia | 1 | 1.6% |
Anesthesiology | 1 | 1.6% |
Anopheles | 1 | 1.6% |
Anti-lock braking system | 1 | 1.6% |
Antiarrhythmic agent | 1 | 1.6% |
Antibiotic | 1 | 1.6% |
Anticoagulant | 1 | 1.6% |
Antimalarial medication | 1 | 1.6% |
Antiretroviral drugs | 1 | 1.6% |
Antiviral drug | 1 | 1.6% |
Apolipoprotein A1 | 1 | 1.6% |
Application software | 1 | 1.6% |
Argonaute | 1 | 1.6% |
Aromatase inhibitor | 1 | 1.6% |
Artemisinin | 1 | 1.6% |
Artesunate | 1 | 1.6% |
Artificial general intelligence | 1 | 1.6% |
Assay | 1 | 1.6% |
Assertive community treatment | 1 | 1.6% |
Astrocyte | 1 | 1.6% |
Atherosclerosis | 1 | 1.6% |
Atrial fibrillation | 1 | 1.6% |
Atrial flutter | 1 | 1.6% |
Attention | 1 | 1.6% |
Auditor's report | 1 | 1.6% |
Autocorrelation | 1 | 1.6% |
Autoimmune disease | 1 | 1.6% |
Automation | 1 | 1.6% |
Avian influenza | 1 | 1.6% |
BCG vaccine | 1 | 1.6% |
BRCA mutation | 1 | 1.6% |
Balance (ability) | 1 | 1.6% |
Bareback (sex) | 1 | 1.6% |
Bellman equation | 1 | 1.6% |
Benign prostatic hyperplasia | 1 | 1.6% |
Beta blocker | 1 | 1.6% |
Big data | 1 | 1.6% |
Binomial distribution | 1 | 1.6% |
Biodiversity | 1 | 1.6% |
Bioethics | 1 | 1.6% |
Biofuel | 1 | 1.6% |
Biological engineering | 1 | 1.6% |
Biological pest control | 1 | 1.6% |
Biomarker (medicine) | 1 | 1.6% |
Biomass | 1 | 1.6% |
Biomedical engineering | 1 | 1.6% |
Biomedicine | 1 | 1.6% |
Biomimetics | 1 | 1.6% |
Biopsy | 1 | 1.6% |
Birth | 1 | 1.6% |
BitTorrent | 1 | 1.6% |
Bivalirudin | 1 | 1.6% |
Blood | 1 | 1.6% |
Blood film | 1 | 1.6% |
Blood sugar level | 1 | 1.6% |
Bombyx mori | 1 | 1.6% |
Botulism | 1 | 1.6% |
Bounce message | 1 | 1.6% |
Bradycardia | 1 | 1.6% |
Brain damage | 1 | 1.6% |
Broiler industry | 1 | 1.6% |
Bruce Keogh | 1 | 1.6% |
C-reactive protein | 1 | 1.6% |
CBRN defense | 1 | 1.6% |
CHA2DS2–VASc score | 1 | 1.6% |
CMA-ES | 1 | 1.6% |
Cachexia | 1 | 1.6% |
Calcium channel blocker | 1 | 1.6% |
Cancer pain | 1 | 1.6% |
Cancer registry | 1 | 1.6% |
Capacity (law) | 1 | 1.6% |
Capitation (healthcare) | 1 | 1.6% |
Carbon nanotube | 1 | 1.6% |
Cardiac arrest | 1 | 1.6% |
Cardiac electrophysiology | 1 | 1.6% |
Cardiac rehabilitation | 1 | 1.6% |
Cardiac resynchronization therapy | 1 | 1.6% |
Cardiotocography | 1 | 1.6% |
Cardioversion | 1 | 1.6% |
Cargo | 1 | 1.6% |
Case–control study | 1 | 1.6% |
Catalysis | 1 | 1.6% |
Catheter ablation | 1 | 1.6% |
Cell therapy | 1 | 1.6% |
Census | 1 | 1.6% |
Central limit theorem | 1 | 1.6% |
Cerebral cortex | 1 | 1.6% |
Cervical cancer | 1 | 1.6% |
Cervical screening | 1 | 1.6% |
Chairperson | 1 | 1.6% |
Charitable organization | 1 | 1.6% |
Charity (practice) | 1 | 1.6% |
Chemical reaction | 1 | 1.6% |
Chemotherapy | 1 | 1.6% |
Chicken | 1 | 1.6% |
Child | 1 | 1.6% |
Child custody | 1 | 1.6% |
Child support | 1 | 1.6% |
Childhood | 1 | 1.6% |
Childhood cancer | 1 | 1.6% |
Chlamydia | 1 | 1.6% |
Chloride | 1 | 1.6% |
Choking | 1 | 1.6% |
Chronic care | 1 | 1.6% |
Chronic pain | 1 | 1.6% |
Cigarette | 1 | 1.6% |
Cirrhosis | 1 | 1.6% |
Citizenship | 1 | 1.6% |
Climate change | 1 | 1.6% |
Climate change mitigation | 1 | 1.6% |
Clinical coder | 1 | 1.6% |
Cloud computing | 1 | 1.6% |
Cloud robotics | 1 | 1.6% |
Code of Federal Regulations | 1 | 1.6% |
Codeine | 1 | 1.6% |
Cogeneration | 1 | 1.6% |
Cognition | 1 | 1.6% |
Cohen's kappa | 1 | 1.6% |
Collaboration | 1 | 1.6% |
Committee | 1 | 1.6% |
Communication | 1 | 1.6% |
Community health worker | 1 | 1.6% |
Community mental health service | 1 | 1.6% |
Computer network | 1 | 1.6% |
Computer science | 1 | 1.6% |
Computer security | 1 | 1.6% |
Conflict of interest | 1 | 1.6% |
Congenital iodine deficiency syndrome | 1 | 1.6% |
Consciousness | 1 | 1.6% |
Consensus decision-making | 1 | 1.6% |
Consent | 1 | 1.6% |
Conservation biology | 1 | 1.6% |
Continuing healthcare | 1 | 1.6% |
Contract | 1 | 1.6% |
Coronary artery bypass surgery | 1 | 1.6% |
Crizotinib | 1 | 1.6% |
Cross-sectional study | 1 | 1.6% |
Curriculum | 1 | 1.6% |
Cyborg | 1 | 1.6% |
DNA | 1 | 1.6% |
Dabigatran | 1 | 1.6% |
Database | 1 | 1.6% |
Decision-making | 1 | 1.6% |
Deep brain stimulation | 1 | 1.6% |
Delirium | 1 | 1.6% |
Dental sealant | 1 | 1.6% |
Dependent and independent variables | 1 | 1.6% |
Design | 1 | 1.6% |
Determinants of health | 1 | 1.6% |
Dexamethasone | 1 | 1.6% |
Diagnosis of malaria | 1 | 1.6% |
Dialysis | 1 | 1.6% |
Diastole | 1 | 1.6% |
Diclofenac | 1 | 1.6% |
Digital health | 1 | 1.6% |
Digoxin | 1 | 1.6% |
Diltiazem | 1 | 1.6% |
Disproportionate share hospital | 1 | 1.6% |
Distal radius fracture | 1 | 1.6% |
Dose (biochemistry) | 1 | 1.6% |
Dronedarone | 1 | 1.6% |
Drug discovery | 1 | 1.6% |
Drug education | 1 | 1.6% |
Drug-eluting stent | 1 | 1.6% |
Drugs | 1 | 1.6% |
Earnings before interest, taxes, depreciation and amortization | 1 | 1.6% |
Economic model | 1 | 1.6% |
Economics | 1 | 1.6% |
Economics of service industries | 1 | 1.6% |
Economy | 1 | 1.6% |
Efficient energy use | 1 | 1.6% |
Elective surgery | 1 | 1.6% |
Electric power transmission | 1 | 1.6% |
Electric vehicle | 1 | 1.6% |
Electrical grid | 1 | 1.6% |
Electrocardiography | 1 | 1.6% |
Electroconvulsive therapy | 1 | 1.6% |
Electronic prescribing | 1 | 1.6% |
Emergence | 1 | 1.6% |
Emergency Medical Treatment and Active Labor Act | 1 | 1.6% |
Emergency medical services | 1 | 1.6% |
Emergency medical services in the United Kingdom | 1 | 1.6% |
Emotion | 1 | 1.6% |
End-of-life care | 1 | 1.6% |
Endoscopy | 1 | 1.6% |
Energy industry | 1 | 1.6% |
Engineering | 1 | 1.6% |
Entrepreneurship | 1 | 1.6% |
Environmental social science | 1 | 1.6% |
Enzyme inhibitor | 1 | 1.6% |
Epidemic | 1 | 1.6% |
Epidemiology of HIV/AIDS | 1 | 1.6% |
Epidural administration | 1 | 1.6% |
Eptifibatide | 1 | 1.6% |
Equal opportunity | 1 | 1.6% |
Errors and residuals | 1 | 1.6% |
Esophagus | 1 | 1.6% |
Essential health benefits | 1 | 1.6% |
Essential hypertension | 1 | 1.6% |
Estimator | 1 | 1.6% |
Evolution | 1 | 1.6% |
Exercise prescription | 1 | 1.6% |
Exposure assessment | 1 | 1.6% |
Fall prevention | 1 | 1.6% |
False Claims Act | 1 | 1.6% |
False alarm | 1 | 1.6% |
Farm | 1 | 1.6% |
Fatigue | 1 | 1.6% |
Feasibility study | 1 | 1.6% |
Federal Employees Health Benefits Program | 1 | 1.6% |
Fertility | 1 | 1.6% |
Fetus | 1 | 1.6% |
Fever | 1 | 1.6% |
File Transfer Protocol | 1 | 1.6% |
Financial statement | 1 | 1.6% |
Flexibility (anatomy) | 1 | 1.6% |
Fluid replacement | 1 | 1.6% |
Flynn effect | 1 | 1.6% |
Fondaparinux | 1 | 1.6% |
Food fortification | 1 | 1.6% |
Formaldehyde | 1 | 1.6% |
Framingham Risk Score | 1 | 1.6% |
Freedom of Information Act (United States) | 1 | 1.6% |
Friends and Family Test | 1 | 1.6% |
Fuel cell | 1 | 1.6% |
Fundraising | 1 | 1.6% |
Funnel plot | 1 | 1.6% |
Furosemide | 1 | 1.6% |
Gabapentin | 1 | 1.6% |
Gel | 1 | 1.6% |
Gene expression | 1 | 1.6% |
Gene silencing | 1 | 1.6% |
Gene therapy | 1 | 1.6% |
Generation IV reactor | 1 | 1.6% |
Genetic counseling | 1 | 1.6% |
Genetic engineering | 1 | 1.6% |
Genome | 1 | 1.6% |
Glia | 1 | 1.6% |
Goitre | 1 | 1.6% |
Gonorrhea | 1 | 1.6% |
Government budget balance | 1 | 1.6% |
Graves' disease | 1 | 1.6% |
Green building | 1 | 1.6% |
Grievance (labour) | 1 | 1.6% |
Health Information Technology for Economic and Clinical Health Act | 1 | 1.6% |
Health and Social Care Act 2012 | 1 | 1.6% |
Health care fraud | 1 | 1.6% |
Health information technology | 1 | 1.6% |
Health technology | 1 | 1.6% |
Healthcare in Cheshire | 1 | 1.6% |
Healthcare industry | 1 | 1.6% |
Heart rate | 1 | 1.6% |
Hematology | 1 | 1.6% |
Hepatitis B | 1 | 1.6% |
Hepatocellular carcinoma | 1 | 1.6% |
Hereditary nonpolyposis colorectal cancer | 1 | 1.6% |
High-risk pregnancy | 1 | 1.6% |
Home care | 1 | 1.6% |
Home care in the United States | 1 | 1.6% |
Hookah | 1 | 1.6% |
Hormonal therapy (oncology) | 1 | 1.6% |
Hospice | 1 | 1.6% |
Hospice care in the United States | 1 | 1.6% |
Household | 1 | 1.6% |
Human | 1 | 1.6% |
Human brain | 1 | 1.6% |
Human development | 1 | 1.6% |
Human genome | 1 | 1.6% |
Human life stages | 1 | 1.6% |
Human pregnancy | 1 | 1.6% |
Human sexuality | 1 | 1.6% |
Hurricane Katrina | 1 | 1.6% |
Hurricane Rita | 1 | 1.6% |
Hydrogen | 1 | 1.6% |
Hydronephrosis | 1 | 1.6% |
Hyperalgesia | 1 | 1.6% |
Hypothyroidism | 1 | 1.6% |
Ibuprofen | 1 | 1.6% |
Immigration | 1 | 1.6% |
Immune system | 1 | 1.6% |
Implantable cardioverter-defibrillator | 1 | 1.6% |
Incidence (epidemiology) | 1 | 1.6% |
Income | 1 | 1.6% |
Income tax | 1 | 1.6% |
Infancy | 1 | 1.6% |
Infant | 1 | 1.6% |
Infant bed | 1 | 1.6% |
Infant mortality | 1 | 1.6% |
Infection control | 1 | 1.6% |
Influenza vaccine | 1 | 1.6% |
Information privacy | 1 | 1.6% |
Information technology | 1 | 1.6% |
Inhibitory postsynaptic potential | 1 | 1.6% |
Inspection | 1 | 1.6% |
Institutional review board | 1 | 1.6% |
Intellectual property | 1 | 1.6% |
Intelligence | 1 | 1.6% |
Intelligence quotient | 1 | 1.6% |
Intendix | 1 | 1.6% |
Inter-rater reliability | 1 | 1.6% |
Intermediate Care Facilities for Individuals with Mental Retardation | 1 | 1.6% |
Internal Revenue Code | 1 | 1.6% |
Intraclass correlation | 1 | 1.6% |
Intrauterine growth restriction | 1 | 1.6% |
Iodine deficiency | 1 | 1.6% |
Iodised salt | 1 | 1.6% |
Josephson effect | 1 | 1.6% |
Junior doctor | 1 | 1.6% |
Ketamine | 1 | 1.6% |
Kevin Warwick | 1 | 1.6% |
Kidney disease | 1 | 1.6% |
Knutsford (UK Parliament constituency) | 1 | 1.6% |
L-form bacteria | 1 | 1.6% |
Laboratory | 1 | 1.6% |
Lamivudine | 1 | 1.6% |
Laparoscopy | 1 | 1.6% |
Laser | 1 | 1.6% |
Leadership | 1 | 1.6% |
Learning disability | 1 | 1.6% |
Left atrial appendage occlusion | 1 | 1.6% |
Legal guardian | 1 | 1.6% |
Lidocaine | 1 | 1.6% |
Life | 1 | 1.6% |
Lipoprotein | 1 | 1.6% |
Lipoprotein(a) | 1 | 1.6% |
Lisinopril | 1 | 1.6% |
Liver | 1 | 1.6% |
Livestock | 1 | 1.6% |
Lobotomy | 1 | 1.6% |
Local anesthetic | 1 | 1.6% |
Logistic regression | 1 | 1.6% |
Logistics | 1 | 1.6% |
Lojze Peterle | 1 | 1.6% |
Long-term care | 1 | 1.6% |
Loop diuretic | 1 | 1.6% |
Low molecular weight heparin | 1 | 1.6% |
Low-threshold treatment programs | 1 | 1.6% |
Lymphedema | 1 | 1.6% |
Macclesfield (UK Parliament constituency) | 1 | 1.6% |
1 | 1.6% | |
Mammalian pregnancy | 1 | 1.6% |
Mammalian sexuality | 1 | 1.6% |
Management | 1 | 1.6% |
Management of atrial fibrillation | 1 | 1.6% |
Marriage | 1 | 1.6% |
Mass media | 1 | 1.6% |
Matched filter | 1 | 1.6% |
Maternal health | 1 | 1.6% |
Mathematical model | 1 | 1.6% |
Mathematics | 1 | 1.6% |
Matron | 1 | 1.6% |
Maturity onset diabetes of the young | 1 | 1.6% |
Mean | 1 | 1.6% |
Medi-Cal | 1 | 1.6% |
Medical Subject Headings | 1 | 1.6% |
Medical education | 1 | 1.6% |
Medical equipment management | 1 | 1.6% |
Medical error | 1 | 1.6% |
Medical prescription | 1 | 1.6% |
Medical statistics | 1 | 1.6% |
Medicare Part D coverage gap | 1 | 1.6% |
Men who have sex with men | 1 | 1.6% |
Mental health professional | 1 | 1.6% |
Messenger RNA | 1 | 1.6% |
MicroRNA | 1 | 1.6% |
Micronutrient | 1 | 1.6% |
Microscopy | 1 | 1.6% |
Midwife | 1 | 1.6% |
Minimally invasive procedure | 1 | 1.6% |
Morphine | 1 | 1.6% |
Mosquito | 1 | 1.6% |
Motherhood | 1 | 1.6% |
Multicast | 1 | 1.6% |
Multistakeholder governance | 1 | 1.6% |
Museum | 1 | 1.6% |
Mycoplasma | 1 | 1.6% |
NHS Direct | 1 | 1.6% |
NHS primary care trust | 1 | 1.6% |
Nanotechnology | 1 | 1.6% |
Natural resource management | 1 | 1.6% |
Needs assessment | 1 | 1.6% |
Nephrology | 1 | 1.6% |
Nerve | 1 | 1.6% |
Neural engineering | 1 | 1.6% |
Neurodegeneration | 1 | 1.6% |
Neurofeedback | 1 | 1.6% |
Neuromodulation (medicine) | 1 | 1.6% |
Neuron | 1 | 1.6% |
Neuropathic pain | 1 | 1.6% |
Neuroplasticity | 1 | 1.6% |
Neuropsychology | 1 | 1.6% |
Neurotechnology | 1 | 1.6% |
Neurotransmitter | 1 | 1.6% |
Nevirapine | 1 | 1.6% |
Nociceptor | 1 | 1.6% |
Non-communicable disease | 1 | 1.6% |
Non-small-cell lung carcinoma | 1 | 1.6% |
Normal distribution | 1 | 1.6% |
Norovirus | 1 | 1.6% |
Nuclear power | 1 | 1.6% |
Obstetrics | 1 | 1.6% |
Oncology | 1 | 1.6% |
Opioid | 1 | 1.6% |
Osteoporosis | 1 | 1.6% |
Ovarian cancer | 1 | 1.6% |
P-value | 1 | 1.6% |
Pancreatic cancer | 1 | 1.6% |
Pap test | 1 | 1.6% |
Paramedic | 1 | 1.6% |
Parasitism | 1 | 1.6% |
Parenteral nutrition | 1 | 1.6% |
Paresthesia | 1 | 1.6% |
Password | 1 | 1.6% |
Patient participation | 1 | 1.6% |
Patient safety organization | 1 | 1.6% |
Patient-reported outcome | 1 | 1.6% |
Pediatrics | 1 | 1.6% |
Peer pressure | 1 | 1.6% |
Peer-to-peer | 1 | 1.6% |
Pelvic inflammatory disease | 1 | 1.6% |
Pension | 1 | 1.6% |
Perception | 1 | 1.6% |
Perinatal mortality | 1 | 1.6% |
Personal Responsibility and Work Opportunity Act | 1 | 1.6% |
Personal exemption | 1 | 1.6% |
Personal genomics | 1 | 1.6% |
Personal trainer | 1 | 1.6% |
Personalized medicine | 1 | 1.6% |
Personally identifiable information | 1 | 1.6% |
Pharmaceutical industry | 1 | 1.6% |
Phenotype | 1 | 1.6% |
Philip Hunt, Baron Hunt of Kings Heath | 1 | 1.6% |
Photosynthesis | 1 | 1.6% |
Photovoltaics | 1 | 1.6% |
Phthalate | 1 | 1.6% |
Physical examination | 1 | 1.6% |
Physical fitness | 1 | 1.6% |
Placebo | 1 | 1.6% |
Placebo-controlled study | 1 | 1.6% |
Plant | 1 | 1.6% |
Plasmodium falciparum | 1 | 1.6% |
Plasmodium vivax | 1 | 1.6% |
Pneumonia | 1 | 1.6% |
Podiatrist | 1 | 1.6% |
Point of care | 1 | 1.6% |
Post-exposure prophylaxis | 1 | 1.6% |
Post-transcriptional regulation | 1 | 1.6% |
Potassium | 1 | 1.6% |
Potassium chloride | 1 | 1.6% |
Poultry | 1 | 1.6% |
Power of attorney | 1 | 1.6% |
Prasugrel | 1 | 1.6% |
Prediction | 1 | 1.6% |
Pregabalin | 1 | 1.6% |
Prenatal development | 1 | 1.6% |
Prenatal testing | 1 | 1.6% |
Prescription drug | 1 | 1.6% |
Preterm birth | 1 | 1.6% |
Prevalence | 1 | 1.6% |
Primary health care | 1 | 1.6% |
Privacy | 1 | 1.6% |
Procurement | 1 | 1.6% |
Prostate | 1 | 1.6% |
Prostate biopsy | 1 | 1.6% |
Prostate disorders | 1 | 1.6% |
Protein | 1 | 1.6% |
Prothrombin time | 1 | 1.6% |
Proton-exchange membrane fuel cell | 1 | 1.6% |
Psycho-oncology | 1 | 1.6% |
Psychological trauma | 1 | 1.6% |
Psychologist | 1 | 1.6% |
Public health surveillance | 1 | 1.6% |
Publication bias | 1 | 1.6% |
Quality Improvement Organizations (QIOs) in Medicare | 1 | 1.6% |
Quality of life (healthcare) | 1 | 1.6% |
RICE (medicine) | 1 | 1.6% |
RNA | 1 | 1.6% |
Radiation therapy | 1 | 1.6% |
Radiography | 1 | 1.6% |
Radiology | 1 | 1.6% |
Rail transport | 1 | 1.6% |
Real-time computing | 1 | 1.6% |
Recovery approach | 1 | 1.6% |
Reference range | 1 | 1.6% |
Regression analysis | 1 | 1.6% |
Reinsurance | 1 | 1.6% |
Relative risk | 1 | 1.6% |
Renewable energy | 1 | 1.6% |
Renin | 1 | 1.6% |
Reperfusion therapy | 1 | 1.6% |
Respiratory therapist | 1 | 1.6% |
Reverse-transcriptase inhibitor | 1 | 1.6% |
Rosuvastatin | 1 | 1.6% |
Rulemaking | 1 | 1.6% |
Safe to Sleep | 1 | 1.6% |
Sample size determination | 1 | 1.6% |
Sanitation | 1 | 1.6% |
Science and Technology Options Assessment | 1 | 1.6% |
Scientific method | 1 | 1.6% |
Section 504 of the Rehabilitation Act | 1 | 1.6% |
Section 508 Amendment to the Rehabilitation Act of 1973 | 1 | 1.6% |
Selection bias | 1 | 1.6% |
Sensory neuron | 1 | 1.6% |
Sepsis | 1 | 1.6% |
Serology | 1 | 1.6% |
Sexology | 1 | 1.6% |
Sexual emotions | 1 | 1.6% |
Sexuality | 1 | 1.6% |
Shared decision-making in medicine | 1 | 1.6% |
Shock (circulatory) | 1 | 1.6% |
Signs and symptoms | 1 | 1.6% |
Silk | 1 | 1.6% |
Simulation | 1 | 1.6% |
Single-port laparoscopy | 1 | 1.6% |
Smart grid | 1 | 1.6% |
Smoking | 1 | 1.6% |
Smoking cessation | 1 | 1.6% |
Snowball sampling | 1 | 1.6% |
Social competence | 1 | 1.6% |
Social influence | 1 | 1.6% |
Social media | 1 | 1.6% |
Social networking service | 1 | 1.6% |
Social services | 1 | 1.6% |
Sociotechnical system | 1 | 1.6% |
Sodium | 1 | 1.6% |
Solar cell | 1 | 1.6% |
Sotalol | 1 | 1.6% |
Specialty (medicine) | 1 | 1.6% |
Sprain | 1 | 1.6% |
Sprained ankle | 1 | 1.6% |
Standard deviation | 1 | 1.6% |
Standard error | 1 | 1.6% |
States and territories of Australia | 1 | 1.6% |
Stationary process | 1 | 1.6% |
Statistical hypothesis testing | 1 | 1.6% |
Statistical theory | 1 | 1.6% |
Stem cell | 1 | 1.6% |
Stem-cell therapy | 1 | 1.6% |
Stepfamily | 1 | 1.6% |
Stereotactic surgery | 1 | 1.6% |
Stomach cancer | 1 | 1.6% |
Strategic planning | 1 | 1.6% |
Streaming media | 1 | 1.6% |
Street fundraising | 1 | 1.6% |
Strength training | 1 | 1.6% |
Strigolactone | 1 | 1.6% |
Substance abuse prevention | 1 | 1.6% |
Substance dependence | 1 | 1.6% |
Substance use disorder | 1 | 1.6% |
Sudden infant death syndrome | 1 | 1.6% |
Superconductivity | 1 | 1.6% |
Supplemental Nutrition Assistance Program | 1 | 1.6% |
Symptom | 1 | 1.6% |
Synapse | 1 | 1.6% |
Synaptic plasticity | 1 | 1.6% |
Synthetic biology | 1 | 1.6% |
System | 1 | 1.6% |
SystmOne | 1 | 1.6% |
TIMI | 1 | 1.6% |
Tax return (United States) | 1 | 1.6% |
Technological convergence | 1 | 1.6% |
Technological singularity | 1 | 1.6% |
Thoracotomy | 1 | 1.6% |
Thrombophilia | 1 | 1.6% |
Thrombosis | 1 | 1.6% |
Thyroid | 1 | 1.6% |
Thyroid hormones | 1 | 1.6% |
Ticagrelor | 1 | 1.6% |
Time | 1 | 1.6% |
Time series | 1 | 1.6% |
Tirofiban | 1 | 1.6% |
Tobacco control | 1 | 1.6% |
Top-down and bottom-up design | 1 | 1.6% |
Transcranial direct-current stimulation | 1 | 1.6% |
Transcranial magnetic stimulation | 1 | 1.6% |
Transient ischemic attack | 1 | 1.6% |
Translation (biology) | 1 | 1.6% |
Translational medicine | 1 | 1.6% |
Trauma center | 1 | 1.6% |
Treatment of cancer | 1 | 1.6% |
Treatment-resistant depression | 1 | 1.6% |
Troponin | 1 | 1.6% |
Trustee | 1 | 1.6% |
Twin-to-twin transfusion syndrome | 1 | 1.6% |
Type I and type II errors | 1 | 1.6% |
U.S. state | 1 | 1.6% |
Ulcer (dermatology) | 1 | 1.6% |
Universal health care | 1 | 1.6% |
Unlicensed assistive personnel | 1 | 1.6% |
Ureter | 1 | 1.6% |
Urinary system | 1 | 1.6% |
Urinary tract infection | 1 | 1.6% |
Urology | 1 | 1.6% |
Utility | 1 | 1.6% |
Utilization management | 1 | 1.6% |
Valvular heart disease | 1 | 1.6% |
Vehicle | 1 | 1.6% |
Venipuncture | 1 | 1.6% |
Venlafaxine | 1 | 1.6% |
Ventricular fibrillation | 1 | 1.6% |
Ventricular tachycardia | 1 | 1.6% |
Verapamil | 1 | 1.6% |
Verification and validation | 1 | 1.6% |
Vertically transmitted infection | 1 | 1.6% |
Veterinarian | 1 | 1.6% |
Viral load | 1 | 1.6% |
Virology | 1 | 1.6% |
Virus | 1 | 1.6% |
Vitamin | 1 | 1.6% |
Volatile organic compound | 1 | 1.6% |
Volume expander | 1 | 1.6% |
Water | 1 | 1.6% |
Web Content Accessibility Guidelines | 1 | 1.6% |
Website | 1 | 1.6% |
Winterbourne View hospital abuse | 1 | 1.6% |
Wolff–Parkinson–White syndrome | 1 | 1.6% |
Women's health | 1 | 1.6% |
World Wide Web | 1 | 1.6% |
World energy consumption | 1 | 1.6% |
Youth | 1 | 1.6% |
Youth smoking | 1 | 1.6% |
Zidovudine | 1 | 1.6% |
abs | rel | |
---|---|---|
Health | 83 | 89.2% |
Medicine | 80 | 86.0% |
Health sciences | 77 | 82.8% |
Health care | 73 | 78.5% |
Medical specialties | 62 | 66.7% |
Clinical medicine | 59 | 63.4% |
Risk | 40 | 43.0% |
Public health | 31 | 33.3% |
Patient | 30 | 32.3% |
Hospital | 26 | 28.0% |
Research | 24 | 25.8% |
Preventive healthcare | 23 | 24.7% |
Disease | 21 | 22.6% |
Infection | 21 | 22.6% |
Health economics | 20 | 21.5% |
Diseases and disorders | 19 | 20.4% |
Human activities | 19 | 20.4% |
Clinical trial | 18 | 19.4% |
Evidence-based medicine | 18 | 19.4% |
Medical diagnosis | 18 | 19.4% |
Randomized controlled trial | 18 | 19.4% |
Epidemiology | 17 | 18.3% |
Cancer | 16 | 17.2% |
Medicare (United States) | 16 | 17.2% |
Meta-analysis | 15 | 16.1% |
Confidence interval | 14 | 15.1% |
Systematic review | 14 | 15.1% |
Therapy | 14 | 15.1% |
Adherence (medicine) | 13 | 14.0% |
Hospital readmission | 13 | 14.0% |
Medication | 13 | 14.0% |
Screening (medicine) | 13 | 14.0% |
Electronic health record | 12 | 12.9% |
Emergency department | 12 | 12.9% |
Evaluation | 12 | 12.9% |
Health policy | 12 | 12.9% |
Medicaid | 12 | 12.9% |
Medical imaging | 12 | 12.9% |
Surgery | 12 | 12.9% |
Virus | 12 | 12.9% |
Biology | 11 | 11.8% |
Cardiology | 11 | 11.8% |
Cardiovascular disease | 11 | 11.8% |
Cardiovascular system | 11 | 11.8% |
Coronary artery disease | 11 | 11.8% |
Health system | 11 | 11.8% |
Myocardial infarction | 11 | 11.8% |
Primary care | 11 | 11.8% |
Stroke | 11 | 11.8% |
Caregiver | 10 | 10.8% |
Chronic condition | 10 | 10.8% |
HIV/AIDS | 10 | 10.8% |
Health informatics | 10 | 10.8% |
Heart | 10 | 10.8% |
Sensitivity and specificity | 10 | 10.8% |
Childbirth | 9 | 9.7% |
Fee-for-service | 9 | 9.7% |
Health care quality | 9 | 9.7% |
Life sciences | 9 | 9.7% |
Management of HIV/AIDS | 9 | 9.7% |
Medical guideline | 9 | 9.7% |
Nursing | 9 | 9.7% |
Self-care | 9 | 9.7% |
Cohort study | 8 | 8.6% |
Magnetic resonance imaging | 8 | 8.6% |
Medical record | 8 | 8.6% |
Blinded experiment | 7 | 7.5% |
General practitioner | 7 | 7.5% |
Health insurance | 7 | 7.5% |
Health professional | 7 | 7.5% |
Hypertension | 7 | 7.5% |
Infectious diseases | 7 | 7.5% |
Internal medicine | 7 | 7.5% |
Mental health | 7 | 7.5% |
Microbiology | 7 | 7.5% |
Patient safety | 7 | 7.5% |
Pregnancy | 7 | 7.5% |
Risk assessment | 7 | 7.5% |
Simulation | 7 | 7.5% |
Statin | 7 | 7.5% |
Statistics | 7 | 7.5% |
Accountable care organization | 6 | 6.5% |
Adverse effect | 6 | 6.5% |
Antimicrobial resistance | 6 | 6.5% |
Cholesterol | 6 | 6.5% |
Clinical commissioning group | 6 | 6.5% |
Database | 6 | 6.5% |
Employment | 6 | 6.5% |
Gene | 6 | 6.5% |
Immunology | 6 | 6.5% |
Insurance | 6 | 6.5% |
International Statistical Classification of Diseases and Related Health Problems | 6 | 6.5% |
Low-density lipoprotein | 6 | 6.5% |
Managed care | 6 | 6.5% |
Mental disorder | 6 | 6.5% |
Patient Protection and Affordable Care Act | 6 | 6.5% |
Physician | 6 | 6.5% |
Sampling (statistics) | 6 | 6.5% |
Sustainability | 6 | 6.5% |
Transmission (medicine) | 6 | 6.5% |
Affordable Care Act | 5 | 5.4% |
Angina | 5 | 5.4% |
Atherosclerosis | 5 | 5.4% |
Biotechnology | 5 | 5.4% |
Blood pressure | 5 | 5.4% |
Breast cancer | 5 | 5.4% |
CT scan | 5 | 5.4% |
Dementia | 5 | 5.4% |
Economics of service industries | 5 | 5.4% |
Genetics | 5 | 5.4% |
Governance | 5 | 5.4% |
Health care in the United States | 5 | 5.4% |
Heart failure | 5 | 5.4% |
Hepatitis | 5 | 5.4% |
Human reproduction | 5 | 5.4% |
Informed consent | 5 | 5.4% |
Medical humanities | 5 | 5.4% |
Medical treatments | 5 | 5.4% |
Pay for performance (healthcare) | 5 | 5.4% |
Pharmacy | 5 | 5.4% |
Positive and negative predictive values | 5 | 5.4% |
Preterm birth | 5 | 5.4% |
Prevention of HIV/AIDS | 5 | 5.4% |
Protein | 5 | 5.4% |
Radiation therapy | 5 | 5.4% |
Radiology | 5 | 5.4% |
Regression analysis | 5 | 5.4% |
Standard deviation | 5 | 5.4% |
Agriculture | 4 | 4.3% |
Allergy | 4 | 4.3% |
Alzheimer's disease | 4 | 4.3% |
Angiology | 4 | 4.3% |
Anticoagulant | 4 | 4.3% |
Atrial fibrillation | 4 | 4.3% |
Birth defect | 4 | 4.3% |
Breastfeeding | 4 | 4.3% |
Chemotherapy | 4 | 4.3% |
Colorectal cancer | 4 | 4.3% |
Comorbidity | 4 | 4.3% |
Condom | 4 | 4.3% |
Coronary artery bypass surgery | 4 | 4.3% |
DNA sequencing | 4 | 4.3% |
Dependent and independent variables | 4 | 4.3% |
Diagnosis of HIV/AIDS | 4 | 4.3% |
Dietary supplement | 4 | 4.3% |
ELISA | 4 | 4.3% |
HIV | 4 | 4.3% |
Health Insurance Portability and Accountability Act | 4 | 4.3% |
Health insurance coverage in the United States | 4 | 4.3% |
Healthcare industry | 4 | 4.3% |
High-density lipoprotein | 4 | 4.3% |
Infant | 4 | 4.3% |
Information | 4 | 4.3% |
Innovation | 4 | 4.3% |
Intensive care unit | 4 | 4.3% |
Ischemia | 4 | 4.3% |
Major depressive disorder | 4 | 4.3% |
Medical Subject Headings | 4 | 4.3% |
Medical test | 4 | 4.3% |
Neurology | 4 | 4.3% |
Patient participation | 4 | 4.3% |
Pharmacology | 4 | 4.3% |
Physical therapy | 4 | 4.3% |
Prenatal development | 4 | 4.3% |
Prescription drug | 4 | 4.3% |
Privacy | 4 | 4.3% |
Qualitative research | 4 | 4.3% |
Safe sex | 4 | 4.3% |
Sexually transmitted infection | 4 | 4.3% |
Technology | 4 | 4.3% |
Thrombosis | 4 | 4.3% |
Transient ischemic attack | 4 | 4.3% |
Tuberculosis | 4 | 4.3% |
Type 2 diabetes | 4 | 4.3% |
Variance | 4 | 4.3% |
Viral load | 4 | 4.3% |
Water | 4 | 4.3% |
Adjuvant therapy | 3 | 3.2% |
Air pollution | 3 | 3.2% |
Amiodarone | 3 | 3.2% |
Analytics | 3 | 3.2% |
Antibody | 3 | 3.2% |
Apixaban | 3 | 3.2% |
Aspirin | 3 | 3.2% |
Asthma | 3 | 3.2% |
Avian influenza | 3 | 3.2% |
Best practice | 3 | 3.2% |
Beta blocker | 3 | 3.2% |
Biochemistry | 3 | 3.2% |
Biofuel | 3 | 3.2% |
Biomarker | 3 | 3.2% |
Biomass | 3 | 3.2% |
Biopsy | 3 | 3.2% |
Bisphosphonate | 3 | 3.2% |
Body mass index | 3 | 3.2% |
Bone | 3 | 3.2% |
Bone density | 3 | 3.2% |
Branches of science | 3 | 3.2% |
Bundled payment | 3 | 3.2% |
Cancer screening | 3 | 3.2% |
Capitation (healthcare) | 3 | 3.2% |
Cardiac stress test | 3 | 3.2% |
Cardiac surgery | 3 | 3.2% |
Cardioversion | 3 | 3.2% |
Community health | 3 | 3.2% |
Confounding | 3 | 3.2% |
Consent | 3 | 3.2% |
Cost-effectiveness analysis | 3 | 3.2% |
Dabigatran | 3 | 3.2% |
Data analysis | 3 | 3.2% |
Decision-making | 3 | 3.2% |
Determinants of health | 3 | 3.2% |
Diabetes | 3 | 3.2% |
Digoxin | 3 | 3.2% |
Dronedarone | 3 | 3.2% |
Drugs | 3 | 3.2% |
Dual-energy X-ray absorptiometry | 3 | 3.2% |
Ebola virus disease | 3 | 3.2% |
Echocardiography | 3 | 3.2% |
Ecology | 3 | 3.2% |
Economics | 3 | 3.2% |
Education | 3 | 3.2% |
Emergency medicine | 3 | 3.2% |
Energy development | 3 | 3.2% |
Engineering | 3 | 3.2% |
Errors and residuals | 3 | 3.2% |
Exercise | 3 | 3.2% |
False positives and false negatives | 3 | 3.2% |
Fever | 3 | 3.2% |
Gas | 3 | 3.2% |
Gasification | 3 | 3.2% |
Gene expression | 3 | 3.2% |
Genomics | 3 | 3.2% |
Global warming | 3 | 3.2% |
Gonorrhea | 3 | 3.2% |
Health maintenance organization | 3 | 3.2% |
ICD-10 | 3 | 3.2% |
Immunoglobulin E | 3 | 3.2% |
Incentive | 3 | 3.2% |
Inflammation | 3 | 3.2% |
Influenza | 3 | 3.2% |
Institutional review board | 3 | 3.2% |
Lung cancer | 3 | 3.2% |
MEDLINE | 3 | 3.2% |
Mean | 3 | 3.2% |
Medical home | 3 | 3.2% |
Natural environment | 3 | 3.2% |
Nature | 3 | 3.2% |
Neuroimaging | 3 | 3.2% |
Occupational safety and health | 3 | 3.2% |
Osteoporosis | 3 | 3.2% |
Overdiagnosis | 3 | 3.2% |
Parameter | 3 | 3.2% |
Pathology | 3 | 3.2% |
Placebo | 3 | 3.2% |
Positron emission tomography | 3 | 3.2% |
Prothrombin time | 3 | 3.2% |
Psychiatry | 3 | 3.2% |
Psychological concepts | 3 | 3.2% |
Psychotherapy | 3 | 3.2% |
Public sphere | 3 | 3.2% |
Quality-adjusted life year | 3 | 3.2% |
Radiofrequency ablation | 3 | 3.2% |
Renal function | 3 | 3.2% |
Reporting bias | 3 | 3.2% |
Rivaroxaban | 3 | 3.2% |
Robot | 3 | 3.2% |
Science | 3 | 3.2% |
Sea | 3 | 3.2% |
Selective serotonin reuptake inhibitor | 3 | 3.2% |
Sensitivity analysis | 3 | 3.2% |
Sepsis | 3 | 3.2% |
Sexual intercourse | 3 | 3.2% |
Sotalol | 3 | 3.2% |
Standard error | 3 | 3.2% |
Study heterogeneity | 3 | 3.2% |
Surveillance | 3 | 3.2% |
Triage | 3 | 3.2% |
Tuberculosis management | 3 | 3.2% |
Venous thrombosis | 3 | 3.2% |
Vitamin | 3 | 3.2% |
Warfarin | 3 | 3.2% |
Welfare | 3 | 3.2% |
Zidovudine | 3 | 3.2% |
Abacavir | 2 | 2.2% |
Adverse drug reaction | 2 | 2.2% |
Allocation concealment | 2 | 2.2% |
Ambulance | 2 | 2.2% |
Anaphylaxis | 2 | 2.2% |
Aneurysm | 2 | 2.2% |
Angiography | 2 | 2.2% |
Angioplasty | 2 | 2.2% |
Antiarrhythmic agent | 2 | 2.2% |
Antibiotic | 2 | 2.2% |
Antidepressant | 2 | 2.2% |
Antiplatelet drug | 2 | 2.2% |
Antipsychotic | 2 | 2.2% |
Aripiprazole | 2 | 2.2% |
Artificial cardiac pacemaker | 2 | 2.2% |
Artificial intelligence | 2 | 2.2% |
Artificial objects | 2 | 2.2% |
Atrial flutter | 2 | 2.2% |
Audit | 2 | 2.2% |
Automation | 2 | 2.2% |
Bacteremia | 2 | 2.2% |
Bacteria | 2 | 2.2% |
Behavior | 2 | 2.2% |
Bias | 2 | 2.2% |
Biodiversity | 2 | 2.2% |
Bioequivalence | 2 | 2.2% |
Birth control | 2 | 2.2% |
Birth weight | 2 | 2.2% |
Bleeding | 2 | 2.2% |
Bone fracture | 2 | 2.2% |
Brain | 2 | 2.2% |
Business | 2 | 2.2% |
Cancer staging | 2 | 2.2% |
Carbon dioxide | 2 | 2.2% |
Cardiovascular diseases | 2 | 2.2% |
Catheter ablation | 2 | 2.2% |
Cerebral shunt | 2 | 2.2% |
Charity care | 2 | 2.2% |
Chemistry | 2 | 2.2% |
Chronic obstructive pulmonary disease | 2 | 2.2% |
Circulatory system | 2 | 2.2% |
Clinical pathology | 2 | 2.2% |
Cognitive behavioral therapy | 2 | 2.2% |
Cognitive science | 2 | 2.2% |
Colonoscopy | 2 | 2.2% |
Combustion | 2 | 2.2% |
Cryopreservation | 2 | 2.2% |
Culture | 2 | 2.2% |
Current Procedural Terminology | 2 | 2.2% |
Cyclooxygenase | 2 | 2.2% |
Data | 2 | 2.2% |
Deep vein thrombosis | 2 | 2.2% |
Diagnosis-related group | 2 | 2.2% |
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2.2% |
Diazepam | 2 | 2.2% |
Dieting | 2 | 2.2% |
Difference in differences | 2 | 2.2% |
Distributed generation | 2 | 2.2% |
Donepezil | 2 | 2.2% |
Dose (biochemistry) | 2 | 2.2% |
Dummy variable (statistics) | 2 | 2.2% |
Ecosystem | 2 | 2.2% |
Efavirenz | 2 | 2.2% |
Effect size | 2 | 2.2% |
Eicosapentaenoic acid | 2 | 2.2% |
Embryonic stem cell | 2 | 2.2% |
Emergency management | 2 | 2.2% |
Emergency medical services | 2 | 2.2% |
Emtricitabine | 2 | 2.2% |
End-of-life care | 2 | 2.2% |
Epidemiology of HIV/AIDS | 2 | 2.2% |
Ethics | 2 | 2.2% |
Exome sequencing | 2 | 2.2% |
Family medicine | 2 | 2.2% |
Fecal occult blood | 2 | 2.2% |
Fetus | 2 | 2.2% |
Fixed effects model | 2 | 2.2% |
Flecainide | 2 | 2.2% |
Fluoxetine | 2 | 2.2% |
Framingham Risk Score | 2 | 2.2% |
Fuel cell | 2 | 2.2% |
Funnel plot | 2 | 2.2% |
General practice | 2 | 2.2% |
Genetic testing | 2 | 2.2% |
Geriatrics | 2 | 2.2% |
Health care industry | 2 | 2.2% |
Health care prices in the United States | 2 | 2.2% |
Health equity | 2 | 2.2% |
Health information exchange | 2 | 2.2% |
Health insurance in the United States | 2 | 2.2% |
Health insurance marketplace | 2 | 2.2% |
Health promotion | 2 | 2.2% |
Health technology in the United States | 2 | 2.2% |
Healthcare | 2 | 2.2% |
Healthcare quality | 2 | 2.2% |
Heart arrhythmia | 2 | 2.2% |
Heat | 2 | 2.2% |
Hepatitis B | 2 | 2.2% |
Hepatitis C | 2 | 2.2% |
Hip fracture | 2 | 2.2% |
Home care | 2 | 2.2% |
Hormone replacement therapy | 2 | 2.2% |
Hospital-acquired infection | 2 | 2.2% |
Human | 2 | 2.2% |
Human nature | 2 | 2.2% |
Human sexual activity | 2 | 2.2% |
Human sexuality | 2 | 2.2% |
Hydrogen | 2 | 2.2% |
Hypercholesterolemia | 2 | 2.2% |
Immigration | 2 | 2.2% |
Immune system | 2 | 2.2% |
Infection control | 2 | 2.2% |
Influenza A virus | 2 | 2.2% |
Influenza A virus subtype H1N1 | 2 | 2.2% |
Influenza pandemic | 2 | 2.2% |
Internet | 2 | 2.2% |
Lamivudine | 2 | 2.2% |
Laparoscopy | 2 | 2.2% |
Leadership | 2 | 2.2% |
Lentiviruses | 2 | 2.2% |
Linear regression | 2 | 2.2% |
Lipoprotein | 2 | 2.2% |
Logistic regression | 2 | 2.2% |
Long-term care | 2 | 2.2% |
Lymphoma | 2 | 2.2% |
Macular degeneration | 2 | 2.2% |
Mammography | 2 | 2.2% |
Management | 2 | 2.2% |
Maternal health | 2 | 2.2% |
Medical prescription | 2 | 2.2% |
Medical tests | 2 | 2.2% |
Medicare Advantage | 2 | 2.2% |
Medicare dual eligible | 2 | 2.2% |
Men who have sex with men | 2 | 2.2% |
Menopause | 2 | 2.2% |
Metastasis | 2 | 2.2% |
Methicillin-resistant Staphylococcus aureus | 2 | 2.2% |
Microbicides for sexually transmitted diseases | 2 | 2.2% |
Microgrid | 2 | 2.2% |
Molecular biology | 2 | 2.2% |
Multi-drug-resistant tuberculosis | 2 | 2.2% |
Nanoparticle | 2 | 2.2% |
Nausea | 2 | 2.2% |
Neonatal intensive care unit | 2 | 2.2% |
Neoplasms | 2 | 2.2% |
Nervous system | 2 | 2.2% |
Nevirapine | 2 | 2.2% |
Nicotine | 2 | 2.2% |
Nicotine replacement therapy | 2 | 2.2% |
Nonsteroidal anti-inflammatory drug | 2 | 2.2% |
Nutrition | 2 | 2.2% |
Obesity | 2 | 2.2% |
Omega-3 fatty acid | 2 | 2.2% |
Ophthalmology | 2 | 2.2% |
Optics | 2 | 2.2% |
Organisms | 2 | 2.2% |
Osteopenia | 2 | 2.2% |
Outcomes research | 2 | 2.2% |
Ovarian cancer | 2 | 2.2% |
P-value | 2 | 2.2% |
Pain | 2 | 2.2% |
Palliative care | 2 | 2.2% |
Paroxetine | 2 | 2.2% |
Penicillin | 2 | 2.2% |
Personal protective equipment | 2 | 2.2% |
Personally identifiable information | 2 | 2.2% |
Pharmaceutical sciences | 2 | 2.2% |
Photovoltaics | 2 | 2.2% |
Polymerase chain reaction | 2 | 2.2% |
Population health | 2 | 2.2% |
Pre-exposure prophylaxis | 2 | 2.2% |
Prevalence | 2 | 2.2% |
Prevention | 2 | 2.2% |
Prostate cancer | 2 | 2.2% |
Psychosocial | 2 | 2.2% |
Public services | 2 | 2.2% |
Quality of life | 2 | 2.2% |
Quality of life (healthcare) | 2 | 2.2% |
Raloxifene | 2 | 2.2% |
Receiver operating characteristic | 2 | 2.2% |
Reinsurance | 2 | 2.2% |
Renewable energy | 2 | 2.2% |
Reproductive health | 2 | 2.2% |
Residency (medicine) | 2 | 2.2% |
Reverse transcription polymerase chain reaction | 2 | 2.2% |
Reverse-transcriptase inhibitor | 2 | 2.2% |
Rifampicin | 2 | 2.2% |
Risperidone | 2 | 2.2% |
Robotics | 2 | 2.2% |
Safety | 2 | 2.2% |
Sample size determination | 2 | 2.2% |
Saturated fat | 2 | 2.2% |
Selection bias | 2 | 2.2% |
Self-insurance | 2 | 2.2% |
Sertraline | 2 | 2.2% |
Service industries | 2 | 2.2% |
Services sector of the economy | 2 | 2.2% |
Sex worker | 2 | 2.2% |
Sexual health | 2 | 2.2% |
Sexually transmitted diseases and infections | 2 | 2.2% |
Shared decision-making in medicine | 2 | 2.2% |
Shortness of breath | 2 | 2.2% |
Smoking cessation | 2 | 2.2% |
Social media | 2 | 2.2% |
Social programs | 2 | 2.2% |
Social stigma | 2 | 2.2% |
Social support | 2 | 2.2% |
Social work | 2 | 2.2% |
Solar power | 2 | 2.2% |
Staphylococcus aureus | 2 | 2.2% |
Stavudine | 2 | 2.2% |
Stem cell | 2 | 2.2% |
Stratified sampling | 2 | 2.2% |
Substance abuse | 2 | 2.2% |
Sustainable development | 2 | 2.2% |
Syphilis | 2 | 2.2% |
Systems biology | 2 | 2.2% |
Tenofovir disoproxil | 2 | 2.2% |
Thyroid hormones | 2 | 2.2% |
Tobacco smoking | 2 | 2.2% |
Tricyclic antidepressant | 2 | 2.2% |
Triiodothyronine | 2 | 2.2% |
Type I and type II errors | 2 | 2.2% |
Unnecessary health care | 2 | 2.2% |
Urology | 2 | 2.2% |
Vaccine | 2 | 2.2% |
Validity (statistics) | 2 | 2.2% |
Venlafaxine | 2 | 2.2% |
Vertically transmitted infection | 2 | 2.2% |
Viral hemorrhagic fever | 2 | 2.2% |
Vitamin D | 2 | 2.2% |
Waste | 2 | 2.2% |
Weather forecasting | 2 | 2.2% |
Whole genome sequencing | 2 | 2.2% |
Wind turbine | 2 | 2.2% |
Zoonosis | 2 | 2.2% |
2009 flu pandemic | 1 | 1.1% |
2009 swine flu pandemic | 1 | 1.1% |
Abdominal aortic aneurysm | 1 | 1.1% |
Academic degree | 1 | 1.1% |
Accuracy and precision | 1 | 1.1% |
Active surveillance of prostate cancer | 1 | 1.1% |
Activities of daily living | 1 | 1.1% |
Acupuncture | 1 | 1.1% |
Adenoma | 1 | 1.1% |
Adhesive | 1 | 1.1% |
Adolescence | 1 | 1.1% |
Advanced practice registered nurse | 1 | 1.1% |
Adverse selection | 1 | 1.1% |
Aedes | 1 | 1.1% |
Aerobic exercise | 1 | 1.1% |
Aflibercept | 1 | 1.1% |
Ageing | 1 | 1.1% |
Air medical services | 1 | 1.1% |
Alanine transaminase | 1 | 1.1% |
Algal bloom | 1 | 1.1% |
Algorithm | 1 | 1.1% |
Allelopathy | 1 | 1.1% |
Alpha-mannosidosis | 1 | 1.1% |
Alternative medicine | 1 | 1.1% |
Amniocentesis | 1 | 1.1% |
Amoxicillin | 1 | 1.1% |
Ampicillin | 1 | 1.1% |
Amputation | 1 | 1.1% |
Amyotrophic lateral sclerosis | 1 | 1.1% |
Anaerobic digestion | 1 | 1.1% |
Anal sex | 1 | 1.1% |
Analysis of variance | 1 | 1.1% |
Anatomy | 1 | 1.1% |
Anecortave acetate | 1 | 1.1% |
Anemia | 1 | 1.1% |
Anesthesia | 1 | 1.1% |
Angiogenesis | 1 | 1.1% |
Animal anatomy | 1 | 1.1% |
Animal bacterial diseases | 1 | 1.1% |
Animal slaughter | 1 | 1.1% |
Animal viral diseases | 1 | 1.1% |
Anopheles | 1 | 1.1% |
Anthropology | 1 | 1.1% |
Anti-inflammatory | 1 | 1.1% |
Anti-lock braking system | 1 | 1.1% |
Antibiotics | 1 | 1.1% |
Anticholinergic | 1 | 1.1% |
Anticonvulsant | 1 | 1.1% |
Antigen | 1 | 1.1% |
Antihypertensive drug | 1 | 1.1% |
Antiviral drug | 1 | 1.1% |
Anti–vascular endothelial growth factor therapy | 1 | 1.1% |
Anxiety | 1 | 1.1% |
Anxiety disorder | 1 | 1.1% |
Aortic aneurysm | 1 | 1.1% |
Aortic dissection | 1 | 1.1% |
Aortic stenosis | 1 | 1.1% |
Aortic valve | 1 | 1.1% |
Aortic valve replacement | 1 | 1.1% |
Apheresis | 1 | 1.1% |
Apolipoprotein | 1 | 1.1% |
Apolipoprotein B | 1 | 1.1% |
Apoptosis | 1 | 1.1% |
Apoptosis-inducing factor | 1 | 1.1% |
Aquaculture | 1 | 1.1% |
Arbovirus | 1 | 1.1% |
ArcGIS | 1 | 1.1% |
Arctic Ocean | 1 | 1.1% |
Asenapine | 1 | 1.1% |
Assistive technology | 1 | 1.1% |
Astronomy | 1 | 1.1% |
Astrophysics | 1 | 1.1% |
Atlantic Ocean | 1 | 1.1% |
Atmosphere of Earth | 1 | 1.1% |
Atrium (heart) | 1 | 1.1% |
Attention deficit hyperactivity disorder | 1 | 1.1% |
Autonomy | 1 | 1.1% |
Autophagy | 1 | 1.1% |
Azithromycin | 1 | 1.1% |
BRCA mutation | 1 | 1.1% |
Bacillus thuringiensis | 1 | 1.1% |
Back pain | 1 | 1.1% |
Bacterial diseases | 1 | 1.1% |
Bacteriology | 1 | 1.1% |
Bacterioplankton | 1 | 1.1% |
Balance (ability) | 1 | 1.1% |
Band gap | 1 | 1.1% |
Barents Sea | 1 | 1.1% |
Basic reproduction number | 1 | 1.1% |
Bazedoxifene | 1 | 1.1% |
Behavior change method | 1 | 1.1% |
Benzatropine | 1 | 1.1% |
Benzodiazepine | 1 | 1.1% |
Beta-lactamase | 1 | 1.1% |
Better Care Fund | 1 | 1.1% |
Bevacizumab | 1 | 1.1% |
Big data | 1 | 1.1% |
Bioenergy | 1 | 1.1% |
Biofouling | 1 | 1.1% |
Biological dispersal | 1 | 1.1% |
Biological pest control | 1 | 1.1% |
Biomechanics | 1 | 1.1% |
Bioproducts | 1 | 1.1% |
Biorefinery | 1 | 1.1% |
Biosafety | 1 | 1.1% |
Biosecurity | 1 | 1.1% |
Biosensor | 1 | 1.1% |
Bipolar disorder | 1 | 1.1% |
Bladder cancer | 1 | 1.1% |
Blood | 1 | 1.1% |
Blood donation | 1 | 1.1% |
Blood lipids | 1 | 1.1% |
Blood plasma | 1 | 1.1% |
Blood transfusion | 1 | 1.1% |
Blood type | 1 | 1.1% |
Bluetongue disease | 1 | 1.1% |
Board of directors | 1 | 1.1% |
Body fluids | 1 | 1.1% |
Bone metastasis | 1 | 1.1% |
Bovine spongiform encephalopathy | 1 | 1.1% |
Brachytherapy | 1 | 1.1% |
Brain tumor | 1 | 1.1% |
Breast cancer screening | 1 | 1.1% |
Breast imaging | 1 | 1.1% |
Broad-spectrum antibiotic | 1 | 1.1% |
Bronchodilator | 1 | 1.1% |
Building-integrated photovoltaics | 1 | 1.1% |
Buprenorphine | 1 | 1.1% |
Buprenorphine/naloxone | 1 | 1.1% |
Bupropion | 1 | 1.1% |
Business ethics | 1 | 1.1% |
C-reactive protein | 1 | 1.1% |
CCR5 | 1 | 1.1% |
CD4 | 1 | 1.1% |
CHA2DS2–VASc score | 1 | 1.1% |
COLD-PCR | 1 | 1.1% |
COX-2 inhibitor | 1 | 1.1% |
Caesarean section | 1 | 1.1% |
Campylobacter | 1 | 1.1% |
Carbapenem | 1 | 1.1% |
Carbon capture and storage | 1 | 1.1% |
Carcinoembryonic antigen | 1 | 1.1% |
Carcinoma | 1 | 1.1% |
Cardiac catheterization | 1 | 1.1% |
Cardiac imaging | 1 | 1.1% |
Cardiac muscle cell | 1 | 1.1% |
Cardiac rehabilitation | 1 | 1.1% |
Cardiotocography | 1 | 1.1% |
Case management (US health system) | 1 | 1.1% |
Case management (US healthcare system) | 1 | 1.1% |
Case–control study | 1 | 1.1% |
Catalysis | 1 | 1.1% |
Cefaclor | 1 | 1.1% |
Celecoxib | 1 | 1.1% |
Cell (biology) | 1 | 1.1% |
Cell growth | 1 | 1.1% |
Cell potency | 1 | 1.1% |
Cell-free fetal DNA | 1 | 1.1% |
Cellular differentiation | 1 | 1.1% |
Census | 1 | 1.1% |
Central venous catheter | 1 | 1.1% |
Cephalosporin | 1 | 1.1% |
Cerebral palsy | 1 | 1.1% |
Cervical cancer | 1 | 1.1% |
Chagas disease | 1 | 1.1% |
Chemicals in medicine | 1 | 1.1% |
Chemotherapy-induced nausea and vomiting | 1 | 1.1% |
Chikungunya | 1 | 1.1% |
Chlamydia | 1 | 1.1% |
Chlamydia infection | 1 | 1.1% |
Cholecystectomy | 1 | 1.1% |
Cholecystitis | 1 | 1.1% |
Choosing Wisely | 1 | 1.1% |
Choosing Wisely Canada | 1 | 1.1% |
Chorioamnionitis | 1 | 1.1% |
Choroidal neovascularization | 1 | 1.1% |
Chronic kidney disease | 1 | 1.1% |
Cigarette | 1 | 1.1% |
Citalopram | 1 | 1.1% |
Citizen science | 1 | 1.1% |
Clathrate hydrate | 1 | 1.1% |
Climate | 1 | 1.1% |
Climate change | 1 | 1.1% |
Climatology | 1 | 1.1% |
Clinic | 1 | 1.1% |
Clinical clerkship | 1 | 1.1% |
Clinical coder | 1 | 1.1% |
Clopidogrel | 1 | 1.1% |
Clothing | 1 | 1.1% |
Clozapine | 1 | 1.1% |
Co-receptor | 1 | 1.1% |
Coagulation | 1 | 1.1% |
Coal | 1 | 1.1% |
Cochrane Library | 1 | 1.1% |
Cofiring | 1 | 1.1% |
Cogeneration | 1 | 1.1% |
Colorectal polyp | 1 | 1.1% |
Compact fluorescent lamp | 1 | 1.1% |
Complement system | 1 | 1.1% |
Complete blood count | 1 | 1.1% |
Complexity | 1 | 1.1% |
Computed tomography angiography | 1 | 1.1% |
Computer file | 1 | 1.1% |
Computer network | 1 | 1.1% |
Computer science | 1 | 1.1% |
Computer security | 1 | 1.1% |
Computer-aided diagnosis | 1 | 1.1% |
Computerized physician order entry | 1 | 1.1% |
Concepts in metaphysics | 1 | 1.1% |
Condensed matter physics | 1 | 1.1% |
Condition monitoring | 1 | 1.1% |
Conflict resolution | 1 | 1.1% |
Conjugated estrogens | 1 | 1.1% |
Consciousness | 1 | 1.1% |
Conservation biology | 1 | 1.1% |
Constraint-induced movement therapy | 1 | 1.1% |
Contact tracing | 1 | 1.1% |
Contrast (vision) | 1 | 1.1% |
Control (management) | 1 | 1.1% |
Control chart | 1 | 1.1% |
Coombs test | 1 | 1.1% |
Coping (psychology) | 1 | 1.1% |
Coronary catheterization | 1 | 1.1% |
Coronary circulation | 1 | 1.1% |
Coronavirus disease 2019 | 1 | 1.1% |
Correlation | 1 | 1.1% |
Correlation and dependence | 1 | 1.1% |
Corticosteroid | 1 | 1.1% |
Corynebacterineae | 1 | 1.1% |
Cost-shifting | 1 | 1.1% |
Cost–benefit analysis | 1 | 1.1% |
Cost–utility analysis | 1 | 1.1% |
Cotinine | 1 | 1.1% |
Cough | 1 | 1.1% |
Creatine kinase | 1 | 1.1% |
Criminalization | 1 | 1.1% |
Crowdsourcing | 1 | 1.1% |
Cryptography | 1 | 1.1% |
Culex | 1 | 1.1% |
Cyberattack | 1 | 1.1% |
Cytogenetics | 1 | 1.1% |
Cytokine | 1 | 1.1% |
D-dimer | 1 | 1.1% |
DNA | 1 | 1.1% |
DNA repair | 1 | 1.1% |
Da Vinci Surgical System | 1 | 1.1% |
Data sharing | 1 | 1.1% |
Deaf culture | 1 | 1.1% |
Death | 1 | 1.1% |
Deception | 1 | 1.1% |
Defensive medicine | 1 | 1.1% |
Dehydroepiandrosterone | 1 | 1.1% |
Delivery (commerce) | 1 | 1.1% |
Demyelinating disease | 1 | 1.1% |
Dendrimer | 1 | 1.1% |
Dengue fever | 1 | 1.1% |
Denosumab | 1 | 1.1% |
Dental public health | 1 | 1.1% |
Desertification | 1 | 1.1% |
Design | 1 | 1.1% |
Desmoteplase | 1 | 1.1% |
Developmental biology | 1 | 1.1% |
Diabetes mellitus | 1 | 1.1% |
Diabetic foot | 1 | 1.1% |
Diabetic foot ulcer | 1 | 1.1% |
Diagnosis code | 1 | 1.1% |
Diarrhea | 1 | 1.1% |
Didanosine | 1 | 1.1% |
Diltiazem | 1 | 1.1% |
Dioscorea alata | 1 | 1.1% |
Discrete choice | 1 | 1.1% |
Disease management (health) | 1 | 1.1% |
Disease registry | 1 | 1.1% |
Disease surveillance | 1 | 1.1% |
Disproportionate share hospital | 1 | 1.1% |
Docosahexaenoic acid | 1 | 1.1% |
Doctor of Medicine | 1 | 1.1% |
Doctor of Philosophy | 1 | 1.1% |
Down syndrome | 1 | 1.1% |
Doxepin | 1 | 1.1% |
Dried blood spot | 1 | 1.1% |
Drinking water | 1 | 1.1% |
Drought | 1 | 1.1% |
Drug eruption | 1 | 1.1% |
Drug injection | 1 | 1.1% |
Drug reaction with eosinophilia and systemic symptoms | 1 | 1.1% |
Drug resistance | 1 | 1.1% |
Drugs acting on the nervous system | 1 | 1.1% |
Ductal carcinoma in situ | 1 | 1.1% |
Dynamo theory | 1 | 1.1% |
EQ-5D | 1 | 1.1% |
East Riding of Yorkshire | 1 | 1.1% |
Eastern equine encephalitis | 1 | 1.1% |
Ebola | 1 | 1.1% |
Eclampsia | 1 | 1.1% |
Econometrics | 1 | 1.1% |
Economic growth | 1 | 1.1% |
Efavirenz/emtricitabine/tenofovir | 1 | 1.1% |
Efficient energy use | 1 | 1.1% |
El Niño–Southern Oscillation | 1 | 1.1% |
Elastography | 1 | 1.1% |
Electric battery | 1 | 1.1% |
Electricity | 1 | 1.1% |
Electrocardiography | 1 | 1.1% |
Electroencephalography | 1 | 1.1% |
Electronic circuit | 1 | 1.1% |
Electronic prescribing | 1 | 1.1% |
Embolism | 1 | 1.1% |
Emergency | 1 | 1.1% |
Emic and etic | 1 | 1.1% |
Emotion | 1 | 1.1% |
Empirical Bayes method | 1 | 1.1% |
Employee Retirement Income Security Act of 1974 | 1 | 1.1% |
Encephalopathy | 1 | 1.1% |
Encryption | 1 | 1.1% |
Endocrine disruptor | 1 | 1.1% |
Endometrial cancer | 1 | 1.1% |
Endometriosis | 1 | 1.1% |
Endovascular aneurysm repair | 1 | 1.1% |
Energy | 1 | 1.1% |
Energy storage | 1 | 1.1% |
Engineering controls | 1 | 1.1% |
Environmental remediation | 1 | 1.1% |
Envisat | 1 | 1.1% |
Enzyme inhibitor | 1 | 1.1% |
Epidermal growth factor receptor | 1 | 1.1% |
Epigenetics | 1 | 1.1% |
Epilepsy | 1 | 1.1% |
Epileptic seizure | 1 | 1.1% |
Epistasis | 1 | 1.1% |
Equation | 1 | 1.1% |
Erectile dysfunction | 1 | 1.1% |
Erlotinib | 1 | 1.1% |
Escitalopram | 1 | 1.1% |
Essential health benefits | 1 | 1.1% |
Estimator | 1 | 1.1% |
Estradiol (medication) | 1 | 1.1% |
Estrogen (medication) | 1 | 1.1% |
Etoricoxib | 1 | 1.1% |
Eutrophication | 1 | 1.1% |
Exhaled nitric oxide | 1 | 1.1% |
Experiment | 1 | 1.1% |
Expert | 1 | 1.1% |
Extensively drug-resistant tuberculosis | 1 | 1.1% |
Extract, transform, load | 1 | 1.1% |
Eye care | 1 | 1.1% |
Factor H | 1 | 1.1% |
Factor X | 1 | 1.1% |
Fat | 1 | 1.1% |
Fatigue | 1 | 1.1% |
Febrile neutropenia | 1 | 1.1% |
Febrile seizure | 1 | 1.1% |
Felicia Cosman | 1 | 1.1% |
Fellow | 1 | 1.1% |
Fenofibrate | 1 | 1.1% |
Fibrate | 1 | 1.1% |
Fibre-reinforced plastic | 1 | 1.1% |
Fibrin | 1 | 1.1% |
Fibrinolysis | 1 | 1.1% |
Fish farming | 1 | 1.1% |
Fish meal | 1 | 1.1% |
Five Year Forward View | 1 | 1.1% |
Flavonoid | 1 | 1.1% |
Flu season | 1 | 1.1% |
Fludeoxyglucose (18F) | 1 | 1.1% |
Fluorescent lamp | 1 | 1.1% |
Focus group | 1 | 1.1% |
Food | 1 | 1.1% |
Food Distribution Program on Indian Reservations | 1 | 1.1% |
Food and drink | 1 | 1.1% |
Food extrusion | 1 | 1.1% |
Food intolerance | 1 | 1.1% |
Food safety | 1 | 1.1% |
Foodborne illness | 1 | 1.1% |
Forest plot | 1 | 1.1% |
Formulary (pharmacy) | 1 | 1.1% |
Fraud | 1 | 1.1% |
Freezing | 1 | 1.1% |
Fuel | 1 | 1.1% |
Functional magnetic resonance imaging | 1 | 1.1% |
Fusidic acid | 1 | 1.1% |
Gabapentin | 1 | 1.1% |
Gallium arsenide | 1 | 1.1% |
Gas to liquids | 1 | 1.1% |
Gefitinib | 1 | 1.1% |
Gender | 1 | 1.1% |
Gene duplication | 1 | 1.1% |
Gene therapy | 1 | 1.1% |
GeneXpert MTB/RIF | 1 | 1.1% |
Generic drug | 1 | 1.1% |
Genetic analysis | 1 | 1.1% |
Genetic counseling | 1 | 1.1% |
Genetic disorder | 1 | 1.1% |
Genetic heterogeneity | 1 | 1.1% |
Genetically modified crops | 1 | 1.1% |
Genetically modified organism | 1 | 1.1% |
Genetically modified tomato | 1 | 1.1% |
Genome-wide association study | 1 | 1.1% |
Gentamicin | 1 | 1.1% |
Geographic information system | 1 | 1.1% |
Geothermal energy | 1 | 1.1% |
Gerontology | 1 | 1.1% |
Gestational age | 1 | 1.1% |
Gestational diabetes | 1 | 1.1% |
Gestational hypertension | 1 | 1.1% |
Glioblastoma | 1 | 1.1% |
Glioma | 1 | 1.1% |
Glycated hemoglobin | 1 | 1.1% |
Goal | 1 | 1.1% |
Government aid programs | 1 | 1.1% |
Graphical user interface | 1 | 1.1% |
Greenhouse gas | 1 | 1.1% |
Gut flora | 1 | 1.1% |
Gynaecologic disorders | 1 | 1.1% |
Gynaecology | 1 | 1.1% |
Gynoid | 1 | 1.1% |
HAS-BLED | 1 | 1.1% |
HER2/neu | 1 | 1.1% |
HIV/AIDS in the United States | 1 | 1.1% |
HVAC | 1 | 1.1% |
Habitat | 1 | 1.1% |
Harm reduction | 1 | 1.1% |
Hazard analysis and critical control points | 1 | 1.1% |
Health Level 7 | 1 | 1.1% |
Health and wellbeing board | 1 | 1.1% |
Health data | 1 | 1.1% |
Health information technology | 1 | 1.1% |
Health research | 1 | 1.1% |
Health services research | 1 | 1.1% |
Healthcare in Canada | 1 | 1.1% |
Healthy diet | 1 | 1.1% |
Hearing loss | 1 | 1.1% |
Heart failure with preserved ejection fraction | 1 | 1.1% |
Heat exchanger | 1 | 1.1% |
Heat pump | 1 | 1.1% |
Hepatocellular carcinoma | 1 | 1.1% |
Herpes simplex | 1 | 1.1% |
Heteroscedasticity | 1 | 1.1% |
High-nutrient, low-chlorophyll regions | 1 | 1.1% |
Hip | 1 | 1.1% |
Hip replacement | 1 | 1.1% |
Hives | 1 | 1.1% |
Home care in the United States | 1 | 1.1% |
Homoscedasticity | 1 | 1.1% |
Homosexuality | 1 | 1.1% |
Hormone | 1 | 1.1% |
Hospital-acquired condition | 1 | 1.1% |
House mouse | 1 | 1.1% |
Household | 1 | 1.1% |
Human decontamination | 1 | 1.1% |
Human diseases and disorders | 1 | 1.1% |
Human eye | 1 | 1.1% |
Human leukocyte antigen | 1 | 1.1% |
Human pregnancy | 1 | 1.1% |
Humanitarian aid | 1 | 1.1% |
Human–computer interaction | 1 | 1.1% |
Human–robot interaction | 1 | 1.1% |
Hydrocephalus | 1 | 1.1% |
Hydrogen production | 1 | 1.1% |
Hydrogen storage | 1 | 1.1% |
Hydrology | 1 | 1.1% |
Hydrothermal vent | 1 | 1.1% |
Hygiene | 1 | 1.1% |
Hyperkinetic disorder | 1 | 1.1% |
Hyperprolactinaemia | 1 | 1.1% |
Hypnotic | 1 | 1.1% |
Hypodermic needle | 1 | 1.1% |
Hysterectomy | 1 | 1.1% |
Iatrogenesis | 1 | 1.1% |
Ice | 1 | 1.1% |
Immunity (medical) | 1 | 1.1% |
Immunization | 1 | 1.1% |
Immunization during pregnancy | 1 | 1.1% |
Immunoassay | 1 | 1.1% |
Immunodeficiency | 1 | 1.1% |
Immunoelectrophoresis | 1 | 1.1% |
Immunohistochemistry | 1 | 1.1% |
Improving Access to Psychological Therapies | 1 | 1.1% |
Incandescent light bulb | 1 | 1.1% |
Incidence (epidemiology) | 1 | 1.1% |
Incidental imaging finding | 1 | 1.1% |
Income | 1 | 1.1% |
Incremental cost-effectiveness ratio | 1 | 1.1% |
Infant mortality | 1 | 1.1% |
Infection prevention and control | 1 | 1.1% |
Infertility | 1 | 1.1% |
Influenza A virus subtype H3N2 | 1 | 1.1% |
Influenza A virus subtype H5N1 | 1 | 1.1% |
Influenza A virus subtype H7N7 | 1 | 1.1% |
Influenza A virus subtype H7N9 | 1 | 1.1% |
Information privacy | 1 | 1.1% |
Infrastructure | 1 | 1.1% |
Injection (medicine) | 1 | 1.1% |
Insomnia | 1 | 1.1% |
Inspection | 1 | 1.1% |
Instrumental variables estimation | 1 | 1.1% |
Insulin | 1 | 1.1% |
Insulin resistance | 1 | 1.1% |
Integrated circuit | 1 | 1.1% |
Intention-to-treat analysis | 1 | 1.1% |
Interactome | 1 | 1.1% |
Interest | 1 | 1.1% |
International Classification of Diseases | 1 | 1.1% |
Interoperability | 1 | 1.1% |
Intraclass correlation | 1 | 1.1% |
Intracranial hemorrhage | 1 | 1.1% |
Intracranial pressure | 1 | 1.1% |
Intravenous therapy | 1 | 1.1% |
Intravitreal administration | 1 | 1.1% |
Invasive carcinoma of no special type | 1 | 1.1% |
Invasive species | 1 | 1.1% |
Isaac Asimov | 1 | 1.1% |
Isoniazid | 1 | 1.1% |
K-nearest neighbors algorithm | 1 | 1.1% |
KRAS | 1 | 1.1% |
Kidney failure | 1 | 1.1% |
Labor induction | 1 | 1.1% |
Laser | 1 | 1.1% |
Laser coagulation | 1 | 1.1% |
Latent tuberculosis | 1 | 1.1% |
Left atrial appendage occlusion | 1 | 1.1% |
Leukemia | 1 | 1.1% |
Life | 1 | 1.1% |
Life history theory | 1 | 1.1% |
Lighting | 1 | 1.1% |
Likelihood function | 1 | 1.1% |
Likelihood ratios in diagnostic testing | 1 | 1.1% |
Linear time-invariant system | 1 | 1.1% |
Linezolid | 1 | 1.1% |
Lisdexamfetamine | 1 | 1.1% |
Lithium (medication) | 1 | 1.1% |
Liver | 1 | 1.1% |
Low birth weight | 1 | 1.1% |
Lower gastrointestinal series | 1 | 1.1% |
Lumen (unit) | 1 | 1.1% |
Lunasin | 1 | 1.1% |
Lung | 1 | 1.1% |
Lung cancer screening | 1 | 1.1% |
Lung disorders | 1 | 1.1% |
Lung nodule | 1 | 1.1% |
Lutein | 1 | 1.1% |
Lysosomal storage disease | 1 | 1.1% |
Machine | 1 | 1.1% |
Macula of retina | 1 | 1.1% |
Macular telangiectasia | 1 | 1.1% |
Malaria | 1 | 1.1% |
Male genital disorders | 1 | 1.1% |
Malware | 1 | 1.1% |
MammaPrint | 1 | 1.1% |
Mammalian pregnancy | 1 | 1.1% |
Management of atrial fibrillation | 1 | 1.1% |
Management of hypertension | 1 | 1.1% |
Management of schizophrenia | 1 | 1.1% |
Mania | 1 | 1.1% |
Mantoux test | 1 | 1.1% |
Mark and recapture | 1 | 1.1% |
Materials science | 1 | 1.1% |
Maternal death | 1 | 1.1% |
Maternal–fetal medicine | 1 | 1.1% |
Mathematical model | 1 | 1.1% |
Mathematical optimization | 1 | 1.1% |
Matter | 1 | 1.1% |
McDonald criteria | 1 | 1.1% |
Mechanical engineering | 1 | 1.1% |
Mechatronics | 1 | 1.1% |
Median | 1 | 1.1% |
Medical genetics | 1 | 1.1% |
Medical history | 1 | 1.1% |
Medical laboratory | 1 | 1.1% |
Medical research | 1 | 1.1% |
Medical school | 1 | 1.1% |
Medical simulation | 1 | 1.1% |
Medical specialty | 1 | 1.1% |
Medicalization | 1 | 1.1% |
Medicare Sustainable Growth Rate | 1 | 1.1% |
Medicinal chemistry | 1 | 1.1% |
Melanocytic nevus | 1 | 1.1% |
Melanoma | 1 | 1.1% |
Melatonin | 1 | 1.1% |
Membrane | 1 | 1.1% |
Membrane bioreactor | 1 | 1.1% |
Meningioma | 1 | 1.1% |
Meningitis | 1 | 1.1% |
Mental Health Act 1983 | 1 | 1.1% |
Mental states | 1 | 1.1% |
Meta-regression | 1 | 1.1% |
Metabolic syndrome | 1 | 1.1% |
Metadata | 1 | 1.1% |
Metagenomics | 1 | 1.1% |
Metamaterial | 1 | 1.1% |
Methadone | 1 | 1.1% |
Methane | 1 | 1.1% |
Methicillin | 1 | 1.1% |
Methodology | 1 | 1.1% |
Methylphenidate | 1 | 1.1% |
Metoprolol | 1 | 1.1% |
Microbiota | 1 | 1.1% |
Microorganism | 1 | 1.1% |
Microsatellite instability | 1 | 1.1% |
Microscopy | 1 | 1.1% |
Microsporidia | 1 | 1.1% |
Middle East respiratory syndrome-related coronavirus | 1 | 1.1% |
Midwife | 1 | 1.1% |
Mild cognitive impairment | 1 | 1.1% |
Milk | 1 | 1.1% |
Millennium Development Goals | 1 | 1.1% |
Minimally invasive procedure | 1 | 1.1% |
Minimaze procedure | 1 | 1.1% |
MinnesotaCare | 1 | 1.1% |
Mirtazapine | 1 | 1.1% |
Miscarriage | 1 | 1.1% |
Mitochondrion | 1 | 1.1% |
Moclobemide | 1 | 1.1% |
Model organism | 1 | 1.1% |
Monoamine oxidase inhibitor | 1 | 1.1% |
Mosquito | 1 | 1.1% |
Mosquito control | 1 | 1.1% |
Mosquito-borne disease | 1 | 1.1% |
Motherhood | 1 | 1.1% |
Motivation | 1 | 1.1% |
Motivational interviewing | 1 | 1.1% |
Mucositis | 1 | 1.1% |
Multiculturalism | 1 | 1.1% |
Multiple drug resistance | 1 | 1.1% |
Multiple myeloma | 1 | 1.1% |
Multiple sclerosis | 1 | 1.1% |
Muscarinic antagonist | 1 | 1.1% |
Musculoskeletal system | 1 | 1.1% |
Music Tech Fest | 1 | 1.1% |
Mutation | 1 | 1.1% |
Mycobacteria | 1 | 1.1% |
Mycoplasma | 1 | 1.1% |
Myelodysplastic syndrome | 1 | 1.1% |
Myocardial perfusion imaging | 1 | 1.1% |
NHS foundation trust | 1 | 1.1% |
Nail biting | 1 | 1.1% |
Nanochemistry | 1 | 1.1% |
Nanomaterials | 1 | 1.1% |
Nanotechnology | 1 | 1.1% |
Nanowire | 1 | 1.1% |
National School Lunch Act | 1 | 1.1% |
Natural gas | 1 | 1.1% |
Natural gas storage | 1 | 1.1% |
Natural reservoir | 1 | 1.1% |
Necrosis | 1 | 1.1% |
Needle and syringe programmes | 1 | 1.1% |
Needle exchange programme | 1 | 1.1% |
Neonatal seizure | 1 | 1.1% |
Neonatology | 1 | 1.1% |
Neoplasm | 1 | 1.1% |
Neovascularization | 1 | 1.1% |
Neurodegeneration | 1 | 1.1% |
Neurological disorder | 1 | 1.1% |
Neuromyelitis optica | 1 | 1.1% |
Neuropathology | 1 | 1.1% |
Neuroscience | 1 | 1.1% |
Neutropenia | 1 | 1.1% |
Non-small-cell lung carcinoma | 1 | 1.1% |
Normal pressure hydrocephalus | 1 | 1.1% |
Nortriptyline | 1 | 1.1% |
Null hypothesis | 1 | 1.1% |
Numeracy | 1 | 1.1% |
Nursing home care | 1 | 1.1% |
Nylon | 1 | 1.1% |
OGT (gene) | 1 | 1.1% |
OIE/FAO Network of Expertise on Animal Influenza | 1 | 1.1% |
OLED | 1 | 1.1% |
Observation | 1 | 1.1% |
Obstetrics | 1 | 1.1% |
Ocean | 1 | 1.1% |
Odds ratio | 1 | 1.1% |
Odor | 1 | 1.1% |
Office of Inspector General (United States) | 1 | 1.1% |
Offshore wind power | 1 | 1.1% |
Olanzapine | 1 | 1.1% |
Open access | 1 | 1.1% |
Open source | 1 | 1.1% |
Optical fiber | 1 | 1.1% |
OraQuick | 1 | 1.1% |
Oral sex | 1 | 1.1% |
Ordinary least squares | 1 | 1.1% |
Organ donation | 1 | 1.1% |
Organ transplantation | 1 | 1.1% |
Osteoarthritis | 1 | 1.1% |
Osteonecrosis of the jaw | 1 | 1.1% |
Ostrinia furnacalis | 1 | 1.1% |
Overfitting | 1 | 1.1% |
Oxidative stress | 1 | 1.1% |
P-glycoprotein | 1 | 1.1% |
P53 | 1 | 1.1% |
PRNP | 1 | 1.1% |
Pain management | 1 | 1.1% |
Paliperidone | 1 | 1.1% |
Pandemic | 1 | 1.1% |
Passive smoking | 1 | 1.1% |
Patent | 1 | 1.1% |
Pathogen | 1 | 1.1% |
Patient choice | 1 | 1.1% |
Patient-reported outcome | 1 | 1.1% |
Paul Ridker | 1 | 1.1% |
Pediatrics | 1 | 1.1% |
Pegaptanib | 1 | 1.1% |
Percutaneous aortic valve replacement | 1 | 1.1% |
Percutaneous coronary intervention | 1 | 1.1% |
Perinatal mortality | 1 | 1.1% |
Peripheral artery disease | 1 | 1.1% |
Peripheral neuropathy | 1 | 1.1% |
Periventricular leukomalacia | 1 | 1.1% |
Personal computer | 1 | 1.1% |
Personal data | 1 | 1.1% |
Personalized medicine | 1 | 1.1% |
Pharmacist | 1 | 1.1% |
Pharmacogenomics | 1 | 1.1% |
Phenobarbital | 1 | 1.1% |
Phenomenology (philosophy) | 1 | 1.1% |
Phenytoin | 1 | 1.1% |
Philosophy | 1 | 1.1% |
Photonics | 1 | 1.1% |
Physical examination | 1 | 1.1% |
Physical fitness | 1 | 1.1% |
Physical medicine and rehabilitation | 1 | 1.1% |
Physical sciences | 1 | 1.1% |
Physician assistant | 1 | 1.1% |
Physics | 1 | 1.1% |
Piezoelectricity | 1 | 1.1% |
Plant disease resistance | 1 | 1.1% |
Plant tissue culture | 1 | 1.1% |
Plasma (physics) | 1 | 1.1% |
Plasmon | 1 | 1.1% |
Platelet | 1 | 1.1% |
Pleural effusion | 1 | 1.1% |
Pneumonia | 1 | 1.1% |
Point of care | 1 | 1.1% |
Polyp (medicine) | 1 | 1.1% |
Polypharmacy | 1 | 1.1% |
Positron emission tomography–magnetic resonance imaging | 1 | 1.1% |
Post-exposure prophylaxis | 1 | 1.1% |
Postterm pregnancy | 1 | 1.1% |
Poultry | 1 | 1.1% |
Poultry farming | 1 | 1.1% |
Poverty | 1 | 1.1% |
Power (statistics) | 1 | 1.1% |
Power station | 1 | 1.1% |
Prasugrel | 1 | 1.1% |
Pre- and post-test probability | 1 | 1.1% |
Pre-eclampsia | 1 | 1.1% |
Prediabetes | 1 | 1.1% |
Prediction | 1 | 1.1% |
Prednisolone | 1 | 1.1% |
Prednisone | 1 | 1.1% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 1.1% |
Pregabalin | 1 | 1.1% |
Prenatal testing | 1 | 1.1% |
Price | 1 | 1.1% |
Primary care physician | 1 | 1.1% |
Prion | 1 | 1.1% |
Probability | 1 | 1.1% |
Probability distribution | 1 | 1.1% |
Problem solving | 1 | 1.1% |
Procurement | 1 | 1.1% |
Production function | 1 | 1.1% |
Profession | 1 | 1.1% |
Prognosis | 1 | 1.1% |
Propensity score matching | 1 | 1.1% |
Propranolol | 1 | 1.1% |
Prospective payment system | 1 | 1.1% |
Prostaglandin-endoperoxide synthase 2 | 1 | 1.1% |
Prostate-specific antigen | 1 | 1.1% |
Prostatectomy | 1 | 1.1% |
Prostitution | 1 | 1.1% |
Pseudomonas | 1 | 1.1% |
Pseudomonas aeruginosa | 1 | 1.1% |
Psychiatric and mental health nursing | 1 | 1.1% |
Psychiatric hospital | 1 | 1.1% |
Psychoactive drugs | 1 | 1.1% |
Psychology | 1 | 1.1% |
Psychosis | 1 | 1.1% |
Public broadcasting | 1 | 1.1% |
Public hospital | 1 | 1.1% |
Publication bias | 1 | 1.1% |
Pulmonary embolism | 1 | 1.1% |
Pump | 1 | 1.1% |
Pyrazinamide | 1 | 1.1% |
QRISK | 1 | 1.1% |
Quality and Outcomes Framework | 1 | 1.1% |
Quality assurance | 1 | 1.1% |
Quality management | 1 | 1.1% |
Quantitative computed tomography | 1 | 1.1% |
Quetiapine | 1 | 1.1% |
RTT | 1 | 1.1% |
Radar | 1 | 1.1% |
Randomness | 1 | 1.1% |
Ranibizumab | 1 | 1.1% |
Rape | 1 | 1.1% |
Readability | 1 | 1.1% |
Real-time polymerase chain reaction | 1 | 1.1% |
Receptor tyrosine kinase | 1 | 1.1% |
Recycling | 1 | 1.1% |
Red blood cell | 1 | 1.1% |
Regeneration (biology) | 1 | 1.1% |
Registered nurse | 1 | 1.1% |
Relational database | 1 | 1.1% |
Relative risk | 1 | 1.1% |
Renal cell carcinoma | 1 | 1.1% |
Request for proposal | 1 | 1.1% |
Research methods | 1 | 1.1% |
Respiratory disease | 1 | 1.1% |
Retina | 1 | 1.1% |
Retirement | 1 | 1.1% |
Reverse osmosis | 1 | 1.1% |
Rice | 1 | 1.1% |
Rifamycin | 1 | 1.1% |
Rifapentine | 1 | 1.1% |
Rights | 1 | 1.1% |
Risk management | 1 | 1.1% |
Rivastigmine | 1 | 1.1% |
Robot-assisted surgery | 1 | 1.1% |
Robust statistics | 1 | 1.1% |
Root | 1 | 1.1% |
Rural health clinic | 1 | 1.1% |
Ryan White | 1 | 1.1% |
SCADA | 1 | 1.1% |
Safeguarding | 1 | 1.1% |
Salbutamol | 1 | 1.1% |
Scanning laser ophthalmoscopy | 1 | 1.1% |
Schizophrenia | 1 | 1.1% |
School Breakfast Program | 1 | 1.1% |
School meal | 1 | 1.1% |
School meal programs in the United States | 1 | 1.1% |
Scientific method | 1 | 1.1% |
Scrapie | 1 | 1.1% |
Seamount | 1 | 1.1% |
Self-driving car | 1 | 1.1% |
Self-funded health care | 1 | 1.1% |
Self-report study | 1 | 1.1% |
Semen | 1 | 1.1% |
Semen analysis | 1 | 1.1% |
Semiconductor | 1 | 1.1% |
Senescence | 1 | 1.1% |
Serosorting | 1 | 1.1% |
Sexuality | 1 | 1.1% |
Sievert | 1 | 1.1% |
Sign language | 1 | 1.1% |
Signs and symptoms | 1 | 1.1% |
Silicon | 1 | 1.1% |
Single-nucleotide polymorphism | 1 | 1.1% |
Single-photon emission computed tomography | 1 | 1.1% |
Skeletal system | 1 | 1.1% |
Smoking | 1 | 1.1% |
Smoking ban | 1 | 1.1% |
Snow | 1 | 1.1% |
Snow science | 1 | 1.1% |
Snowball sampling | 1 | 1.1% |
Social Security (United States) | 1 | 1.1% |
Social networking service | 1 | 1.1% |
Social robot | 1 | 1.1% |
Social science | 1 | 1.1% |
Software | 1 | 1.1% |
Soil | 1 | 1.1% |
Solar cell | 1 | 1.1% |
Solar energy | 1 | 1.1% |
Solar panel | 1 | 1.1% |
Solar thermal collector | 1 | 1.1% |
Solar thermal energy | 1 | 1.1% |
Solar tracker | 1 | 1.1% |
Spasticity | 1 | 1.1% |
Specialty (medicine) | 1 | 1.1% |
Species | 1 | 1.1% |
Species complex | 1 | 1.1% |
Spina bifida | 1 | 1.1% |
Spirometry | 1 | 1.1% |
Standard score | 1 | 1.1% |
Staphylococcus | 1 | 1.1% |
Statistical hypothesis testing | 1 | 1.1% |
Statistical model | 1 | 1.1% |
Statistical significance | 1 | 1.1% |
Stenotrophomonas maltophilia | 1 | 1.1% |
Stevens–Johnson syndrome | 1 | 1.1% |
Stillbirth | 1 | 1.1% |
Strategic planning | 1 | 1.1% |
Stress (biology) | 1 | 1.1% |
Strontium ranelate | 1 | 1.1% |
Student's t-test | 1 | 1.1% |
Substance dependence | 1 | 1.1% |
Supercritical fluid | 1 | 1.1% |
Supplemental Nutrition Assistance Program | 1 | 1.1% |
Supplier-induced demand | 1 | 1.1% |
Surgical mask | 1 | 1.1% |
Swine influenza | 1 | 1.1% |
Synthetic membrane | 1 | 1.1% |
Synthetic-aperture radar | 1 | 1.1% |
System | 1 | 1.1% |
T-statistic | 1 | 1.1% |
TAL effector | 1 | 1.1% |
Tamoxifen | 1 | 1.1% |
Tariff | 1 | 1.1% |
Telehealth | 1 | 1.1% |
Teriparatide | 1 | 1.1% |
Tetraplegia | 1 | 1.1% |
Textile | 1 | 1.1% |
Thalidomide | 1 | 1.1% |
Thermal management (electronics) | 1 | 1.1% |
Thermal power station | 1 | 1.1% |
Thesis | 1 | 1.1% |
Thorax | 1 | 1.1% |
Thrombin | 1 | 1.1% |
Thrombus | 1 | 1.1% |
Through-silicon via | 1 | 1.1% |
Thyroid nodule | 1 | 1.1% |
Ticagrelor | 1 | 1.1% |
Tirofiban | 1 | 1.1% |
Tissue plasminogen activator | 1 | 1.1% |
Tissues (biology) | 1 | 1.1% |
Titanium dioxide | 1 | 1.1% |
Toleration | 1 | 1.1% |
Tomosynthesis | 1 | 1.1% |
Tort reform | 1 | 1.1% |
Tourism | 1 | 1.1% |
Transitional care | 1 | 1.1% |
Translational research | 1 | 1.1% |
Transmissible spongiform encephalopathy | 1 | 1.1% |
Transposable element | 1 | 1.1% |
Treatment | 1 | 1.1% |
Treatment of bipolar disorder | 1 | 1.1% |
Treatment of cancer | 1 | 1.1% |
Treponema pallidum | 1 | 1.1% |
Triatoma protracta | 1 | 1.1% |
Trichomoniasis | 1 | 1.1% |
Triglyceride | 1 | 1.1% |
Tuberculosis diagnosis | 1 | 1.1% |
Turbine | 1 | 1.1% |
U.S. state | 1 | 1.1% |
Ultrasound | 1 | 1.1% |
Ultraviolet | 1 | 1.1% |
Uncertainty | 1 | 1.1% |
Unemployment | 1 | 1.1% |
Unemployment benefits | 1 | 1.1% |
Uniform distribution (continuous) | 1 | 1.1% |
United States budget sequestration in 2013 | 1 | 1.1% |
United States federal government continuity of operations | 1 | 1.1% |
University | 1 | 1.1% |
Upwelling | 1 | 1.1% |
Usability | 1 | 1.1% |
Uterine fibroid | 1 | 1.1% |
Uterine prolapse | 1 | 1.1% |
Vagina | 1 | 1.1% |
Vaginal lubrication | 1 | 1.1% |
Valproate | 1 | 1.1% |
Valvular heart disease | 1 | 1.1% |
Varenicline | 1 | 1.1% |
Vascular dementia | 1 | 1.1% |
Vascular endothelial growth factor | 1 | 1.1% |
Vector (epidemiology) | 1 | 1.1% |
Vector (molecular biology) | 1 | 1.1% |
Vector control | 1 | 1.1% |
Vein | 1 | 1.1% |
Venereal Disease Research Laboratory test | 1 | 1.1% |
Verapamil | 1 | 1.1% |
Verification and validation | 1 | 1.1% |
Vertebral column | 1 | 1.1% |
Vesicle (biology and chemistry) | 1 | 1.1% |
Violence | 1 | 1.1% |
Viral vector | 1 | 1.1% |
Virtual colonoscopy | 1 | 1.1% |
Virtual reality | 1 | 1.1% |
Vision | 1 | 1.1% |
Visual acuity | 1 | 1.1% |
Visual impairment | 1 | 1.1% |
Visual prosthesis | 1 | 1.1% |
Vitamin B12 | 1 | 1.1% |
Vitamin D deficiency | 1 | 1.1% |
Vitamin E | 1 | 1.1% |
Volcano | 1 | 1.1% |
Wafer (electronics) | 1 | 1.1% |
Water purification | 1 | 1.1% |
Water quality | 1 | 1.1% |
Water vapor | 1 | 1.1% |
Weather | 1 | 1.1% |
Weight loss | 1 | 1.1% |
West Nile fever | 1 | 1.1% |
West Nile virus | 1 | 1.1% |
Western African Ebola virus epidemic | 1 | 1.1% |
Whooping cough | 1 | 1.1% |
Wind power | 1 | 1.1% |
Wnt signaling pathway | 1 | 1.1% |
Wristband | 1 | 1.1% |
Xanthomonas oryzae pv. oryzae | 1 | 1.1% |
Xenopus | 1 | 1.1% |
Yam (vegetable) | 1 | 1.1% |
Yogurt | 1 | 1.1% |
Zeaxanthin | 1 | 1.1% |
Zinc | 1 | 1.1% |
Zoledronic acid | 1 | 1.1% |
Zolpidem | 1 | 1.1% |
Β-lactam antibiotic | 1 | 1.1% |
abs | rel | |
---|---|---|
Health | 118 | 92.9% |
Medicine | 113 | 89.0% |
Health sciences | 108 | 85.0% |
Health care | 100 | 78.7% |
Medical specialties | 88 | 69.3% |
Clinical medicine | 77 | 60.6% |
Public health | 60 | 47.2% |
Risk | 46 | 36.2% |
Disease | 43 | 33.9% |
Infection | 41 | 32.3% |
Diseases and disorders | 38 | 29.9% |
Epidemiology | 35 | 27.6% |
Human activities | 35 | 27.6% |
Health economics | 32 | 25.2% |
Preventive healthcare | 32 | 25.2% |
Patient | 28 | 22.0% |
Hospital | 27 | 21.3% |
Evidence-based medicine | 26 | 20.5% |
Research | 26 | 20.5% |
Chronic condition | 24 | 18.9% |
Health policy | 22 | 17.3% |
Nursing | 22 | 17.3% |
HIV/AIDS | 21 | 16.5% |
Adherence (medicine) | 20 | 15.7% |
Emergency department | 20 | 15.7% |
Evaluation | 19 | 15.0% |
Medical guideline | 19 | 15.0% |
Medical humanities | 19 | 15.0% |
Medicare (United States) | 18 | 14.2% |
Childbirth | 17 | 13.4% |
Medical diagnosis | 17 | 13.4% |
General practitioner | 16 | 12.6% |
Health professional | 16 | 12.6% |
Primary care | 16 | 12.6% |
Cardiovascular disease | 15 | 11.8% |
Management of HIV/AIDS | 15 | 11.8% |
Patient safety | 15 | 11.8% |
Randomized controlled trial | 15 | 11.8% |
Stroke | 15 | 11.8% |
Tuberculosis | 15 | 11.8% |
Biology | 14 | 11.0% |
Caregiver | 14 | 11.0% |
Ebola virus disease | 14 | 11.0% |
Hospital readmission | 14 | 11.0% |
Infectious diseases | 14 | 11.0% |
Surgery | 14 | 11.0% |
Systematic review | 14 | 11.0% |
Cancer | 13 | 10.2% |
Clinical trial | 13 | 10.2% |
Health system | 13 | 10.2% |
Medication | 13 | 10.2% |
Immunology | 12 | 9.4% |
Medicaid | 12 | 9.4% |
Meta-analysis | 12 | 9.4% |
Public sphere | 12 | 9.4% |
Screening (medicine) | 12 | 9.4% |
Electronic health record | 11 | 8.7% |
Governance | 11 | 8.7% |
Health care quality | 11 | 8.7% |
Risk assessment | 11 | 8.7% |
Cohort study | 10 | 7.9% |
Confidence interval | 10 | 7.9% |
Employment | 10 | 7.9% |
Exercise | 10 | 7.9% |
Microbiology | 10 | 7.9% |
Myocardial infarction | 10 | 7.9% |
Sensitivity and specificity | 10 | 7.9% |
Statistics | 10 | 7.9% |
Sustainability | 10 | 7.9% |
Technology | 10 | 7.9% |
Virus | 10 | 7.9% |
Antimicrobial resistance | 9 | 7.1% |
Emergency management | 9 | 7.1% |
Fee-for-service | 9 | 7.1% |
Hepatitis | 9 | 7.1% |
Influenza | 9 | 7.1% |
Obesity | 9 | 7.1% |
Osteoporosis | 9 | 7.1% |
Physician | 9 | 7.1% |
Risk management | 9 | 7.1% |
Sexually transmitted infection | 9 | 7.1% |
Therapy | 9 | 7.1% |
Audit | 8 | 6.3% |
Best practice | 8 | 6.3% |
Clinical commissioning group | 8 | 6.3% |
Health informatics | 8 | 6.3% |
Heart | 8 | 6.3% |
Innovation | 8 | 6.3% |
Mental health | 8 | 6.3% |
Physical therapy | 8 | 6.3% |
Science | 8 | 6.3% |
Vaccine | 8 | 6.3% |
Blood pressure | 7 | 5.5% |
Cholesterol | 7 | 5.5% |
Clinical governance | 7 | 5.5% |
Coronary artery disease | 7 | 5.5% |
Cost-effectiveness analysis | 7 | 5.5% |
Dementia | 7 | 5.5% |
Disease management (health) | 7 | 5.5% |
Human reproduction | 7 | 5.5% |
Infection control | 7 | 5.5% |
Life sciences | 7 | 5.5% |
Managed care | 7 | 5.5% |
Pharmacy | 7 | 5.5% |
Pneumonia | 7 | 5.5% |
Pregnancy | 7 | 5.5% |
Qualitative research | 7 | 5.5% |
Reproductive health | 7 | 5.5% |
Social work | 7 | 5.5% |
Thrombosis | 7 | 5.5% |
Venous thrombosis | 7 | 5.5% |
Antibiotic | 6 | 4.7% |
Anticoagulant | 6 | 4.7% |
Breast cancer | 6 | 4.7% |
Cardiovascular system | 6 | 4.7% |
Comorbidity | 6 | 4.7% |
Data analysis | 6 | 4.7% |
Deep vein thrombosis | 6 | 4.7% |
GeneXpert MTB/RIF | 6 | 4.7% |
HIV | 6 | 4.7% |
Hypertension | 6 | 4.7% |
Influenza pandemic | 6 | 4.7% |
Low-density lipoprotein | 6 | 4.7% |
Medical treatments | 6 | 4.7% |
Mental disorder | 6 | 4.7% |
Multi-drug-resistant tuberculosis | 6 | 4.7% |
Safe sex | 6 | 4.7% |
Surveillance | 6 | 4.7% |
Transmission (medicine) | 6 | 4.7% |
Tuberculosis management | 6 | 4.7% |
Western African Ebola virus epidemic | 6 | 4.7% |
Zoonosis | 6 | 4.7% |
Artificial intelligence | 5 | 3.9% |
Atrial fibrillation | 5 | 3.9% |
Avian influenza | 5 | 3.9% |
Birth control | 5 | 3.9% |
Breastfeeding | 5 | 3.9% |
Breastfeeding and HIV | 5 | 3.9% |
Chronic kidney disease | 5 | 3.9% |
Cochrane Library | 5 | 3.9% |
Cognitive science | 5 | 3.9% |
Colorectal cancer | 5 | 3.9% |
Community health | 5 | 3.9% |
Condom | 5 | 3.9% |
Diagnosis of HIV/AIDS | 5 | 3.9% |
Disability-adjusted life year | 5 | 3.9% |
Extensively drug-resistant tuberculosis | 5 | 3.9% |
Inflammation | 5 | 3.9% |
Information | 5 | 3.9% |
International Statistical Classification of Diseases and Related Health Problems | 5 | 3.9% |
Leadership | 5 | 3.9% |
Lung cancer | 5 | 3.9% |
MEDLINE | 5 | 3.9% |
Major depressive disorder | 5 | 3.9% |
Medical error | 5 | 3.9% |
Medical home | 5 | 3.9% |
Medical imaging | 5 | 3.9% |
Nanotechnology | 5 | 3.9% |
Palliative care | 5 | 3.9% |
Quality-adjusted life year | 5 | 3.9% |
Quantitative research | 5 | 3.9% |
Reliability engineering | 5 | 3.9% |
Renal function | 5 | 3.9% |
Robot | 5 | 3.9% |
Safety | 5 | 3.9% |
Sampling (statistics) | 5 | 3.9% |
Statin | 5 | 3.9% |
Survey methodology | 5 | 3.9% |
Telehealth | 5 | 3.9% |
Type 2 diabetes | 5 | 3.9% |
Adjuvant therapy | 4 | 3.1% |
Adolescence | 4 | 3.1% |
Antihypertensive drug | 4 | 3.1% |
Antiviral drug | 4 | 3.1% |
Asthma | 4 | 3.1% |
Autonomy | 4 | 3.1% |
Bias | 4 | 3.1% |
Bone | 4 | 3.1% |
Bone density | 4 | 3.1% |
Brain | 4 | 3.1% |
CD4 | 4 | 3.1% |
Case management (US health system) | 4 | 3.1% |
Chemotherapy | 4 | 3.1% |
Chikungunya | 4 | 3.1% |
Clinical audit | 4 | 3.1% |
Cognition | 4 | 3.1% |
Data | 4 | 3.1% |
Decision-making | 4 | 3.1% |
Diabetes | 4 | 3.1% |
Diabetes mellitus type 2 | 4 | 3.1% |
Disease burden | 4 | 3.1% |
Drugs | 4 | 3.1% |
Dual-energy X-ray absorptiometry | 4 | 3.1% |
Economics of service industries | 4 | 3.1% |
Epidemiology of HIV/AIDS | 4 | 3.1% |
Ethics | 4 | 3.1% |
Family planning | 4 | 3.1% |
Genetics | 4 | 3.1% |
Global Outbreak Alert and Response Network | 4 | 3.1% |
Glycated hemoglobin | 4 | 3.1% |
Goal | 4 | 3.1% |
Harm reduction | 4 | 3.1% |
High-density lipoprotein | 4 | 3.1% |
Hip fracture | 4 | 3.1% |
Human | 4 | 3.1% |
Influenza A virus subtype H7N9 | 4 | 3.1% |
Internal control | 4 | 3.1% |
International Classification of Diseases | 4 | 3.1% |
Malaria | 4 | 3.1% |
Medical prescription | 4 | 3.1% |
Medroxyprogesterone acetate | 4 | 3.1% |
Menopause | 4 | 3.1% |
Methicillin-resistant Staphylococcus aureus | 4 | 3.1% |
Millennium Development Goals | 4 | 3.1% |
NHS foundation trust | 4 | 3.1% |
Neoplasms | 4 | 3.1% |
Prescription drug | 4 | 3.1% |
Quality assurance | 4 | 3.1% |
Recruitment | 4 | 3.1% |
Regulatory compliance | 4 | 3.1% |
Self-care | 4 | 3.1% |
Sexual intercourse | 4 | 3.1% |
Shortness of breath | 4 | 3.1% |
Simulation | 4 | 3.1% |
Social programs | 4 | 3.1% |
Violence | 4 | 3.1% |
2009 flu pandemic | 3 | 2.4% |
Adverse effect | 3 | 2.4% |
Allergy | 3 | 2.4% |
Animal diseases | 3 | 2.4% |
Antidepressant | 3 | 2.4% |
Antimicrobial | 3 | 2.4% |
Assay | 3 | 2.4% |
Benzodiazepine | 3 | 2.4% |
Beta blocker | 3 | 2.4% |
Bioethics | 3 | 2.4% |
Blinded experiment | 3 | 2.4% |
Board of directors | 3 | 2.4% |
Body mass index | 3 | 2.4% |
Bone fracture | 3 | 2.4% |
Caesarean section | 3 | 2.4% |
Cardiology | 3 | 2.4% |
Case–control study | 3 | 2.4% |
Chronic obstructive pulmonary disease | 3 | 2.4% |
Clinical coder | 3 | 2.4% |
Combined oral contraceptive pill | 3 | 2.4% |
Confidentiality | 3 | 2.4% |
DNA sequencing | 3 | 2.4% |
Database | 3 | 2.4% |
Dependent and independent variables | 3 | 2.4% |
Diabetes management | 3 | 2.4% |
Disability | 3 | 2.4% |
Disease surveillance | 3 | 2.4% |
Echocardiography | 3 | 2.4% |
Ecology | 3 | 2.4% |
Education | 3 | 2.4% |
Electric vehicle | 3 | 2.4% |
Electroencephalography | 3 | 2.4% |
Emergency | 3 | 2.4% |
Emergency contraception | 3 | 2.4% |
Emergency medicine | 3 | 2.4% |
Emotion | 3 | 2.4% |
End-of-life care | 3 | 2.4% |
Engineering | 3 | 2.4% |
Epidemic | 3 | 2.4% |
Expert | 3 | 2.4% |
Fall prevention | 3 | 2.4% |
Flu season | 3 | 2.4% |
Google Scholar | 3 | 2.4% |
Gross domestic product | 3 | 2.4% |
HER2/neu | 3 | 2.4% |
Health Information Technology for Economic and Clinical Health Act | 3 | 2.4% |
Health care in the United States | 3 | 2.4% |
Health equity | 3 | 2.4% |
Health insurance coverage in the United States | 3 | 2.4% |
Hepatitis C | 3 | 2.4% |
Homelessness | 3 | 2.4% |
Hormonal contraception | 3 | 2.4% |
Hormone replacement therapy | 3 | 2.4% |
Incidence (epidemiology) | 3 | 2.4% |
Infant | 3 | 2.4% |
Influenza A virus subtype H5N1 | 3 | 2.4% |
Intensive care unit | 3 | 2.4% |
Internal audit | 3 | 2.4% |
Kidney failure | 3 | 2.4% |
Laboratory | 3 | 2.4% |
Levonorgestrel | 3 | 2.4% |
Linear regression | 3 | 2.4% |
Liver | 3 | 2.4% |
Low-carbon economy | 3 | 2.4% |
Medi-Cal | 3 | 2.4% |
Medical device | 3 | 2.4% |
Medical record | 3 | 2.4% |
Medical research | 3 | 2.4% |
Medical test | 3 | 2.4% |
Medicare dual eligible | 3 | 2.4% |
Men who have sex with men | 3 | 2.4% |
Metastasis | 3 | 2.4% |
Middle East respiratory syndrome-related coronavirus | 3 | 2.4% |
Mind | 3 | 2.4% |
Mortality rate | 3 | 2.4% |
Nervous system | 3 | 2.4% |
Neuron | 3 | 2.4% |
Nevirapine | 3 | 2.4% |
Non-communicable disease | 3 | 2.4% |
Nursing home | 3 | 2.4% |
Occupational safety and health | 3 | 2.4% |
Pandemic | 3 | 2.4% |
Patient Protection and Affordable Care Act | 3 | 2.4% |
Peripheral neuropathy | 3 | 2.4% |
Pharmacology | 3 | 2.4% |
Policy | 3 | 2.4% |
Polio | 3 | 2.4% |
Population health | 3 | 2.4% |
Post-exposure prophylaxis | 3 | 2.4% |
Postpartum period | 3 | 2.4% |
Poverty | 3 | 2.4% |
Prevention of HIV/AIDS | 3 | 2.4% |
Psychiatry | 3 | 2.4% |
Public services | 3 | 2.4% |
Pulse | 3 | 2.4% |
Quality and Outcomes Framework | 3 | 2.4% |
Radiation therapy | 3 | 2.4% |
Reliability (statistics) | 3 | 2.4% |
Reproductive rights | 3 | 2.4% |
Respiratory disease | 3 | 2.4% |
Robotics | 3 | 2.4% |
Scientific method | 3 | 2.4% |
Selective serotonin reuptake inhibitor | 3 | 2.4% |
Self-driving car | 3 | 2.4% |
Sensitivity analysis | 3 | 2.4% |
Sepsis | 3 | 2.4% |
Service industries | 3 | 2.4% |
Services sector of the economy | 3 | 2.4% |
Sex worker | 3 | 2.4% |
Sexual health | 3 | 2.4% |
Society | 3 | 2.4% |
Spirometry | 3 | 2.4% |
Tax | 3 | 2.4% |
Transcranial magnetic stimulation | 3 | 2.4% |
Variance | 3 | 2.4% |
Vein | 3 | 2.4% |
Vertically transmitted infection | 3 | 2.4% |
Viral hemorrhagic fever | 3 | 2.4% |
Vitamin D | 3 | 2.4% |
Warfarin | 3 | 2.4% |
Web of Science | 3 | 2.4% |
3D printing | 2 | 1.6% |
ACE inhibitor | 2 | 1.6% |
Abacavir | 2 | 1.6% |
Abdominal obesity | 2 | 1.6% |
Abstract (summary) | 2 | 1.6% |
Accountable care organization | 2 | 1.6% |
Aid | 2 | 1.6% |
Air pollution | 2 | 1.6% |
Allocation concealment | 2 | 1.6% |
Amniocentesis | 2 | 1.6% |
Amputation | 2 | 1.6% |
Angiology | 2 | 1.6% |
Angiotensin II receptor blocker | 2 | 1.6% |
Ankle–brachial pressure index | 2 | 1.6% |
Arthritis | 2 | 1.6% |
Artificial objects | 2 | 1.6% |
Assumption | 2 | 1.6% |
Atherosclerosis | 2 | 1.6% |
Athetosis | 2 | 1.6% |
Audit committee | 2 | 1.6% |
Auditor's report | 2 | 1.6% |
Automation | 2 | 1.6% |
Bacteria | 2 | 1.6% |
Bibliometrics | 2 | 1.6% |
Big data | 2 | 1.6% |
Bilirubin | 2 | 1.6% |
Biochemistry | 2 | 1.6% |
Biodiversity | 2 | 1.6% |
Biofilm | 2 | 1.6% |
Biofuel | 2 | 1.6% |
Biotechnology | 2 | 1.6% |
Blood sugar level | 2 | 1.6% |
Bootstrapping (statistics) | 2 | 1.6% |
Brain–computer interface | 2 | 1.6% |
Branches of science | 2 | 1.6% |
Bronchodilator | 2 | 1.6% |
CCR5 | 2 | 1.6% |
CHA2DS2–VASc score | 2 | 1.6% |
Cancer screening | 2 | 1.6% |
Capacity building | 2 | 1.6% |
Case study | 2 | 1.6% |
Cellular differentiation | 2 | 1.6% |
Central venous catheter | 2 | 1.6% |
Cerebral cortex | 2 | 1.6% |
Circumcision | 2 | 1.6% |
Clinical pathology | 2 | 1.6% |
Clostridioides difficile infection | 2 | 1.6% |
Co-receptor | 2 | 1.6% |
Committee | 2 | 1.6% |
Communication | 2 | 1.6% |
Community | 2 | 1.6% |
Community health worker | 2 | 1.6% |
Computer | 2 | 1.6% |
Confounding | 2 | 1.6% |
Conjoint analysis | 2 | 1.6% |
Consciousness | 2 | 1.6% |
Consent | 2 | 1.6% |
Coronary artery bypass surgery | 2 | 1.6% |
Cosmetics | 2 | 1.6% |
Decision tree learning | 2 | 1.6% |
Delphi method | 2 | 1.6% |
Dengue fever | 2 | 1.6% |
Dentistry | 2 | 1.6% |
Diabetes mellitus | 2 | 1.6% |
Dietary supplement | 2 | 1.6% |
Directly observed treatment, short-course | 2 | 1.6% |
Disproportionate share hospital | 2 | 1.6% |
Dose (biochemistry) | 2 | 1.6% |
Down syndrome | 2 | 1.6% |
Economic growth | 2 | 1.6% |
Economics | 2 | 1.6% |
Educational technology | 2 | 1.6% |
Efficient energy use | 2 | 1.6% |
Electric battery | 2 | 1.6% |
Electricity generation | 2 | 1.6% |
Emerging technologies | 2 | 1.6% |
Endothelium | 2 | 1.6% |
Epilepsy | 2 | 1.6% |
Erlotinib | 2 | 1.6% |
Ethinylestradiol | 2 | 1.6% |
Etonogestrel | 2 | 1.6% |
European Neighbourhood Policy | 2 | 1.6% |
Family medicine | 2 | 1.6% |
Five Year Forward View | 2 | 1.6% |
Focus group | 2 | 1.6% |
Food | 2 | 1.6% |
Food safety | 2 | 1.6% |
Framingham Risk Score | 2 | 1.6% |
Fraud | 2 | 1.6% |
Fuel | 2 | 1.6% |
Fuel cell | 2 | 1.6% |
Genetic engineering | 2 | 1.6% |
Genetic testing | 2 | 1.6% |
Geriatrics | 2 | 1.6% |
Global warming | 2 | 1.6% |
Gonorrhea | 2 | 1.6% |
Group B streptococcal infection | 2 | 1.6% |
H-index | 2 | 1.6% |
HIV/AIDS research | 2 | 1.6% |
Habitat | 2 | 1.6% |
Health Insurance Portability and Accountability Act | 2 | 1.6% |
Health and wellbeing board | 2 | 1.6% |
Health insurance | 2 | 1.6% |
Health promotion | 2 | 1.6% |
Healthcare industry | 2 | 1.6% |
Healthcare quality | 2 | 1.6% |
Heart failure | 2 | 1.6% |
Hemolytic disease of the newborn | 2 | 1.6% |
Hepatitis B | 2 | 1.6% |
Hepatocellular carcinoma | 2 | 1.6% |
Homosexuality | 2 | 1.6% |
Hospital-acquired infection | 2 | 1.6% |
Human pregnancy | 2 | 1.6% |
Hydrogen | 2 | 1.6% |
Hyperlipidemia | 2 | 1.6% |
Immunodeficiency | 2 | 1.6% |
Incentive | 2 | 1.6% |
Incremental cost-effectiveness ratio | 2 | 1.6% |
Influenza A virus | 2 | 1.6% |
Influenza A virus subtype H1N1 | 2 | 1.6% |
Influenza vaccine | 2 | 1.6% |
Information governance | 2 | 1.6% |
Informed consent | 2 | 1.6% |
Insulin | 2 | 1.6% |
Insulin resistance | 2 | 1.6% |
Intensive care medicine | 2 | 1.6% |
Internal medicine | 2 | 1.6% |
Internet of things | 2 | 1.6% |
Intrauterine device | 2 | 1.6% |
Invasive species | 2 | 1.6% |
Ischemia | 2 | 1.6% |
Jaundice | 2 | 1.6% |
Kernicterus | 2 | 1.6% |
Kidney | 2 | 1.6% |
Kidney disease | 2 | 1.6% |
Leukemia | 2 | 1.6% |
Light therapy | 2 | 1.6% |
Likert scale | 2 | 1.6% |
Logistic regression | 2 | 1.6% |
Low birth weight | 2 | 1.6% |
Magnetic resonance imaging | 2 | 1.6% |
Management | 2 | 1.6% |
Maternal death | 2 | 1.6% |
Maternal health | 2 | 1.6% |
Mathematical optimization | 2 | 1.6% |
Measles | 2 | 1.6% |
Medical statistics | 2 | 1.6% |
Mestranol | 2 | 1.6% |
Methodology | 2 | 1.6% |
Minimally invasive procedure | 2 | 1.6% |
Miscarriage | 2 | 1.6% |
Mood disorder | 2 | 1.6% |
Multiple-criteria decision analysis | 2 | 1.6% |
Nanoparticle | 2 | 1.6% |
Nature | 2 | 1.6% |
Neonatal infection | 2 | 1.6% |
Neonatal jaundice | 2 | 1.6% |
Neuroethics | 2 | 1.6% |
Neurofeedback | 2 | 1.6% |
Neuroscience | 2 | 1.6% |
Nursing home care | 2 | 1.6% |
Obstetrics | 2 | 1.6% |
Old age | 2 | 1.6% |
Osteopenia | 2 | 1.6% |
Ovarian cancer | 2 | 1.6% |
Overdiagnosis | 2 | 1.6% |
Pain | 2 | 1.6% |
Parameter | 2 | 1.6% |
Pathogen | 2 | 1.6% |
Patient safety organization | 2 | 1.6% |
Pay for performance (healthcare) | 2 | 1.6% |
Peer support | 2 | 1.6% |
Pension | 2 | 1.6% |
Performance appraisal | 2 | 1.6% |
Performance indicator | 2 | 1.6% |
Personal protective equipment | 2 | 1.6% |
Pharmacovigilance | 2 | 1.6% |
Phases of clinical research | 2 | 1.6% |
Philosophy | 2 | 1.6% |
Physical examination | 2 | 1.6% |
Physical fitness | 2 | 1.6% |
Plasmon | 2 | 1.6% |
Point of care | 2 | 1.6% |
Polymerase chain reaction | 2 | 1.6% |
Positron emission tomography | 2 | 1.6% |
Prediabetes | 2 | 1.6% |
Prediction | 2 | 1.6% |
Preterm birth | 2 | 1.6% |
Prevalence | 2 | 1.6% |
Progestogen-only pill | 2 | 1.6% |
Proteinuria | 2 | 1.6% |
Psychological concepts | 2 | 1.6% |
Psychology | 2 | 1.6% |
Public Health Emergency of International Concern | 2 | 1.6% |
Public hospital | 2 | 1.6% |
Publication bias | 2 | 1.6% |
Pulse oximetry | 2 | 1.6% |
Quantum dot | 2 | 1.6% |
Raltegravir | 2 | 1.6% |
Receiver operating characteristic | 2 | 1.6% |
Regression analysis | 2 | 1.6% |
Reporting bias | 2 | 1.6% |
Research methods | 2 | 1.6% |
Residency (medicine) | 2 | 1.6% |
Reverse-transcriptase inhibitor | 2 | 1.6% |
Ritonavir | 2 | 1.6% |
Screening, brief intervention and referral to treatment | 2 | 1.6% |
Simvastatin | 2 | 1.6% |
Sleep | 2 | 1.6% |
Smoking | 2 | 1.6% |
Solar energy | 2 | 1.6% |
Solar power | 2 | 1.6% |
Stem cell | 2 | 1.6% |
Streptococcus | 2 | 1.6% |
Streptococcus agalactiae | 2 | 1.6% |
Superficial vein thrombosis | 2 | 1.6% |
SystmOne | 2 | 1.6% |
Technological convergence | 2 | 1.6% |
Telecare | 2 | 1.6% |
Tooth decay | 2 | 1.6% |
Toxicology | 2 | 1.6% |
Transient ischemic attack | 2 | 1.6% |
Transport | 2 | 1.6% |
Trust law | 2 | 1.6% |
Uncertainty | 2 | 1.6% |
Usability | 2 | 1.6% |
Validity (statistics) | 2 | 1.6% |
Viral load | 2 | 1.6% |
Virtual wards | 2 | 1.6% |
Waste | 2 | 1.6% |
Water | 2 | 1.6% |
2009 flu pandemic in the United Kingdom | 1 | 0.8% |
3D bioprinting | 1 | 0.8% |
5G | 1 | 0.8% |
API | 1 | 0.8% |
Academic degree | 1 | 0.8% |
Accountability | 1 | 0.8% |
Active surveillance of prostate cancer | 1 | 0.8% |
Acute kidney injury | 1 | 0.8% |
Acute lymphoblastic leukemia | 1 | 0.8% |
Acute myeloid leukemia | 1 | 0.8% |
Acute promyelocytic leukemia | 1 | 0.8% |
Acute respiratory distress syndrome | 1 | 0.8% |
Addiction | 1 | 0.8% |
Adipocyte | 1 | 0.8% |
Adipose tissue | 1 | 0.8% |
Adverse event | 1 | 0.8% |
Aedes | 1 | 0.8% |
Aerobic exercise | 1 | 0.8% |
Affordable Care Act | 1 | 0.8% |
Ageing | 1 | 0.8% |
Agriculture | 1 | 0.8% |
Agronomy | 1 | 0.8% |
Alcoholism | 1 | 0.8% |
Algae fuel | 1 | 0.8% |
Allopurinol | 1 | 0.8% |
Alpha wave | 1 | 0.8% |
Alpha-fetoprotein | 1 | 0.8% |
Alternating current | 1 | 0.8% |
Alzheimer's disease | 1 | 0.8% |
Ambulance | 1 | 0.8% |
Amenorrhea | 1 | 0.8% |
Amplitude | 1 | 0.8% |
Amyotrophic lateral sclerosis | 1 | 0.8% |
Anal sex | 1 | 0.8% |
Analysis | 1 | 0.8% |
Anaphylaxis | 1 | 0.8% |
Anesthetic | 1 | 0.8% |
Angina | 1 | 0.8% |
Angiography | 1 | 0.8% |
Animal testing | 1 | 0.8% |
Anopheles | 1 | 0.8% |
Antenna (radio) | 1 | 0.8% |
Anthracycline | 1 | 0.8% |
Anthropology | 1 | 0.8% |
Anti-Müllerian hormone | 1 | 0.8% |
Antibody | 1 | 0.8% |
Anticonvulsant | 1 | 0.8% |
Antigen | 1 | 0.8% |
Antimicrobial stewardship | 1 | 0.8% |
Antineoplastic and immunomodulating drugs | 1 | 0.8% |
Antineoplastic drugs | 1 | 0.8% |
Antiplatelet drug | 1 | 0.8% |
Antipsychotic | 1 | 0.8% |
Anxiolytic | 1 | 0.8% |
Apremilast | 1 | 0.8% |
Arbovirus | 1 | 0.8% |
ArcGIS | 1 | 0.8% |
Artery | 1 | 0.8% |
Artificial cardiac pacemaker | 1 | 0.8% |
Artificial general intelligence | 1 | 0.8% |
Asbestos | 1 | 0.8% |
Asbestos-related diseases | 1 | 0.8% |
Asbestosis | 1 | 0.8% |
Aspirin | 1 | 0.8% |
Atezolizumab | 1 | 0.8% |
Atheroma | 1 | 0.8% |
Atmosphere of Earth | 1 | 0.8% |
Atorvastatin | 1 | 0.8% |
Attention | 1 | 0.8% |
Attention deficit hyperactivity disorder | 1 | 0.8% |
Atypical pneumonia | 1 | 0.8% |
Auckland | 1 | 0.8% |
Audiology | 1 | 0.8% |
Autoimmunity | 1 | 0.8% |
Automated driving system | 1 | 0.8% |
Automated external defibrillator | 1 | 0.8% |
Automated guided vehicle | 1 | 0.8% |
Autonomous underwater vehicle | 1 | 0.8% |
Avelumab | 1 | 0.8% |
Axon | 1 | 0.8% |
BRCA mutation | 1 | 0.8% |
BRCA1 | 1 | 0.8% |
BRCA2 | 1 | 0.8% |
Balance (ability) | 1 | 0.8% |
Barbiturate | 1 | 0.8% |
Baricitinib | 1 | 0.8% |
Basic life support | 1 | 0.8% |
Basic reproduction number | 1 | 0.8% |
Bayesian inference | 1 | 0.8% |
Behavior | 1 | 0.8% |
Behavioural sciences | 1 | 0.8% |
Benign tumor | 1 | 0.8% |
Beta cell | 1 | 0.8% |
Better Care Fund | 1 | 0.8% |
Bevacizumab | 1 | 0.8% |
Bicycle | 1 | 0.8% |
Binimetinib | 1 | 0.8% |
Biobank | 1 | 0.8% |
Biological dispersal | 1 | 0.8% |
Biological engineering | 1 | 0.8% |
Biomass | 1 | 0.8% |
Biomedical engineering | 1 | 0.8% |
Biomedicine | 1 | 0.8% |
Biometrics | 1 | 0.8% |
Biomimetics | 1 | 0.8% |
Biosafety | 1 | 0.8% |
Biosecurity | 1 | 0.8% |
Biosimilar | 1 | 0.8% |
Bipolar disorder | 1 | 0.8% |
Bird vocalization | 1 | 0.8% |
Birth defect | 1 | 0.8% |
Bisphosphonate | 1 | 0.8% |
Bladder cancer | 1 | 0.8% |
Bleeding | 1 | 0.8% |
Blinatumomab | 1 | 0.8% |
Blood donation | 1 | 0.8% |
Blood vessel | 1 | 0.8% |
Bloodstream infections | 1 | 0.8% |
Bone marrow | 1 | 0.8% |
Bone resorption | 1 | 0.8% |
Botany | 1 | 0.8% |
Brain metastasis | 1 | 0.8% |
Brain tumor | 1 | 0.8% |
Breast cancer screening | 1 | 0.8% |
Breast milk | 1 | 0.8% |
Breathing | 1 | 0.8% |
Bronchiectasis | 1 | 0.8% |
Budesonide | 1 | 0.8% |
Budesonide/formoterol | 1 | 0.8% |
Burden of proof (law) | 1 | 0.8% |
Business | 1 | 0.8% |
CD19 | 1 | 0.8% |
CRC Energy Efficiency Scheme | 1 | 0.8% |
CRISPR | 1 | 0.8% |
CT scan | 1 | 0.8% |
Cancer immunotherapy | 1 | 0.8% |
Cancer research | 1 | 0.8% |
Cancer survivor | 1 | 0.8% |
Cancer treatments | 1 | 0.8% |
Capitation (healthcare) | 1 | 0.8% |
Car | 1 | 0.8% |
Carbon capture and storage | 1 | 0.8% |
Carbon cycle | 1 | 0.8% |
Carbon dioxide | 1 | 0.8% |
Carbon neutrality | 1 | 0.8% |
Cardiac arrest | 1 | 0.8% |
Cardiac muscle | 1 | 0.8% |
Cardiopulmonary resuscitation | 1 | 0.8% |
Cardiothoracic surgery | 1 | 0.8% |
Cardioversion | 1 | 0.8% |
Case management (US healthcare system) | 1 | 0.8% |
Cattle | 1 | 0.8% |
Causes of death | 1 | 0.8% |
Cell culture | 1 | 0.8% |
Cell potency | 1 | 0.8% |
Cell therapy | 1 | 0.8% |
Cellulitis | 1 | 0.8% |
Central processing unit | 1 | 0.8% |
Cerebrovascular disease | 1 | 0.8% |
Cervical cancer | 1 | 0.8% |
Cervical screening | 1 | 0.8% |
Chairperson | 1 | 0.8% |
Chaka Fattah | 1 | 0.8% |
Chemical synapse | 1 | 0.8% |
Chest pain | 1 | 0.8% |
Chest radiograph | 1 | 0.8% |
Child | 1 | 0.8% |
Child mortality | 1 | 0.8% |
Childhood immunizations in the United States | 1 | 0.8% |
Chimeric antigen receptor T cell | 1 | 0.8% |
Chlamydia infection | 1 | 0.8% |
Cholecalciferol | 1 | 0.8% |
Chromatin | 1 | 0.8% |
Chronic fatigue syndrome | 1 | 0.8% |
Chronic lymphocytic leukemia | 1 | 0.8% |
Chrysotile | 1 | 0.8% |
Circumcision and HIV | 1 | 0.8% |
Citizenship | 1 | 0.8% |
Climate change | 1 | 0.8% |
Climate change feedback | 1 | 0.8% |
Clinical pathway | 1 | 0.8% |
Clinical research | 1 | 0.8% |
Clopidogrel | 1 | 0.8% |
Clorazepate | 1 | 0.8% |
Clostridioides difficile (bacteria) | 1 | 0.8% |
Coagulation | 1 | 0.8% |
Coefficient of determination | 1 | 0.8% |
Coefficient of performance | 1 | 0.8% |
Cogeneration | 1 | 0.8% |
Cohen's kappa | 1 | 0.8% |
Collision avoidance system | 1 | 0.8% |
Combined hormonal contraception | 1 | 0.8% |
Common cold | 1 | 0.8% |
Communication protocol | 1 | 0.8% |
Community mental health service | 1 | 0.8% |
Compression stockings | 1 | 0.8% |
Computer network | 1 | 0.8% |
Conflict of interest | 1 | 0.8% |
Consolidated Omnibus Budget Reconciliation Act of 1985 | 1 | 0.8% |
Continuing medical education | 1 | 0.8% |
Copanlisib | 1 | 0.8% |
Copyright | 1 | 0.8% |
Coronavirus | 1 | 0.8% |
Corporate governance | 1 | 0.8% |
Corruption | 1 | 0.8% |
Corticosteroid | 1 | 0.8% |
Cost–utility analysis | 1 | 0.8% |
Cough | 1 | 0.8% |
Creatinine | 1 | 0.8% |
Crizotinib | 1 | 0.8% |
Culex | 1 | 0.8% |
Culture | 1 | 0.8% |
Custirsen | 1 | 0.8% |
Cyclin-dependent kinase | 1 | 0.8% |
Cystatin C | 1 | 0.8% |
Cystic fibrosis | 1 | 0.8% |
Cystic fibrosis transmembrane conductance regulator | 1 | 0.8% |
DNA | 1 | 0.8% |
DPT vaccine | 1 | 0.8% |
Dabigatran | 1 | 0.8% |
Daratumumab | 1 | 0.8% |
Data quality | 1 | 0.8% |
Death | 1 | 0.8% |
Decriminalizing sex work | 1 | 0.8% |
Defibrillation | 1 | 0.8% |
Delirium | 1 | 0.8% |
Demcizumab | 1 | 0.8% |
Dementia with Lewy bodies | 1 | 0.8% |
Demographic and Health Surveys | 1 | 0.8% |
Demography | 1 | 0.8% |
Dendrite | 1 | 0.8% |
Dendritic spine | 1 | 0.8% |
Denosumab | 1 | 0.8% |
Dental public health | 1 | 0.8% |
Depression (mood) | 1 | 0.8% |
Design | 1 | 0.8% |
Development aid | 1 | 0.8% |
Diabetic foot | 1 | 0.8% |
Diabetic nephropathy | 1 | 0.8% |
Diagnosis code | 1 | 0.8% |
Diagnosis-related group | 1 | 0.8% |
Diazepam | 1 | 0.8% |
Dieting | 1 | 0.8% |
Difference in differences | 1 | 0.8% |
Diffuse large B-cell lymphoma | 1 | 0.8% |
Diffusion of innovations | 1 | 0.8% |
Disease-modifying antirheumatic drug | 1 | 0.8% |
Docetaxel | 1 | 0.8% |
Dolutegravir | 1 | 0.8% |
Dopamine | 1 | 0.8% |
Doxorubicin | 1 | 0.8% |
Dronedarone | 1 | 0.8% |
Drug development | 1 | 0.8% |
Drug injection | 1 | 0.8% |
Drug liberalization | 1 | 0.8% |
Drug resistance | 1 | 0.8% |
Drug user | 1 | 0.8% |
Dual diagnosis | 1 | 0.8% |
Dummy variable (statistics) | 1 | 0.8% |
ELISA | 1 | 0.8% |
East Riding of Yorkshire | 1 | 0.8% |
Eastern equine encephalitis | 1 | 0.8% |
Eclampsia | 1 | 0.8% |
Edema | 1 | 0.8% |
Educational assessment | 1 | 0.8% |
Effect size | 1 | 0.8% |
Elderly care | 1 | 0.8% |
Electrocardiography | 1 | 0.8% |
Electroconvulsive therapy | 1 | 0.8% |
Electronic prescribing | 1 | 0.8% |
Embolic stroke of undetermined source | 1 | 0.8% |
Embolism | 1 | 0.8% |
Embryoid body | 1 | 0.8% |
Emergence | 1 | 0.8% |
Emergency medical services | 1 | 0.8% |
Employee Retirement Income Security Act of 1974 | 1 | 0.8% |
Employee retention | 1 | 0.8% |
Empowerment | 1 | 0.8% |
Endocrine disruptor | 1 | 0.8% |
Endocrine system | 1 | 0.8% |
Endoscopic mucosal resection | 1 | 0.8% |
Energy | 1 | 0.8% |
Environmental health | 1 | 0.8% |
Environmental remediation | 1 | 0.8% |
Epidermal growth factor receptor | 1 | 0.8% |
Epigraphy | 1 | 0.8% |
Epileptic seizure | 1 | 0.8% |
Ergocalciferol | 1 | 0.8% |
Essential health benefits | 1 | 0.8% |
Estrogen | 1 | 0.8% |
Etomidate | 1 | 0.8% |
Eugenics | 1 | 0.8% |
Evaluation methods | 1 | 0.8% |
Evidence-based practice | 1 | 0.8% |
Evolution | 1 | 0.8% |
Exemestane | 1 | 0.8% |
Exhaled nitric oxide | 1 | 0.8% |
Expanded Program on Immunization | 1 | 0.8% |
Expected utility hypothesis | 1 | 0.8% |
Expense | 1 | 0.8% |
Experiment | 1 | 0.8% |
External auditor | 1 | 0.8% |
FDA Food Safety Modernization Act | 1 | 0.8% |
Falls in older adults | 1 | 0.8% |
Fecal occult blood | 1 | 0.8% |
Federally Qualified Health Center | 1 | 0.8% |
Fee | 1 | 0.8% |
Fertility | 1 | 0.8% |
Fever | 1 | 0.8% |
Fibrate | 1 | 0.8% |
Financial audit | 1 | 0.8% |
Fixed effects model | 1 | 0.8% |
Fluorescence microscope | 1 | 0.8% |
Flurazepam | 1 | 0.8% |
Folate | 1 | 0.8% |
Follicle-stimulating hormone | 1 | 0.8% |
Food and drink | 1 | 0.8% |
Food security | 1 | 0.8% |
Foodborne illness | 1 | 0.8% |
Foot | 1 | 0.8% |
Forecasting | 1 | 0.8% |
Forestry | 1 | 0.8% |
Free will | 1 | 0.8% |
Frequentist inference | 1 | 0.8% |
Friends and Family Test | 1 | 0.8% |
Fuel cell vehicle | 1 | 0.8% |
Functional magnetic resonance imaging | 1 | 0.8% |
Fundraising | 1 | 0.8% |
Förster resonance energy transfer | 1 | 0.8% |
Gangrene | 1 | 0.8% |
Gene | 1 | 0.8% |
Gene therapy | 1 | 0.8% |
Genealogy | 1 | 0.8% |
General Schedule (US civil service pay scale) | 1 | 0.8% |
General anaesthesia | 1 | 0.8% |
General circulation model | 1 | 0.8% |
General medical services | 1 | 0.8% |
General practice | 1 | 0.8% |
Generalized linear model | 1 | 0.8% |
Generic drug | 1 | 0.8% |
Genetic counseling | 1 | 0.8% |
Genome | 1 | 0.8% |
Genomics | 1 | 0.8% |
Geographic information system | 1 | 0.8% |
Glioblastoma | 1 | 0.8% |
Global Burden of Disease Study | 1 | 0.8% |
Glomerular filtration rate | 1 | 0.8% |
Glucose test | 1 | 0.8% |
Glucose tolerance test | 1 | 0.8% |
Going concern | 1 | 0.8% |
Gout | 1 | 0.8% |
Government | 1 | 0.8% |
Granzyme | 1 | 0.8% |
Graphene | 1 | 0.8% |
Graphics processing unit | 1 | 0.8% |
Greenhouse gas | 1 | 0.8% |
Gums | 1 | 0.8% |
Gynaecology | 1 | 0.8% |
HAS-BLED | 1 | 0.8% |
HIV and pregnancy | 1 | 0.8% |
HIV tropism | 1 | 0.8% |
Hazard analysis and critical control points | 1 | 0.8% |
Health and Social Care Act 2012 | 1 | 0.8% |
Health belief model | 1 | 0.8% |
Health care prices in the United States | 1 | 0.8% |
Health data | 1 | 0.8% |
Health effects of sunlight exposure | 1 | 0.8% |
Health forecasting | 1 | 0.8% |
Health literacy | 1 | 0.8% |
Health maintenance organization | 1 | 0.8% |
Health reimbursement account | 1 | 0.8% |
Health research | 1 | 0.8% |
Health risk assessment | 1 | 0.8% |
Health technology | 1 | 0.8% |
Health technology in the United States | 1 | 0.8% |
Healthcare Cost and Utilization Project | 1 | 0.8% |
Healthcare in Italy | 1 | 0.8% |
Hearing aid | 1 | 0.8% |
Hearing loss | 1 | 0.8% |
Heart arrhythmia | 1 | 0.8% |
Hematuria | 1 | 0.8% |
Hemoglobin | 1 | 0.8% |
Hemoglobinopathy | 1 | 0.8% |
Hemostasis | 1 | 0.8% |
Heparin | 1 | 0.8% |
Hepatectomy | 1 | 0.8% |
Hepatic stellate cell | 1 | 0.8% |
Hepatitis C virus | 1 | 0.8% |
Hepatocyte | 1 | 0.8% |
Hereditary nonpolyposis colorectal cancer | 1 | 0.8% |
Hib vaccine | 1 | 0.8% |
Hierarchy of evidence | 1 | 0.8% |
Holter monitor | 1 | 0.8% |
Home care in the United States | 1 | 0.8% |
Honiara | 1 | 0.8% |
Hospital-acquired condition | 1 | 0.8% |
Host (biology) | 1 | 0.8% |
Hot flash | 1 | 0.8% |
Human Development Index | 1 | 0.8% |
Human brain | 1 | 0.8% |
Human chorionic gonadotropin | 1 | 0.8% |
Human diseases and disorders | 1 | 0.8% |
Human enhancement | 1 | 0.8% |
Human genome | 1 | 0.8% |
Human papillomavirus infection | 1 | 0.8% |
Human parainfluenza viruses | 1 | 0.8% |
Human respiratory syncytial virus | 1 | 0.8% |
Human sexual activity | 1 | 0.8% |
Human sexuality | 1 | 0.8% |
Human tooth | 1 | 0.8% |
Hypercholesterolemia | 1 | 0.8% |
Hyperuricemia | 1 | 0.8% |
Hypothermia | 1 | 0.8% |
Hypoxemia | 1 | 0.8% |
Hypoxia (medical) | 1 | 0.8% |
ICD-10 | 1 | 0.8% |
Igneous rock | 1 | 0.8% |
Immigration | 1 | 0.8% |
Immune system | 1 | 0.8% |
Immunization | 1 | 0.8% |
Immunosuppressive drug | 1 | 0.8% |
Immunotherapy | 1 | 0.8% |
Impact factor | 1 | 0.8% |
Imputation (statistics) | 1 | 0.8% |
In silico | 1 | 0.8% |
In vitro | 1 | 0.8% |
Indication (medicine) | 1 | 0.8% |
Induced pluripotent stem cell | 1 | 0.8% |
Infant mortality | 1 | 0.8% |
Infection prevention and control | 1 | 0.8% |
Infectious mononucleosis | 1 | 0.8% |
Influenza A virus subtype H3N2 | 1 | 0.8% |
Influenza-like illness | 1 | 0.8% |
Information and communications technology | 1 | 0.8% |
Information privacy | 1 | 0.8% |
Information security | 1 | 0.8% |
Infrared | 1 | 0.8% |
Infrastructure | 1 | 0.8% |
Inhaler | 1 | 0.8% |
Inpatient care | 1 | 0.8% |
Insomnia | 1 | 0.8% |
Institutional review board | 1 | 0.8% |
Insurance | 1 | 0.8% |
Integrated disease surveillance program | 1 | 0.8% |
Intellectual property | 1 | 0.8% |
Intelligence | 1 | 0.8% |
Intention-to-treat analysis | 1 | 0.8% |
Interest | 1 | 0.8% |
Interleukin 17 | 1 | 0.8% |
International Health Regulations | 1 | 0.8% |
Intervertebral disc | 1 | 0.8% |
Intima-media thickness | 1 | 0.8% |
Introduced species | 1 | 0.8% |
Investment | 1 | 0.8% |
Ipilimumab | 1 | 0.8% |
Iris recognition | 1 | 0.8% |
Issues in ethics | 1 | 0.8% |
Join (SQL) | 1 | 0.8% |
Jonathan D. Moreno | 1 | 0.8% |
Kingston upon Hull | 1 | 0.8% |
Labour economics | 1 | 0.8% |
Learning | 1 | 0.8% |
Legionella | 1 | 0.8% |
Legionnaires' disease | 1 | 0.8% |
Licensed practical nurse | 1 | 0.8% |
Life expectancy | 1 | 0.8% |
Life history theory | 1 | 0.8% |
Life satisfaction | 1 | 0.8% |
Life sciences industry | 1 | 0.8% |
Life-cycle assessment | 1 | 0.8% |
Likelihood function | 1 | 0.8% |
Listeria | 1 | 0.8% |
Listeriosis | 1 | 0.8% |
Lithium (medication) | 1 | 0.8% |
Lithium–air battery | 1 | 0.8% |
Liver cancer | 1 | 0.8% |
Logistic function | 1 | 0.8% |
Long non-coding RNA | 1 | 0.8% |
Long-term care | 1 | 0.8% |
Long-term effects of alcohol consumption | 1 | 0.8% |
Long-term potentiation | 1 | 0.8% |
Lorazepam | 1 | 0.8% |
Low-molecular-weight heparin | 1 | 0.8% |
Lung | 1 | 0.8% |
Lung cancer screening | 1 | 0.8% |
Lung nodule | 1 | 0.8% |
Lymphocyte | 1 | 0.8% |
Lymphoma | 1 | 0.8% |
Lysergic acid diethylamide | 1 | 0.8% |
MTOR inhibitors | 1 | 0.8% |
Magnetoencephalography | 1 | 0.8% |
Malnutrition | 1 | 0.8% |
MammaPrint | 1 | 0.8% |
Mammography | 1 | 0.8% |
Management of atrial fibrillation | 1 | 0.8% |
Marburg virus disease | 1 | 0.8% |
Marine protected area | 1 | 0.8% |
Marketing authorisation | 1 | 0.8% |
Marriage | 1 | 0.8% |
Maternal–fetal medicine | 1 | 0.8% |
Matron | 1 | 0.8% |
Median | 1 | 0.8% |
Medical Subject Headings | 1 | 0.8% |
Medical education | 1 | 0.8% |
Medical eligibility criteria for contraceptive use | 1 | 0.8% |
Medical emergencies | 1 | 0.8% |
Medical microbiology | 1 | 0.8% |
Medical school | 1 | 0.8% |
Medical specialty | 1 | 0.8% |
Medical technology | 1 | 0.8% |
Medical ultrasound | 1 | 0.8% |
Medicinal chemistry | 1 | 0.8% |
Mediterranean Sea | 1 | 0.8% |
Melanoma | 1 | 0.8% |
Memory | 1 | 0.8% |
Meningitis | 1 | 0.8% |
Menstrual cycle | 1 | 0.8% |
Menstruation | 1 | 0.8% |
Mergers and acquisitions | 1 | 0.8% |
Mesenchymal stem cell | 1 | 0.8% |
Mesothelioma | 1 | 0.8% |
Metabolic syndrome | 1 | 0.8% |
Metabolomics | 1 | 0.8% |
Metastatic breast cancer | 1 | 0.8% |
Meteorology | 1 | 0.8% |
Metered-dose inhaler | 1 | 0.8% |
Metformin | 1 | 0.8% |
Methods of birth control | 1 | 0.8% |
Methylphenidate | 1 | 0.8% |
MicroRNA | 1 | 0.8% |
Microalbuminuria | 1 | 0.8% |
Microscopy | 1 | 0.8% |
Microwave | 1 | 0.8% |
Midazolam | 1 | 0.8% |
Middle East respiratory syndrome | 1 | 0.8% |
Midwife | 1 | 0.8% |
Midwifery | 1 | 0.8% |
Mineral dust | 1 | 0.8% |
Minimally invasive procedures | 1 | 0.8% |
Mitochondrion | 1 | 0.8% |
Mobile app | 1 | 0.8% |
Model organism | 1 | 0.8% |
Mold | 1 | 0.8% |
Molecular biology | 1 | 0.8% |
Molecular diagnostics | 1 | 0.8% |
Molecular machine | 1 | 0.8% |
Molecular phylogenetics | 1 | 0.8% |
Monitoring (medicine) | 1 | 0.8% |
Monoamine oxidase inhibitor | 1 | 0.8% |
Mosquito | 1 | 0.8% |
Mosquito control | 1 | 0.8% |
Mosquito-borne disease | 1 | 0.8% |
Mouth | 1 | 0.8% |
Multilevel model | 1 | 0.8% |
Multimethodology | 1 | 0.8% |
Multiomics | 1 | 0.8% |
Mycobacterium bovis | 1 | 0.8% |
Māori people | 1 | 0.8% |
NHS dentistry | 1 | 0.8% |
NHS health check | 1 | 0.8% |
Nanodiamond | 1 | 0.8% |
Nanomaterials | 1 | 0.8% |
Nanotoxicology | 1 | 0.8% |
Natural environment | 1 | 0.8% |
Natural gas | 1 | 0.8% |
Natural reservoir | 1 | 0.8% |
Needle exchange programme | 1 | 0.8% |
Needlestick injury | 1 | 0.8% |
Needs assessment | 1 | 0.8% |
Neglected tropical diseases | 1 | 0.8% |
Neonatal intensive care unit | 1 | 0.8% |
Neoplasm | 1 | 0.8% |
Nerve guidance conduit | 1 | 0.8% |
Neural engineering | 1 | 0.8% |
Neural oscillation | 1 | 0.8% |
Neurodegeneration | 1 | 0.8% |
Neuroeconomics | 1 | 0.8% |
Neuroenhancement | 1 | 0.8% |
Neuroimaging | 1 | 0.8% |
Neurology | 1 | 0.8% |
Neuromodulation (medicine) | 1 | 0.8% |
Neuropathic arthropathy | 1 | 0.8% |
Neuropathic pain | 1 | 0.8% |
Neuroprosthetics | 1 | 0.8% |
Neuropsychology | 1 | 0.8% |
Neuropsychopharmacology | 1 | 0.8% |
Neuroregeneration | 1 | 0.8% |
Neurostimulation | 1 | 0.8% |
Neurotechnology | 1 | 0.8% |
Neurotransmitter | 1 | 0.8% |
Neurotrophin | 1 | 0.8% |
New Drug Application | 1 | 0.8% |
Newborn screening | 1 | 0.8% |
Nicotine replacement therapy | 1 | 0.8% |
Nightmare | 1 | 0.8% |
Nivolumab | 1 | 0.8% |
Non-executive director | 1 | 0.8% |
Non-governmental organization | 1 | 0.8% |
Non-small-cell lung carcinoma | 1 | 0.8% |
Nonsteroidal anti-inflammatory drug | 1 | 0.8% |
Nootropic | 1 | 0.8% |
Norethisterone enanthate | 1 | 0.8% |
Northumberland | 1 | 0.8% |
Nuchal scan | 1 | 0.8% |
Nucleic acid sequence | 1 | 0.8% |
Nursing in the United Kingdom | 1 | 0.8% |
Nutrition | 1 | 0.8% |
Obstetric ultrasonography | 1 | 0.8% |
Obstructive lung disease | 1 | 0.8% |
Occupational therapist | 1 | 0.8% |
Ocean | 1 | 0.8% |
Ocean acidification | 1 | 0.8% |
Oceanography | 1 | 0.8% |
Odds ratio | 1 | 0.8% |
Off-label use | 1 | 0.8% |
Oral hygiene | 1 | 0.8% |
Organ donation | 1 | 0.8% |
Organ transplantation | 1 | 0.8% |
Organ-on-a-chip | 1 | 0.8% |
Organism | 1 | 0.8% |
Organization | 1 | 0.8% |
Orthotics | 1 | 0.8% |
Oseltamivir | 1 | 0.8% |
Osteoarthritis | 1 | 0.8% |
Osteocyte | 1 | 0.8% |
Otoacoustic emission | 1 | 0.8% |
Outbreak | 1 | 0.8% |
Ovary | 1 | 0.8% |
Ownership | 1 | 0.8% |
Oxaliplatin | 1 | 0.8% |
Oxazepam | 1 | 0.8% |
Oxygen therapy | 1 | 0.8% |
PD-L1 | 1 | 0.8% |
Pain management | 1 | 0.8% |
Palbociclib | 1 | 0.8% |
Pancreatic cancer | 1 | 0.8% |
Pancreatic islets | 1 | 0.8% |
Pancreatitis | 1 | 0.8% |
Pandemrix | 1 | 0.8% |
Parasomnia | 1 | 0.8% |
Parathyroid hormone | 1 | 0.8% |
Parental leave | 1 | 0.8% |
Paresthesia | 1 | 0.8% |
Particulates | 1 | 0.8% |
Partnership | 1 | 0.8% |
Passive smoking | 1 | 0.8% |
Patient portal | 1 | 0.8% |
Patient-reported outcome | 1 | 0.8% |
Payment by Results | 1 | 0.8% |
Pembrolizumab | 1 | 0.8% |
Perception | 1 | 0.8% |
Percutaneous coronary intervention | 1 | 0.8% |
Periodontal disease | 1 | 0.8% |
Periodontology | 1 | 0.8% |
Peripheral artery disease | 1 | 0.8% |
Personal genomics | 1 | 0.8% |
Personalized medicine | 1 | 0.8% |
Peter C. Gøtzsche | 1 | 0.8% |
Phantom limb | 1 | 0.8% |
Pharmaceutical sciences | 1 | 0.8% |
Pharmaceutics | 1 | 0.8% |
Pharmacokinetics | 1 | 0.8% |
Pharyngitis | 1 | 0.8% |
Phenylketonuria | 1 | 0.8% |
Photonics | 1 | 0.8% |
Photovoltaic system | 1 | 0.8% |
Photovoltaics | 1 | 0.8% |
Physiologically based pharmacokinetic modelling | 1 | 0.8% |
Physiology | 1 | 0.8% |
Placebo-controlled study | 1 | 0.8% |
Plankton | 1 | 0.8% |
Plant | 1 | 0.8% |
Plastic | 1 | 0.8% |
Plug-in hybrid | 1 | 0.8% |
Pneumococcal vaccine | 1 | 0.8% |
Pneumocystis pneumonia | 1 | 0.8% |
Podiatrist | 1 | 0.8% |
Podiatry | 1 | 0.8% |
Point of sale | 1 | 0.8% |
Polio vaccine | 1 | 0.8% |
Pollinator | 1 | 0.8% |
Pollinator decline | 1 | 0.8% |
Pollution | 1 | 0.8% |
Polymer | 1 | 0.8% |
Polysomnography | 1 | 0.8% |
Population | 1 | 0.8% |
Positive and negative predictive values | 1 | 0.8% |
Post-traumatic stress disorder | 1 | 0.8% |
Posttraumatic stress disorder | 1 | 0.8% |
Poultry diseases | 1 | 0.8% |
Power (statistics) | 1 | 0.8% |
Pre-eclampsia | 1 | 0.8% |
Pre-exposure prophylaxis | 1 | 0.8% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 0.8% |
Premature ovarian failure | 1 | 0.8% |
Prenatal development | 1 | 0.8% |
Prenatal testing | 1 | 0.8% |
Pressure ulcer | 1 | 0.8% |
Primary care physician | 1 | 0.8% |
Primary healthcare | 1 | 0.8% |
Prior probability | 1 | 0.8% |
Prison | 1 | 0.8% |
Privacy | 1 | 0.8% |
Private finance initiative | 1 | 0.8% |
Problem gambling | 1 | 0.8% |
Procedural sedation and analgesia | 1 | 0.8% |
Procurement | 1 | 0.8% |
Professional degrees of public health | 1 | 0.8% |
Program optimization | 1 | 0.8% |
Programmed cell death protein 1 | 1 | 0.8% |
Progress | 1 | 0.8% |
Progressive tax | 1 | 0.8% |
Proof of concept | 1 | 0.8% |
Propensity score matching | 1 | 0.8% |
Propofol | 1 | 0.8% |
Prostate cancer | 1 | 0.8% |
Prostatectomy | 1 | 0.8% |
Prosthesis | 1 | 0.8% |
Prostitution | 1 | 0.8% |
Protein | 1 | 0.8% |
Proteomics | 1 | 0.8% |
Prothrombin time | 1 | 0.8% |
Pseudomonas | 1 | 0.8% |
Pseudomonas aeruginosa | 1 | 0.8% |
Psoriasis | 1 | 0.8% |
Psoriatic arthritis | 1 | 0.8% |
Psychological resilience | 1 | 0.8% |
Psychosis | 1 | 0.8% |
Psychotherapy | 1 | 0.8% |
Puberty | 1 | 0.8% |
Public engagement | 1 | 0.8% |
Public–private partnership | 1 | 0.8% |
Pulmonary embolism | 1 | 0.8% |
Pulmonary rehabilitation | 1 | 0.8% |
Pulmonology | 1 | 0.8% |
Pulse wave velocity | 1 | 0.8% |
Q fever | 1 | 0.8% |
Quality | 1 | 0.8% |
Quality management | 1 | 0.8% |
Quality of life (healthcare) | 1 | 0.8% |
Quantitative computed tomography | 1 | 0.8% |
Quarantine | 1 | 0.8% |
Quasi-experiment | 1 | 0.8% |
RHOA | 1 | 0.8% |
RNA interference | 1 | 0.8% |
ROS1 | 1 | 0.8% |
Radar | 1 | 0.8% |
Radiology | 1 | 0.8% |
Radiosurgery | 1 | 0.8% |
Ragweed | 1 | 0.8% |
Ramucirumab | 1 | 0.8% |
Randomness | 1 | 0.8% |
Rapid eye movement sleep | 1 | 0.8% |
Rapid eye movement sleep behavior disorder | 1 | 0.8% |
Reactive oxygen species | 1 | 0.8% |
Real-time polymerase chain reaction | 1 | 0.8% |
Recovery approach | 1 | 0.8% |
Reference range | 1 | 0.8% |
Regenerative medicine | 1 | 0.8% |
Regulatory Flexibility Act | 1 | 0.8% |
Regulatory science | 1 | 0.8% |
Reinsurance | 1 | 0.8% |
Rekrei | 1 | 0.8% |
Relational database management system | 1 | 0.8% |
Renewable energy | 1 | 0.8% |
Representative Concentration Pathway | 1 | 0.8% |
Residential care | 1 | 0.8% |
Respite care | 1 | 0.8% |
Reuptake inhibitor | 1 | 0.8% |
Reward system | 1 | 0.8% |
Rheumatic fever | 1 | 0.8% |
Rheumatoid arthritis | 1 | 0.8% |
Rheumatology | 1 | 0.8% |
Risk ratio | 1 | 0.8% |
Road | 1 | 0.8% |
Road slipperiness | 1 | 0.8% |
Road surface | 1 | 0.8% |
Road traffic safety | 1 | 0.8% |
Robert Guthrie | 1 | 0.8% |
Rock (geology) | 1 | 0.8% |
Rural health | 1 | 0.8% |
Safeguarding | 1 | 0.8% |
Salary | 1 | 0.8% |
Schizophrenia | 1 | 0.8% |
Science and Technology Options Assessment | 1 | 0.8% |
Science and technology | 1 | 0.8% |
Sea | 1 | 0.8% |
Secukinumab | 1 | 0.8% |
Sedation | 1 | 0.8% |
Self-esteem | 1 | 0.8% |
Self-insurance | 1 | 0.8% |
Serosorting | 1 | 0.8% |
Sex and drugs | 1 | 0.8% |
Shared decision-making in medicine | 1 | 0.8% |
Sickle cell disease | 1 | 0.8% |
Sidewalk | 1 | 0.8% |
Simon Stevens | 1 | 0.8% |
Sleep apnea | 1 | 0.8% |
Slow-wave sleep | 1 | 0.8% |
Smoking cessation | 1 | 0.8% |
Social determinants of health | 1 | 0.8% |
Social media | 1 | 0.8% |
Social support | 1 | 0.8% |
Sociotechnical system | 1 | 0.8% |
Software testing | 1 | 0.8% |
Soil | 1 | 0.8% |
Solar cell | 1 | 0.8% |
Solid oxide fuel cell | 1 | 0.8% |
Sorafenib | 1 | 0.8% |
Sotalol | 1 | 0.8% |
Space-based solar power | 1 | 0.8% |
Species | 1 | 0.8% |
Species complex | 1 | 0.8% |
Spinal cord | 1 | 0.8% |
Spinal disc herniation | 1 | 0.8% |
Spinal fusion | 1 | 0.8% |
Statistical classification | 1 | 0.8% |
Statistical process control | 1 | 0.8% |
Stavudine | 1 | 0.8% |
Stimulant | 1 | 0.8% |
Strategic leadership | 1 | 0.8% |
Student-centered learning | 1 | 0.8% |
Subsidy | 1 | 0.8% |
Substance abuse | 1 | 0.8% |
Substance use disorder | 1 | 0.8% |
Sudden infant death syndrome | 1 | 0.8% |
Sulfonylurea | 1 | 0.8% |
Sunitinib | 1 | 0.8% |
Supplemental Security Income | 1 | 0.8% |
Supported employment | 1 | 0.8% |
Supportive housing | 1 | 0.8% |
Survey (archaeology) | 1 | 0.8% |
Survival analysis | 1 | 0.8% |
Sustainable Development Goals | 1 | 0.8% |
Sustainable energy | 1 | 0.8% |
Swine influenza | 1 | 0.8% |
Synapse | 1 | 0.8% |
Synaptic plasticity | 1 | 0.8% |
Synthetic biology | 1 | 0.8% |
System | 1 | 0.8% |
Systemic lupus erythematosus | 1 | 0.8% |
Systems biology | 1 | 0.8% |
T cell | 1 | 0.8% |
TNF inhibitor | 1 | 0.8% |
Tamoxifen | 1 | 0.8% |
Technological singularity | 1 | 0.8% |
Telemedicine | 1 | 0.8% |
Telenursing | 1 | 0.8% |
Temazepam | 1 | 0.8% |
Tetanus vaccine | 1 | 0.8% |
Tetraplegia | 1 | 0.8% |
The European Semester | 1 | 0.8% |
Thermosetting polymer | 1 | 0.8% |
Thought | 1 | 0.8% |
Thrombophilia | 1 | 0.8% |
Thrombosis prevention | 1 | 0.8% |
Time series | 1 | 0.8% |
Tisagenlecleucel | 1 | 0.8% |
Tissue engineering | 1 | 0.8% |
Tobacco control | 1 | 0.8% |
Tobacco smoking | 1 | 0.8% |
Tocilizumab | 1 | 0.8% |
Toe | 1 | 0.8% |
Tofacitinib | 1 | 0.8% |
Top-down and bottom-up design | 1 | 0.8% |
Toxicity | 1 | 0.8% |
Toxicogenomics | 1 | 0.8% |
Trabecula | 1 | 0.8% |
Tracheotomy | 1 | 0.8% |
Traffic | 1 | 0.8% |
Traffic collision | 1 | 0.8% |
Training | 1 | 0.8% |
Transcranial direct-current stimulation | 1 | 0.8% |
Transhumanism | 1 | 0.8% |
Transmitter | 1 | 0.8% |
Transtheoretical model | 1 | 0.8% |
Trastuzumab | 1 | 0.8% |
Triage | 1 | 0.8% |
Triglyceride | 1 | 0.8% |
Triple test | 1 | 0.8% |
Tumor microenvironment | 1 | 0.8% |
Tumor necrosis factor alpha | 1 | 0.8% |
Turnover (employment) | 1 | 0.8% |
Two-photon excitation microscopy | 1 | 0.8% |
Type I and type II errors | 1 | 0.8% |
Ulcer (dermatology) | 1 | 0.8% |
Ulipristal acetate | 1 | 0.8% |
Ultimatum game | 1 | 0.8% |
Unmanned aerial vehicle | 1 | 0.8% |
Unwarranted variation | 1 | 0.8% |
Uric acid | 1 | 0.8% |
Urinary tract infection | 1 | 0.8% |
Ustekinumab | 1 | 0.8% |
Vaccination | 1 | 0.8% |
Vaccination schedule | 1 | 0.8% |
Varicose veins | 1 | 0.8% |
Vector (epidemiology) | 1 | 0.8% |
Vector control | 1 | 0.8% |
Vehicle | 1 | 0.8% |
Venezuelan equine encephalitis virus | 1 | 0.8% |
Veterinary medicine | 1 | 0.8% |
Virtua | 1 | 0.8% |
Virtual reality | 1 | 0.8% |
Visual impairment | 1 | 0.8% |
Vitamin | 1 | 0.8% |
Volcano | 1 | 0.8% |
WHO Framework Convention on Tobacco Control | 1 | 0.8% |
Waist–hip ratio | 1 | 0.8% |
Waitematā Harbour | 1 | 0.8% |
Water resource management | 1 | 0.8% |
Weather forecasting | 1 | 0.8% |
Weighted arithmetic mean | 1 | 0.8% |
Welfare | 1 | 0.8% |
West Nile fever | 1 | 0.8% |
Wheeze | 1 | 0.8% |
Whistleblower | 1 | 0.8% |
Whole genome sequencing | 1 | 0.8% |
Wind power | 1 | 0.8% |
Winter service vehicle | 1 | 0.8% |
Wireless sensor network | 1 | 0.8% |
World Water Forum | 1 | 0.8% |
World Wide Web | 1 | 0.8% |
Wound | 1 | 0.8% |
XML | 1 | 0.8% |
XML schema | 1 | 0.8% |
Youth | 1 | 0.8% |
Zebrafish | 1 | 0.8% |
Zero-emissions vehicle | 1 | 0.8% |
Zidovudine | 1 | 0.8% |
Zoledronic acid | 1 | 0.8% |
abs | rel | |
---|---|---|
Health | 123 | 93.2% |
Health sciences | 115 | 87.1% |
Medicine | 115 | 87.1% |
Health care | 107 | 81.1% |
Medical specialties | 96 | 72.7% |
Clinical medicine | 88 | 66.7% |
Public health | 49 | 37.1% |
Health economics | 42 | 31.8% |
Risk | 41 | 31.1% |
Human activities | 39 | 29.5% |
Preventive healthcare | 37 | 28.0% |
Cardiovascular disease | 32 | 24.2% |
Diseases and disorders | 30 | 22.7% |
Disease | 29 | 22.0% |
Infection | 29 | 22.0% |
Chronic condition | 28 | 21.2% |
Cancer | 26 | 19.7% |
Epidemiology | 26 | 19.7% |
Hospital | 26 | 19.7% |
Hypertension | 26 | 19.7% |
Evidence-based medicine | 24 | 18.2% |
Medication | 24 | 18.2% |
Randomized controlled trial | 24 | 18.2% |
Adherence (medicine) | 23 | 17.4% |
Clinical trial | 22 | 16.7% |
Health policy | 21 | 15.9% |
Health system | 21 | 15.9% |
Medical diagnosis | 21 | 15.9% |
Patient | 21 | 15.9% |
Health professional | 20 | 15.2% |
Obesity | 20 | 15.2% |
Blood pressure | 19 | 14.4% |
Major depressive disorder | 19 | 14.4% |
HIV/AIDS | 18 | 13.6% |
Medicaid | 18 | 13.6% |
Myocardial infarction | 18 | 13.6% |
Systematic review | 18 | 13.6% |
Coronary artery disease | 17 | 12.9% |
Evaluation | 17 | 12.9% |
Medical guideline | 17 | 12.9% |
Medical humanities | 16 | 12.1% |
Medicare (United States) | 16 | 12.1% |
Research | 16 | 12.1% |
Stroke | 16 | 12.1% |
Emergency department | 15 | 11.4% |
Mental health | 15 | 11.4% |
Nursing | 15 | 11.4% |
Public sphere | 15 | 11.4% |
Electronic health record | 14 | 10.6% |
Exercise | 14 | 10.6% |
Meta-analysis | 14 | 10.6% |
Biology | 13 | 9.8% |
Caregiver | 13 | 9.8% |
Statin | 13 | 9.8% |
Tuberculosis | 13 | 9.8% |
Body mass index | 12 | 9.1% |
Primary care | 12 | 9.1% |
Sensitivity and specificity | 12 | 9.1% |
Therapy | 12 | 9.1% |
Health care quality | 11 | 8.3% |
Heart | 11 | 8.3% |
Immunology | 11 | 8.3% |
Low-density lipoprotein | 11 | 8.3% |
Self-care | 11 | 8.3% |
Blood sugar level | 10 | 7.6% |
Childbirth | 10 | 7.6% |
Glycated hemoglobin | 10 | 7.6% |
High-density lipoprotein | 10 | 7.6% |
Hospital readmission | 10 | 7.6% |
Patient safety | 10 | 7.6% |
Sexually transmitted infection | 10 | 7.6% |
Antimicrobial resistance | 9 | 6.8% |
Atherosclerosis | 9 | 6.8% |
Cardiovascular system | 9 | 6.8% |
Cholesterol | 9 | 6.8% |
Cohort study | 9 | 6.8% |
Diabetes | 9 | 6.8% |
Diabetes mellitus type 2 | 9 | 6.8% |
Physical therapy | 9 | 6.8% |
Physician | 9 | 6.8% |
Saturated fat | 9 | 6.8% |
Screening (medicine) | 9 | 6.8% |
Type 2 diabetes | 9 | 6.8% |
Weight loss | 9 | 6.8% |
Antihypertensive drug | 8 | 6.1% |
Chronic kidney disease | 8 | 6.1% |
Confidence interval | 8 | 6.1% |
Diagnosis of HIV/AIDS | 8 | 6.1% |
General practitioner | 8 | 6.1% |
Governance | 8 | 6.1% |
Health informatics | 8 | 6.1% |
Healthy diet | 8 | 6.1% |
Hypercholesterolemia | 8 | 6.1% |
Infectious diseases | 8 | 6.1% |
Life sciences | 8 | 6.1% |
Management of HIV/AIDS | 8 | 6.1% |
Medical home | 8 | 6.1% |
Medical treatments | 8 | 6.1% |
Men who have sex with men | 8 | 6.1% |
Mental disorder | 8 | 6.1% |
Pain | 8 | 6.1% |
Surgery | 8 | 6.1% |
Sustainability | 8 | 6.1% |
Accountable care organization | 7 | 5.3% |
Audit | 7 | 5.3% |
Behavior | 7 | 5.3% |
Blinded experiment | 7 | 5.3% |
Breastfeeding | 7 | 5.3% |
Chemotherapy | 7 | 5.3% |
Community health | 7 | 5.3% |
Diabetes mellitus | 7 | 5.3% |
Dieting | 7 | 5.3% |
Education | 7 | 5.3% |
Fee-for-service | 7 | 5.3% |
Non-communicable disease | 7 | 5.3% |
Patient Protection and Affordable Care Act | 7 | 5.3% |
Pharmacy | 7 | 5.3% |
Pneumonia | 7 | 5.3% |
Pre-exposure prophylaxis | 7 | 5.3% |
Prevention of HIV/AIDS | 7 | 5.3% |
Renal function | 7 | 5.3% |
Vaccination | 7 | 5.3% |
Virus | 7 | 5.3% |
Adverse effect | 6 | 4.5% |
Alcoholism | 6 | 4.5% |
Best practice | 6 | 4.5% |
Cardiology | 6 | 4.5% |
Cost-effectiveness analysis | 6 | 4.5% |
Data analysis | 6 | 4.5% |
Dementia | 6 | 4.5% |
Determinants of health | 6 | 4.5% |
Diabetes management | 6 | 4.5% |
Dose (biochemistry) | 6 | 4.5% |
Drugs | 6 | 4.5% |
Food | 6 | 4.5% |
Innovation | 6 | 4.5% |
Internal medicine | 6 | 4.5% |
Managed care | 6 | 4.5% |
Methicillin-resistant Staphylococcus aureus | 6 | 4.5% |
Microbiology | 6 | 4.5% |
Pay for performance (healthcare) | 6 | 4.5% |
Phytosterol | 6 | 4.5% |
Post-exposure prophylaxis | 6 | 4.5% |
Poverty | 6 | 4.5% |
Prediabetes | 6 | 4.5% |
Public services | 6 | 4.5% |
Quality-adjusted life year | 6 | 4.5% |
Risk assessment | 6 | 4.5% |
Safety | 6 | 4.5% |
Social programs | 6 | 4.5% |
Social work | 6 | 4.5% |
Statistics | 6 | 4.5% |
Technology | 6 | 4.5% |
Thrombosis | 6 | 4.5% |
Angiology | 5 | 3.8% |
Antibiotic | 5 | 3.8% |
Anticoagulant | 5 | 3.8% |
Aspirin | 5 | 3.8% |
CT scan | 5 | 3.8% |
Capacity building | 5 | 3.8% |
Case management (US health system) | 5 | 3.8% |
Circulatory system | 5 | 3.8% |
Clinical commissioning group | 5 | 3.8% |
Comorbidity | 5 | 3.8% |
Deep vein thrombosis | 5 | 3.8% |
Diet (nutrition) | 5 | 3.8% |
Disability | 5 | 3.8% |
Economics of service industries | 5 | 3.8% |
Employment | 5 | 3.8% |
Fat | 5 | 3.8% |
HIV | 5 | 3.8% |
Health information technology | 5 | 3.8% |
Health insurance coverage in the United States | 5 | 3.8% |
Human reproduction | 5 | 3.8% |
Influenza | 5 | 3.8% |
Intensive care unit | 5 | 3.8% |
Medical imaging | 5 | 3.8% |
Medicare dual eligible | 5 | 3.8% |
Physical activity | 5 | 3.8% |
Physical examination | 5 | 3.8% |
Population health | 5 | 3.8% |
Pregnancy | 5 | 3.8% |
Psychiatry | 5 | 3.8% |
Psychotherapy | 5 | 3.8% |
RTT | 5 | 3.8% |
Schizophrenia | 5 | 3.8% |
Sepsis | 5 | 3.8% |
Telehealth | 5 | 3.8% |
Transient ischemic attack | 5 | 3.8% |
Vaccine | 5 | 3.8% |
Venous thrombosis | 5 | 3.8% |
Violence | 5 | 3.8% |
ACE inhibitor | 4 | 3.0% |
Acute coronary syndrome | 4 | 3.0% |
Angina | 4 | 3.0% |
Animal diseases | 4 | 3.0% |
Antiplatelet drug | 4 | 3.0% |
Asthma | 4 | 3.0% |
Atorvastatin | 4 | 3.0% |
Bipolar disorder | 4 | 3.0% |
Blood | 4 | 3.0% |
Breast cancer | 4 | 3.0% |
Canagliflozin | 4 | 3.0% |
Child | 4 | 3.0% |
Clopidogrel | 4 | 3.0% |
Combined oral contraceptive pill | 4 | 3.0% |
Community | 4 | 3.0% |
Community health worker | 4 | 3.0% |
Coronary artery bypass surgery | 4 | 3.0% |
Culture | 4 | 3.0% |
Current Procedural Terminology | 4 | 3.0% |
Disability-adjusted life year | 4 | 3.0% |
Disorders of endocrine pancreas | 4 | 3.0% |
Ebola virus disease | 4 | 3.0% |
Effect size | 4 | 3.0% |
Epidemic | 4 | 3.0% |
Fish oil | 4 | 3.0% |
GeneXpert MTB/RIF | 4 | 3.0% |
Health equity | 4 | 3.0% |
Health promotion | 4 | 3.0% |
Heart failure | 4 | 3.0% |
Hepatitis | 4 | 3.0% |
Hyperglycemia | 4 | 3.0% |
Hypoglycemia | 4 | 3.0% |
Influenza A virus subtype H5N1 | 4 | 3.0% |
Laboratory | 4 | 3.0% |
Leadership | 4 | 3.0% |
Medical prescription | 4 | 3.0% |
Medical record | 4 | 3.0% |
Metabolic syndrome | 4 | 3.0% |
Millennium Development Goals | 4 | 3.0% |
Neoplasms | 4 | 3.0% |
Nervous system | 4 | 3.0% |
Omega-3 fatty acid | 4 | 3.0% |
Ovarian cancer | 4 | 3.0% |
Pediatrics | 4 | 3.0% |
Peripheral neuropathy | 4 | 3.0% |
Physical fitness | 4 | 3.0% |
Physiology | 4 | 3.0% |
Point of care | 4 | 3.0% |
Primary health care | 4 | 3.0% |
Risk management | 4 | 3.0% |
Safe sex | 4 | 3.0% |
Services sector of the economy | 4 | 3.0% |
Smoking | 4 | 3.0% |
Social determinants of health | 4 | 3.0% |
Substance abuse | 4 | 3.0% |
Tax | 4 | 3.0% |
Tissues (biology) | 4 | 3.0% |
Tobacco smoking | 4 | 3.0% |
Zidovudine | 4 | 3.0% |
Adolescence | 3 | 2.3% |
Ageing | 3 | 2.3% |
Alcoholic drink | 3 | 2.3% |
Analgesic | 3 | 2.3% |
Anesthesia | 3 | 2.3% |
Angiotensin II receptor blocker | 3 | 2.3% |
Animal viral diseases | 3 | 2.3% |
Anxiety disorder | 3 | 2.3% |
Arthritis | 3 | 2.3% |
Attention | 3 | 2.3% |
Audiology | 3 | 2.3% |
Biomarker | 3 | 2.3% |
Birth control | 3 | 2.3% |
Bleeding | 3 | 2.3% |
Bupropion | 3 | 2.3% |
CD4 | 3 | 2.3% |
Cardiovascular diseases | 3 | 2.3% |
Certification | 3 | 2.3% |
Childhood obesity | 3 | 2.3% |
Cigar | 3 | 2.3% |
Cigarette | 3 | 2.3% |
Clinical governance | 3 | 2.3% |
Clinical psychology | 3 | 2.3% |
Cognitive behavioral therapy | 3 | 2.3% |
Condom | 3 | 2.3% |
Diabetic retinopathy | 3 | 2.3% |
Diagnosis-related group | 3 | 2.3% |
Dietary supplement | 3 | 2.3% |
Dietitian | 3 | 2.3% |
Disease management (health) | 3 | 2.3% |
Disease surveillance | 3 | 2.3% |
Dysmenorrhea | 3 | 2.3% |
Electrocardiography | 3 | 2.3% |
Electronic cigarette | 3 | 2.3% |
Endocrine system | 3 | 2.3% |
Extensively drug-resistant tuberculosis | 3 | 2.3% |
Framingham Risk Score | 3 | 2.3% |
General practice | 3 | 2.3% |
Goal | 3 | 2.3% |
Gonorrhea | 3 | 2.3% |
Health care in the United States | 3 | 2.3% |
Health insurance | 3 | 2.3% |
Healthcare industry | 3 | 2.3% |
Hematology | 3 | 2.3% |
Homelessness | 3 | 2.3% |
Infection control | 3 | 2.3% |
Influenza A virus | 3 | 2.3% |
Influenza pandemic | 3 | 2.3% |
Influenza vaccine | 3 | 2.3% |
Influenza-like illness | 3 | 2.3% |
Information | 3 | 2.3% |
Insulin | 3 | 2.3% |
Insulin (medication) | 3 | 2.3% |
International Statistical Classification of Diseases and Related Health Problems | 3 | 2.3% |
Intrauterine device | 3 | 2.3% |
Ischemia | 3 | 2.3% |
Lamivudine | 3 | 2.3% |
Lentiviruses | 3 | 2.3% |
Liraglutide | 3 | 2.3% |
Long-term care | 3 | 2.3% |
Long-term effects of alcohol consumption | 3 | 2.3% |
Lymphoma | 3 | 2.3% |
MEDLINE | 3 | 2.3% |
Malaria | 3 | 2.3% |
Medical test | 3 | 2.3% |
Mediterranean diet | 3 | 2.3% |
Metformin | 3 | 2.3% |
Mortality rate | 3 | 2.3% |
Multi-drug-resistant tuberculosis | 3 | 2.3% |
Nicotine | 3 | 2.3% |
Nicotine replacement therapy | 3 | 2.3% |
Non-governmental organization | 3 | 2.3% |
Nursing home care | 3 | 2.3% |
Nutrition | 3 | 2.3% |
Off-label use | 3 | 2.3% |
Old age | 3 | 2.3% |
Outcomes research | 3 | 2.3% |
Palliative care | 3 | 2.3% |
Pandemic | 3 | 2.3% |
Parkinson's disease | 3 | 2.3% |
Passive smoking | 3 | 2.3% |
Patient participation | 3 | 2.3% |
Perception | 3 | 2.3% |
Percutaneous coronary intervention | 3 | 2.3% |
Pharmacology | 3 | 2.3% |
Placebo | 3 | 2.3% |
Placebo-controlled study | 3 | 2.3% |
Polymerase chain reaction | 3 | 2.3% |
Prescription drug | 3 | 2.3% |
Preventive medicine | 3 | 2.3% |
Problem solving | 3 | 2.3% |
Prothrombin time | 3 | 2.3% |
Psychosis | 3 | 2.3% |
Pulmonary embolism | 3 | 2.3% |
Quality assurance | 3 | 2.3% |
Radiation therapy | 3 | 2.3% |
Regression analysis | 3 | 2.3% |
Reliability engineering | 3 | 2.3% |
Reporting bias | 3 | 2.3% |
Reverse-transcriptase inhibitor | 3 | 2.3% |
Rivaroxaban | 3 | 2.3% |
Robot | 3 | 2.3% |
SGLT2 inhibitor | 3 | 2.3% |
Sensitivity analysis | 3 | 2.3% |
Service industries | 3 | 2.3% |
Sexual health | 3 | 2.3% |
Sexual intercourse | 3 | 2.3% |
Shared decision-making in medicine | 3 | 2.3% |
Shortness of breath | 3 | 2.3% |
Simvastatin | 3 | 2.3% |
Smoking cessation | 3 | 2.3% |
Stanol ester | 3 | 2.3% |
Stavudine | 3 | 2.3% |
Study heterogeneity | 3 | 2.3% |
Surveillance | 3 | 2.3% |
Sustainable Development Goals | 3 | 2.3% |
Tetanus | 3 | 2.3% |
Thrombophilia | 3 | 2.3% |
Training | 3 | 2.3% |
Tuberculosis management | 3 | 2.3% |
Unit of alcohol | 3 | 2.3% |
Varenicline | 3 | 2.3% |
Vitamin | 3 | 2.3% |
Vitamin E | 3 | 2.3% |
Warfarin | 3 | 2.3% |
Welfare | 3 | 2.3% |
Youth | 3 | 2.3% |
Action plan | 2 | 1.5% |
Acute myeloid leukemia | 2 | 1.5% |
Africa | 2 | 1.5% |
Amyotrophic lateral sclerosis | 2 | 1.5% |
Anatomical terms of motion | 2 | 1.5% |
Angiography | 2 | 1.5% |
Anti-diabetic medication | 2 | 1.5% |
Antimalarial medication | 2 | 1.5% |
Antimicrobial stewardship | 2 | 1.5% |
Antiviral drug | 2 | 1.5% |
Arrhythmia | 2 | 1.5% |
Artificial intelligence | 2 | 1.5% |
Assay | 2 | 1.5% |
Atheroma | 2 | 1.5% |
Atrial fibrillation | 2 | 1.5% |
Avian influenza | 2 | 1.5% |
BRCA mutation | 2 | 1.5% |
Baby Friendly Hospital Initiative | 2 | 1.5% |
Balance (ability) | 2 | 1.5% |
Bariatric surgery | 2 | 1.5% |
Beta blocker | 2 | 1.5% |
Bias | 2 | 1.5% |
Biopsy | 2 | 1.5% |
Biotechnology | 2 | 1.5% |
Blood film | 2 | 1.5% |
Blood glucose monitoring | 2 | 1.5% |
Body fluids | 2 | 1.5% |
Bone marrow | 2 | 1.5% |
Branches of science | 2 | 1.5% |
CT pulmonary angiogram | 2 | 1.5% |
Cannabidiol | 2 | 1.5% |
Cannabinoid | 2 | 1.5% |
Cannabis (drug) | 2 | 1.5% |
Carbapenem-resistant enterobacteriaceae | 2 | 1.5% |
Cardiac muscle | 2 | 1.5% |
Cardiac stress test | 2 | 1.5% |
Cardiothoracic surgery | 2 | 1.5% |
Case management (US healthcare system) | 2 | 1.5% |
Cerebrospinal fluid | 2 | 1.5% |
Cervical cancer | 2 | 1.5% |
Chemistry | 2 | 1.5% |
Circumcision and HIV | 2 | 1.5% |
Clinic | 2 | 1.5% |
Clinical audit | 2 | 1.5% |
Clostridioides difficile infection | 2 | 1.5% |
Cochrane Library | 2 | 1.5% |
Cognition | 2 | 1.5% |
Colorectal cancer | 2 | 1.5% |
Communication | 2 | 1.5% |
Competence (human resources) | 2 | 1.5% |
Computed tomography angiography | 2 | 1.5% |
Confounding | 2 | 1.5% |
Contrast (vision) | 2 | 1.5% |
Corporate social responsibility | 2 | 1.5% |
Corrective and preventive action | 2 | 1.5% |
Cost–utility analysis | 2 | 1.5% |
Creatinine | 2 | 1.5% |
Curriculum | 2 | 1.5% |
D-dimer | 2 | 1.5% |
DNA sequencing | 2 | 1.5% |
Dabigatran | 2 | 1.5% |
Database | 2 | 1.5% |
Death | 2 | 1.5% |
Development aid | 2 | 1.5% |
Diabetic ketoacidosis | 2 | 1.5% |
Diagnosis of malaria | 2 | 1.5% |
Dietary fiber | 2 | 1.5% |
Diffuse large B-cell lymphoma | 2 | 1.5% |
Disseminated intravascular coagulation | 2 | 1.5% |
Driving | 2 | 1.5% |
Dronabinol | 2 | 1.5% |
Early intervention in psychosis | 2 | 1.5% |
Echocardiography | 2 | 1.5% |
Emergency | 2 | 1.5% |
Emergency contraception | 2 | 1.5% |
Emergency management | 2 | 1.5% |
Emergency medicine | 2 | 1.5% |
Empowerment | 2 | 1.5% |
End-of-life care | 2 | 1.5% |
Endocrine pancreas | 2 | 1.5% |
Endometriosis | 2 | 1.5% |
Epidural administration | 2 | 1.5% |
Executive functions | 2 | 1.5% |
Exenatide | 2 | 1.5% |
Facilitator | 2 | 1.5% |
Familial hypercholesterolemia | 2 | 1.5% |
Federally Qualified Health Center | 2 | 1.5% |
Five Year Forward View | 2 | 1.5% |
Flu season | 2 | 1.5% |
Follicular lymphoma | 2 | 1.5% |
Food and drink | 2 | 1.5% |
Food safety | 2 | 1.5% |
Formulary (pharmacy) | 2 | 1.5% |
Fraction (mathematics) | 2 | 1.5% |
Functional magnetic resonance imaging | 2 | 1.5% |
Gender | 2 | 1.5% |
Gene | 2 | 1.5% |
Gene expression | 2 | 1.5% |
Genetics | 2 | 1.5% |
Gestational diabetes | 2 | 1.5% |
Global warming | 2 | 1.5% |
Glucagon-like peptide-1 | 2 | 1.5% |
Glucose tolerance test | 2 | 1.5% |
Glycemic index | 2 | 1.5% |
Gynaecologic disorders | 2 | 1.5% |
Hazard | 2 | 1.5% |
Headache | 2 | 1.5% |
Health Information Technology for Economic and Clinical Health Act | 2 | 1.5% |
Health Insurance Portability and Accountability Act | 2 | 1.5% |
Health Level 7 | 2 | 1.5% |
Health human resources | 2 | 1.5% |
Healthcare in Greater Manchester | 2 | 1.5% |
Healthcare management | 2 | 1.5% |
Healthcare quality | 2 | 1.5% |
Hearing | 2 | 1.5% |
Hearing loss | 2 | 1.5% |
Heart arrhythmia | 2 | 1.5% |
Heart failure with preserved ejection fraction | 2 | 1.5% |
Heart-type fatty acid binding protein | 2 | 1.5% |
Hematopoietic stem cell transplantation | 2 | 1.5% |
Hodgkin's lymphoma | 2 | 1.5% |
Hormonal contraception | 2 | 1.5% |
Hospital-acquired infection | 2 | 1.5% |
Human papillomavirus infection | 2 | 1.5% |
ISO 9000 | 2 | 1.5% |
Immunodeficiency | 2 | 1.5% |
Impact evaluation | 2 | 1.5% |
Incremental cost-effectiveness ratio | 2 | 1.5% |
Incretin | 2 | 1.5% |
Infant mortality | 2 | 1.5% |
Influenza A virus subtype H7N9 | 2 | 1.5% |
Information security | 2 | 1.5% |
Information technology | 2 | 1.5% |
Infrastructure | 2 | 1.5% |
Insulin analog | 2 | 1.5% |
Insulin degludec | 2 | 1.5% |
Insulin pump | 2 | 1.5% |
Intensive care medicine | 2 | 1.5% |
International Health Regulations | 2 | 1.5% |
Intravenous therapy | 2 | 1.5% |
Junk food | 2 | 1.5% |
Knowledge | 2 | 1.5% |
Laparoscopy | 2 | 1.5% |
Leukemia | 2 | 1.5% |
Lithium (medication) | 2 | 1.5% |
Lixisenatide | 2 | 1.5% |
Logistics | 2 | 1.5% |
Lumbar puncture | 2 | 1.5% |
Magnetic resonance imaging | 2 | 1.5% |
Male genital disorders | 2 | 1.5% |
Management | 2 | 1.5% |
Mania | 2 | 1.5% |
Measles | 2 | 1.5% |
Medical cannabis | 2 | 1.5% |
Medical history | 2 | 1.5% |
Medical microbiology | 2 | 1.5% |
Medical research | 2 | 1.5% |
Medicare Sustainable Growth Rate | 2 | 1.5% |
Medroxyprogesterone acetate | 2 | 1.5% |
Memory | 2 | 1.5% |
Menopause | 2 | 1.5% |
MicroRNA | 2 | 1.5% |
Microscope | 2 | 1.5% |
Microscope slide | 2 | 1.5% |
Microscopy | 2 | 1.5% |
Middle East respiratory syndrome coronavirus | 2 | 1.5% |
Midwife | 2 | 1.5% |
Molecular diagnostics | 2 | 1.5% |
Multiple drug resistance | 2 | 1.5% |
Multiple sclerosis | 2 | 1.5% |
Mycobacterium bovis | 2 | 1.5% |
NHS Connecting for Health | 2 | 1.5% |
Nabiximols | 2 | 1.5% |
Needle exchange programme | 2 | 1.5% |
Neonatal alloimmune thrombocytopenia | 2 | 1.5% |
Neurology | 2 | 1.5% |
Neuron | 2 | 1.5% |
Neuropathic pain | 2 | 1.5% |
Nevirapine | 2 | 1.5% |
Non-Hodgkin lymphoma | 2 | 1.5% |
Non-alcoholic fatty liver disease | 2 | 1.5% |
Nurse practitioner | 2 | 1.5% |
Occupational safety and health | 2 | 1.5% |
Occupational therapist | 2 | 1.5% |
Occupational therapy | 2 | 1.5% |
Ondansetron | 2 | 1.5% |
Optical microscope | 2 | 1.5% |
Organs (anatomy) | 2 | 1.5% |
Osteoarthritis | 2 | 1.5% |
PH | 2 | 1.5% |
Pain management | 2 | 1.5% |
Parasitism | 2 | 1.5% |
Partner notification | 2 | 1.5% |
Pathogen | 2 | 1.5% |
Pathology | 2 | 1.5% |
Pediatric nursing | 2 | 1.5% |
Peripheral artery disease | 2 | 1.5% |
Pharmaceutical sciences | 2 | 1.5% |
Phases of clinical research | 2 | 1.5% |
Physical sciences | 2 | 1.5% |
Plasmodium falciparum | 2 | 1.5% |
Plasmodium malariae | 2 | 1.5% |
Plasmodium vivax | 2 | 1.5% |
Platelet | 2 | 1.5% |
Platelet transfusion | 2 | 1.5% |
Policy | 2 | 1.5% |
Poliomyelitis | 2 | 1.5% |
Poliomyelitis eradication | 2 | 1.5% |
Polypharmacy | 2 | 1.5% |
Positron emission tomography | 2 | 1.5% |
Posttraumatic stress disorder | 2 | 1.5% |
Poverty threshold | 2 | 1.5% |
Power of a test | 2 | 1.5% |
Pre-eclampsia | 2 | 1.5% |
Preterm birth | 2 | 1.5% |
Privacy | 2 | 1.5% |
Propensity score matching | 2 | 1.5% |
Psychoactive drug | 2 | 1.5% |
Psychological resilience | 2 | 1.5% |
Publication bias | 2 | 1.5% |
QT interval | 2 | 1.5% |
Quality and Outcomes Framework | 2 | 1.5% |
Radiology | 2 | 1.5% |
Real-time polymerase chain reaction | 2 | 1.5% |
Recovery approach | 2 | 1.5% |
Regulatory compliance | 2 | 1.5% |
Relative risk | 2 | 1.5% |
Reproductive health | 2 | 1.5% |
Retirement | 2 | 1.5% |
Rheumatoid arthritis | 2 | 1.5% |
Rheumatology | 2 | 1.5% |
Rosuvastatin | 2 | 1.5% |
Sampling (statistics) | 2 | 1.5% |
Saxagliptin | 2 | 1.5% |
Sex worker | 2 | 1.5% |
Sexually transmitted diseases and infections | 2 | 1.5% |
Sickle cell disease | 2 | 1.5% |
Snellen chart | 2 | 1.5% |
Social inequality | 2 | 1.5% |
Spasticity | 2 | 1.5% |
Spinal anaesthesia | 2 | 1.5% |
Staining | 2 | 1.5% |
Statistical significance | 2 | 1.5% |
Stress (biology) | 2 | 1.5% |
Substance dependence | 2 | 1.5% |
Supportive housing | 2 | 1.5% |
Surface epithelial-stromal tumor | 2 | 1.5% |
Sustainability and transformation plan | 2 | 1.5% |
Syncope (medicine) | 2 | 1.5% |
Test (assessment) | 2 | 1.5% |
Tetrahydrocannabinol | 2 | 1.5% |
Thrombocytopenia | 2 | 1.5% |
Tourette syndrome | 2 | 1.5% |
Toxicity | 2 | 1.5% |
Traffic | 2 | 1.5% |
Traffic collision | 2 | 1.5% |
Traumatic brain injury | 2 | 1.5% |
Treatment as prevention | 2 | 1.5% |
Troponin | 2 | 1.5% |
Uncertainty | 2 | 1.5% |
United Nations System | 2 | 1.5% |
Urinary incontinence | 2 | 1.5% |
Usability | 2 | 1.5% |
Vein | 2 | 1.5% |
Veterinary medicine | 2 | 1.5% |
Virology | 2 | 1.5% |
Virtual reality | 2 | 1.5% |
Visual acuity | 2 | 1.5% |
Visual impairment | 2 | 1.5% |
Visual perception | 2 | 1.5% |
Waste | 2 | 1.5% |
Well-being | 2 | 1.5% |
White blood cell | 2 | 1.5% |
Women's health | 2 | 1.5% |
Working memory | 2 | 1.5% |
Workplace wellness | 2 | 1.5% |
World Wide Web | 2 | 1.5% |
Zoonosis | 2 | 1.5% |
2009 flu pandemic | 1 | 0.8% |
2016 United States wireless spectrum auction | 1 | 0.8% |
Abacavir | 1 | 0.8% |
Abdomen | 1 | 0.8% |
Abdominal obesity | 1 | 0.8% |
Academy (English school) | 1 | 0.8% |
Accessibility | 1 | 0.8% |
Adalimumab | 1 | 0.8% |
Adjustable gastric band | 1 | 0.8% |
Adjuvant therapy | 1 | 0.8% |
Affordable Care Act | 1 | 0.8% |
Affordable housing | 1 | 0.8% |
Aflibercept | 1 | 0.8% |
African Americans | 1 | 0.8% |
Air pollution | 1 | 0.8% |
Alcohol | 1 | 0.8% |
Alirocumab | 1 | 0.8% |
Allocation concealment | 1 | 0.8% |
Alpha-Linolenic acid | 1 | 0.8% |
AlphaGo | 1 | 0.8% |
Ambulance | 1 | 0.8% |
American Recovery and Reinvestment Act of 2009 | 1 | 0.8% |
Aminoglycoside | 1 | 0.8% |
Amlodipine | 1 | 0.8% |
Amoxicillin | 1 | 0.8% |
Amphotericin B | 1 | 0.8% |
Ampicillin | 1 | 0.8% |
Analysis of variance | 1 | 0.8% |
Angiotensin-converting enzyme | 1 | 0.8% |
Animal testing | 1 | 0.8% |
Animal virology | 1 | 0.8% |
Animals | 1 | 0.8% |
Animals and humans | 1 | 0.8% |
Ankyloglossia | 1 | 0.8% |
Anopheles | 1 | 0.8% |
Anovulation | 1 | 0.8% |
Antibiotic prophylaxis | 1 | 0.8% |
Antibiotic sensitivity | 1 | 0.8% |
Anticonvulsant | 1 | 0.8% |
Antimicrobial | 1 | 0.8% |
Antiphospholipid syndrome | 1 | 0.8% |
Anxiety | 1 | 0.8% |
Aorta | 1 | 0.8% |
Aortic aneurysm | 1 | 0.8% |
Aortic dissection | 1 | 0.8% |
Aortic stenosis | 1 | 0.8% |
Aortic valve | 1 | 0.8% |
Aortic valve replacement | 1 | 0.8% |
Apixaban | 1 | 0.8% |
Apolipoprotein | 1 | 0.8% |
Applied and interdisciplinary physics | 1 | 0.8% |
Argument | 1 | 0.8% |
Artery | 1 | 0.8% |
Artificial objects | 1 | 0.8% |
Ascending cholangitis | 1 | 0.8% |
Assessment of kidney function | 1 | 0.8% |
Assisted living | 1 | 0.8% |
Atrium (heart) | 1 | 0.8% |
Attachment theory | 1 | 0.8% |
Attentional control | 1 | 0.8% |
Auditor's report | 1 | 0.8% |
Autism | 1 | 0.8% |
Autism spectrum | 1 | 0.8% |
Autophagy | 1 | 0.8% |
Ayurveda | 1 | 0.8% |
Azacitidine | 1 | 0.8% |
Bacteremia | 1 | 0.8% |
Bacteriuria | 1 | 0.8% |
Beef cattle | 1 | 0.8% |
Behaviour therapy | 1 | 0.8% |
Behavioural sciences | 1 | 0.8% |
Beta cell | 1 | 0.8% |
Beta thalassemia | 1 | 0.8% |
Beta-Sitosterol | 1 | 0.8% |
Beta-lactamase | 1 | 0.8% |
Big data | 1 | 0.8% |
Bile duct | 1 | 0.8% |
BioWatch | 1 | 0.8% |
Biodiversity | 1 | 0.8% |
Bioinformatics | 1 | 0.8% |
Biomarker (medicine) | 1 | 0.8% |
Biomedical waste | 1 | 0.8% |
Biopsychosocial model | 1 | 0.8% |
Biosafety | 1 | 0.8% |
Biosafety cabinet | 1 | 0.8% |
Biosafety level | 1 | 0.8% |
Biosecurity | 1 | 0.8% |
Bioterrorism | 1 | 0.8% |
Birth defect | 1 | 0.8% |
Birth weight | 1 | 0.8% |
Bladder cancer | 1 | 0.8% |
Blood cell | 1 | 0.8% |
Blood lipids | 1 | 0.8% |
Blood transfusion | 1 | 0.8% |
Blood-borne disease | 1 | 0.8% |
Borderline personality disorder | 1 | 0.8% |
Borna disease | 1 | 0.8% |
Borrelia | 1 | 0.8% |
Bovine leukemia virus | 1 | 0.8% |
Brain | 1 | 0.8% |
Brain death | 1 | 0.8% |
Brain–computer interface | 1 | 0.8% |
Breast cancer screening | 1 | 0.8% |
Breast milk | 1 | 0.8% |
Breastfeeding and HIV | 1 | 0.8% |
Broad-spectrum antibiotic | 1 | 0.8% |
Broadcasting | 1 | 0.8% |
Brucella | 1 | 0.8% |
Bundled payment | 1 | 0.8% |
C-reactive protein | 1 | 0.8% |
CA-125 | 1 | 0.8% |
CHOP | 1 | 0.8% |
COX-3 | 1 | 0.8% |
CRISPR | 1 | 0.8% |
CRISPR gene editing | 1 | 0.8% |
Caesarean section | 1 | 0.8% |
Cancer Drugs Fund | 1 | 0.8% |
Cancer registry | 1 | 0.8% |
Cancer screening | 1 | 0.8% |
Cancer staging | 1 | 0.8% |
Capability Maturity Model Integration | 1 | 0.8% |
Carbapenem | 1 | 0.8% |
Carcinogenesis | 1 | 0.8% |
Carcinoma | 1 | 0.8% |
Cardiac catheterization | 1 | 0.8% |
Cardiac imaging | 1 | 0.8% |
Cardiac magnetic resonance imaging | 1 | 0.8% |
Cardiac marker | 1 | 0.8% |
Cardiac monitoring | 1 | 0.8% |
Cardiac rehabilitation | 1 | 0.8% |
Cardiac surgery | 1 | 0.8% |
Cardiovascular physiology | 1 | 0.8% |
Case study | 1 | 0.8% |
Categorical variable | 1 | 0.8% |
Cattle | 1 | 0.8% |
Causes of death | 1 | 0.8% |
Ceftazidime | 1 | 0.8% |
Cell potency | 1 | 0.8% |
Cellular differentiation | 1 | 0.8% |
Cephalosporin | 1 | 0.8% |
Cerebrovascular disease | 1 | 0.8% |
Cervical screening | 1 | 0.8% |
Change management | 1 | 0.8% |
Charity care | 1 | 0.8% |
Chemical substance | 1 | 0.8% |
Chikungunya | 1 | 0.8% |
Child mortality | 1 | 0.8% |
Childhood | 1 | 0.8% |
Children's rights | 1 | 0.8% |
Chlamydia infection | 1 | 0.8% |
Chlortalidone | 1 | 0.8% |
Cholecystectomy | 1 | 0.8% |
Cholecystitis | 1 | 0.8% |
Chronic fatigue syndrome | 1 | 0.8% |
Chronic lymphocytic leukemia | 1 | 0.8% |
Chronic obstructive pulmonary disease | 1 | 0.8% |
Chronotype | 1 | 0.8% |
Ciprofloxacin | 1 | 0.8% |
Circadian rhythm | 1 | 0.8% |
Climate change | 1 | 0.8% |
Clinical pathology | 1 | 0.8% |
Clostridial infections | 1 | 0.8% |
Clostridium difficile infection | 1 | 0.8% |
Cloud computing | 1 | 0.8% |
Coagulation | 1 | 0.8% |
Coenzyme Q10 | 1 | 0.8% |
Cognitive science | 1 | 0.8% |
Colonoscopy | 1 | 0.8% |
Common bile duct stone | 1 | 0.8% |
Community mental health service | 1 | 0.8% |
Community-acquired pneumonia | 1 | 0.8% |
Computer network | 1 | 0.8% |
Computer security | 1 | 0.8% |
Computerized physician order entry | 1 | 0.8% |
Computing | 1 | 0.8% |
Condensed matter physics | 1 | 0.8% |
Confidentiality | 1 | 0.8% |
Consultant (medicine) | 1 | 0.8% |
Copeptin | 1 | 0.8% |
Coronary CT angiography | 1 | 0.8% |
Coronary CT calcium scan | 1 | 0.8% |
Coronary catheterization | 1 | 0.8% |
Coronary circulation | 1 | 0.8% |
Coronavirus | 1 | 0.8% |
Coronavirus disease 2019 | 1 | 0.8% |
Creatine kinase | 1 | 0.8% |
Credentialing | 1 | 0.8% |
Crohn's disease | 1 | 0.8% |
Cryptococcosis | 1 | 0.8% |
Cure | 1 | 0.8% |
Cyclooxygenase | 1 | 0.8% |
Cystoscopy | 1 | 0.8% |
Cytopathology | 1 | 0.8% |
DNA | 1 | 0.8% |
DNA annotation | 1 | 0.8% |
Data | 1 | 0.8% |
Data quality | 1 | 0.8% |
Decentralization | 1 | 0.8% |
Decomposition | 1 | 0.8% |
Defined daily dose | 1 | 0.8% |
Delirium | 1 | 0.8% |
Demographic dividend | 1 | 0.8% |
Demographic transition | 1 | 0.8% |
Demography | 1 | 0.8% |
Dendrite | 1 | 0.8% |
Dependency ratio | 1 | 0.8% |
Dependent and independent variables | 1 | 0.8% |
Depression (mood) | 1 | 0.8% |
Designer baby | 1 | 0.8% |
Diabetes medication | 1 | 0.8% |
Diabetes mellitus type 1 | 1 | 0.8% |
Diabetic hypoglycemia | 1 | 0.8% |
Diabetic nephropathy | 1 | 0.8% |
Diabetic neuropathy | 1 | 0.8% |
Diarrhea | 1 | 0.8% |
Diastole | 1 | 0.8% |
Didanosine | 1 | 0.8% |
Difference in differences | 1 | 0.8% |
Digestive diseases | 1 | 0.8% |
Digestive system | 1 | 0.8% |
Digital health | 1 | 0.8% |
Digitization | 1 | 0.8% |
Diltiazem | 1 | 0.8% |
Directly observed treatment, short-course | 1 | 0.8% |
Discovery (law) | 1 | 0.8% |
Disease burden | 1 | 0.8% |
Disinfectant | 1 | 0.8% |
Disproportionate share hospital | 1 | 0.8% |
Do not resuscitate | 1 | 0.8% |
Docosahexaenoic acid | 1 | 0.8% |
Doctor of Medicine | 1 | 0.8% |
Dog | 1 | 0.8% |
Dopamine | 1 | 0.8% |
Dose–response relationship | 1 | 0.8% |
Dr Foster Intelligence | 1 | 0.8% |
Drug-induced QT prolongation | 1 | 0.8% |
Dual diagnosis | 1 | 0.8% |
Dummy variable (statistics) | 1 | 0.8% |
Dynamic stochastic general equilibrium | 1 | 0.8% |
Dyslipidemia | 1 | 0.8% |
ELISA | 1 | 0.8% |
EPSDT | 1 | 0.8% |
Ebola vaccine | 1 | 0.8% |
Echinococcus multilocularis | 1 | 0.8% |
Economic growth | 1 | 0.8% |
Economic inequality | 1 | 0.8% |
Economy | 1 | 0.8% |
Ecosystem | 1 | 0.8% |
Ectopic pregnancy | 1 | 0.8% |
Educational assessment | 1 | 0.8% |
Efficient energy use | 1 | 0.8% |
Eicosapentaenoic acid | 1 | 0.8% |
Electroencephalography | 1 | 0.8% |
Embolic stroke of undetermined source | 1 | 0.8% |
Emtricitabine/tenofovir | 1 | 0.8% |
Endocrine, nutritional and metabolic diseases | 1 | 0.8% |
Endometrial cancer | 1 | 0.8% |
Endoscopic retrograde cholangiopancreatography | 1 | 0.8% |
Environmental governance | 1 | 0.8% |
Environmental resource management | 1 | 0.8% |
Epidemiology of HIV/AIDS | 1 | 0.8% |
Epigenetics | 1 | 0.8% |
Equianalgesic | 1 | 0.8% |
Eradication of infectious diseases | 1 | 0.8% |
Estrogen | 1 | 0.8% |
Estrogen (medication) | 1 | 0.8% |
Ethinylestradiol | 1 | 0.8% |
Eurasian beaver | 1 | 0.8% |
Exotic pet | 1 | 0.8% |
Expert | 1 | 0.8% |
Expressed emotion | 1 | 0.8% |
Ezetimibe | 1 | 0.8% |
Ezetimibe/simvastatin | 1 | 0.8% |
FDA Food Safety Modernization Act | 1 | 0.8% |
Factor V Leiden | 1 | 0.8% |
Factor analysis | 1 | 0.8% |
Family medicine | 1 | 0.8% |
Family planning | 1 | 0.8% |
Fecal occult blood | 1 | 0.8% |
Federal Food, Drug, and Cosmetic Act | 1 | 0.8% |
Federal Information Security Management Act of 2002 | 1 | 0.8% |
Fenofibrate | 1 | 0.8% |
Fertility | 1 | 0.8% |
Fibrate | 1 | 0.8% |
Field Epidemiology Training Program | 1 | 0.8% |
Field epidemiology | 1 | 0.8% |
Finance | 1 | 0.8% |
Financial audit | 1 | 0.8% |
Fine-needle aspiration | 1 | 0.8% |
Fluconazole | 1 | 0.8% |
Flucytosine | 1 | 0.8% |
Fludeoxyglucose (18F) | 1 | 0.8% |
Fluid replacement | 1 | 0.8% |
Fluorescence in situ hybridization | 1 | 0.8% |
Fluvastatin | 1 | 0.8% |
Focus group | 1 | 0.8% |
Food Distribution Program on Indian Reservations | 1 | 0.8% |
Food defense | 1 | 0.8% |
Food politics | 1 | 0.8% |
Forest plot | 1 | 0.8% |
Fraud | 1 | 0.8% |
Fresh frozen plasma | 1 | 0.8% |
Friends and Family Test | 1 | 0.8% |
Frozen section procedure | 1 | 0.8% |
G2 phase | 1 | 0.8% |
Gallstone | 1 | 0.8% |
Gastroenterology | 1 | 0.8% |
Gender equality | 1 | 0.8% |
Gene drive | 1 | 0.8% |
Gene expression profiling | 1 | 0.8% |
Gene therapy | 1 | 0.8% |
Generalized anxiety disorder | 1 | 0.8% |
Genetic counseling | 1 | 0.8% |
Genetic engineering | 1 | 0.8% |
Genomics | 1 | 0.8% |
Gestational trophoblastic disease | 1 | 0.8% |
Gliflozin | 1 | 0.8% |
Global health | 1 | 0.8% |
Globalization | 1 | 0.8% |
Glomerular filtration rate | 1 | 0.8% |
Glucose test | 1 | 0.8% |
Glutaric aciduria type 1 | 1 | 0.8% |
Good governance | 1 | 0.8% |
Government | 1 | 0.8% |
Government aid programs | 1 | 0.8% |
Government spending | 1 | 0.8% |
Grid cell | 1 | 0.8% |
Gun violence | 1 | 0.8% |
Gynaecology | 1 | 0.8% |
HIV-positive people | 1 | 0.8% |
Haematopoiesis | 1 | 0.8% |
Haemophilia | 1 | 0.8% |
Haptic technology | 1 | 0.8% |
Hazard ratio | 1 | 0.8% |
Health care reforms proposed during the Obama administration | 1 | 0.8% |
Health education | 1 | 0.8% |
Health literacy | 1 | 0.8% |
Health research | 1 | 0.8% |
Health services research | 1 | 0.8% |
Health visitor | 1 | 0.8% |
Healthcare reform in the United States | 1 | 0.8% |
Healthcare shortage area | 1 | 0.8% |
Hearing aid | 1 | 0.8% |
Heart valve | 1 | 0.8% |
Helicobacter pylori | 1 | 0.8% |
Hematopoietic stem cell | 1 | 0.8% |
Hematuria | 1 | 0.8% |
Henipavirus | 1 | 0.8% |
Heparin | 1 | 0.8% |
Hepatitis B | 1 | 0.8% |
Hepatitis B vaccine | 1 | 0.8% |
Hepatitis E | 1 | 0.8% |
Hepatocellular carcinoma | 1 | 0.8% |
Hepatotoxicity | 1 | 0.8% |
Herbal medicine | 1 | 0.8% |
Hereditary nonpolyposis colorectal cancer | 1 | 0.8% |
High-grade serous carcinoma | 1 | 0.8% |
High-throughput screening | 1 | 0.8% |
Holter monitor | 1 | 0.8% |
Home care | 1 | 0.8% |
Hormonal IUDs | 1 | 0.8% |
Hormone replacement therapy | 1 | 0.8% |
Hospital-acquired pneumonia | 1 | 0.8% |
Human Development Index | 1 | 0.8% |
Human Development Report | 1 | 0.8% |
Human body temperature | 1 | 0.8% |
Human capital | 1 | 0.8% |
Human development (economics) | 1 | 0.8% |
Human nutrition | 1 | 0.8% |
Human respiratory syncytial virus | 1 | 0.8% |
Human sex ratio | 1 | 0.8% |
Human sexual activity | 1 | 0.8% |
Humanitarian aid | 1 | 0.8% |
Hyperlipidemia | 1 | 0.8% |
Hypokinesia | 1 | 0.8% |
Hypothermia | 1 | 0.8% |
Hypothesis | 1 | 0.8% |
IUCLID | 1 | 0.8% |
Ibrutinib | 1 | 0.8% |
Immigration | 1 | 0.8% |
Immunization | 1 | 0.8% |
Immunosuppressive drug | 1 | 0.8% |
Immunotherapy | 1 | 0.8% |
Implantable cardioverter-defibrillator | 1 | 0.8% |
Implementation | 1 | 0.8% |
Improving Access to Psychological Therapies | 1 | 0.8% |
In vitro | 1 | 0.8% |
Incidence (epidemiology) | 1 | 0.8% |
Incident management | 1 | 0.8% |
Infant | 1 | 0.8% |
Infection prevention and control | 1 | 0.8% |
Inferior vena cava | 1 | 0.8% |
Inferior vena cava filter | 1 | 0.8% |
Inflammatory bowel disease | 1 | 0.8% |
Infliximab | 1 | 0.8% |
Influenza A virus subtype H1N1 | 1 | 0.8% |
Influenza A virus subtype H3N2 | 1 | 0.8% |
Influenza research | 1 | 0.8% |
Infographic | 1 | 0.8% |
Informal economy | 1 | 0.8% |
Insulin aspart | 1 | 0.8% |
Insulin lispro | 1 | 0.8% |
Insulin resistance | 1 | 0.8% |
Insurance | 1 | 0.8% |
Integrated Management of Childhood Illness | 1 | 0.8% |
Integrated disease surveillance program | 1 | 0.8% |
Intellectual property | 1 | 0.8% |
Intelligence | 1 | 0.8% |
Intensive insulin therapy | 1 | 0.8% |
Intention-to-treat analysis | 1 | 0.8% |
Internal audit | 1 | 0.8% |
International Classification of Diseases | 1 | 0.8% |
International Prognostic Index | 1 | 0.8% |
Interoperability | 1 | 0.8% |
Intraclass correlation | 1 | 0.8% |
Intravitreal administration | 1 | 0.8% |
Inventory | 1 | 0.8% |
Ionizing radiation | 1 | 0.8% |
Ipilimumab | 1 | 0.8% |
Islet cell transplantation | 1 | 0.8% |
Junior doctor | 1 | 0.8% |
Kidney disease | 1 | 0.8% |
Kidney failure | 1 | 0.8% |
Klebsiella pneumoniae | 1 | 0.8% |
Kosterlitz–Thouless transition | 1 | 0.8% |
Laboratory Response Network | 1 | 0.8% |
Lassa fever | 1 | 0.8% |
Lasting power of attorney | 1 | 0.8% |
Learning | 1 | 0.8% |
Legionella | 1 | 0.8% |
Legionnaires' disease | 1 | 0.8% |
Leprosy | 1 | 0.8% |
Levofloxacin | 1 | 0.8% |
Liaison psychiatry | 1 | 0.8% |
Licensure | 1 | 0.8% |
Life expectancy | 1 | 0.8% |
Likelihood function | 1 | 0.8% |
Linezolid | 1 | 0.8% |
Liver | 1 | 0.8% |
Loan | 1 | 0.8% |
Local anesthetic | 1 | 0.8% |
Logic model | 1 | 0.8% |
Logistic regression | 1 | 0.8% |
Long QT syndrome | 1 | 0.8% |
Long-acting reversible contraception | 1 | 0.8% |
Lovastatin | 1 | 0.8% |
Low birth weight | 1 | 0.8% |
Low molecular weight heparin | 1 | 0.8% |
Low-Income Housing Tax Credit | 1 | 0.8% |
Low-molecular-weight heparin | 1 | 0.8% |
Lung cancer | 1 | 0.8% |
Luteinizing hormone | 1 | 0.8% |
Lyme disease | 1 | 0.8% |
Lymphadenectomy | 1 | 0.8% |
Lymphadenopathy | 1 | 0.8% |
MALT lymphoma | 1 | 0.8% |
Machine | 1 | 0.8% |
Machine learning | 1 | 0.8% |
Macular degeneration | 1 | 0.8% |
Major trauma | 1 | 0.8% |
Malnutrition | 1 | 0.8% |
Management of acute coronary syndrome | 1 | 0.8% |
Mantle cell lymphoma | 1 | 0.8% |
Maternal death | 1 | 0.8% |
Matron | 1 | 0.8% |
Maturity onset diabetes of the young | 1 | 0.8% |
Median | 1 | 0.8% |
Medical device | 1 | 0.8% |
Medical error | 1 | 0.8% |
Medical laboratory | 1 | 0.8% |
Medical ultrasound | 1 | 0.8% |
Medically unexplained physical symptoms | 1 | 0.8% |
Melanoma | 1 | 0.8% |
Menstruation | 1 | 0.8% |
Mental health professional | 1 | 0.8% |
Menu | 1 | 0.8% |
Mestranol | 1 | 0.8% |
Metabolic disorders | 1 | 0.8% |
Metabolic equivalent of task | 1 | 0.8% |
Metabolism | 1 | 0.8% |
Metabolomics | 1 | 0.8% |
Metadata | 1 | 0.8% |
Metagenomics | 1 | 0.8% |
Metastasis | 1 | 0.8% |
Methodology | 1 | 0.8% |
Microalbuminuria | 1 | 0.8% |
Microvascular angina | 1 | 0.8% |
Mid-level practitioner | 1 | 0.8% |
Middle East respiratory syndrome | 1 | 0.8% |
Midwifery | 1 | 0.8% |
Migraine | 1 | 0.8% |
Mindfulness-based cognitive therapy | 1 | 0.8% |
Minimally invasive procedure | 1 | 0.8% |
Minimally invasive procedures | 1 | 0.8% |
Missing data | 1 | 0.8% |
Molecular machine | 1 | 0.8% |
Molecule | 1 | 0.8% |
Monitoring (medicine) | 1 | 0.8% |
Monitoring and evaluation | 1 | 0.8% |
Monoclonal B-cell lymphocytosis | 1 | 0.8% |
Monounsaturated fat | 1 | 0.8% |
Mood disorder | 1 | 0.8% |
Morphine | 1 | 0.8% |
Mortgage loan | 1 | 0.8% |
Motivation | 1 | 0.8% |
Motivational interviewing | 1 | 0.8% |
Muriel Bowser | 1 | 0.8% |
Music | 1 | 0.8% |
Myc | 1 | 0.8% |
Myocardial perfusion imaging | 1 | 0.8% |
National Health Interview Survey | 1 | 0.8% |
National School Lunch Act | 1 | 0.8% |
Needle and syringe programmes | 1 | 0.8% |
Needs assessment | 1 | 0.8% |
Nelfinavir | 1 | 0.8% |
Neonatal diabetes mellitus | 1 | 0.8% |
Neonatal intensive care unit | 1 | 0.8% |
Neoplasm | 1 | 0.8% |
Neural coding | 1 | 0.8% |
Neuromorphic engineering | 1 | 0.8% |
Neuroscience | 1 | 0.8% |
Neurotransmitter | 1 | 0.8% |
Newborn screening | 1 | 0.8% |
Nobel Prize in Chemistry | 1 | 0.8% |
Nobel Prize in Physiology or Medicine | 1 | 0.8% |
Non-heart-beating donation | 1 | 0.8% |
Nonsteroidal anti-inflammatory drug | 1 | 0.8% |
Norethisterone | 1 | 0.8% |
Norwegian language | 1 | 0.8% |
Number needed to treat | 1 | 0.8% |
Nursing home | 1 | 0.8% |
Obstructive sleep apnea | 1 | 0.8% |
Odor | 1 | 0.8% |
Office of Inspector General (United States) | 1 | 0.8% |
Omega-3 acid ethyl esters | 1 | 0.8% |
Oncology | 1 | 0.8% |
Opioid | 1 | 0.8% |
Optimism | 1 | 0.8% |
Optimism bias | 1 | 0.8% |
Organ donation | 1 | 0.8% |
Organ transplantation | 1 | 0.8% |
Organism | 1 | 0.8% |
Orthohantavirus | 1 | 0.8% |
Otitis media | 1 | 0.8% |
Otoacoustic emission | 1 | 0.8% |
Ovarian cyst | 1 | 0.8% |
Overweight | 1 | 0.8% |
Ovulation | 1 | 0.8% |
P-value | 1 | 0.8% |
PET-CT | 1 | 0.8% |
PHQ-9 | 1 | 0.8% |
Packed red blood cells | 1 | 0.8% |
Palpitations | 1 | 0.8% |
Pancreas | 1 | 0.8% |
Pancreatic islets | 1 | 0.8% |
Pancreatitis | 1 | 0.8% |
Pandemic H1N1/09 virus | 1 | 0.8% |
Paracetamol | 1 | 0.8% |
Paradigm | 1 | 0.8% |
Particulates | 1 | 0.8% |
Patient choice | 1 | 0.8% |
Patient navigators | 1 | 0.8% |
Patient portal | 1 | 0.8% |
Patient safety organization | 1 | 0.8% |
Patient-controlled analgesia | 1 | 0.8% |
Patient-reported outcome | 1 | 0.8% |
Peer support | 1 | 0.8% |
Pelvic inflammatory disease | 1 | 0.8% |
Per- and polyfluoroalkyl substances | 1 | 0.8% |
Percutaneous aortic valve replacement | 1 | 0.8% |
Perfusion | 1 | 0.8% |
Periodontology | 1 | 0.8% |
Perioperative | 1 | 0.8% |
Peritoneum | 1 | 0.8% |
Personal protective equipment | 1 | 0.8% |
Personalized medicine | 1 | 0.8% |
Pet | 1 | 0.8% |
Pharmacist | 1 | 0.8% |
Pharmacodynamics | 1 | 0.8% |
Pharmacokinetics | 1 | 0.8% |
Pharmacovigilance | 1 | 0.8% |
Pharmacy benefit management | 1 | 0.8% |
Pharmacy management system | 1 | 0.8% |
Pharyngitis | 1 | 0.8% |
Phenylketonuria | 1 | 0.8% |
Physical security | 1 | 0.8% |
Physics | 1 | 0.8% |
Pioglitazone | 1 | 0.8% |
Plant litter | 1 | 0.8% |
Plateletpheresis | 1 | 0.8% |
Polio | 1 | 0.8% |
Polycystic ovary syndrome | 1 | 0.8% |
Polyp (medicine) | 1 | 0.8% |
Population | 1 | 0.8% |
Population pyramid | 1 | 0.8% |
Positive and negative predictive values | 1 | 0.8% |
Post-thrombotic syndrome | 1 | 0.8% |
Postpartum period | 1 | 0.8% |
Potassium iodide | 1 | 0.8% |
Poverty in the United States | 1 | 0.8% |
Poverty reduction | 1 | 0.8% |
Prasugrel | 1 | 0.8% |
Pravastatin | 1 | 0.8% |
Pre- and post-test probability | 1 | 0.8% |
Prediction | 1 | 0.8% |
Pressure ulcer | 1 | 0.8% |
Prevention | 1 | 0.8% |
Primary healthcare | 1 | 0.8% |
Primer (molecular biology) | 1 | 0.8% |
Procalcitonin | 1 | 0.8% |
Professional certification | 1 | 0.8% |
Progestin | 1 | 0.8% |
Progestogen-only pill | 1 | 0.8% |
Program evaluation | 1 | 0.8% |
Project management | 1 | 0.8% |
Propranolol | 1 | 0.8% |
Prosthesis | 1 | 0.8% |
Proteinuria | 1 | 0.8% |
Prothrombin G20210A | 1 | 0.8% |
Provisioning (telecommunications) | 1 | 0.8% |
Psychological concepts | 1 | 0.8% |
Psychology | 1 | 0.8% |
Psychosocial | 1 | 0.8% |
Puberty | 1 | 0.8% |
Public Health Emergency of International Concern | 1 | 0.8% |
Public broadcasting | 1 | 0.8% |
Public finance | 1 | 0.8% |
Public hospital | 1 | 0.8% |
Public–private partnership | 1 | 0.8% |
Pulse | 1 | 0.8% |
Pulse oximetry | 1 | 0.8% |
Pulse pressure | 1 | 0.8% |
Pulse wave velocity | 1 | 0.8% |
Qualitative research | 1 | 0.8% |
Quality | 1 | 0.8% |
Quality of life | 1 | 0.8% |
Quantitative structure–activity relationship | 1 | 0.8% |
Quinolone antibiotic | 1 | 0.8% |
Rabbit haemorrhagic disease | 1 | 0.8% |
Race and ethnicity in the United States Census | 1 | 0.8% |
Radiation protection | 1 | 0.8% |
Radioactive contamination | 1 | 0.8% |
Radiographer | 1 | 0.8% |
Rat | 1 | 0.8% |
Receiver operating characteristic | 1 | 0.8% |
Recovery model | 1 | 0.8% |
Registration, Evaluation, Authorisation and Restriction of Chemicals | 1 | 0.8% |
Regulatory science | 1 | 0.8% |
Relevance | 1 | 0.8% |
Reliability (statistics) | 1 | 0.8% |
Religious Freedom Restoration Act | 1 | 0.8% |
Reproductive medicine | 1 | 0.8% |
Research methods | 1 | 0.8% |
Residency (medicine) | 1 | 0.8% |
Respiratory disease | 1 | 0.8% |
Respiratory diseases | 1 | 0.8% |
Responsive web design | 1 | 0.8% |
Reverse mortgage | 1 | 0.8% |
Revised National Tuberculosis Control Program | 1 | 0.8% |
Richter's transformation | 1 | 0.8% |
Road traffic safety | 1 | 0.8% |
Robert Guthrie | 1 | 0.8% |
Robotics | 1 | 0.8% |
Rosiglitazone | 1 | 0.8% |
Rotavirus | 1 | 0.8% |
Rural health clinic | 1 | 0.8% |
Ryan White | 1 | 0.8% |
Ryan White CARE Act | 1 | 0.8% |
SBAR | 1 | 0.8% |
SWOT analysis | 1 | 0.8% |
Safeguarding | 1 | 0.8% |
Saline (medicine) | 1 | 0.8% |
Scalability | 1 | 0.8% |
School meal | 1 | 0.8% |
School meal programs in the United States | 1 | 0.8% |
Science | 1 | 0.8% |
Science and technology | 1 | 0.8% |
Scientific control | 1 | 0.8% |
Scientific method | 1 | 0.8% |
Section 8 (housing) | 1 | 0.8% |
Sedentary lifestyle | 1 | 0.8% |
Select agent | 1 | 0.8% |
Selection bias | 1 | 0.8% |
Self-report study | 1 | 0.8% |
Sensor | 1 | 0.8% |
Sequence alignment | 1 | 0.8% |
Serosorting | 1 | 0.8% |
Severe combined immunodeficiency | 1 | 0.8% |
Sex-selective abortion | 1 | 0.8% |
Simon Stevens | 1 | 0.8% |
Single-photon emission computed tomography | 1 | 0.8% |
Sinusitis | 1 | 0.8% |
Sleep | 1 | 0.8% |
Social Security (United States) | 1 | 0.8% |
Social distancing | 1 | 0.8% |
Social policy | 1 | 0.8% |
Social stigma | 1 | 0.8% |
Sodium hypochlorite | 1 | 0.8% |
Soil | 1 | 0.8% |
Southern United States | 1 | 0.8% |
Special education | 1 | 0.8% |
Specification (technical standard) | 1 | 0.8% |
Spinal cord | 1 | 0.8% |
Sputum | 1 | 0.8% |
Standard deviation | 1 | 0.8% |
Standardized mortality ratio | 1 | 0.8% |
Statistical hypothesis testing | 1 | 0.8% |
Stem cell | 1 | 0.8% |
Stomach cancer | 1 | 0.8% |
Strategic management | 1 | 0.8% |
Strategic planning | 1 | 0.8% |
Strength training | 1 | 0.8% |
Stunted growth | 1 | 0.8% |
Substance use disorder | 1 | 0.8% |
Substantia nigra | 1 | 0.8% |
Suicide | 1 | 0.8% |
Sulfonylurea | 1 | 0.8% |
Summary Care Record | 1 | 0.8% |
Supercomputer | 1 | 0.8% |
Superficial thrombophlebitis | 1 | 0.8% |
Superficial vein thrombosis | 1 | 0.8% |
Supplemental Nutrition Assistance Program | 1 | 0.8% |
Suprachiasmatic nucleus | 1 | 0.8% |
Symptom | 1 | 0.8% |
Synapse | 1 | 0.8% |
System | 1 | 0.8% |
Systematics | 1 | 0.8% |
Systemic lupus erythematosus | 1 | 0.8% |
Systole | 1 | 0.8% |
TNF inhibitor | 1 | 0.8% |
TRIPS Agreement | 1 | 0.8% |
Tag (metadata) | 1 | 0.8% |
Takotsubo cardiomyopathy | 1 | 0.8% |
Targeted temperature management | 1 | 0.8% |
Telecare | 1 | 0.8% |
Temporary Assistance for Needy Families | 1 | 0.8% |
Theiler's disease | 1 | 0.8% |
Thiazide | 1 | 0.8% |
Thromboelastography | 1 | 0.8% |
Thromboelastometry | 1 | 0.8% |
Thrombolysis | 1 | 0.8% |
Thrombosis prevention | 1 | 0.8% |
Ticagrelor | 1 | 0.8% |
Till Roenneberg | 1 | 0.8% |
Tobacco control | 1 | 0.8% |
Tomography | 1 | 0.8% |
Tooth decay | 1 | 0.8% |
Top-down and bottom-up design | 1 | 0.8% |
Torsades de pointes | 1 | 0.8% |
Total fertility rate | 1 | 0.8% |
Toxicodynamics | 1 | 0.8% |
Toxicokinetics | 1 | 0.8% |
Toxicology | 1 | 0.8% |
Traditional medicine | 1 | 0.8% |
Transcriptomics technologies | 1 | 0.8% |
Transfusion-related acute lung injury | 1 | 0.8% |
Transitional care | 1 | 0.8% |
Translational research | 1 | 0.8% |
Transmission (medicine) | 1 | 0.8% |
Tumor necrosis factor alpha | 1 | 0.8% |
Tumors of the hematopoietic and lymphoid tissues | 1 | 0.8% |
Type 1 diabetes | 1 | 0.8% |
Type 26 frigate | 1 | 0.8% |
Type I and type II errors | 1 | 0.8% |
Ulcer (dermatology) | 1 | 0.8% |
Underweight | 1 | 0.8% |
Unemployment | 1 | 0.8% |
Unemployment benefits | 1 | 0.8% |
Unintended pregnancy | 1 | 0.8% |
United States budget sequestration in 2013 | 1 | 0.8% |
Universal neonatal hearing screening | 1 | 0.8% |
Unsaturated fat | 1 | 0.8% |
Unwarranted variation | 1 | 0.8% |
Urbanization | 1 | 0.8% |
Vaccine-preventable diseases | 1 | 0.8% |
Vaginal ring | 1 | 0.8% |
Valvular heart disease | 1 | 0.8% |
Varicose veins | 1 | 0.8% |
Venetoclax | 1 | 0.8% |
Ventilator-associated pneumonia | 1 | 0.8% |
Ventricle (heart) | 1 | 0.8% |
Viral hemorrhagic fever | 1 | 0.8% |
Vital statistics (government records) | 1 | 0.8% |
Volunteering | 1 | 0.8% |
Vulnerability (computing) | 1 | 0.8% |
WHO Framework Convention on Tobacco Control | 1 | 0.8% |
WIC | 1 | 0.8% |
Web of Science | 1 | 0.8% |
Website | 1 | 0.8% |
Weight management | 1 | 0.8% |
Whole grain | 1 | 0.8% |
Woman | 1 | 0.8% |
World population | 1 | 0.8% |
Zoning | 1 | 0.8% |
abs | rel | |
---|---|---|
Health | 145 | 90.1% |
Health care | 127 | 78.9% |
Medicine | 126 | 78.3% |
Health sciences | 114 | 70.8% |
Medical specialties | 94 | 58.4% |
Clinical medicine | 90 | 55.9% |
Risk | 66 | 41.0% |
Public health | 50 | 31.1% |
Human activities | 43 | 26.7% |
Clinical trial | 41 | 25.5% |
Diseases and disorders | 38 | 23.6% |
Hospital | 35 | 21.7% |
Evidence-based medicine | 33 | 20.5% |
Infection | 31 | 19.3% |
Medicare (United States) | 31 | 19.3% |
Health economics | 30 | 18.6% |
Disease | 29 | 18.0% |
Medication | 29 | 18.0% |
Meta-analysis | 29 | 18.0% |
Systematic review | 29 | 18.0% |
Randomized controlled trial | 28 | 17.4% |
Patient | 27 | 16.8% |
Preventive healthcare | 27 | 16.8% |
Cancer | 26 | 16.1% |
Epidemiology | 26 | 16.1% |
Medicaid | 25 | 15.5% |
Surgery | 22 | 13.7% |
Research | 21 | 13.0% |
Biology | 20 | 12.4% |
Medical diagnosis | 20 | 12.4% |
Emergency department | 19 | 11.8% |
Medical guideline | 19 | 11.8% |
Nursing | 19 | 11.8% |
Therapy | 19 | 11.8% |
Mental health | 18 | 11.2% |
Adherence (medicine) | 17 | 10.6% |
Health policy | 17 | 10.6% |
Antimicrobial resistance | 16 | 9.9% |
Immunology | 16 | 9.9% |
Sensitivity and specificity | 16 | 9.9% |
Evaluation | 15 | 9.3% |
Health informatics | 15 | 9.3% |
Health system | 15 | 9.3% |
Risk assessment | 15 | 9.3% |
Sustainability | 15 | 9.3% |
Coronary artery disease | 14 | 8.7% |
Life sciences | 14 | 8.7% |
Technology | 14 | 8.7% |
Cardiovascular disease | 13 | 8.1% |
Childbirth | 13 | 8.1% |
Chronic condition | 13 | 8.1% |
Electronic health record | 13 | 8.1% |
Governance | 13 | 8.1% |
Medical humanities | 13 | 8.1% |
Public sphere | 13 | 8.1% |
Stroke | 13 | 8.1% |
Vaccine | 13 | 8.1% |
Audit | 12 | 7.5% |
Caregiver | 12 | 7.5% |
Health professional | 12 | 7.5% |
Heart | 12 | 7.5% |
Hypertension | 12 | 7.5% |
Infectious diseases | 12 | 7.5% |
Innovation | 12 | 7.5% |
Myocardial infarction | 12 | 7.5% |
Pregnancy | 12 | 7.5% |
Primary care | 12 | 7.5% |
Accountable care organization | 11 | 6.8% |
Antibiotic | 11 | 6.8% |
Blinded experiment | 11 | 6.8% |
Blood pressure | 11 | 6.8% |
Employment | 11 | 6.8% |
General practitioner | 11 | 6.8% |
HIV/AIDS | 11 | 6.8% |
Microbiology | 11 | 6.8% |
Risk management | 11 | 6.8% |
Tuberculosis | 11 | 6.8% |
Virus | 11 | 6.8% |
Clinical commissioning group | 10 | 6.2% |
Confidence interval | 10 | 6.2% |
Economics of service industries | 10 | 6.2% |
Fee-for-service | 10 | 6.2% |
Government | 10 | 6.2% |
Hospital readmission | 10 | 6.2% |
Managed care | 10 | 6.2% |
Management | 10 | 6.2% |
Population health | 10 | 6.2% |
Screening (medicine) | 10 | 6.2% |
Adverse effect | 9 | 5.6% |
Business | 9 | 5.6% |
Cohort study | 9 | 5.6% |
Data analysis | 9 | 5.6% |
Genetics | 9 | 5.6% |
Hepatitis | 9 | 5.6% |
Major depressive disorder | 9 | 5.6% |
Medical imaging | 9 | 5.6% |
Neoplasms | 9 | 5.6% |
Obesity | 9 | 5.6% |
Patient safety | 9 | 5.6% |
Pay for performance (healthcare) | 9 | 5.6% |
Poverty | 9 | 5.6% |
Bias | 8 | 5.0% |
Biotechnology | 8 | 5.0% |
Breast cancer | 8 | 5.0% |
Cardiology | 8 | 5.0% |
Emergency management | 8 | 5.0% |
Health Insurance Portability and Accountability Act | 8 | 5.0% |
Health care quality | 8 | 5.0% |
Insurance | 8 | 5.0% |
Medical treatments | 8 | 5.0% |
Mental disorder | 8 | 5.0% |
Multi-drug-resistant tuberculosis | 8 | 5.0% |
Palliative care | 8 | 5.0% |
Pharmacy | 8 | 5.0% |
Physical therapy | 8 | 5.0% |
Privacy | 8 | 5.0% |
Psychiatry | 8 | 5.0% |
Quality-adjusted life year | 8 | 5.0% |
Statistics | 8 | 5.0% |
Tax | 8 | 5.0% |
Antibody | 7 | 4.3% |
Artificial intelligence | 7 | 4.3% |
Cardiovascular system | 7 | 4.3% |
Comorbidity | 7 | 4.3% |
Cost-effectiveness analysis | 7 | 4.3% |
Drug development | 7 | 4.3% |
Extensively drug-resistant tuberculosis | 7 | 4.3% |
Health insurance | 7 | 4.3% |
Human reproduction | 7 | 4.3% |
Influenza | 7 | 4.3% |
Leadership | 7 | 4.3% |
Low-density lipoprotein | 7 | 4.3% |
Medical device | 7 | 4.3% |
Physician | 7 | 4.3% |
Psychology | 7 | 4.3% |
Reporting bias | 7 | 4.3% |
Science | 7 | 4.3% |
Service industries | 7 | 4.3% |
Social work | 7 | 4.3% |
Agriculture | 6 | 3.7% |
Best practice | 6 | 3.7% |
Circulatory system | 6 | 3.7% |
DNA sequencing | 6 | 3.7% |
Decision-making | 6 | 3.7% |
Diabetes mellitus | 6 | 3.7% |
Emergency medical services | 6 | 3.7% |
Food | 6 | 3.7% |
Gene | 6 | 3.7% |
GeneXpert MTB/RIF | 6 | 3.7% |
Health information technology | 6 | 3.7% |
Intensive care medicine | 6 | 3.7% |
Intensive care unit | 6 | 3.7% |
Internal medicine | 6 | 3.7% |
Maternal health | 6 | 3.7% |
Miscarriage | 6 | 3.7% |
Organ transplantation | 6 | 3.7% |
Patient Protection and Affordable Care Act | 6 | 3.7% |
Pharmacology | 6 | 3.7% |
Pneumonia | 6 | 3.7% |
Politics | 6 | 3.7% |
Psychotherapy | 6 | 3.7% |
Safety | 6 | 3.7% |
Self-care | 6 | 3.7% |
Statin | 6 | 3.7% |
Transmission (medicine) | 6 | 3.7% |
Tuberculosis management | 6 | 3.7% |
Amniocentesis | 5 | 3.1% |
Anticoagulant | 5 | 3.1% |
Branches of science | 5 | 3.1% |
Chemotherapy | 5 | 3.1% |
Cholesterol | 5 | 3.1% |
Chronic kidney disease | 5 | 3.1% |
Cognition | 5 | 3.1% |
Cognitive science | 5 | 3.1% |
Confounding | 5 | 3.1% |
Contract | 5 | 3.1% |
Creative Commons license | 5 | 3.1% |
Disability | 5 | 3.1% |
Dose (biochemistry) | 5 | 3.1% |
Drugs | 5 | 3.1% |
Emergency | 5 | 3.1% |
Ethics | 5 | 3.1% |
Fetus | 5 | 3.1% |
Immune system | 5 | 3.1% |
Information | 5 | 3.1% |
Lung cancer | 5 | 3.1% |
Magnetic resonance imaging | 5 | 3.1% |
Measles | 5 | 3.1% |
Medical research | 5 | 3.1% |
Medicare dual eligible | 5 | 3.1% |
NHS foundation trust | 5 | 3.1% |
Ovarian cancer | 5 | 3.1% |
Pharmacovigilance | 5 | 3.1% |
Positive and negative predictive values | 5 | 3.1% |
Prenatal development | 5 | 3.1% |
Prenatal testing | 5 | 3.1% |
Preterm birth | 5 | 3.1% |
RTT | 5 | 3.1% |
Receiver operating characteristic | 5 | 3.1% |
Regulatory compliance | 5 | 3.1% |
Sampling (statistics) | 5 | 3.1% |
Sepsis | 5 | 3.1% |
Study heterogeneity | 5 | 3.1% |
Substance dependence | 5 | 3.1% |
Supplemental Nutrition Assistance Program | 5 | 3.1% |
Telehealth | 5 | 3.1% |
Thrombosis | 5 | 3.1% |
Vaccination | 5 | 3.1% |
Venous thrombosis | 5 | 3.1% |
Visual impairment | 5 | 3.1% |
Welfare | 5 | 3.1% |
Adjuvant therapy | 4 | 2.5% |
Angina | 4 | 2.5% |
Anti-diabetic medication | 4 | 2.5% |
Antiviral drug | 4 | 2.5% |
Aortic stenosis | 4 | 2.5% |
Aspirin | 4 | 2.5% |
Assay | 4 | 2.5% |
Atheroma | 4 | 2.5% |
BRCA1 | 4 | 2.5% |
Biopsy | 4 | 2.5% |
Birth defect | 4 | 2.5% |
Bundled payment | 4 | 2.5% |
Colorectal cancer | 4 | 2.5% |
Computer security | 4 | 2.5% |
Culture | 4 | 2.5% |
Deep vein thrombosis | 4 | 2.5% |
Down syndrome | 4 | 2.5% |
Education | 4 | 2.5% |
Effect size | 4 | 2.5% |
Emergency medicine | 4 | 2.5% |
Fraud | 4 | 2.5% |
Gene therapy | 4 | 2.5% |
Genetic engineering | 4 | 2.5% |
Genomics | 4 | 2.5% |
Glycated hemoglobin | 4 | 2.5% |
Heart failure | 4 | 2.5% |
Hepatitis C | 4 | 2.5% |
High-density lipoprotein | 4 | 2.5% |
Human | 4 | 2.5% |
Human pregnancy | 4 | 2.5% |
Internal control | 4 | 2.5% |
Intravenous therapy | 4 | 2.5% |
Kidney transplantation | 4 | 2.5% |
Latent tuberculosis | 4 | 2.5% |
MEDLINE | 4 | 2.5% |
MMR vaccine | 4 | 2.5% |
Medical prescription | 4 | 2.5% |
Medicare Advantage | 4 | 2.5% |
Metastasis | 4 | 2.5% |
Mutation | 4 | 2.5% |
Nervous system | 4 | 2.5% |
Neuroscience | 4 | 2.5% |
Nursing home | 4 | 2.5% |
Obstetric ultrasonography | 4 | 2.5% |
Obstetrics | 4 | 2.5% |
Opioid | 4 | 2.5% |
Organisms | 4 | 2.5% |
Pension | 4 | 2.5% |
Personalized medicine | 4 | 2.5% |
Placebo | 4 | 2.5% |
Precision medicine | 4 | 2.5% |
Publication bias | 4 | 2.5% |
Reference range | 4 | 2.5% |
Regression analysis | 4 | 2.5% |
Renal function | 4 | 2.5% |
Robot | 4 | 2.5% |
Rubella | 4 | 2.5% |
Self-driving car | 4 | 2.5% |
Shared decision-making in medicine | 4 | 2.5% |
Social programs | 4 | 2.5% |
Substance abuse | 4 | 2.5% |
Substance use disorder | 4 | 2.5% |
Sustainable Development Goals | 4 | 2.5% |
Vein | 4 | 2.5% |
Zika fever | 4 | 2.5% |
Adverse drug reaction | 3 | 1.9% |
Affordable Care Act | 3 | 1.9% |
Ageing | 3 | 1.9% |
Analytics | 3 | 1.9% |
Anesthesiology | 3 | 1.9% |
Angiography | 3 | 1.9% |
Angiology | 3 | 1.9% |
Antimicrobial | 3 | 1.9% |
Antimicrobial stewardship | 3 | 1.9% |
Aortic valve | 3 | 1.9% |
Artificial objects | 3 | 1.9% |
Atrial fibrillation | 3 | 1.9% |
Behavior | 3 | 1.9% |
Bioinformatics | 3 | 1.9% |
Biomarker | 3 | 1.9% |
Biosecurity | 3 | 1.9% |
Biosimilar | 3 | 1.9% |
Brain | 3 | 1.9% |
Budget | 3 | 1.9% |
Business intelligence | 3 | 1.9% |
CT scan | 3 | 1.9% |
Chemistry | 3 | 1.9% |
Chickenpox | 3 | 1.9% |
Chikungunya | 3 | 1.9% |
Children's Health Insurance Program | 3 | 1.9% |
Cochrane Library | 3 | 1.9% |
Committee | 3 | 1.9% |
Confidentiality | 3 | 1.9% |
Cornea | 3 | 1.9% |
Current Procedural Terminology | 3 | 1.9% |
Cyberwarfare | 3 | 1.9% |
DPT vaccine | 3 | 1.9% |
Deep learning | 3 | 1.9% |
Dementia | 3 | 1.9% |
Diagnosis-related group | 3 | 1.9% |
Dialysis | 3 | 1.9% |
Diet (nutrition) | 3 | 1.9% |
ELISA | 3 | 1.9% |
Earned income tax credit | 3 | 1.9% |
Economic growth | 3 | 1.9% |
Economics | 3 | 1.9% |
Economy | 3 | 1.9% |
Electrocardiography | 3 | 1.9% |
Electronic prescribing | 3 | 1.9% |
End-of-life care | 3 | 1.9% |
Epidemic | 3 | 1.9% |
Exercise | 3 | 1.9% |
Eye care | 3 | 1.9% |
Federal Information Technology Acquisition Reform Act | 3 | 1.9% |
Federally Qualified Health Center | 3 | 1.9% |
Fever | 3 | 1.9% |
Food safety | 3 | 1.9% |
Gene expression | 3 | 1.9% |
Genetically modified food | 3 | 1.9% |
Genetically modified organism | 3 | 1.9% |
Genome editing | 3 | 1.9% |
Geriatrics | 3 | 1.9% |
Gestational age | 3 | 1.9% |
Gestational diabetes | 3 | 1.9% |
HIV | 3 | 1.9% |
Healthcare | 3 | 1.9% |
Healthcare industry | 3 | 1.9% |
Hearing loss | 3 | 1.9% |
Heart valve | 3 | 1.9% |
Hemodialysis | 3 | 1.9% |
Hepatitis B | 3 | 1.9% |
Human papillomavirus infection | 3 | 1.9% |
Immunity (medical) | 3 | 1.9% |
Immunization | 3 | 1.9% |
Immunodeficiency | 3 | 1.9% |
Immunoglobulin G | 3 | 1.9% |
Incidence (epidemiology) | 3 | 1.9% |
Incremental cost-effectiveness ratio | 3 | 1.9% |
Infection control | 3 | 1.9% |
Influenza pandemic | 3 | 1.9% |
Influenza vaccine | 3 | 1.9% |
Institutional review board | 3 | 1.9% |
Intention-to-treat analysis | 3 | 1.9% |
International Statistical Classification of Diseases and Related Health Problems | 3 | 1.9% |
Interoperability | 3 | 1.9% |
Ischemia | 3 | 1.9% |
Low molecular weight heparin | 3 | 1.9% |
Mammography | 3 | 1.9% |
Mantoux test | 3 | 1.9% |
Maryland hospital payment system | 3 | 1.9% |
Medical home | 3 | 1.9% |
Medical record | 3 | 1.9% |
Medical specialty | 3 | 1.9% |
Medical ultrasound | 3 | 1.9% |
Medicare Sustainable Growth Rate | 3 | 1.9% |
Millennium Development Goals | 3 | 1.9% |
Missing data | 3 | 1.9% |
Motherhood | 3 | 1.9% |
Natalizumab | 3 | 1.9% |
Nature | 3 | 1.9% |
Neonatal intensive care unit | 3 | 1.9% |
Neurology | 3 | 1.9% |
Neuron | 3 | 1.9% |
Neutropenia | 3 | 1.9% |
Nuchal scan | 3 | 1.9% |
Nursing home care | 3 | 1.9% |
Old age | 3 | 1.9% |
Ophthalmology | 3 | 1.9% |
Opiate | 3 | 1.9% |
Opioid use disorder | 3 | 1.9% |
Organ donation | 3 | 1.9% |
Osteoporosis | 3 | 1.9% |
P-value | 3 | 1.9% |
Pancreatic cancer | 3 | 1.9% |
Pandemic | 3 | 1.9% |
Paramedic | 3 | 1.9% |
Pathology | 3 | 1.9% |
Pediatrics | 3 | 1.9% |
Personally identifiable information | 3 | 1.9% |
Pharmaceutical industry | 3 | 1.9% |
Pharmaceutical sciences | 3 | 1.9% |
Phases of clinical research | 3 | 1.9% |
Physical sciences | 3 | 1.9% |
Physiology | 3 | 1.9% |
Point of care | 3 | 1.9% |
Polymerase chain reaction | 3 | 1.9% |
Positron emission tomography | 3 | 1.9% |
Powered exoskeleton | 3 | 1.9% |
Prediction | 3 | 1.9% |
Prenatal care | 3 | 1.9% |
Prescription drug | 3 | 1.9% |
Project management | 3 | 1.9% |
Prostate cancer | 3 | 1.9% |
Prostate-specific antigen | 3 | 1.9% |
Protein | 3 | 1.9% |
Prothrombin time | 3 | 1.9% |
Public policy | 3 | 1.9% |
Public services | 3 | 1.9% |
Quality management | 3 | 1.9% |
Radiation therapy | 3 | 1.9% |
Recycling | 3 | 1.9% |
Residency (medicine) | 3 | 1.9% |
Retirement | 3 | 1.9% |
Rivaroxaban | 3 | 1.9% |
Robotics | 3 | 1.9% |
Sample size determination | 3 | 1.9% |
Scientific method | 3 | 1.9% |
Sea | 3 | 1.9% |
Sensitivity analysis | 3 | 1.9% |
Septic shock | 3 | 1.9% |
Simulation | 3 | 1.9% |
Smoking cessation | 3 | 1.9% |
Social media | 3 | 1.9% |
Spirometry | 3 | 1.9% |
Standard deviation | 3 | 1.9% |
Stillbirth | 3 | 1.9% |
Stomach cancer | 3 | 1.9% |
Sugar | 3 | 1.9% |
Surveillance | 3 | 1.9% |
Survey methodology | 3 | 1.9% |
Temporary Assistance for Needy Families | 3 | 1.9% |
Tobacco smoking | 3 | 1.9% |
Toxic Substances Control Act of 1976 | 3 | 1.9% |
Transient ischemic attack | 3 | 1.9% |
Transplant rejection | 3 | 1.9% |
Treatment of cancer | 3 | 1.9% |
Triage | 3 | 1.9% |
Tuberculosis diagnosis | 3 | 1.9% |
Type 2 diabetes | 3 | 1.9% |
Vertically transmitted infection | 3 | 1.9% |
Vision | 3 | 1.9% |
WIC | 3 | 1.9% |
Waste | 3 | 1.9% |
Women's health | 3 | 1.9% |
Acute coronary syndrome | 2 | 1.2% |
Adverse event | 2 | 1.2% |
Agreement on the Application of Sanitary and Phytosanitary Measures | 2 | 1.2% |
Air pollution | 2 | 1.2% |
Alirocumab | 2 | 1.2% |
Allergy | 2 | 1.2% |
Allocation concealment | 2 | 1.2% |
Alternative medicine | 2 | 1.2% |
Alzheimer's disease | 2 | 1.2% |
Anaphylaxis | 2 | 1.2% |
Animal diseases | 2 | 1.2% |
Antidepressant | 2 | 1.2% |
Antihypertensive drug | 2 | 1.2% |
Appropriation (law) | 2 | 1.2% |
Appropriations bill (United States) | 2 | 1.2% |
AquAdvantage salmon | 2 | 1.2% |
Arrhythmia | 2 | 1.2% |
Arthritis | 2 | 1.2% |
Artificial cardiac pacemaker | 2 | 1.2% |
Asthma | 2 | 1.2% |
Atherosclerosis | 2 | 1.2% |
Automation | 2 | 1.2% |
Automotive safety | 2 | 1.2% |
Avian influenza | 2 | 1.2% |
BRCA mutation | 2 | 1.2% |
Bacteremia | 2 | 1.2% |
Belmont Report | 2 | 1.2% |
Bendamustine | 2 | 1.2% |
Bevacizumab | 2 | 1.2% |
Biodiversity | 2 | 1.2% |
Biopharmaceutical | 2 | 1.2% |
Biosafety | 2 | 1.2% |
Bipolar disorder | 2 | 1.2% |
Birth weight | 2 | 1.2% |
Bleeding | 2 | 1.2% |
Blood | 2 | 1.2% |
Blood sugar level | 2 | 1.2% |
Blood transfusion | 2 | 1.2% |
Board of directors | 2 | 1.2% |
Body mass index | 2 | 1.2% |
Bond (finance) | 2 | 1.2% |
Bone density | 2 | 1.2% |
Bone fracture | 2 | 1.2% |
Bovine spongiform encephalopathy | 2 | 1.2% |
Brain tumor | 2 | 1.2% |
Breakthrough therapy | 2 | 1.2% |
Buprenorphine/naloxone | 2 | 1.2% |
C-reactive protein | 2 | 1.2% |
CRISPR | 2 | 1.2% |
Cancer screening | 2 | 1.2% |
Car | 2 | 1.2% |
Carbohydrate | 2 | 1.2% |
Carcinoma | 2 | 1.2% |
Cardiotocography | 2 | 1.2% |
Cardiovascular physiology | 2 | 1.2% |
Carotid artery stenosis | 2 | 1.2% |
Cas9 | 2 | 1.2% |
Case–control study | 2 | 1.2% |
Cataract | 2 | 1.2% |
Cataract surgery | 2 | 1.2% |
Cell (biology) | 2 | 1.2% |
Cell signaling | 2 | 1.2% |
Cell-free fetal DNA | 2 | 1.2% |
Census | 2 | 1.2% |
Central venous catheter | 2 | 1.2% |
Cervical cancer | 2 | 1.2% |
Childhood obesity | 2 | 1.2% |
Clinical research | 2 | 1.2% |
Coagulation | 2 | 1.2% |
Colonoscopy | 2 | 1.2% |
Community | 2 | 1.2% |
Community health | 2 | 1.2% |
Competence (human resources) | 2 | 1.2% |
Computerized physician order entry | 2 | 1.2% |
Contact lens | 2 | 1.2% |
Coronary circulation | 2 | 1.2% |
Cost–utility analysis | 2 | 1.2% |
Cytopathology | 2 | 1.2% |
DNA | 2 | 1.2% |
Dabigatran | 2 | 1.2% |
Daclizumab | 2 | 1.2% |
Data sharing | 2 | 1.2% |
Database | 2 | 1.2% |
Debt | 2 | 1.2% |
Declaration of Helsinki | 2 | 1.2% |
Deficit spending | 2 | 1.2% |
Delirium | 2 | 1.2% |
Dengue fever | 2 | 1.2% |
Developmental disability | 2 | 1.2% |
Diabetes mellitus type 2 | 2 | 1.2% |
Diphtheria vaccine | 2 | 1.2% |
Doppler ultrasonography | 2 | 1.2% |
Drink | 2 | 1.2% |
Dual-energy X-ray absorptiometry | 2 | 1.2% |
Ebola virus disease | 2 | 1.2% |
Echocardiography | 2 | 1.2% |
Efficient energy use | 2 | 1.2% |
Electronic benefit transfer | 2 | 1.2% |
Emerging technologies | 2 | 1.2% |
Endophthalmitis | 2 | 1.2% |
Energy storage | 2 | 1.2% |
Engineering | 2 | 1.2% |
Exhaust gas | 2 | 1.2% |
Ezetimibe | 2 | 1.2% |
Familial hypercholesterolemia | 2 | 1.2% |
Febrile neutropenia | 2 | 1.2% |
Fecal occult blood | 2 | 1.2% |
Federal Insecticide, Fungicide, and Rodenticide Act | 2 | 1.2% |
Five Year Forward View | 2 | 1.2% |
Flavivirus | 2 | 1.2% |
Fluconazole | 2 | 1.2% |
Food and drink | 2 | 1.2% |
Food security | 2 | 1.2% |
Framingham Risk Score | 2 | 1.2% |
Fuel cell | 2 | 1.2% |
Fund accounting | 2 | 1.2% |
Genome | 2 | 1.2% |
Glaucoma | 2 | 1.2% |
Global health | 2 | 1.2% |
Global warming | 2 | 1.2% |
Glyphosate | 2 | 1.2% |
Government budget balance | 2 | 1.2% |
Great Society programs | 2 | 1.2% |
Grocery store | 2 | 1.2% |
Gynaecology | 2 | 1.2% |
HER2/neu | 2 | 1.2% |
HPV vaccine | 2 | 1.2% |
Hand washing | 2 | 1.2% |
Health Information Technology for Economic and Clinical Health Act | 2 | 1.2% |
Health care in the United States | 2 | 1.2% |
Health care industry | 2 | 1.2% |
Health data | 2 | 1.2% |
Health research | 2 | 1.2% |
Health risk assessment | 2 | 1.2% |
Healthy diet | 2 | 1.2% |
Heart rate | 2 | 1.2% |
Hepatitis B vaccine | 2 | 1.2% |
Hepatocellular carcinoma | 2 | 1.2% |
Heroin | 2 | 1.2% |
Hib vaccine | 2 | 1.2% |
Hip fracture | 2 | 1.2% |
Hives | 2 | 1.2% |
Hormone replacement therapy | 2 | 1.2% |
Human brain | 2 | 1.2% |
Human diseases and disorders | 2 | 1.2% |
Human eye | 2 | 1.2% |
Human subject research | 2 | 1.2% |
Hygiene | 2 | 1.2% |
Hypercholesterolemia | 2 | 1.2% |
Hyperkalemia | 2 | 1.2% |
Hypoxia (medical) | 2 | 1.2% |
Hysterectomy | 2 | 1.2% |
Incentive | 2 | 1.2% |
Indigestion | 2 | 1.2% |
Influenza A virus subtype H7N9 | 2 | 1.2% |
Information privacy | 2 | 1.2% |
Information security | 2 | 1.2% |
Informed consent | 2 | 1.2% |
Intellectual property | 2 | 1.2% |
Intelligence | 2 | 1.2% |
Internal audit | 2 | 1.2% |
International Health Regulations | 2 | 1.2% |
Intraocular lens | 2 | 1.2% |
Intrauterine growth restriction | 2 | 1.2% |
Kinder Surprise | 2 | 1.2% |
Laboratory | 2 | 1.2% |
Laparoscopy | 2 | 1.2% |
Leukemia | 2 | 1.2% |
License | 2 | 1.2% |
Long-term care | 2 | 1.2% |
Low-carbon economy | 2 | 1.2% |
Lymphoma | 2 | 1.2% |
MHealth | 2 | 1.2% |
MMRV vaccine | 2 | 1.2% |
Malaria | 2 | 1.2% |
Malnutrition | 2 | 1.2% |
Mammalian pregnancy | 2 | 1.2% |
Materials science | 2 | 1.2% |
Maternal death | 2 | 1.2% |
Maternal–fetal medicine | 2 | 1.2% |
Maturity onset diabetes of the young | 2 | 1.2% |
Medi-Cal | 2 | 1.2% |
Medical history | 2 | 1.2% |
Medical test | 2 | 1.2% |
Medicare and Medicaid (United States) | 2 | 1.2% |
Medicare fraud | 2 | 1.2% |
Melanoma | 2 | 1.2% |
Meningitis | 2 | 1.2% |
Meningococcal vaccine | 2 | 1.2% |
Menopause | 2 | 1.2% |
Mergers and acquisitions | 2 | 1.2% |
Methicillin-resistant Staphylococcus aureus | 2 | 1.2% |
MicroRNA | 2 | 1.2% |
Middle East respiratory syndrome | 2 | 1.2% |
Milk | 2 | 1.2% |
Mitral valve | 2 | 1.2% |
Monitoring (medicine) | 2 | 1.2% |
Monitoring and evaluation | 2 | 1.2% |
Motivation | 2 | 1.2% |
Mumps | 2 | 1.2% |
Neonicotinoid | 2 | 1.2% |
Neoplasm | 2 | 1.2% |
Neuroimaging | 2 | 1.2% |
Nicotine | 2 | 1.2% |
Nicotine replacement therapy | 2 | 1.2% |
Nivolumab | 2 | 1.2% |
Non-executive director | 2 | 1.2% |
Nuremberg Code | 2 | 1.2% |
Nutrient | 2 | 1.2% |
Nutrition | 2 | 1.2% |
Occupational safety and health | 2 | 1.2% |
Office of Inspector General (United States) | 2 | 1.2% |
Outpatient surgery | 2 | 1.2% |
Oxaliplatin | 2 | 1.2% |
PCSK9 | 2 | 1.2% |
2 | 1.2% | |
Packaging and labeling | 2 | 1.2% |
Particulates | 2 | 1.2% |
Pathogen | 2 | 1.2% |
Patient education | 2 | 1.2% |
Patient participation | 2 | 1.2% |
Patient-reported outcome | 2 | 1.2% |
Pembrolizumab | 2 | 1.2% |
Percutaneous aortic valve replacement | 2 | 1.2% |
Perinatal mortality | 2 | 1.2% |
Peripheral artery disease | 2 | 1.2% |
Peritoneal dialysis | 2 | 1.2% |
Pesticide | 2 | 1.2% |
Phencyclidine | 2 | 1.2% |
Physical examination | 2 | 1.2% |
Physics | 2 | 1.2% |
Pleural effusion | 2 | 1.2% |
Pneumococcal conjugate vaccine | 2 | 1.2% |
Pneumococcal vaccine | 2 | 1.2% |
Point of sale | 2 | 1.2% |
Policy | 2 | 1.2% |
Polio vaccine | 2 | 1.2% |
Post-transplant lymphoproliferative disorder | 2 | 1.2% |
Potassium | 2 | 1.2% |
Pre-eclampsia | 2 | 1.2% |
Precautionary principle | 2 | 1.2% |
Prediabetes | 2 | 1.2% |
Prednisone | 2 | 1.2% |
President of the United States | 2 | 1.2% |
Preventive medicine | 2 | 1.2% |
Primary care physician | 2 | 1.2% |
Prior authorization | 2 | 1.2% |
Probiotic | 2 | 1.2% |
Procalcitonin | 2 | 1.2% |
Proteomics | 2 | 1.2% |
Protocol (science) | 2 | 1.2% |
Psychiatric and mental health nursing | 2 | 1.2% |
Psychiatric hospital | 2 | 1.2% |
Psychosocial | 2 | 1.2% |
Public health surveillance | 2 | 1.2% |
Pulse oximetry | 2 | 1.2% |
Pyrazinamide | 2 | 1.2% |
QT interval | 2 | 1.2% |
Qualitative research | 2 | 1.2% |
Radiology | 2 | 1.2% |
Raw milk | 2 | 1.2% |
Real estate appraisal | 2 | 1.2% |
Reconciliation (United States Congress) | 2 | 1.2% |
Refractive surgery | 2 | 1.2% |
Regulation of therapeutic goods | 2 | 1.2% |
Reliability (statistics) | 2 | 1.2% |
Renewable energy | 2 | 1.2% |
Retail | 2 | 1.2% |
Robust statistics | 2 | 1.2% |
Safe sex | 2 | 1.2% |
Salt | 2 | 1.2% |
Severe acute respiratory syndrome | 2 | 1.2% |
Sexual intercourse | 2 | 1.2% |
Sexually transmitted infection | 2 | 1.2% |
Shock (circulatory) | 2 | 1.2% |
Smoking | 2 | 1.2% |
Social Security Disability Insurance | 2 | 1.2% |
Social science | 2 | 1.2% |
Society | 2 | 1.2% |
Soft drink | 2 | 1.2% |
Specialty (medicine) | 2 | 1.2% |
Specification (technical standard) | 2 | 1.2% |
Stakeholder (corporate) | 2 | 1.2% |
Standard error | 2 | 1.2% |
Strategic management | 2 | 1.2% |
Summary Care Record | 2 | 1.2% |
Supplemental Security Income | 2 | 1.2% |
Sustainability and transformation plan | 2 | 1.2% |
Sweetened beverage | 2 | 1.2% |
SystmOne | 2 | 1.2% |
T cell | 2 | 1.2% |
Tetanus vaccine | 2 | 1.2% |
Thrombosis prevention | 2 | 1.2% |
Toxicity | 2 | 1.2% |
Traffic collision | 2 | 1.2% |
Trans fat | 2 | 1.2% |
Transatlantic Trade and Investment Partnership | 2 | 1.2% |
Transitional care | 2 | 1.2% |
Transmissible spongiform encephalopathy | 2 | 1.2% |
Transport | 2 | 1.2% |
Trastuzumab | 2 | 1.2% |
Umbilical cord | 2 | 1.2% |
Vaccines | 2 | 1.2% |
Vagina | 2 | 1.2% |
Valvular heart disease | 2 | 1.2% |
Variant Creutzfeldt–Jakob disease | 2 | 1.2% |
Varicella vaccine | 2 | 1.2% |
Vegetable | 2 | 1.2% |
Ventricle (heart) | 2 | 1.2% |
Veterinary medicine | 2 | 1.2% |
Viral vector | 2 | 1.2% |
Vulnerability (computing) | 2 | 1.2% |
Warfarin | 2 | 1.2% |
Water | 2 | 1.2% |
White blood cell | 2 | 1.2% |
Zidovudine | 2 | 1.2% |
Zika virus | 2 | 1.2% |
Zoonosis | 2 | 1.2% |
100,000 Genomes Project | 1 | 0.6% |
3D bioprinting | 1 | 0.6% |
3D printing | 1 | 0.6% |
APACHE II | 1 | 0.6% |
Abrupt climate change | 1 | 0.6% |
Acanthamoeba keratitis | 1 | 0.6% |
Accuracy and precision | 1 | 0.6% |
Active surveillance of prostate cancer | 1 | 0.6% |
Acupressure | 1 | 0.6% |
Acute promyelocytic leukemia | 1 | 0.6% |
Adalimumab | 1 | 0.6% |
Added sugar | 1 | 0.6% |
Aflatoxin M1 | 1 | 0.6% |
Agenda for Change | 1 | 0.6% |
Aid | 1 | 0.6% |
Airborne disease | 1 | 0.6% |
Alcoholism | 1 | 0.6% |
Alectinib | 1 | 0.6% |
Alemtuzumab | 1 | 0.6% |
Algorithmic trading | 1 | 0.6% |
All-payer rate setting | 1 | 0.6% |
Allele | 1 | 0.6% |
Allen Brain Atlas | 1 | 0.6% |
Alpha-fetoprotein | 1 | 0.6% |
Ambulance | 1 | 0.6% |
American Health Care Act of 2017 | 1 | 0.6% |
Americans with Disabilities Act of 1990 | 1 | 0.6% |
Aminoglycoside | 1 | 0.6% |
Amoxicillin | 1 | 0.6% |
Amphotericin B | 1 | 0.6% |
Amplicon | 1 | 0.6% |
Anaerobic digestion | 1 | 0.6% |
Analgesic | 1 | 0.6% |
Analysis | 1 | 0.6% |
Analytical chemistry | 1 | 0.6% |
Anaplastic lymphoma kinase | 1 | 0.6% |
Andrew Wakefield | 1 | 0.6% |
Anesthesia | 1 | 0.6% |
Aneuploidy | 1 | 0.6% |
Animal physiology | 1 | 0.6% |
Antarctica | 1 | 0.6% |
Anterior chamber of eyeball | 1 | 0.6% |
Anterior cruciate ligament | 1 | 0.6% |
Anterior cruciate ligament injury | 1 | 0.6% |
Anthracycline | 1 | 0.6% |
Anti-thymocyte globulin | 1 | 0.6% |
Anticipatory governance | 1 | 0.6% |
Antigen | 1 | 0.6% |
Antigen-presenting cell | 1 | 0.6% |
Antihistamine | 1 | 0.6% |
Antimalarial medication | 1 | 0.6% |
Antioxidant | 1 | 0.6% |
Antiplatelet drug | 1 | 0.6% |
Antivenom | 1 | 0.6% |
Anxiety disorder | 1 | 0.6% |
Aorta | 1 | 0.6% |
Aortic dissection | 1 | 0.6% |
Aortic insufficiency | 1 | 0.6% |
Aortic valve replacement | 1 | 0.6% |
Apixaban | 1 | 0.6% |
Appetite | 1 | 0.6% |
Applications of artificial intelligence | 1 | 0.6% |
Applied and interdisciplinary physics | 1 | 0.6% |
Applied mathematics | 1 | 0.6% |
Aquaculture | 1 | 0.6% |
Aqueous humour | 1 | 0.6% |
Archaeology | 1 | 0.6% |
Arsenic | 1 | 0.6% |
Arsenic trioxide | 1 | 0.6% |
Artificial general intelligence | 1 | 0.6% |
Artificial neural network | 1 | 0.6% |
Asepsis | 1 | 0.6% |
Aspergillosis | 1 | 0.6% |
Assessment of kidney function | 1 | 0.6% |
Assisted living | 1 | 0.6% |
Assisted reproductive technology | 1 | 0.6% |
Astigmatism | 1 | 0.6% |
Astronomy | 1 | 0.6% |
Atezolizumab | 1 | 0.6% |
Atmosphere | 1 | 0.6% |
Atmosphere of Earth | 1 | 0.6% |
Atrial septal defect | 1 | 0.6% |
Atrium (heart) | 1 | 0.6% |
Attention | 1 | 0.6% |
Attention deficit hyperactivity disorder | 1 | 0.6% |
Audit committee | 1 | 0.6% |
Autism | 1 | 0.6% |
Aztreonam | 1 | 0.6% |
BRCA2 | 1 | 0.6% |
Bacillus thuringiensis | 1 | 0.6% |
Back pain | 1 | 0.6% |
Background check | 1 | 0.6% |
Bacteria | 1 | 0.6% |
Bacterial vaginosis | 1 | 0.6% |
Bacteriuria | 1 | 0.6% |
BadgerCare | 1 | 0.6% |
Bank | 1 | 0.6% |
Barley | 1 | 0.6% |
Basal-cell carcinoma | 1 | 0.6% |
Bayley Scales of Infant Development | 1 | 0.6% |
Bedaquiline | 1 | 0.6% |
Behavior change method | 1 | 0.6% |
Behavioural sciences | 1 | 0.6% |
Benchmarking | 1 | 0.6% |
Benign tumor | 1 | 0.6% |
Beta blocker | 1 | 0.6% |
Beta distribution | 1 | 0.6% |
Beta-lactamase | 1 | 0.6% |
Big data | 1 | 0.6% |
Bill (law) | 1 | 0.6% |
Billericay | 1 | 0.6% |
Biochemistry | 1 | 0.6% |
Biodefense | 1 | 0.6% |
Bioethics | 1 | 0.6% |
Biogas | 1 | 0.6% |
Biomarker (medicine) | 1 | 0.6% |
Biomass | 1 | 0.6% |
Biomechanics | 1 | 0.6% |
Biomedical waste | 1 | 0.6% |
Bioprospecting | 1 | 0.6% |
Birds | 1 | 0.6% |
Birth | 1 | 0.6% |
Bladder cancer | 1 | 0.6% |
Blood cell | 1 | 0.6% |
Blood culture | 1 | 0.6% |
Blood donation | 1 | 0.6% |
Blood glucose monitoring | 1 | 0.6% |
Blood plasma | 1 | 0.6% |
Blood vessel | 1 | 0.6% |
Blood-borne disease | 1 | 0.6% |
Blue Brain Project | 1 | 0.6% |
Blumeria graminis | 1 | 0.6% |
Body fluids | 1 | 0.6% |
Bone | 1 | 0.6% |
Bone marrow | 1 | 0.6% |
Borough of Halton | 1 | 0.6% |
Boundary Waters Canoe Area Wilderness | 1 | 0.6% |
Brain mapping | 1 | 0.6% |
Brain metastasis | 1 | 0.6% |
Brain–computer interface | 1 | 0.6% |
Breast cancer screening | 1 | 0.6% |
Breastfeeding | 1 | 0.6% |
Breathing | 1 | 0.6% |
Brigatinib | 1 | 0.6% |
Bt cotton | 1 | 0.6% |
Buckling | 1 | 0.6% |
Burroughs MCP | 1 | 0.6% |
Business continuity planning | 1 | 0.6% |
Business ethics | 1 | 0.6% |
Business process | 1 | 0.6% |
CA-125 | 1 | 0.6% |
CBRN defense | 1 | 0.6% |
CD86 | 1 | 0.6% |
CE marking | 1 | 0.6% |
CHA2DS2–VASc score | 1 | 0.6% |
Caesarean section | 1 | 0.6% |
Calibration | 1 | 0.6% |
Cancer biomarker | 1 | 0.6% |
Cancer immunotherapy | 1 | 0.6% |
Cancer research | 1 | 0.6% |
Cancer staging | 1 | 0.6% |
Cancer survivor | 1 | 0.6% |
Cancer-related fatigue | 1 | 0.6% |
Candida (fungus) | 1 | 0.6% |
Candida albicans | 1 | 0.6% |
Candida glabrata | 1 | 0.6% |
Candidiasis | 1 | 0.6% |
Carbon | 1 | 0.6% |
Carbon capture and storage | 1 | 0.6% |
Carbon dioxide | 1 | 0.6% |
Carbon footprint | 1 | 0.6% |
Carbon nanotube | 1 | 0.6% |
Carbon neutrality | 1 | 0.6% |
Carcinoembryonic antigen | 1 | 0.6% |
Cardiac arrest | 1 | 0.6% |
Cardiac fibrosis | 1 | 0.6% |
Cardiac muscle | 1 | 0.6% |
Cardiac muscle cell | 1 | 0.6% |
Cardiac stress test | 1 | 0.6% |
Cardiac surgery | 1 | 0.6% |
Cardiopulmonary resuscitation | 1 | 0.6% |
Cardiothoracic surgery | 1 | 0.6% |
Cardiovascular diseases | 1 | 0.6% |
Carotid endarterectomy | 1 | 0.6% |
Carotid stenting | 1 | 0.6% |
Case management (US health system) | 1 | 0.6% |
Case management (US healthcare system) | 1 | 0.6% |
Case study | 1 | 0.6% |
Caspofungin | 1 | 0.6% |
Causes of death | 1 | 0.6% |
Ceftriaxone | 1 | 0.6% |
Cell adhesion | 1 | 0.6% |
Cell biology | 1 | 0.6% |
Cell membrane | 1 | 0.6% |
Cellular differentiation | 1 | 0.6% |
Cerebral hypoxia | 1 | 0.6% |
Cerebral palsy | 1 | 0.6% |
Ceritinib | 1 | 0.6% |
Certification | 1 | 0.6% |
Cetuximab | 1 | 0.6% |
Chairperson | 1 | 0.6% |
Charity care | 1 | 0.6% |
Chemical equilibrium | 1 | 0.6% |
Chemical product engineering | 1 | 0.6% |
Chemical substance | 1 | 0.6% |
Chemical warfare | 1 | 0.6% |
Cheshire | 1 | 0.6% |
Chest tube | 1 | 0.6% |
Chi-squared test | 1 | 0.6% |
Child Protective Services | 1 | 0.6% |
Childhood leukemia | 1 | 0.6% |
Chlamydia infection | 1 | 0.6% |
Chlorhexidine | 1 | 0.6% |
Choice | 1 | 0.6% |
Cholera | 1 | 0.6% |
Chronic fatigue syndrome | 1 | 0.6% |
Chronic obstructive pulmonary disease | 1 | 0.6% |
Chuck Schumer | 1 | 0.6% |
Cigarette | 1 | 0.6% |
Ciprofloxacin | 1 | 0.6% |
Circular economy | 1 | 0.6% |
City | 1 | 0.6% |
Climate | 1 | 0.6% |
Climate resilience | 1 | 0.6% |
Clinical decision support system | 1 | 0.6% |
Clinical psychology | 1 | 0.6% |
Clinical urine tests | 1 | 0.6% |
Clopidogrel | 1 | 0.6% |
Clostridioides difficile infection | 1 | 0.6% |
Clotrimazole | 1 | 0.6% |
Cloud | 1 | 0.6% |
Cloud computing | 1 | 0.6% |
Clozapine | 1 | 0.6% |
Coefficient of determination | 1 | 0.6% |
Coefficient of variation | 1 | 0.6% |
Cogeneration | 1 | 0.6% |
Cognitive behavioral therapy | 1 | 0.6% |
Cognitive rehabilitation therapy | 1 | 0.6% |
Colchester Community Stadium | 1 | 0.6% |
Collaboration | 1 | 0.6% |
Coma | 1 | 0.6% |
Common cold | 1 | 0.6% |
Community mental health service | 1 | 0.6% |
Company secretary | 1 | 0.6% |
Comparative genomic hybridization | 1 | 0.6% |
Complementary DNA | 1 | 0.6% |
Complex traits | 1 | 0.6% |
Compliance (psychology) | 1 | 0.6% |
Computer science | 1 | 0.6% |
Computer-assisted surgery | 1 | 0.6% |
Computing | 1 | 0.6% |
Concentrated solar power | 1 | 0.6% |
Concepts in metaphysics | 1 | 0.6% |
Condensed matter physics | 1 | 0.6% |
Confidential Information Protection and Statistical Efficiency Act | 1 | 0.6% |
Conflict of interest | 1 | 0.6% |
Confocal microscopy | 1 | 0.6% |
Congenital heart defect | 1 | 0.6% |
Congressional oversight | 1 | 0.6% |
Consciousness | 1 | 0.6% |
Consensus decision-making | 1 | 0.6% |
Continuum mechanics | 1 | 0.6% |
Convention on Biological Diversity | 1 | 0.6% |
Coral reef | 1 | 0.6% |
Corneal pachymetry | 1 | 0.6% |
Corneal transplantation | 1 | 0.6% |
Coronary catheterization | 1 | 0.6% |
Coronavirus | 1 | 0.6% |
Corporate governance | 1 | 0.6% |
Corporate social responsibility | 1 | 0.6% |
Correlation and dependence | 1 | 0.6% |
Cosmic dust | 1 | 0.6% |
Cotinine | 1 | 0.6% |
Counseling psychology | 1 | 0.6% |
Criminal record | 1 | 0.6% |
Crizotinib | 1 | 0.6% |
Crop rotation | 1 | 0.6% |
Croup | 1 | 0.6% |
Cure | 1 | 0.6% |
Cyberattack | 1 | 0.6% |
Cyst | 1 | 0.6% |
Cytokinesis | 1 | 0.6% |
DNA repair | 1 | 0.6% |
Da Vinci Surgical System | 1 | 0.6% |
Dansgaard–Oeschger event | 1 | 0.6% |
Dashboard (business) | 1 | 0.6% |
Data | 1 | 0.6% |
Data center | 1 | 0.6% |
Deafblindness | 1 | 0.6% |
Debridement (dental) | 1 | 0.6% |
Decentralization | 1 | 0.6% |
Deep sea mining | 1 | 0.6% |
Defined benefit pension plan | 1 | 0.6% |
Deforestation | 1 | 0.6% |
Deformation (engineering) | 1 | 0.6% |
Deformation (mechanics) | 1 | 0.6% |
Delphi method | 1 | 0.6% |
Demand response | 1 | 0.6% |
Dendritic cell | 1 | 0.6% |
Dengue vaccine | 1 | 0.6% |
Denosumab | 1 | 0.6% |
Dentistry | 1 | 0.6% |
Dependent and independent variables | 1 | 0.6% |
Dermatology Life Quality Index | 1 | 0.6% |
Designer baby | 1 | 0.6% |
Detection limit | 1 | 0.6% |
Developing country | 1 | 0.6% |
Diabetes | 1 | 0.6% |
Diabetes management | 1 | 0.6% |
Diabetes mellitus type 1 | 1 | 0.6% |
Diabetic retinopathy | 1 | 0.6% |
Diarrhea | 1 | 0.6% |
Diastole | 1 | 0.6% |
Dietary supplement | 1 | 0.6% |
Dieting | 1 | 0.6% |
Dietitian | 1 | 0.6% |
Diffuse large B-cell lymphoma | 1 | 0.6% |
Digital Revolution | 1 | 0.6% |
Digital health | 1 | 0.6% |
Discovery (law) | 1 | 0.6% |
Disease management (health) | 1 | 0.6% |
Disease surveillance | 1 | 0.6% |
Disorders of endocrine pancreas | 1 | 0.6% |
Disseminated intravascular coagulation | 1 | 0.6% |
Distributed generation | 1 | 0.6% |
Diwata-1 | 1 | 0.6% |
Diwata-2 | 1 | 0.6% |
Docetaxel | 1 | 0.6% |
Doctor of Philosophy | 1 | 0.6% |
Domperidone | 1 | 0.6% |
Drought tolerance | 1 | 0.6% |
Drug nomenclature | 1 | 0.6% |
Drug overdose | 1 | 0.6% |
Drug test | 1 | 0.6% |
Ductal carcinoma in situ | 1 | 0.6% |
EConsult | 1 | 0.6% |
EHealth | 1 | 0.6% |
Eagle River, Anchorage | 1 | 0.6% |
Early childhood intervention | 1 | 0.6% |
Earth | 1 | 0.6% |
Earth sciences | 1 | 0.6% |
Earth's magnetic field | 1 | 0.6% |
Ebola virus | 1 | 0.6% |
Ebola virus epidemic in Liberia | 1 | 0.6% |
Econometrics | 1 | 0.6% |
Economic development | 1 | 0.6% |
Economic model | 1 | 0.6% |
Edoxaban | 1 | 0.6% |
Educational assessment | 1 | 0.6% |
Egg allergy | 1 | 0.6% |
Ejection fraction | 1 | 0.6% |
Elasticity (physics) | 1 | 0.6% |
Electric battery | 1 | 0.6% |
Electric vehicle | 1 | 0.6% |
Electrical grid | 1 | 0.6% |
Electricity generation | 1 | 0.6% |
Electronic waste | 1 | 0.6% |
Electroporation | 1 | 0.6% |
Embolism | 1 | 0.6% |
Emergency medical technician | 1 | 0.6% |
Emotion | 1 | 0.6% |
Empowerment | 1 | 0.6% |
Endocrine, nutritional and metabolic diseases | 1 | 0.6% |
Endocytosis | 1 | 0.6% |
Endophyte | 1 | 0.6% |
Endoscopic mucosal resection | 1 | 0.6% |
Endoscopic submucosal dissection | 1 | 0.6% |
Endoscopy | 1 | 0.6% |
Energy | 1 | 0.6% |
Energy conservation | 1 | 0.6% |
Energy development | 1 | 0.6% |
Energy harvesting | 1 | 0.6% |
Enterovirus 71 | 1 | 0.6% |
Environmental enrichment | 1 | 0.6% |
Epidermal growth factor receptor | 1 | 0.6% |
Epigenetics | 1 | 0.6% |
Epigenomics | 1 | 0.6% |
Epilepsy | 1 | 0.6% |
Epstein–Barr virus | 1 | 0.6% |
Eradication of infectious diseases | 1 | 0.6% |
Erlotinib | 1 | 0.6% |
Errors and residuals | 1 | 0.6% |
Esophageal cancer | 1 | 0.6% |
Esophagus | 1 | 0.6% |
Essex | 1 | 0.6% |
Eusociality | 1 | 0.6% |
Evaluation methods | 1 | 0.6% |
Evaluation of binary classifiers | 1 | 0.6% |
Evidence-based policy | 1 | 0.6% |
Evidence-based practice | 1 | 0.6% |
Evolution | 1 | 0.6% |
Executive Order 13813 | 1 | 0.6% |
Exome sequencing | 1 | 0.6% |
Expenditures in the United States federal budget | 1 | 0.6% |
Expense | 1 | 0.6% |
Experiment | 1 | 0.6% |
Expert | 1 | 0.6% |
External auditor | 1 | 0.6% |
Eye | 1 | 0.6% |
FRAX | 1 | 0.6% |
Failure mode and effects analysis | 1 | 0.6% |
Fatigue | 1 | 0.6% |
Feeding tube | 1 | 0.6% |
Ferry | 1 | 0.6% |
Fetal movement | 1 | 0.6% |
Field Epidemiology Training Program | 1 | 0.6% |
Fifth disease | 1 | 0.6% |
Finance | 1 | 0.6% |
Financial audit | 1 | 0.6% |
Financial transaction | 1 | 0.6% |
Financialization | 1 | 0.6% |
Finasteride | 1 | 0.6% |
Fine-needle aspiration | 1 | 0.6% |
Finite element method | 1 | 0.6% |
Finite strain theory | 1 | 0.6% |
Fire | 1 | 0.6% |
Flu season | 1 | 0.6% |
Fluid dynamics | 1 | 0.6% |
Fluid replacement | 1 | 0.6% |
Fluorophore | 1 | 0.6% |
Focal segmental glomerulosclerosis | 1 | 0.6% |
Food waste | 1 | 0.6% |
Foodborne illness | 1 | 0.6% |
Formulary (pharmacy) | 1 | 0.6% |
Fracture | 1 | 0.6% |
Fracture mechanics | 1 | 0.6% |
Fracture toughness | 1 | 0.6% |
Frailty syndrome | 1 | 0.6% |
Fraud deterrence | 1 | 0.6% |
Fresh frozen plasma | 1 | 0.6% |
Fulvestrant | 1 | 0.6% |
Functional magnetic resonance imaging | 1 | 0.6% |
Funding of science | 1 | 0.6% |
Fundus photography | 1 | 0.6% |
Fungicide | 1 | 0.6% |
Fungus | 1 | 0.6% |
GLUT1 | 1 | 0.6% |
GOES-16 | 1 | 0.6% |
Gadolinium | 1 | 0.6% |
Gallbladder | 1 | 0.6% |
Gas | 1 | 0.6% |
Gastroesophageal reflux disease | 1 | 0.6% |
Gastrointestinal tract | 1 | 0.6% |
Gel | 1 | 0.6% |
Gene expression profiling | 1 | 0.6% |
Gene knockdown | 1 | 0.6% |
Gene regulatory network | 1 | 0.6% |
Gene silencing | 1 | 0.6% |
General practice | 1 | 0.6% |
Generalized linear model | 1 | 0.6% |
Genetic disorder | 1 | 0.6% |
Genetically modified crops | 1 | 0.6% |
Genital wart | 1 | 0.6% |
Genome-wide association study | 1 | 0.6% |
Genotype | 1 | 0.6% |
Geomagnetic reversal | 1 | 0.6% |
Gibbs free energy | 1 | 0.6% |
Global governance | 1 | 0.6% |
Globally Harmonized System of Classification and Labelling of Chemicals | 1 | 0.6% |
Glomerular filtration rate | 1 | 0.6% |
Glucose tolerance test | 1 | 0.6% |
Glut1 deficiency | 1 | 0.6% |
Glycemic index | 1 | 0.6% |
Glycomics | 1 | 0.6% |
Goal | 1 | 0.6% |
Going concern | 1 | 0.6% |
Gonorrhea | 1 | 0.6% |
Good laboratory practice | 1 | 0.6% |
Good manufacturing practice | 1 | 0.6% |
Granulocyte colony-stimulating factor | 1 | 0.6% |
Great Recession | 1 | 0.6% |
Greenhouse effect | 1 | 0.6% |
Greenhouse gas | 1 | 0.6% |
Greenland ice sheet | 1 | 0.6% |
Gross domestic product | 1 | 0.6% |
Group home | 1 | 0.6% |
HAL (robot) | 1 | 0.6% |
HBsAg | 1 | 0.6% |
Halton (UK Parliament constituency) | 1 | 0.6% |
Hand sanitizer | 1 | 0.6% |
Harm reduction | 1 | 0.6% |
Hazard | 1 | 0.6% |
Hazard ratio | 1 | 0.6% |
Head and neck cancer | 1 | 0.6% |
Health and Social Care Network | 1 | 0.6% |
Health and wellbeing board | 1 | 0.6% |
Health care prices in the United States | 1 | 0.6% |
Health information exchange | 1 | 0.6% |
Health insurance coverage in the United States | 1 | 0.6% |
Health insurance mandate | 1 | 0.6% |
Health maintenance organization | 1 | 0.6% |
Health promotion | 1 | 0.6% |
Health technology | 1 | 0.6% |
Healthcare reform | 1 | 0.6% |
Healthcare reform in the United States | 1 | 0.6% |
Heart arrhythmia | 1 | 0.6% |
Heart rate variability | 1 | 0.6% |
Hematology | 1 | 0.6% |
Hematopoietic stem cell transplantation | 1 | 0.6% |
Hemodynamics | 1 | 0.6% |
Hemorrhoid | 1 | 0.6% |
Hemothorax | 1 | 0.6% |
Hepatectomy | 1 | 0.6% |
Hepatic arterial infusion | 1 | 0.6% |
Hepatitis C virus | 1 | 0.6% |
Hereditary nonpolyposis colorectal cancer | 1 | 0.6% |
Heredity | 1 | 0.6% |
Herpes simplex | 1 | 0.6% |
High-grade serous carcinoma | 1 | 0.6% |
High-risk pregnancy | 1 | 0.6% |
Histamine | 1 | 0.6% |
Holocene | 1 | 0.6% |
Home care | 1 | 0.6% |
Home care in the United States | 1 | 0.6% |
Homelessness | 1 | 0.6% |
Hospice | 1 | 0.6% |
Hospital-acquired infection | 1 | 0.6% |
Human T-lymphotropic virus | 1 | 0.6% |
Human betaherpesvirus 5 | 1 | 0.6% |
Human chorionic gonadotropin | 1 | 0.6% |
Human development | 1 | 0.6% |
Human enhancement | 1 | 0.6% |
Human gastrointestinal microbiota | 1 | 0.6% |
Human genome | 1 | 0.6% |
Human nutrition | 1 | 0.6% |
Human resources | 1 | 0.6% |
Human respiratory syncytial virus | 1 | 0.6% |
Human–robot interaction | 1 | 0.6% |
Hydroxyethyl starch | 1 | 0.6% |
Hyperemesis gravidarum | 1 | 0.6% |
Hyperglycemia | 1 | 0.6% |
Hyperoxia | 1 | 0.6% |
Hyperspectral imaging | 1 | 0.6% |
Hypoglycemia | 1 | 0.6% |
Hypopnea | 1 | 0.6% |
Hypotension | 1 | 0.6% |
Hypothermia | 1 | 0.6% |
Hypothesis | 1 | 0.6% |
IRS tax forms | 1 | 0.6% |
Ice | 1 | 0.6% |
Ice age | 1 | 0.6% |
Ice core | 1 | 0.6% |
Identity document | 1 | 0.6% |
Idiopathic pulmonary fibrosis | 1 | 0.6% |
Immune thrombocytopenic purpura | 1 | 0.6% |
Immunoglobulin M | 1 | 0.6% |
Immunoglobulin therapy | 1 | 0.6% |
Immunosuppressive drug | 1 | 0.6% |
Immunotherapy | 1 | 0.6% |
Implantable cardioverter-defibrillator | 1 | 0.6% |
Incident management | 1 | 0.6% |
Index Medicus | 1 | 0.6% |
Individualized Education Program | 1 | 0.6% |
Industrial robot | 1 | 0.6% |
Infant | 1 | 0.6% |
Infection prevention and control | 1 | 0.6% |
Infectious mononucleosis | 1 | 0.6% |
Inflammation | 1 | 0.6% |
Inflation | 1 | 0.6% |
Infliximab | 1 | 0.6% |
Influenza A virus | 1 | 0.6% |
Influenza A virus subtype H1N1 | 1 | 0.6% |
Influenza A virus subtype H5N1 | 1 | 0.6% |
Influenza A virus subtype H5N8 | 1 | 0.6% |
Influenza A virus subtype H9N2 | 1 | 0.6% |
Information Sharing Environment | 1 | 0.6% |
Information science | 1 | 0.6% |
Information technology | 1 | 0.6% |
Inquiry | 1 | 0.6% |
Insight | 1 | 0.6% |
Insomnia | 1 | 0.6% |
Insulin | 1 | 0.6% |
Insulin (medication) | 1 | 0.6% |
Insulin glargine | 1 | 0.6% |
Insulin resistance | 1 | 0.6% |
Intellectual disability | 1 | 0.6% |
Intensive farming | 1 | 0.6% |
Inter-rater reliability | 1 | 0.6% |
Interdisciplinary subfields | 1 | 0.6% |
Intermediate Care Facilities for Individuals with Intellectual Disabilities | 1 | 0.6% |
Intima-media thickness | 1 | 0.6% |
Intraductal papillary mucinous neoplasm | 1 | 0.6% |
Intraocular pressure | 1 | 0.6% |
Intrauterine hypoxia | 1 | 0.6% |
Intraventricular hemorrhage | 1 | 0.6% |
Invasive carcinoma of no special type | 1 | 0.6% |
Inventory | 1 | 0.6% |
Invitation to tender | 1 | 0.6% |
Invoice | 1 | 0.6% |
Isolation (health care) | 1 | 0.6% |
Isoniazid | 1 | 0.6% |
Ivacaftor | 1 | 0.6% |
Janus kinase | 1 | 0.6% |
KRAS | 1 | 0.6% |
Keloid | 1 | 0.6% |
Kennel cough | 1 | 0.6% |
Kidney | 1 | 0.6% |
Kidney failure | 1 | 0.6% |
Klinefelter syndrome | 1 | 0.6% |
Labor induction | 1 | 0.6% |
Labour economics | 1 | 0.6% |
Lactobacillus | 1 | 0.6% |
Lactobacillus acidophilus | 1 | 0.6% |
Lactobacillus fermentum | 1 | 0.6% |
Lactobacillus rhamnosus | 1 | 0.6% |
Landscape | 1 | 0.6% |
Language interpretation | 1 | 0.6% |
Laryngeal cancer | 1 | 0.6% |
Lassa fever | 1 | 0.6% |
Lateral flow test | 1 | 0.6% |
Law | 1 | 0.6% |
Layoff | 1 | 0.6% |
Leaf spot | 1 | 0.6% |
Learning | 1 | 0.6% |
Lease | 1 | 0.6% |
Legal guardian | 1 | 0.6% |
Lenalidomide | 1 | 0.6% |
Lentiviral vector in gene therapy | 1 | 0.6% |
Lentivirus | 1 | 0.6% |
Levofloxacin | 1 | 0.6% |
Licensed professional counselor | 1 | 0.6% |
Licensure | 1 | 0.6% |
Light therapy | 1 | 0.6% |
Likelihood function | 1 | 0.6% |
Likelihood ratios in diagnostic testing | 1 | 0.6% |
Limited English proficiency | 1 | 0.6% |
Linezolid | 1 | 0.6% |
Linguistics | 1 | 0.6% |
Lipid bilayer | 1 | 0.6% |
Liver cancer | 1 | 0.6% |
Liver function tests | 1 | 0.6% |
Livestock | 1 | 0.6% |
Logistic regression | 1 | 0.6% |
Long QT syndrome | 1 | 0.6% |
Loratadine | 1 | 0.6% |
Low birth weight | 1 | 0.6% |
Low-carbohydrate diet | 1 | 0.6% |
Lower gastrointestinal series | 1 | 0.6% |
Lower respiratory tract infection | 1 | 0.6% |
Lymph node | 1 | 0.6% |
Lymphadenectomy | 1 | 0.6% |
Lymphatic system | 1 | 0.6% |
Lymphatic vessel | 1 | 0.6% |
MMR vaccine and autism | 1 | 0.6% |
MRI contrast agent | 1 | 0.6% |
MUC1 | 1 | 0.6% |
Machine learning | 1 | 0.6% |
Macula of retina | 1 | 0.6% |
Magnetic resonance angiography | 1 | 0.6% |
MammaPrint | 1 | 0.6% |
Management of HIV/AIDS | 1 | 0.6% |
Management of depression | 1 | 0.6% |
Mastectomy | 1 | 0.6% |
Materials | 1 | 0.6% |
Mathematics | 1 | 0.6% |
Matter | 1 | 0.6% |
Maximum likelihood estimation | 1 | 0.6% |
Mean | 1 | 0.6% |
Meat | 1 | 0.6% |
Mechanical engineering | 1 | 0.6% |
Mechanics | 1 | 0.6% |
Medical Subject Headings | 1 | 0.6% |
Medical emergencies | 1 | 0.6% |
Medical equipment | 1 | 0.6% |
Medical error | 1 | 0.6% |
Medical genetics | 1 | 0.6% |
Medical laboratory | 1 | 0.6% |
Medical privacy | 1 | 0.6% |
Medical school | 1 | 0.6% |
Medical statistics | 1 | 0.6% |
Mediterranean diet | 1 | 0.6% |
Mefloquine | 1 | 0.6% |
Memory | 1 | 0.6% |
Men who have sex with men | 1 | 0.6% |
Meningococcal disease | 1 | 0.6% |
Mental health counselor | 1 | 0.6% |
Mentorship | 1 | 0.6% |
Mesothelioma | 1 | 0.6% |
Metagenomics | 1 | 0.6% |
Metastatic liver disease | 1 | 0.6% |
Meteoroid | 1 | 0.6% |
Metformin | 1 | 0.6% |
Methotrexate | 1 | 0.6% |
Metropolitan area | 1 | 0.6% |
Metropolitan statistical area | 1 | 0.6% |
Microbiota | 1 | 0.6% |
Microcephaly | 1 | 0.6% |
Microplastics | 1 | 0.6% |
Microscopy | 1 | 0.6% |
Microstate (statistical mechanics) | 1 | 0.6% |
Microtia | 1 | 0.6% |
Middle East respiratory syndrome coronavirus | 1 | 0.6% |
Midwife | 1 | 0.6% |
Miliary tuberculosis | 1 | 0.6% |
Military robot | 1 | 0.6% |
Mind | 1 | 0.6% |
Mining | 1 | 0.6% |
Misinformation | 1 | 0.6% |
Mitral insufficiency | 1 | 0.6% |
Mobile app | 1 | 0.6% |
Model organism | 1 | 0.6% |
Molecular biology | 1 | 0.6% |
Molecular imaging | 1 | 0.6% |
Monoamine oxidase inhibitor | 1 | 0.6% |
Monoclonal antibody | 1 | 0.6% |
Monoclonal antibody therapy | 1 | 0.6% |
Mosquito | 1 | 0.6% |
Mosquito-borne disease | 1 | 0.6% |
Motivational interviewing | 1 | 0.6% |
Multidrug-resistant tuberculosis | 1 | 0.6% |
Multiple drug resistance | 1 | 0.6% |
Multiple myeloma | 1 | 0.6% |
Muromonab-CD3 | 1 | 0.6% |
Muscle | 1 | 0.6% |
Musculoskeletal system | 1 | 0.6% |
Mycobacterium bovis | 1 | 0.6% |
Mycobacterium tuberculosis | 1 | 0.6% |
Myelofibrosis | 1 | 0.6% |
Myocardial perfusion imaging | 1 | 0.6% |
Myogenesis | 1 | 0.6% |
NHS primary care trust | 1 | 0.6% |
NHS trust | 1 | 0.6% |
Nanocapsule | 1 | 0.6% |
Nanoparticle | 1 | 0.6% |
Nanotechnology | 1 | 0.6% |
Nasopharynx cancer | 1 | 0.6% |
National Insurance | 1 | 0.6% |
Native Americans in the United States | 1 | 0.6% |
Natural environment | 1 | 0.6% |
Natural killer cell | 1 | 0.6% |
Nausea | 1 | 0.6% |
Near-sightedness | 1 | 0.6% |
Necrotizing enterocolitis | 1 | 0.6% |
Neglected tropical diseases | 1 | 0.6% |
Neisseria meningitidis | 1 | 0.6% |
Nephrology | 1 | 0.6% |
Nephrotic syndrome | 1 | 0.6% |
Neural circuit | 1 | 0.6% |
Neuroenhancement | 1 | 0.6% |
Neuroethics | 1 | 0.6% |
Neurolaw | 1 | 0.6% |
Neurological disorder | 1 | 0.6% |
Neuromorphic engineering | 1 | 0.6% |
Neurostimulation | 1 | 0.6% |
Neurotechnology | 1 | 0.6% |
Nicotine dependence | 1 | 0.6% |
Noctilucent cloud | 1 | 0.6% |
Noise | 1 | 0.6% |
Noise pollution | 1 | 0.6% |
Non-communicable disease | 1 | 0.6% |
Non-governmental organization | 1 | 0.6% |
Non-small-cell lung carcinoma | 1 | 0.6% |
Notified body | 1 | 0.6% |
Nuclear power | 1 | 0.6% |
Nursing shortage | 1 | 0.6% |
Nutrition education | 1 | 0.6% |
Obstructive sleep apnea | 1 | 0.6% |
Occupational therapist | 1 | 0.6% |
Occupational therapy | 1 | 0.6% |
Ocean | 1 | 0.6% |
Oceanography | 1 | 0.6% |
Ocular tonometry | 1 | 0.6% |
Off-label use | 1 | 0.6% |
Oligonucleotide | 1 | 0.6% |
Oncology | 1 | 0.6% |
Oncology Care Model | 1 | 0.6% |
Online analytical processing | 1 | 0.6% |
Oophorectomy | 1 | 0.6% |
Open access | 1 | 0.6% |
Open data | 1 | 0.6% |
Open innovation | 1 | 0.6% |
Open science | 1 | 0.6% |
Optic disc | 1 | 0.6% |
Optic nerve | 1 | 0.6% |
Optical coherence tomography | 1 | 0.6% |
Optogenetics | 1 | 0.6% |
Optometry | 1 | 0.6% |
Oral sex | 1 | 0.6% |
Organ (anatomy) | 1 | 0.6% |
Organic farming | 1 | 0.6% |
Organic food | 1 | 0.6% |
Organization | 1 | 0.6% |
Organizational structure | 1 | 0.6% |
Organs (anatomy) | 1 | 0.6% |
Orphan drug | 1 | 0.6% |
Orthomyxoviridae | 1 | 0.6% |
Oseltamivir | 1 | 0.6% |
Outbreak | 1 | 0.6% |
Outcomes research | 1 | 0.6% |
Outlier | 1 | 0.6% |
Ovarian cyst | 1 | 0.6% |
Ovary | 1 | 0.6% |
Overhead (business) | 1 | 0.6% |
Oxygen saturation (medicine) | 1 | 0.6% |
Oxygen therapy | 1 | 0.6% |
Ozone depletion | 1 | 0.6% |
PUVA therapy | 1 | 0.6% |
Pain | 1 | 0.6% |
Paleoclimatology | 1 | 0.6% |
Pancreas | 1 | 0.6% |
Pancreatic mucinous cystic neoplasm | 1 | 0.6% |
Pandemic and All-Hazards Preparedness Act | 1 | 0.6% |
Panitumumab | 1 | 0.6% |
Paper | 1 | 0.6% |
Parameter | 1 | 0.6% |
Paratyphoid fever | 1 | 0.6% |
Parkinson's disease | 1 | 0.6% |
Paro (robot) | 1 | 0.6% |
Partition coefficient | 1 | 0.6% |
Passive smoking | 1 | 0.6% |
Patau syndrome | 1 | 0.6% |
Patent ductus arteriosus | 1 | 0.6% |
Patient portal | 1 | 0.6% |
Payment by Results | 1 | 0.6% |
Payroll tax | 1 | 0.6% |
Penile cancer | 1 | 0.6% |
Percutaneous coronary intervention | 1 | 0.6% |
Perennial plant | 1 | 0.6% |
Performance indicator | 1 | 0.6% |
Periodontology | 1 | 0.6% |
Perioperative | 1 | 0.6% |
Peripheral neuropathy | 1 | 0.6% |
Personal Responsibility and Work Opportunity Act | 1 | 0.6% |
Personal protective equipment | 1 | 0.6% |
Pet | 1 | 0.6% |
Phacoemulsification | 1 | 0.6% |
Pharmaceutical Benefits Scheme | 1 | 0.6% |
Pharmacogenetics | 1 | 0.6% |
Pharmacogenomics | 1 | 0.6% |
Pharmacokinetics | 1 | 0.6% |
Pharmacopoeia | 1 | 0.6% |
Pharyngitis | 1 | 0.6% |
Philanthropy | 1 | 0.6% |
Philosophy | 1 | 0.6% |
Photosynthesis | 1 | 0.6% |
Photovoltaics | 1 | 0.6% |
Physical chemistry | 1 | 0.6% |
Piperacillin | 1 | 0.6% |
Piperaquine | 1 | 0.6% |
Placebo-controlled study | 1 | 0.6% |
Placenta | 1 | 0.6% |
Placental abruption | 1 | 0.6% |
Plant breeding | 1 | 0.6% |
Plant disease resistance | 1 | 0.6% |
Plant-based diet | 1 | 0.6% |
Plate tectonics | 1 | 0.6% |
Platelet | 1 | 0.6% |
Platelet transfusion | 1 | 0.6% |
Plateletpheresis | 1 | 0.6% |
Pleural empyema | 1 | 0.6% |
Pneumothorax | 1 | 0.6% |
Podiatry | 1 | 0.6% |
Police officer | 1 | 0.6% |
Poliomyelitis | 1 | 0.6% |
Poliovirus | 1 | 0.6% |
Pollination | 1 | 0.6% |
Pollinator | 1 | 0.6% |
Pollution | 1 | 0.6% |
Polyclonal B cell response | 1 | 0.6% |
Polyclonal antibodies | 1 | 0.6% |
Polycythemia vera | 1 | 0.6% |
Polymer | 1 | 0.6% |
Polysomnography | 1 | 0.6% |
Positive airway pressure | 1 | 0.6% |
Post-exposure prophylaxis | 1 | 0.6% |
Postoperative nausea and vomiting | 1 | 0.6% |
Poultry | 1 | 0.6% |
Poverty threshold | 1 | 0.6% |
Powdery mildew | 1 | 0.6% |
Power (statistics) | 1 | 0.6% |
Power station | 1 | 0.6% |
Pre- and post-test probability | 1 | 0.6% |
Pre-existing condition | 1 | 0.6% |
Pre-exposure prophylaxis | 1 | 0.6% |
Prebiotic (nutrition) | 1 | 0.6% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 0.6% |
Premature ventricular contraction | 1 | 0.6% |
Prevention of HIV/AIDS | 1 | 0.6% |
Primer (molecular biology) | 1 | 0.6% |
Prison | 1 | 0.6% |
Privacy Act of 1974 | 1 | 0.6% |
Privacy engineering | 1 | 0.6% |
Privacy-enhancing technologies | 1 | 0.6% |
Problem solving | 1 | 0.6% |
Productivity | 1 | 0.6% |
Programmed cell death protein 1 | 1 | 0.6% |
Property tax | 1 | 0.6% |
Property tax in the United States | 1 | 0.6% |
Propfan | 1 | 0.6% |
Prophylactic salpingectomy | 1 | 0.6% |
Prostatitis | 1 | 0.6% |
Prosthesis | 1 | 0.6% |
Proxy (climate) | 1 | 0.6% |
Pseudoaneurysm | 1 | 0.6% |
Pseudoexfoliation syndrome | 1 | 0.6% |
Psoriasis | 1 | 0.6% |
Psoriatic arthritis | 1 | 0.6% |
Psychological concepts | 1 | 0.6% |
Psychological resilience | 1 | 0.6% |
Psychologist | 1 | 0.6% |
Public engagement | 1 | 0.6% |
Public health nursing | 1 | 0.6% |
Public participation (decision making) | 1 | 0.6% |
Pulmonary edema | 1 | 0.6% |
Pump | 1 | 0.6% |
Pyelonephritis | 1 | 0.6% |
Pyridoxine/doxylamine | 1 | 0.6% |
Quality and Outcomes Framework | 1 | 0.6% |
Quality assurance | 1 | 0.6% |
Quality management system | 1 | 0.6% |
Quality of life | 1 | 0.6% |
Quality of life (healthcare) | 1 | 0.6% |
QuantiFERON | 1 | 0.6% |
Quantitative computed tomography | 1 | 0.6% |
Quantitative research | 1 | 0.6% |
Quantitative structure–activity relationship | 1 | 0.6% |
Quantitative trait locus | 1 | 0.6% |
Quarantine | 1 | 0.6% |
Quinolone antibiotic | 1 | 0.6% |
RNA | 1 | 0.6% |
RNA interference | 1 | 0.6% |
ROS1 | 1 | 0.6% |
Race and ethnicity in the United States census | 1 | 0.6% |
Radiographer | 1 | 0.6% |
Ramucirumab | 1 | 0.6% |
Rare disease | 1 | 0.6% |
Rationalization (economics) | 1 | 0.6% |
Reactive oxygen species | 1 | 0.6% |
Real world evidence | 1 | 0.6% |
Rechargeable battery | 1 | 0.6% |
Reciprocity (social and political philosophy) | 1 | 0.6% |
Recombinant DNA | 1 | 0.6% |
Recovery model | 1 | 0.6% |
Recruitment | 1 | 0.6% |
Regenerative medicine | 1 | 0.6% |
Registered nurse | 1 | 0.6% |
Registration, Evaluation, Authorisation and Restriction of Chemicals | 1 | 0.6% |
Relative risk | 1 | 0.6% |
Representative elementary volume | 1 | 0.6% |
Reproducibility | 1 | 0.6% |
Reproductive health | 1 | 0.6% |
Research Excellence Framework | 1 | 0.6% |
Research methods | 1 | 0.6% |
Resource | 1 | 0.6% |
Respiratory disease | 1 | 0.6% |
Respiratory system | 1 | 0.6% |
Respiratory therapist | 1 | 0.6% |
Respiratory tract infection | 1 | 0.6% |
Resting state fMRI | 1 | 0.6% |
Retinopathy | 1 | 0.6% |
Retinopathy of prematurity | 1 | 0.6% |
Reuse | 1 | 0.6% |
Revenue | 1 | 0.6% |
Reverse transcriptase | 1 | 0.6% |
Revised Cardiac Risk Index | 1 | 0.6% |
Rheumatoid arthritis | 1 | 0.6% |
Rifampicin | 1 | 0.6% |
Rituximab | 1 | 0.6% |
Robert Mueller | 1 | 0.6% |
Robot ethics | 1 | 0.6% |
Robotic vacuum cleaner | 1 | 0.6% |
Roseola | 1 | 0.6% |
Rumor | 1 | 0.6% |
Runcorn | 1 | 0.6% |
Rural area | 1 | 0.6% |
Ruxolitinib | 1 | 0.6% |
SOFA score | 1 | 0.6% |
Salary | 1 | 0.6% |
Salmonella | 1 | 0.6% |
Satellite | 1 | 0.6% |
Scanning laser ophthalmoscopy | 1 | 0.6% |
Scarlet fever | 1 | 0.6% |
School voucher | 1 | 0.6% |
Scott Walker (politician) | 1 | 0.6% |
Screening, brief intervention and referral to treatment | 1 | 0.6% |
Sea ice | 1 | 0.6% |
Seat belt | 1 | 0.6% |
Section 8 (housing) | 1 | 0.6% |
Securitization | 1 | 0.6% |
Security clearance | 1 | 0.6% |
Security hacker | 1 | 0.6% |
Selection bias | 1 | 0.6% |
Self-control | 1 | 0.6% |
Sense (molecular biology) | 1 | 0.6% |
Senses | 1 | 0.6% |
Serology | 1 | 0.6% |
Services sector of the economy | 1 | 0.6% |
Sex robot | 1 | 0.6% |
Sexual anatomy | 1 | 0.6% |
Sharps waste | 1 | 0.6% |
Sheffield | 1 | 0.6% |
Sherry Turkle | 1 | 0.6% |
Shingles | 1 | 0.6% |
Shortness of breath | 1 | 0.6% |
Sick leave | 1 | 0.6% |
Sigmoidoscopy | 1 | 0.6% |
Single-nucleotide polymorphism | 1 | 0.6% |
Single-photon emission computed tomography | 1 | 0.6% |
Sintering | 1 | 0.6% |
Situation awareness | 1 | 0.6% |
Skin cancer | 1 | 0.6% |
Sleep | 1 | 0.6% |
Sleep and breathing | 1 | 0.6% |
Sleep apnea | 1 | 0.6% |
Sleep disorder | 1 | 0.6% |
Sleep medicine | 1 | 0.6% |
Slit lamp | 1 | 0.6% |
Small and medium-sized enterprises | 1 | 0.6% |
Small for gestational age | 1 | 0.6% |
Small interfering RNA | 1 | 0.6% |
Small satellite | 1 | 0.6% |
Smallpox | 1 | 0.6% |
Smokeless tobacco | 1 | 0.6% |
Smoking and pregnancy | 1 | 0.6% |
Smoking ban | 1 | 0.6% |
Snakebite | 1 | 0.6% |
Social determinants of health | 1 | 0.6% |
Social distancing | 1 | 0.6% |
Social policy | 1 | 0.6% |
Social robot | 1 | 0.6% |
Sofosbuvir | 1 | 0.6% |
Soft tissue | 1 | 0.6% |
Software | 1 | 0.6% |
Solar System | 1 | 0.6% |
Solar activity and climate | 1 | 0.6% |
Solar cell | 1 | 0.6% |
Solar energy | 1 | 0.6% |
Solar power | 1 | 0.6% |
Solar thermal energy | 1 | 0.6% |
Spectrum disorder | 1 | 0.6% |
Speech–language pathology | 1 | 0.6% |
Standardization | 1 | 0.6% |
State of emergency | 1 | 0.6% |
Statistical area (United States) | 1 | 0.6% |
Statistical hypothesis testing | 1 | 0.6% |
Statistical physics | 1 | 0.6% |
Stem cell | 1 | 0.6% |
Stomach | 1 | 0.6% |
Strategic National Stockpile | 1 | 0.6% |
Strategic planning | 1 | 0.6% |
Stress (mechanics) | 1 | 0.6% |
Stress hyperglycemia | 1 | 0.6% |
Stroke recovery | 1 | 0.6% |
Subacute sclerosing panencephalitis | 1 | 0.6% |
Succinate dehydrogenase | 1 | 0.6% |
Sulfonylurea | 1 | 0.6% |
Supraventricular tachycardia | 1 | 0.6% |
Surface science | 1 | 0.6% |
Surrogate endpoint | 1 | 0.6% |
Surveying | 1 | 0.6% |
Survival analysis | 1 | 0.6% |
Survival rate | 1 | 0.6% |
Symptom | 1 | 0.6% |
Synthetic biology | 1 | 0.6% |
Syphilis | 1 | 0.6% |
Systemic inflammatory response syndrome | 1 | 0.6% |
Systems biology | 1 | 0.6% |
TNM staging system | 1 | 0.6% |
Tachycardia | 1 | 0.6% |
Tax assessment | 1 | 0.6% |
Taxation in the United States | 1 | 0.6% |
Teacher | 1 | 0.6% |
Team | 1 | 0.6% |
Technetium-99m | 1 | 0.6% |
Technological convergence | 1 | 0.6% |
Technology assessment | 1 | 0.6% |
Telecommuting | 1 | 0.6% |
Telerobotics | 1 | 0.6% |
Thalidomide | 1 | 0.6% |
Thematic analysis | 1 | 0.6% |
Thermal power station | 1 | 0.6% |
Thermodynamic equilibrium | 1 | 0.6% |
Thiomersal | 1 | 0.6% |
Thoracentesis | 1 | 0.6% |
Thoracotomy | 1 | 0.6% |
Thorax (human anatomy) | 1 | 0.6% |
Thought | 1 | 0.6% |
Thrombocytopenia | 1 | 0.6% |
Thrombus | 1 | 0.6% |
Thymoglobulin | 1 | 0.6% |
Ticagrelor | 1 | 0.6% |
Ticlopidine | 1 | 0.6% |
Tigecycline | 1 | 0.6% |
Tipping points in the climate system | 1 | 0.6% |
Tissue engineering | 1 | 0.6% |
Tissue plasminogen activator | 1 | 0.6% |
Tissues (biology) | 1 | 0.6% |
Tooth enamel | 1 | 0.6% |
Torsades de pointes | 1 | 0.6% |
Total quality management | 1 | 0.6% |
Toxicology | 1 | 0.6% |
Traction force microscopy | 1 | 0.6% |
Trade-off | 1 | 0.6% |
Traditional knowledge | 1 | 0.6% |
Training | 1 | 0.6% |
Tramadol | 1 | 0.6% |
Transcranial direct-current stimulation | 1 | 0.6% |
Transcription (biology) | 1 | 0.6% |
Transcription activator-like effector nuclease | 1 | 0.6% |
Transfection | 1 | 0.6% |
Transfusion-related acute lung injury | 1 | 0.6% |
Translational research | 1 | 0.6% |
Transparency (behavior) | 1 | 0.6% |
Transposition of the great vessels | 1 | 0.6% |
Traumatic brain injury | 1 | 0.6% |
Tretinoin | 1 | 0.6% |
Trichomoniasis | 1 | 0.6% |
Triple test | 1 | 0.6% |
Troponin | 1 | 0.6% |
Trust (emotion) | 1 | 0.6% |
Trust law | 1 | 0.6% |
Tumors of the hematopoietic and lymphoid tissues | 1 | 0.6% |
Turner syndrome | 1 | 0.6% |
Twin-to-twin transfusion syndrome | 1 | 0.6% |
Type 1 diabetes | 1 | 0.6% |
Typhoid fever | 1 | 0.6% |
Ulcer (dermatology) | 1 | 0.6% |
Unanimous consent | 1 | 0.6% |
Uncanny valley | 1 | 0.6% |
Unemployment | 1 | 0.6% |
United States Code | 1 | 0.6% |
United States budget process | 1 | 0.6% |
United States elder law | 1 | 0.6% |
United States federal budget | 1 | 0.6% |
Unmanned aerial vehicle | 1 | 0.6% |
Unnecessary health care | 1 | 0.6% |
Urban agriculture | 1 | 0.6% |
Urgent care center | 1 | 0.6% |
Urgent care centers | 1 | 0.6% |
Urinary tract infection | 1 | 0.6% |
Urine | 1 | 0.6% |
Urine test strip | 1 | 0.6% |
Urology | 1 | 0.6% |
Usability | 1 | 0.6% |
Utility | 1 | 0.6% |
Utilization management | 1 | 0.6% |
Uttlesford | 1 | 0.6% |
Uveitis | 1 | 0.6% |
Vaccine-preventable diseases | 1 | 0.6% |
Vaginal discharge | 1 | 0.6% |
Vaginal flora | 1 | 0.6% |
Vaginal yeast infection | 1 | 0.6% |
Vaginitis | 1 | 0.6% |
Validity (statistics) | 1 | 0.6% |
Value (ethics) | 1 | 0.6% |
Vancomycin | 1 | 0.6% |
Vancomycin-resistant Enterococcus | 1 | 0.6% |
Vandetanib | 1 | 0.6% |
Varenicline | 1 | 0.6% |
Vector (epidemiology) | 1 | 0.6% |
Veganism | 1 | 0.6% |
Vegetarianism | 1 | 0.6% |
Venipuncture | 1 | 0.6% |
Ventricular hypertrophy | 1 | 0.6% |
Ventricular natriuretic peptide | 1 | 0.6% |
Verification and validation | 1 | 0.6% |
Vertebra | 1 | 0.6% |
Vertebral column | 1 | 0.6% |
Veterinary physician | 1 | 0.6% |
Video-assisted thoracoscopic surgery | 1 | 0.6% |
VigiBase | 1 | 0.6% |
Viral load | 1 | 0.6% |
Virtual colonoscopy | 1 | 0.6% |
Viruses | 1 | 0.6% |
Visual acuity | 1 | 0.6% |
Volume expander | 1 | 0.6% |
Warrington | 1 | 0.6% |
Watson (computer) | 1 | 0.6% |
Wearable technology | 1 | 0.6% |
Weather satellite | 1 | 0.6% |
Web of Science | 1 | 0.6% |
Weight loss | 1 | 0.6% |
Welfare economics | 1 | 0.6% |
Well-being | 1 | 0.6% |
Whole genome sequencing | 1 | 0.6% |
Whooping cough | 1 | 0.6% |
Wi-Fi | 1 | 0.6% |
Wildfire | 1 | 0.6% |
Workplace wellness | 1 | 0.6% |
Wound | 1 | 0.6% |
XYY syndrome | 1 | 0.6% |
Yellow fever | 1 | 0.6% |
Zinc finger nuclease | 1 | 0.6% |
Zygosity | 1 | 0.6% |
Zymoseptoria tritici | 1 | 0.6% |
abs | rel | |
---|---|---|
Health | 171 | 94.0% |
Medicine | 155 | 85.2% |
Health care | 151 | 83.0% |
Health sciences | 140 | 76.9% |
Medical specialties | 121 | 66.5% |
Clinical medicine | 111 | 61.0% |
Risk | 69 | 37.9% |
Public health | 64 | 35.2% |
Disease | 48 | 26.4% |
Human activities | 45 | 24.7% |
Patient | 45 | 24.7% |
Diseases and disorders | 44 | 24.2% |
Epidemiology | 43 | 23.6% |
Infection | 43 | 23.6% |
Hospital | 40 | 22.0% |
Adherence (medicine) | 35 | 19.2% |
Preventive healthcare | 35 | 19.2% |
Evidence-based medicine | 33 | 18.1% |
Clinical trial | 31 | 17.0% |
Health economics | 31 | 17.0% |
Randomized controlled trial | 31 | 17.0% |
Medicare (United States) | 29 | 15.9% |
Nursing | 29 | 15.9% |
Research | 29 | 15.9% |
Medication | 28 | 15.4% |
Surgery | 27 | 14.8% |
Medical diagnosis | 26 | 14.3% |
Meta-analysis | 26 | 14.3% |
Emergency department | 25 | 13.7% |
Systematic review | 25 | 13.7% |
Therapy | 24 | 13.2% |
Cancer | 23 | 12.6% |
Chronic condition | 22 | 12.1% |
Medicaid | 22 | 12.1% |
Electronic health record | 21 | 11.5% |
Sensitivity and specificity | 20 | 11.0% |
Sustainability | 20 | 11.0% |
Health policy | 19 | 10.4% |
Mental health | 19 | 10.4% |
HIV/AIDS | 18 | 9.9% |
Health system | 18 | 9.9% |
Patient safety | 18 | 9.9% |
Infectious diseases | 17 | 9.3% |
Pharmacy | 16 | 8.8% |
Screening (medicine) | 16 | 8.8% |
Tuberculosis | 16 | 8.8% |
Blinded experiment | 15 | 8.2% |
Childbirth | 15 | 8.2% |
Evaluation | 15 | 8.2% |
Governance | 15 | 8.2% |
Health care quality | 15 | 8.2% |
Hospital readmission | 15 | 8.2% |
Biology | 14 | 7.7% |
Confidence interval | 14 | 7.7% |
Hypertension | 14 | 7.7% |
Risk management | 14 | 7.7% |
Business | 13 | 7.1% |
Data analysis | 13 | 7.1% |
General practitioner | 13 | 7.1% |
Health informatics | 13 | 7.1% |
Heart | 13 | 7.1% |
Immunology | 13 | 7.1% |
Life sciences | 13 | 7.1% |
Medical imaging | 13 | 7.1% |
Mental disorder | 13 | 7.1% |
Accountable care organization | 12 | 6.6% |
Antimicrobial resistance | 12 | 6.6% |
Cardiovascular disease | 12 | 6.6% |
Clinical commissioning group | 12 | 6.6% |
Health professional | 12 | 6.6% |
Pregnancy | 12 | 6.6% |
Primary care | 12 | 6.6% |
Risk assessment | 12 | 6.6% |
Safety | 12 | 6.6% |
Sexually transmitted infection | 12 | 6.6% |
Audit | 11 | 6.0% |
Cohort study | 11 | 6.0% |
Fee-for-service | 11 | 6.0% |
Hepatitis | 11 | 6.0% |
Innovation | 11 | 6.0% |
Medical guideline | 11 | 6.0% |
Medical humanities | 11 | 6.0% |
Statistics | 11 | 6.0% |
Blood pressure | 10 | 5.5% |
Cardiovascular system | 10 | 5.5% |
Caregiver | 10 | 5.5% |
Management of HIV/AIDS | 10 | 5.5% |
Myocardial infarction | 10 | 5.5% |
Obesity | 10 | 5.5% |
Physical therapy | 10 | 5.5% |
Receiver operating characteristic | 10 | 5.5% |
Antibiotic | 9 | 4.9% |
Behavior | 9 | 4.9% |
Economics of service industries | 9 | 4.9% |
Exercise | 9 | 4.9% |
Influenza | 9 | 4.9% |
Information | 9 | 4.9% |
Microbiology | 9 | 4.9% |
Occupational safety and health | 9 | 4.9% |
Pay for performance (healthcare) | 9 | 4.9% |
Technology | 9 | 4.9% |
Tuberculosis management | 9 | 4.9% |
Air pollution | 8 | 4.4% |
Biomarker | 8 | 4.4% |
Breast cancer | 8 | 4.4% |
CT scan | 8 | 4.4% |
Dementia | 8 | 4.4% |
Diagnosis of HIV/AIDS | 8 | 4.4% |
Employment | 8 | 4.4% |
Health insurance | 8 | 4.4% |
Insurance | 8 | 4.4% |
Leadership | 8 | 4.4% |
Major depressive disorder | 8 | 4.4% |
Managed care | 8 | 4.4% |
Management | 8 | 4.4% |
Percutaneous coronary intervention | 8 | 4.4% |
Population health | 8 | 4.4% |
Public sphere | 8 | 4.4% |
Science | 8 | 4.4% |
Sepsis | 8 | 4.4% |
Stroke | 8 | 4.4% |
Substance abuse | 8 | 4.4% |
Transmission (medicine) | 8 | 4.4% |
Vaccination | 8 | 4.4% |
Vaccine | 8 | 4.4% |
Adverse effect | 7 | 3.8% |
Bias | 7 | 3.8% |
Bisphosphonate | 7 | 3.8% |
Chemotherapy | 7 | 3.8% |
Colorectal cancer | 7 | 3.8% |
Community health | 7 | 3.8% |
Current Procedural Terminology | 7 | 3.8% |
Dose (biochemistry) | 7 | 3.8% |
Dual-energy X-ray absorptiometry | 7 | 3.8% |
Education | 7 | 3.8% |
Emergency management | 7 | 3.8% |
Heart failure | 7 | 3.8% |
Infection prevention and control | 7 | 3.8% |
Intensive care unit | 7 | 3.8% |
Medical record | 7 | 3.8% |
Midwife | 7 | 3.8% |
Multi-drug-resistant tuberculosis | 7 | 3.8% |
Neoplasms | 7 | 3.8% |
Osteoporosis | 7 | 3.8% |
Pneumonia | 7 | 3.8% |
Prescription drug | 7 | 3.8% |
Toxicity | 7 | 3.8% |
Biotechnology | 6 | 3.3% |
Bone density | 6 | 3.3% |
Cardiology | 6 | 3.3% |
Chronic kidney disease | 6 | 3.3% |
Chronic obstructive pulmonary disease | 6 | 3.3% |
Clinical governance | 6 | 3.3% |
Comorbidity | 6 | 3.3% |
Cost-effectiveness analysis | 6 | 3.3% |
Food | 6 | 3.3% |
Glycated hemoglobin | 6 | 3.3% |
Hazard | 6 | 3.3% |
Health information technology | 6 | 3.3% |
High-density lipoprotein | 6 | 3.3% |
Intravenous therapy | 6 | 3.3% |
Laboratory | 6 | 3.3% |
Magnetic resonance imaging | 6 | 3.3% |
Medical home | 6 | 3.3% |
Men who have sex with men | 6 | 3.3% |
Methicillin-resistant Staphylococcus aureus | 6 | 3.3% |
Patient Protection and Affordable Care Act | 6 | 3.3% |
Patient participation | 6 | 3.3% |
Performance indicator | 6 | 3.3% |
Pharmacology | 6 | 3.3% |
Physician | 6 | 3.3% |
Positive and negative predictive values | 6 | 3.3% |
Poverty | 6 | 3.3% |
Prostate cancer | 6 | 3.3% |
Psychiatry | 6 | 3.3% |
Quality-adjusted life year | 6 | 3.3% |
Regulatory compliance | 6 | 3.3% |
Renal function | 6 | 3.3% |
Sampling (statistics) | 6 | 3.3% |
Self-care | 6 | 3.3% |
Shortness of breath | 6 | 3.3% |
Sustainable Development Goals | 6 | 3.3% |
Telehealth | 6 | 3.3% |
Virus | 6 | 3.3% |
Vitamin D | 6 | 3.3% |
Adjuvant therapy | 5 | 2.7% |
Alzheimer's disease | 5 | 2.7% |
Anticoagulant | 5 | 2.7% |
Antiviral drug | 5 | 2.7% |
Apprenticeship | 5 | 2.7% |
Asthma | 5 | 2.7% |
Atrial fibrillation | 5 | 2.7% |
Benchmarking | 5 | 2.7% |
Best practice | 5 | 2.7% |
Bipolar disorder | 5 | 2.7% |
Bone | 5 | 2.7% |
Bone fracture | 5 | 2.7% |
Communication | 5 | 2.7% |
Creative Commons license | 5 | 2.7% |
DNA sequencing | 5 | 2.7% |
Diabetes | 5 | 2.7% |
Drugs | 5 | 2.7% |
Government | 5 | 2.7% |
Health equity | 5 | 2.7% |
Hepatitis C | 5 | 2.7% |
Human reproduction | 5 | 2.7% |
Incentive | 5 | 2.7% |
Internal control | 5 | 2.7% |
International Statistical Classification of Diseases and Related Health Problems | 5 | 2.7% |
Kidney | 5 | 2.7% |
Kidney failure | 5 | 2.7% |
Low-density lipoprotein | 5 | 2.7% |
Machine learning | 5 | 2.7% |
Medical prescription | 5 | 2.7% |
Medical test | 5 | 2.7% |
Nursing home care | 5 | 2.7% |
Opioid | 5 | 2.7% |
Osteopenia | 5 | 2.7% |
Pediatrics | 5 | 2.7% |
Personal protective equipment | 5 | 2.7% |
Pesticide | 5 | 2.7% |
Policy | 5 | 2.7% |
Polymerase chain reaction | 5 | 2.7% |
Privacy | 5 | 2.7% |
Publication bias | 5 | 2.7% |
Radiology | 5 | 2.7% |
Reporting bias | 5 | 2.7% |
Sensitivity analysis | 5 | 2.7% |
Service industries | 5 | 2.7% |
Substance use disorder | 5 | 2.7% |
Surveillance | 5 | 2.7% |
Survey methodology | 5 | 2.7% |
Urinary tract infection | 5 | 2.7% |
Vagina | 5 | 2.7% |
Venous thrombosis | 5 | 2.7% |
3D printing | 4 | 2.2% |
Adolescence | 4 | 2.2% |
Biopsy | 4 | 2.2% |
Bloodstream infections | 4 | 2.2% |
Board of directors | 4 | 2.2% |
Breastfeeding and HIV | 4 | 2.2% |
CD4 | 4 | 2.2% |
Cervical cancer | 4 | 2.2% |
Chief executive officer | 4 | 2.2% |
Child | 4 | 2.2% |
Cirrhosis | 4 | 2.2% |
Clinic | 4 | 2.2% |
Colonoscopy | 4 | 2.2% |
Community | 4 | 2.2% |
Contract | 4 | 2.2% |
Control chart | 4 | 2.2% |
Coronary artery disease | 4 | 2.2% |
Cost–utility analysis | 4 | 2.2% |
Dentistry | 4 | 2.2% |
Diagnosis-related group | 4 | 2.2% |
Directly observed treatment, short-course | 4 | 2.2% |
Fecal occult blood | 4 | 2.2% |
Finance | 4 | 2.2% |
GeneXpert MTB/RIF | 4 | 2.2% |
Genetics | 4 | 2.2% |
Goal | 4 | 2.2% |
Gonorrhea | 4 | 2.2% |
Government budget balance | 4 | 2.2% |
HER2/neu | 4 | 2.2% |
Healthcare industry | 4 | 2.2% |
Hematuria | 4 | 2.2% |
Hepatitis B | 4 | 2.2% |
Hepatocellular carcinoma | 4 | 2.2% |
Implantable cardioverter-defibrillator | 4 | 2.2% |
Influenza-like illness | 4 | 2.2% |
Information technology | 4 | 2.2% |
Intensive care medicine | 4 | 2.2% |
Maternal death | 4 | 2.2% |
Medical Subject Headings | 4 | 2.2% |
Menopause | 4 | 2.2% |
Metastasis | 4 | 2.2% |
Midwifery | 4 | 2.2% |
Nanotechnology | 4 | 2.2% |
Office of Inspector General (United States) | 4 | 2.2% |
Opioid use disorder | 4 | 2.2% |
Pediatric nursing | 4 | 2.2% |
Pharmacist | 4 | 2.2% |
Placebo | 4 | 2.2% |
Post-exposure prophylaxis | 4 | 2.2% |
Prediction | 4 | 2.2% |
Pressure ulcer | 4 | 2.2% |
Preterm birth | 4 | 2.2% |
Public services | 4 | 2.2% |
Qualitative research | 4 | 2.2% |
Raloxifene | 4 | 2.2% |
Regression analysis | 4 | 2.2% |
Scientific method | 4 | 2.2% |
Simulation | 4 | 2.2% |
Social media | 4 | 2.2% |
Social work | 4 | 2.2% |
Specialty (medicine) | 4 | 2.2% |
Surety | 4 | 2.2% |
Teriparatide | 4 | 2.2% |
Thrombosis | 4 | 2.2% |
Tissue engineering | 4 | 2.2% |
Toxicology | 4 | 2.2% |
Transitional care | 4 | 2.2% |
Urology | 4 | 2.2% |
Vein | 4 | 2.2% |
Violence | 4 | 2.2% |
Zoledronic acid | 4 | 2.2% |
ACE inhibitor | 3 | 1.6% |
Agriculture | 3 | 1.6% |
Alanine transaminase | 3 | 1.6% |
Alcoholism | 3 | 1.6% |
Allocation concealment | 3 | 1.6% |
Anesthesia | 3 | 1.6% |
Anti-diabetic medication | 3 | 1.6% |
Artificial intelligence | 3 | 1.6% |
Assay | 3 | 1.6% |
BCG vaccine | 3 | 1.6% |
Bacteria | 3 | 1.6% |
Beta blocker | 3 | 1.6% |
Big data | 3 | 1.6% |
Biochemistry | 3 | 1.6% |
Biosafety | 3 | 1.6% |
Biosafety level | 3 | 1.6% |
Bioterrorism | 3 | 1.6% |
Birth defect | 3 | 1.6% |
Breastfeeding | 3 | 1.6% |
Bronchitis | 3 | 1.6% |
Bundled payment | 3 | 1.6% |
Caesarean section | 3 | 1.6% |
Cancer screening | 3 | 1.6% |
Capacity building | 3 | 1.6% |
Carcinogen | 3 | 1.6% |
Case management (US healthcare system) | 3 | 1.6% |
Central venous catheter | 3 | 1.6% |
Chemistry | 3 | 1.6% |
Cholesterol | 3 | 1.6% |
Cochrane Library | 3 | 1.6% |
Cognition | 3 | 1.6% |
Condom | 3 | 1.6% |
Confounding | 3 | 1.6% |
DPT vaccine | 3 | 1.6% |
Data | 3 | 1.6% |
Death | 3 | 1.6% |
Deep vein thrombosis | 3 | 1.6% |
Denosumab | 3 | 1.6% |
Diagnosis code | 3 | 1.6% |
Dietary supplement | 3 | 1.6% |
Disability | 3 | 1.6% |
Disease management (health) | 3 | 1.6% |
EQ-5D | 3 | 1.6% |
Economic growth | 3 | 1.6% |
Ejection fraction | 3 | 1.6% |
Emergency | 3 | 1.6% |
Emergency medicine | 3 | 1.6% |
Environmental health | 3 | 1.6% |
Epidemic | 3 | 1.6% |
Epidemiology of HIV/AIDS | 3 | 1.6% |
Experiment | 3 | 1.6% |
Extensively drug-resistant tuberculosis | 3 | 1.6% |
Federally Qualified Health Center | 3 | 1.6% |
Financial statement | 3 | 1.6% |
Five Year Forward View | 3 | 1.6% |
Foodborne illness | 3 | 1.6% |
Fraud | 3 | 1.6% |
Gastroenterology | 3 | 1.6% |
HBsAg | 3 | 1.6% |
HIV | 3 | 1.6% |
Health Insurance Portability and Accountability Act | 3 | 1.6% |
Health care industry | 3 | 1.6% |
Healthcare Effectiveness Data and Information Set | 3 | 1.6% |
Heart failure with preserved ejection fraction | 3 | 1.6% |
Hematology | 3 | 1.6% |
Hepatitis B virus | 3 | 1.6% |
Homelessness | 3 | 1.6% |
Hospital-acquired infection | 3 | 1.6% |
Hyperlipidemia | 3 | 1.6% |
Incidence (epidemiology) | 3 | 1.6% |
Infertility | 3 | 1.6% |
Influenza vaccine | 3 | 1.6% |
Inspection | 3 | 1.6% |
Internal medicine | 3 | 1.6% |
Interoperability | 3 | 1.6% |
Kidney disease | 3 | 1.6% |
Lentiviruses | 3 | 1.6% |
Liver | 3 | 1.6% |
Liver biopsy | 3 | 1.6% |
Liver disease | 3 | 1.6% |
Liver function tests | 3 | 1.6% |
Long-term care | 3 | 1.6% |
MEDLINE | 3 | 1.6% |
MHealth | 3 | 1.6% |
Malaria | 3 | 1.6% |
Malnutrition | 3 | 1.6% |
MammaPrint | 3 | 1.6% |
Maternal health | 3 | 1.6% |
Medical research | 3 | 1.6% |
Medical school | 3 | 1.6% |
Medical sign | 3 | 1.6% |
Medical treatments | 3 | 1.6% |
Methylprednisolone | 3 | 1.6% |
Missing data | 3 | 1.6% |
NHS foundation trust | 3 | 1.6% |
Neurology | 3 | 1.6% |
Non-alcoholic fatty liver disease | 3 | 1.6% |
Odds ratio | 3 | 1.6% |
Organisms | 3 | 1.6% |
Organs (anatomy) | 3 | 1.6% |
Osteonecrosis of the jaw | 3 | 1.6% |
Over-the-counter drug | 3 | 1.6% |
Palliative care | 3 | 1.6% |
Particulates | 3 | 1.6% |
Patient safety organization | 3 | 1.6% |
Pension | 3 | 1.6% |
Point of care | 3 | 1.6% |
Posttraumatic stress disorder | 3 | 1.6% |
Prednisolone | 3 | 1.6% |
Prednisone | 3 | 1.6% |
Prevention of HIV/AIDS | 3 | 1.6% |
Preventive medicine | 3 | 1.6% |
Productivity | 3 | 1.6% |
Psychology | 3 | 1.6% |
Quality assurance | 3 | 1.6% |
Radiation therapy | 3 | 1.6% |
Recruitment | 3 | 1.6% |
Reliability engineering | 3 | 1.6% |
Reproductive health | 3 | 1.6% |
Respiratory disease | 3 | 1.6% |
Revenue | 3 | 1.6% |
Safe sex | 3 | 1.6% |
Selective laser sintering | 3 | 1.6% |
Sex worker | 3 | 1.6% |
Social determinants of health | 3 | 1.6% |
Social exclusion | 3 | 1.6% |
Social programs | 3 | 1.6% |
Specification (technical standard) | 3 | 1.6% |
Staphylococcus aureus | 3 | 1.6% |
Statin | 3 | 1.6% |
Statistical process control | 3 | 1.6% |
Strontium ranelate | 3 | 1.6% |
Study heterogeneity | 3 | 1.6% |
System | 3 | 1.6% |
Thrombocytopenia | 3 | 1.6% |
Transient ischemic attack | 3 | 1.6% |
Transparency (behavior) | 3 | 1.6% |
Type 2 diabetes | 3 | 1.6% |
Urinary incontinence | 3 | 1.6% |
Vaginitis | 3 | 1.6% |
Vertebral augmentation | 3 | 1.6% |
Vitamin | 3 | 1.6% |
WIC | 3 | 1.6% |
Women's health | 3 | 1.6% |
Workforce development | 3 | 1.6% |
3D modeling | 2 | 1.1% |
3D scanning | 2 | 1.1% |
Abdomen | 2 | 1.1% |
Abscess | 2 | 1.1% |
Active surveillance of prostate cancer | 2 | 1.1% |
All-payer rate setting | 2 | 1.1% |
Allergen | 2 | 1.1% |
American Health Care Act of 2017 | 2 | 1.1% |
Analytics | 2 | 1.1% |
Anatomical terms of location | 2 | 1.1% |
Anesthesiology | 2 | 1.1% |
Angiology | 2 | 1.1% |
Angioplasty | 2 | 1.1% |
Angiotensin II receptor blocker | 2 | 1.1% |
Antibody | 2 | 1.1% |
Antihypertensive drug | 2 | 1.1% |
Antipsychotic | 2 | 1.1% |
Appropriations bill (United States) | 2 | 1.1% |
Arrhythmia | 2 | 1.1% |
Ascending cholangitis | 2 | 1.1% |
Assisted reproductive technology | 2 | 1.1% |
Atrial flutter | 2 | 1.1% |
Atrial septal defect | 2 | 1.1% |
Atrium (heart) | 2 | 1.1% |
Atrophic vaginitis | 2 | 1.1% |
Attention deficit hyperactivity disorder | 2 | 1.1% |
Audit committee | 2 | 1.1% |
Autoimmune hepatitis | 2 | 1.1% |
Bachelor of Science in Nursing | 2 | 1.1% |
Bacterial vaginosis | 2 | 1.1% |
Bacteriuria | 2 | 1.1% |
Biodiversity | 2 | 1.1% |
Bioinformatics | 2 | 1.1% |
Biosafety cabinet | 2 | 1.1% |
Biosensor | 2 | 1.1% |
Bleeding | 2 | 1.1% |
Blood | 2 | 1.1% |
Blood culture | 2 | 1.1% |
Blood transfusion | 2 | 1.1% |
Blood-borne disease | 2 | 1.1% |
Board certification | 2 | 1.1% |
Body mass index | 2 | 1.1% |
Botulinum toxin | 2 | 1.1% |
Brain natriuretic peptide | 2 | 1.1% |
Branches of science | 2 | 1.1% |
Breast cancer classification | 2 | 1.1% |
C-reactive protein | 2 | 1.1% |
CAD/CAM dentistry | 2 | 1.1% |
CHA2DS2–VASc score | 2 | 1.1% |
Calcium supplement | 2 | 1.1% |
Cancer research | 2 | 1.1% |
Capitation (healthcare) | 2 | 1.1% |
Cardiac catheterization | 2 | 1.1% |
Cardiac muscle | 2 | 1.1% |
Cardiopulmonary rehabilitation | 2 | 1.1% |
Cardiopulmonary resuscitation | 2 | 1.1% |
Cardiothoracic surgery | 2 | 1.1% |
Case management (US health system) | 2 | 1.1% |
Case study | 2 | 1.1% |
Case–control study | 2 | 1.1% |
Catheter ablation | 2 | 1.1% |
Cattle | 2 | 1.1% |
Cervix | 2 | 1.1% |
Charity care | 2 | 1.1% |
Chart | 2 | 1.1% |
Chickenpox | 2 | 1.1% |
Chief financial officer | 2 | 1.1% |
Child care | 2 | 1.1% |
Chlamydia | 2 | 1.1% |
Circumcision | 2 | 1.1% |
Clinical audit | 2 | 1.1% |
Clinical decision support system | 2 | 1.1% |
Clinical endpoint | 2 | 1.1% |
Clostridioides difficile infection | 2 | 1.1% |
Coagulation | 2 | 1.1% |
Community health worker | 2 | 1.1% |
Complete blood count | 2 | 1.1% |
Computer security | 2 | 1.1% |
Coronary artery bypass surgery | 2 | 1.1% |
Corporation | 2 | 1.1% |
Cost–benefit analysis | 2 | 1.1% |
Creatinine | 2 | 1.1% |
Cross-validation (statistics) | 2 | 1.1% |
DICOM | 2 | 1.1% |
Data visualization | 2 | 1.1% |
Debt | 2 | 1.1% |
Decision-making | 2 | 1.1% |
Defibrillation | 2 | 1.1% |
Delirium | 2 | 1.1% |
Dengue fever | 2 | 1.1% |
Dental implant | 2 | 1.1% |
Design | 2 | 1.1% |
Development aid | 2 | 1.1% |
Dialysis | 2 | 1.1% |
Dieldrin | 2 | 1.1% |
Digestive system | 2 | 1.1% |
Disability-adjusted life year | 2 | 1.1% |
Disease burden | 2 | 1.1% |
Dose–response relationship | 2 | 1.1% |
Drug development | 2 | 1.1% |
Earth | 2 | 1.1% |
Ecology | 2 | 1.1% |
Economy | 2 | 1.1% |
Elderly care | 2 | 1.1% |
Electrocardiography | 2 | 1.1% |
Emergency medical services | 2 | 1.1% |
Employee Retirement Income Security Act of 1974 | 2 | 1.1% |
Employee retention | 2 | 1.1% |
Endocrine system | 2 | 1.1% |
Endoscopy | 2 | 1.1% |
Engineering | 2 | 1.1% |
Engineering controls | 2 | 1.1% |
Environmental protection | 2 | 1.1% |
Epidural administration | 2 | 1.1% |
Epilepsy | 2 | 1.1% |
Equal opportunity | 2 | 1.1% |
Equalization payments | 2 | 1.1% |
Esophagus | 2 | 1.1% |
Estrogen receptor | 2 | 1.1% |
Ethics | 2 | 1.1% |
Evolution | 2 | 1.1% |
Expense | 2 | 1.1% |
Exposure assessment | 2 | 1.1% |
Extracellular matrix | 2 | 1.1% |
Failure mode and effects analysis | 2 | 1.1% |
Fall prevention | 2 | 1.1% |
Fever | 2 | 1.1% |
Fiscal year | 2 | 1.1% |
Flowchart | 2 | 1.1% |
Flu season | 2 | 1.1% |
Food and drink | 2 | 1.1% |
Food security | 2 | 1.1% |
Forecasting | 2 | 1.1% |
Frailty syndrome | 2 | 1.1% |
Free clinic | 2 | 1.1% |
Function (mathematics) | 2 | 1.1% |
Fused filament fabrication | 2 | 1.1% |
Gene | 2 | 1.1% |
Gene expression profiling | 2 | 1.1% |
Gene expression profiling in cancer | 2 | 1.1% |
Gene signature | 2 | 1.1% |
General Data Protection Regulation | 2 | 1.1% |
Genetic engineering | 2 | 1.1% |
Genome | 2 | 1.1% |
Genome editing | 2 | 1.1% |
Geriatrics | 2 | 1.1% |
Global health | 2 | 1.1% |
Global warming | 2 | 1.1% |
Gross domestic product | 2 | 1.1% |
Gynaecologic disorders | 2 | 1.1% |
Gynaecology | 2 | 1.1% |
HIV-positive people | 2 | 1.1% |
HIV/AIDS in Africa | 2 | 1.1% |
Health Information Technology for Economic and Clinical Health Act | 2 | 1.1% |
Health insurance coverage in the United States | 2 | 1.1% |
Health literacy | 2 | 1.1% |
Health technology in the United States | 2 | 1.1% |
Hearing aid | 2 | 1.1% |
Hematopoietic stem cell transplantation | 2 | 1.1% |
Hemodialysis | 2 | 1.1% |
Hepatitis B vaccine | 2 | 1.1% |
Hepatology | 2 | 1.1% |
Hip fracture | 2 | 1.1% |
Home care in the United States | 2 | 1.1% |
Hormesis | 2 | 1.1% |
Hormone replacement therapy | 2 | 1.1% |
Hospital accreditation | 2 | 1.1% |
Human papillomavirus infection | 2 | 1.1% |
Hypercholesterolemia | 2 | 1.1% |
Hyperglycemia | 2 | 1.1% |
Hypertrophic cardiomyopathy | 2 | 1.1% |
Hypothermia | 2 | 1.1% |
ICD-10 | 2 | 1.1% |
Immigration | 2 | 1.1% |
Immune system | 2 | 1.1% |
Immunodeficiency | 2 | 1.1% |
Implant (medicine) | 2 | 1.1% |
In vitro fertilisation | 2 | 1.1% |
Infant | 2 | 1.1% |
Infant mortality | 2 | 1.1% |
Infection control | 2 | 1.1% |
Inflammation | 2 | 1.1% |
Inflation | 2 | 1.1% |
Influenza A virus | 2 | 1.1% |
Influenza A virus subtype H1N1 | 2 | 1.1% |
Influenza A virus subtype H7N9 | 2 | 1.1% |
Information governance | 2 | 1.1% |
Information security | 2 | 1.1% |
Innate immune system | 2 | 1.1% |
Insecticide | 2 | 1.1% |
Institution | 2 | 1.1% |
Internal audit | 2 | 1.1% |
Ionizing radiation | 2 | 1.1% |
Ischemia | 2 | 1.1% |
Kidney transplantation | 2 | 1.1% |
Lentigo maligna | 2 | 1.1% |
Likelihood ratios in diagnostic testing | 2 | 1.1% |
Limited liability company | 2 | 1.1% |
Linear no-threshold model | 2 | 1.1% |
Logistic function | 2 | 1.1% |
Logistic regression | 2 | 1.1% |
Lung cancer | 2 | 1.1% |
MMR vaccine | 2 | 1.1% |
Major trauma | 2 | 1.1% |
Management of atrial fibrillation | 2 | 1.1% |
Maryland hospital payment system | 2 | 1.1% |
Mass spectrometry | 2 | 1.1% |
Mathematical optimization | 2 | 1.1% |
Medical device | 2 | 1.1% |
Medical microbiology | 2 | 1.1% |
Medical tests | 2 | 1.1% |
Medical ultrasound | 2 | 1.1% |
Medicare Advantage | 2 | 1.1% |
Melanoma | 2 | 1.1% |
Microsimulation | 2 | 1.1% |
Minimum Data Set | 2 | 1.1% |
Molecular biology | 2 | 1.1% |
Molecular diagnostics | 2 | 1.1% |
Moon | 2 | 1.1% |
Mycobacterium bovis | 2 | 1.1% |
N-terminal prohormone of brain natriuretic peptide | 2 | 1.1% |
Nanomaterials | 2 | 1.1% |
Nanoparticle | 2 | 1.1% |
Natural environment | 2 | 1.1% |
Neoplasm | 2 | 1.1% |
Nephrology | 2 | 1.1% |
Nervous system | 2 | 1.1% |
Neuroimaging | 2 | 1.1% |
Neuroscience | 2 | 1.1% |
Nevirapine | 2 | 1.1% |
Nevus | 2 | 1.1% |
Non-communicable disease | 2 | 1.1% |
Notary public | 2 | 1.1% |
Nursing home | 2 | 1.1% |
Nutrition | 2 | 1.1% |
Occupational Safety and Health Act (United States) | 2 | 1.1% |
Organism | 2 | 1.1% |
Oseltamivir | 2 | 1.1% |
Outcomes research | 2 | 1.1% |
Overactive bladder | 2 | 1.1% |
Ownership | 2 | 1.1% |
PCSK9 | 2 | 1.1% |
PDCA | 2 | 1.1% |
PHQ-9 | 2 | 1.1% |
Pathogen | 2 | 1.1% |
Patient portal | 2 | 1.1% |
Performance improvement | 2 | 1.1% |
Personalized medicine | 2 | 1.1% |
Pharmaceutical Benefits Scheme | 2 | 1.1% |
Pharmaceutical industry | 2 | 1.1% |
Pharmaceutical sciences | 2 | 1.1% |
Pharmacovigilance | 2 | 1.1% |
Phases of clinical research | 2 | 1.1% |
Physical examination | 2 | 1.1% |
Plant breeding | 2 | 1.1% |
Plant disease resistance | 2 | 1.1% |
Platelet | 2 | 1.1% |
Platelet transfusion | 2 | 1.1% |
Pollution | 2 | 1.1% |
Pre- and post-test probability | 2 | 1.1% |
Precision medicine | 2 | 1.1% |
Prediabetes | 2 | 1.1% |
Primary biliary cholangitis | 2 | 1.1% |
Primary health care | 2 | 1.1% |
Project Bioshield Act | 2 | 1.1% |
Prosthesis | 2 | 1.1% |
Protein | 2 | 1.1% |
Prothrombin time | 2 | 1.1% |
Psychotherapy | 2 | 1.1% |
Public health surveillance | 2 | 1.1% |
Public hospital | 2 | 1.1% |
Pulmonary embolism | 2 | 1.1% |
Pyelonephritis | 2 | 1.1% |
Quality and Outcomes Framework | 2 | 1.1% |
Quantitative computed tomography | 2 | 1.1% |
Random forest | 2 | 1.1% |
Reference range | 2 | 1.1% |
Regulation | 2 | 1.1% |
Regulatory science | 2 | 1.1% |
Respiratory system | 2 | 1.1% |
Revised National Tuberculosis Control Program | 2 | 1.1% |
Robot | 2 | 1.1% |
Robot-assisted surgery | 2 | 1.1% |
Rosuvastatin | 2 | 1.1% |
Rubella | 2 | 1.1% |
Rulemaking | 2 | 1.1% |
Rural health | 2 | 1.1% |
Salary | 2 | 1.1% |
Sample size determination | 2 | 1.1% |
Sanitization (classified information) | 2 | 1.1% |
Schizophrenia | 2 | 1.1% |
Scientific community | 2 | 1.1% |
Scientific modelling | 2 | 1.1% |
Selective estrogen receptor modulator | 2 | 1.1% |
Sexual intercourse | 2 | 1.1% |
Shared decision-making in medicine | 2 | 1.1% |
Shingles | 2 | 1.1% |
Simon Stevens | 2 | 1.1% |
Single-nucleotide polymorphism | 2 | 1.1% |
Sintering | 2 | 1.1% |
Skin condition | 2 | 1.1% |
Slum | 2 | 1.1% |
Smoking cessation | 2 | 1.1% |
Social Security (United States) | 2 | 1.1% |
Social protection | 2 | 1.1% |
Soil | 2 | 1.1% |
Solid | 2 | 1.1% |
Spinal cord | 2 | 1.1% |
Standard deviation | 2 | 1.1% |
Stereolithography | 2 | 1.1% |
Strategic planning | 2 | 1.1% |
Strategy | 2 | 1.1% |
Stress (biology) | 2 | 1.1% |
Student financial aid (United States) | 2 | 1.1% |
Sustainability and transformation plan | 2 | 1.1% |
Tachycardia | 2 | 1.1% |
Talent management | 2 | 1.1% |
Tamoxifen | 2 | 1.1% |
Teledermatology | 2 | 1.1% |
Text mining | 2 | 1.1% |
Thematic analysis | 2 | 1.1% |
Tissues (biology) | 2 | 1.1% |
Toxic Substances Control Act of 1976 | 2 | 1.1% |
Trade Adjustment Assistance | 2 | 1.1% |
Training | 2 | 1.1% |
Trauma center | 2 | 1.1% |
Traumatic brain injury | 2 | 1.1% |
Trichomonas vaginalis | 2 | 1.1% |
Trichomoniasis | 2 | 1.1% |
Triple-negative breast cancer | 2 | 1.1% |
Tropical medicine | 2 | 1.1% |
Uncertainty | 2 | 1.1% |
Unemployment | 2 | 1.1% |
Unemployment benefits | 2 | 1.1% |
Unstructured data | 2 | 1.1% |
Urethra | 2 | 1.1% |
Urine test strip | 2 | 1.1% |
Vaginal discharge | 2 | 1.1% |
Ventricle (heart) | 2 | 1.1% |
Vertically transmitted infection | 2 | 1.1% |
Violence against women | 2 | 1.1% |
Viral load | 2 | 1.1% |
Virology | 2 | 1.1% |
Virtual colonoscopy | 2 | 1.1% |
Vital signs | 2 | 1.1% |
Vitamin D deficiency | 2 | 1.1% |
Vocational education | 2 | 1.1% |
Water | 2 | 1.1% |
Welfare | 2 | 1.1% |
Whole genome sequencing | 2 | 1.1% |
Wound | 2 | 1.1% |
Zika fever | 2 | 1.1% |
100,000 Genomes Project | 1 | 0.5% |
2009 flu pandemic | 1 | 0.5% |
3D bioprinting | 1 | 0.5% |
3D computer graphics | 1 | 0.5% |
3D printing processes | 1 | 0.5% |
ABC (medicine) | 1 | 0.5% |
Abidjan | 1 | 0.5% |
Abiotic stress | 1 | 0.5% |
Aboriginal Australians | 1 | 0.5% |
Absorption (skin) | 1 | 0.5% |
Abuse | 1 | 0.5% |
Academic degree | 1 | 0.5% |
Accounting | 1 | 0.5% |
Accuracy and precision | 1 | 0.5% |
Aclidinium bromide | 1 | 0.5% |
Acute prostatitis | 1 | 0.5% |
Adaptive immune system | 1 | 0.5% |
Added sugar | 1 | 0.5% |
Adenoma | 1 | 0.5% |
Adenoviridae | 1 | 0.5% |
Adipose tissue | 1 | 0.5% |
Advanced trauma life support | 1 | 0.5% |
Advertising | 1 | 0.5% |
Advertising to children | 1 | 0.5% |
Aerosol | 1 | 0.5% |
African trypanosomiasis | 1 | 0.5% |
Aggression | 1 | 0.5% |
Agrobacterium tumefaciens | 1 | 0.5% |
Ailments of unknown cause | 1 | 0.5% |
Albumin | 1 | 0.5% |
Alcoholic liver disease | 1 | 0.5% |
Algorithm | 1 | 0.5% |
Alkaline phosphatase | 1 | 0.5% |
Allelopathy | 1 | 0.5% |
Allergy | 1 | 0.5% |
Alzheimer's disease biomarkers | 1 | 0.5% |
Amiodarone | 1 | 0.5% |
Amplicon | 1 | 0.5% |
Amyloid beta | 1 | 0.5% |
Amyloidosis | 1 | 0.5% |
Anaerobic digestion | 1 | 0.5% |
Analytical chemistry | 1 | 0.5% |
Anaphylaxis | 1 | 0.5% |
Anatomical Therapeutic Chemical Classification System | 1 | 0.5% |
Anatomical terms of motion | 1 | 0.5% |
Andrew R. Wheeler | 1 | 0.5% |
Anemia | 1 | 0.5% |
Aneurysm | 1 | 0.5% |
Angina | 1 | 0.5% |
Angiography | 1 | 0.5% |
Angiotensin-converting enzyme | 1 | 0.5% |
Animal anatomy | 1 | 0.5% |
Animal testing | 1 | 0.5% |
Ankle | 1 | 0.5% |
Anti-Müllerian hormone | 1 | 0.5% |
Anti-nuclear antibody | 1 | 0.5% |
Anti-social behaviour | 1 | 0.5% |
Antiarrhythmic agent | 1 | 0.5% |
Antifungal | 1 | 0.5% |
Antigen | 1 | 0.5% |
Antimicrobial | 1 | 0.5% |
Antimicrobial stewardship | 1 | 0.5% |
Antiplatelet drug | 1 | 0.5% |
Aorta | 1 | 0.5% |
Aortic aneurysm | 1 | 0.5% |
Apixaban | 1 | 0.5% |
Apnea | 1 | 0.5% |
Arabidopsis thaliana | 1 | 0.5% |
Arcenciel | 1 | 0.5% |
Area Health Education Centers Program | 1 | 0.5% |
Arm | 1 | 0.5% |
Artesunate | 1 | 0.5% |
Arthroscopy | 1 | 0.5% |
Artificial cardiac pacemaker | 1 | 0.5% |
Artificial gene synthesis | 1 | 0.5% |
Artificial objects | 1 | 0.5% |
Ascites | 1 | 0.5% |
Asepsis | 1 | 0.5% |
Aspirin | 1 | 0.5% |
Assessment of kidney function | 1 | 0.5% |
Asset | 1 | 0.5% |
Assisted living | 1 | 0.5% |
Association mapping | 1 | 0.5% |
Asystole | 1 | 0.5% |
Atheroma | 1 | 0.5% |
Atherosclerosis | 1 | 0.5% |
Athletic heart syndrome | 1 | 0.5% |
Atmosphere | 1 | 0.5% |
Atmosphere of Earth | 1 | 0.5% |
Atorvastatin | 1 | 0.5% |
Atrial natriuretic peptide | 1 | 0.5% |
Attachment theory | 1 | 0.5% |
Attention | 1 | 0.5% |
Attitude (psychology) | 1 | 0.5% |
AutoPulse | 1 | 0.5% |
Autoantibody | 1 | 0.5% |
Autoimmunity | 1 | 0.5% |
Automation | 1 | 0.5% |
Autopsy | 1 | 0.5% |
Avian influenza | 1 | 0.5% |
Bacillus anthracis | 1 | 0.5% |
Bacillus cereus | 1 | 0.5% |
Bacillus thuringiensis | 1 | 0.5% |
Badger culling in the United Kingdom | 1 | 0.5% |
BadgerCare | 1 | 0.5% |
Bariatric surgery | 1 | 0.5% |
Baroreflex | 1 | 0.5% |
Basal-cell carcinoma | 1 | 0.5% |
Basic life support | 1 | 0.5% |
Bayesian inference | 1 | 0.5% |
Beech | 1 | 0.5% |
Benign prostatic hyperplasia | 1 | 0.5% |
Benign tumor | 1 | 0.5% |
Beta distribution | 1 | 0.5% |
Beta-lactamase | 1 | 0.5% |
Beta-secretase 1 | 1 | 0.5% |
Bilirubin | 1 | 0.5% |
BioWatch | 1 | 0.5% |
Biobank | 1 | 0.5% |
Biocide | 1 | 0.5% |
Bioethics | 1 | 0.5% |
Biogas | 1 | 0.5% |
Biomarker (medicine) | 1 | 0.5% |
Biomedical waste | 1 | 0.5% |
Biopharmaceutical | 1 | 0.5% |
Biosecurity | 1 | 0.5% |
Biosignature | 1 | 0.5% |
Biotic stress | 1 | 0.5% |
Bladder cancer | 1 | 0.5% |
Bleach | 1 | 0.5% |
Blepharoplasty | 1 | 0.5% |
Blockchain | 1 | 0.5% |
Blood disorders | 1 | 0.5% |
Blood lipids | 1 | 0.5% |
Blood plasma | 1 | 0.5% |
Blood sugar level | 1 | 0.5% |
Body fluids | 1 | 0.5% |
Bone cyst | 1 | 0.5% |
Bone resorption | 1 | 0.5% |
Booster dose | 1 | 0.5% |
Botulism | 1 | 0.5% |
Brain | 1 | 0.5% |
Brain–computer interface | 1 | 0.5% |
Brand | 1 | 0.5% |
Breast implant | 1 | 0.5% |
Breast milk | 1 | 0.5% |
Breast reconstruction | 1 | 0.5% |
Breathability | 1 | 0.5% |
Brisbane Diamantina Health Partners | 1 | 0.5% |
British National Formulary | 1 | 0.5% |
Bronchiolitis | 1 | 0.5% |
Bronchodilator | 1 | 0.5% |
Brucella | 1 | 0.5% |
Budget | 1 | 0.5% |
Bulimia nervosa | 1 | 0.5% |
Bullying | 1 | 0.5% |
Bunker gear | 1 | 0.5% |
Burkholderia | 1 | 0.5% |
Burkholderia mallei | 1 | 0.5% |
Burkholderia pseudomallei | 1 | 0.5% |
Business process | 1 | 0.5% |
CRISPR gene editing | 1 | 0.5% |
Ca2+/calmodulin-dependent protein kinase II | 1 | 0.5% |
Calcitriol | 1 | 0.5% |
Candesartan | 1 | 0.5% |
Candidiasis | 1 | 0.5% |
Cannabis (drug) | 1 | 0.5% |
Canola oil | 1 | 0.5% |
Cardiac arrest | 1 | 0.5% |
Cardiac magnetic resonance imaging | 1 | 0.5% |
Cardiac rehabilitation | 1 | 0.5% |
Cardiac surgery | 1 | 0.5% |
Cardiac tamponade | 1 | 0.5% |
Cardiomegaly | 1 | 0.5% |
Cardiotocography | 1 | 0.5% |
Cardioversion | 1 | 0.5% |
Caring for people with dementia | 1 | 0.5% |
Catheter | 1 | 0.5% |
Causality | 1 | 0.5% |
Causes of death | 1 | 0.5% |
Cell (biology) | 1 | 0.5% |
Cell culture | 1 | 0.5% |
Cell nucleus | 1 | 0.5% |
Cell potency | 1 | 0.5% |
Cellular differentiation | 1 | 0.5% |
Cellulitis | 1 | 0.5% |
Census | 1 | 0.5% |
Cereal | 1 | 0.5% |
Cerebral shunt | 1 | 0.5% |
Cerebrospinal fluid | 1 | 0.5% |
Cerebrovascular disease | 1 | 0.5% |
Cetuximab | 1 | 0.5% |
Chairperson | 1 | 0.5% |
Charitable organization | 1 | 0.5% |
Chemical element | 1 | 0.5% |
Chief operating officer | 1 | 0.5% |
Chief risk officer | 1 | 0.5% |
Child mortality | 1 | 0.5% |
Child protection | 1 | 0.5% |
Childhood | 1 | 0.5% |
Childhood obesity | 1 | 0.5% |
Chirality (chemistry) | 1 | 0.5% |
Chlamydia infection | 1 | 0.5% |
Chlamydia trachomatis | 1 | 0.5% |
Chlortalidone | 1 | 0.5% |
Cholecalciferol | 1 | 0.5% |
Cholestasis | 1 | 0.5% |
Choosing Wisely | 1 | 0.5% |
Cigarette | 1 | 0.5% |
Circadian rhythm | 1 | 0.5% |
Circulating tumor DNA | 1 | 0.5% |
Circulatory system | 1 | 0.5% |
Circumstellar habitable zone | 1 | 0.5% |
Classification of ethnicity in the United Kingdom | 1 | 0.5% |
Clavicle fracture | 1 | 0.5% |
Clean Air Act (United States) | 1 | 0.5% |
Clean Air Act of 1963 | 1 | 0.5% |
Climate resilience | 1 | 0.5% |
Clinical pathology | 1 | 0.5% |
ClinicalTrials.gov | 1 | 0.5% |
Cloning | 1 | 0.5% |
Clothing | 1 | 0.5% |
Coalworker's pneumoconiosis | 1 | 0.5% |
Cognitive disorders | 1 | 0.5% |
Cognitive science | 1 | 0.5% |
Combustion | 1 | 0.5% |
Common carotid artery | 1 | 0.5% |
Common cold | 1 | 0.5% |
Community mental health service | 1 | 0.5% |
Community-acquired pneumonia | 1 | 0.5% |
Compartmental models in epidemiology | 1 | 0.5% |
Complementarity (molecular biology) | 1 | 0.5% |
Complex traits | 1 | 0.5% |
Composite material | 1 | 0.5% |
Comprehensive medication management | 1 | 0.5% |
Computer-aided design | 1 | 0.5% |
Conceptual model | 1 | 0.5% |
Concussion | 1 | 0.5% |
Confidentiality | 1 | 0.5% |
Congenital hypothyroidism | 1 | 0.5% |
Conjunctivitis | 1 | 0.5% |
Consensus decision-making | 1 | 0.5% |
Consent | 1 | 0.5% |
Conservation biology | 1 | 0.5% |
Construction | 1 | 0.5% |
Contact tracing | 1 | 0.5% |
Contractual term | 1 | 0.5% |
Controlled ovarian hyperstimulation | 1 | 0.5% |
Coronary circulation | 1 | 0.5% |
Coronavirus | 1 | 0.5% |
Coronavirus disease 2019 | 1 | 0.5% |
Corruption | 1 | 0.5% |
Cotinine | 1 | 0.5% |
Cotton | 1 | 0.5% |
Credit | 1 | 0.5% |
Crenezumab | 1 | 0.5% |
Crop rotation | 1 | 0.5% |
Crossover study | 1 | 0.5% |
Crown (dentistry) | 1 | 0.5% |
Cryptococcosis | 1 | 0.5% |
Cultured meat | 1 | 0.5% |
Cycling | 1 | 0.5% |
D-dimer | 1 | 0.5% |
DNA | 1 | 0.5% |
DNA microarray | 1 | 0.5% |
Da Vinci Surgical System | 1 | 0.5% |
Dabigatran | 1 | 0.5% |
Damages | 1 | 0.5% |
Dashboard (business) | 1 | 0.5% |
Data Protection Act 1998 | 1 | 0.5% |
Data center | 1 | 0.5% |
Data quality | 1 | 0.5% |
Data sharing | 1 | 0.5% |
Database | 1 | 0.5% |
Debridement | 1 | 0.5% |
Decision tree learning | 1 | 0.5% |
Deepwater Horizon oil spill | 1 | 0.5% |
Dehydration | 1 | 0.5% |
Demographic and Health Surveys | 1 | 0.5% |
Demography | 1 | 0.5% |
Dental restoration | 1 | 0.5% |
Department of Motor Vehicles | 1 | 0.5% |
Dependent and independent variables | 1 | 0.5% |
Deposit account | 1 | 0.5% |
Dermatitis | 1 | 0.5% |
Dermatophytosis | 1 | 0.5% |
Dermatoscopy | 1 | 0.5% |
Designer baby | 1 | 0.5% |
Determinants of health | 1 | 0.5% |
Dexamethasone | 1 | 0.5% |
Diabetes mellitus | 1 | 0.5% |
Diabetes mellitus type 2 | 1 | 0.5% |
Diagnosis of schizophrenia | 1 | 0.5% |
Diarrhea | 1 | 0.5% |
Diastereomer | 1 | 0.5% |
Diastole | 1 | 0.5% |
Diet (nutrition) | 1 | 0.5% |
Digoxin | 1 | 0.5% |
Diphtheria | 1 | 0.5% |
Diphtheria vaccine | 1 | 0.5% |
Directed evolution | 1 | 0.5% |
Discovery (law) | 1 | 0.5% |
Disease surveillance | 1 | 0.5% |
Diseases of poverty | 1 | 0.5% |
Disinfectant | 1 | 0.5% |
Dislocated shoulder | 1 | 0.5% |
Disorders of endocrine pancreas | 1 | 0.5% |
Disseminated intravascular coagulation | 1 | 0.5% |
Domestic violence | 1 | 0.5% |
Dominance (genetics) | 1 | 0.5% |
Drink | 1 | 0.5% |
Drug test | 1 | 0.5% |
Dual-use technology | 1 | 0.5% |
Ductal carcinoma in situ | 1 | 0.5% |
Dura mater | 1 | 0.5% |
Dysentery | 1 | 0.5% |
Dysplastic nevus | 1 | 0.5% |
EHealth | 1 | 0.5% |
Earth analog | 1 | 0.5% |
Eating disorder | 1 | 0.5% |
Ebola virus disease | 1 | 0.5% |
Echocardiography | 1 | 0.5% |
Eclampsia | 1 | 0.5% |
Economic equilibrium | 1 | 0.5% |
Ecosystem | 1 | 0.5% |
Ecosystem management | 1 | 0.5% |
Ecosystem services | 1 | 0.5% |
Educational technology | 1 | 0.5% |
Effect size | 1 | 0.5% |
Efficacy | 1 | 0.5% |
Efficient energy use | 1 | 0.5% |
Egg allergy | 1 | 0.5% |
Elaine Marley | 1 | 0.5% |
Elastography | 1 | 0.5% |
Elbow | 1 | 0.5% |
Electronic benefit transfer | 1 | 0.5% |
Embolism | 1 | 0.5% |
Embolization | 1 | 0.5% |
Emergency medical technician | 1 | 0.5% |
Employee benefits | 1 | 0.5% |
Emulsion | 1 | 0.5% |
Enantiomer | 1 | 0.5% |
End-of-life care | 1 | 0.5% |
Endocrine diseases | 1 | 0.5% |
Endocrine pancreas | 1 | 0.5% |
Endocrine, nutritional and metabolic diseases | 1 | 0.5% |
Endocrinology | 1 | 0.5% |
Endovascular aneurysm repair | 1 | 0.5% |
Energy poverty and cooking | 1 | 0.5% |
Entecavir | 1 | 0.5% |
Enterococcus | 1 | 0.5% |
Enuresis | 1 | 0.5% |
Environmental governance | 1 | 0.5% |
Environmental policy | 1 | 0.5% |
Environmental remediation | 1 | 0.5% |
Environmental science | 1 | 0.5% |
Enzyme | 1 | 0.5% |
Eplerenone | 1 | 0.5% |
Errors and residuals | 1 | 0.5% |
Escherichia coli | 1 | 0.5% |
Esophageal varices | 1 | 0.5% |
Estrogen | 1 | 0.5% |
Evidence-based practice | 1 | 0.5% |
Evolution of influenza | 1 | 0.5% |
ExoMars | 1 | 0.5% |
Exocrine system | 1 | 0.5% |
Exoplanet | 1 | 0.5% |
Expert | 1 | 0.5% |
Exponential distribution | 1 | 0.5% |
Exposure (photography) | 1 | 0.5% |
Ezetimibe | 1 | 0.5% |
Ezetimibe/simvastatin | 1 | 0.5% |
False positives and false negatives | 1 | 0.5% |
Fascia | 1 | 0.5% |
Fast food | 1 | 0.5% |
Fast food restaurant | 1 | 0.5% |
Fatty liver disease | 1 | 0.5% |
Fax | 1 | 0.5% |
Fecal incontinence | 1 | 0.5% |
Femoral fracture | 1 | 0.5% |
Fenofibrate | 1 | 0.5% |
Fertilizer | 1 | 0.5% |
Fetus | 1 | 0.5% |
Fibrinogen | 1 | 0.5% |
FibroTest | 1 | 0.5% |
Fibroadenoma | 1 | 0.5% |
Field triage | 1 | 0.5% |
Filariasis | 1 | 0.5% |
Fine-needle aspiration | 1 | 0.5% |
Fire | 1 | 0.5% |
Fire department | 1 | 0.5% |
Firefighter | 1 | 0.5% |
Firefighting | 1 | 0.5% |
First Nations | 1 | 0.5% |
Fish oil | 1 | 0.5% |
Fishing | 1 | 0.5% |
Fishing trawler | 1 | 0.5% |
Fixed asset | 1 | 0.5% |
Flextime | 1 | 0.5% |
Fluconazole | 1 | 0.5% |
Flucytosine | 1 | 0.5% |
Fluid replacement | 1 | 0.5% |
Focus group | 1 | 0.5% |
Follicle-stimulating hormone | 1 | 0.5% |
Food choice | 1 | 0.5% |
Food defense | 1 | 0.5% |
Food marketing | 1 | 0.5% |
Food safety | 1 | 0.5% |
Food safety in China | 1 | 0.5% |
Foot | 1 | 0.5% |
Forearm | 1 | 0.5% |
Forest plot | 1 | 0.5% |
Forgery | 1 | 0.5% |
Forward genetics | 1 | 0.5% |
Fosfomycin | 1 | 0.5% |
Foster care | 1 | 0.5% |
Fraction (mathematics) | 1 | 0.5% |
Francis Collins | 1 | 0.5% |
Fraud deterrence | 1 | 0.5% |
Free flap breast reconstruction | 1 | 0.5% |
Fresh frozen plasma | 1 | 0.5% |
Fundraising | 1 | 0.5% |
Fungicide | 1 | 0.5% |
Furosemide | 1 | 0.5% |
Gabapentin | 1 | 0.5% |
Gas detector | 1 | 0.5% |
Gene delivery | 1 | 0.5% |
Gene expression | 1 | 0.5% |
Gene gun | 1 | 0.5% |
Generic drug | 1 | 0.5% |
Genetic disorder | 1 | 0.5% |
Genetic marker | 1 | 0.5% |
Genetic testing | 1 | 0.5% |
Genetically modified crops | 1 | 0.5% |
Genetically modified organism | 1 | 0.5% |
Gene–environment interaction | 1 | 0.5% |
Genome-wide association study | 1 | 0.5% |
Genomics | 1 | 0.5% |
Genotoxicity | 1 | 0.5% |
Geriatric psychiatry | 1 | 0.5% |
Gestational age | 1 | 0.5% |
Gestational hypertension | 1 | 0.5% |
Gilbert's syndrome | 1 | 0.5% |
Glands | 1 | 0.5% |
Globalization | 1 | 0.5% |
Globally Harmonized System of Classification and Labelling of Chemicals | 1 | 0.5% |
Glomerular filtration rate | 1 | 0.5% |
Glomerulonephritis | 1 | 0.5% |
Glomerulus (kidney) | 1 | 0.5% |
Glucocorticoid | 1 | 0.5% |
Glucose | 1 | 0.5% |
Glucose tolerance test | 1 | 0.5% |
Glutamate carboxypeptidase II | 1 | 0.5% |
Glyphosate | 1 | 0.5% |
Good laboratory practice | 1 | 0.5% |
Great Society programs | 1 | 0.5% |
Green Revolution | 1 | 0.5% |
Green building | 1 | 0.5% |
Green chemistry | 1 | 0.5% |
Green infrastructure | 1 | 0.5% |
Group home | 1 | 0.5% |
Group purchasing organization | 1 | 0.5% |
HARPS-N | 1 | 0.5% |
HAS-BLED | 1 | 0.5% |
HELLP syndrome | 1 | 0.5% |
HIV and pregnancy | 1 | 0.5% |
HPV-positive oropharyngeal cancer | 1 | 0.5% |
Hand | 1 | 0.5% |
Hand washing | 1 | 0.5% |
Hawker centre | 1 | 0.5% |
Hazard ratio | 1 | 0.5% |
Head and neck cancer | 1 | 0.5% |
Head injury | 1 | 0.5% |
Health Level 7 | 1 | 0.5% |
Health at Every Size | 1 | 0.5% |
Health care fraud | 1 | 0.5% |
Health care in the United States | 1 | 0.5% |
Health care management | 1 | 0.5% |
Health care prices in the United States | 1 | 0.5% |
Health data | 1 | 0.5% |
Health risk assessment | 1 | 0.5% |
Health savings account | 1 | 0.5% |
Health technology | 1 | 0.5% |
Healthcare | 1 | 0.5% |
Healthcare in Greater Manchester | 1 | 0.5% |
Healthcare in Norfolk | 1 | 0.5% |
Healthy diet | 1 | 0.5% |
Hearing | 1 | 0.5% |
Hearing loss | 1 | 0.5% |
Heat | 1 | 0.5% |
Hemiparesis | 1 | 0.5% |
Heparin | 1 | 0.5% |
Hepatic encephalopathy | 1 | 0.5% |
Herbicide | 1 | 0.5% |
Hernia | 1 | 0.5% |
Heroin | 1 | 0.5% |
Heuristics in judgment and decision-making | 1 | 0.5% |
Hib vaccine | 1 | 0.5% |
Hip | 1 | 0.5% |
Histogram | 1 | 0.5% |
Hormonal therapy (oncology) | 1 | 0.5% |
Household income in the United States | 1 | 0.5% |
Housing First | 1 | 0.5% |
Human | 1 | 0.5% |
Human anatomy | 1 | 0.5% |
Human cloning | 1 | 0.5% |
Human female reproductive system | 1 | 0.5% |
Human germline engineering | 1 | 0.5% |
Human leg | 1 | 0.5% |
Human metapneumovirus | 1 | 0.5% |
Human migration | 1 | 0.5% |
Human mission to Mars | 1 | 0.5% |
Human orthopneumovirus | 1 | 0.5% |
Human pregnancy | 1 | 0.5% |
Humerus | 1 | 0.5% |
Humidity | 1 | 0.5% |
Hunger | 1 | 0.5% |
Hydralazine | 1 | 0.5% |
Hydrazine | 1 | 0.5% |
Hygiene | 1 | 0.5% |
Hyperparathyroidism | 1 | 0.5% |
Hypertelorism | 1 | 0.5% |
Hypertensive disease of pregnancy | 1 | 0.5% |
Hyperthermia | 1 | 0.5% |
Hypocalcemia | 1 | 0.5% |
Hypodermic needle | 1 | 0.5% |
Hypothyroidism | 1 | 0.5% |
Hypovolemic shock | 1 | 0.5% |
ISO 22000 | 1 | 0.5% |
Ibandronic acid | 1 | 0.5% |
Icodextrin | 1 | 0.5% |
Immune thrombocytopenic purpura | 1 | 0.5% |
Immunity (medical) | 1 | 0.5% |
Immunization | 1 | 0.5% |
Immunoglobulin A | 1 | 0.5% |
Immunohistochemistry | 1 | 0.5% |
Immunotherapy | 1 | 0.5% |
Impetigo | 1 | 0.5% |
In vitro | 1 | 0.5% |
Incident management | 1 | 0.5% |
Inclusion (education) | 1 | 0.5% |
Incremental cost-effectiveness ratio | 1 | 0.5% |
Index (economics) | 1 | 0.5% |
Indigenous Australians | 1 | 0.5% |
Indo-Fijians | 1 | 0.5% |
Indoor residual spraying | 1 | 0.5% |
Industries | 1 | 0.5% |
Inflammatory cytokine | 1 | 0.5% |
Influenza A virus subtype H3N2 | 1 | 0.5% |
Influenza A virus subtype H5N1 | 1 | 0.5% |
Influenza pandemic | 1 | 0.5% |
Information privacy | 1 | 0.5% |
Infrared | 1 | 0.5% |
Infrastructure | 1 | 0.5% |
Injection (medicine) | 1 | 0.5% |
Insect | 1 | 0.5% |
Institutional review board | 1 | 0.5% |
Insulin resistance | 1 | 0.5% |
Integrated pest management | 1 | 0.5% |
Intellectual disability | 1 | 0.5% |
Intensive farming | 1 | 0.5% |
Inter-rater reliability | 1 | 0.5% |
Interest | 1 | 0.5% |
Interest rate | 1 | 0.5% |
Interferon | 1 | 0.5% |
Interleukin-1 family | 1 | 0.5% |
International Classification of Diseases | 1 | 0.5% |
International Classification of Diseases for Oncology | 1 | 0.5% |
International development | 1 | 0.5% |
Internet of things | 1 | 0.5% |
Internship | 1 | 0.5% |
Interstitial cystitis | 1 | 0.5% |
Intracranial hemorrhage | 1 | 0.5% |
Intracytoplasmic sperm injection | 1 | 0.5% |
Intrauterine growth restriction | 1 | 0.5% |
Intravenous pyelogram | 1 | 0.5% |
Inventory | 1 | 0.5% |
Iodine deficiency | 1 | 0.5% |
Iron overload | 1 | 0.5% |
Iron-deficiency anemia | 1 | 0.5% |
Isolation (health care) | 1 | 0.5% |
Isotope | 1 | 0.5% |
Issues in ethics | 1 | 0.5% |
Ivabradine | 1 | 0.5% |
Ivermectin | 1 | 0.5% |
Jaundice | 1 | 0.5% |
Job satisfaction | 1 | 0.5% |
John J. Zhang | 1 | 0.5% |
Joint dislocation | 1 | 0.5% |
Junior doctor | 1 | 0.5% |
KRAS | 1 | 0.5% |
Kaplan–Meier estimator | 1 | 0.5% |
Kegel exercise | 1 | 0.5% |
Kidney stone disease | 1 | 0.5% |
Knee | 1 | 0.5% |
Knowledge | 1 | 0.5% |
Kt/V | 1 | 0.5% |
LOINC | 1 | 0.5% |
Labor | 1 | 0.5% |
Labor induction | 1 | 0.5% |
Laboratory Response Network | 1 | 0.5% |
Laboratory diagnosis of viral infections | 1 | 0.5% |
Lamivudine | 1 | 0.5% |
Laparoscopy | 1 | 0.5% |
Lassa fever | 1 | 0.5% |
Latent tuberculosis | 1 | 0.5% |
Law | 1 | 0.5% |
Le Fort fracture of skull | 1 | 0.5% |
LeChuck | 1 | 0.5% |
Leaching (agriculture) | 1 | 0.5% |
Leaf | 1 | 0.5% |
Learning | 1 | 0.5% |
Leishmaniasis | 1 | 0.5% |
Leprosy | 1 | 0.5% |
Leptospirosis | 1 | 0.5% |
Levothyroxine | 1 | 0.5% |
License | 1 | 0.5% |
Licensed practical nurse | 1 | 0.5% |
Life | 1 | 0.5% |
Life support system | 1 | 0.5% |
Likelihood function | 1 | 0.5% |
Limited partnership | 1 | 0.5% |
Linear particle accelerator | 1 | 0.5% |
Lipopolysaccharide | 1 | 0.5% |
Liver transplantation | 1 | 0.5% |
Local anesthetic | 1 | 0.5% |
Logic model | 1 | 0.5% |
Long-acting beta-adrenoceptor agonist | 1 | 0.5% |
Long-term care insurance in Germany | 1 | 0.5% |
Low molecular weight heparin | 1 | 0.5% |
Lower respiratory tract infection | 1 | 0.5% |
Lumbar puncture | 1 | 0.5% |
Lumpectomy | 1 | 0.5% |
Lyme disease | 1 | 0.5% |
Lymphatic filariasis | 1 | 0.5% |
MMRV vaccine | 1 | 0.5% |
Macroeconomics | 1 | 0.5% |
Mammaplasty | 1 | 0.5% |
Mammography | 1 | 0.5% |
Management of dehydration | 1 | 0.5% |
Mandible | 1 | 0.5% |
Mandibular fracture | 1 | 0.5% |
Mani Menon | 1 | 0.5% |
Marker-assisted selection | 1 | 0.5% |
Market (economics) | 1 | 0.5% |
Marketing | 1 | 0.5% |
Marketing research | 1 | 0.5% |
Mars | 1 | 0.5% |
Mass drug administration | 1 | 0.5% |
Mass media | 1 | 0.5% |
Mastectomy | 1 | 0.5% |
Mastopexy | 1 | 0.5% |
Maxilla | 1 | 0.5% |
Maximum likelihood estimation | 1 | 0.5% |
Measles | 1 | 0.5% |
Meat | 1 | 0.5% |
Median | 1 | 0.5% |
Mediastinitis | 1 | 0.5% |
Medical emergencies | 1 | 0.5% |
Medical error | 1 | 0.5% |
Medical history | 1 | 0.5% |
Medical laboratory | 1 | 0.5% |
Medicare Sustainable Growth Rate | 1 | 0.5% |
Medicare and Medicaid (United States) | 1 | 0.5% |
Medicare dual eligible | 1 | 0.5% |
Medicare fraud | 1 | 0.5% |
Mediterranean diet | 1 | 0.5% |
Melanocytic nevus | 1 | 0.5% |
Melioidosis | 1 | 0.5% |
Melting point | 1 | 0.5% |
Meningitis | 1 | 0.5% |
Meningococcal disease | 1 | 0.5% |
Meningococcal vaccine | 1 | 0.5% |
Menu | 1 | 0.5% |
Messenger RNA | 1 | 0.5% |
Metabolic engineering | 1 | 0.5% |
Metabolic pathway | 1 | 0.5% |
Metabolic syndrome | 1 | 0.5% |
Metabolism | 1 | 0.5% |
Metabolomics | 1 | 0.5% |
Metadata | 1 | 0.5% |
Metal foam | 1 | 0.5% |
Metastatic breast cancer | 1 | 0.5% |
Metformin | 1 | 0.5% |
Methods of detecting exoplanets | 1 | 0.5% |
Metoclopramide | 1 | 0.5% |
Metolazone | 1 | 0.5% |
Metronidazole | 1 | 0.5% |
Middle East respiratory syndrome | 1 | 0.5% |
Middle East respiratory syndrome coronavirus | 1 | 0.5% |
Middle East respiratory syndrome-related coronavirus | 1 | 0.5% |
Millennium Development Goals | 1 | 0.5% |
Minimally invasive procedure | 1 | 0.5% |
Mitochondrial DNA | 1 | 0.5% |
Mitochondrial disease | 1 | 0.5% |
Mitochondrial replacement therapy | 1 | 0.5% |
Mitochondrion | 1 | 0.5% |
Modern Slavery Act 2015 | 1 | 0.5% |
Molecular marker | 1 | 0.5% |
Molecule | 1 | 0.5% |
Monitoring and evaluation | 1 | 0.5% |
Mood disorder | 1 | 0.5% |
Mortality rate | 1 | 0.5% |
Mosquito | 1 | 0.5% |
Motivation | 1 | 0.5% |
Motivational interviewing | 1 | 0.5% |
Motorcycle | 1 | 0.5% |
Moving average | 1 | 0.5% |
Multiple myeloma | 1 | 0.5% |
Mumps | 1 | 0.5% |
Musculoskeletal system | 1 | 0.5% |
Mutation | 1 | 0.5% |
Mycoplasma | 1 | 0.5% |
Myelofibrosis | 1 | 0.5% |
Myeloproliferative neoplasm | 1 | 0.5% |
NHS targets | 1 | 0.5% |
Nanocarriers | 1 | 0.5% |
National health insurance | 1 | 0.5% |
Natural reservoir | 1 | 0.5% |
Natural selection | 1 | 0.5% |
Nature | 1 | 0.5% |
Nausea | 1 | 0.5% |
Near-infrared spectroscopy | 1 | 0.5% |
Needs assessment | 1 | 0.5% |
Neglected tropical diseases | 1 | 0.5% |
Neisseria gonorrhoeae | 1 | 0.5% |
Neisseria meningitidis | 1 | 0.5% |
Neonatal alloimmune thrombocytopenia | 1 | 0.5% |
Neonatal intensive care unit | 1 | 0.5% |
Nephrectomy | 1 | 0.5% |
Neuroethics | 1 | 0.5% |
Neurological disorder | 1 | 0.5% |
Neuropsychological test | 1 | 0.5% |
Neuropsychology | 1 | 0.5% |
Neurostimulation | 1 | 0.5% |
Neurosurgery | 1 | 0.5% |
Neurotechnology | 1 | 0.5% |
Newborn screening | 1 | 0.5% |
Nipple | 1 | 0.5% |
Nitrogen dioxide | 1 | 0.5% |
Non-governmental organization | 1 | 0.5% |
Nonsteroidal anti-inflammatory drug | 1 | 0.5% |
Normal distribution | 1 | 0.5% |
Norovirus | 1 | 0.5% |
Nuclear and radiation accidents and incidents | 1 | 0.5% |
Nuclear fuel | 1 | 0.5% |
Nuclear fusion | 1 | 0.5% |
Nucleic acid sequence | 1 | 0.5% |
Nucleic acid test | 1 | 0.5% |
Nurse practitioner | 1 | 0.5% |
Nutrient | 1 | 0.5% |
Nutrition facts label | 1 | 0.5% |
Obesity in Australia | 1 | 0.5% |
Obeticholic acid | 1 | 0.5% |
Obstetrics | 1 | 0.5% |
Occupational burnout | 1 | 0.5% |
Old age | 1 | 0.5% |
Ombudsman | 1 | 0.5% |
Onchocerciasis | 1 | 0.5% |
Open access | 1 | 0.5% |
Open innovation | 1 | 0.5% |
Open science | 1 | 0.5% |
Opioid epidemic | 1 | 0.5% |
Opioid epidemic in the United States | 1 | 0.5% |
Oral cancer | 1 | 0.5% |
Oral rehydration therapy | 1 | 0.5% |
Orbit | 1 | 0.5% |
Orbit (anatomy) | 1 | 0.5% |
Ordinary least squares | 1 | 0.5% |
Organ (anatomy) | 1 | 0.5% |
Organ donation | 1 | 0.5% |
Organ transplantation | 1 | 0.5% |
Organic farming | 1 | 0.5% |
Organic, including symptomatic, mental disorders | 1 | 0.5% |
Organophosphate | 1 | 0.5% |
Orthotics | 1 | 0.5% |
Osteotomy | 1 | 0.5% |
Otitis media | 1 | 0.5% |
Outbreak | 1 | 0.5% |
Outsourcing | 1 | 0.5% |
Ovarian follicle | 1 | 0.5% |
Ovarian hyperstimulation syndrome | 1 | 0.5% |
Ovarian reserve | 1 | 0.5% |
Ovary | 1 | 0.5% |
Ovulation induction | 1 | 0.5% |
Oxybutynin | 1 | 0.5% |
Oxygen therapy | 1 | 0.5% |
P-value | 1 | 0.5% |
Pain | 1 | 0.5% |
Pain management | 1 | 0.5% |
Palivizumab | 1 | 0.5% |
Pandemic | 1 | 0.5% |
Panitumumab | 1 | 0.5% |
Panton–Valentine leukocidin | 1 | 0.5% |
Parameter | 1 | 0.5% |
Parathyroid hormone | 1 | 0.5% |
Partition coefficient | 1 | 0.5% |
Partnership | 1 | 0.5% |
Passive smoking | 1 | 0.5% |
Pathology | 1 | 0.5% |
Peer review | 1 | 0.5% |
Peer support | 1 | 0.5% |
Pelvic examination | 1 | 0.5% |
Pelvic inflammatory disease | 1 | 0.5% |
Pelvis | 1 | 0.5% |
Peramivir | 1 | 0.5% |
Percentage | 1 | 0.5% |
Percutaneous aortic valve replacement | 1 | 0.5% |
Percutaneous tibial nerve stimulation | 1 | 0.5% |
Pericardiocentesis | 1 | 0.5% |
Pericarditis | 1 | 0.5% |
Pericardium | 1 | 0.5% |
Perioperative | 1 | 0.5% |
Peritoneal dialysis | 1 | 0.5% |
Peritoneum | 1 | 0.5% |
Personal Responsibility and Work Opportunity Act | 1 | 0.5% |
Personal health record | 1 | 0.5% |
Pertussis vaccine | 1 | 0.5% |
Pest control | 1 | 0.5% |
Pesticide residue | 1 | 0.5% |
Pesticide resistance | 1 | 0.5% |
Pharmacogenetics | 1 | 0.5% |
Pharmacokinetics | 1 | 0.5% |
Pharmacy (shop) | 1 | 0.5% |
Pharmacy benefit management | 1 | 0.5% |
Phenotype | 1 | 0.5% |
Phenotypic trait | 1 | 0.5% |
Phenylketonuria | 1 | 0.5% |
Phosphorus | 1 | 0.5% |
Photomask | 1 | 0.5% |
Photopolymer | 1 | 0.5% |
Photosynthesis | 1 | 0.5% |
Photovoltaics | 1 | 0.5% |
Physical fitness | 1 | 0.5% |
Physical sciences | 1 | 0.5% |
Physical security | 1 | 0.5% |
Physiology | 1 | 0.5% |
Phytophthora infestans | 1 | 0.5% |
Placebo-controlled study | 1 | 0.5% |
Placenta | 1 | 0.5% |
Placental abruption | 1 | 0.5% |
Planetary habitability | 1 | 0.5% |
Planetary protection | 1 | 0.5% |
Planetary science | 1 | 0.5% |
Plant | 1 | 0.5% |
Plant pathology | 1 | 0.5% |
Plateletpheresis | 1 | 0.5% |
Pneumococcal conjugate vaccine | 1 | 0.5% |
Pneumococcal vaccine | 1 | 0.5% |
Politics | 1 | 0.5% |
Polylactic acid | 1 | 0.5% |
Polyp (medicine) | 1 | 0.5% |
Portal hypertension | 1 | 0.5% |
Positron emission tomography | 1 | 0.5% |
Post-thrombotic syndrome | 1 | 0.5% |
Postpartum bleeding | 1 | 0.5% |
Postpartum infections | 1 | 0.5% |
Postpartum period | 1 | 0.5% |
Potato | 1 | 0.5% |
Poverty threshold | 1 | 0.5% |
Powder bed and inkjet head 3D printing | 1 | 0.5% |
Power (statistics) | 1 | 0.5% |
Power of a test | 1 | 0.5% |
Pre-clinical development | 1 | 0.5% |
Pre-eclampsia | 1 | 0.5% |
Pre-exposure prophylaxis | 1 | 0.5% |
Precision agriculture | 1 | 0.5% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 0.5% |
Preimplantation genetic diagnosis | 1 | 0.5% |
Prelabor rupture of membranes | 1 | 0.5% |
Prenatal care | 1 | 0.5% |
Prenatal development | 1 | 0.5% |
Prevalence | 1 | 0.5% |
Pricing | 1 | 0.5% |
Primary sclerosing cholangitis | 1 | 0.5% |
Probability distribution | 1 | 0.5% |
Problem solving | 1 | 0.5% |
Procalcitonin | 1 | 0.5% |
Procurement | 1 | 0.5% |
Professional degrees of public health | 1 | 0.5% |
Promoter (genetics) | 1 | 0.5% |
Proof of concept | 1 | 0.5% |
Protected health information | 1 | 0.5% |
Proteinuria | 1 | 0.5% |
Proteomics | 1 | 0.5% |
Pseudoaneurysm | 1 | 0.5% |
Pseudonymization | 1 | 0.5% |
Psychiatric rehabilitation | 1 | 0.5% |
Psychiatrist | 1 | 0.5% |
Psychological resilience | 1 | 0.5% |
Psychological trauma | 1 | 0.5% |
Psychometrics | 1 | 0.5% |
Psychosis | 1 | 0.5% |
Psychosocial | 1 | 0.5% |
Puberty | 1 | 0.5% |
Public engagement | 1 | 0.5% |
Public policy | 1 | 0.5% |
Pulmonology | 1 | 0.5% |
Pulse | 1 | 0.5% |
Q fever | 1 | 0.5% |
Quality management | 1 | 0.5% |
Quality of life | 1 | 0.5% |
Quantitative structure–activity relationship | 1 | 0.5% |
Quantitative trait locus | 1 | 0.5% |
RANKL | 1 | 0.5% |
RNA | 1 | 0.5% |
RNA interference | 1 | 0.5% |
RTT | 1 | 0.5% |
Race (human categorization) | 1 | 0.5% |
Race and ethnicity in the United States Census | 1 | 0.5% |
Radiation hardening | 1 | 0.5% |
Radiation protection | 1 | 0.5% |
Radioactive contamination | 1 | 0.5% |
Radiofrequency ablation | 1 | 0.5% |
Radiographer | 1 | 0.5% |
Radiography | 1 | 0.5% |
Radius (bone) | 1 | 0.5% |
Rare disease | 1 | 0.5% |
Read code | 1 | 0.5% |
Record linkage | 1 | 0.5% |
Recycling | 1 | 0.5% |
Reference Daily Intake | 1 | 0.5% |
Reference dose | 1 | 0.5% |
Regeneration (biology) | 1 | 0.5% |
Registered nurse | 1 | 0.5% |
Regulation of nanotechnology | 1 | 0.5% |
Relative atomic mass | 1 | 0.5% |
Relative risk | 1 | 0.5% |
Reliability (statistics) | 1 | 0.5% |
Renal sympathetic denervation | 1 | 0.5% |
Reproduction | 1 | 0.5% |
Research and development | 1 | 0.5% |
Respiratory droplet | 1 | 0.5% |
Return on investment | 1 | 0.5% |
Reverse transcription polymerase chain reaction | 1 | 0.5% |
Rhinovirus | 1 | 0.5% |
Rhytidectomy | 1 | 0.5% |
Ribavirin | 1 | 0.5% |
Rice | 1 | 0.5% |
Ricin | 1 | 0.5% |
Rifampicin | 1 | 0.5% |
Rivaroxaban | 1 | 0.5% |
Robotics | 1 | 0.5% |
Rock (geology) | 1 | 0.5% |
Rocket propellant | 1 | 0.5% |
Root | 1 | 0.5% |
Rotator cuff | 1 | 0.5% |
Route of administration | 1 | 0.5% |
Rover (space exploration) | 1 | 0.5% |
RuBisCO | 1 | 0.5% |
Rural health clinic | 1 | 0.5% |
Ryanodine receptor 2 | 1 | 0.5% |
SOFA score | 1 | 0.5% |
Sacubitril/valsartan | 1 | 0.5% |
Safeguarding | 1 | 0.5% |
Safety culture | 1 | 0.5% |
Safety net hospital | 1 | 0.5% |
Salmeterol | 1 | 0.5% |
Sample-return mission | 1 | 0.5% |
Satellite | 1 | 0.5% |
Saxitoxin | 1 | 0.5% |
Scabies | 1 | 0.5% |
Schistosomiasis | 1 | 0.5% |
Scientific visualization | 1 | 0.5% |
Scott Walker (politician) | 1 | 0.5% |
Screening, brief intervention and referral to treatment | 1 | 0.5% |
Seasonality | 1 | 0.5% |
Seismology | 1 | 0.5% |
Select agent | 1 | 0.5% |
Selective laser melting | 1 | 0.5% |
Selective serotonin reuptake inhibitor | 1 | 0.5% |
Self-contained breathing apparatus | 1 | 0.5% |
Self-harm | 1 | 0.5% |
Sentiment analysis | 1 | 0.5% |
Sequencing | 1 | 0.5% |
Serology | 1 | 0.5% |
Severe acute respiratory syndrome | 1 | 0.5% |
Severe acute respiratory syndrome coronavirus | 1 | 0.5% |
Sexual health | 1 | 0.5% |
Sexual reproduction | 1 | 0.5% |
Sexual violence | 1 | 0.5% |
Sexually transmitted diseases and infections | 1 | 0.5% |
Shift work | 1 | 0.5% |
Shock (circulatory) | 1 | 0.5% |
Shoulder | 1 | 0.5% |
Sigmoidoscopy | 1 | 0.5% |
Signs and symptoms | 1 | 0.5% |
Simvastatin | 1 | 0.5% |
Sinusitis | 1 | 0.5% |
Sitosterolemia | 1 | 0.5% |
Sjögren syndrome | 1 | 0.5% |
Skin cancer | 1 | 0.5% |
Skin grafting | 1 | 0.5% |
Skull | 1 | 0.5% |
Skull fracture | 1 | 0.5% |
Slavery in the 21st century | 1 | 0.5% |
Sleep | 1 | 0.5% |
Sleep apnea | 1 | 0.5% |
Smartphone | 1 | 0.5% |
Smoke | 1 | 0.5% |
Smoke detector | 1 | 0.5% |
Smoking | 1 | 0.5% |
Smoking ban | 1 | 0.5% |
Social competence | 1 | 0.5% |
Social group | 1 | 0.5% |
Social innovation | 1 | 0.5% |
Social norm | 1 | 0.5% |
Social science | 1 | 0.5% |
Social stigma | 1 | 0.5% |
Social stigma of obesity | 1 | 0.5% |
Society | 1 | 0.5% |
Socioeconomic status | 1 | 0.5% |
Sodium hypochlorite | 1 | 0.5% |
Soft drink | 1 | 0.5% |
Software | 1 | 0.5% |
Software-defined networking | 1 | 0.5% |
Soil pH | 1 | 0.5% |
Solanaceae | 1 | 0.5% |
Solanezumab | 1 | 0.5% |
Space exploration | 1 | 0.5% |
Species | 1 | 0.5% |
Speech recognition | 1 | 0.5% |
Spinal anaesthesia | 1 | 0.5% |
Spirometry | 1 | 0.5% |
Spironolactone | 1 | 0.5% |
Standardization | 1 | 0.5% |
Staphylococcus | 1 | 0.5% |
Star | 1 | 0.5% |
Statistical area (United States) | 1 | 0.5% |
Stem cell | 1 | 0.5% |
Stereoisomerism | 1 | 0.5% |
Sternum | 1 | 0.5% |
Stool test | 1 | 0.5% |
Strength training | 1 | 0.5% |
Streptococcus pyogenes | 1 | 0.5% |
Stress incontinence | 1 | 0.5% |
Student's t-test | 1 | 0.5% |
Subarachnoid hemorrhage | 1 | 0.5% |
Subdural hematoma | 1 | 0.5% |
Sucrose | 1 | 0.5% |
Sudden infant death syndrome | 1 | 0.5% |
Sugar | 1 | 0.5% |
Sugary drink tax | 1 | 0.5% |
Sun | 1 | 0.5% |
Supplemental Nutrition Assistance Program | 1 | 0.5% |
Supply chain | 1 | 0.5% |
Supportive housing | 1 | 0.5% |
Supraspinatus muscle | 1 | 0.5% |
Supraventricular tachycardia | 1 | 0.5% |
Survival analysis | 1 | 0.5% |
Survival rate | 1 | 0.5% |
Sustainable Development Goal 7 | 1 | 0.5% |
Sweetened beverage | 1 | 0.5% |
Synergy | 1 | 0.5% |
Synthetic biology | 1 | 0.5% |
Synthetic-aperture radar | 1 | 0.5% |
Systemic inflammatory response syndrome | 1 | 0.5% |
Systemic lupus erythematosus | 1 | 0.5% |
Systems biology | 1 | 0.5% |
Systole | 1 | 0.5% |
TLR4 | 1 | 0.5% |
Targeted temperature management | 1 | 0.5% |
Tax | 1 | 0.5% |
Team | 1 | 0.5% |
Telemedicine | 1 | 0.5% |
Temporomandibular joint | 1 | 0.5% |
Tenofovir disoproxil | 1 | 0.5% |
Terminal illness | 1 | 0.5% |
Terminator (genetics) | 1 | 0.5% |
Terrestrial planet | 1 | 0.5% |
Tetanus | 1 | 0.5% |
Tetanus vaccine | 1 | 0.5% |
The Midlands | 1 | 0.5% |
Thorax | 1 | 0.5% |
Thorax (human anatomy) | 1 | 0.5% |
Thrombolysis | 1 | 0.5% |
Thrombosis prevention | 1 | 0.5% |
Thrombus | 1 | 0.5% |
Thumb | 1 | 0.5% |
Thyroid | 1 | 0.5% |
Thyroid disease | 1 | 0.5% |
Thyroid hormones | 1 | 0.5% |
Thyroid-stimulating hormone | 1 | 0.5% |
Tinnitus | 1 | 0.5% |
Tissue plasminogen activator | 1 | 0.5% |
Tobacco smoking | 1 | 0.5% |
Toilet | 1 | 0.5% |
Toll-like receptor | 1 | 0.5% |
Toxin | 1 | 0.5% |
Tracheotomy | 1 | 0.5% |
Transformation (genetics) | 1 | 0.5% |
Transfusion-related acute lung injury | 1 | 0.5% |
Translation | 1 | 0.5% |
Transplant rejection | 1 | 0.5% |
Trastuzumab | 1 | 0.5% |
Trawling | 1 | 0.5% |
Triage | 1 | 0.5% |
Tropical disease | 1 | 0.5% |
Trust law | 1 | 0.5% |
Tsetse fly | 1 | 0.5% |
Type I and type II errors | 1 | 0.5% |
Typhoid fever | 1 | 0.5% |
Ulcer (dermatology) | 1 | 0.5% |
United States elder law | 1 | 0.5% |
United States federal probation and supervised release | 1 | 0.5% |
Universal health care | 1 | 0.5% |
Universal precautions | 1 | 0.5% |
Unlicensed assistive personnel | 1 | 0.5% |
Unwarranted variation | 1 | 0.5% |
Uracil-DNA glycosylase | 1 | 0.5% |
Urethritis | 1 | 0.5% |
Urgent care center | 1 | 0.5% |
Urinary cast | 1 | 0.5% |
Urinary retention | 1 | 0.5% |
Urinary system | 1 | 0.5% |
Urination | 1 | 0.5% |
Ursodeoxycholic acid | 1 | 0.5% |
Usability | 1 | 0.5% |
Utilization management | 1 | 0.5% |
Vaccines | 1 | 0.5% |
Vaginal lubrication | 1 | 0.5% |
Validity (statistics) | 1 | 0.5% |
Valsartan | 1 | 0.5% |
Value (ethics) | 1 | 0.5% |
Value-Based Insurance Design | 1 | 0.5% |
Vancomycin-resistant Enterococcus | 1 | 0.5% |
Vector control | 1 | 0.5% |
Venipuncture | 1 | 0.5% |
Ventilation (architecture) | 1 | 0.5% |
Ventricular assist device | 1 | 0.5% |
Ventricular fibrillation | 1 | 0.5% |
Ventricular natriuretic peptide | 1 | 0.5% |
Verification and validation | 1 | 0.5% |
Vertebra | 1 | 0.5% |
Vertebral column | 1 | 0.5% |
Viral evolution | 1 | 0.5% |
Viral hemorrhagic fever | 1 | 0.5% |
Viral load monitoring for HIV | 1 | 0.5% |
Viral vector | 1 | 0.5% |
Virtual community | 1 | 0.5% |
Visceral leishmaniasis | 1 | 0.5% |
Vitamin C | 1 | 0.5% |
Vitamin E | 1 | 0.5% |
Volatile organic compound | 1 | 0.5% |
Volunteering | 1 | 0.5% |
Vulnerability (computing) | 1 | 0.5% |
Warfarin | 1 | 0.5% |
Waste | 1 | 0.5% |
Waste management | 1 | 0.5% |
Water on Mars | 1 | 0.5% |
Water pollution | 1 | 0.5% |
Weather station | 1 | 0.5% |
Weathering | 1 | 0.5% |
Weed | 1 | 0.5% |
Wheat | 1 | 0.5% |
Whole grain | 1 | 0.5% |
Whooping cough | 1 | 0.5% |
Wildfire | 1 | 0.5% |
Wildfire suppression | 1 | 0.5% |
Wind | 1 | 0.5% |
Woman | 1 | 0.5% |
Working group | 1 | 0.5% |
Wrist | 1 | 0.5% |
Yeast | 1 | 0.5% |
Zanamivir | 1 | 0.5% |
Zidovudine | 1 | 0.5% |
Zika virus | 1 | 0.5% |
Zoonosis | 1 | 0.5% |
Zygomatic bone | 1 | 0.5% |
abs | rel | |
---|---|---|
Health | 184 | 89.8% |
Health care | 175 | 85.4% |
Medicine | 161 | 78.5% |
Health sciences | 151 | 73.7% |
Medical specialties | 118 | 57.6% |
Clinical medicine | 113 | 55.1% |
Risk | 80 | 39.0% |
Human activities | 59 | 28.8% |
Hospital | 55 | 26.8% |
Public health | 50 | 24.4% |
Nursing | 47 | 22.9% |
Patient | 45 | 22.0% |
Diseases and disorders | 41 | 20.0% |
Infection | 41 | 20.0% |
Health economics | 39 | 19.0% |
Research | 39 | 19.0% |
Disease | 37 | 18.0% |
Cancer | 36 | 17.6% |
Evidence-based medicine | 34 | 16.6% |
Adherence (medicine) | 32 | 15.6% |
Emergency department | 32 | 15.6% |
Randomized controlled trial | 32 | 15.6% |
Audit | 31 | 15.1% |
Epidemiology | 31 | 15.1% |
Medicare (United States) | 31 | 15.1% |
Medication | 31 | 15.1% |
Preventive healthcare | 30 | 14.6% |
Medicaid | 29 | 14.1% |
Surgery | 29 | 14.1% |
Biology | 27 | 13.2% |
Electronic health record | 27 | 13.2% |
Systematic review | 27 | 13.2% |
Patient safety | 25 | 12.2% |
Caregiver | 24 | 11.7% |
Chronic condition | 23 | 11.2% |
Clinical trial | 23 | 11.2% |
Mental health | 23 | 11.2% |
Screening (medicine) | 23 | 11.2% |
Therapy | 23 | 11.2% |
Health policy | 22 | 10.7% |
Medical diagnosis | 22 | 10.7% |
Artificial intelligence | 21 | 10.2% |
Life sciences | 21 | 10.2% |
Medical imaging | 21 | 10.2% |
Pharmacy | 21 | 10.2% |
Technology | 21 | 10.2% |
Antimicrobial resistance | 20 | 9.8% |
Clinical commissioning group | 20 | 9.8% |
Cardiovascular disease | 19 | 9.3% |
General practitioner | 19 | 9.3% |
Governance | 19 | 9.3% |
Risk assessment | 19 | 9.3% |
Sustainability | 19 | 9.3% |
Health professional | 18 | 8.8% |
Regulatory compliance | 18 | 8.8% |
Stroke | 18 | 8.8% |
Childbirth | 17 | 8.3% |
Government | 17 | 8.3% |
Management | 17 | 8.3% |
Science | 17 | 8.3% |
Breast cancer | 16 | 7.8% |
Business | 16 | 7.8% |
Meta-analysis | 16 | 7.8% |
HIV/AIDS | 15 | 7.3% |
Myocardial infarction | 15 | 7.3% |
Safety | 15 | 7.3% |
Cohort study | 14 | 6.8% |
Coronary artery disease | 14 | 6.8% |
Dementia | 14 | 6.8% |
Education | 14 | 6.8% |
Heart | 14 | 6.8% |
Long-term care | 14 | 6.8% |
Employment | 13 | 6.3% |
Health system | 13 | 6.3% |
Information | 13 | 6.3% |
Medical guideline | 13 | 6.3% |
Mental disorder | 13 | 6.3% |
Prescription drug | 13 | 6.3% |
Primary care | 13 | 6.3% |
Sensitivity and specificity | 13 | 6.3% |
Antibiotic | 12 | 5.9% |
Evaluation | 12 | 5.9% |
Hypertension | 12 | 5.9% |
Innovation | 12 | 5.9% |
Leadership | 12 | 5.9% |
Public sphere | 12 | 5.9% |
Risk management | 12 | 5.9% |
Tuberculosis | 12 | 5.9% |
Hepatitis | 11 | 5.4% |
Infectious diseases | 11 | 5.4% |
Major depressive disorder | 11 | 5.4% |
Managed care | 11 | 5.4% |
Medical humanities | 11 | 5.4% |
Medical prescription | 11 | 5.4% |
Physician | 11 | 5.4% |
Privacy | 11 | 5.4% |
Virus | 11 | 5.4% |
Alzheimer's disease | 10 | 4.9% |
CT scan | 10 | 4.9% |
Cardiology | 10 | 4.9% |
Confidence interval | 10 | 4.9% |
Data analysis | 10 | 4.9% |
Emergency management | 10 | 4.9% |
Genetics | 10 | 4.9% |
Hospital-acquired infection | 10 | 4.9% |
Immunology | 10 | 4.9% |
Medical treatments | 10 | 4.9% |
Recruitment | 10 | 4.9% |
Self-care | 10 | 4.9% |
Best practice | 9 | 4.4% |
Blinded experiment | 9 | 4.4% |
Cardiovascular system | 9 | 4.4% |
Computer security | 9 | 4.4% |
Disability | 9 | 4.4% |
Fee-for-service | 9 | 4.4% |
Health care quality | 9 | 4.4% |
Hepatitis C | 9 | 4.4% |
Internal control | 9 | 4.4% |
Internet of things | 9 | 4.4% |
Obesity | 9 | 4.4% |
Psychotherapy | 9 | 4.4% |
Receiver operating characteristic | 9 | 4.4% |
Sepsis | 9 | 4.4% |
Social programs | 9 | 4.4% |
Accountable care organization | 8 | 3.9% |
Biotechnology | 8 | 3.9% |
Blood pressure | 8 | 3.9% |
Cholesterol | 8 | 3.9% |
Clostridioides difficile infection | 8 | 3.9% |
Community health | 8 | 3.9% |
DNA sequencing | 8 | 3.9% |
Decision-making | 8 | 3.9% |
Diabetes | 8 | 3.9% |
Drugs | 8 | 3.9% |
Health informatics | 8 | 3.9% |
Infection prevention and control | 8 | 3.9% |
Influenza | 8 | 3.9% |
Internal audit | 8 | 3.9% |
Machine learning | 8 | 3.9% |
Nursing home care | 8 | 3.9% |
Physical therapy | 8 | 3.9% |
Psychiatry | 8 | 3.9% |
Quality-adjusted life year | 8 | 3.9% |
Radiology | 8 | 3.9% |
Renal function | 8 | 3.9% |
Smoking cessation | 8 | 3.9% |
Social work | 8 | 3.9% |
Statin | 8 | 3.9% |
Tobacco smoking | 8 | 3.9% |
Vaccine | 8 | 3.9% |
Venous thrombosis | 8 | 3.9% |
Angina | 7 | 3.4% |
Audit committee | 7 | 3.4% |
Biomarker | 7 | 3.4% |
Chronic obstructive pulmonary disease | 7 | 3.4% |
Comorbidity | 7 | 3.4% |
Gene | 7 | 3.4% |
Glycated hemoglobin | 7 | 3.4% |
Government budget balance | 7 | 3.4% |
Health information technology | 7 | 3.4% |
Low-density lipoprotein | 7 | 3.4% |
Magnetic resonance imaging | 7 | 3.4% |
Mammography | 7 | 3.4% |
Microbiology | 7 | 3.4% |
Multi-drug-resistant tuberculosis | 7 | 3.4% |
Neoplasms | 7 | 3.4% |
Organ transplantation | 7 | 3.4% |
Patient Protection and Affordable Care Act | 7 | 3.4% |
Performance indicator | 7 | 3.4% |
Pharmacology | 7 | 3.4% |
Policy | 7 | 3.4% |
Population health | 7 | 3.4% |
Public services | 7 | 3.4% |
Radiation therapy | 7 | 3.4% |
Services sector of the economy | 7 | 3.4% |
Statistics | 7 | 3.4% |
Welfare | 7 | 3.4% |
Antihypertensive drug | 6 | 2.9% |
Atherosclerosis | 6 | 2.9% |
Automation | 6 | 2.9% |
Brain | 6 | 2.9% |
Chemotherapy | 6 | 2.9% |
Clinical audit | 6 | 2.9% |
Cloud computing | 6 | 2.9% |
Dentistry | 6 | 2.9% |
Employee retention | 6 | 2.9% |
Engineering | 6 | 2.9% |
Genome editing | 6 | 2.9% |
Geriatrics | 6 | 2.9% |
Health care industry | 6 | 2.9% |
Health insurance | 6 | 2.9% |
Hospital readmission | 6 | 2.9% |
Hypercholesterolemia | 6 | 2.9% |
Immune system | 6 | 2.9% |
Medical record | 6 | 2.9% |
Metastasis | 6 | 2.9% |
Midwife | 6 | 2.9% |
Physical examination | 6 | 2.9% |
Placebo | 6 | 2.9% |
Pneumonia | 6 | 2.9% |
Politics | 6 | 2.9% |
Prediction | 6 | 2.9% |
Quality assurance | 6 | 2.9% |
Substance abuse | 6 | 2.9% |
Transmission (medicine) | 6 | 2.9% |
Type 2 diabetes | 6 | 2.9% |
Atheroma | 5 | 2.4% |
Biopsy | 5 | 2.4% |
Branches of science | 5 | 2.4% |
Cancer immunotherapy | 5 | 2.4% |
Cancer screening | 5 | 2.4% |
Cervical cancer | 5 | 2.4% |
Chemistry | 5 | 2.4% |
Chronic kidney disease | 5 | 2.4% |
Clinical governance | 5 | 2.4% |
Cognitive behavioral therapy | 5 | 2.4% |
Colorectal cancer | 5 | 2.4% |
Contract | 5 | 2.4% |
Cost-effectiveness analysis | 5 | 2.4% |
Cyberattack | 5 | 2.4% |
Cytopathology | 5 | 2.4% |
Data quality | 5 | 2.4% |
Database | 5 | 2.4% |
Delirium | 5 | 2.4% |
Development aid | 5 | 2.4% |
Diabetes management | 5 | 2.4% |
Diabetes mellitus | 5 | 2.4% |
Economics of service industries | 5 | 2.4% |
Economy | 5 | 2.4% |
End-of-life care | 5 | 2.4% |
Exercise | 5 | 2.4% |
Fall prevention | 5 | 2.4% |
Food | 5 | 2.4% |
Hazard | 5 | 2.4% |
Hepatitis B | 5 | 2.4% |
High-density lipoprotein | 5 | 2.4% |
Human | 5 | 2.4% |
Infrastructure | 5 | 2.4% |
Interoperability | 5 | 2.4% |
Laparoscopy | 5 | 2.4% |
Medicare dual eligible | 5 | 2.4% |
Methicillin-resistant Staphylococcus aureus | 5 | 2.4% |
Neoplasm | 5 | 2.4% |
Nervous system | 5 | 2.4% |
Neuroscience | 5 | 2.4% |
Nursing home | 5 | 2.4% |
Organ donation | 5 | 2.4% |
Palliative care | 5 | 2.4% |
Pre-exposure prophylaxis | 5 | 2.4% |
Prostate cancer | 5 | 2.4% |
Service industries | 5 | 2.4% |
Shared decision-making in medicine | 5 | 2.4% |
Social determinants of health | 5 | 2.4% |
Strategic planning | 5 | 2.4% |
Survey methodology | 5 | 2.4% |
Thrombosis | 5 | 2.4% |
Tuberculosis management | 5 | 2.4% |
Turnover (employment) | 5 | 2.4% |
Violence | 5 | 2.4% |
ACE inhibitor | 4 | 2.0% |
Abuse | 4 | 2.0% |
Accessibility | 4 | 2.0% |
Adjuvant therapy | 4 | 2.0% |
Ageing | 4 | 2.0% |
Algorithm | 4 | 2.0% |
Anesthesia | 4 | 2.0% |
Anticoagulant | 4 | 2.0% |
Antiviral drug | 4 | 2.0% |
Artificial neural network | 4 | 2.0% |
Aspirin | 4 | 2.0% |
Autism | 4 | 2.0% |
BCG vaccine | 4 | 2.0% |
Bacteria | 4 | 2.0% |
Behavior | 4 | 2.0% |
Bias | 4 | 2.0% |
Blood sugar level | 4 | 2.0% |
Bloodstream infections | 4 | 2.0% |
Board of directors | 4 | 2.0% |
Body mass index | 4 | 2.0% |
Budget | 4 | 2.0% |
CRISPR | 4 | 2.0% |
Case management (US health system) | 4 | 2.0% |
Causes of death | 4 | 2.0% |
Circulatory system | 4 | 2.0% |
Classified information in the United States | 4 | 2.0% |
Climate resilience | 4 | 2.0% |
Cognition | 4 | 2.0% |
Community | 4 | 2.0% |
Congressional oversight | 4 | 2.0% |
Coronary artery bypass surgery | 4 | 2.0% |
Emergency medicine | 4 | 2.0% |
Ethics | 4 | 2.0% |
Expert | 4 | 2.0% |
Gene therapy | 4 | 2.0% |
GeneXpert MTB/RIF | 4 | 2.0% |
Genetic engineering | 4 | 2.0% |
Head and neck cancer | 4 | 2.0% |
Health Insurance Portability and Accountability Act | 4 | 2.0% |
Home care in the United States | 4 | 2.0% |
Homelessness | 4 | 2.0% |
Human papillomavirus infection | 4 | 2.0% |
Hygiene | 4 | 2.0% |
Informed consent | 4 | 2.0% |
Intellectual disability | 4 | 2.0% |
Intensive care unit | 4 | 2.0% |
Internal medicine | 4 | 2.0% |
Ischemia | 4 | 2.0% |
Kidney disease | 4 | 2.0% |
Kidney transplantation | 4 | 2.0% |
Logistic regression | 4 | 2.0% |
Lung cancer | 4 | 2.0% |
Maternal death | 4 | 2.0% |
Medical home | 4 | 2.0% |
NHS foundation trust | 4 | 2.0% |
National security | 4 | 2.0% |
Nicotine replacement therapy | 4 | 2.0% |
Occupational safety and health | 4 | 2.0% |
Osteoporosis | 4 | 2.0% |
Patient participation | 4 | 2.0% |
Pay for performance (healthcare) | 4 | 2.0% |
Percutaneous coronary intervention | 4 | 2.0% |
Pharmacist | 4 | 2.0% |
Positive and negative predictive values | 4 | 2.0% |
Pregnancy | 4 | 2.0% |
Pressure ulcer | 4 | 2.0% |
Preterm birth | 4 | 2.0% |
Prostate-specific antigen | 4 | 2.0% |
Psychology | 4 | 2.0% |
Registered nurse | 4 | 2.0% |
Rifampicin | 4 | 2.0% |
Schizophrenia | 4 | 2.0% |
Scientific method | 4 | 2.0% |
Security clearance | 4 | 2.0% |
Simulation | 4 | 2.0% |
Simvastatin | 4 | 2.0% |
Supplemental Nutrition Assistance Program | 4 | 2.0% |
Sustainable Development Goals | 4 | 2.0% |
T cell | 4 | 2.0% |
Tax | 4 | 2.0% |
Telehealth | 4 | 2.0% |
Transient ischemic attack | 4 | 2.0% |
Urinary tract infection | 4 | 2.0% |
Urology | 4 | 2.0% |
Accuracy and precision | 3 | 1.5% |
Activities of daily living | 3 | 1.5% |
Acute kidney injury | 3 | 1.5% |
Addiction | 3 | 1.5% |
Adverse effect | 3 | 1.5% |
Anesthesiology | 3 | 1.5% |
Angiography | 3 | 1.5% |
Antibody | 3 | 1.5% |
Appropriations bill (United States) | 3 | 1.5% |
Assay | 3 | 1.5% |
Assumption | 3 | 1.5% |
Asthma | 3 | 1.5% |
Atrial fibrillation | 3 | 1.5% |
Autism spectrum | 3 | 1.5% |
Balance sheet | 3 | 1.5% |
Behavioural sciences | 3 | 1.5% |
Big data | 3 | 1.5% |
Biochemistry | 3 | 1.5% |
Bioinformatics | 3 | 1.5% |
Biological warfare | 3 | 1.5% |
Biopharmaceutical | 3 | 1.5% |
Biosafety | 3 | 1.5% |
Biosecurity | 3 | 1.5% |
Birth defect | 3 | 1.5% |
Bisphosphonate | 3 | 1.5% |
Bone density | 3 | 1.5% |
Brain–computer interface | 3 | 1.5% |
Breast cancer screening | 3 | 1.5% |
Breastfeeding | 3 | 1.5% |
Bupropion | 3 | 1.5% |
Cancer staging | 3 | 1.5% |
Cardiac catheterization | 3 | 1.5% |
Cardiac surgery | 3 | 1.5% |
Cervical screening | 3 | 1.5% |
Chief financial officer | 3 | 1.5% |
Cigarette | 3 | 1.5% |
Cirrhosis | 3 | 1.5% |
Classified information | 3 | 1.5% |
Clinic | 3 | 1.5% |
Cognitive science | 3 | 1.5% |
Committee | 3 | 1.5% |
Confidentiality | 3 | 1.5% |
Consensus decision-making | 3 | 1.5% |
Consent | 3 | 1.5% |
Corporate governance | 3 | 1.5% |
Creative Commons license | 3 | 1.5% |
Cyberwarfare | 3 | 1.5% |
DNA | 3 | 1.5% |
Dapagliflozin | 3 | 1.5% |
Dashboard (business) | 3 | 1.5% |
Denosumab | 3 | 1.5% |
Determinants of health | 3 | 1.5% |
Diabetes mellitus type 2 | 3 | 1.5% |
Diagnosis of HIV/AIDS | 3 | 1.5% |
Dialysis | 3 | 1.5% |
Diarrhea | 3 | 1.5% |
Dietitian | 3 | 1.5% |
Disease management (health) | 3 | 1.5% |
Dose (biochemistry) | 3 | 1.5% |
Earnings before interest, taxes, depreciation and amortization | 3 | 1.5% |
Echocardiography | 3 | 1.5% |
Economic growth | 3 | 1.5% |
Economics | 3 | 1.5% |
Electrocardiography | 3 | 1.5% |
Empagliflozin | 3 | 1.5% |
Endometrial cancer | 3 | 1.5% |
Evidence-based practice | 3 | 1.5% |
External beam radiotherapy | 3 | 1.5% |
Fecal occult blood | 3 | 1.5% |
Finance | 3 | 1.5% |
Frailty syndrome | 3 | 1.5% |
Fraud | 3 | 1.5% |
Gastrointestinal tract | 3 | 1.5% |
Genome | 3 | 1.5% |
Health equity | 3 | 1.5% |
Health information exchange | 3 | 1.5% |
Health technology in the United States | 3 | 1.5% |
Heart failure | 3 | 1.5% |
Hematopoietic stem cell transplantation | 3 | 1.5% |
Hepatocellular carcinoma | 3 | 1.5% |
Hereditary nonpolyposis colorectal cancer | 3 | 1.5% |
Home care | 3 | 1.5% |
Hormone replacement therapy | 3 | 1.5% |
Human reproduction | 3 | 1.5% |
Hyperlipidemia | 3 | 1.5% |
Incremental cost-effectiveness ratio | 3 | 1.5% |
Information governance | 3 | 1.5% |
Intensive care medicine | 3 | 1.5% |
International Statistical Classification of Diseases and Related Health Problems | 3 | 1.5% |
International development | 3 | 1.5% |
Isolation (health care) | 3 | 1.5% |
Kidney failure | 3 | 1.5% |
Legal guardian | 3 | 1.5% |
Licensed practical nurse | 3 | 1.5% |
Lipoprotein | 3 | 1.5% |
Liver | 3 | 1.5% |
MammaPrint | 3 | 1.5% |
Management of HIV/AIDS | 3 | 1.5% |
Maternal health | 3 | 1.5% |
Medical Subject Headings | 3 | 1.5% |
Medical device | 3 | 1.5% |
Medical history | 3 | 1.5% |
Medical statistics | 3 | 1.5% |
Medical test | 3 | 1.5% |
Men who have sex with men | 3 | 1.5% |
Meningitis | 3 | 1.5% |
Menopause | 3 | 1.5% |
Metformin | 3 | 1.5% |
Midwifery | 3 | 1.5% |
Millennium Development Goals | 3 | 1.5% |
Minimally invasive procedure | 3 | 1.5% |
Mutation | 3 | 1.5% |
Neonatal intensive care unit | 3 | 1.5% |
Nephrology | 3 | 1.5% |
Neuron | 3 | 1.5% |
Newborn screening | 3 | 1.5% |
Non-communicable disease | 3 | 1.5% |
Office of Inspector General (United States) | 3 | 1.5% |
Old age | 3 | 1.5% |
Organisms | 3 | 1.5% |
Osteopenia | 3 | 1.5% |
Pain | 3 | 1.5% |
Parameter | 3 | 1.5% |
Peripheral artery disease | 3 | 1.5% |
Personal data | 3 | 1.5% |
Pesticide | 3 | 1.5% |
Pharmaceutical industry | 3 | 1.5% |
Pharmacy benefit management | 3 | 1.5% |
Polymerase chain reaction | 3 | 1.5% |
Post-exposure prophylaxis | 3 | 1.5% |
Poverty | 3 | 1.5% |
Prediabetes | 3 | 1.5% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 3 | 1.5% |
Primary health care | 3 | 1.5% |
Programmed cell death protein 1 | 3 | 1.5% |
Prostate cancer screening | 3 | 1.5% |
Protein | 3 | 1.5% |
Prothrombin time | 3 | 1.5% |
Psychological concepts | 3 | 1.5% |
Qualitative research | 3 | 1.5% |
Quality of life | 3 | 1.5% |
Raloxifene | 3 | 1.5% |
Random forest | 3 | 1.5% |
Robot | 3 | 1.5% |
Robot-assisted surgery | 3 | 1.5% |
Safeguarding | 3 | 1.5% |
Sampling (statistics) | 3 | 1.5% |
Saturated fat | 3 | 1.5% |
Sexually transmitted infection | 3 | 1.5% |
Single-nucleotide polymorphism | 3 | 1.5% |
Statistical classification | 3 | 1.5% |
Study heterogeneity | 3 | 1.5% |
Supplemental Security Income | 3 | 1.5% |
Surveillance | 3 | 1.5% |
Synthetic biology | 3 | 1.5% |
System | 3 | 1.5% |
Thorax (human anatomy) | 3 | 1.5% |
Training | 3 | 1.5% |
Training, validation, and test sets | 3 | 1.5% |
Transmissible spongiform encephalopathy | 3 | 1.5% |
Traumatic brain injury | 3 | 1.5% |
Treatment of cancer | 3 | 1.5% |
Usability | 3 | 1.5% |
Utilization management | 3 | 1.5% |
Varenicline | 3 | 1.5% |
WIC | 3 | 1.5% |
Warfarin | 3 | 1.5% |
Water | 3 | 1.5% |
Weapon | 3 | 1.5% |
Wi-Fi | 3 | 1.5% |
Zoledronic acid | 3 | 1.5% |
3D printing | 2 | 1.0% |
Aboriginal Australians | 2 | 1.0% |
Abscess | 2 | 1.0% |
Academic degree | 2 | 1.0% |
Accountability | 2 | 1.0% |
Accounting | 2 | 1.0% |
Acute coronary syndrome | 2 | 1.0% |
Adaptive behavior | 2 | 1.0% |
Agriculture | 2 | 1.0% |
Amos Tversky | 2 | 1.0% |
Analgesic | 2 | 1.0% |
Anticonvulsant | 2 | 1.0% |
Antimicrobial stewardship | 2 | 1.0% |
Antiplatelet drug | 2 | 1.0% |
Antipsychotic | 2 | 1.0% |
Aortic stenosis | 2 | 1.0% |
Aortic valve | 2 | 1.0% |
Aortic valve replacement | 2 | 1.0% |
Apoptosis | 2 | 1.0% |
Appendicitis | 2 | 1.0% |
Application programming interface | 2 | 1.0% |
Arms control | 2 | 1.0% |
Artificial cardiac pacemaker | 2 | 1.0% |
Asset | 2 | 1.0% |
Atrial septal defect | 2 | 1.0% |
Axon | 2 | 1.0% |
BRCA1 | 2 | 1.0% |
BRCA2 | 2 | 1.0% |
Bachelor of Science in Nursing | 2 | 1.0% |
Background check | 2 | 1.0% |
Bank | 2 | 1.0% |
Blood culture | 2 | 1.0% |
Bone | 2 | 1.0% |
Bone fracture | 2 | 1.0% |
Brain tumor | 2 | 1.0% |
Breast self-examination | 2 | 1.0% |
Bronchodilator | 2 | 1.0% |
CHA2DS2–VASc score | 2 | 1.0% |
Canagliflozin | 2 | 1.0% |
Capacity building | 2 | 1.0% |
Cardiac arrest | 2 | 1.0% |
Cardiac stress test | 2 | 1.0% |
Cardiothoracic surgery | 2 | 1.0% |
Carotid artery stenosis | 2 | 1.0% |
Cas9 | 2 | 1.0% |
Case management (US healthcare system) | 2 | 1.0% |
Case–control study | 2 | 1.0% |
Cell therapy | 2 | 1.0% |
Cervical intraepithelial neoplasia | 2 | 1.0% |
Cervix | 2 | 1.0% |
Chemical weapon | 2 | 1.0% |
Chemicals in medicine | 2 | 1.0% |
Child Protective Services | 2 | 1.0% |
Child care | 2 | 1.0% |
Chlamydia | 2 | 1.0% |
Choosing Wisely | 2 | 1.0% |
Clinical decision support system | 2 | 1.0% |
Clinical urine tests | 2 | 1.0% |
Colonoscopy | 2 | 1.0% |
Colposcopy | 2 | 1.0% |
Comprehensive geriatric assessment | 2 | 1.0% |
Computer | 2 | 1.0% |
Conflict of interest | 2 | 1.0% |
Confounding | 2 | 1.0% |
Coronary catheterization | 2 | 1.0% |
Correlation and dependence | 2 | 1.0% |
Creatinine | 2 | 1.0% |
Cryoablation | 2 | 1.0% |
Culture | 2 | 1.0% |
DICOM | 2 | 1.0% |
Da Vinci Surgical System | 2 | 1.0% |
Daniel Kahneman | 2 | 1.0% |
Deep learning | 2 | 1.0% |
Deep vein thrombosis | 2 | 1.0% |
Dental assistant | 2 | 1.0% |
Dental therapist | 2 | 1.0% |
Dependent and independent variables | 2 | 1.0% |
Deprescribing | 2 | 1.0% |
Developmental disability | 2 | 1.0% |
Diabetes mellitus type 1 | 2 | 1.0% |
Diabetic ketoacidosis | 2 | 1.0% |
Dietary supplement | 2 | 1.0% |
Digital health | 2 | 1.0% |
Disorders of endocrine pancreas | 2 | 1.0% |
Do not resuscitate | 2 | 1.0% |
Donabedian model | 2 | 1.0% |
Doppler ultrasonography | 2 | 1.0% |
Dual diagnosis | 2 | 1.0% |
Dual-energy X-ray absorptiometry | 2 | 1.0% |
Dual-use technology | 2 | 1.0% |
EPSDT | 2 | 1.0% |
EQ-5D | 2 | 1.0% |
Ebola | 2 | 1.0% |
Ecology | 2 | 1.0% |
Electric battery | 2 | 1.0% |
Electroconvulsive therapy | 2 | 1.0% |
Electroencephalography | 2 | 1.0% |
Electronic benefit transfer | 2 | 1.0% |
Electronic prescribing | 2 | 1.0% |
Emergency medical services | 2 | 1.0% |
Extensively drug-resistant tuberculosis | 2 | 1.0% |
Familial hypercholesterolemia | 2 | 1.0% |
Family medicine | 2 | 1.0% |
Fetus | 2 | 1.0% |
Financial statement | 2 | 1.0% |
Fixed asset | 2 | 1.0% |
Foodborne illness | 2 | 1.0% |
Formulary (pharmacy) | 2 | 1.0% |
Fractional flow reserve | 2 | 1.0% |
Fuel cell | 2 | 1.0% |
Gene expression | 2 | 1.0% |
Genetic testing | 2 | 1.0% |
Genome-wide association study | 2 | 1.0% |
Genomics | 2 | 1.0% |
Gentamicin | 2 | 1.0% |
Gerontological nursing | 2 | 1.0% |
Gestational age | 2 | 1.0% |
Gestational diabetes | 2 | 1.0% |
Goal | 2 | 1.0% |
Gonorrhea | 2 | 1.0% |
Greenhouse gas | 2 | 1.0% |
Grievance (labour) | 2 | 1.0% |
HER2/neu | 2 | 1.0% |
HIV | 2 | 1.0% |
HPV vaccine | 2 | 1.0% |
Health Information Technology for Economic and Clinical Health Act | 2 | 1.0% |
Health literacy | 2 | 1.0% |
Health technology | 2 | 1.0% |
Healthcare in Cheshire | 2 | 1.0% |
Healthcare management | 2 | 1.0% |
Hearing loss | 2 | 1.0% |
Heart valve | 2 | 1.0% |
Hemodialysis | 2 | 1.0% |
Hepatectomy | 2 | 1.0% |
Hierarchy of evidence | 2 | 1.0% |
Hip fracture | 2 | 1.0% |
Hyperglycemia | 2 | 1.0% |
Immunotherapy | 2 | 1.0% |
Impact evaluation | 2 | 1.0% |
Implant (medicine) | 2 | 1.0% |
Implantable cardioverter-defibrillator | 2 | 1.0% |
Improving Access to Psychological Therapies | 2 | 1.0% |
Incentive | 2 | 1.0% |
Indigenous Australians | 2 | 1.0% |
Infective endocarditis | 2 | 1.0% |
Influenza A virus subtype H7N9 | 2 | 1.0% |
Information privacy | 2 | 1.0% |
Inhaler | 2 | 1.0% |
Insomnia | 2 | 1.0% |
Inspection | 2 | 1.0% |
Insurance | 2 | 1.0% |
Intermediate Care Facilities for Individuals with Mental Retardation | 2 | 1.0% |
Internet | 2 | 1.0% |
Invoice | 2 | 1.0% |
Ionizing radiation | 2 | 1.0% |
Kidney | 2 | 1.0% |
Laboratory | 2 | 1.0% |
Lassa fever | 2 | 1.0% |
Lasso (statistics) | 2 | 1.0% |
Law | 2 | 1.0% |
Lawsuit | 2 | 1.0% |
Left atrial appendage occlusion | 2 | 1.0% |
Leukemia | 2 | 1.0% |
Life | 2 | 1.0% |
Listeria monocytogenes | 2 | 1.0% |
Listeriosis | 2 | 1.0% |
Liver cancer | 2 | 1.0% |
Liver transplantation | 2 | 1.0% |
Lung | 2 | 1.0% |
Lymphoma | 2 | 1.0% |
Malaria | 2 | 1.0% |
Market (economics) | 2 | 1.0% |
Medi-Cal | 2 | 1.0% |
Medical error | 2 | 1.0% |
Medical microbiology | 2 | 1.0% |
Medical specialty | 2 | 1.0% |
Medical tests | 2 | 1.0% |
Medical ultrasound | 2 | 1.0% |
Metabolic syndrome | 2 | 1.0% |
Metabolism | 2 | 1.0% |
Metronidazole | 2 | 1.0% |
Microsatellite instability | 2 | 1.0% |
Microwave ablation | 2 | 1.0% |
Mind | 2 | 1.0% |
Miscarriage | 2 | 1.0% |
Mitochondrion | 2 | 1.0% |
Model organism | 2 | 1.0% |
Molecular biology | 2 | 1.0% |
Monitoring (medicine) | 2 | 1.0% |
Moral hazard | 2 | 1.0% |
Multilocus sequence typing | 2 | 1.0% |
Mycobacterium | 2 | 1.0% |
Neonicotinoid | 2 | 1.0% |
Nerve | 2 | 1.0% |
Neuroimaging | 2 | 1.0% |
Neuropathic pain | 2 | 1.0% |
Neurotechnology | 2 | 1.0% |
Nicotine | 2 | 1.0% |
Nivolumab | 2 | 1.0% |
Non-executive director | 2 | 1.0% |
Non-small-cell lung carcinoma | 2 | 1.0% |
Nuchal scan | 2 | 1.0% |
Nutrition | 2 | 1.0% |
Obstetrics | 2 | 1.0% |
Occam's razor | 2 | 1.0% |
Oral cancer | 2 | 1.0% |
Ordinary least squares | 2 | 1.0% |
Organism | 2 | 1.0% |
Organization development | 2 | 1.0% |
Osteonecrosis of the jaw | 2 | 1.0% |
Ovarian cancer | 2 | 1.0% |
Overdiagnosis | 2 | 1.0% |
PCSK9 | 2 | 1.0% |
PD-L1 | 2 | 1.0% |
Pain management | 2 | 1.0% |
Pap test | 2 | 1.0% |
Parkinson's disease | 2 | 1.0% |
Pathogen | 2 | 1.0% |
Peptic ulcer disease | 2 | 1.0% |
Percutaneous aortic valve replacement | 2 | 1.0% |
Performance appraisal | 2 | 1.0% |
Peripheral neuropathy | 2 | 1.0% |
Personalized medicine | 2 | 1.0% |
Physical sciences | 2 | 1.0% |
Point of care | 2 | 1.0% |
Polyp (medicine) | 2 | 1.0% |
Polypharmacy | 2 | 1.0% |
Portal hypertension | 2 | 1.0% |
Precision medicine | 2 | 1.0% |
Predictive modelling | 2 | 1.0% |
Prenatal development | 2 | 1.0% |
Prenatal testing | 2 | 1.0% |
Prescription monitoring program | 2 | 1.0% |
Prison | 2 | 1.0% |
Procurement | 2 | 1.0% |
Productivity | 2 | 1.0% |
Prosecutor | 2 | 1.0% |
Proton-exchange membrane fuel cell | 2 | 1.0% |
Psychological resilience | 2 | 1.0% |
Psychological trauma | 2 | 1.0% |
Psychosis | 2 | 1.0% |
Psychosocial | 2 | 1.0% |
Public health surveillance | 2 | 1.0% |
Public policy | 2 | 1.0% |
Publication bias | 2 | 1.0% |
Pyrazinamide | 2 | 1.0% |
Quality management | 2 | 1.0% |
RTT | 2 | 1.0% |
Rabies | 2 | 1.0% |
Real-time polymerase chain reaction | 2 | 1.0% |
Regression analysis | 2 | 1.0% |
Regularization (mathematics) | 2 | 1.0% |
Relative risk | 2 | 1.0% |
Reliability engineering | 2 | 1.0% |
Remote surgery | 2 | 1.0% |
Reporting bias | 2 | 1.0% |
Representativeness heuristic | 2 | 1.0% |
Respiratory disease | 2 | 1.0% |
Respite care | 2 | 1.0% |
Retail | 2 | 1.0% |
Retinoblastoma | 2 | 1.0% |
Rituximab | 2 | 1.0% |
Robotics | 2 | 1.0% |
Rosiglitazone | 2 | 1.0% |
Rosuvastatin | 2 | 1.0% |
Selective estrogen receptor modulator | 2 | 1.0% |
Selective internal radiation therapy | 2 | 1.0% |
Sensitivity analysis | 2 | 1.0% |
Sexually transmitted diseases and infections | 2 | 1.0% |
Sickle cell disease | 2 | 1.0% |
Sievert | 2 | 1.0% |
Sigmoidoscopy | 2 | 1.0% |
Signal transduction | 2 | 1.0% |
Single-payer healthcare | 2 | 1.0% |
Sleep | 2 | 1.0% |
Social Security (United States) | 2 | 1.0% |
Social media | 2 | 1.0% |
Social responsibility | 2 | 1.0% |
Sofosbuvir | 2 | 1.0% |
Software | 2 | 1.0% |
Solar cell | 2 | 1.0% |
Sorafenib | 2 | 1.0% |
Spirometry | 2 | 1.0% |
Standard deviation | 2 | 1.0% |
Standardization | 2 | 1.0% |
Staphylococcus aureus | 2 | 1.0% |
Statistical model | 2 | 1.0% |
Statistical process control | 2 | 1.0% |
Statute of limitations | 2 | 1.0% |
Stem cell | 2 | 1.0% |
Substance-related disorders | 2 | 1.0% |
Supply chain | 2 | 1.0% |
Sustainability and transformation plan | 2 | 1.0% |
Syphilis | 2 | 1.0% |
Systemic lupus erythematosus | 2 | 1.0% |
Team | 2 | 1.0% |
Temporary Assistance for Needy Families | 2 | 1.0% |
Teriparatide | 2 | 1.0% |
Toxicity | 2 | 1.0% |
Toxin | 2 | 1.0% |
Transcatheter arterial chemoembolization | 2 | 1.0% |
Transcranial direct-current stimulation | 2 | 1.0% |
Transcription (biology) | 2 | 1.0% |
Translational research | 2 | 1.0% |
Transport | 2 | 1.0% |
Troponin | 2 | 1.0% |
Unmanned aerial vehicle | 2 | 1.0% |
Urgent care center | 2 | 1.0% |
Ventricle (heart) | 2 | 1.0% |
Ventricular tachycardia | 2 | 1.0% |
Vertebral augmentation | 2 | 1.0% |
Vertically transmitted infection | 2 | 1.0% |
Viral hemorrhagic fever | 2 | 1.0% |
Virtual reality | 2 | 1.0% |
Voting | 2 | 1.0% |
Wearable technology | 2 | 1.0% |
Whole genome sequencing | 2 | 1.0% |
World Wide Web | 2 | 1.0% |
Zoonosis | 2 | 1.0% |
100 metres | 1 | 0.5% |
5G | 1 | 0.5% |
Abacavir | 1 | 0.5% |
Abaloparatide | 1 | 0.5% |
Abdominal aortic aneurysm | 1 | 0.5% |
Aberrations of the eye | 1 | 0.5% |
Abortion | 1 | 0.5% |
Absorbed dose | 1 | 0.5% |
Abu Bakr al-Baghdadi | 1 | 0.5% |
Acetylcholine | 1 | 0.5% |
Acetylcholinesterase | 1 | 0.5% |
Acetylcysteine | 1 | 0.5% |
Aciclovir | 1 | 0.5% |
Acinetobacter | 1 | 0.5% |
Acrylamide | 1 | 0.5% |
Actigraphy | 1 | 0.5% |
Action at a distance | 1 | 0.5% |
Active mobility | 1 | 0.5% |
Acute exacerbation of chronic obstructive pulmonary disease | 1 | 0.5% |
Acute lymphoblastic leukemia | 1 | 0.5% |
Acute myeloid leukemia | 1 | 0.5% |
Adenosine | 1 | 0.5% |
Adjuvant | 1 | 0.5% |
Administrative License Suspension | 1 | 0.5% |
Adult daycare center | 1 | 0.5% |
Advanced practice nurse | 1 | 0.5% |
Adverse Childhood Experiences Study | 1 | 0.5% |
Adverse drug reaction | 1 | 0.5% |
Agarose gel electrophoresis | 1 | 0.5% |
Agenda (meeting) | 1 | 0.5% |
Agenda for Change | 1 | 0.5% |
Aggression | 1 | 0.5% |
Air pollution | 1 | 0.5% |
Airline | 1 | 0.5% |
Albert Einstein | 1 | 0.5% |
Alcohol abuse | 1 | 0.5% |
Alcohol intoxication | 1 | 0.5% |
Alcoholic drink | 1 | 0.5% |
Alcoholism | 1 | 0.5% |
Allele | 1 | 0.5% |
Allergen | 1 | 0.5% |
Allergen immunotherapy | 1 | 0.5% |
Allergy | 1 | 0.5% |
Ambulatory blood pressure | 1 | 0.5% |
Amikacin | 1 | 0.5% |
Aminoglycoside | 1 | 0.5% |
Amniocentesis | 1 | 0.5% |
Amoebiasis | 1 | 0.5% |
Amoxicillin | 1 | 0.5% |
Amphotericin B | 1 | 0.5% |
Ampicillin | 1 | 0.5% |
Ampicillin/sulbactam | 1 | 0.5% |
Amplicon | 1 | 0.5% |
Amyloid beta | 1 | 0.5% |
Amyloid precursor protein | 1 | 0.5% |
Amyloid-beta precursor protein | 1 | 0.5% |
Anabolic steroid | 1 | 0.5% |
Anaerobic infection | 1 | 0.5% |
Analytics | 1 | 0.5% |
Anastrozole | 1 | 0.5% |
Anemia | 1 | 0.5% |
Aneuploidy | 1 | 0.5% |
Angiology | 1 | 0.5% |
Angiotensin II receptor blocker | 1 | 0.5% |
Animal bite | 1 | 0.5% |
Anthropometry of the upper arm | 1 | 0.5% |
Anti-diabetic medication | 1 | 0.5% |
Anti-dsDNA antibodies | 1 | 0.5% |
Anti-nuclear antibody | 1 | 0.5% |
Antibiotic prophylaxis | 1 | 0.5% |
Antibiotic sensitivity | 1 | 0.5% |
Antibiotics | 1 | 0.5% |
Antibody-drug conjugate | 1 | 0.5% |
Antidepressant | 1 | 0.5% |
Antifungal | 1 | 0.5% |
Antigen | 1 | 0.5% |
Antioxidant | 1 | 0.5% |
Anxiety disorder | 1 | 0.5% |
Aortic insufficiency | 1 | 0.5% |
Apixaban | 1 | 0.5% |
Apolipoprotein E | 1 | 0.5% |
Appendectomy | 1 | 0.5% |
Applied behavior analysis | 1 | 0.5% |
Applied ethics | 1 | 0.5% |
Aquaculture | 1 | 0.5% |
Aromatase inhibitor | 1 | 0.5% |
Aromatic compounds | 1 | 0.5% |
Arrhythmia | 1 | 0.5% |
Arthur Eddington | 1 | 0.5% |
Artificial gene synthesis | 1 | 0.5% |
Artificial kidney | 1 | 0.5% |
Ascending cholangitis | 1 | 0.5% |
Aspergillosis | 1 | 0.5% |
Assisted reproductive technology | 1 | 0.5% |
Assurance services | 1 | 0.5% |
Astigmatism | 1 | 0.5% |
Astronomical objects | 1 | 0.5% |
Astronomy | 1 | 0.5% |
Atorvastatin | 1 | 0.5% |
Attention deficit hyperactivity disorder | 1 | 0.5% |
Attitude (psychology) | 1 | 0.5% |
Augmented reality | 1 | 0.5% |
Australian Organ Donor Register | 1 | 0.5% |
Autism therapies | 1 | 0.5% |
Autoimmune disease | 1 | 0.5% |
Autoimmunity | 1 | 0.5% |
Autologous chondrocyte implantation | 1 | 0.5% |
Automatic identification system | 1 | 0.5% |
Autonomy | 1 | 0.5% |
Axicabtagene ciloleucel | 1 | 0.5% |
Azathioprine | 1 | 0.5% |
Azo dye | 1 | 0.5% |
B cell | 1 | 0.5% |
B1 cell | 1 | 0.5% |
BRCA mutation | 1 | 0.5% |
Back-illuminated sensor | 1 | 0.5% |
Balanced Budget Act of 1997 | 1 | 0.5% |
Barley yellow dwarf | 1 | 0.5% |
Baseline (budgeting) | 1 | 0.5% |
Bedaquiline | 1 | 0.5% |
Beta-Carotene | 1 | 0.5% |
Beta-catenin | 1 | 0.5% |
Beta-galactosidase | 1 | 0.5% |
Beta-lactamase | 1 | 0.5% |
Bicycle | 1 | 0.5% |
Binge drinking | 1 | 0.5% |
Biobank | 1 | 0.5% |
Biochar | 1 | 0.5% |
Biochemical cascade | 1 | 0.5% |
Biochemistry methods | 1 | 0.5% |
Biocide | 1 | 0.5% |
Biodefense | 1 | 0.5% |
Bioethics | 1 | 0.5% |
Biological Weapons Convention | 1 | 0.5% |
Biological techniques and tools | 1 | 0.5% |
Biomedical waste | 1 | 0.5% |
Biomedicine | 1 | 0.5% |
Bioreactor | 1 | 0.5% |
Biosafety level | 1 | 0.5% |
Biosensor | 1 | 0.5% |
Bipolar disorder | 1 | 0.5% |
Birth weight | 1 | 0.5% |
Bladder cancer | 1 | 0.5% |
Bleeding | 1 | 0.5% |
Blockchain | 1 | 0.5% |
Blood alcohol content | 1 | 0.5% |
Blood glucose monitoring | 1 | 0.5% |
Blood lipids | 1 | 0.5% |
Blood-borne disease | 1 | 0.5% |
Body integrity dysphoria | 1 | 0.5% |
Bone marrow | 1 | 0.5% |
Bone resorption | 1 | 0.5% |
Borderline personality disorder | 1 | 0.5% |
Botany | 1 | 0.5% |
Bottled water | 1 | 0.5% |
Bovine spongiform encephalopathy | 1 | 0.5% |
Brachytherapy | 1 | 0.5% |
Brain abscess | 1 | 0.5% |
Brain damage | 1 | 0.5% |
Brain ischemia | 1 | 0.5% |
Brain metastasis | 1 | 0.5% |
BrainGate | 1 | 0.5% |
Brainstorming | 1 | 0.5% |
Breast cancer classification | 1 | 0.5% |
Breast milk | 1 | 0.5% |
Breathalyzer | 1 | 0.5% |
Brexit | 1 | 0.5% |
Bronchiectasis | 1 | 0.5% |
Bruce Keogh | 1 | 0.5% |
Brugada syndrome | 1 | 0.5% |
Budesonide | 1 | 0.5% |
Budesonide/formoterol | 1 | 0.5% |
Bullous pemphigoid | 1 | 0.5% |
Bumetanide | 1 | 0.5% |
Burn | 1 | 0.5% |
Business process | 1 | 0.5% |
C-reactive protein | 1 | 0.5% |
CCR5 | 1 | 0.5% |
CD135 | 1 | 0.5% |
CD19 | 1 | 0.5% |
CD4 | 1 | 0.5% |
CD4+ T cells and antitumor immunity | 1 | 0.5% |
CE marking | 1 | 0.5% |
CHEK2 | 1 | 0.5% |
CHOP | 1 | 0.5% |
CRISPR gene editing | 1 | 0.5% |
CRISPR/Cpf1 | 1 | 0.5% |
CYP3A4 | 1 | 0.5% |
Cadmium | 1 | 0.5% |
Caesarean section | 1 | 0.5% |
California County Routes in zone G | 1 | 0.5% |
Campylobacter | 1 | 0.5% |
Campylobacter jejuni | 1 | 0.5% |
Cancer prevention | 1 | 0.5% |
Cancer registry | 1 | 0.5% |
Candidiasis | 1 | 0.5% |
Canon PowerShot G | 1 | 0.5% |
Car | 1 | 0.5% |
Carbamazepine | 1 | 0.5% |
Carbapenem | 1 | 0.5% |
Carbapenem-resistant enterobacteriaceae | 1 | 0.5% |
Carbon footprint | 1 | 0.5% |
Carcinogen | 1 | 0.5% |
Carcinoma | 1 | 0.5% |
Cardiac monitoring | 1 | 0.5% |
Cardiac muscle | 1 | 0.5% |
Cardiac rehabilitation | 1 | 0.5% |
Cardiogenic shock | 1 | 0.5% |
Cardiotocography | 1 | 0.5% |
Carotid endarterectomy | 1 | 0.5% |
Carotid stenting | 1 | 0.5% |
Cartilage | 1 | 0.5% |
Caspofungin | 1 | 0.5% |
Cat | 1 | 0.5% |
Catalysis | 1 | 0.5% |
Catheter | 1 | 0.5% |
Cathode | 1 | 0.5% |
Cattle | 1 | 0.5% |
Cefazolin | 1 | 0.5% |
Cefotaxime | 1 | 0.5% |
Ceftriaxone | 1 | 0.5% |
Cell (biology) | 1 | 0.5% |
Cell biology | 1 | 0.5% |
Cell growth | 1 | 0.5% |
Cell signaling | 1 | 0.5% |
Cell-free fetal DNA | 1 | 0.5% |
Cellular network | 1 | 0.5% |
Cellular respiration | 1 | 0.5% |
Central nervous system | 1 | 0.5% |
Cephalosporin | 1 | 0.5% |
Cerebrospinal fluid | 1 | 0.5% |
Chain of custody | 1 | 0.5% |
Chairperson | 1 | 0.5% |
Chancroid | 1 | 0.5% |
Charge-coupled device | 1 | 0.5% |
Charitable organization | 1 | 0.5% |
Charitable trust | 1 | 0.5% |
Chemical Weapons Convention | 1 | 0.5% |
Chest radiograph | 1 | 0.5% |
Chief executive officer | 1 | 0.5% |
Children's Health Insurance Program | 1 | 0.5% |
Chimeric antigen receptor | 1 | 0.5% |
Chimeric antigen receptor T cell | 1 | 0.5% |
Chlorpyrifos | 1 | 0.5% |
Cholecystectomy | 1 | 0.5% |
Cholinesterase | 1 | 0.5% |
Chronic care management | 1 | 0.5% |
Chronic lymphocytic leukemia | 1 | 0.5% |
Chronic myelogenous leukemia | 1 | 0.5% |
Chronic pain | 1 | 0.5% |
Chronic wasting disease | 1 | 0.5% |
Chylomicron | 1 | 0.5% |
Circadian rhythm | 1 | 0.5% |
Circular RNA | 1 | 0.5% |
Citalopram | 1 | 0.5% |
Classification of ethnicity in the United Kingdom | 1 | 0.5% |
Clerk of the United States House of Representatives | 1 | 0.5% |
Climate change | 1 | 0.5% |
Climate change mitigation | 1 | 0.5% |
Clindamycin | 1 | 0.5% |
Clinical psychology | 1 | 0.5% |
Clostridioides difficile (bacteria) | 1 | 0.5% |
Cluster analysis | 1 | 0.5% |
Co-stimulation | 1 | 0.5% |
Cochlea | 1 | 0.5% |
Cochlear implant | 1 | 0.5% |
Cochrane Library | 1 | 0.5% |
Code of Virginia | 1 | 0.5% |
Coefficient of determination | 1 | 0.5% |
Coenzyme A | 1 | 0.5% |
Cognitive reserve | 1 | 0.5% |
Cold chain | 1 | 0.5% |
Collaboration | 1 | 0.5% |
Common Foreign and Security Policy | 1 | 0.5% |
Communication | 1 | 0.5% |
Communication protocol | 1 | 0.5% |
Community health worker | 1 | 0.5% |
Community integration | 1 | 0.5% |
Community mental health service | 1 | 0.5% |
Commuting | 1 | 0.5% |
Competition | 1 | 0.5% |
Complaint | 1 | 0.5% |
Complementary DNA | 1 | 0.5% |
Computational phylogenetics | 1 | 0.5% |
Computer network | 1 | 0.5% |
Computer science | 1 | 0.5% |
Computer-aided diagnosis | 1 | 0.5% |
Computing | 1 | 0.5% |
Concussion | 1 | 0.5% |
Condom | 1 | 0.5% |
Congenital cytomegalovirus infection | 1 | 0.5% |
Congenital heart defect | 1 | 0.5% |
Contig | 1 | 0.5% |
Continuing healthcare | 1 | 0.5% |
Control chart | 1 | 0.5% |
Control of Substances Hazardous to Health Regulations 2002 | 1 | 0.5% |
Controlled Substances Act | 1 | 0.5% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 1 | 0.5% |
Convolutional neural network | 1 | 0.5% |
Coronagraph | 1 | 0.5% |
Coronary artery anomaly | 1 | 0.5% |
Coronary circulation | 1 | 0.5% |
Corporate social responsibility | 1 | 0.5% |
Cortical implant | 1 | 0.5% |
Cosmic dust | 1 | 0.5% |
Cosmology | 1 | 0.5% |
Cost | 1 | 0.5% |
Cost–benefit analysis | 1 | 0.5% |
Courier | 1 | 0.5% |
CpG site | 1 | 0.5% |
Creutzfeldt–Jakob disease | 1 | 0.5% |
Cryptococcosis | 1 | 0.5% |
Current Procedural Terminology | 1 | 0.5% |
Current liability | 1 | 0.5% |
Curriculum | 1 | 0.5% |
Customer satisfaction | 1 | 0.5% |
Cyclin-dependent kinase | 1 | 0.5% |
Cycling | 1 | 0.5% |
Cystic fibrosis transmembrane conductance regulator | 1 | 0.5% |
Cystoscopy | 1 | 0.5% |
Cytokine | 1 | 0.5% |
Cytotoxic T cell | 1 | 0.5% |
DNA methylation | 1 | 0.5% |
DNA replication | 1 | 0.5% |
Dabigatran | 1 | 0.5% |
Dangerous goods | 1 | 0.5% |
Data | 1 | 0.5% |
De-escalation | 1 | 0.5% |
Death | 1 | 0.5% |
Debt | 1 | 0.5% |
Deep brain stimulation | 1 | 0.5% |
Defibrillation | 1 | 0.5% |
Deficit spending | 1 | 0.5% |
Deformation (mechanics) | 1 | 0.5% |
Dental implant | 1 | 0.5% |
Design | 1 | 0.5% |
Desktop virtualization | 1 | 0.5% |
Desmopressin | 1 | 0.5% |
Desogestrel | 1 | 0.5% |
Deuterium | 1 | 0.5% |
Dexamethasone | 1 | 0.5% |
Diabetic cardiomyopathy | 1 | 0.5% |
Diabetic neuropathy | 1 | 0.5% |
Dietary Reference Intake | 1 | 0.5% |
Dieting | 1 | 0.5% |
Diffuse large B-cell lymphoma | 1 | 0.5% |
Dignity | 1 | 0.5% |
Dioxins and dioxin-like compounds | 1 | 0.5% |
Discrete trial training | 1 | 0.5% |
Disease burden | 1 | 0.5% |
Distributed generation | 1 | 0.5% |
Do-it-yourself biology | 1 | 0.5% |
Docosahexaenoic acid | 1 | 0.5% |
Doctor of Philosophy | 1 | 0.5% |
Dog | 1 | 0.5% |
Domperidone | 1 | 0.5% |
Donald Trump | 1 | 0.5% |
Down syndrome | 1 | 0.5% |
Driving under the influence | 1 | 0.5% |
Droperidol | 1 | 0.5% |
Drug brand names | 1 | 0.5% |
Drug development | 1 | 0.5% |
Drugs acting on the nervous system | 1 | 0.5% |
Drunk drivers | 1 | 0.5% |
Drunk driving in the United States | 1 | 0.5% |
Duchenne muscular dystrophy | 1 | 0.5% |
Duloxetine | 1 | 0.5% |
Duty of candour | 1 | 0.5% |
Dysphagia | 1 | 0.5% |
EHealth | 1 | 0.5% |
ELISA | 1 | 0.5% |
Ear | 1 | 0.5% |
Early-onset Alzheimer's disease | 1 | 0.5% |
Ebola virus disease | 1 | 0.5% |
Edge computing | 1 | 0.5% |
Educational technology | 1 | 0.5% |
Eicosapentaenoic acid | 1 | 0.5% |
Elderly care | 1 | 0.5% |
Electric vehicle | 1 | 0.5% |
Electrical grid | 1 | 0.5% |
Electrochemistry | 1 | 0.5% |
Electrocorticography | 1 | 0.5% |
Electrolysis | 1 | 0.5% |
Electromagnetic metasurface | 1 | 0.5% |
Electromyography | 1 | 0.5% |
Electronic design automation | 1 | 0.5% |
Embolization | 1 | 0.5% |
Emergency | 1 | 0.5% |
Emergency medical technician | 1 | 0.5% |
Emerging technologies | 1 | 0.5% |
Emotional self-regulation | 1 | 0.5% |
Employee engagement | 1 | 0.5% |
Empowerment | 1 | 0.5% |
Emtricitabine | 1 | 0.5% |
End Stage Renal Disease Program | 1 | 0.5% |
End user | 1 | 0.5% |
Endocrine system | 1 | 0.5% |
Endometriosis | 1 | 0.5% |
Endometrium | 1 | 0.5% |
Endoscopic mucosal resection | 1 | 0.5% |
Endoscopic submucosal dissection | 1 | 0.5% |
Enema | 1 | 0.5% |
Entamoeba | 1 | 0.5% |
Enterococcus | 1 | 0.5% |
Enterococcus faecalis | 1 | 0.5% |
Enterprise content management | 1 | 0.5% |
Environmental factor | 1 | 0.5% |
Environmental social science | 1 | 0.5% |
Enzyme | 1 | 0.5% |
Enzyme inhibitor | 1 | 0.5% |
Epidural administration | 1 | 0.5% |
Equity (finance) | 1 | 0.5% |
Erythropoietin | 1 | 0.5% |
Escherichia coli | 1 | 0.5% |
Esophageal cancer | 1 | 0.5% |
Essential health benefits | 1 | 0.5% |
Estradiol (medication) | 1 | 0.5% |
Estrogen | 1 | 0.5% |
Eteplirsen | 1 | 0.5% |
Ethinylestradiol | 1 | 0.5% |
Ethyl eicosapentaenoic acid | 1 | 0.5% |
Euripides | 1 | 0.5% |
European Nucleotide Archive | 1 | 0.5% |
European emission standards | 1 | 0.5% |
Evaluation of binary classifiers | 1 | 0.5% |
Eviction | 1 | 0.5% |
Evidence | 1 | 0.5% |
Evolution | 1 | 0.5% |
Exemestane | 1 | 0.5% |
Exoplanet | 1 | 0.5% |
Exosome (vesicle) | 1 | 0.5% |
Expense | 1 | 0.5% |
Experiment | 1 | 0.5% |
Exposure assessment | 1 | 0.5% |
External auditor | 1 | 0.5% |
External cephalic version | 1 | 0.5% |
Ezetimibe | 1 | 0.5% |
FRAX | 1 | 0.5% |
Fair Labor Standards Act of 1938 | 1 | 0.5% |
Familial adenomatous polyposis | 1 | 0.5% |
Family caregivers | 1 | 0.5% |
Fat | 1 | 0.5% |
Fatigue | 1 | 0.5% |
Fatty acid | 1 | 0.5% |
Febrile neutropenia | 1 | 0.5% |
Federal Information Security Management Act of 2002 | 1 | 0.5% |
Federally Qualified Health Center | 1 | 0.5% |
Feeling | 1 | 0.5% |
Fenofibrate | 1 | 0.5% |
Fentanyl | 1 | 0.5% |
Fetal movement | 1 | 0.5% |
Fibrate | 1 | 0.5% |
Fibrocystic breast changes | 1 | 0.5% |
Fidaxomicin | 1 | 0.5% |
File Transfer Protocol | 1 | 0.5% |
File format | 1 | 0.5% |
FinFET | 1 | 0.5% |
Financial audit | 1 | 0.5% |
Fine-needle aspiration | 1 | 0.5% |
Flight surgeon | 1 | 0.5% |
Flow battery | 1 | 0.5% |
Fluconazole | 1 | 0.5% |
Flucytosine | 1 | 0.5% |
Fluticasone propionate | 1 | 0.5% |
Fluvastatin | 1 | 0.5% |
Follicular lymphoma | 1 | 0.5% |
Food and drink | 1 | 0.5% |
Food energy | 1 | 0.5% |
Food safety | 1 | 0.5% |
Framingham Risk Score | 1 | 0.5% |
Francis Crick | 1 | 0.5% |
Franklin Stahl | 1 | 0.5% |
Frozen section procedure | 1 | 0.5% |
Fuel economy in automobiles | 1 | 0.5% |
Functional electrical stimulation | 1 | 0.5% |
Functional groups | 1 | 0.5% |
Functional magnetic resonance imaging | 1 | 0.5% |
Functional near-infrared spectroscopy | 1 | 0.5% |
Fund accounting | 1 | 0.5% |
Fundraising | 1 | 0.5% |
Furosemide | 1 | 0.5% |
Gabapentin | 1 | 0.5% |
Galanin | 1 | 0.5% |
Ganciclovir | 1 | 0.5% |
Gardasil | 1 | 0.5% |
Gardner's syndrome | 1 | 0.5% |
Gastric bypass surgery | 1 | 0.5% |
Gastroenteritis | 1 | 0.5% |
Gastrointestinal bleeding | 1 | 0.5% |
Gel electrophoresis | 1 | 0.5% |
Gene drive | 1 | 0.5% |
General Data Protection Regulation | 1 | 0.5% |
General practice | 1 | 0.5% |
General relativity | 1 | 0.5% |
Generic drug | 1 | 0.5% |
Genetic counseling | 1 | 0.5% |
Genetic disorder | 1 | 0.5% |
Genetic linkage | 1 | 0.5% |
Geneva Protocol | 1 | 0.5% |
Genital wart | 1 | 0.5% |
Globalization | 1 | 0.5% |
Glutathione | 1 | 0.5% |
Good manufacturing practice | 1 | 0.5% |
Graft-versus-host disease | 1 | 0.5% |
Great Society | 1 | 0.5% |
Gynaecologic disorders | 1 | 0.5% |
HBB | 1 | 0.5% |
HIV-positive people | 1 | 0.5% |
Haematopoiesis | 1 | 0.5% |
Hair cell | 1 | 0.5% |
Hand washing | 1 | 0.5% |
Haptic technology | 1 | 0.5% |
Harassment | 1 | 0.5% |
Hash function | 1 | 0.5% |
He Jiankui | 1 | 0.5% |
Healing | 1 | 0.5% |
Health and Social Care Act 2012 | 1 | 0.5% |
Health and wellbeing board | 1 | 0.5% |
Health care brands | 1 | 0.5% |
Health care prices in the United States | 1 | 0.5% |
Health effects of tobacco | 1 | 0.5% |
Health insurance coverage in the United States | 1 | 0.5% |
Health insurance in the United States | 1 | 0.5% |
Health savings account | 1 | 0.5% |
Healthcare | 1 | 0.5% |
Healthcare Effectiveness Data and Information Set | 1 | 0.5% |
Healthcare industry | 1 | 0.5% |
Healthcare quality | 1 | 0.5% |
Healthy diet | 1 | 0.5% |
Hearing | 1 | 0.5% |
Heart failure with preserved ejection fraction | 1 | 0.5% |
Heart rate | 1 | 0.5% |
Heaven | 1 | 0.5% |
Heavy water | 1 | 0.5% |
Helicobacter pylori | 1 | 0.5% |
Help desk | 1 | 0.5% |
Hematuria | 1 | 0.5% |
Hemoglobin | 1 | 0.5% |
Henry Kissinger | 1 | 0.5% |
Hepatitis B virus | 1 | 0.5% |
Hepatitis C virus | 1 | 0.5% |
Hepatotoxicity | 1 | 0.5% |
Hershey–Chase experiment | 1 | 0.5% |
Histocompatibility | 1 | 0.5% |
Histoplasmosis | 1 | 0.5% |
Holography | 1 | 0.5% |
Home hemodialysis | 1 | 0.5% |
Homo sapiens | 1 | 0.5% |
Housekeeping | 1 | 0.5% |
Human cytomegalovirus | 1 | 0.5% |
Human leukocyte antigen | 1 | 0.5% |
Human nature | 1 | 0.5% |
Human resource management | 1 | 0.5% |
Human rights | 1 | 0.5% |
Human sexuality | 1 | 0.5% |
Human spaceflight | 1 | 0.5% |
Human subject research | 1 | 0.5% |
Humanities | 1 | 0.5% |
Humanoid robot | 1 | 0.5% |
Human–computer interaction | 1 | 0.5% |
Hurricane Maria | 1 | 0.5% |
Hydrogen | 1 | 0.5% |
Hydronephrosis | 1 | 0.5% |
Hypercapnia | 1 | 0.5% |
Hyperinsulinemia | 1 | 0.5% |
Hypertriglyceridemia | 1 | 0.5% |
Hypertrophic cardiomyopathy | 1 | 0.5% |
Hypnotic | 1 | 0.5% |
Hypoglycemia | 1 | 0.5% |
Hypopnea | 1 | 0.5% |
Hypotension | 1 | 0.5% |
Hypothesis | 1 | 0.5% |
Hysterectomy | 1 | 0.5% |
IL17A | 1 | 0.5% |
IRS tax forms | 1 | 0.5% |
Ibandronic acid | 1 | 0.5% |
Identity management | 1 | 0.5% |
Ignition interlock device | 1 | 0.5% |
Image segmentation | 1 | 0.5% |
Image sensor | 1 | 0.5% |
Immune thrombocytopenic purpura | 1 | 0.5% |
Immunodeficiency | 1 | 0.5% |
Immunoglobulin therapy | 1 | 0.5% |
Immunoprecipitation | 1 | 0.5% |
Immunosuppressive drug | 1 | 0.5% |
Impulsivity | 1 | 0.5% |
In vitro | 1 | 0.5% |
Incidence (epidemiology) | 1 | 0.5% |
Inclusion (education) | 1 | 0.5% |
Index Medicus | 1 | 0.5% |
Indigenous health in Australia | 1 | 0.5% |
Individualized Education Program | 1 | 0.5% |
Infant | 1 | 0.5% |
Infant mortality | 1 | 0.5% |
Inflammation | 1 | 0.5% |
Influenza A virus | 1 | 0.5% |
Influenza A virus subtype H1N1 | 1 | 0.5% |
Influenza A virus subtype H3N2 | 1 | 0.5% |
Influenza pandemic | 1 | 0.5% |
Influenza vaccine | 1 | 0.5% |
Information security | 1 | 0.5% |
Infrared | 1 | 0.5% |
Insulin | 1 | 0.5% |
Insulin (medication) | 1 | 0.5% |
Insulin analog | 1 | 0.5% |
Insulin glargine | 1 | 0.5% |
Insulin resistance | 1 | 0.5% |
Intelligence quotient | 1 | 0.5% |
Intention | 1 | 0.5% |
Interest | 1 | 0.5% |
Interferon gamma | 1 | 0.5% |
Interleukin 15 | 1 | 0.5% |
Interleukin 2 | 1 | 0.5% |
Interleukin 6 | 1 | 0.5% |
Interleukin-1 family | 1 | 0.5% |
International Health Regulations | 1 | 0.5% |
Intranet | 1 | 0.5% |
Intravenous therapy | 1 | 0.5% |
Irrigation | 1 | 0.5% |
Irritable bowel syndrome | 1 | 0.5% |
Isoniazid | 1 | 0.5% |
Itraconazole | 1 | 0.5% |
Ivabradine | 1 | 0.5% |
Jacques Monod | 1 | 0.5% |
James Watson | 1 | 0.5% |
John F. Kennedy | 1 | 0.5% |
KIT (gene) | 1 | 0.5% |
Kinase | 1 | 0.5% |
Kosciuszko Institute | 1 | 0.5% |
Laboratories | 1 | 0.5% |
Laboratory techniques | 1 | 0.5% |
Lactate dehydrogenase | 1 | 0.5% |
Lamivudine | 1 | 0.5% |
Language interpretation | 1 | 0.5% |
Laxative | 1 | 0.5% |
Learning | 1 | 0.5% |
Learning disability | 1 | 0.5% |
Lentiviruses | 1 | 0.5% |
Lenvatinib | 1 | 0.5% |
Lethal autonomous weapon | 1 | 0.5% |
Licensed behavior analyst | 1 | 0.5% |
Lidocaine | 1 | 0.5% |
Light-emitting diode | 1 | 0.5% |
Linezolid | 1 | 0.5% |
Linkage disequilibrium | 1 | 0.5% |
Linus Pauling | 1 | 0.5% |
Lipids | 1 | 0.5% |
Lipoprotein(a) | 1 | 0.5% |
Liquor | 1 | 0.5% |
Liraglutide | 1 | 0.5% |
Lithium | 1 | 0.5% |
Lithium (medication) | 1 | 0.5% |
Lithium-ion battery | 1 | 0.5% |
Live-in caregiver | 1 | 0.5% |
Liver biopsy | 1 | 0.5% |
Liver disease | 1 | 0.5% |
Li–Fraumeni syndrome | 1 | 0.5% |
Lobular carcinoma in situ | 1 | 0.5% |
Local anesthetic | 1 | 0.5% |
Logistics | 1 | 0.5% |
Long non-coding RNA | 1 | 0.5% |
Loop diuretic | 1 | 0.5% |
Low molecular weight heparin | 1 | 0.5% |
Low-carbohydrate diet | 1 | 0.5% |
Lung cancer screening | 1 | 0.5% |
Lung nodule | 1 | 0.5% |
Lymphadenectomy | 1 | 0.5% |
Lymphocyte | 1 | 0.5% |
Lymphogranuloma venereum | 1 | 0.5% |
Lyssavirus | 1 | 0.5% |
MEDLINE | 1 | 0.5% |
MHealth | 1 | 0.5% |
MLH1 | 1 | 0.5% |
MSH2 | 1 | 0.5% |
MSH6 | 1 | 0.5% |
Machine | 1 | 0.5% |
Macrogol | 1 | 0.5% |
Macromolecules | 1 | 0.5% |
Magnetic resonance angiography | 1 | 0.5% |
Magnetoencephalography | 1 | 0.5% |
Major histocompatibility complex | 1 | 0.5% |
Malcolm B. Frost | 1 | 0.5% |
Male genital disorders | 1 | 0.5% |
Mammary tumor | 1 | 0.5% |
Mantoux test | 1 | 0.5% |
Marburg virus disease | 1 | 0.5% |
Market segmentation | 1 | 0.5% |
Marketing | 1 | 0.5% |
Mass media | 1 | 0.5% |
Materials science | 1 | 0.5% |
Maternal–fetal medicine | 1 | 0.5% |
Mathematical model | 1 | 0.5% |
Matthew Meselson | 1 | 0.5% |
Max Delbrück | 1 | 0.5% |
McGeorge Bundy | 1 | 0.5% |
Mean | 1 | 0.5% |
Meat | 1 | 0.5% |
Media (communication) | 1 | 0.5% |
Medical director | 1 | 0.5% |
Medical research | 1 | 0.5% |
Medicare Advantage | 1 | 0.5% |
Medicinal chemistry | 1 | 0.5% |
Medroxyprogesterone acetate | 1 | 0.5% |
Melanoma | 1 | 0.5% |
Memory | 1 | 0.5% |
Mentorship | 1 | 0.5% |
Mesenchymal stem cell | 1 | 0.5% |
Mesothelioma | 1 | 0.5% |
Metabolomics | 1 | 0.5% |
Metadata | 1 | 0.5% |
Metal | 1 | 0.5% |
Metastasectomy | 1 | 0.5% |
Metastatic liver disease | 1 | 0.5% |
Metered-dose inhaler | 1 | 0.5% |
Methods of detecting exoplanets | 1 | 0.5% |
Methylprednisolone | 1 | 0.5% |
Michael Barratt (astronaut) | 1 | 0.5% |
Microbiota | 1 | 0.5% |
Microplastics | 1 | 0.5% |
Midazolam | 1 | 0.5% |
Midostaurin | 1 | 0.5% |
Miliary tuberculosis | 1 | 0.5% |
Military science | 1 | 0.5% |
Minimum Data Set | 1 | 0.5% |
Minimum inhibitory concentration | 1 | 0.5% |
Minimum wage | 1 | 0.5% |
Minutes | 1 | 0.5% |
Missing data | 1 | 0.5% |
Mitochondrial DNA | 1 | 0.5% |
MitraClip | 1 | 0.5% |
Mitral insufficiency | 1 | 0.5% |
Mitral valve | 1 | 0.5% |
Mitral valve repair | 1 | 0.5% |
Modafinil | 1 | 0.5% |
Model for End-Stage Liver Disease | 1 | 0.5% |
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid | 1 | 0.5% |
Monoclonal antibody | 1 | 0.5% |
Monounsaturated fat | 1 | 0.5% |
Moon | 1 | 0.5% |
Mortality rate | 1 | 0.5% |
Mother | 1 | 0.5% |
Motion sickness | 1 | 0.5% |
Multiple drug resistance | 1 | 0.5% |
Muscular dystrophy | 1 | 0.5% |
Myc | 1 | 0.5% |
Mycobacteria | 1 | 0.5% |
Mycobacterium bovis | 1 | 0.5% |
Mycobacterium tuberculosis | 1 | 0.5% |
Mycophenolic acid | 1 | 0.5% |
Mycoplasma | 1 | 0.5% |
Myzus persicae | 1 | 0.5% |
NEEMO | 1 | 0.5% |
NHS Connecting for Health | 1 | 0.5% |
Nanomaterials | 1 | 0.5% |
Nanoparticle | 1 | 0.5% |
Nanotechnology | 1 | 0.5% |
National Flood Insurance Program | 1 | 0.5% |
Natural reservoir | 1 | 0.5% |
Nature | 1 | 0.5% |
Nausea | 1 | 0.5% |
Near-sightedness | 1 | 0.5% |
Nebular hypothesis | 1 | 0.5% |
Nebulizer | 1 | 0.5% |
Needlestick injury | 1 | 0.5% |
Needs assessment | 1 | 0.5% |
Neglected tropical diseases | 1 | 0.5% |
Neisseria gonorrhoeae | 1 | 0.5% |
Neisseria meningitidis | 1 | 0.5% |
Neural dust | 1 | 0.5% |
Neuralgia | 1 | 0.5% |
Neurodegeneration | 1 | 0.5% |
Neuroethics | 1 | 0.5% |
Neurology | 1 | 0.5% |
Neuromarketing | 1 | 0.5% |
Neuromodulation (medicine) | 1 | 0.5% |
Neuroplasticity | 1 | 0.5% |
Neuropsychology | 1 | 0.5% |
Neurostimulation | 1 | 0.5% |
Neutropenia | 1 | 0.5% |
Niacin | 1 | 0.5% |
Nifedipine | 1 | 0.5% |
Non-alcoholic fatty liver disease | 1 | 0.5% |
Non-invasive ventilation | 1 | 0.5% |
Nonprofit organization | 1 | 0.5% |
Norethisterone | 1 | 0.5% |
Norgestimate | 1 | 0.5% |
Nuclear proliferation | 1 | 0.5% |
Nuclear weapon | 1 | 0.5% |
Nucleic acid double helix | 1 | 0.5% |
Nucleic acid sequence | 1 | 0.5% |
Nucleic acids | 1 | 0.5% |
Nucleotides | 1 | 0.5% |
Number needed to treat | 1 | 0.5% |
Nutrients | 1 | 0.5% |
Oath of office | 1 | 0.5% |
Obstetric ultrasonography | 1 | 0.5% |
Obstructive sleep apnea | 1 | 0.5% |
Occupational disease | 1 | 0.5% |
Occupational therapy | 1 | 0.5% |
Older Americans Act | 1 | 0.5% |
Omalizumab | 1 | 0.5% |
Omega-3 fatty acid | 1 | 0.5% |
Omeprazole | 1 | 0.5% |
Oncology | 1 | 0.5% |
Oncolytic virus | 1 | 0.5% |
Ondansetron | 1 | 0.5% |
Online transaction processing | 1 | 0.5% |
Oophorectomy | 1 | 0.5% |
Operating margin | 1 | 0.5% |
Opioid | 1 | 0.5% |
Optics | 1 | 0.5% |
Optogenetics | 1 | 0.5% |
Organ (anatomy) | 1 | 0.5% |
Organ (biology) | 1 | 0.5% |
Organ donation in Australia | 1 | 0.5% |
Organ procurement | 1 | 0.5% |
Organic compounds | 1 | 0.5% |
Organic solar cell | 1 | 0.5% |
Organoid | 1 | 0.5% |
Organs (anatomy) | 1 | 0.5% |
Orphan drug | 1 | 0.5% |
Orthodontics | 1 | 0.5% |
Osteoclast | 1 | 0.5% |
Ototoxicity | 1 | 0.5% |
Outcomes research | 1 | 0.5% |
Outer space | 1 | 0.5% |
Outpatient surgery | 1 | 0.5% |
Ovarian cyst | 1 | 0.5% |
Overview and Scrutiny | 1 | 0.5% |
Oxidative stress | 1 | 0.5% |
P53 | 1 | 0.5% |
PHQ-9 | 1 | 0.5% |
PMS2 | 1 | 0.5% |
PRISM (surveillance program) | 1 | 0.5% |
PSEN1 | 1 | 0.5% |
PTEN (gene) | 1 | 0.5% |
Packaging and labeling | 1 | 0.5% |
Pancreatitis | 1 | 0.5% |
Pandemic | 1 | 0.5% |
Pandemic H1N1/09 virus | 1 | 0.5% |
Paracetamol | 1 | 0.5% |
Paramedic | 1 | 0.5% |
Parathyroid hormone | 1 | 0.5% |
Parenting | 1 | 0.5% |
Partition coefficient | 1 | 0.5% |
Party leaders of the United States House of Representatives | 1 | 0.5% |
Passive smoking | 1 | 0.5% |
Patent | 1 | 0.5% |
Pathology | 1 | 0.5% |
Patient safety organization | 1 | 0.5% |
Paula Vennells | 1 | 0.5% |
Payment | 1 | 0.5% |
Pectus excavatum | 1 | 0.5% |
Pediatric intensive care unit | 1 | 0.5% |
Pediatrics | 1 | 0.5% |
Peer review | 1 | 0.5% |
Pelvic inflammatory disease | 1 | 0.5% |
Pemphigoid | 1 | 0.5% |
Pemphigus | 1 | 0.5% |
Penicillin | 1 | 0.5% |
Pension | 1 | 0.5% |
Percentile | 1 | 0.5% |
Perception | 1 | 0.5% |
Pericardiocentesis | 1 | 0.5% |
Pericardium | 1 | 0.5% |
Perinatal mortality | 1 | 0.5% |
Peritoneal dialysis | 1 | 0.5% |
Perovskite (structure) | 1 | 0.5% |
Perovskite solar cell | 1 | 0.5% |
Personal protective equipment | 1 | 0.5% |
Personality disorder | 1 | 0.5% |
Pervasive developmental disorder | 1 | 0.5% |
Pervasive developmental disorder not otherwise specified | 1 | 0.5% |
Pharmaceutical sciences | 1 | 0.5% |
Pharmacovigilance | 1 | 0.5% |
Phenylketonuria | 1 | 0.5% |
Photoluminescence | 1 | 0.5% |
Photonics | 1 | 0.5% |
Photosynthesis | 1 | 0.5% |
Photovoltaics | 1 | 0.5% |
Phylogenetic tree | 1 | 0.5% |
Physical activity | 1 | 0.5% |
Physical restraint | 1 | 0.5% |
Physics | 1 | 0.5% |
Picture archiving and communication system | 1 | 0.5% |
Pioglitazone | 1 | 0.5% |
Piperacillin | 1 | 0.5% |
Pixantrone | 1 | 0.5% |
Placebo-controlled study | 1 | 0.5% |
Planetary core | 1 | 0.5% |
Planetary habitability | 1 | 0.5% |
Planetary science | 1 | 0.5% |
Planetary system | 1 | 0.5% |
Plant | 1 | 0.5% |
Plant breeding | 1 | 0.5% |
Plant disease resistance | 1 | 0.5% |
Plants | 1 | 0.5% |
Platelet | 1 | 0.5% |
Pledge of Allegiance | 1 | 0.5% |
Pleural effusion | 1 | 0.5% |
Pneumococcal conjugate vaccine | 1 | 0.5% |
Pneumococcal vaccine | 1 | 0.5% |
Pneumocystis pneumonia | 1 | 0.5% |
Polio | 1 | 0.5% |
Polychlorinated dibenzodioxins | 1 | 0.5% |
Polyethylene terephthalate | 1 | 0.5% |
Polymer | 1 | 0.5% |
Polypill | 1 | 0.5% |
Polysomnography | 1 | 0.5% |
Porcine circovirus | 1 | 0.5% |
Positron emission tomography | 1 | 0.5% |
Postgraduate education | 1 | 0.5% |
Postherpetic neuralgia | 1 | 0.5% |
Postoperative nausea and vomiting | 1 | 0.5% |
Posttraumatic stress disorder | 1 | 0.5% |
Potato | 1 | 0.5% |
Potato leafroll virus | 1 | 0.5% |
Potato mop-top virus | 1 | 0.5% |
Potato virus Y | 1 | 0.5% |
Powdery scab | 1 | 0.5% |
Power of a test | 1 | 0.5% |
Prasugrel | 1 | 0.5% |
Pravastatin | 1 | 0.5% |
Pre-eclampsia | 1 | 0.5% |
Pregabalin | 1 | 0.5% |
Premium tax credit | 1 | 0.5% |
Prenatal care | 1 | 0.5% |
Preventive medicine | 1 | 0.5% |
Primaquine | 1 | 0.5% |
Primary care network | 1 | 0.5% |
Primer (molecular biology) | 1 | 0.5% |
Privacy law | 1 | 0.5% |
Private finance initiative | 1 | 0.5% |
Probation | 1 | 0.5% |
Profession | 1 | 0.5% |
Program optimization | 1 | 0.5% |
Progress | 1 | 0.5% |
Promoter (genetics) | 1 | 0.5% |
Prosthesis | 1 | 0.5% |
Protein kinase | 1 | 0.5% |
Psychiatric and mental health nursing | 1 | 0.5% |
Psychiatric hospital | 1 | 0.5% |
Psychiatric rehabilitation | 1 | 0.5% |
Psychological evaluation | 1 | 0.5% |
Public transport | 1 | 0.5% |
Pulmonary fibrosis | 1 | 0.5% |
Pulmonology | 1 | 0.5% |
Quality | 1 | 0.5% |
Quality and Outcomes Framework | 1 | 0.5% |
Quantitative structure–activity relationship | 1 | 0.5% |
Quantum computing | 1 | 0.5% |
Quantum dot | 1 | 0.5% |
Quantum entanglement | 1 | 0.5% |
Quantum simulator | 1 | 0.5% |
Quetiapine | 1 | 0.5% |
Quinolone antibiotic | 1 | 0.5% |
Quorum | 1 | 0.5% |
RNA | 1 | 0.5% |
RNA interference | 1 | 0.5% |
RNA-Seq | 1 | 0.5% |
Radar | 1 | 0.5% |
Radon | 1 | 0.5% |
Rail transport | 1 | 0.5% |
Random checkpoint | 1 | 0.5% |
Readability | 1 | 0.5% |
Receptor antagonist | 1 | 0.5% |
Rechargeable battery | 1 | 0.5% |
Recovery approach | 1 | 0.5% |
Reference dose | 1 | 0.5% |
Reference range | 1 | 0.5% |
Refugee | 1 | 0.5% |
Regeneration (biology) | 1 | 0.5% |
Regenerative medicine | 1 | 0.5% |
Regulatory Flexibility Act | 1 | 0.5% |
Rehabilitation Act of 1973 | 1 | 0.5% |
Relapse | 1 | 0.5% |
Renewable energy | 1 | 0.5% |
Reperfusion injury | 1 | 0.5% |
Reperfusion therapy | 1 | 0.5% |
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations | 1 | 0.5% |
Residential treatment center | 1 | 0.5% |
Respiratory tract | 1 | 0.5% |
Resting state fMRI | 1 | 0.5% |
Retina | 1 | 0.5% |
Retinal implant | 1 | 0.5% |
Reuse | 1 | 0.5% |
Reverse transcriptase | 1 | 0.5% |
Reverse transcription polymerase chain reaction | 1 | 0.5% |
Revised National Tuberculosis Control Program | 1 | 0.5% |
Revolution in Military Affairs | 1 | 0.5% |
Rhabdomyolysis | 1 | 0.5% |
Rheumatic fever | 1 | 0.5% |
Rheumatoid arthritis | 1 | 0.5% |
Richard Nixon | 1 | 0.5% |
Rights | 1 | 0.5% |
Rights of nature | 1 | 0.5% |
Rivaroxaban | 1 | 0.5% |
Road traffic safety | 1 | 0.5% |
Robonaut | 1 | 0.5% |
Rosalind Franklin | 1 | 0.5% |
Rubella | 1 | 0.5% |
SGK1 | 1 | 0.5% |
SGLT2 inhibitor | 1 | 0.5% |
SWOT analysis | 1 | 0.5% |
Safe sex | 1 | 0.5% |
Safety data sheet | 1 | 0.5% |
Salary | 1 | 0.5% |
Salbutamol | 1 | 0.5% |
Salmonella | 1 | 0.5% |
Salt | 1 | 0.5% |
Sanger sequencing | 1 | 0.5% |
Sanitation | 1 | 0.5% |
Saving | 1 | 0.5% |
Saxagliptin | 1 | 0.5% |
Scar | 1 | 0.5% |
Schizoaffective disorder | 1 | 0.5% |
Scientific techniques | 1 | 0.5% |
Screening, brief intervention and referral to treatment | 1 | 0.5% |
Section 504 of the Rehabilitation Act | 1 | 0.5% |
Secure copy | 1 | 0.5% |
Select agent | 1 | 0.5% |
Selective serotonin reuptake inhibitor | 1 | 0.5% |
Self-driving car | 1 | 0.5% |
Semiconductor | 1 | 0.5% |
Sensorineural hearing loss | 1 | 0.5% |
Sequence alignment | 1 | 0.5% |
Seroconversion | 1 | 0.5% |
Serology | 1 | 0.5% |
Serum amyloid A1 | 1 | 0.5% |
Sex worker | 1 | 0.5% |
Sexual health | 1 | 0.5% |
Sheriffs in the United States | 1 | 0.5% |
Shigatoxigenic and verotoxigenic Escherichia coli | 1 | 0.5% |
Shingles | 1 | 0.5% |
Shortness of breath | 1 | 0.5% |
Simeprevir | 1 | 0.5% |
Single sign-on | 1 | 0.5% |
Sleep apnea | 1 | 0.5% |
Sleep disorder | 1 | 0.5% |
Smoking | 1 | 0.5% |
Social exclusion | 1 | 0.5% |
Social institutions | 1 | 0.5% |
Social isolation | 1 | 0.5% |
Social science | 1 | 0.5% |
Social stratification | 1 | 0.5% |
Social support | 1 | 0.5% |
Society | 1 | 0.5% |
Soil-borne wheat mosaic virus | 1 | 0.5% |
Solar System | 1 | 0.5% |
Solar cell efficiency | 1 | 0.5% |
Solar energy | 1 | 0.5% |
Solar power | 1 | 0.5% |
Southeast Asia | 1 | 0.5% |
Space Shuttle | 1 | 0.5% |
Space exploration | 1 | 0.5% |
Space science | 1 | 0.5% |
Spaceflight | 1 | 0.5% |
Spanish flu | 1 | 0.5% |
Speaker of the United States House of Representatives | 1 | 0.5% |
Species | 1 | 0.5% |
Spontaneous bacterial peritonitis | 1 | 0.5% |
Sport of athletics | 1 | 0.5% |
Squamous cell carcinoma | 1 | 0.5% |
Standard drink | 1 | 0.5% |
Star | 1 | 0.5% |
Startup company | 1 | 0.5% |
Stellar astronomy | 1 | 0.5% |
Sternum | 1 | 0.5% |
Stillbirth | 1 | 0.5% |
Stool guaiac test | 1 | 0.5% |
Strategy | 1 | 0.5% |
Streptococcus agalactiae | 1 | 0.5% |
Streptomycin | 1 | 0.5% |
Stress (biology) | 1 | 0.5% |
Subsidy | 1 | 0.5% |
Substance use disorder | 1 | 0.5% |
Suicide | 1 | 0.5% |
Sulfonylurea | 1 | 0.5% |
Super-Earth | 1 | 0.5% |
Superlens | 1 | 0.5% |
Supernatural | 1 | 0.5% |
Surface epithelial-stromal tumor | 1 | 0.5% |
Surfactant protein B | 1 | 0.5% |
Surrogacy | 1 | 0.5% |
Sustainable Development Goal 12 | 1 | 0.5% |
Sustainable city | 1 | 0.5% |
Symptoms and signs | 1 | 0.5% |
Symptoms and signs: General | 1 | 0.5% |
Synapse | 1 | 0.5% |
Syncope (medicine) | 1 | 0.5% |
System on a chip | 1 | 0.5% |
T helper cell | 1 | 0.5% |
TRAPPIST-1 | 1 | 0.5% |
Tachycardia | 1 | 0.5% |
Tag SNP | 1 | 0.5% |
Talent management | 1 | 0.5% |
Talimogene laherparepvec | 1 | 0.5% |
Tamoxifen | 1 | 0.5% |
Tau protein | 1 | 0.5% |
Technology roadmap | 1 | 0.5% |
Telecommunication | 1 | 0.5% |
Telemedicine | 1 | 0.5% |
Telerobotics | 1 | 0.5% |
Telescope | 1 | 0.5% |
Temporary work | 1 | 0.5% |
Tenofovir disoproxil | 1 | 0.5% |
Terminal illness | 1 | 0.5% |
Terrestrial planet | 1 | 0.5% |
Terrorism | 1 | 0.5% |
Testosterone | 1 | 0.5% |
Testosterone (medication) | 1 | 0.5% |
Tetraplegia | 1 | 0.5% |
Text mining | 1 | 0.5% |
Textile | 1 | 0.5% |
Tf–idf | 1 | 0.5% |
Thalassemia | 1 | 0.5% |
The Double Helix | 1 | 0.5% |
Thematic analysis | 1 | 0.5% |
Theory | 1 | 0.5% |
Theory of planned behavior | 1 | 0.5% |
Theory of relativity | 1 | 0.5% |
Thought | 1 | 0.5% |
Threat (computer) | 1 | 0.5% |
Threshold limit value | 1 | 0.5% |
Thrombocytopenia | 1 | 0.5% |
Thrombus | 1 | 0.5% |
Tibolone | 1 | 0.5% |
Time | 1 | 0.5% |
Tiotropium bromide | 1 | 0.5% |
Tisagenlecleucel | 1 | 0.5% |
Tissue plasminogen activator | 1 | 0.5% |
Tobacco control | 1 | 0.5% |
Tobacco rattle virus | 1 | 0.5% |
Toilet | 1 | 0.5% |
Tomato brown rugose fruit virus | 1 | 0.5% |
Tourism | 1 | 0.5% |
Toxic equivalency factor | 1 | 0.5% |
Toxicology | 1 | 0.5% |
Tracheotomy | 1 | 0.5% |
Traffic collision | 1 | 0.5% |
Train | 1 | 0.5% |
Transcranial magnetic stimulation | 1 | 0.5% |
Transcutaneous electrical nerve stimulation | 1 | 0.5% |
Transhumanism | 1 | 0.5% |
Transitional care | 1 | 0.5% |
Trauma center | 1 | 0.5% |
Treatment and control groups | 1 | 0.5% |
Treatment of lung cancer | 1 | 0.5% |
Treaty | 1 | 0.5% |
Tremor | 1 | 0.5% |
Triage | 1 | 0.5% |
Trichomoniasis | 1 | 0.5% |
Tricyclic antidepressant | 1 | 0.5% |
Triglyceride | 1 | 0.5% |
Triple test | 1 | 0.5% |
Truck driver | 1 | 0.5% |
Trucking industry in the United States | 1 | 0.5% |
Trust (social science) | 1 | 0.5% |
Truth | 1 | 0.5% |
Tuberculosis in relation to HIV | 1 | 0.5% |
Tubo-ovarian abscess | 1 | 0.5% |
Tuition payments | 1 | 0.5% |
Tumor microenvironment | 1 | 0.5% |
Type I and type II errors | 1 | 0.5% |
U.S. state | 1 | 0.5% |
United States Code | 1 | 0.5% |
United States biological defense program | 1 | 0.5% |
United States budget sequestration in 2013 | 1 | 0.5% |
United States congressional committee | 1 | 0.5% |
United States federal budget | 1 | 0.5% |
Universal health care | 1 | 0.5% |
Universe | 1 | 0.5% |
Unwarranted variation | 1 | 0.5% |
Ureter | 1 | 0.5% |
Urological conditions | 1 | 0.5% |
Use case | 1 | 0.5% |
User interface | 1 | 0.5% |
Uterine fibroid | 1 | 0.5% |
Uterine prolapse | 1 | 0.5% |
VKORC1 | 1 | 0.5% |
Vaccination | 1 | 0.5% |
Vaccines for Children Program | 1 | 0.5% |
Vaginal bleeding | 1 | 0.5% |
Vaginal yeast infection | 1 | 0.5% |
Vaginitis | 1 | 0.5% |
Vagus nerve stimulation | 1 | 0.5% |
Valproate | 1 | 0.5% |
Valsartan | 1 | 0.5% |
Valvular heart disease | 1 | 0.5% |
Vancomycin | 1 | 0.5% |
Ventricular assist device | 1 | 0.5% |
Ventricular natriuretic peptide | 1 | 0.5% |
Venture capital | 1 | 0.5% |
Very low-density lipoprotein | 1 | 0.5% |
Video game | 1 | 0.5% |
Viral load | 1 | 0.5% |
Viral replication | 1 | 0.5% |
Viral vector | 1 | 0.5% |
Virtual colonoscopy | 1 | 0.5% |
Virtual reality headset | 1 | 0.5% |
Virtualization | 1 | 0.5% |
Virus latency | 1 | 0.5% |
Virus quantification | 1 | 0.5% |
Visual field test | 1 | 0.5% |
Visual impairment | 1 | 0.5% |
Visual perception | 1 | 0.5% |
Vitamin | 1 | 0.5% |
Vitamin A | 1 | 0.5% |
Vomiting | 1 | 0.5% |
Vulnerable plaque | 1 | 0.5% |
WASH | 1 | 0.5% |
War | 1 | 0.5% |
Wart | 1 | 0.5% |
Waste | 1 | 0.5% |
Weapon of mass destruction | 1 | 0.5% |
Weed | 1 | 0.5% |
Weight loss | 1 | 0.5% |
Western African Ebola virus epidemic | 1 | 0.5% |
Wheat streak mosaic virus | 1 | 0.5% |
Wireless | 1 | 0.5% |
Wireless power transfer | 1 | 0.5% |
Wnt signaling pathway | 1 | 0.5% |
Wound | 1 | 0.5% |
Wound healing | 1 | 0.5% |
Yellow rain | 1 | 0.5% |
Youth | 1 | 0.5% |
Zygosity | 1 | 0.5% |
abs | rel | |
---|---|---|
Health | 199 | 90.5% |
Health sciences | 186 | 84.5% |
Medicine | 182 | 82.7% |
Health care | 175 | 79.5% |
Medical specialties | 141 | 64.1% |
Clinical medicine | 120 | 54.5% |
Risk | 101 | 45.9% |
Public health | 82 | 37.3% |
Human activities | 77 | 35.0% |
Disease | 75 | 34.1% |
Hospital | 70 | 31.8% |
Infection | 64 | 29.1% |
Patient | 60 | 27.3% |
Diseases and disorders | 52 | 23.6% |
Coronavirus disease 2019 | 49 | 22.3% |
COVID-19 pandemic | 45 | 20.5% |
Epidemiology | 44 | 20.0% |
Nursing | 44 | 20.0% |
Research | 43 | 19.5% |
Clinical trial | 35 | 15.9% |
Preventive healthcare | 35 | 15.9% |
Surgery | 34 | 15.5% |
Cancer | 33 | 15.0% |
Governance | 32 | 14.5% |
Chronic condition | 31 | 14.1% |
Emergency department | 31 | 14.1% |
Health economics | 31 | 14.1% |
Mental health | 31 | 14.1% |
Caregiver | 29 | 13.2% |
Health system | 28 | 12.7% |
Medicare (United States) | 28 | 12.7% |
Biology | 26 | 11.8% |
Safety | 26 | 11.8% |
Medication | 25 | 11.4% |
Risk assessment | 25 | 11.4% |
Therapy | 25 | 11.4% |
Patient safety | 24 | 10.9% |
Cardiovascular disease | 23 | 10.5% |
Medical diagnosis | 23 | 10.5% |
Telehealth | 23 | 10.5% |
Evidence-based medicine | 22 | 10.0% |
Medicaid | 22 | 10.0% |
Randomized controlled trial | 22 | 10.0% |
Virus | 22 | 10.0% |
Audit | 21 | 9.5% |
Diabetes | 21 | 9.5% |
Primary care | 21 | 9.5% |
Adherence (medicine) | 20 | 9.1% |
Health professional | 20 | 9.1% |
Obesity | 20 | 9.1% |
Screening (medicine) | 20 | 9.1% |
Vaccine | 20 | 9.1% |
Personal protective equipment | 19 | 8.6% |
Pregnancy | 19 | 8.6% |
Severe acute respiratory syndrome coronavirus 2 | 19 | 8.6% |
Artificial intelligence | 18 | 8.2% |
Clinical commissioning group | 18 | 8.2% |
General practitioner | 18 | 8.2% |
Infectious diseases | 18 | 8.2% |
Health equity | 17 | 7.7% |
Mental disorder | 17 | 7.7% |
Policy | 17 | 7.7% |
Public sphere | 17 | 7.7% |
COVID-19 | 16 | 7.3% |
Childbirth | 16 | 7.3% |
Disability | 16 | 7.3% |
Infection prevention and control | 16 | 7.3% |
Innovation | 16 | 7.3% |
Life sciences | 16 | 7.3% |
Medical humanities | 16 | 7.3% |
Regulatory compliance | 15 | 6.8% |
Social work | 15 | 6.8% |
Systematic review | 15 | 6.8% |
Technology | 15 | 6.8% |
Evaluation | 14 | 6.4% |
Hospital readmission | 14 | 6.4% |
Hypertension | 14 | 6.4% |
Sustainability | 14 | 6.4% |
Triage | 14 | 6.4% |
Food | 13 | 5.9% |
Health policy | 13 | 5.9% |
Information | 13 | 5.9% |
Pandemic | 13 | 5.9% |
Pharmacy | 13 | 5.9% |
Transmission (medicine) | 13 | 5.9% |
Type 2 diabetes | 13 | 5.9% |
Branches of science | 12 | 5.5% |
Comorbidity | 12 | 5.5% |
Emergency | 12 | 5.5% |
Medical guideline | 12 | 5.5% |
Medical imaging | 12 | 5.5% |
Myocardial infarction | 12 | 5.5% |
Physical therapy | 12 | 5.5% |
Physician | 12 | 5.5% |
Science | 12 | 5.5% |
Emergency management | 11 | 5.0% |
HIV/AIDS | 11 | 5.0% |
Health promotion | 11 | 5.0% |
Occupational safety and health | 11 | 5.0% |
Privacy | 11 | 5.0% |
Sensitivity and specificity | 11 | 5.0% |
Business | 10 | 4.5% |
Confidence interval | 10 | 4.5% |
Creative Commons license | 10 | 4.5% |
Dementia | 10 | 4.5% |
Government | 10 | 4.5% |
Health care quality | 10 | 4.5% |
Immunology | 10 | 4.5% |
Influenza | 10 | 4.5% |
Insurance | 10 | 4.5% |
Machine learning | 10 | 4.5% |
Meta-analysis | 10 | 4.5% |
Nursing home | 10 | 4.5% |
Quality assurance | 10 | 4.5% |
Self-care | 10 | 4.5% |
Best practice | 9 | 4.1% |
CT scan | 9 | 4.1% |
Chronic kidney disease | 9 | 4.1% |
Coronavirus | 9 | 4.1% |
Electronic health record | 9 | 4.1% |
Fee-for-service | 9 | 4.1% |
Heart | 9 | 4.1% |
Heart failure | 9 | 4.1% |
Intensive care unit | 9 | 4.1% |
Kidney failure | 9 | 4.1% |
Magnetic resonance imaging | 9 | 4.1% |
Microbiology | 9 | 4.1% |
Population health | 9 | 4.1% |
Quarantine | 9 | 4.1% |
Radiation therapy | 9 | 4.1% |
Radiology | 9 | 4.1% |
Risk management | 9 | 4.1% |
Social programs | 9 | 4.1% |
2019–20 coronavirus outbreak | 8 | 3.6% |
Adverse effect | 8 | 3.6% |
Analytics | 8 | 3.6% |
Antimicrobial resistance | 8 | 3.6% |
Bank | 8 | 3.6% |
Behavior | 8 | 3.6% |
Budget | 8 | 3.6% |
Cardiology | 8 | 3.6% |
Cohort study | 8 | 3.6% |
Coronary artery disease | 8 | 3.6% |
Employment | 8 | 3.6% |
Exercise | 8 | 3.6% |
Health informatics | 8 | 3.6% |
Health information technology | 8 | 3.6% |
Hygiene | 8 | 3.6% |
Infection control | 8 | 3.6% |
Isolation (health care) | 8 | 3.6% |
Lung cancer | 8 | 3.6% |
Non-communicable disease | 8 | 3.6% |
Pathology | 8 | 3.6% |
Public services | 8 | 3.6% |
Receiver operating characteristic | 8 | 3.6% |
Statistics | 8 | 3.6% |
Accountable care organization | 7 | 3.2% |
Antibiotic | 7 | 3.2% |
Bleeding | 7 | 3.2% |
COVID-19 testing | 7 | 3.2% |
Cervical cancer | 7 | 3.2% |
Chronic obstructive pulmonary disease | 7 | 3.2% |
Contract | 7 | 3.2% |
Diabetes management | 7 | 3.2% |
EHealth | 7 | 3.2% |
Education | 7 | 3.2% |
Family medicine | 7 | 3.2% |
Food safety | 7 | 3.2% |
Foodborne illness | 7 | 3.2% |
Information privacy | 7 | 3.2% |
Intensive care medicine | 7 | 3.2% |
Medical device | 7 | 3.2% |
Medical prescription | 7 | 3.2% |
Medical statistics | 7 | 3.2% |
Medical test | 7 | 3.2% |
Politics | 7 | 3.2% |
Poverty | 7 | 3.2% |
Prostate cancer | 7 | 3.2% |
Psychiatry | 7 | 3.2% |
Recovery approach | 7 | 3.2% |
Signs and symptoms | 7 | 3.2% |
Social distancing | 7 | 3.2% |
Stroke | 7 | 3.2% |
Substance abuse | 7 | 3.2% |
Surgical mask | 7 | 3.2% |
Surveillance | 7 | 3.2% |
Symptom | 7 | 3.2% |
Tuberculosis | 7 | 3.2% |
Ageing | 6 | 2.7% |
Angina | 6 | 2.7% |
Biomarker | 6 | 2.7% |
Cancer screening | 6 | 2.7% |
Carcinogen | 6 | 2.7% |
Chemotherapy | 6 | 2.7% |
Cognition | 6 | 2.7% |
Contact tracing | 6 | 2.7% |
Emergency medicine | 6 | 2.7% |
Expense | 6 | 2.7% |
Glycated hemoglobin | 6 | 2.7% |
Health insurance | 6 | 2.7% |
Homelessness | 6 | 2.7% |
Human papillomavirus infection | 6 | 2.7% |
Immunodeficiency | 6 | 2.7% |
Interoperability | 6 | 2.7% |
Laparoscopy | 6 | 2.7% |
Leadership | 6 | 2.7% |
Major depressive disorder | 6 | 2.7% |
Managed care | 6 | 2.7% |
Management | 6 | 2.7% |
Maternal health | 6 | 2.7% |
Medical treatments | 6 | 2.7% |
Medical ultrasound | 6 | 2.7% |
Mobile app | 6 | 2.7% |
Mortality rate | 6 | 2.7% |
Nursing home care | 6 | 2.7% |
Organisms | 6 | 2.7% |
Prescription drug | 6 | 2.7% |
Psychosis | 6 | 2.7% |
Regression analysis | 6 | 2.7% |
Severe acute respiratory syndrome | 6 | 2.7% |
Shortness of breath | 6 | 2.7% |
Simulation | 6 | 2.7% |
Statistical process control | 6 | 2.7% |
Transmission-based precautions | 6 | 2.7% |
Urology | 6 | 2.7% |
Vaccination | 6 | 2.7% |
Agriculture | 5 | 2.3% |
Anesthesia | 5 | 2.3% |
Anticoagulant | 5 | 2.3% |
Antigen | 5 | 2.3% |
Antiviral drug | 5 | 2.3% |
Blood sugar level | 5 | 2.3% |
Board of directors | 5 | 2.3% |
Body mass index | 5 | 2.3% |
Breast cancer | 5 | 2.3% |
Cardiovascular system | 5 | 2.3% |
Case management (US health system) | 5 | 2.3% |
Cervical screening | 5 | 2.3% |
Clinic | 5 | 2.3% |
Clinical audit | 5 | 2.3% |
Clinical governance | 5 | 2.3% |
Communication | 5 | 2.3% |
Community | 5 | 2.3% |
Community health | 5 | 2.3% |
Computer security | 5 | 2.3% |
Confidentiality | 5 | 2.3% |
DNA sequencing | 5 | 2.3% |
Data analysis | 5 | 2.3% |
Dependent and independent variables | 5 | 2.3% |
Dose (biochemistry) | 5 | 2.3% |
Early intervention in psychosis | 5 | 2.3% |
Echocardiography | 5 | 2.3% |
False positives and false negatives | 5 | 2.3% |
Forecasting | 5 | 2.3% |
Goal | 5 | 2.3% |
Hand washing | 5 | 2.3% |
Hepatitis | 5 | 2.3% |
Home care in the United States | 5 | 2.3% |
Human reproduction | 5 | 2.3% |
Immune system | 5 | 2.3% |
Immunization | 5 | 2.3% |
Influenza vaccine | 5 | 2.3% |
Lung | 5 | 2.3% |
NHS foundation trust | 5 | 2.3% |
Neoplasms | 5 | 2.3% |
Nephrology | 5 | 2.3% |
Nurse practitioner | 5 | 2.3% |
Ophthalmology | 5 | 2.3% |
Organ transplantation | 5 | 2.3% |
Paramedic | 5 | 2.3% |
Personal data | 5 | 2.3% |
Point of care | 5 | 2.3% |
Prediction | 5 | 2.3% |
Psychotherapy | 5 | 2.3% |
Public Health Emergency of International Concern | 5 | 2.3% |
Pulmonary embolism | 5 | 2.3% |
Qualitative research | 5 | 2.3% |
Quality of life | 5 | 2.3% |
Recruitment | 5 | 2.3% |
Respirator | 5 | 2.3% |
Respiratory disease | 5 | 2.3% |
Services sector of the economy | 5 | 2.3% |
Sustainable Development Goals | 5 | 2.3% |
Thrombosis | 5 | 2.3% |
Toxicity | 5 | 2.3% |
Treatment of cancer | 5 | 2.3% |
Type I and type II errors | 5 | 2.3% |
Venous thrombosis | 5 | 2.3% |
Violence | 5 | 2.3% |
Welfare | 5 | 2.3% |
Adolescence | 4 | 1.8% |
Animal testing | 4 | 1.8% |
Appropriations bill (United States) | 4 | 1.8% |
Artificial intelligence in healthcare | 4 | 1.8% |
Asset | 4 | 1.8% |
Asthma | 4 | 1.8% |
Atypical pneumonias | 4 | 1.8% |
Audit committee | 4 | 1.8% |
Bacteria | 4 | 1.8% |
Biopsy | 4 | 1.8% |
Blood | 4 | 1.8% |
Blood pressure | 4 | 1.8% |
Blood transfusion | 4 | 1.8% |
C-reactive protein | 4 | 1.8% |
COVID-19 pandemic in the United Kingdom | 4 | 1.8% |
Cancer survivor | 4 | 1.8% |
Capacity building | 4 | 1.8% |
Cardiac magnetic resonance imaging | 4 | 1.8% |
Causes of death | 4 | 1.8% |
Classification of ethnicity in the United Kingdom | 4 | 1.8% |
Clinical decision support system | 4 | 1.8% |
Colorectal cancer | 4 | 1.8% |
Confounding | 4 | 1.8% |
Control chart | 4 | 1.8% |
Cost-effectiveness analysis | 4 | 1.8% |
Decision-making | 4 | 1.8% |
Deep vein thrombosis | 4 | 1.8% |
Diagnosis of HIV/AIDS | 4 | 1.8% |
Disease burden | 4 | 1.8% |
Disease management (health) | 4 | 1.8% |
Doppler ultrasonography | 4 | 1.8% |
Economics of service industries | 4 | 1.8% |
Electrocardiography | 4 | 1.8% |
Electroencephalography | 4 | 1.8% |
Emergency medical services | 4 | 1.8% |
Endoscopy | 4 | 1.8% |
Environmental social science | 4 | 1.8% |
Epidemic | 4 | 1.8% |
FFP standards | 4 | 1.8% |
Face masks during the COVID-19 pandemic | 4 | 1.8% |
Finance | 4 | 1.8% |
Fund accounting | 4 | 1.8% |
General Data Protection Regulation | 4 | 1.8% |
Genotoxicity | 4 | 1.8% |
Gynaecology | 4 | 1.8% |
Health care in the United States | 4 | 1.8% |
Health data | 4 | 1.8% |
Health technology in the United States | 4 | 1.8% |
Histopathology | 4 | 1.8% |
Human pregnancy | 4 | 1.8% |
Hysterectomy | 4 | 1.8% |
Improving Access to Psychological Therapies | 4 | 1.8% |
Laboratory | 4 | 1.8% |
Listeria | 4 | 1.8% |
Listeriosis | 4 | 1.8% |
Logistic regression | 4 | 1.8% |
Long-term care | 4 | 1.8% |
Low-molecular-weight heparin | 4 | 1.8% |
Lymphoma | 4 | 1.8% |
Malaria | 4 | 1.8% |
Medical home | 4 | 1.8% |
Medical record | 4 | 1.8% |
Mental Health Act 1983 | 4 | 1.8% |
Middle East respiratory syndrome | 4 | 1.8% |
Motherhood | 4 | 1.8% |
Multi-drug-resistant tuberculosis | 4 | 1.8% |
Neoplasm | 4 | 1.8% |
Non-alcoholic fatty liver disease | 4 | 1.8% |
Organs (anatomy) | 4 | 1.8% |
Pain | 4 | 1.8% |
Palliative care | 4 | 1.8% |
Pay for performance (healthcare) | 4 | 1.8% |
Pharmacist | 4 | 1.8% |
Physical examination | 4 | 1.8% |
Prenatal development | 4 | 1.8% |
Prevention | 4 | 1.8% |
Prostatectomy | 4 | 1.8% |
Psychology | 4 | 1.8% |
Radiography | 4 | 1.8% |
Renal function | 4 | 1.8% |
Respirator fit test | 4 | 1.8% |
Revenue | 4 | 1.8% |
Sampling (statistics) | 4 | 1.8% |
Sarbecovirus | 4 | 1.8% |
Sensitivity analysis | 4 | 1.8% |
Social determinants of health | 4 | 1.8% |
Standard deviation | 4 | 1.8% |
Statin | 4 | 1.8% |
Statistical classification | 4 | 1.8% |
Virtual community | 4 | 1.8% |
Accessibility | 3 | 1.4% |
Accountability | 3 | 1.4% |
Air pollution | 3 | 1.4% |
Alzheimer's disease | 3 | 1.4% |
Ambulance | 3 | 1.4% |
Anatomy | 3 | 1.4% |
Anesthesiology | 3 | 1.4% |
Angiography | 3 | 1.4% |
Antibody | 3 | 1.4% |
Antipsychotic | 3 | 1.4% |
Assay | 3 | 1.4% |
Atherosclerosis | 3 | 1.4% |
Autism spectrum | 3 | 1.4% |
Benign tumor | 3 | 1.4% |
Bias of an estimator | 3 | 1.4% |
Biomonitoring | 3 | 1.4% |
Biosensor | 3 | 1.4% |
Biotechnology | 3 | 1.4% |
Birth | 3 | 1.4% |
Blinded experiment | 3 | 1.4% |
Brachytherapy | 3 | 1.4% |
Brain | 3 | 1.4% |
Breastfeeding | 3 | 1.4% |
Bundled payment | 3 | 1.4% |
COVID-19 pandemic in Papua New Guinea | 3 | 1.4% |
CT pulmonary angiogram | 3 | 1.4% |
Cancer prevention | 3 | 1.4% |
Capitation (healthcare) | 3 | 1.4% |
Cardiothoracic surgery | 3 | 1.4% |
Chest radiograph | 3 | 1.4% |
Chief financial officer | 3 | 1.4% |
Cholesterol | 3 | 1.4% |
Circulatory system | 3 | 1.4% |
Cloud computing | 3 | 1.4% |
Cognitive behavioral therapy | 3 | 1.4% |
Cognitive science | 3 | 1.4% |
Community mental health service | 3 | 1.4% |
Congressional oversight | 3 | 1.4% |
Correlation and dependence | 3 | 1.4% |
Current Procedural Terminology | 3 | 1.4% |
D-dimer | 3 | 1.4% |
Da Vinci Surgical System | 3 | 1.4% |
Deep learning | 3 | 1.4% |
Depression (mood) | 3 | 1.4% |
Dietary supplement | 3 | 1.4% |
Dieting | 3 | 1.4% |
Digital health | 3 | 1.4% |
Disinfectant | 3 | 1.4% |
Earnings before interest, taxes, depreciation and amortization | 3 | 1.4% |
Elastography | 3 | 1.4% |
End-of-life care | 3 | 1.4% |
Endocrine system | 3 | 1.4% |
Enga Province | 3 | 1.4% |
Estimator | 3 | 1.4% |
Food and drink | 3 | 1.4% |
Genetics | 3 | 1.4% |
Geriatrics | 3 | 1.4% |
Government budget balance | 3 | 1.4% |
Health literacy | 3 | 1.4% |
Hela Province | 3 | 1.4% |
Hematopoietic stem cell transplantation | 3 | 1.4% |
Hemodialysis | 3 | 1.4% |
Herd immunity | 3 | 1.4% |
Human development | 3 | 1.4% |
Hypothesis | 3 | 1.4% |
Immunotherapy | 3 | 1.4% |
Incremental cost-effectiveness ratio | 3 | 1.4% |
Indication (medicine) | 3 | 1.4% |
Infant | 3 | 1.4% |
Influenza pandemic | 3 | 1.4% |
Information security | 3 | 1.4% |
Insulin | 3 | 1.4% |
Internal medicine | 3 | 1.4% |
Kidney | 3 | 1.4% |
Kidney transplantation | 3 | 1.4% |
Learning disability | 3 | 1.4% |
License | 3 | 1.4% |
Life expectancy | 3 | 1.4% |
Likelihood function | 3 | 1.4% |
Linear regression | 3 | 1.4% |
MHealth | 3 | 1.4% |
Mammography | 3 | 1.4% |
Management of COVID-19 | 3 | 1.4% |
Management of HIV/AIDS | 3 | 1.4% |
Mechanical filter (respirator) | 3 | 1.4% |
Medical tests | 3 | 1.4% |
Medicare dual eligible | 3 | 1.4% |
Minimally invasive procedure | 3 | 1.4% |
Miscarriage | 3 | 1.4% |
Monitoring (medicine) | 3 | 1.4% |
Myocardial perfusion imaging | 3 | 1.4% |
Nature | 3 | 1.4% |
Neonicotinoid | 3 | 1.4% |
Nephrectomy | 3 | 1.4% |
Nonsteroidal anti-inflammatory drug | 3 | 1.4% |
Nuclear medicine | 3 | 1.4% |
Obstetrics | 3 | 1.4% |
Office of Inspector General (United States) | 3 | 1.4% |
Outcomes research | 3 | 1.4% |
Pap test | 3 | 1.4% |
Parameter | 3 | 1.4% |
Percutaneous coronary intervention | 3 | 1.4% |
Personalized medicine | 3 | 1.4% |
Platelet | 3 | 1.4% |
Positive and negative predictive values | 3 | 1.4% |
Pre-exposure prophylaxis | 3 | 1.4% |
Prediabetes | 3 | 1.4% |
Procurement | 3 | 1.4% |
Prosecutor | 3 | 1.4% |
Psychological resilience | 3 | 1.4% |
Pulmonary fibrosis | 3 | 1.4% |
Recovery model | 3 | 1.4% |
Reference range | 3 | 1.4% |
Reproductive health | 3 | 1.4% |
Respiratory droplet | 3 | 1.4% |
Robot-assisted surgery | 3 | 1.4% |
Safeguarding | 3 | 1.4% |
Schizophrenia | 3 | 1.4% |
Seafood | 3 | 1.4% |
Social Security (United States) | 3 | 1.4% |
Social media | 3 | 1.4% |
Specialty (medicine) | 3 | 1.4% |
Sustainability and transformation plan | 3 | 1.4% |
Synthetic biology | 3 | 1.4% |
System | 3 | 1.4% |
Telecommuting | 3 | 1.4% |
Toxicology | 3 | 1.4% |
Training | 3 | 1.4% |
Trust law | 3 | 1.4% |
Type 1 diabetes | 3 | 1.4% |
United States Code | 3 | 1.4% |
Urinary tract infection | 3 | 1.4% |
Utilization management | 3 | 1.4% |
Warfarin | 3 | 1.4% |
Wearable technology | 3 | 1.4% |
Women's health | 3 | 1.4% |
Zoonosis | 3 | 1.4% |
2019–20 coronavirus pandemic | 2 | 0.9% |
3D printing | 2 | 0.9% |
Accuracy and precision | 2 | 0.9% |
Active surveillance of prostate cancer | 2 | 0.9% |
Activities of daily living | 2 | 0.9% |
Acute kidney injury | 2 | 0.9% |
Acute respiratory distress syndrome | 2 | 0.9% |
Adenoma | 2 | 0.9% |
Adenoviridae | 2 | 0.9% |
Adjuvant therapy | 2 | 0.9% |
Alcoholism | 2 | 0.9% |
Algorithm | 2 | 0.9% |
Alternatives to animal testing | 2 | 0.9% |
Ames test | 2 | 0.9% |
Analysis | 2 | 0.9% |
Analysis of variance | 2 | 0.9% |
Angiology | 2 | 0.9% |
Animal slaughter | 2 | 0.9% |
Animal welfare | 2 | 0.9% |
Anti-diabetic medication | 2 | 0.9% |
Anxiety | 2 | 0.9% |
Aorta | 2 | 0.9% |
Appropriation bill | 2 | 0.9% |
Artificial neural network | 2 | 0.9% |
Aspirin | 2 | 0.9% |
Assisted living | 2 | 0.9% |
Attention | 2 | 0.9% |
Autism | 2 | 0.9% |
BCG vaccine | 2 | 0.9% |
Balanced budget amendment | 2 | 0.9% |
Barley yellow dwarf | 2 | 0.9% |
Bee | 2 | 0.9% |
Beehive | 2 | 0.9% |
Beta cell | 2 | 0.9% |
Big data | 2 | 0.9% |
Bioconcentration | 2 | 0.9% |
Biodiversity | 2 | 0.9% |
Birth control | 2 | 0.9% |
Birth defect | 2 | 0.9% |
Birth weight | 2 | 0.9% |
Blood donation | 2 | 0.9% |
Blood glucose monitoring | 2 | 0.9% |
Blood lead level | 2 | 0.9% |
Blood-borne disease | 2 | 0.9% |
BlueTrace | 2 | 0.9% |
Bluetooth | 2 | 0.9% |
Body fluids | 2 | 0.9% |
Bone fracture | 2 | 0.9% |
Border control | 2 | 0.9% |
Botany | 2 | 0.9% |
Brexit | 2 | 0.9% |
Brexit withdrawal agreement | 2 | 0.9% |
CE marking | 2 | 0.9% |
COVID-19 apps | 2 | 0.9% |
Caesarean section | 2 | 0.9% |
Carcinogenesis | 2 | 0.9% |
Cardiac stress test | 2 | 0.9% |
Cardiac surgery | 2 | 0.9% |
Cardiotocography | 2 | 0.9% |
Case mix | 2 | 0.9% |
Case–control study | 2 | 0.9% |
Change management | 2 | 0.9% |
Charitable organization | 2 | 0.9% |
Cheese | 2 | 0.9% |
Chief executive officer | 2 | 0.9% |
Childhood | 2 | 0.9% |
Chimeric antigen receptor T cell | 2 | 0.9% |
Chlamydia | 2 | 0.9% |
Chronic care | 2 | 0.9% |
Cirrhosis | 2 | 0.9% |
Climate resilience | 2 | 0.9% |
Clinical pharmacy | 2 | 0.9% |
Clozapine | 2 | 0.9% |
Coagulation | 2 | 0.9% |
Cochrane Library | 2 | 0.9% |
Colonoscopy | 2 | 0.9% |
Complication (medicine) | 2 | 0.9% |
Computed tomography angiography | 2 | 0.9% |
Computer-aided diagnosis | 2 | 0.9% |
Convolutional neural network | 2 | 0.9% |
Copyright | 2 | 0.9% |
Coronary catheterization | 2 | 0.9% |
Cough | 2 | 0.9% |
Cystectomy | 2 | 0.9% |
Cystoscopy | 2 | 0.9% |
Cytochrome P450 | 2 | 0.9% |
Cytopathology | 2 | 0.9% |
Data sharing | 2 | 0.9% |
Deferred adjudication | 2 | 0.9% |
Dessert | 2 | 0.9% |
Determinants of health | 2 | 0.9% |
Developing country | 2 | 0.9% |
Diabetic retinopathy | 2 | 0.9% |
Diagnosis-related group | 2 | 0.9% |
Dialysis | 2 | 0.9% |
Digital divide | 2 | 0.9% |
Disaster recovery and business continuity auditing | 2 | 0.9% |
Disorders of endocrine pancreas | 2 | 0.9% |
Do not resuscitate | 2 | 0.9% |
Drug metabolism | 2 | 0.9% |
Dual-energy X-ray absorptiometry | 2 | 0.9% |
ELISA | 2 | 0.9% |
EPSDT | 2 | 0.9% |
Ebola virus disease | 2 | 0.9% |
Ecology | 2 | 0.9% |
Economic growth | 2 | 0.9% |
Ecosystem | 2 | 0.9% |
Ejection fraction | 2 | 0.9% |
Electronic benefit transfer | 2 | 0.9% |
Emergency medical technician | 2 | 0.9% |
Endocrine disruptor | 2 | 0.9% |
Endocrinology | 2 | 0.9% |
Endovascular aneurysm repair | 2 | 0.9% |
Epithelium | 2 | 0.9% |
Esophagogastroduodenoscopy | 2 | 0.9% |
Essential health benefits | 2 | 0.9% |
Ethics | 2 | 0.9% |
Eur-Lex | 2 | 0.9% |
Exhaled nitric oxide | 2 | 0.9% |
Experiment | 2 | 0.9% |
Expert | 2 | 0.9% |
External beam radiotherapy | 2 | 0.9% |
Externality | 2 | 0.9% |
Extracorporeal membrane oxygenation | 2 | 0.9% |
Facial recognition system | 2 | 0.9% |
Fecal occult blood | 2 | 0.9% |
Fetus | 2 | 0.9% |
Food security | 2 | 0.9% |
Foods | 2 | 0.9% |
Frailty syndrome | 2 | 0.9% |
Fraud | 2 | 0.9% |
Gene therapy | 2 | 0.9% |
GeneXpert MTB/RIF | 2 | 0.9% |
General anaesthesia | 2 | 0.9% |
General practice | 2 | 0.9% |
Genome editing | 2 | 0.9% |
Gestational age | 2 | 0.9% |
Gestational diabetes | 2 | 0.9% |
Global Outbreak Alert and Response Network | 2 | 0.9% |
Global health | 2 | 0.9% |
Global warming | 2 | 0.9% |
Globally Harmonized System of Classification and Labelling of Chemicals | 2 | 0.9% |
Goat | 2 | 0.9% |
Good manufacturing practice | 2 | 0.9% |
HIV | 2 | 0.9% |
HPV vaccine | 2 | 0.9% |
Health Insurance Portability and Accountability Act | 2 | 0.9% |
Health in All Policies | 2 | 0.9% |
Health insurance coverage in the United States | 2 | 0.9% |
Healthcare industry | 2 | 0.9% |
Hematology | 2 | 0.9% |
Hematuria | 2 | 0.9% |
Hepatitis C | 2 | 0.9% |
Hepatocellular carcinoma | 2 | 0.9% |
Hip fracture | 2 | 0.9% |
Hip replacement | 2 | 0.9% |
Hormone replacement therapy | 2 | 0.9% |
Hospital-acquired infection | 2 | 0.9% |
Human anatomy | 2 | 0.9% |
Human diseases and disorders | 2 | 0.9% |
Human eye | 2 | 0.9% |
Human resource management | 2 | 0.9% |
Human–computer interaction | 2 | 0.9% |
Hyperglycemia | 2 | 0.9% |
Hypoglycemia | 2 | 0.9% |
Immunity (medical) | 2 | 0.9% |
Immunosuppression | 2 | 0.9% |
In vitro | 2 | 0.9% |
Infant mortality | 2 | 0.9% |
Inflammation | 2 | 0.9% |
Inflation | 2 | 0.9% |
Influenza-like illness | 2 | 0.9% |
Infrastructure | 2 | 0.9% |
Insulin (medication) | 2 | 0.9% |
Insulin resistance | 2 | 0.9% |
Internal audit | 2 | 0.9% |
Internal control | 2 | 0.9% |
International Statistical Classification of Diseases and Related Health Problems | 2 | 0.9% |
Internet of things | 2 | 0.9% |
Interventional radiology | 2 | 0.9% |
Intranet | 2 | 0.9% |
Ionizing radiation | 2 | 0.9% |
Isoniazid | 2 | 0.9% |
Kidney disease | 2 | 0.9% |
Labor induction | 2 | 0.9% |
Laparoscopic radical prostatectomy | 2 | 0.9% |
Lead poisoning | 2 | 0.9% |
Learning | 2 | 0.9% |
Legal guardian | 2 | 0.9% |
Leukemia | 2 | 0.9% |
Liability insurance | 2 | 0.9% |
Listeria monocytogenes | 2 | 0.9% |
Liver transplantation | 2 | 0.9% |
Low-density lipoprotein | 2 | 0.9% |
MEDLINE | 2 | 0.9% |
Mammalian pregnancy | 2 | 0.9% |
Manufacturing | 2 | 0.9% |
Market (economics) | 2 | 0.9% |
Maryland hospital payment system | 2 | 0.9% |
Maternal death | 2 | 0.9% |
Matron | 2 | 0.9% |
Medi-Cal | 2 | 0.9% |
Medical Subject Headings | 2 | 0.9% |
Medical director | 2 | 0.9% |
Medical emergency | 2 | 0.9% |
Medical specialty | 2 | 0.9% |
Megakaryocyte | 2 | 0.9% |
Melanoma | 2 | 0.9% |
Memory | 2 | 0.9% |
Men who have sex with men | 2 | 0.9% |
Mental health professional | 2 | 0.9% |
Metastasis | 2 | 0.9% |
Metformin | 2 | 0.9% |
Micronucleus | 2 | 0.9% |
Middle East respiratory syndrome-related coronavirus | 2 | 0.9% |
Midwife | 2 | 0.9% |
Midwifery | 2 | 0.9% |
Mitigating factor | 2 | 0.9% |
Mouse | 2 | 0.9% |
Mutagen | 2 | 0.9% |
Myzus persicae | 2 | 0.9% |
N95 respirator | 2 | 0.9% |
NHS targets | 2 | 0.9% |
NIOSH air filtration rating | 2 | 0.9% |
Nanomedicine | 2 | 0.9% |
Nanotechnology | 2 | 0.9% |
Needs assessment | 2 | 0.9% |
Nerve | 2 | 0.9% |
Nervous system | 2 | 0.9% |
Neuroscience | 2 | 0.9% |
Non-small-cell lung carcinoma | 2 | 0.9% |
Obsessive–compulsive disorder | 2 | 0.9% |
Opioid | 2 | 0.9% |
Osteoarthritis | 2 | 0.9% |
Osteoporosis | 2 | 0.9% |
Outsourcing | 2 | 0.9% |
P-value | 2 | 0.9% |
Paracetamol | 2 | 0.9% |
Parenting | 2 | 0.9% |
Pathogen | 2 | 0.9% |
Pathology of pregnancy, childbirth and the puerperium | 2 | 0.9% |
Patient Protection and Affordable Care Act | 2 | 0.9% |
Payroll tax | 2 | 0.9% |
Pediatrics | 2 | 0.9% |
Pension | 2 | 0.9% |
Perception | 2 | 0.9% |
Perinatal mortality | 2 | 0.9% |
Perioperative | 2 | 0.9% |
Perioperative mortality | 2 | 0.9% |
Perioperative nursing | 2 | 0.9% |
Pesticide | 2 | 0.9% |
Pharmaceutical industry | 2 | 0.9% |
Pharmacovigilance | 2 | 0.9% |
Phases of clinical research | 2 | 0.9% |
Physiologically based pharmacokinetic modelling | 2 | 0.9% |
Physiology | 2 | 0.9% |
Phytoplankton | 2 | 0.9% |
Placebo | 2 | 0.9% |
Plant breeding | 2 | 0.9% |
Plant disease resistance | 2 | 0.9% |
Plants | 2 | 0.9% |
Plasmodium vivax | 2 | 0.9% |
Platelet transfusion | 2 | 0.9% |
Plea bargain | 2 | 0.9% |
Pneumonia | 2 | 0.9% |
Polymerase chain reaction | 2 | 0.9% |
Positron emission tomography | 2 | 0.9% |
Potato | 2 | 0.9% |
Potato leafroll virus | 2 | 0.9% |
Potato mop-top virus | 2 | 0.9% |
Potato virus Y | 2 | 0.9% |
Powdery scab | 2 | 0.9% |
Prenatal care | 2 | 0.9% |
Preterm birth | 2 | 0.9% |
Prevalence | 2 | 0.9% |
Prevention of HIV/AIDS | 2 | 0.9% |
Projectional radiography | 2 | 0.9% |
Propensity score matching | 2 | 0.9% |
Prostate-specific antigen | 2 | 0.9% |
Prothrombin time | 2 | 0.9% |
Public health surveillance | 2 | 0.9% |
Public policy | 2 | 0.9% |
Pulmonary function testing | 2 | 0.9% |
Quality and Outcomes Framework | 2 | 0.9% |
Quality management | 2 | 0.9% |
Quality-adjusted life year | 2 | 0.9% |
Quantitative research | 2 | 0.9% |
Quantitative structure–activity relationship | 2 | 0.9% |
ROS1 | 2 | 0.9% |
Rabies | 2 | 0.9% |
Radiographer | 2 | 0.9% |
Radiosurgery | 2 | 0.9% |
Raw milk | 2 | 0.9% |
Reason | 2 | 0.9% |
Registered nurse | 2 | 0.9% |
Relative risk | 2 | 0.9% |
Reliability engineering | 2 | 0.9% |
Remdesivir | 2 | 0.9% |
Reproduction in mammals | 2 | 0.9% |
Research and development | 2 | 0.9% |
Research methods | 2 | 0.9% |
Residency (medicine) | 2 | 0.9% |
Respite care | 2 | 0.9% |
Retinopathy | 2 | 0.9% |
Reverse transcription polymerase chain reaction | 2 | 0.9% |
Robot | 2 | 0.9% |
Robotics | 2 | 0.9% |
Rubella | 2 | 0.9% |
Salary | 2 | 0.9% |
Salmonellosis | 2 | 0.9% |
Saving | 2 | 0.9% |
Scenario analysis | 2 | 0.9% |
Schengen Area | 2 | 0.9% |
Scientific method | 2 | 0.9% |
Service industries | 2 | 0.9% |
Severe acute respiratory syndrome coronavirus | 2 | 0.9% |
Single-photon emission computed tomography | 2 | 0.9% |
Sleep | 2 | 0.9% |
Smart city | 2 | 0.9% |
Smoking | 2 | 0.9% |
Smoking cessation | 2 | 0.9% |
Social Security Act | 2 | 0.9% |
Social inequality | 2 | 0.9% |
Software verification and validation | 2 | 0.9% |
Soil-borne wheat mosaic virus | 2 | 0.9% |
Special agent | 2 | 0.9% |
Spice | 2 | 0.9% |
Spirometry | 2 | 0.9% |
Stillbirth | 2 | 0.9% |
Strategic planning | 2 | 0.9% |
Substance use disorder | 2 | 0.9% |
Suicide | 2 | 0.9% |
Sulfonylurea | 2 | 0.9% |
Supplemental Nutrition Assistance Program | 2 | 0.9% |
Support-vector machine | 2 | 0.9% |
Surgical procedures and techniques | 2 | 0.9% |
Survey methodology | 2 | 0.9% |
Survival analysis | 2 | 0.9% |
Symptoms of COVID-19 | 2 | 0.9% |
TCN Protocol | 2 | 0.9% |
Tax | 2 | 0.9% |
Tedros Adhanom | 2 | 0.9% |
Teenage pregnancy | 2 | 0.9% |
Thorax | 2 | 0.9% |
Thrombocytopenia | 2 | 0.9% |
Thrombopoietin | 2 | 0.9% |
Thrombosis prevention | 2 | 0.9% |
Tissues (biology) | 2 | 0.9% |
Tobacco rattle virus | 2 | 0.9% |
Tobacco smoking | 2 | 0.9% |
Tomato brown rugose fruit virus | 2 | 0.9% |
Tomography | 2 | 0.9% |
Tracheal intubation | 2 | 0.9% |
Trade Adjustment Assistance | 2 | 0.9% |
Transcriptomics technologies | 2 | 0.9% |
Transient ischemic attack | 2 | 0.9% |
Transitional care | 2 | 0.9% |
Transmission of COVID-19 | 2 | 0.9% |
Traumatic brain injury | 2 | 0.9% |
Trustee | 2 | 0.9% |
Tuberculosis management | 2 | 0.9% |
Turnover (employment) | 2 | 0.9% |
Unemployment benefits | 2 | 0.9% |
Unlicensed assistive personnel | 2 | 0.9% |
Unmanned aerial vehicle | 2 | 0.9% |
Urinary bladder | 2 | 0.9% |
Urinary incontinence | 2 | 0.9% |
Usability | 2 | 0.9% |
User interface | 2 | 0.9% |
Variance | 2 | 0.9% |
Vascular surgery | 2 | 0.9% |
Ventricular natriuretic peptide | 2 | 0.9% |
Viral replication | 2 | 0.9% |
Viral vector | 2 | 0.9% |
Vitamin | 2 | 0.9% |
Vitamin D | 2 | 0.9% |
WIC | 2 | 0.9% |
Waste | 2 | 0.9% |
Weight loss | 2 | 0.9% |
Wheat streak mosaic virus | 2 | 0.9% |
Whole genome sequencing | 2 | 0.9% |
Women | 2 | 0.9% |
Workers' compensation | 2 | 0.9% |
X-ray | 2 | 0.9% |
100,000 Genomes Project | 1 | 0.5% |
2,3,7,8-Tetrachlorodibenzodioxin | 1 | 0.5% |
ACE inhibitor | 1 | 0.5% |
ACN-PCN method | 1 | 0.5% |
ASA physical status classification system | 1 | 0.5% |
Abdomen | 1 | 0.5% |
Abdominal aortic aneurysm | 1 | 0.5% |
Abu Dhabi | 1 | 0.5% |
Accounts receivable | 1 | 0.5% |
Acetabular labrum | 1 | 0.5% |
Acromegaly | 1 | 0.5% |
Actuarial science | 1 | 0.5% |
Acute myeloid leukemia | 1 | 0.5% |
Adalimumab | 1 | 0.5% |
Adaptive immune system | 1 | 0.5% |
Addiction | 1 | 0.5% |
Adenocarcinoma | 1 | 0.5% |
Adipose tissue | 1 | 0.5% |
Adjudication | 1 | 0.5% |
Advanced life support | 1 | 0.5% |
Advanced practice nurse | 1 | 0.5% |
Aedes aegypti | 1 | 0.5% |
Affordable Care Act | 1 | 0.5% |
Aflibercept | 1 | 0.5% |
African clawed frog | 1 | 0.5% |
Aggression | 1 | 0.5% |
Agreement on the Application of Sanitary and Phytosanitary Measures | 1 | 0.5% |
Airborne transmission | 1 | 0.5% |
Airway management | 1 | 0.5% |
Alanine transaminase | 1 | 0.5% |
Albedo | 1 | 0.5% |
Alcohol advertising | 1 | 0.5% |
Alcohol and cancer | 1 | 0.5% |
Aldosterone | 1 | 0.5% |
Algal bloom | 1 | 0.5% |
All-payer rate setting | 1 | 0.5% |
Allied health professions | 1 | 0.5% |
Allocation concealment | 1 | 0.5% |
Alma Karlin | 1 | 0.5% |
Americans with Disabilities Act of 1990 | 1 | 0.5% |
Anal sex | 1 | 0.5% |
Analgesic | 1 | 0.5% |
Anatomical terms of location | 1 | 0.5% |
Anatomical terms of motion | 1 | 0.5% |
Androgen deprivation therapy | 1 | 0.5% |
Aneurysm | 1 | 0.5% |
Angiotensin | 1 | 0.5% |
Angiotensin II receptor blocker | 1 | 0.5% |
Angiotensin-converting enzyme | 1 | 0.5% |
Animal diseases | 1 | 0.5% |
Animal viral diseases | 1 | 0.5% |
Animal virology | 1 | 0.5% |
Anomaly scan | 1 | 0.5% |
Antenatal steroid | 1 | 0.5% |
Antenna (radio) | 1 | 0.5% |
Anthracycline | 1 | 0.5% |
Antideficiency Act | 1 | 0.5% |
Antifungal | 1 | 0.5% |
Antihypertensive drug | 1 | 0.5% |
Antimalarial medication | 1 | 0.5% |
Antimineralocorticoid | 1 | 0.5% |
Antiphospholipid syndrome | 1 | 0.5% |
Antiplatelet drug | 1 | 0.5% |
Antiserum | 1 | 0.5% |
Antivenom | 1 | 0.5% |
Aortic aneurysm | 1 | 0.5% |
Aortic dissection | 1 | 0.5% |
Aortic stenosis | 1 | 0.5% |
Apiary | 1 | 0.5% |
Apitherapy | 1 | 0.5% |
Apolipoprotein | 1 | 0.5% |
Apolipoprotein B | 1 | 0.5% |
Apolipoprotein L1 | 1 | 0.5% |
Appeal | 1 | 0.5% |
Appendectomy | 1 | 0.5% |
Appendicitis | 1 | 0.5% |
Application software | 1 | 0.5% |
Applied behavior analysis | 1 | 0.5% |
Apprenticeship | 1 | 0.5% |
Aquaculture | 1 | 0.5% |
Arabs | 1 | 0.5% |
Arctic | 1 | 0.5% |
Arctic ecology | 1 | 0.5% |
Arrhythmia | 1 | 0.5% |
Art | 1 | 0.5% |
Artemisinin | 1 | 0.5% |
Arthritis | 1 | 0.5% |
Arthrogram | 1 | 0.5% |
Arthroscopy | 1 | 0.5% |
Artificial cardiac pacemaker | 1 | 0.5% |
Artificial kidney | 1 | 0.5% |
Asbestos | 1 | 0.5% |
Asperger syndrome | 1 | 0.5% |
Assessment of kidney function | 1 | 0.5% |
Assistive technology | 1 | 0.5% |
Assumption | 1 | 0.5% |
Atmosphere of Earth | 1 | 0.5% |
Atorvastatin | 1 | 0.5% |
Atrial septal defect | 1 | 0.5% |
Autism therapies | 1 | 0.5% |
Autologous chondrocyte implantation | 1 | 0.5% |
Automation | 1 | 0.5% |
Autonomic nervous system | 1 | 0.5% |
Avascular necrosis | 1 | 0.5% |
Average treatment effect | 1 | 0.5% |
Avian influenza | 1 | 0.5% |
Awareness | 1 | 0.5% |
Azaspiracid | 1 | 0.5% |
BRCA mutation | 1 | 0.5% |
Basal metabolic rate | 1 | 0.5% |
Battlespace | 1 | 0.5% |
Beekeeper | 1 | 0.5% |
Beekeeping | 1 | 0.5% |
Behaviorism | 1 | 0.5% |
Behaviour therapy | 1 | 0.5% |
Behavioural sciences | 1 | 0.5% |
Benchmarking | 1 | 0.5% |
Benjamin Netanyahu | 1 | 0.5% |
Bernard Lown | 1 | 0.5% |
Bethesda system | 1 | 0.5% |
Bevacizumab | 1 | 0.5% |
Bias | 1 | 0.5% |
Bioaccumulation | 1 | 0.5% |
Biobank | 1 | 0.5% |
Biodefense | 1 | 0.5% |
Biodegradation | 1 | 0.5% |
Biomass | 1 | 0.5% |
Biomedical waste | 1 | 0.5% |
Biopharmaceutical | 1 | 0.5% |
Biosafety | 1 | 0.5% |
Biosecurity | 1 | 0.5% |
Biosimilar | 1 | 0.5% |
Bipolar disorder | 1 | 0.5% |
Black Death | 1 | 0.5% |
Blast injury | 1 | 0.5% |
Bleach | 1 | 0.5% |
Blepharoplasty | 1 | 0.5% |
Blockchain | 1 | 0.5% |
Blood plasma | 1 | 0.5% |
Body composition | 1 | 0.5% |
Bone | 1 | 0.5% |
Borrelia | 1 | 0.5% |
Bourbon virus | 1 | 0.5% |
Bovine spongiform encephalopathy | 1 | 0.5% |
Brachial plexus | 1 | 0.5% |
Brain metastasis | 1 | 0.5% |
Brain–computer interface | 1 | 0.5% |
Brand | 1 | 0.5% |
Brassica | 1 | 0.5% |
Breach of contract | 1 | 0.5% |
Broccoli | 1 | 0.5% |
Bronchiectasis | 1 | 0.5% |
Bubonic plague | 1 | 0.5% |
Built environment | 1 | 0.5% |
Burroughs MCP | 1 | 0.5% |
Business model | 1 | 0.5% |
CONTEST | 1 | 0.5% |
COVID-19 Surveillance | 1 | 0.5% |
COVID-19 pandemic in Iceland | 1 | 0.5% |
COVID-19 pandemic in New Jersey | 1 | 0.5% |
COVID-19 pandemic in Scotland | 1 | 0.5% |
COVID-19 pandemic in the United States | 1 | 0.5% |
COVID-19 vaccine | 1 | 0.5% |
COX-2 inhibitor | 1 | 0.5% |
CRC Energy Efficiency Scheme | 1 | 0.5% |
CRISPR | 1 | 0.5% |
CRISPR gene editing | 1 | 0.5% |
Calcium | 1 | 0.5% |
Calibration | 1 | 0.5% |
Campylobacter | 1 | 0.5% |
Canagliflozin | 1 | 0.5% |
Cancer immunotherapy | 1 | 0.5% |
Cancer rehabilitation | 1 | 0.5% |
Cancer research | 1 | 0.5% |
Cancer staging | 1 | 0.5% |
Cancer syndrome | 1 | 0.5% |
Candidiasis | 1 | 0.5% |
Cannabidiol | 1 | 0.5% |
Cannabis (drug) | 1 | 0.5% |
Carbon fiber reinforced polymer | 1 | 0.5% |
Carbon neutrality | 1 | 0.5% |
Carbon tax | 1 | 0.5% |
Carboplatin | 1 | 0.5% |
Carcinoma | 1 | 0.5% |
Cardiac imaging | 1 | 0.5% |
Cardiac muscle | 1 | 0.5% |
Cardiac rehabilitation | 1 | 0.5% |
Cardiomyopathy | 1 | 0.5% |
Cardiopulmonary resuscitation | 1 | 0.5% |
Carlos Finlay | 1 | 0.5% |
Cartilage | 1 | 0.5% |
Cas9 | 1 | 0.5% |
Case study | 1 | 0.5% |
Cataract surgery | 1 | 0.5% |
Causes of cancer | 1 | 0.5% |
Cecil County, Maryland | 1 | 0.5% |
Cell potency | 1 | 0.5% |
Central nervous system | 1 | 0.5% |
Cerebral cortex | 1 | 0.5% |
Cerebral organoid | 1 | 0.5% |
Cerebrovascular disease | 1 | 0.5% |
Certified Registered Nurse Anesthetist | 1 | 0.5% |
Certified reference materials | 1 | 0.5% |
Cervical cerclage | 1 | 0.5% |
Cervical intraepithelial neoplasia | 1 | 0.5% |
Cervix | 1 | 0.5% |
Chalazion | 1 | 0.5% |
Chemistry | 1 | 0.5% |
Chief operating officer | 1 | 0.5% |
Chikungunya | 1 | 0.5% |
Child | 1 | 0.5% |
Child Protective Services | 1 | 0.5% |
Child abuse | 1 | 0.5% |
Child protection | 1 | 0.5% |
Childhood cancer | 1 | 0.5% |
Chimbu Province | 1 | 0.5% |
Chlorine dioxide | 1 | 0.5% |
Chloroquine | 1 | 0.5% |
Chocolate | 1 | 0.5% |
Cholecystectomy | 1 | 0.5% |
Chronic care management | 1 | 0.5% |
Chronic myelomonocytic leukemia | 1 | 0.5% |
Chronic thromboembolic pulmonary hypertension | 1 | 0.5% |
Cigarette | 1 | 0.5% |
Cisplatin | 1 | 0.5% |
Cleaning agent | 1 | 0.5% |
Clinical pathology | 1 | 0.5% |
Clostridioides difficile infection | 1 | 0.5% |
Clothing | 1 | 0.5% |
Clotrimazole | 1 | 0.5% |
Coefficient of determination | 1 | 0.5% |
Cognitive liberty | 1 | 0.5% |
Colposcopy | 1 | 0.5% |
Combined oral contraceptive pill | 1 | 0.5% |
Comet assay | 1 | 0.5% |
Community health worker | 1 | 0.5% |
Compact of Free Association | 1 | 0.5% |
Complexity | 1 | 0.5% |
Complications of diabetes | 1 | 0.5% |
Composite material | 1 | 0.5% |
Computer | 1 | 0.5% |
Computer hardware | 1 | 0.5% |
Computer network | 1 | 0.5% |
Computing | 1 | 0.5% |
Concrete | 1 | 0.5% |
Condom | 1 | 0.5% |
Confectionery | 1 | 0.5% |
Congenital heart defect | 1 | 0.5% |
Congressional Budget and Impoundment Control Act of 1974 | 1 | 0.5% |
Consent | 1 | 0.5% |
Conservation biology | 1 | 0.5% |
Consolidated Omnibus Budget Reconciliation Act of 1985 | 1 | 0.5% |
Contact (law) | 1 | 0.5% |
Content analysis | 1 | 0.5% |
Continuing healthcare | 1 | 0.5% |
Coronary CT angiography | 1 | 0.5% |
Coronary CT calcium scan | 1 | 0.5% |
Coronary artery bypass surgery | 1 | 0.5% |
Coronary circulation | 1 | 0.5% |
Coronaviridae | 1 | 0.5% |
Coroner | 1 | 0.5% |
Corruption | 1 | 0.5% |
Corticosteroid | 1 | 0.5% |
Cost–benefit analysis | 1 | 0.5% |
Cost–utility analysis | 1 | 0.5% |
Country of origin | 1 | 0.5% |
Creatinine | 1 | 0.5% |
Crime | 1 | 0.5% |
Crisis | 1 | 0.5% |
Cross-sectional study | 1 | 0.5% |
Crush syndrome | 1 | 0.5% |
Cryptography | 1 | 0.5% |
Curriculum | 1 | 0.5% |
Cushing's disease | 1 | 0.5% |
Cushing's syndrome | 1 | 0.5% |
Customer experience | 1 | 0.5% |
Customer satisfaction | 1 | 0.5% |
Cyclophosphamide | 1 | 0.5% |
Cystic fibrosis | 1 | 0.5% |
DNA | 1 | 0.5% |
DNA repair | 1 | 0.5% |
DNA replication | 1 | 0.5% |
Darbepoetin alfa | 1 | 0.5% |
Data | 1 | 0.5% |
Data Protection Act 1998 | 1 | 0.5% |
Data quality | 1 | 0.5% |
De-identification | 1 | 0.5% |
Death | 1 | 0.5% |
Debt | 1 | 0.5% |
Decompression sickness | 1 | 0.5% |
Deferred Action for Childhood Arrivals | 1 | 0.5% |
Demography | 1 | 0.5% |
Dengue fever | 1 | 0.5% |
Dentistry | 1 | 0.5% |
Design | 1 | 0.5% |
Development aid | 1 | 0.5% |
Development of the nervous system | 1 | 0.5% |
Diabetes medication | 1 | 0.5% |
Diabetic ketoacidosis | 1 | 0.5% |
Diagnosis code | 1 | 0.5% |
Diagnostic and Statistical Manual of Mental Disorders | 1 | 0.5% |
Dialect | 1 | 0.5% |
Diarrhea | 1 | 0.5% |
Diet (nutrition) | 1 | 0.5% |
Dietitian | 1 | 0.5% |
Difference in differences | 1 | 0.5% |
Digital pathology | 1 | 0.5% |
Diplomacy | 1 | 0.5% |
Directivity | 1 | 0.5% |
Disability-adjusted life year | 1 | 0.5% |
Discovery (law) | 1 | 0.5% |
Discrete trial training | 1 | 0.5% |
Disease surveillance | 1 | 0.5% |
Disseminated intravascular coagulation | 1 | 0.5% |
Docetaxel | 1 | 0.5% |
Doctor of Philosophy | 1 | 0.5% |
Dog | 1 | 0.5% |
Dosimetry | 1 | 0.5% |
Draize test | 1 | 0.5% |
Drug | 1 | 0.5% |
Drug overdose | 1 | 0.5% |
Dual diagnosis | 1 | 0.5% |
Dumpling | 1 | 0.5% |
Duodenum | 1 | 0.5% |
Dysglycemia | 1 | 0.5% |
E-procurement | 1 | 0.5% |
E-services | 1 | 0.5% |
Eating | 1 | 0.5% |
Ebola | 1 | 0.5% |
Ecological resilience | 1 | 0.5% |
Ecological stability | 1 | 0.5% |
Ecological succession | 1 | 0.5% |
Economic development | 1 | 0.5% |
Economic inequality | 1 | 0.5% |
Economics | 1 | 0.5% |
Economy | 1 | 0.5% |
Educational assessment | 1 | 0.5% |
Educational technology | 1 | 0.5% |
Effect size | 1 | 0.5% |
Electromyography | 1 | 0.5% |
Electronic cigarette | 1 | 0.5% |
Electronic warfare | 1 | 0.5% |
Emerging technologies | 1 | 0.5% |
Emotion | 1 | 0.5% |
Emotional eating | 1 | 0.5% |
Empagliflozin | 1 | 0.5% |
Employee Retirement Income Security Act of 1974 | 1 | 0.5% |
Employee retention | 1 | 0.5% |
Empowerment | 1 | 0.5% |
Encryption | 1 | 0.5% |
Endocrine pancreas | 1 | 0.5% |
Endometrial cancer | 1 | 0.5% |
Endometrium | 1 | 0.5% |
Energy | 1 | 0.5% |
Engineering | 1 | 0.5% |
Enoxaparin sodium | 1 | 0.5% |
Enterprise content management | 1 | 0.5% |
Entrectinib | 1 | 0.5% |
Entrepreneurship | 1 | 0.5% |
Entropy | 1 | 0.5% |
Environmental health | 1 | 0.5% |
Environmental monitoring | 1 | 0.5% |
Epidermal growth factor receptor | 1 | 0.5% |
Epididymis | 1 | 0.5% |
Epigenomics | 1 | 0.5% |
Equity (finance) | 1 | 0.5% |
Eradication of infectious diseases | 1 | 0.5% |
Erythrocyte sedimentation rate | 1 | 0.5% |
Erythropoietin | 1 | 0.5% |
Estradiol | 1 | 0.5% |
Estrogen | 1 | 0.5% |
Estrogen receptor alpha | 1 | 0.5% |
Estrogen receptor beta | 1 | 0.5% |
Estrous cycle | 1 | 0.5% |
Etiquette | 1 | 0.5% |
European Health Insurance Card | 1 | 0.5% |
European polecat | 1 | 0.5% |
Evaluation methods | 1 | 0.5% |
Everolimus | 1 | 0.5% |
Evidence | 1 | 0.5% |
Exercise prescription | 1 | 0.5% |
Exhalation | 1 | 0.5% |
Exophthalmos | 1 | 0.5% |
Exposure (photography) | 1 | 0.5% |
Exposure Notification | 1 | 0.5% |
Exposure therapy | 1 | 0.5% |
Extensively drug-resistant tuberculosis | 1 | 0.5% |
External validity | 1 | 0.5% |
Extracellular matrix | 1 | 0.5% |
Eye care | 1 | 0.5% |
Eye neoplasm | 1 | 0.5% |
Eye protection | 1 | 0.5% |
Eye surgery | 1 | 0.5% |
Eyelid | 1 | 0.5% |
Ezetimibe | 1 | 0.5% |
FDA Food Safety Modernization Act | 1 | 0.5% |
FDA warning letter | 1 | 0.5% |
Face shield | 1 | 0.5% |
Facial trauma | 1 | 0.5% |
Fall prevention | 1 | 0.5% |
Familial hypercholesterolemia | 1 | 0.5% |
Fashion | 1 | 0.5% |
Fatty liver disease | 1 | 0.5% |
Federal Food, Drug, and Cosmetic Act | 1 | 0.5% |
Federal Information Security Management Act of 2002 | 1 | 0.5% |
Federally Qualified Health Center | 1 | 0.5% |
Fee | 1 | 0.5% |
Feed-in tariff | 1 | 0.5% |
Femoral artery | 1 | 0.5% |
Femoroacetabular impingement | 1 | 0.5% |
Fentanyl | 1 | 0.5% |
Ferret | 1 | 0.5% |
Fetal alcohol spectrum disorder | 1 | 0.5% |
Fibre-reinforced plastic | 1 | 0.5% |
Field epidemiology | 1 | 0.5% |
Financial statement | 1 | 0.5% |
First Nations | 1 | 0.5% |
Fish farming | 1 | 0.5% |
Fish slaughter | 1 | 0.5% |
Five Year Forward View | 1 | 0.5% |
Flag | 1 | 0.5% |
Flag of Slovenia | 1 | 0.5% |
Flower | 1 | 0.5% |
Flu season | 1 | 0.5% |
Focus group | 1 | 0.5% |
Folate | 1 | 0.5% |
Food allergy | 1 | 0.5% |
Food frequency questionnaire | 1 | 0.5% |
Food industry | 1 | 0.5% |
Food safety-risk analysis | 1 | 0.5% |
Food web | 1 | 0.5% |
Forest | 1 | 0.5% |
Forestry | 1 | 0.5% |
Formal verification | 1 | 0.5% |
Fossil fuel | 1 | 0.5% |
Fraction (mathematics) | 1 | 0.5% |
Fraction of inspired oxygen | 1 | 0.5% |
Fractional flow reserve | 1 | 0.5% |
France Prešeren | 1 | 0.5% |
Francisco Javier de Balmis | 1 | 0.5% |
Freedom of Information Act (United States) | 1 | 0.5% |
Freedom of Information Act 2000 | 1 | 0.5% |
Friends and Family Test | 1 | 0.5% |
Frozen section procedure | 1 | 0.5% |
Fructosamine | 1 | 0.5% |
Fuel | 1 | 0.5% |
Fundus photography | 1 | 0.5% |
Fungus | 1 | 0.5% |
Fused filament fabrication | 1 | 0.5% |
Gas chromatography | 1 | 0.5% |
Gastrointestinal bleeding | 1 | 0.5% |
Gastrointestinal tract | 1 | 0.5% |
Gaza Strip | 1 | 0.5% |
Gemcitabine | 1 | 0.5% |
Gender | 1 | 0.5% |
Gene | 1 | 0.5% |
General surgery | 1 | 0.5% |
Genetic engineering | 1 | 0.5% |
Genetic testing | 1 | 0.5% |
Genomics | 1 | 0.5% |
Germline mutation | 1 | 0.5% |
Gestational trophoblastic disease | 1 | 0.5% |
Giant-cell arteritis | 1 | 0.5% |
Glands | 1 | 0.5% |
Glasses | 1 | 0.5% |
Glaucoma | 1 | 0.5% |
Global catastrophic risk | 1 | 0.5% |
Glove | 1 | 0.5% |
Glucagon-like peptide-1 | 1 | 0.5% |
Glucose | 1 | 0.5% |
Glucose test | 1 | 0.5% |
Glucose tolerance test | 1 | 0.5% |
Glucose-6-phosphate dehydrogenase deficiency | 1 | 0.5% |
Glutamate dehydrogenase | 1 | 0.5% |
Granulocyte colony-stimulating factor | 1 | 0.5% |
Graves' ophthalmopathy | 1 | 0.5% |
Gray (unit) | 1 | 0.5% |
Greater trochanteric pain syndrome | 1 | 0.5% |
Greenhouse gas | 1 | 0.5% |
Greenland ice sheet | 1 | 0.5% |
Ground-glass opacity | 1 | 0.5% |
Growth hormone | 1 | 0.5% |
Gunshot wound | 1 | 0.5% |
Gynaecologic disorders | 1 | 0.5% |
HER2/neu | 1 | 0.5% |
HIV-positive people | 1 | 0.5% |
Haemaphysalis longicornis | 1 | 0.5% |
Hand dryer | 1 | 0.5% |
Hand sanitizer | 1 | 0.5% |
Harm reduction | 1 | 0.5% |
Harmful algal bloom | 1 | 0.5% |
Hazard analysis and critical control points | 1 | 0.5% |
Hazard ratio | 1 | 0.5% |
Head and neck cancer | 1 | 0.5% |
Health Information Technology for Economic and Clinical Health Act | 1 | 0.5% |
Health and Social Care Act 2012 | 1 | 0.5% |
Health and Social Care Network | 1 | 0.5% |
Health care fraud | 1 | 0.5% |
Health education | 1 | 0.5% |
Health human resources | 1 | 0.5% |
Health insurance marketplace | 1 | 0.5% |
Health reimbursement account | 1 | 0.5% |
Health risk assessment | 1 | 0.5% |
Health services research | 1 | 0.5% |
Health technology | 1 | 0.5% |
Health technology assessment | 1 | 0.5% |
Healthcare Effectiveness Data and Information Set | 1 | 0.5% |
Healthcare in Greater Manchester | 1 | 0.5% |
Healthy diet | 1 | 0.5% |
Heart failure with preserved ejection fraction | 1 | 0.5% |
Heart valve | 1 | 0.5% |
Helicobacter | 1 | 0.5% |
Helicobacter pylori | 1 | 0.5% |
Hemofiltration | 1 | 0.5% |
Heparin | 1 | 0.5% |
Hepatitis B | 1 | 0.5% |
Herpes simplex | 1 | 0.5% |
Hierarchy of evidence | 1 | 0.5% |
High-density lipoprotein | 1 | 0.5% |
High-intensity focused ultrasound | 1 | 0.5% |
High-performance plastics | 1 | 0.5% |
Hip arthroscopy | 1 | 0.5% |
Hip dislocation | 1 | 0.5% |
Hip pain | 1 | 0.5% |
Hispanic and Latino Americans | 1 | 0.5% |
Histology | 1 | 0.5% |
Honey | 1 | 0.5% |
Honey bee | 1 | 0.5% |
Hormone | 1 | 0.5% |
Horse | 1 | 0.5% |
Hospice care in the United States | 1 | 0.5% |
Hospital-acquired condition | 1 | 0.5% |
Human | 1 | 0.5% |
Human betaherpesvirus 5 | 1 | 0.5% |
Human chorionic gonadotropin | 1 | 0.5% |
Human decontamination | 1 | 0.5% |
Human orthopneumovirus | 1 | 0.5% |
Human resources | 1 | 0.5% |
Human services | 1 | 0.5% |
Human sexuality | 1 | 0.5% |
Hybridization probe | 1 | 0.5% |
Hypercholesterolemia | 1 | 0.5% |
Hyperkalemia | 1 | 0.5% |
Hyperlipidemia | 1 | 0.5% |
Hyperprolactinaemia | 1 | 0.5% |
Hyperthermia therapy | 1 | 0.5% |
Hypnotic | 1 | 0.5% |
Hypokalemia | 1 | 0.5% |
Hypopituitarism | 1 | 0.5% |
Hypoxemia | 1 | 0.5% |
Hypoxia (medical) | 1 | 0.5% |
ICD-10 | 1 | 0.5% |
ISO/IEC 27001 | 1 | 0.5% |
ITIL | 1 | 0.5% |
Ibuprofen | 1 | 0.5% |
Image scanner | 1 | 0.5% |
Immunoassay | 1 | 0.5% |
Immunoglobulin G | 1 | 0.5% |
Immunoglobulin M | 1 | 0.5% |
Immunosuppressive drug | 1 | 0.5% |
Impact evaluation | 1 | 0.5% |
Imputation (statistics) | 1 | 0.5% |
Incentive | 1 | 0.5% |
Incidence (epidemiology) | 1 | 0.5% |
Indigenous Australians | 1 | 0.5% |
Individualized Education Program | 1 | 0.5% |
Indole-3-carbinol | 1 | 0.5% |
Indoor tanning | 1 | 0.5% |
Induced pluripotent stem cell | 1 | 0.5% |
Influenza A virus subtype H1N1 | 1 | 0.5% |
Informal economy | 1 | 0.5% |
Information and communications technology | 1 | 0.5% |
Information governance | 1 | 0.5% |
Information security management | 1 | 0.5% |
Information sensitivity | 1 | 0.5% |
Informed consent | 1 | 0.5% |
Inquest | 1 | 0.5% |
Insect-borne diseases | 1 | 0.5% |
Inspection | 1 | 0.5% |
Integrated care system | 1 | 0.5% |
Intellectual disability | 1 | 0.5% |
Intelligence quotient | 1 | 0.5% |
Intention-to-treat analysis | 1 | 0.5% |
Interagency Coordinating Committee on the Validation of Alternative Methods | 1 | 0.5% |
Interdisciplinary subfields | 1 | 0.5% |
Interferon | 1 | 0.5% |
Interleukin | 1 | 0.5% |
Intermittent preventive therapy | 1 | 0.5% |
Internal validity | 1 | 0.5% |
International Classification of Diseases | 1 | 0.5% |
International Health Regulations | 1 | 0.5% |
Internet privacy | 1 | 0.5% |
Intracranial pressure | 1 | 0.5% |
Intrauterine growth restriction | 1 | 0.5% |
Intravenous therapy | 1 | 0.5% |
Invasive species | 1 | 0.5% |
Investment | 1 | 0.5% |
Ischemia | 1 | 0.5% |
Israeli settlement | 1 | 0.5% |
Issues in ethics | 1 | 0.5% |
Janez Janša | 1 | 0.5% |
Jejunum | 1 | 0.5% |
Jerusalem | 1 | 0.5% |
Joint Monitoring Programme for Water Supply and Sanitation | 1 | 0.5% |
Jože Plečnik | 1 | 0.5% |
Junior doctor | 1 | 0.5% |
Kaplan–Meier estimator | 1 | 0.5% |
Kings Cross, London | 1 | 0.5% |
Knee | 1 | 0.5% |
Knitted fabric | 1 | 0.5% |
LGBT community | 1 | 0.5% |
LOINC | 1 | 0.5% |
Laboratory information management system | 1 | 0.5% |
Laboratory rat | 1 | 0.5% |
Laminoplasty | 1 | 0.5% |
Landlord | 1 | 0.5% |
Language | 1 | 0.5% |
Laparotomy | 1 | 0.5% |
Laptop | 1 | 0.5% |
Laser coagulation | 1 | 0.5% |
Lasso (statistics) | 1 | 0.5% |
Laura Lechuga | 1 | 0.5% |
Law of the United States | 1 | 0.5% |
Leaf | 1 | 0.5% |
Leasehold estate | 1 | 0.5% |
Legal remedy | 1 | 0.5% |
Legislation | 1 | 0.5% |
Lenalidomide | 1 | 0.5% |
Lentiviruses | 1 | 0.5% |
Level crossing | 1 | 0.5% |
Licensed practical nurse | 1 | 0.5% |
Licensure | 1 | 0.5% |
Life insurance | 1 | 0.5% |
Likelihood ratios in diagnostic testing | 1 | 0.5% |
Limited liability partnership | 1 | 0.5% |
Lipizzan | 1 | 0.5% |
Lipoprotein | 1 | 0.5% |
Lipoprotein(a) | 1 | 0.5% |
Liraglutide | 1 | 0.5% |
Literacy | 1 | 0.5% |
Liver | 1 | 0.5% |
Liver biopsy | 1 | 0.5% |
Living wage | 1 | 0.5% |
Ljubljana | 1 | 0.5% |
Loan | 1 | 0.5% |
Locum | 1 | 0.5% |
Logistics | 1 | 0.5% |
London Borough of Camden | 1 | 0.5% |
Loneliness | 1 | 0.5% |
Long-term effects of alcohol | 1 | 0.5% |
Long-term effects of alcohol consumption | 1 | 0.5% |
Loop diuretic | 1 | 0.5% |
Lung nodule | 1 | 0.5% |
Lupus | 1 | 0.5% |
Lyme disease | 1 | 0.5% |
Lymphadenectomy | 1 | 0.5% |
Lymphatic system | 1 | 0.5% |
Lymphatic vessel | 1 | 0.5% |
MMR vaccine | 1 | 0.5% |
MOX fuel | 1 | 0.5% |
Macular degeneration | 1 | 0.5% |
Magnesium | 1 | 0.5% |
Magnesium deficiency | 1 | 0.5% |
Magnetoencephalography | 1 | 0.5% |
Major trauma | 1 | 0.5% |
Male genital disorders | 1 | 0.5% |
Malignancy | 1 | 0.5% |
Management of hypertension | 1 | 0.5% |
Mantoux test | 1 | 0.5% |
Manus Island | 1 | 0.5% |
Mariposa County, California | 1 | 0.5% |
Marketing | 1 | 0.5% |
Mass-casualty incident | 1 | 0.5% |
Maternal–fetal medicine | 1 | 0.5% |
Mathematical and quantitative methods (economics) | 1 | 0.5% |
Mathematical optimization | 1 | 0.5% |
Median | 1 | 0.5% |
Medical cannabis | 1 | 0.5% |
Medical classification | 1 | 0.5% |
Medical emergencies | 1 | 0.5% |
Medical equipment | 1 | 0.5% |
Medical laboratory | 1 | 0.5% |
Medical laboratory scientist | 1 | 0.5% |
Medical microbiology | 1 | 0.5% |
Medical physics | 1 | 0.5% |
Medical research | 1 | 0.5% |
Medical school | 1 | 0.5% |
Medical ventilator | 1 | 0.5% |
Medicare Advantage | 1 | 0.5% |
Memorandum of understanding | 1 | 0.5% |
Meningococcal disease | 1 | 0.5% |
Meningococcal vaccine | 1 | 0.5% |
Menopause | 1 | 0.5% |
Meralgia paraesthetica | 1 | 0.5% |
Messenger RNA | 1 | 0.5% |
Meta-regression | 1 | 0.5% |
Metabolic syndrome | 1 | 0.5% |
Metabolomics | 1 | 0.5% |
Metagenomics | 1 | 0.5% |
Micronucleus test | 1 | 0.5% |
Microplastics | 1 | 0.5% |
Midazolam | 1 | 0.5% |
Middle East respiratory syndrome–related coronavirus | 1 | 0.5% |
Milan Spasić | 1 | 0.5% |
Milk | 1 | 0.5% |
Millennium Development Goals | 1 | 0.5% |
Mind | 1 | 0.5% |
Misoprostol | 1 | 0.5% |
Missing data | 1 | 0.5% |
Mitochondrion | 1 | 0.5% |
Mitral valve replacement | 1 | 0.5% |
Mixed-member proportional representation | 1 | 0.5% |
Mobile phone | 1 | 0.5% |
Model organism | 1 | 0.5% |
Molecular cloning | 1 | 0.5% |
Mood disorder | 1 | 0.5% |
Moral injury | 1 | 0.5% |
Morobe Province | 1 | 0.5% |
Mosquito | 1 | 0.5% |
Mosquito-borne disease | 1 | 0.5% |
Moss | 1 | 0.5% |
Mountaineering | 1 | 0.5% |
Multidrug-resistant tuberculosis | 1 | 0.5% |
Multiple comparisons problem | 1 | 0.5% |
Multiple myeloma | 1 | 0.5% |
Multistakeholder governance model | 1 | 0.5% |
Multisystem inflammatory syndrome in children | 1 | 0.5% |
Mustelidae | 1 | 0.5% |
Mutation | 1 | 0.5% |
Mycoplasma | 1 | 0.5% |
Myelodysplastic syndrome | 1 | 0.5% |
Myocarditis | 1 | 0.5% |
Myrosinase | 1 | 0.5% |
NHS Long Term Plan | 1 | 0.5% |
NHS Test and Trace | 1 | 0.5% |
Naloxone | 1 | 0.5% |
Nanomaterials | 1 | 0.5% |
Nanoparticle | 1 | 0.5% |
Naproxen | 1 | 0.5% |
Nasolacrimal duct obstruction | 1 | 0.5% |
National Federation of Independent Business v. Sebelius | 1 | 0.5% |
National Flood Insurance Program | 1 | 0.5% |
National coverage determination | 1 | 0.5% |
National debt of the United States | 1 | 0.5% |
National security | 1 | 0.5% |
Natural environment | 1 | 0.5% |
Natural reservoir | 1 | 0.5% |
Nature-based solutions | 1 | 0.5% |
Naypyidaw | 1 | 0.5% |
Necrotizing fasciitis | 1 | 0.5% |
Needlestick injury | 1 | 0.5% |
Neglected tropical diseases | 1 | 0.5% |
Neisseria meningitidis | 1 | 0.5% |
Neonatal intensive care unit | 1 | 0.5% |
Nerve compression syndrome | 1 | 0.5% |
Nerve conduction study | 1 | 0.5% |
Neural tube defect | 1 | 0.5% |
Neurodegeneration | 1 | 0.5% |
Neuroergonomics | 1 | 0.5% |
Neuroimaging | 1 | 0.5% |
Neuron | 1 | 0.5% |
Neuroplasticity | 1 | 0.5% |
Neuropsychology | 1 | 0.5% |
Neurostimulation | 1 | 0.5% |
Neurosurgery | 1 | 0.5% |
Neurotechnology | 1 | 0.5% |
Neutralizing antibody | 1 | 0.5% |
New Britain | 1 | 0.5% |
Next of kin | 1 | 0.5% |
Nick Bostrom | 1 | 0.5% |
Nicotine | 1 | 0.5% |
Nidovirales | 1 | 0.5% |
Non-executive director | 1 | 0.5% |
Non-governmental organization | 1 | 0.5% |
Non-invasive ventilation | 1 | 0.5% |
Non-tariff barriers to trade | 1 | 0.5% |
Nuclear reactor | 1 | 0.5% |
Nuclear safety and security | 1 | 0.5% |
Null hypothesis | 1 | 0.5% |
Nutri-Score | 1 | 0.5% |
Nutrition | 1 | 0.5% |
Occult fracture | 1 | 0.5% |
Occupational therapist | 1 | 0.5% |
Occupational therapy | 1 | 0.5% |
Oculoplastics | 1 | 0.5% |
Old age | 1 | 0.5% |
Omics | 1 | 0.5% |
Oncology | 1 | 0.5% |
Oncovirus | 1 | 0.5% |
Opioid use disorder | 1 | 0.5% |
Optic neuropathy | 1 | 0.5% |
Orbit (anatomy) | 1 | 0.5% |
Orbital blowout fracture | 1 | 0.5% |
Organ donation | 1 | 0.5% |
Organism | 1 | 0.5% |
Organoid | 1 | 0.5% |
Osteopathy | 1 | 0.5% |
Ostreopsis | 1 | 0.5% |
Otorhinolaryngology | 1 | 0.5% |
Outlier | 1 | 0.5% |
Ovarian cancer | 1 | 0.5% |
Over-the-counter drug | 1 | 0.5% |
Overdispersion | 1 | 0.5% |
Oxygen saturation (medicine) | 1 | 0.5% |
Oxygen therapy | 1 | 0.5% |
Ozone depletion | 1 | 0.5% |
PCSK9 | 1 | 0.5% |
PET-CT | 1 | 0.5% |
Paclitaxel | 1 | 0.5% |
Pain management | 1 | 0.5% |
Palestinian territories | 1 | 0.5% |
Pancreas | 1 | 0.5% |
Pancreaticoduodenectomy | 1 | 0.5% |
Pancreatitis | 1 | 0.5% |
Pandemics | 1 | 0.5% |
Papillomaviridae | 1 | 0.5% |
Paresthesia | 1 | 0.5% |
Partnership | 1 | 0.5% |
Passive smoking | 1 | 0.5% |
Patient navigators | 1 | 0.5% |
Patient participation | 1 | 0.5% |
Patient-reported outcome | 1 | 0.5% |
Patiromer | 1 | 0.5% |
Pay-per-click | 1 | 0.5% |
Payment | 1 | 0.5% |
Payment by Results | 1 | 0.5% |
Peer review | 1 | 0.5% |
Peer support | 1 | 0.5% |
Pelvis | 1 | 0.5% |
Pembrolizumab | 1 | 0.5% |
Penetrating trauma | 1 | 0.5% |
Per diem | 1 | 0.5% |
Performance indicator | 1 | 0.5% |
Perfusion | 1 | 0.5% |
Pericarditis | 1 | 0.5% |
Pericardium | 1 | 0.5% |
Peripheral artery disease | 1 | 0.5% |
Peripheral nervous system | 1 | 0.5% |
Pervasive developmental disorder | 1 | 0.5% |
Pervasive developmental disorder not otherwise specified | 1 | 0.5% |
Pet | 1 | 0.5% |
Pharmacogenomics | 1 | 0.5% |
Pharmacy technician | 1 | 0.5% |
Photography | 1 | 0.5% |
Physical fitness | 1 | 0.5% |
Physical sciences | 1 | 0.5% |
Physician Orders for Life-Sustaining Treatment | 1 | 0.5% |
Physician assistant | 1 | 0.5% |
Physician supply | 1 | 0.5% |
Physics | 1 | 0.5% |
Pioglitazone | 1 | 0.5% |
Piperaquine | 1 | 0.5% |
Pituitary adenoma | 1 | 0.5% |
Placebo-controlled study | 1 | 0.5% |
Plain language | 1 | 0.5% |
Plant | 1 | 0.5% |
Plasmodium | 1 | 0.5% |
Plasmodium falciparum | 1 | 0.5% |
Plasmodium knowlesi | 1 | 0.5% |
Plasmodium ovale | 1 | 0.5% |
Plastic surgery | 1 | 0.5% |
Pledge of Allegiance | 1 | 0.5% |
Pneumococcal conjugate vaccine | 1 | 0.5% |
Pneumococcal vaccine | 1 | 0.5% |
Poaching | 1 | 0.5% |
Point-of-care testing | 1 | 0.5% |
Poisson distribution | 1 | 0.5% |
Police National Computer | 1 | 0.5% |
Polio | 1 | 0.5% |
Polio eradication | 1 | 0.5% |
Polio vaccine | 1 | 0.5% |
Poliovirus | 1 | 0.5% |
Pollinator | 1 | 0.5% |
Pollution | 1 | 0.5% |
Polyether ether ketone | 1 | 0.5% |
Polypharmacy | 1 | 0.5% |
Polysomnography | 1 | 0.5% |
Polystyrene sulfonate | 1 | 0.5% |
Pork | 1 | 0.5% |
Positive airway pressure | 1 | 0.5% |
Post-exposure prophylaxis | 1 | 0.5% |
Post-thrombotic syndrome | 1 | 0.5% |
Postpartum period | 1 | 0.5% |
Potassium | 1 | 0.5% |
Potassium binder | 1 | 0.5% |
Powassan virus | 1 | 0.5% |
Power of a test | 1 | 0.5% |
Powered air-purifying respirator | 1 | 0.5% |
Pravastatin | 1 | 0.5% |
Pre-eclampsia | 1 | 0.5% |
Pre-preg | 1 | 0.5% |
Precision and recall | 1 | 0.5% |
Predictive analytics | 1 | 0.5% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 0.5% |
Prescription monitoring program | 1 | 0.5% |
President of the United States | 1 | 0.5% |
Pressure ulcer | 1 | 0.5% |
Preventive medicine | 1 | 0.5% |
Primaquine | 1 | 0.5% |
Primary health care | 1 | 0.5% |
Primary healthcare | 1 | 0.5% |
Primary immunodeficiency | 1 | 0.5% |
Prince George's County, Maryland | 1 | 0.5% |
Privacy law | 1 | 0.5% |
Privacy policy | 1 | 0.5% |
Probability | 1 | 0.5% |
Procalcitonin | 1 | 0.5% |
Process modeling | 1 | 0.5% |
Productivity | 1 | 0.5% |
Program evaluation | 1 | 0.5% |
Project management | 1 | 0.5% |
Prolactinoma | 1 | 0.5% |
Prolotherapy | 1 | 0.5% |
Proportional hazards model | 1 | 0.5% |
Prostate biopsy | 1 | 0.5% |
Prostate cancer screening | 1 | 0.5% |
Prosthesis | 1 | 0.5% |
Protected area | 1 | 0.5% |
Proton-pump inhibitor | 1 | 0.5% |
Protozoal diseases | 1 | 0.5% |
Pseudo-nitzschia | 1 | 0.5% |
Pseudoaneurysm | 1 | 0.5% |
Psychiatric history | 1 | 0.5% |
Psychological concepts | 1 | 0.5% |
Psychological trauma | 1 | 0.5% |
Ptosis (eyelid) | 1 | 0.5% |
Public Health Security and Bioterrorism Preparedness and Response Act | 1 | 0.5% |
Public health genomics | 1 | 0.5% |
Public toilet | 1 | 0.5% |
Public–private partnership | 1 | 0.5% |
Pulmonology | 1 | 0.5% |
Pulse oximetry | 1 | 0.5% |
QRISK | 1 | 0.5% |
QuantiFERON | 1 | 0.5% |
RET proto-oncogene | 1 | 0.5% |
Rabies in animals | 1 | 0.5% |
Rabies vaccine | 1 | 0.5% |
Rabies virus | 1 | 0.5% |
Race (human categorization) | 1 | 0.5% |
Race and ethnicity in the United States Census | 1 | 0.5% |
Radiation protection | 1 | 0.5% |
Radiomics | 1 | 0.5% |
Radiopharmaceutical | 1 | 0.5% |
Radon | 1 | 0.5% |
Rail transport | 1 | 0.5% |
Rainforest | 1 | 0.5% |
Ranibizumab | 1 | 0.5% |
Ratio | 1 | 0.5% |
Rationality | 1 | 0.5% |
Readability | 1 | 0.5% |
Real-time polymerase chain reaction | 1 | 0.5% |
Records management | 1 | 0.5% |
Recycling | 1 | 0.5% |
Reference dose | 1 | 0.5% |
Regeneration (biology) | 1 | 0.5% |
Regulation | 1 | 0.5% |
Regulatory affairs | 1 | 0.5% |
Remote dispensing | 1 | 0.5% |
Renal cell carcinoma | 1 | 0.5% |
Renin | 1 | 0.5% |
Renting | 1 | 0.5% |
Reperfusion therapy | 1 | 0.5% |
Reporting bias | 1 | 0.5% |
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations | 1 | 0.5% |
Reputation | 1 | 0.5% |
Residential care | 1 | 0.5% |
Residential segregation in the United States | 1 | 0.5% |
Residential treatment center | 1 | 0.5% |
Resource | 1 | 0.5% |
Respiratory system | 1 | 0.5% |
Respiratory therapist | 1 | 0.5% |
Response rate (survey) | 1 | 0.5% |
Retail | 1 | 0.5% |
Retroviridae | 1 | 0.5% |
Reuse | 1 | 0.5% |
Revised Cardiac Risk Index | 1 | 0.5% |
Rhabdomyolysis | 1 | 0.5% |
Rheumatoid arthritis | 1 | 0.5% |
Rhinorrhea | 1 | 0.5% |
Rifampicin | 1 | 0.5% |
Risk appetite | 1 | 0.5% |
Rivaroxaban | 1 | 0.5% |
Robust statistics | 1 | 0.5% |
Rosuvastatin | 1 | 0.5% |
SARS-CoV-2 | 1 | 0.5% |
SGLT2 inhibitor | 1 | 0.5% |
Sacrum | 1 | 0.5% |
Safe sex | 1 | 0.5% |
Sales | 1 | 0.5% |
Sample (statistics) | 1 | 0.5% |
Sample size determination | 1 | 0.5% |
Santa Clara County, California | 1 | 0.5% |
Sarcopenia | 1 | 0.5% |
Satellite | 1 | 0.5% |
Savannah River Site | 1 | 0.5% |
Science and Technology Options Assessment | 1 | 0.5% |
Science, technology, engineering, and mathematics | 1 | 0.5% |
Sea | 1 | 0.5% |
Section 504 of the Rehabilitation Act | 1 | 0.5% |
Selenium | 1 | 0.5% |
Self-assessment | 1 | 0.5% |
Self-harm | 1 | 0.5% |
Self-report study | 1 | 0.5% |
Sentence (linguistics) | 1 | 0.5% |
Sepsis | 1 | 0.5% |
Sequential analysis | 1 | 0.5% |
Sergej Mašera | 1 | 0.5% |
Serious Mental Illness | 1 | 0.5% |
Seroconversion | 1 | 0.5% |
Sexual anatomy | 1 | 0.5% |
Sexual health | 1 | 0.5% |
Sexual intercourse | 1 | 0.5% |
Sexually transmitted diseases and infections | 1 | 0.5% |
Sexually transmitted infection | 1 | 0.5% |
Shared decision-making in medicine | 1 | 0.5% |
Shelf life | 1 | 0.5% |
Shingles | 1 | 0.5% |
Ship | 1 | 0.5% |
Shoulder | 1 | 0.5% |
Shoulder impingement syndrome | 1 | 0.5% |
Sideroblastic anemia | 1 | 0.5% |
Sigmoidoscopy | 1 | 0.5% |
Simvastatin | 1 | 0.5% |
Single-payer healthcare | 1 | 0.5% |
Sirolimus | 1 | 0.5% |
Situation awareness | 1 | 0.5% |
Skin cancer | 1 | 0.5% |
Sleep apnea | 1 | 0.5% |
Slovene language | 1 | 0.5% |
Sláintecare | 1 | 0.5% |
Small for gestational age | 1 | 0.5% |
Small intestine | 1 | 0.5% |
Small satellite | 1 | 0.5% |
Small-cell carcinoma | 1 | 0.5% |
Smallpox | 1 | 0.5% |
Smart grid | 1 | 0.5% |
Snakebite | 1 | 0.5% |
Social care in England | 1 | 0.5% |
Social exclusion | 1 | 0.5% |
Social isolation | 1 | 0.5% |
Social justice | 1 | 0.5% |
Social services | 1 | 0.5% |
Social stigma | 1 | 0.5% |
Social vulnerability | 1 | 0.5% |
Socio-ecological system | 1 | 0.5% |
Socioeconomic status | 1 | 0.5% |
Soil | 1 | 0.5% |
Source control (respiratory disease) | 1 | 0.5% |
South London | 1 | 0.5% |
Spanish flu | 1 | 0.5% |
Speaker of the United States House of Representatives | 1 | 0.5% |
Species | 1 | 0.5% |
Specific performance | 1 | 0.5% |
Specification (technical standard) | 1 | 0.5% |
Spent nuclear fuel | 1 | 0.5% |
Spinal fusion | 1 | 0.5% |
Star | 1 | 0.5% |
Star cluster | 1 | 0.5% |
Star formation | 1 | 0.5% |
Statistical analysis | 1 | 0.5% |
Statistical hypothesis testing | 1 | 0.5% |
Statistical methods | 1 | 0.5% |
Statistical significance | 1 | 0.5% |
Stereotactic surgery | 1 | 0.5% |
Stomach cancer | 1 | 0.5% |
Strain (injury) | 1 | 0.5% |
Strategy | 1 | 0.5% |
Strength training | 1 | 0.5% |
Stress (biology) | 1 | 0.5% |
Stress hyperglycemia | 1 | 0.5% |
Subclavian artery | 1 | 0.5% |
Substance dependence | 1 | 0.5% |
Suicide prevention | 1 | 0.5% |
Sun tanning | 1 | 0.5% |
Supplemental Security Income | 1 | 0.5% |
Supplier-induced demand | 1 | 0.5% |
Supply chain | 1 | 0.5% |
Supply chain management | 1 | 0.5% |
Sussex | 1 | 0.5% |
Sustainable development | 1 | 0.5% |
Sustainable fashion | 1 | 0.5% |
Sympathetic nervous system | 1 | 0.5% |
Syndemic | 1 | 0.5% |
Systems biology | 1 | 0.5% |
Systems engineering | 1 | 0.5% |
SystmOne | 1 | 0.5% |
Systole | 1 | 0.5% |
Tabubil | 1 | 0.5% |
Tacrolimus | 1 | 0.5% |
TaqMan | 1 | 0.5% |
Tattoo | 1 | 0.5% |
Technology transfer | 1 | 0.5% |
Telepharmacy | 1 | 0.5% |
Tendinopathy | 1 | 0.5% |
The Hallmarks of Cancer | 1 | 0.5% |
Thematic analysis | 1 | 0.5% |
Thought | 1 | 0.5% |
Thromboelastography | 1 | 0.5% |
Thromboelastometry | 1 | 0.5% |
Thrombophilia | 1 | 0.5% |
Thyroid-stimulating hormone | 1 | 0.5% |
Tibia | 1 | 0.5% |
Tick | 1 | 0.5% |
Tissue Doppler echocardiography | 1 | 0.5% |
Title X | 1 | 0.5% |
Tobacco Master Settlement Agreement | 1 | 0.5% |
Toilet | 1 | 0.5% |
Tort | 1 | 0.5% |
Tourism | 1 | 0.5% |
Tozinameran | 1 | 0.5% |
Trafford | 1 | 0.5% |
Train | 1 | 0.5% |
Transesophageal echocardiogram | 1 | 0.5% |
Transfusion medicine | 1 | 0.5% |
Translational medicine | 1 | 0.5% |
Transparency (behavior) | 1 | 0.5% |
Transplant rejection | 1 | 0.5% |
Transport | 1 | 0.5% |
Transverse mode | 1 | 0.5% |
Tree | 1 | 0.5% |
Tree of life (biology) | 1 | 0.5% |
Triglav | 1 | 0.5% |
Tropical diseases | 1 | 0.5% |
Tropical rainforest | 1 | 0.5% |
Troponin | 1 | 0.5% |
Trust (social science) | 1 | 0.5% |
Tuberculosis diagnosis | 1 | 0.5% |
Tundra | 1 | 0.5% |
Tyrosine kinase | 1 | 0.5% |
U.S. state | 1 | 0.5% |
Ultraviolet | 1 | 0.5% |
Understanding | 1 | 0.5% |
Underwriting | 1 | 0.5% |
United Nations Security Council Resolution 478 | 1 | 0.5% |
United States budget process | 1 | 0.5% |
United States budget sequestration in 2013 | 1 | 0.5% |
Universal health care | 1 | 0.5% |
Universal precautions | 1 | 0.5% |
Unnecessary health care | 1 | 0.5% |
Upper Carniola | 1 | 0.5% |
Upper gastrointestinal series | 1 | 0.5% |
Urinary system | 1 | 0.5% |
Urological conditions | 1 | 0.5% |
VO2 max | 1 | 0.5% |
Vaccine efficacy | 1 | 0.5% |
Vagina | 1 | 0.5% |
Validity (statistics) | 1 | 0.5% |
Valvular heart disease | 1 | 0.5% |
Vector (epidemiology) | 1 | 0.5% |
Vector control | 1 | 0.5% |
Vegetable | 1 | 0.5% |
Vein | 1 | 0.5% |
Ventilation (architecture) | 1 | 0.5% |
Ventilator | 1 | 0.5% |
Ventricle (heart) | 1 | 0.5% |
Ventricular hypertrophy | 1 | 0.5% |
Venture capital | 1 | 0.5% |
Verification and validation | 1 | 0.5% |
Vertebral column | 1 | 0.5% |
Veterinary medicine | 1 | 0.5% |
Viral diseases | 1 | 0.5% |
Virology | 1 | 0.5% |
Viruses | 1 | 0.5% |
Vision | 1 | 0.5% |
Visual impairment | 1 | 0.5% |
Vital signs | 1 | 0.5% |
Vitamin D deficiency | 1 | 0.5% |
Volcano | 1 | 0.5% |
Volume | 1 | 0.5% |
Vulnerability (computing) | 1 | 0.5% |
WASH | 1 | 0.5% |
Wakame | 1 | 0.5% |
Water | 1 | 0.5% |
Waveguide | 1 | 0.5% |
Web conferencing | 1 | 0.5% |
Well-being | 1 | 0.5% |
West Bank | 1 | 0.5% |
West Nile virus | 1 | 0.5% |
Western African Ebola virus epidemic | 1 | 0.5% |
White Americans | 1 | 0.5% |
Whooping cough | 1 | 0.5% |
Wi-Fi | 1 | 0.5% |
Witness | 1 | 0.5% |
Years of potential life lost | 1 | 0.5% |
Zdravljica | 1 | 0.5% |
Zebrafish | 1 | 0.5% |
Zika fever | 1 | 0.5% |
Zika virus | 1 | 0.5% |
Zoster vaccine | 1 | 0.5% |
abs | rel | |
---|---|---|
Health | 189 | 91.3% |
Health care | 166 | 80.2% |
Health sciences | 165 | 79.7% |
Medicine | 159 | 76.8% |
Medical specialties | 128 | 61.8% |
Clinical medicine | 126 | 60.9% |
Public health | 81 | 39.1% |
Risk | 80 | 38.6% |
Hospital | 63 | 30.4% |
Human activities | 61 | 29.5% |
Diseases and disorders | 60 | 29.0% |
COVID-19 pandemic | 58 | 28.0% |
Infection | 56 | 27.1% |
Disease | 54 | 26.1% |
Patient | 52 | 25.1% |
Vaccine | 49 | 23.7% |
Nursing | 45 | 21.7% |
Epidemiology | 44 | 21.3% |
Cancer | 41 | 19.8% |
Life sciences | 39 | 18.8% |
Research | 35 | 16.9% |
Emergency department | 32 | 15.5% |
Medication | 32 | 15.5% |
Biology | 31 | 15.0% |
Clinical trial | 31 | 15.0% |
Immunology | 31 | 15.0% |
Severe acute respiratory syndrome coronavirus 2 | 31 | 15.0% |
Artificial intelligence | 30 | 14.5% |
COVID-19 | 30 | 14.5% |
Health professional | 30 | 14.5% |
Preventive healthcare | 30 | 14.5% |
Governance | 29 | 14.0% |
Health economics | 29 | 14.0% |
Health policy | 28 | 13.5% |
Coronavirus disease 2019 | 27 | 13.0% |
Chronic condition | 26 | 12.6% |
Health system | 26 | 12.6% |
Screening (medicine) | 26 | 12.6% |
COVID-19 vaccine | 25 | 12.1% |
Sustainability | 25 | 12.1% |
Adherence (medicine) | 24 | 11.6% |
Evidence-based medicine | 24 | 11.6% |
Infectious diseases | 24 | 11.6% |
Mental health | 24 | 11.6% |
Regulatory compliance | 23 | 11.1% |
Technology | 23 | 11.1% |
Audit | 22 | 10.6% |
Medical diagnosis | 22 | 10.6% |
Surgery | 22 | 10.6% |
Branches of science | 21 | 10.1% |
Patient safety | 21 | 10.1% |
Heart | 20 | 9.7% |
Cardiovascular disease | 19 | 9.2% |
Health equity | 19 | 9.2% |
Mental disorder | 19 | 9.2% |
Pregnancy | 19 | 9.2% |
Randomized controlled trial | 19 | 9.2% |
Childbirth | 18 | 8.7% |
Cohort study | 18 | 8.7% |
Hypertension | 18 | 8.7% |
Isolation (health care) | 18 | 8.7% |
Primary care | 18 | 8.7% |
Sensitivity and specificity | 18 | 8.7% |
Systematic review | 18 | 8.7% |
Diabetes | 17 | 8.2% |
Innovation | 17 | 8.2% |
Pharmacy | 17 | 8.2% |
Risk assessment | 17 | 8.2% |
Science | 17 | 8.2% |
HIV/AIDS | 16 | 7.7% |
Infection prevention and control | 16 | 7.7% |
Influenza | 16 | 7.7% |
Medical humanities | 16 | 7.7% |
Pandemic | 16 | 7.7% |
Social work | 16 | 7.7% |
Caregiver | 15 | 7.2% |
Health care quality | 15 | 7.2% |
Medical imaging | 15 | 7.2% |
Medicare (United States) | 15 | 7.2% |
Microbiology | 15 | 7.2% |
Physician | 15 | 7.2% |
Policy | 15 | 7.2% |
Safety | 15 | 7.2% |
Stroke | 15 | 7.2% |
Therapy | 15 | 7.2% |
Virus | 15 | 7.2% |
Business | 14 | 6.8% |
Clinical commissioning group | 14 | 6.8% |
Electronic health record | 14 | 6.8% |
Personal protective equipment | 14 | 6.8% |
Risk management | 14 | 6.8% |
Social distancing | 14 | 6.8% |
Audit committee | 13 | 6.3% |
Cardiology | 13 | 6.3% |
Internal audit | 13 | 6.3% |
Medicaid | 13 | 6.3% |
Medical device | 13 | 6.3% |
Obesity | 13 | 6.3% |
Radiology | 13 | 6.3% |
Transmission (medicine) | 13 | 6.3% |
Vaccination | 13 | 6.3% |
Board of directors | 12 | 5.8% |
Cardiovascular system | 12 | 5.8% |
Comorbidity | 12 | 5.8% |
Dose (biochemistry) | 12 | 5.8% |
Employment | 12 | 5.8% |
Immunodeficiency | 12 | 5.8% |
Major depressive disorder | 12 | 5.8% |
Tuberculosis | 12 | 5.8% |
Type 2 diabetes | 12 | 5.8% |
Breast cancer | 11 | 5.3% |
Breastfeeding | 11 | 5.3% |
Coronary artery disease | 11 | 5.3% |
Economy | 11 | 5.3% |
General practitioner | 11 | 5.3% |
Internal control | 11 | 5.3% |
Machine learning | 11 | 5.3% |
Management | 11 | 5.3% |
Medical guideline | 11 | 5.3% |
Meta-analysis | 11 | 5.3% |
NHS foundation trust | 11 | 5.3% |
Social determinants of health | 11 | 5.3% |
Social programs | 11 | 5.3% |
Telehealth | 11 | 5.3% |
Antimicrobial resistance | 10 | 4.8% |
Clinical governance | 10 | 4.8% |
Emergency | 10 | 4.8% |
Face masks during the COVID-19 pandemic | 10 | 4.8% |
Food | 10 | 4.8% |
Gene | 10 | 4.8% |
Immunization | 10 | 4.8% |
Public services | 10 | 4.8% |
Education | 9 | 4.3% |
Emergency management | 9 | 4.3% |
Evaluation | 9 | 4.3% |
Going concern | 9 | 4.3% |
HIV | 9 | 4.3% |
Heart failure | 9 | 4.3% |
Medical statistics | 9 | 4.3% |
Occupational safety and health | 9 | 4.3% |
Quality assurance | 9 | 4.3% |
Sustainable Development Goals | 9 | 4.3% |
Trust law | 9 | 4.3% |
Accounting | 8 | 3.9% |
Antibiotic | 8 | 3.9% |
Asthma | 8 | 3.9% |
Cost-effectiveness analysis | 8 | 3.9% |
Drugs | 8 | 3.9% |
Health technology | 8 | 3.9% |
Hospital-acquired infection | 8 | 3.9% |
Immune system | 8 | 3.9% |
Informed consent | 8 | 3.9% |
Lung | 8 | 3.9% |
Maternal health | 8 | 3.9% |
Nursing home | 8 | 3.9% |
Palliative care | 8 | 3.9% |
Pharmacology | 8 | 3.9% |
Phases of clinical research | 8 | 3.9% |
Public sphere | 8 | 3.9% |
Self-care | 8 | 3.9% |
Services sector of the economy | 8 | 3.9% |
Adverse effect | 7 | 3.4% |
Analytics | 7 | 3.4% |
Antibody | 7 | 3.4% |
Biomarker | 7 | 3.4% |
Biotechnology | 7 | 3.4% |
Blood pressure | 7 | 3.4% |
COVID-19 testing | 7 | 3.4% |
CT scan | 7 | 3.4% |
Chronic obstructive pulmonary disease | 7 | 3.4% |
Cognition | 7 | 3.4% |
DNA sequencing | 7 | 3.4% |
Diabetes management | 7 | 3.4% |
Ethics | 7 | 3.4% |
Genetics | 7 | 3.4% |
Health informatics | 7 | 3.4% |
Information | 7 | 3.4% |
Intensive care unit | 7 | 3.4% |
Management of HIV/AIDS | 7 | 3.4% |
Medical treatments | 7 | 3.4% |
Mortality rate | 7 | 3.4% |
Myocardial infarction | 7 | 3.4% |
Neutralizing antibody | 7 | 3.4% |
Pension | 7 | 3.4% |
Physical therapy | 7 | 3.4% |
Positive and negative predictive values | 7 | 3.4% |
Prescription drug | 7 | 3.4% |
Protein | 7 | 3.4% |
Quality-adjusted life year | 7 | 3.4% |
Radiation therapy | 7 | 3.4% |
Salary | 7 | 3.4% |
Serology | 7 | 3.4% |
Surgical mask | 7 | 3.4% |
Affordable Care Act | 6 | 2.9% |
Agriculture | 6 | 2.9% |
Artificial cardiac pacemaker | 6 | 2.9% |
Budget | 6 | 2.9% |
COVID-19 pandemic in the United Kingdom | 6 | 2.9% |
Casirivimab/imdevimab | 6 | 2.9% |
Child | 6 | 2.9% |
Clinic | 6 | 2.9% |
Corporate governance | 6 | 2.9% |
Creative Commons license | 6 | 2.9% |
Data quality | 6 | 2.9% |
Emergency medical services | 6 | 2.9% |
Exercise | 6 | 2.9% |
Fee-for-service | 6 | 2.9% |
Financial statement | 6 | 2.9% |
Food safety | 6 | 2.9% |
Genomics | 6 | 2.9% |
Glycated hemoglobin | 6 | 2.9% |
Government budget balance | 6 | 2.9% |
Hepatitis | 6 | 2.9% |
Homelessness | 6 | 2.9% |
Hygiene | 6 | 2.9% |
Infant | 6 | 2.9% |
Inflammation | 6 | 2.9% |
Leadership | 6 | 2.9% |
Malaria | 6 | 2.9% |
Managed care | 6 | 2.9% |
Measles | 6 | 2.9% |
Medical record | 6 | 2.9% |
Methicillin-resistant Staphylococcus aureus | 6 | 2.9% |
Multidrug-resistant tuberculosis | 6 | 2.9% |
Mutation | 6 | 2.9% |
Natural reservoir | 6 | 2.9% |
Non-communicable disease | 6 | 2.9% |
Non-executive director | 6 | 2.9% |
Pediatrics | 6 | 2.9% |
Pfizer–BioNTech COVID-19 vaccine | 6 | 2.9% |
Pharmacovigilance | 6 | 2.9% |
Poverty | 6 | 2.9% |
Preterm birth | 6 | 2.9% |
Privacy | 6 | 2.9% |
Psychology | 6 | 2.9% |
Receiver operating characteristic | 6 | 2.9% |
Respirator | 6 | 2.9% |
Signs and symptoms | 6 | 2.9% |
Triage | 6 | 2.9% |
Waste | 6 | 2.9% |
Zoonosis | 6 | 2.9% |
Air pollution | 5 | 2.4% |
Angina | 5 | 2.4% |
Breast cancer screening | 5 | 2.4% |
Cancer screening | 5 | 2.4% |
Cell (biology) | 5 | 2.4% |
Cervical cancer | 5 | 2.4% |
Charitable organization | 5 | 2.4% |
Chemistry | 5 | 2.4% |
Cirrhosis | 5 | 2.4% |
Clinical endpoint | 5 | 2.4% |
Data analysis | 5 | 2.4% |
Deep learning | 5 | 2.4% |
Dexamethasone | 5 | 2.4% |
Disinfectant | 5 | 2.4% |
Emergency medicine | 5 | 2.4% |
Expanded Program on Immunization | 5 | 2.4% |
Expert | 5 | 2.4% |
External auditor | 5 | 2.4% |
Frailty syndrome | 5 | 2.4% |
Genome | 5 | 2.4% |
Hand washing | 5 | 2.4% |
Hypogammaglobulinemia | 5 | 2.4% |
Immunoglobulin therapy | 5 | 2.4% |
Incremental cost-effectiveness ratio | 5 | 2.4% |
Infrastructure | 5 | 2.4% |
Inspection | 5 | 2.4% |
Interoperability | 5 | 2.4% |
Interventional radiology | 5 | 2.4% |
Leukemia | 5 | 2.4% |
Lung cancer | 5 | 2.4% |
Mammography | 5 | 2.4% |
Medical test | 5 | 2.4% |
Moderna COVID-19 vaccine | 5 | 2.4% |
N95 respirator | 5 | 2.4% |
Percutaneous coronary intervention | 5 | 2.4% |
Pesticide | 5 | 2.4% |
Preventive medicine | 5 | 2.4% |
Quarantine | 5 | 2.4% |
Remdesivir | 5 | 2.4% |
Respiratory disease | 5 | 2.4% |
Robotics | 5 | 2.4% |
Smoking cessation | 5 | 2.4% |
Statistics | 5 | 2.4% |
Strategy | 5 | 2.4% |
Substance use disorder | 5 | 2.4% |
Surveillance | 5 | 2.4% |
Tocilizumab | 5 | 2.4% |
Vaccine adverse event | 5 | 2.4% |
Accountable care organization | 4 | 1.9% |
Airborne transmission | 4 | 1.9% |
Allergy | 4 | 1.9% |
Antigen | 4 | 1.9% |
Anxiety | 4 | 1.9% |
Assay | 4 | 1.9% |
Atrial fibrillation | 4 | 1.9% |
Augmented reality | 4 | 1.9% |
Autoimmunity | 4 | 1.9% |
Automation | 4 | 1.9% |
Autonomy | 4 | 1.9% |
Avian influenza | 4 | 1.9% |
Basic reproduction number | 4 | 1.9% |
Biopsy | 4 | 1.9% |
Bipolar disorder | 4 | 1.9% |
Body mass index | 4 | 1.9% |
Booster dose | 4 | 1.9% |
Brain–computer interface | 4 | 1.9% |
Breast milk | 4 | 1.9% |
Bronchiectasis | 4 | 1.9% |
Cardiac catheterization | 4 | 1.9% |
Cardiothoracic surgery | 4 | 1.9% |
Chronic kidney disease | 4 | 1.9% |
Climate change | 4 | 1.9% |
Climate resilience | 4 | 1.9% |
Compartmental models in epidemiology | 4 | 1.9% |
Consent | 4 | 1.9% |
Copyright | 4 | 1.9% |
DPT vaccine | 4 | 1.9% |
Data | 4 | 1.9% |
Digital health | 4 | 1.9% |
Disability | 4 | 1.9% |
Efficient energy use | 4 | 1.9% |
Environmental social science | 4 | 1.9% |
Epidemic | 4 | 1.9% |
Familial hypercholesterolemia | 4 | 1.9% |
Finance | 4 | 1.9% |
GeneXpert MTB/RIF | 4 | 1.9% |
Genome editing | 4 | 1.9% |
Government | 4 | 1.9% |
Health care in the United States | 4 | 1.9% |
Health data | 4 | 1.9% |
Health human resources | 4 | 1.9% |
Health information technology | 4 | 1.9% |
Health insurance | 4 | 1.9% |
Hospital readmission | 4 | 1.9% |
Human | 4 | 1.9% |
Hypercholesterolemia | 4 | 1.9% |
Immunity (medical) | 4 | 1.9% |
Indication (medicine) | 4 | 1.9% |
Intravenous therapy | 4 | 1.9% |
Johnson & Johnson COVID-19 vaccine | 4 | 1.9% |
Long-term care | 4 | 1.9% |
Low-density lipoprotein | 4 | 1.9% |
Medical Subject Headings | 4 | 1.9% |
Medical research | 4 | 1.9% |
Midwife | 4 | 1.9% |
Non-pharmaceutical intervention (epidemiology) | 4 | 1.9% |
Pay for performance (healthcare) | 4 | 1.9% |
Pharmaceutical industry | 4 | 1.9% |
Physical examination | 4 | 1.9% |
Primary health care | 4 | 1.9% |
Proteomics | 4 | 1.9% |
Psychotherapy | 4 | 1.9% |
Public health surveillance | 4 | 1.9% |
Recovery model | 4 | 1.9% |
Recruitment | 4 | 1.9% |
Recycling | 4 | 1.9% |
Regulation | 4 | 1.9% |
Sepsis | 4 | 1.9% |
Severe acute respiratory syndrome | 4 | 1.9% |
Shared decision-making in medicine | 4 | 1.9% |
Shortness of breath | 4 | 1.9% |
Statin | 4 | 1.9% |
Supply chain | 4 | 1.9% |
Thorax (human anatomy) | 4 | 1.9% |
Tobacco smoking | 4 | 1.9% |
Tuberculosis management | 4 | 1.9% |
Type 1 diabetes | 4 | 1.9% |
Variants of SARS-CoV-2 | 4 | 1.9% |
Vein | 4 | 1.9% |
Venous thrombosis | 4 | 1.9% |
Ventilator | 4 | 1.9% |
Water | 4 | 1.9% |
Wearable technology | 4 | 1.9% |
3D printing | 3 | 1.4% |
Acute coronary syndrome | 3 | 1.4% |
Adolescence | 3 | 1.4% |
Adverse event | 3 | 1.4% |
Analysis | 3 | 1.4% |
Anaphylaxis | 3 | 1.4% |
Angiology | 3 | 1.4% |
Animal viral diseases | 3 | 1.4% |
Antipsychotic | 3 | 1.4% |
Antiviral drug | 3 | 1.4% |
Arrhythmia | 3 | 1.4% |
Aspirin | 3 | 1.4% |
Assessment of kidney function | 3 | 1.4% |
Attention deficit hyperactivity disorder | 3 | 1.4% |
Biochemistry | 3 | 1.4% |
Bioethics | 3 | 1.4% |
Bioinformatics | 3 | 1.4% |
Blood plasma | 3 | 1.4% |
Blood sugar level | 3 | 1.4% |
Blood transfusion | 3 | 1.4% |
Bovine spongiform encephalopathy | 3 | 1.4% |
Brain | 3 | 1.4% |
Breakthrough infection | 3 | 1.4% |
Carbon neutrality | 3 | 1.4% |
Case management (US healthcare system) | 3 | 1.4% |
Catheter | 3 | 1.4% |
Chemotherapy | 3 | 1.4% |
Cholesterol | 3 | 1.4% |
Chronic lymphocytic leukemia | 3 | 1.4% |
Cloth face mask | 3 | 1.4% |
Cloud computing | 3 | 1.4% |
Cognitive science | 3 | 1.4% |
Cold chain | 3 | 1.4% |
Colorectal cancer | 3 | 1.4% |
Committee | 3 | 1.4% |
Common variable immunodeficiency | 3 | 1.4% |
Community health | 3 | 1.4% |
Competence (human resources) | 3 | 1.4% |
Computer security | 3 | 1.4% |
Computer-aided diagnosis | 3 | 1.4% |
Cost–utility analysis | 3 | 1.4% |
DNA | 3 | 1.4% |
Decision-making | 3 | 1.4% |
Dementia | 3 | 1.4% |
Diabetic retinopathy | 3 | 1.4% |
Diagnosis of HIV/AIDS | 3 | 1.4% |
Dignity | 3 | 1.4% |
Disease surveillance | 3 | 1.4% |
Ductal carcinoma in situ | 3 | 1.4% |
Dyslipidemia | 3 | 1.4% |
Ebola | 3 | 1.4% |
Economics | 3 | 1.4% |
Electroencephalography | 3 | 1.4% |
Emergency Use Authorization | 3 | 1.4% |
Emerging infectious disease | 3 | 1.4% |
Emerging technologies | 3 | 1.4% |
Expense | 3 | 1.4% |
Ezetimibe | 3 | 1.4% |
FFP standards | 3 | 1.4% |
Foodborne illness | 3 | 1.4% |
Fraud deterrence | 3 | 1.4% |
Functional magnetic resonance imaging | 3 | 1.4% |
Gene expression | 3 | 1.4% |
Gene therapy | 3 | 1.4% |
Geriatrics | 3 | 1.4% |
Gestational age | 3 | 1.4% |
Global health | 3 | 1.4% |
Good manufacturing practice | 3 | 1.4% |
Health Insurance Portability and Accountability Act | 3 | 1.4% |
Health literacy | 3 | 1.4% |
Health promotion | 3 | 1.4% |
Healthcare in Greater Manchester | 3 | 1.4% |
Hematopoietic stem cell transplantation | 3 | 1.4% |
Herd immunity | 3 | 1.4% |
High-density lipoprotein | 3 | 1.4% |
Human diseases and disorders | 3 | 1.4% |
Human microbiome | 3 | 1.4% |
Hyperglycemia | 3 | 1.4% |
Hypoglycemia | 3 | 1.4% |
Hypothesis | 3 | 1.4% |
Image segmentation | 3 | 1.4% |
Immunoglobulin G | 3 | 1.4% |
Immunosuppressive drug | 3 | 1.4% |
Implant (medicine) | 3 | 1.4% |
Infant mortality | 3 | 1.4% |
Influenza A virus subtype H5N1 | 3 | 1.4% |
Information governance | 3 | 1.4% |
Information privacy | 3 | 1.4% |
Insulin (medication) | 3 | 1.4% |
Intensive care medicine | 3 | 1.4% |
Internet | 3 | 1.4% |
Internet of things | 3 | 1.4% |
Ischemia | 3 | 1.4% |
Kidney | 3 | 1.4% |
Knowledge | 3 | 1.4% |
Law | 3 | 1.4% |
Lineage B.1.1.7 | 3 | 1.4% |
Lipoprotein | 3 | 1.4% |
Logistics | 3 | 1.4% |
Lung cancer screening | 3 | 1.4% |
Lung nodule | 3 | 1.4% |
Magnetic resonance imaging | 3 | 1.4% |
Maternal death | 3 | 1.4% |
Mechanical filter (respirator) | 3 | 1.4% |
Mechanical ventilation | 3 | 1.4% |
Medical ethics | 3 | 1.4% |
Medical prescription | 3 | 1.4% |
Metastasis | 3 | 1.4% |
Metformin | 3 | 1.4% |
Microbiota | 3 | 1.4% |
Molecular biology | 3 | 1.4% |
Motivation | 3 | 1.4% |
Multiomics | 3 | 1.4% |
Multiple sclerosis | 3 | 1.4% |
Nanotechnology | 3 | 1.4% |
Neurostimulation | 3 | 1.4% |
Off-label use | 3 | 1.4% |
Open access | 3 | 1.4% |
Opioid | 3 | 1.4% |
Organ transplantation | 3 | 1.4% |
Outcomes research | 3 | 1.4% |
Overdiagnosis | 3 | 1.4% |
Oxford–AstraZeneca COVID-19 vaccine | 3 | 1.4% |
Pap test | 3 | 1.4% |
Particulates | 3 | 1.4% |
Patient-reported outcome | 3 | 1.4% |
Performance appraisal | 3 | 1.4% |
Performance indicator | 3 | 1.4% |
Pericardium | 3 | 1.4% |
Personal data | 3 | 1.4% |
Pharmaceutical sciences | 3 | 1.4% |
Pharmacist | 3 | 1.4% |
Physical sciences | 3 | 1.4% |
Placebo | 3 | 1.4% |
Placebo-controlled study | 3 | 1.4% |
Point of care | 3 | 1.4% |
Point-of-care testing | 3 | 1.4% |
Polio vaccine | 3 | 1.4% |
Polymerase chain reaction | 3 | 1.4% |
Positive airway pressure | 3 | 1.4% |
Postpartum period | 3 | 1.4% |
Prediabetes | 3 | 1.4% |
Prenatal care | 3 | 1.4% |
Primary immunodeficiency | 3 | 1.4% |
Private finance initiative | 3 | 1.4% |
Procurement | 3 | 1.4% |
Proteinuria | 3 | 1.4% |
Psychological resilience | 3 | 1.4% |
RNA | 3 | 1.4% |
Radiography | 3 | 1.4% |
Registration, Evaluation, Authorisation and Restriction of Chemicals | 3 | 1.4% |
Respiratory droplet | 3 | 1.4% |
Robot | 3 | 1.4% |
Rubella | 3 | 1.4% |
SARS-CoV-2 Beta variant | 3 | 1.4% |
SARS-CoV-2 Delta variant | 3 | 1.4% |
Schizophrenia | 3 | 1.4% |
Section 504 of the Rehabilitation Act | 3 | 1.4% |
Service industries | 3 | 1.4% |
Severe combined immunodeficiency | 3 | 1.4% |
Sleep apnea | 3 | 1.4% |
Social media | 3 | 1.4% |
Source control (respiratory disease) | 3 | 1.4% |
Standardization | 3 | 1.4% |
Stem cell | 3 | 1.4% |
Study heterogeneity | 3 | 1.4% |
Survey methodology | 3 | 1.4% |
Sustainability and transformation plan | 3 | 1.4% |
Tax | 3 | 1.4% |
Tetanus vaccine | 3 | 1.4% |
Thought | 3 | 1.4% |
Thrombosis | 3 | 1.4% |
Training, validation, and test sets | 3 | 1.4% |
Transcriptomics technologies | 3 | 1.4% |
Transient ischemic attack | 3 | 1.4% |
Transmission-based precautions | 3 | 1.4% |
Transport | 3 | 1.4% |
Type I and type II errors | 3 | 1.4% |
Unnecessary health care | 3 | 1.4% |
Valvular heart disease | 3 | 1.4% |
Variant Creutzfeldt–Jakob disease | 3 | 1.4% |
Virtual reality | 3 | 1.4% |
Waste management | 3 | 1.4% |
Women's health | 3 | 1.4% |
3D bioprinting | 2 | 1.0% |
Aboriginal Australians | 2 | 1.0% |
Abstract (summary) | 2 | 1.0% |
Accountability | 2 | 1.0% |
Acute respiratory distress syndrome | 2 | 1.0% |
Adaptive immune system | 2 | 1.0% |
Adenoviridae | 2 | 1.0% |
Adjuvant therapy | 2 | 1.0% |
Administrative Procedure Act (United States) | 2 | 1.0% |
Advance healthcare directive | 2 | 1.0% |
Advertising | 2 | 1.0% |
Airborne diseases | 2 | 1.0% |
Alirocumab | 2 | 1.0% |
Allied health professions | 2 | 1.0% |
Americans with Disabilities Act of 1990 | 2 | 1.0% |
Anesthesia | 2 | 1.0% |
Animal testing | 2 | 1.0% |
Anticoagulant | 2 | 1.0% |
Antidepressant | 2 | 1.0% |
Antimicrobial | 2 | 1.0% |
Antiserum | 2 | 1.0% |
Aortic stenosis | 2 | 1.0% |
Aortic valve | 2 | 1.0% |
Aortic valve replacement | 2 | 1.0% |
Apolipoprotein | 2 | 1.0% |
Asset | 2 | 1.0% |
Astronomy | 2 | 1.0% |
Atheroma | 2 | 1.0% |
Atherosclerosis | 2 | 1.0% |
Atmosphere | 2 | 1.0% |
Atrial septal defect | 2 | 1.0% |
Atypical pneumonias | 2 | 1.0% |
Auditor's report | 2 | 1.0% |
Australians | 2 | 1.0% |
Autoimmune disease | 2 | 1.0% |
B cell | 2 | 1.0% |
Back pain | 2 | 1.0% |
Bacteria | 2 | 1.0% |
Baricitinib | 2 | 1.0% |
Behavior | 2 | 1.0% |
Bempedoic acid | 2 | 1.0% |
Beta blocker | 2 | 1.0% |
Big data | 2 | 1.0% |
Biocide | 2 | 1.0% |
Biodiversity | 2 | 1.0% |
Biosecurity | 2 | 1.0% |
Birth weight | 2 | 1.0% |
Bleeding | 2 | 1.0% |
Blinded experiment | 2 | 1.0% |
Blockchain | 2 | 1.0% |
Blood bank | 2 | 1.0% |
Blood type | 2 | 1.0% |
Border | 2 | 1.0% |
C-reactive protein | 2 | 1.0% |
COVID-19 pandemic in the United States | 2 | 1.0% |
COVID-19 vaccination in the United Kingdom | 2 | 1.0% |
CRISPR gene editing | 2 | 1.0% |
Capacity building | 2 | 1.0% |
Carbon footprint | 2 | 1.0% |
Carcinoma | 2 | 1.0% |
Cardiac surgery | 2 | 1.0% |
Cardiopulmonary resuscitation | 2 | 1.0% |
Cardioversion | 2 | 1.0% |
Case–control study | 2 | 1.0% |
Causes of death | 2 | 1.0% |
Cell signaling | 2 | 1.0% |
Census in Australia | 2 | 1.0% |
Cerebrovascular disease | 2 | 1.0% |
Cervical intraepithelial neoplasia | 2 | 1.0% |
Chairperson | 2 | 1.0% |
Chlorine dioxide | 2 | 1.0% |
Chorioamnionitis | 2 | 1.0% |
Chronic pain | 2 | 1.0% |
Circulatory system | 2 | 1.0% |
Climate | 2 | 1.0% |
Clinical decision support system | 2 | 1.0% |
Cogeneration | 2 | 1.0% |
Cognitive behavioral therapy | 2 | 1.0% |
Cognitive liberty | 2 | 1.0% |
Colposcopy | 2 | 1.0% |
Common cold | 2 | 1.0% |
Community mental health service | 2 | 1.0% |
Computer vision | 2 | 1.0% |
Confidence interval | 2 | 1.0% |
CoronaVac | 2 | 1.0% |
Cost–benefit analysis | 2 | 1.0% |
Crowdsourcing | 2 | 1.0% |
Cystic fibrosis | 2 | 1.0% |
DICOM | 2 | 1.0% |
DNA methylation | 2 | 1.0% |
Dark matter | 2 | 1.0% |
Database | 2 | 1.0% |
Death | 2 | 1.0% |
Debt | 2 | 1.0% |
Defibrillation | 2 | 1.0% |
Demographic and Health Surveys | 2 | 1.0% |
Demography | 2 | 1.0% |
Deployment of COVID-19 vaccines | 2 | 1.0% |
Diabetes medication | 2 | 1.0% |
Diabetic ketoacidosis | 2 | 1.0% |
Dietary supplement | 2 | 1.0% |
Dieting | 2 | 1.0% |
Disease registry | 2 | 1.0% |
Disorders of endocrine pancreas | 2 | 1.0% |
Do not resuscitate | 2 | 1.0% |
Doxorubicin | 2 | 1.0% |
Drug development | 2 | 1.0% |
EHealth | 2 | 1.0% |
Early intervention in psychosis | 2 | 1.0% |
Earnings before interest, taxes, depreciation and amortization | 2 | 1.0% |
Earth | 2 | 1.0% |
Echocardiography | 2 | 1.0% |
Economics of service industries | 2 | 1.0% |
Electrocardiography | 2 | 1.0% |
Electrocorticography | 2 | 1.0% |
Electronic data interchange | 2 | 1.0% |
Embolization | 2 | 1.0% |
Emergency medical technician | 2 | 1.0% |
End-of-life care | 2 | 1.0% |
Endoscopy | 2 | 1.0% |
Engineering | 2 | 1.0% |
Environmental factor | 2 | 1.0% |
Epigenetics | 2 | 1.0% |
Epilepsy | 2 | 1.0% |
Eradication of infectious diseases | 2 | 1.0% |
European Green Deal | 2 | 1.0% |
Evolution | 2 | 1.0% |
Experiment | 2 | 1.0% |
Extensively drug-resistant tuberculosis | 2 | 1.0% |
Family medicine | 2 | 1.0% |
Fat | 2 | 1.0% |
Fatty liver disease | 2 | 1.0% |
Fetus | 2 | 1.0% |
Fraction | 2 | 1.0% |
Free will | 2 | 1.0% |
Generic drug | 2 | 1.0% |
Genetic engineering | 2 | 1.0% |
Genetic marker | 2 | 1.0% |
Genetically modified organism | 2 | 1.0% |
Geology | 2 | 1.0% |
Gestational diabetes | 2 | 1.0% |
Goal | 2 | 1.0% |
Good laboratory practice | 2 | 1.0% |
Graft-versus-host disease | 2 | 1.0% |
Group A streptococcal infection | 2 | 1.0% |
Group B streptococcal infection | 2 | 1.0% |
Gynaecology | 2 | 1.0% |
HPV vaccine | 2 | 1.0% |
Hand dryer | 2 | 1.0% |
He Jiankui | 2 | 1.0% |
Health care prices in the United States | 2 | 1.0% |
Health security | 2 | 1.0% |
Healthcare industry | 2 | 1.0% |
Hepatitis B vaccine | 2 | 1.0% |
Histoplasmosis | 2 | 1.0% |
Human nature | 2 | 1.0% |
Human papillomavirus infection | 2 | 1.0% |
Human reproduction | 2 | 1.0% |
Hypertrophic cardiomyopathy | 2 | 1.0% |
Immigration | 2 | 1.0% |
Immunotherapy | 2 | 1.0% |
Implementation | 2 | 1.0% |
Indigenous Australians | 2 | 1.0% |
Influenza A virus | 2 | 1.0% |
Influenza A virus subtype H5N8 | 2 | 1.0% |
Influenza pandemic | 2 | 1.0% |
Influenza vaccine | 2 | 1.0% |
Information system | 2 | 1.0% |
Integrated care system | 2 | 1.0% |
Integrated circuit | 2 | 1.0% |
Intelligence | 2 | 1.0% |
Interest | 2 | 1.0% |
International Classification of Diseases | 2 | 1.0% |
International Health Regulations | 2 | 1.0% |
Intranet | 2 | 1.0% |
Invoice | 2 | 1.0% |
Janssen COVID-19 vaccine | 2 | 1.0% |
Jupiter | 2 | 1.0% |
Kidney failure | 2 | 1.0% |
Kidney transplantation | 2 | 1.0% |
Laboratory | 2 | 1.0% |
Lentiviruses | 2 | 1.0% |
License | 2 | 1.0% |
Life expectancy | 2 | 1.0% |
Lineage B.1.351 | 2 | 1.0% |
Liver | 2 | 1.0% |
Livestock | 2 | 1.0% |
Loan | 2 | 1.0% |
Loneliness | 2 | 1.0% |
Long COVID | 2 | 1.0% |
Low back pain | 2 | 1.0% |
Low-carbon economy | 2 | 1.0% |
Lymphocyte | 2 | 1.0% |
MMR vaccine | 2 | 1.0% |
MRNA vaccine | 2 | 1.0% |
Magnetoencephalography | 2 | 1.0% |
Mars | 2 | 1.0% |
MedDRA | 2 | 1.0% |
Medical error | 2 | 1.0% |
Medical home | 2 | 1.0% |
Medical school | 2 | 1.0% |
Medical specialty | 2 | 1.0% |
Medicinal chemistry | 2 | 1.0% |
Mental health professional | 2 | 1.0% |
Metabolism | 2 | 1.0% |
Metabolomics | 2 | 1.0% |
Middle East respiratory syndrome | 2 | 1.0% |
Middle East respiratory syndrome–related coronavirus | 2 | 1.0% |
Midwifery | 2 | 1.0% |
Mind | 2 | 1.0% |
Minimally invasive procedure | 2 | 1.0% |
Miscarriage | 2 | 1.0% |
Mobile app | 2 | 1.0% |
Monitoring (medicine) | 2 | 1.0% |
Moon | 2 | 1.0% |
Multiple birth | 2 | 1.0% |
Multisystem inflammatory syndrome in children | 2 | 1.0% |
National Federation of Independent Business v. Sebelius | 2 | 1.0% |
Natural environment | 2 | 1.0% |
Nature | 2 | 1.0% |
Needs assessment | 2 | 1.0% |
Neonatal infection | 2 | 1.0% |
Neonatal intensive care unit | 2 | 1.0% |
Neonatal sepsis | 2 | 1.0% |
Nervous system | 2 | 1.0% |
Neuroethics | 2 | 1.0% |
Neuroimaging | 2 | 1.0% |
Neuromodulation (medicine) | 2 | 1.0% |
Neuroprosthetics | 2 | 1.0% |
Neuroscience | 2 | 1.0% |
Neurotechnology | 2 | 1.0% |
Nightmare | 2 | 1.0% |
Notifiable disease | 2 | 1.0% |
Novel food | 2 | 1.0% |
Nutrition | 2 | 1.0% |
Obstetrics | 2 | 1.0% |
Obstructive sleep apnea | 2 | 1.0% |
Omics | 2 | 1.0% |
Open science | 2 | 1.0% |
Opioid overdose | 2 | 1.0% |
Orphan drug | 2 | 1.0% |
Overactive bladder | 2 | 1.0% |
PCSK9 | 2 | 1.0% |
Pain | 2 | 1.0% |
Pain management | 2 | 1.0% |
Pandemics | 2 | 1.0% |
Paramedic | 2 | 1.0% |
Pathogen | 2 | 1.0% |
Payment by Results | 2 | 1.0% |
Pectus excavatum | 2 | 1.0% |
Pentavalent vaccine | 2 | 1.0% |
Perception | 2 | 1.0% |
Pericardiocentesis | 2 | 1.0% |
Pest (organism) | 2 | 1.0% |
Pesticide residue | 2 | 1.0% |
Pharmacy benefit management | 2 | 1.0% |
Philippine national identity card | 2 | 1.0% |
Philosophy | 2 | 1.0% |
Photonics | 2 | 1.0% |
Physics | 2 | 1.0% |
Physiology | 2 | 1.0% |
Picture archiving and communication system | 2 | 1.0% |
Planet | 2 | 1.0% |
Pneumonia | 2 | 1.0% |
Polio | 2 | 1.0% |
Polio eradication | 2 | 1.0% |
Politics | 2 | 1.0% |
Population health | 2 | 1.0% |
Poultry | 2 | 1.0% |
Powered air-purifying respirator | 2 | 1.0% |
Precision medicine | 2 | 1.0% |
Prenatal development | 2 | 1.0% |
Prescription monitoring program | 2 | 1.0% |
Present value | 2 | 1.0% |
Primary care physician | 2 | 1.0% |
Prison | 2 | 1.0% |
Programmed cell death protein 1 | 2 | 1.0% |
Prostate cancer | 2 | 1.0% |
Proton therapy | 2 | 1.0% |
Psychiatry | 2 | 1.0% |
Public Health Emergency of International Concern | 2 | 1.0% |
Public–private partnership | 2 | 1.0% |
Pulmonary fibrosis | 2 | 1.0% |
Q fever | 2 | 1.0% |
Qualitative research | 2 | 1.0% |
Quality of life | 2 | 1.0% |
Quantitative research | 2 | 1.0% |
Radio | 2 | 1.0% |
Radiographer | 2 | 1.0% |
Regenerative medicine | 2 | 1.0% |
Regulation of pesticides in the European Union | 2 | 1.0% |
Regulatory Flexibility Act | 2 | 1.0% |
Rehabilitation Act of 1973 | 2 | 1.0% |
Reperfusion therapy | 2 | 1.0% |
Research and development | 2 | 1.0% |
Residential treatment center | 2 | 1.0% |
Respiratory syncytial virus | 2 | 1.0% |
Retail | 2 | 1.0% |
Retinopathy | 2 | 1.0% |
Rheumatic fever | 2 | 1.0% |
Rheumatoid arthritis | 2 | 1.0% |
Rifampicin | 2 | 1.0% |
Rights | 2 | 1.0% |
Rock (geology) | 2 | 1.0% |
Rulemaking | 2 | 1.0% |
SARS-CoV-2 | 2 | 1.0% |
SARS-CoV-2 Alpha variant | 2 | 1.0% |
Saturn | 2 | 1.0% |
Scientific method | 2 | 1.0% |
Semiconductor device fabrication | 2 | 1.0% |
Sensitivity analysis | 2 | 1.0% |
Sensor | 2 | 1.0% |
Severe acute respiratory syndrome coronavirus | 2 | 1.0% |
Sexually transmitted infection | 2 | 1.0% |
Single-nucleotide polymorphism | 2 | 1.0% |
Sinopharm BIBP COVID-19 vaccine | 2 | 1.0% |
Smoking | 2 | 1.0% |
Soil | 2 | 1.0% |
Solar System | 2 | 1.0% |
Star | 2 | 1.0% |
Statistical classification | 2 | 1.0% |
Sternum | 2 | 1.0% |
Strategic planning | 2 | 1.0% |
Substance abuse | 2 | 1.0% |
Sunset provision | 2 | 1.0% |
Supermarket | 2 | 1.0% |
Swarm behaviour | 2 | 1.0% |
Swine influenza | 2 | 1.0% |
System | 2 | 1.0% |
T cell | 2 | 1.0% |
Tissue engineering | 2 | 1.0% |
Toxicodynamics | 2 | 1.0% |
Toxicology | 2 | 1.0% |
Tracheal intubation | 2 | 1.0% |
Traffic collision | 2 | 1.0% |
Transcranial magnetic stimulation | 2 | 1.0% |
Transitional care | 2 | 1.0% |
Transmissible spongiform encephalopathy | 2 | 1.0% |
Transparency (behavior) | 2 | 1.0% |
Uncertainty | 2 | 1.0% |
Unemployment | 2 | 1.0% |
United States Code | 2 | 1.0% |
Universal health care | 2 | 1.0% |
Unmanned aerial vehicle | 2 | 1.0% |
Unwarranted variation | 2 | 1.0% |
Urinary incontinence | 2 | 1.0% |
Usability | 2 | 1.0% |
Ventricular fibrillation | 2 | 1.0% |
Verification and validation | 2 | 1.0% |
Veteran | 2 | 1.0% |
VigiBase | 2 | 1.0% |
Violence | 2 | 1.0% |
Viral respiratory tract infections | 2 | 1.0% |
Viral vector | 2 | 1.0% |
Virus-like particle | 2 | 1.0% |
Vital signs | 2 | 1.0% |
Wafer (electronics) | 2 | 1.0% |
Welfare | 2 | 1.0% |
Whole genome sequencing | 2 | 1.0% |
Woman | 2 | 1.0% |
Zidovudine | 2 | 1.0% |
10199 Chariklo | 1 | 0.5% |
2009 swine flu pandemic | 1 | 0.5% |
486958 Arrokoth | 1 | 0.5% |
5G | 1 | 0.5% |
Abiogenesis | 1 | 0.5% |
Abiraterone acetate | 1 | 0.5% |
Abuse | 1 | 0.5% |
Academic degree | 1 | 0.5% |
Academic publishing | 1 | 0.5% |
Access to COVID-19 Tools Accelerator | 1 | 0.5% |
Accessibility | 1 | 0.5% |
Accounts payable | 1 | 0.5% |
Accuracy and precision | 1 | 0.5% |
Acute lymphoblastic leukemia | 1 | 0.5% |
Acute myeloid leukemia | 1 | 0.5% |
Addiction | 1 | 0.5% |
Adeno-associated virus | 1 | 0.5% |
Adolescent health | 1 | 0.5% |
Aducanumab | 1 | 0.5% |
Adverse childhood experiences | 1 | 0.5% |
Adverse drug reaction | 1 | 0.5% |
Aegis Combat System | 1 | 0.5% |
Aerosol | 1 | 0.5% |
Africa | 1 | 0.5% |
Ageing | 1 | 0.5% |
Agenda for Change | 1 | 0.5% |
Air conditioning | 1 | 0.5% |
Air traffic control | 1 | 0.5% |
Alcoholic drink | 1 | 0.5% |
Alma Ata Declaration | 1 | 0.5% |
Alteplase | 1 | 0.5% |
Alzheimer's disease | 1 | 0.5% |
Amblyopia | 1 | 0.5% |
Ambulance | 1 | 0.5% |
Ambulatory care | 1 | 0.5% |
Amiodarone | 1 | 0.5% |
Amyotrophic lateral sclerosis | 1 | 0.5% |
Anal fissure | 1 | 0.5% |
Anatomy | 1 | 0.5% |
André the Giant | 1 | 0.5% |
Anesthesiology | 1 | 0.5% |
Animal disease model | 1 | 0.5% |
Animal welfare | 1 | 0.5% |
Animals and humans | 1 | 0.5% |
Anismus | 1 | 0.5% |
Annual report | 1 | 0.5% |
Antagonistic pleiotropy hypothesis | 1 | 0.5% |
Anthony Fauci | 1 | 0.5% |
Anthropology | 1 | 0.5% |
Anti-NMDA receptor encephalitis | 1 | 0.5% |
Anti-inflammatory | 1 | 0.5% |
Anti-obesity medication | 1 | 0.5% |
Antiarrhythmic agent | 1 | 0.5% |
Anticonvulsant | 1 | 0.5% |
Antifungal | 1 | 0.5% |
Antigen-presenting cell | 1 | 0.5% |
Antihypertensive drug | 1 | 0.5% |
Antimalarial medication | 1 | 0.5% |
Antimicrobial stewardship | 1 | 0.5% |
Antiplatelet drug | 1 | 0.5% |
Antiretroviral drugs | 1 | 0.5% |
Anxiety disorder | 1 | 0.5% |
Apheresis | 1 | 0.5% |
Apixaban | 1 | 0.5% |
Appetite | 1 | 0.5% |
Applications of artificial intelligence | 1 | 0.5% |
Applied ethics | 1 | 0.5% |
Appropriations bill (United States) | 1 | 0.5% |
Argument | 1 | 0.5% |
Arteriovenous malformation | 1 | 0.5% |
Arthritis | 1 | 0.5% |
Article processing charge | 1 | 0.5% |
Artificial heart valve | 1 | 0.5% |
Artificial neural network | 1 | 0.5% |
Asia | 1 | 0.5% |
Assisted reproductive technology | 1 | 0.5% |
Asteroseismology | 1 | 0.5% |
Astrophysics | 1 | 0.5% |
Atezolizumab | 1 | 0.5% |
Atmosphere of Earth | 1 | 0.5% |
Atopy | 1 | 0.5% |
Atorvastatin | 1 | 0.5% |
Attachment theory | 1 | 0.5% |
Attenuated vaccine | 1 | 0.5% |
Aurora | 1 | 0.5% |
Authentication | 1 | 0.5% |
Autism | 1 | 0.5% |
Autism spectrum | 1 | 0.5% |
Autoimmune hemolytic anemia | 1 | 0.5% |
Autophagy | 1 | 0.5% |
BCG vaccine | 1 | 0.5% |
BK virus | 1 | 0.5% |
BRCA1 | 1 | 0.5% |
Bag valve mask | 1 | 0.5% |
Balance sheet | 1 | 0.5% |
Bank | 1 | 0.5% |
Bariatric surgery | 1 | 0.5% |
Bariatrics | 1 | 0.5% |
Baseline (budgeting) | 1 | 0.5% |
Bat | 1 | 0.5% |
Battle of Ia Drang | 1 | 0.5% |
Bayesian inference | 1 | 0.5% |
Bayesian statistics | 1 | 0.5% |
Bedford | 1 | 0.5% |
Bedfordshire | 1 | 0.5% |
Beetle | 1 | 0.5% |
Behaviour therapy | 1 | 0.5% |
Behavioural sciences | 1 | 0.5% |
Belief | 1 | 0.5% |
Bempedoic acid/ezetimibe | 1 | 0.5% |
Benchmarking | 1 | 0.5% |
Best practice | 1 | 0.5% |
Bethesda system | 1 | 0.5% |
Biochemical cascade | 1 | 0.5% |
Biofeedback | 1 | 0.5% |
Biogas | 1 | 0.5% |
Biological globalization | 1 | 0.5% |
Biological pest control | 1 | 0.5% |
Biomarker (medicine) | 1 | 0.5% |
Biomedical waste | 1 | 0.5% |
Biomedicine | 1 | 0.5% |
Biomonitoring | 1 | 0.5% |
Biophysics | 1 | 0.5% |
Biosafety | 1 | 0.5% |
Biosensor | 1 | 0.5% |
Biosignature | 1 | 0.5% |
Biosimilar | 1 | 0.5% |
Birth | 1 | 0.5% |
Birth control | 1 | 0.5% |
Bisulfite sequencing | 1 | 0.5% |
Blastocyst | 1 | 0.5% |
Blood | 1 | 0.5% |
Blood donation | 1 | 0.5% |
Blood glucose monitoring | 1 | 0.5% |
Body fluids | 1 | 0.5% |
Bone | 1 | 0.5% |
Bone density | 1 | 0.5% |
Bone fracture | 1 | 0.5% |
Bone health | 1 | 0.5% |
Botulinum toxin | 1 | 0.5% |
Brand | 1 | 0.5% |
Brexit | 1 | 0.5% |
Bribery | 1 | 0.5% |
Bribery Act 2010 | 1 | 0.5% |
Brick and mortar | 1 | 0.5% |
Brilacidin | 1 | 0.5% |
Bronchoscopy | 1 | 0.5% |
Bruno Siciliano (engineer) | 1 | 0.5% |
Built environment | 1 | 0.5% |
Buprenorphine | 1 | 0.5% |
Bupropion | 1 | 0.5% |
Business continuity planning | 1 | 0.5% |
Business ethics | 1 | 0.5% |
CD135 | 1 | 0.5% |
CD4 | 1 | 0.5% |
CHA2DS2–VASc score | 1 | 0.5% |
COVID-19 drug development | 1 | 0.5% |
COVID-19 in pregnancy | 1 | 0.5% |
COVID-19 pandemic in New Zealand | 1 | 0.5% |
COVID-19 pandemic in Pakistan | 1 | 0.5% |
COVID-19 pandemic in Papua New Guinea | 1 | 0.5% |
COVID-19 pandemic in Ukraine | 1 | 0.5% |
Calorie restriction | 1 | 0.5% |
Camera | 1 | 0.5% |
Cancer immunotherapy | 1 | 0.5% |
Cancer prevention | 1 | 0.5% |
Cancer-associated fibroblast | 1 | 0.5% |
Cannabis (drug) | 1 | 0.5% |
Capitation (healthcare) | 1 | 0.5% |
Capsule endoscopy | 1 | 0.5% |
Carbohydrate | 1 | 0.5% |
Carbon dioxide | 1 | 0.5% |
Cardiac arrest | 1 | 0.5% |
Cardiac electrophysiology | 1 | 0.5% |
Cardiac magnetic resonance imaging | 1 | 0.5% |
Cardiac rehabilitation | 1 | 0.5% |
Cardiac resynchronization therapy | 1 | 0.5% |
Cardiovascular diseases | 1 | 0.5% |
Cardiovascular physiology | 1 | 0.5% |
Cargo | 1 | 0.5% |
Cattle | 1 | 0.5% |
Cefiderocol | 1 | 0.5% |
Cell potency | 1 | 0.5% |
Cell-mediated immunity | 1 | 0.5% |
Cellular network | 1 | 0.5% |
Cellular senescence | 1 | 0.5% |
Central Asia | 1 | 0.5% |
Central venous catheter | 1 | 0.5% |
Cervical screening | 1 | 0.5% |
Cervix | 1 | 0.5% |
Chagas disease | 1 | 0.5% |
Chemical element | 1 | 0.5% |
Chemical substance | 1 | 0.5% |
Chemical substances | 1 | 0.5% |
Chemicals in medicine | 1 | 0.5% |
Chemotherapy-induced peripheral neuropathy | 1 | 0.5% |
Chest radiograph | 1 | 0.5% |
Chickenpox | 1 | 0.5% |
Chief executive officer | 1 | 0.5% |
Chief financial officer | 1 | 0.5% |
Chief information officer | 1 | 0.5% |
Chief risk officer | 1 | 0.5% |
Child development | 1 | 0.5% |
Child neglect | 1 | 0.5% |
Child protection | 1 | 0.5% |
Child sexual abuse | 1 | 0.5% |
Children Act 1989 | 1 | 0.5% |
Children with Special Healthcare Needs in the United States | 1 | 0.5% |
Chiller | 1 | 0.5% |
Chimeric antigen receptor T cell | 1 | 0.5% |
Chlorine-releasing compounds | 1 | 0.5% |
Cholera vaccine | 1 | 0.5% |
Chronic fatigue syndrome | 1 | 0.5% |
Chronic inflammatory demyelinating polyneuropathy | 1 | 0.5% |
Cigarette | 1 | 0.5% |
Circulating tumor DNA | 1 | 0.5% |
Classification of ethnicity in the United Kingdom | 1 | 0.5% |
Claytronics | 1 | 0.5% |
Cloning | 1 | 0.5% |
Clopidogrel | 1 | 0.5% |
Closed-circuit television | 1 | 0.5% |
Clostridioides difficile infection | 1 | 0.5% |
Clozapine | 1 | 0.5% |
Coagulation | 1 | 0.5% |
Cochrane Library | 1 | 0.5% |
Code of Federal Regulations | 1 | 0.5% |
Colesevelam | 1 | 0.5% |
Colestyramine | 1 | 0.5% |
Collaboratory | 1 | 0.5% |
Colonoscopy | 1 | 0.5% |
Combination therapy | 1 | 0.5% |
Communication | 1 | 0.5% |
Community | 1 | 0.5% |
Company (military unit) | 1 | 0.5% |
Competition | 1 | 0.5% |
Competition (economics) | 1 | 0.5% |
Comprehensive geriatric assessment | 1 | 0.5% |
Computer network | 1 | 0.5% |
Computer science | 1 | 0.5% |
Concepts in metaphysics | 1 | 0.5% |
Confidentiality | 1 | 0.5% |
Conflict of interest | 1 | 0.5% |
Congressional Record | 1 | 0.5% |
Conjugate vaccine | 1 | 0.5% |
Consciousness | 1 | 0.5% |
Conservation biology | 1 | 0.5% |
Constipation | 1 | 0.5% |
Consumer price index | 1 | 0.5% |
Contact tracing | 1 | 0.5% |
Continuous glucose monitor | 1 | 0.5% |
Continuous positive airway pressure | 1 | 0.5% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 1 | 0.5% |
Convention on Biological Diversity | 1 | 0.5% |
Convolutional neural network | 1 | 0.5% |
Coronary artery bypass surgery | 1 | 0.5% |
Coronavirus spike protein | 1 | 0.5% |
Corporate social responsibility | 1 | 0.5% |
Correlation and dependence | 1 | 0.5% |
Corruption | 1 | 0.5% |
Cosmetics | 1 | 0.5% |
Cough | 1 | 0.5% |
County Durham | 1 | 0.5% |
CpG site | 1 | 0.5% |
Cracking (chemistry) | 1 | 0.5% |
Creatinine | 1 | 0.5% |
Credit | 1 | 0.5% |
Creutzfeldt–Jakob disease | 1 | 0.5% |
Crimean–Congo hemorrhagic fever | 1 | 0.5% |
Crohn's disease | 1 | 0.5% |
Cross-reactivity | 1 | 0.5% |
Cross-validation (statistics) | 1 | 0.5% |
Crust (geology) | 1 | 0.5% |
Current events | 1 | 0.5% |
Customer relationship management | 1 | 0.5% |
Customs | 1 | 0.5% |
Cyberattack | 1 | 0.5% |
Cyberwarfare | 1 | 0.5% |
Cyborg | 1 | 0.5% |
Cystatin C | 1 | 0.5% |
Cytotoxic T cell | 1 | 0.5% |
DMARC | 1 | 0.5% |
DNA repair | 1 | 0.5% |
DNA vaccination | 1 | 0.5% |
DNA vaccine | 1 | 0.5% |
Dabigatran | 1 | 0.5% |
Daratumumab | 1 | 0.5% |
Dark energy | 1 | 0.5% |
Dark matter halo | 1 | 0.5% |
Darunavir | 1 | 0.5% |
Dasatinib | 1 | 0.5% |
Deep brain stimulation | 1 | 0.5% |
Defecation | 1 | 0.5% |
Dehumidifier | 1 | 0.5% |
Delivery drone | 1 | 0.5% |
Dendritic cell | 1 | 0.5% |
Depression (mood) | 1 | 0.5% |
Deradicalization | 1 | 0.5% |
Dermatomyositis | 1 | 0.5% |
Desalination | 1 | 0.5% |
Developing country | 1 | 0.5% |
Diabetic foot ulcer | 1 | 0.5% |
Diabetic nephropathy | 1 | 0.5% |
Diagnosis | 1 | 0.5% |
Diarrhea | 1 | 0.5% |
Diffuse large B-cell lymphoma | 1 | 0.5% |
Digital pathology | 1 | 0.5% |
Digital polymerase chain reaction | 1 | 0.5% |
Digital twin | 1 | 0.5% |
Digoxin | 1 | 0.5% |
Diltiazem | 1 | 0.5% |
Diphtheria | 1 | 0.5% |
Diphtheria vaccine | 1 | 0.5% |
Directly observed treatment, short-course | 1 | 0.5% |
Disability-adjusted life year | 1 | 0.5% |
Discovery (law) | 1 | 0.5% |
Disease burden | 1 | 0.5% |
Disease management (health) | 1 | 0.5% |
Disease outbreak | 1 | 0.5% |
Disease outbreaks | 1 | 0.5% |
Dispatcher | 1 | 0.5% |
Dividend | 1 | 0.5% |
Docking (molecular) | 1 | 0.5% |
Doctor of Philosophy | 1 | 0.5% |
DomainKeys Identified Mail | 1 | 0.5% |
Dragonfly (spacecraft) | 1 | 0.5% |
Drink | 1 | 0.5% |
Dronedarone | 1 | 0.5% |
Drug discovery | 1 | 0.5% |
Drug overdose | 1 | 0.5% |
Dual-use technology | 1 | 0.5% |
Dynamo theory | 1 | 0.5% |
Dysprosium | 1 | 0.5% |
Dystonia | 1 | 0.5% |
E-commerce | 1 | 0.5% |
ELISA | 1 | 0.5% |
EPSDT | 1 | 0.5% |
EQ-5D | 1 | 0.5% |
Eating | 1 | 0.5% |
Ebola vaccine | 1 | 0.5% |
Echinocandin | 1 | 0.5% |
Ecology | 1 | 0.5% |
Ecosystem | 1 | 0.5% |
Educational assessment | 1 | 0.5% |
Effect size | 1 | 0.5% |
Elastomeric respirator | 1 | 0.5% |
Elderly care | 1 | 0.5% |
Electroblotting | 1 | 0.5% |
Electronic prescribing | 1 | 0.5% |
Embolism | 1 | 0.5% |
Embryo | 1 | 0.5% |
Emotion | 1 | 0.5% |
Employee retention | 1 | 0.5% |
Encephalitis | 1 | 0.5% |
Endocrine pancreas | 1 | 0.5% |
Endocrine system | 1 | 0.5% |
Endocrine, nutritional and metabolic diseases | 1 | 0.5% |
Endocrinology | 1 | 0.5% |
Endometrial cancer | 1 | 0.5% |
Endoplasmic reticulum | 1 | 0.5% |
Energy management | 1 | 0.5% |
Enterovirus | 1 | 0.5% |
Enterprise content management | 1 | 0.5% |
Entrepreneurship | 1 | 0.5% |
Environmental justice | 1 | 0.5% |
Enzyme inhibitor | 1 | 0.5% |
Epidemics | 1 | 0.5% |
Epigenetic clock | 1 | 0.5% |
Epigenomics | 1 | 0.5% |
Equal opportunity | 1 | 0.5% |
Equity (finance) | 1 | 0.5% |
Erlotinib | 1 | 0.5% |
Escherichia coli | 1 | 0.5% |
Esophageal achalasia | 1 | 0.5% |
Estimand | 1 | 0.5% |
Evaporative cooler | 1 | 0.5% |
Evidence-based practice | 1 | 0.5% |
Evolution of ageing | 1 | 0.5% |
Exclusion of the null hypothesis | 1 | 0.5% |
Executive Order 12866 | 1 | 0.5% |
Executive order | 1 | 0.5% |
Exhalation | 1 | 0.5% |
Exhaled nitric oxide | 1 | 0.5% |
Exoplanet | 1 | 0.5% |
Experience | 1 | 0.5% |
Exploration of the Moon | 1 | 0.5% |
Extracorporeal membrane oxygenation | 1 | 0.5% |
Eye protection | 1 | 0.5% |
FDA Food Safety Modernization Act | 1 | 0.5% |
Factor VIII | 1 | 0.5% |
Factor X | 1 | 0.5% |
Fall prevention | 1 | 0.5% |
False positives and false negatives | 1 | 0.5% |
Family planning | 1 | 0.5% |
Fecal incontinence | 1 | 0.5% |
Federal Insecticide, Fungicide, and Rodenticide Act | 1 | 0.5% |
Federally Qualified Health Center | 1 | 0.5% |
Fenofibrate | 1 | 0.5% |
Fertilizer | 1 | 0.5% |
Fever | 1 | 0.5% |
Fibrate | 1 | 0.5% |
Fibrinogen | 1 | 0.5% |
Filtering facepiece respirator | 1 | 0.5% |
Financial risk | 1 | 0.5% |
Fire | 1 | 0.5% |
Fiscal year | 1 | 0.5% |
Fisheries management | 1 | 0.5% |
Fishing | 1 | 0.5% |
Five Year Forward View | 1 | 0.5% |
Fixed asset | 1 | 0.5% |
Fluoride therapy | 1 | 0.5% |
Fluvastatin | 1 | 0.5% |
Focus group | 1 | 0.5% |
Food and drink | 1 | 0.5% |
Food security | 1 | 0.5% |
Foodservice | 1 | 0.5% |
Formation and evolution of the Solar System | 1 | 0.5% |
Formulary (pharmacy) | 1 | 0.5% |
Fourth Industrial Revolution | 1 | 0.5% |
Framingham Risk Score | 1 | 0.5% |
Fresh frozen plasma | 1 | 0.5% |
Functional near-infrared spectroscopy | 1 | 0.5% |
Fundraising | 1 | 0.5% |
Fundus photography | 1 | 0.5% |
GISAID | 1 | 0.5% |
Gain of function research | 1 | 0.5% |
Galactic halo | 1 | 0.5% |
Galactose-1-phosphate uridylyltransferase deficiency | 1 | 0.5% |
Galactosemia | 1 | 0.5% |
Galilean moons | 1 | 0.5% |
Galileo (spacecraft) | 1 | 0.5% |
Gas detector | 1 | 0.5% |
Gaza Strip | 1 | 0.5% |
Gender | 1 | 0.5% |
Gender equality | 1 | 0.5% |
General Data Protection Regulation | 1 | 0.5% |
General practice | 1 | 0.5% |
Genetic disorder | 1 | 0.5% |
Genetic testing | 1 | 0.5% |
Genome-wide association study | 1 | 0.5% |
Genotype | 1 | 0.5% |
Gerontological nursing | 1 | 0.5% |
Gerontology | 1 | 0.5% |
Glasses | 1 | 0.5% |
Global Food Safety Initiative | 1 | 0.5% |
Global security law | 1 | 0.5% |
Globular cluster | 1 | 0.5% |
Glomerular filtration rate | 1 | 0.5% |
Glucose meter | 1 | 0.5% |
Glucose tolerance test | 1 | 0.5% |
Glucose-6-phosphate dehydrogenase | 1 | 0.5% |
Glycan | 1 | 0.5% |
Glycemic index | 1 | 0.5% |
Glycome | 1 | 0.5% |
Glycomics | 1 | 0.5% |
Gravity | 1 | 0.5% |
Gray goo | 1 | 0.5% |
Greenhouse gas | 1 | 0.5% |
Gut flora | 1 | 0.5% |
Gut microbiota | 1 | 0.5% |
HIV/AIDS in Africa | 1 | 0.5% |
HTTPS | 1 | 0.5% |
Hadfield, Derbyshire | 1 | 0.5% |
Haemophilia | 1 | 0.5% |
Haemophilia B | 1 | 0.5% |
Hafnium | 1 | 0.5% |
Hand sanitizer | 1 | 0.5% |
Haplotype | 1 | 0.5% |
Haumea | 1 | 0.5% |
Hazard analysis and critical control points | 1 | 0.5% |
Head-mounted display | 1 | 0.5% |
Headache | 1 | 0.5% |
Health care industry | 1 | 0.5% |
Health claim | 1 | 0.5% |
Health disasters | 1 | 0.5% |
Health in All Policies | 1 | 0.5% |
Health insurance coverage in the United States | 1 | 0.5% |
Health issues in pregnancy | 1 | 0.5% |
Health law | 1 | 0.5% |
Health maintenance organization | 1 | 0.5% |
Health research | 1 | 0.5% |
Health risk assessment | 1 | 0.5% |
Health visitor | 1 | 0.5% |
Healthcare Cost and Utilization Project | 1 | 0.5% |
Heart diseases | 1 | 0.5% |
Heart rate | 1 | 0.5% |
Heart valve | 1 | 0.5% |
Heat wave | 1 | 0.5% |
Heated humidified high-flow therapy | 1 | 0.5% |
Heating, ventilation, and air conditioning | 1 | 0.5% |
Hela Province | 1 | 0.5% |
Helicopter | 1 | 0.5% |
Helminthiasis | 1 | 0.5% |
Hematology | 1 | 0.5% |
Henipavirus | 1 | 0.5% |
Heparin-induced thrombocytopenia | 1 | 0.5% |
Hepatitis B | 1 | 0.5% |
Hepatitis C | 1 | 0.5% |
Hepatocellular carcinoma | 1 | 0.5% |
Herbal medicine | 1 | 0.5% |
Hereditary nonpolyposis colorectal cancer | 1 | 0.5% |
Heterosexuality | 1 | 0.5% |
Hib vaccine | 1 | 0.5% |
Hierarchy of evidence | 1 | 0.5% |
High-intensity interval training | 1 | 0.5% |
Hispanic and Latino Americans | 1 | 0.5% |
Histopathology | 1 | 0.5% |
History | 1 | 0.5% |
Holter monitor | 1 | 0.5% |
Hospice care in the United States | 1 | 0.5% |
Housing First | 1 | 0.5% |
Huanan Seafood Wholesale Market | 1 | 0.5% |
Human development | 1 | 0.5% |
Human enhancement | 1 | 0.5% |
Human evolution | 1 | 0.5% |
Human genome | 1 | 0.5% |
Human germline engineering | 1 | 0.5% |
Human migration | 1 | 0.5% |
Human pregnancy | 1 | 0.5% |
Human resource management | 1 | 0.5% |
Human rights | 1 | 0.5% |
Human services | 1 | 0.5% |
Human subject research | 1 | 0.5% |
Human trafficking | 1 | 0.5% |
Human–computer interaction | 1 | 0.5% |
Human–robot interaction | 1 | 0.5% |
Humidity | 1 | 0.5% |
Humoral immunity | 1 | 0.5% |
Hunger | 1 | 0.5% |
Hunger (physiology) | 1 | 0.5% |
Hydroxychloroquine | 1 | 0.5% |
Hyperhidrosis | 1 | 0.5% |
Hyperparameter optimization | 1 | 0.5% |
Hypopnea | 1 | 0.5% |
Hypothyroidism | 1 | 0.5% |
Hysterectomy | 1 | 0.5% |
IFRS 9 | 1 | 0.5% |
IR35 | 1 | 0.5% |
ISO 22000 | 1 | 0.5% |
ISO 9000 | 1 | 0.5% |
Idiopathic pulmonary fibrosis | 1 | 0.5% |
Illicit cigarette trade | 1 | 0.5% |
Image resolution | 1 | 0.5% |
Image-guided surgery | 1 | 0.5% |
Imatinib | 1 | 0.5% |
Immune response | 1 | 0.5% |
Immune thrombocytopenic purpura | 1 | 0.5% |
Immunologic adjuvant | 1 | 0.5% |
Immunosenescence | 1 | 0.5% |
Implantable cardioverter-defibrillator | 1 | 0.5% |
Improving Access to Psychological Therapies | 1 | 0.5% |
In vitro fertilisation | 1 | 0.5% |
Incentive | 1 | 0.5% |
Incubation period | 1 | 0.5% |
Indefinite leave to remain | 1 | 0.5% |
Indiana vesiculovirus | 1 | 0.5% |
Indigenous peoples of Polynesia | 1 | 0.5% |
Inflation | 1 | 0.5% |
Influenza A virus subtype H1N1 | 1 | 0.5% |
Influenza-like illness | 1 | 0.5% |
Informal economy | 1 | 0.5% |
Innate immune system | 1 | 0.5% |
Institutional review board | 1 | 0.5% |
Insulin | 1 | 0.5% |
Insulin analog | 1 | 0.5% |
Insulin aspart | 1 | 0.5% |
Insurance | 1 | 0.5% |
Intellectual disability | 1 | 0.5% |
Interdisciplinarity | 1 | 0.5% |
Interest rate | 1 | 0.5% |
Internal medicine | 1 | 0.5% |
International humanitarian law | 1 | 0.5% |
Internet of Military Things | 1 | 0.5% |
Interstitial lung disease | 1 | 0.5% |
Interval training | 1 | 0.5% |
Interview | 1 | 0.5% |
Investigations into the origin of COVID-19 | 1 | 0.5% |
Io (moon) | 1 | 0.5% |
Ionizing radiation | 1 | 0.5% |
Islam | 1 | 0.5% |
Issues in ethics | 1 | 0.5% |
Iwi | 1 | 0.5% |
JLENS | 1 | 0.5% |
Janus kinase | 1 | 0.5% |
Jews | 1 | 0.5% |
Judaism | 1 | 0.5% |
Jupiter Icy Moons Explorer | 1 | 0.5% |
Juvenile dermatomyositis | 1 | 0.5% |
Juvenile idiopathic arthritis | 1 | 0.5% |
KIT (gene) | 1 | 0.5% |
Kangaroo care | 1 | 0.5% |
Kaposi's sarcoma-associated herpesvirus | 1 | 0.5% |
Kilowatt-hour | 1 | 0.5% |
Kinase | 1 | 0.5% |
KiwiSaver | 1 | 0.5% |
Klamath River | 1 | 0.5% |
Kris Faafoi | 1 | 0.5% |
Kuala Lumpur International Airport | 1 | 0.5% |
LOINC | 1 | 0.5% |
Lab-on-a-chip | 1 | 0.5% |
Labor induction | 1 | 0.5% |
Lake | 1 | 0.5% |
Lambert–Eaton myasthenic syndrome | 1 | 0.5% |
Lamivudine | 1 | 0.5% |
Laparoscopic radical prostatectomy | 1 | 0.5% |
Laparoscopy | 1 | 0.5% |
Large for gestational age | 1 | 0.5% |
Lassa fever | 1 | 0.5% |
Latent tuberculosis | 1 | 0.5% |
Learning | 1 | 0.5% |
Learning disability | 1 | 0.5% |
Legislative branch of the United States government | 1 | 0.5% |
Leishmaniasis | 1 | 0.5% |
Licensed practical nurse | 1 | 0.5% |
Licensure | 1 | 0.5% |
Life | 1 | 0.5% |
Life on Titan | 1 | 0.5% |
Life-cycle assessment | 1 | 0.5% |
Ligand (biochemistry) | 1 | 0.5% |
Likelihood function | 1 | 0.5% |
Lineage P.1 | 1 | 0.5% |
Lipidomics | 1 | 0.5% |
Liraglutide | 1 | 0.5% |
Literacy | 1 | 0.5% |
Lobular carcinoma in situ | 1 | 0.5% |
Logistic regression | 1 | 0.5% |
Longevity | 1 | 0.5% |
Low birth weight | 1 | 0.5% |
Lunar magma ocean | 1 | 0.5% |
Lunar rover | 1 | 0.5% |
Lupus | 1 | 0.5% |
Luton | 1 | 0.5% |
Lymphoma | 1 | 0.5% |
MHealth | 1 | 0.5% |
MMRV vaccine | 1 | 0.5% |
MRNA-1273 | 1 | 0.5% |
MTOR | 1 | 0.5% |
Machining | 1 | 0.5% |
Macrophage | 1 | 0.5% |
Macular degeneration | 1 | 0.5% |
Magma | 1 | 0.5% |
Magnetosphere | 1 | 0.5% |
Magnetosphere of Jupiter | 1 | 0.5% |
Malignancy | 1 | 0.5% |
Malnutrition | 1 | 0.5% |
MammaPrint | 1 | 0.5% |
Mammalian pregnancy | 1 | 0.5% |
Management of COVID-19 | 1 | 0.5% |
Management of atrial fibrillation | 1 | 0.5% |
Management of depression | 1 | 0.5% |
Management of obesity | 1 | 0.5% |
Mandibular advancement splint | 1 | 0.5% |
Mantoux test | 1 | 0.5% |
Marburg virus | 1 | 0.5% |
Market (economics) | 1 | 0.5% |
Marketing | 1 | 0.5% |
Mass-casualty incident | 1 | 0.5% |
Mastocytosis | 1 | 0.5% |
Matariki | 1 | 0.5% |
Maternal mortality in the United States | 1 | 0.5% |
Mathematical optimization | 1 | 0.5% |
Matron | 1 | 0.5% |
Matter | 1 | 0.5% |
Mayor of London | 1 | 0.5% |
Meal | 1 | 0.5% |
Meat | 1 | 0.5% |
Medi-Cal | 1 | 0.5% |
Median | 1 | 0.5% |
Mediastinum | 1 | 0.5% |
Medical Priority Dispatch System | 1 | 0.5% |
Medical education | 1 | 0.5% |
Medical genetics | 1 | 0.5% |
Medical microbiology | 1 | 0.5% |
Medical physics | 1 | 0.5% |
Medical prevention | 1 | 0.5% |
Medicare dual eligible | 1 | 0.5% |
Meige's syndrome | 1 | 0.5% |
Membrane | 1 | 0.5% |
Memory | 1 | 0.5% |
Memory B cell | 1 | 0.5% |
Memory T cell | 1 | 0.5% |
Men who have sex with men | 1 | 0.5% |
Men's health | 1 | 0.5% |
Meningitis | 1 | 0.5% |
Meningococcal vaccine | 1 | 0.5% |
Mental Health Parity Act | 1 | 0.5% |
Mental distress | 1 | 0.5% |
Mental health literacy | 1 | 0.5% |
Metabolic disorders | 1 | 0.5% |
Metabolic pathway | 1 | 0.5% |
Metabolic syndrome | 1 | 0.5% |
Metabolome | 1 | 0.5% |
Metagenomics | 1 | 0.5% |
Metaproteomics | 1 | 0.5% |
Metered-dose inhaler | 1 | 0.5% |
Methamphetamine | 1 | 0.5% |
Methods of detecting exoplanets | 1 | 0.5% |
Methylphenidate | 1 | 0.5% |
Metoprolol | 1 | 0.5% |
Microfluidics | 1 | 0.5% |
Microplastics | 1 | 0.5% |
Microsatellite | 1 | 0.5% |
Migraine | 1 | 0.5% |
Milky Way | 1 | 0.5% |
Minimum wage | 1 | 0.5% |
Missing data | 1 | 0.5% |
Mitochondrial DNA | 1 | 0.5% |
Mitochondrial disease | 1 | 0.5% |
Mitochondrial replacement therapy | 1 | 0.5% |
Mitochondrion | 1 | 0.5% |
Mitophagy | 1 | 0.5% |
MitraClip | 1 | 0.5% |
Mitral regurgitation | 1 | 0.5% |
Mitral stenosis | 1 | 0.5% |
Mitral valve | 1 | 0.5% |
Mitral valve replacement | 1 | 0.5% |
Molecular binding | 1 | 0.5% |
Molecular diagnostics | 1 | 0.5% |
Molecular machine | 1 | 0.5% |
Molecule | 1 | 0.5% |
Monocyte | 1 | 0.5% |
Mood disorder | 1 | 0.5% |
Mood stabilizer | 1 | 0.5% |
Morality | 1 | 0.5% |
Motherhood | 1 | 0.5% |
Motivational interviewing | 1 | 0.5% |
Mucus | 1 | 0.5% |
Multi-factor authentication | 1 | 0.5% |
Multifocal motor neuropathy | 1 | 0.5% |
Multiple myeloma | 1 | 0.5% |
Mumps | 1 | 0.5% |
Municipal Police (France) | 1 | 0.5% |
Musicians from Florida | 1 | 0.5% |
Myasthenia gravis | 1 | 0.5% |
Mycobacteria | 1 | 0.5% |
Mycobacterium tuberculosis | 1 | 0.5% |
Mycotoxin | 1 | 0.5% |
Myocarditis | 1 | 0.5% |
Māori | 1 | 0.5% |
Māori music | 1 | 0.5% |
NHS Test and Trace | 1 | 0.5% |
NHS targets | 1 | 0.5% |
Naive T cell | 1 | 0.5% |
Naltrexone | 1 | 0.5% |
Nanolithography | 1 | 0.5% |
Nanoparticle | 1 | 0.5% |
Nanotoxicology | 1 | 0.5% |
Narrative | 1 | 0.5% |
National Immunization Technical Advisory Group | 1 | 0.5% |
National Lung Screening Trial | 1 | 0.5% |
Native Americans in the United States | 1 | 0.5% |
Natural killer cell | 1 | 0.5% |
Natural selection | 1 | 0.5% |
Nature versus nurture | 1 | 0.5% |
Navigation | 1 | 0.5% |
Nebulizer | 1 | 0.5% |
Needlestick injury | 1 | 0.5% |
Neglected tropical diseases | 1 | 0.5% |
Neonatal alloimmune thrombocytopenia | 1 | 0.5% |
Neonatal tetanus | 1 | 0.5% |
Neoplasms | 1 | 0.5% |
Nephrology | 1 | 0.5% |
Neptune | 1 | 0.5% |
Neurodegeneration | 1 | 0.5% |
Neurofeedback | 1 | 0.5% |
Neurology | 1 | 0.5% |
Neuromarketing | 1 | 0.5% |
Neutrophil | 1 | 0.5% |
Nevirapine | 1 | 0.5% |
Nicotinamide adenine dinucleotide | 1 | 0.5% |
Nicotine | 1 | 0.5% |
Nicotine replacement therapy | 1 | 0.5% |
Nilotinib | 1 | 0.5% |
Nintedanib | 1 | 0.5% |
Nirmatrelvir | 1 | 0.5% |
Nitrogen | 1 | 0.5% |
Nivolumab | 1 | 0.5% |
Non-alcoholic fatty liver disease | 1 | 0.5% |
Non-coding DNA | 1 | 0.5% |
Non-invasive ventilation | 1 | 0.5% |
Nordic countries | 1 | 0.5% |
Notified body | 1 | 0.5% |
Nuclear medicine | 1 | 0.5% |
Nucleic acid | 1 | 0.5% |
Numerical | 1 | 0.5% |
Nutrient | 1 | 0.5% |
Nutrient sensing | 1 | 0.5% |
Objective structured clinical examination | 1 | 0.5% |
Observer-expectancy effect | 1 | 0.5% |
Obstetric labor complication | 1 | 0.5% |
Occultation | 1 | 0.5% |
Occupational therapist | 1 | 0.5% |
Odor | 1 | 0.5% |
Office of Inspector General (United States) | 1 | 0.5% |
Okara (food) | 1 | 0.5% |
Olanzapine | 1 | 0.5% |
Old age | 1 | 0.5% |
On-the-job training | 1 | 0.5% |
Oncolytic adenovirus | 1 | 0.5% |
Ongoing events | 1 | 0.5% |
Online advertising | 1 | 0.5% |
Online shopping | 1 | 0.5% |
Oocyte | 1 | 0.5% |
Open data | 1 | 0.5% |
Operating surplus | 1 | 0.5% |
Operations research | 1 | 0.5% |
Opsoclonus myoclonus syndrome | 1 | 0.5% |
Optics | 1 | 0.5% |
Orbit | 1 | 0.5% |
Organisms | 1 | 0.5% |
Organization | 1 | 0.5% |
Organizational culture | 1 | 0.5% |
Organs (anatomy) | 1 | 0.5% |
Orlistat | 1 | 0.5% |
Orphan Drug Act of 1983 | 1 | 0.5% |
Orthomyxoviridae | 1 | 0.5% |
Oseltamivir | 1 | 0.5% |
Osmosis | 1 | 0.5% |
Osteoarthritis | 1 | 0.5% |
Osteopenia | 1 | 0.5% |
Osteoporosis | 1 | 0.5% |
Otitis media | 1 | 0.5% |
Outpatient clinic (hospital department) | 1 | 0.5% |
Overfitting | 1 | 0.5% |
P-value | 1 | 0.5% |
PANDAS | 1 | 0.5% |
PD-L1 | 1 | 0.5% |
PHQ-9 | 1 | 0.5% |
Palbociclib | 1 | 0.5% |
Palpitations | 1 | 0.5% |
Paper | 1 | 0.5% |
Paper towel | 1 | 0.5% |
Paratrooper | 1 | 0.5% |
Particle physics | 1 | 0.5% |
Passive ventilation | 1 | 0.5% |
Pathology | 1 | 0.5% |
Pathology of pregnancy, childbirth and the puerperium | 1 | 0.5% |
Patient participation | 1 | 0.5% |
Pelvic floor | 1 | 0.5% |
Pelvic floor dysfunction | 1 | 0.5% |
Pembrolizumab | 1 | 0.5% |
Pemphigus | 1 | 0.5% |
Pentose phosphate pathway | 1 | 0.5% |
Percentage | 1 | 0.5% |
Percutaneous aortic valve replacement | 1 | 0.5% |
Peripherally inserted central catheter | 1 | 0.5% |
Perovskite (structure) | 1 | 0.5% |
Perseverance (rover) | 1 | 0.5% |
Personal identity | 1 | 0.5% |
Personalized medicine | 1 | 0.5% |
Pertuzumab | 1 | 0.5% |
Phagocyte | 1 | 0.5% |
Phenotype | 1 | 0.5% |
Phenotypic trait | 1 | 0.5% |
Philip Auerswald | 1 | 0.5% |
Phosphoinositide 3-kinase | 1 | 0.5% |
Physical cosmology | 1 | 0.5% |
Physical fitness | 1 | 0.5% |
Physician Orders for Life-Sustaining Treatment | 1 | 0.5% |
Pirfenidone | 1 | 0.5% |
Piriformis syndrome | 1 | 0.5% |
Placental abruption | 1 | 0.5% |
Plain tobacco packaging | 1 | 0.5% |
Planetary core | 1 | 0.5% |
Planetary habitability | 1 | 0.5% |
Planetary science | 1 | 0.5% |
Planets beyond Neptune | 1 | 0.5% |
Planning | 1 | 0.5% |
Plasma (physics) | 1 | 0.5% |
Plasmapheresis | 1 | 0.5% |
Plasmodium | 1 | 0.5% |
Plasmodium falciparum | 1 | 0.5% |
Platelet | 1 | 0.5% |
Plateletpheresis | 1 | 0.5% |
Pluto | 1 | 0.5% |
Pneumococcal conjugate vaccine | 1 | 0.5% |
Pneumococcal vaccine | 1 | 0.5% |
Pneumothorax | 1 | 0.5% |
Point of sale | 1 | 0.5% |
Poliovirus | 1 | 0.5% |
Political corruption | 1 | 0.5% |
Political science | 1 | 0.5% |
Pollution | 1 | 0.5% |
Polymer | 1 | 0.5% |
Polynesian New Zealander | 1 | 0.5% |
Polypharmacy | 1 | 0.5% |
Population genetics | 1 | 0.5% |
Populism | 1 | 0.5% |
Positron emission tomography | 1 | 0.5% |
Post-exposure prophylaxis | 1 | 0.5% |
Postdoctoral researcher | 1 | 0.5% |
Postgraduate education | 1 | 0.5% |
Postpartum bleeding | 1 | 0.5% |
Power of a test | 1 | 0.5% |
Powered exoskeleton | 1 | 0.5% |
Praseodymium | 1 | 0.5% |
Prasugrel | 1 | 0.5% |
Pre-eclampsia | 1 | 0.5% |
Pre-exposure prophylaxis | 1 | 0.5% |
Preclinical development | 1 | 0.5% |
Prediction | 1 | 0.5% |
Predictive analytics | 1 | 0.5% |
Preimplantation genetic diagnosis | 1 | 0.5% |
Premature ventricular contraction | 1 | 0.5% |
Prenatal testing | 1 | 0.5% |
President pro tempore of the United States Senate | 1 | 0.5% |
Prevalence | 1 | 0.5% |
Prevalence of tobacco use | 1 | 0.5% |
Prevention of HIV/AIDS | 1 | 0.5% |
Prince George's County, Maryland | 1 | 0.5% |
Prion | 1 | 0.5% |
Prisoner | 1 | 0.5% |
Probability distribution | 1 | 0.5% |
Probiotic | 1 | 0.5% |
Productivity | 1 | 0.5% |
Profession | 1 | 0.5% |
Prognosis | 1 | 0.5% |
Programmable matter | 1 | 0.5% |
Prolapse | 1 | 0.5% |
Propranolol | 1 | 0.5% |
Prosocial behavior | 1 | 0.5% |
Prostate cancer screening | 1 | 0.5% |
Prostate-specific antigen | 1 | 0.5% |
Prosthesis | 1 | 0.5% |
Protein C | 1 | 0.5% |
Protein complex | 1 | 0.5% |
Protein kinase | 1 | 0.5% |
Proteome | 1 | 0.5% |
Proteostasis | 1 | 0.5% |
Prothrombin time | 1 | 0.5% |
Protocell | 1 | 0.5% |
Psychiatric hospital | 1 | 0.5% |
Psychological concepts | 1 | 0.5% |
Psychosis | 1 | 0.5% |
Public health insurance option | 1 | 0.5% |
Public hospital | 1 | 0.5% |
Public policy | 1 | 0.5% |
Publication bias | 1 | 0.5% |
Pulmonary alveolus | 1 | 0.5% |
Pulmonology | 1 | 0.5% |
Pulp (paper) | 1 | 0.5% |
Pulse | 1 | 0.5% |
Pyrazinamide | 1 | 0.5% |
Quality (business) | 1 | 0.5% |
Quality management | 1 | 0.5% |
Quality management system | 1 | 0.5% |
Quality of life (healthcare) | 1 | 0.5% |
QuantiFERON | 1 | 0.5% |
Quantum computing | 1 | 0.5% |
Quantum key distribution | 1 | 0.5% |
Quantum mechanics | 1 | 0.5% |
Quitline | 1 | 0.5% |
RNA-Seq | 1 | 0.5% |
RTT | 1 | 0.5% |
Race and ethnicity in the United States Census | 1 | 0.5% |
Radiofrequency ablation | 1 | 0.5% |
Radiosurgery | 1 | 0.5% |
Raltegravir | 1 | 0.5% |
Raman spectroscopy | 1 | 0.5% |
Rangi Mātāmua | 1 | 0.5% |
Rare disease | 1 | 0.5% |
Rare-earth element | 1 | 0.5% |
Real estate appraisal | 1 | 0.5% |
Real-time polymerase chain reaction | 1 | 0.5% |
Recovery approach | 1 | 0.5% |
Rectocele | 1 | 0.5% |
Rectum | 1 | 0.5% |
Regression analysis | 1 | 0.5% |
Regulatory impact analysis | 1 | 0.5% |
Regurgitation (circulation) | 1 | 0.5% |
Reliability engineering | 1 | 0.5% |
Remand (detention) | 1 | 0.5% |
Remote sensing | 1 | 0.5% |
Reproducibility | 1 | 0.5% |
Reproduction | 1 | 0.5% |
Reproduction in mammals | 1 | 0.5% |
Reproductive health | 1 | 0.5% |
Republic | 1 | 0.5% |
Reputation | 1 | 0.5% |
Resident Coordinator | 1 | 0.5% |
Residential segregation in the United States | 1 | 0.5% |
Respiration | 1 | 0.5% |
Respirator fit test | 1 | 0.5% |
Respiratory diseases | 1 | 0.5% |
Respiratory failure | 1 | 0.5% |
Respiratory system | 1 | 0.5% |
Respiratory therapist | 1 | 0.5% |
Respite care | 1 | 0.5% |
Retina | 1 | 0.5% |
Retirement | 1 | 0.5% |
Reverse osmosis | 1 | 0.5% |
Rheumatology | 1 | 0.5% |
Ribose 5-phosphate | 1 | 0.5% |
Ring system | 1 | 0.5% |
Risk appetite | 1 | 0.5% |
Risk–benefit ratio | 1 | 0.5% |
Ritonavir | 1 | 0.5% |
Rituximab | 1 | 0.5% |
Rivaroxaban | 1 | 0.5% |
Robot-assisted surgery | 1 | 0.5% |
Rosuvastatin | 1 | 0.5% |
Rotorcraft | 1 | 0.5% |
Rover (space exploration) | 1 | 0.5% |
Rubidium | 1 | 0.5% |
Russian language | 1 | 0.5% |
SARS-CoV-2 Omicron variant | 1 | 0.5% |
SWOT analysis | 1 | 0.5% |
Safeguarding | 1 | 0.5% |
Safety culture | 1 | 0.5% |
Sales | 1 | 0.5% |
Salt | 1 | 0.5% |
Sampling (statistics) | 1 | 0.5% |
Satellite | 1 | 0.5% |
Satellite navigation | 1 | 0.5% |
Scanning electron microscope | 1 | 0.5% |
Scenario analysis | 1 | 0.5% |
Science and technology | 1 | 0.5% |
Science, technology, engineering, and mathematics | 1 | 0.5% |
Scrubs (clothing) | 1 | 0.5% |
Seasonal energy efficiency ratio | 1 | 0.5% |
Security token | 1 | 0.5% |
Self-assembled monolayer | 1 | 0.5% |
Self-assembly | 1 | 0.5% |
Self-determination theory | 1 | 0.5% |
Self-driving car | 1 | 0.5% |
Self-employment | 1 | 0.5% |
Self-healing material | 1 | 0.5% |
Semaglutide | 1 | 0.5% |
Semiconductor | 1 | 0.5% |
Sender Policy Framework | 1 | 0.5% |
Senescence | 1 | 0.5% |
Sense | 1 | 0.5% |
Sensory substitution | 1 | 0.5% |
Sequencing | 1 | 0.5% |
Sequential Intercept Model | 1 | 0.5% |
Sequential analysis | 1 | 0.5% |
Serious mental illness | 1 | 0.5% |
Severe acute respiratory syndrome coronavirus 1 | 1 | 0.5% |
Severe acute respiratory syndrome–related coronavirus | 1 | 0.5% |
Sexually transmitted diseases and infections | 1 | 0.5% |
Shanty town | 1 | 0.5% |
Ship | 1 | 0.5% |
Shortages related to the COVID-19 pandemic | 1 | 0.5% |
Sick leave | 1 | 0.5% |
Simon Stevens | 1 | 0.5% |
Simvastatin | 1 | 0.5% |
Single cell sequencing | 1 | 0.5% |
Single-cell transcriptomics | 1 | 0.5% |
Sirolimus | 1 | 0.5% |
Sleep | 1 | 0.5% |
Smoking ban | 1 | 0.5% |
Social discount rate | 1 | 0.5% |
Social impact bond | 1 | 0.5% |
Social inequality | 1 | 0.5% |
Social protection | 1 | 0.5% |
Social stigma | 1 | 0.5% |
Society | 1 | 0.5% |
Sociology | 1 | 0.5% |
Sofosbuvir | 1 | 0.5% |
Soft drink | 1 | 0.5% |
Software | 1 | 0.5% |
Software development | 1 | 0.5% |
Software testing | 1 | 0.5% |
Solitary confinement | 1 | 0.5% |
Somatic cell nuclear transfer | 1 | 0.5% |
Somatosensory system | 1 | 0.5% |
Somerset County, Maryland | 1 | 0.5% |
Sotalol | 1 | 0.5% |
South Yorkshire | 1 | 0.5% |
Space exploration | 1 | 0.5% |
Spasmodic torticollis | 1 | 0.5% |
Spasticity | 1 | 0.5% |
Species | 1 | 0.5% |
Specification (technical standard) | 1 | 0.5% |
Spreadsheet | 1 | 0.5% |
Standard error | 1 | 0.5% |
Standard of care | 1 | 0.5% |
Staphylococcus aureus | 1 | 0.5% |
Star cluster | 1 | 0.5% |
Startup company | 1 | 0.5% |
Statistical methods | 1 | 0.5% |
Steam cracking | 1 | 0.5% |
Stem cell factor | 1 | 0.5% |
Stereotactic surgery | 1 | 0.5% |
Stillbirth | 1 | 0.5% |
Strategy implementation | 1 | 0.5% |
Streptococcus agalactiae | 1 | 0.5% |
Structure formation | 1 | 0.5% |
Subsidy | 1 | 0.5% |
Sugar | 1 | 0.5% |
Suicidal ideation | 1 | 0.5% |
Suicide | 1 | 0.5% |
Suicide prevention | 1 | 0.5% |
Sulfonylurea | 1 | 0.5% |
Summary Care Record | 1 | 0.5% |
Supervised learning | 1 | 0.5% |
Surface-enhanced Raman spectroscopy | 1 | 0.5% |
Surrogate endpoint | 1 | 0.5% |
Sustainable Development Goal 3 | 1 | 0.5% |
Sustainable development | 1 | 0.5% |
Sweetened beverage | 1 | 0.5% |
Symptom | 1 | 0.5% |
Symptoms of COVID-19 | 1 | 0.5% |
Synthetic biology | 1 | 0.5% |
Syphilis | 1 | 0.5% |
Systole | 1 | 0.5% |
T helper cell | 1 | 0.5% |
Tangata whenua | 1 | 0.5% |
Telecommuting | 1 | 0.5% |
Telenursing | 1 | 0.5% |
Telepathology | 1 | 0.5% |
Telomere | 1 | 0.5% |
Temporomandibular joint dysfunction | 1 | 0.5% |
Tendon | 1 | 0.5% |
Tenofovir disoproxil | 1 | 0.5% |
Terminal illness | 1 | 0.5% |
Tetanus | 1 | 0.5% |
Theory | 1 | 0.5% |
Thiazide | 1 | 0.5% |
Thorax | 1 | 0.5% |
Thrombin | 1 | 0.5% |
Thrombocytopenia | 1 | 0.5% |
Ticagrelor | 1 | 0.5% |
Tirofiban | 1 | 0.5% |
Tissues (biology) | 1 | 0.5% |
Titan (moon) | 1 | 0.5% |
Title X | 1 | 0.5% |
Tobacco | 1 | 0.5% |
Tobacco control | 1 | 0.5% |
Tom Petty | 1 | 0.5% |
Toothpaste | 1 | 0.5% |
Torticollis | 1 | 0.5% |
Toxicity | 1 | 0.5% |
Traceability | 1 | 0.5% |
Tracheotomy | 1 | 0.5% |
Trade facilitation | 1 | 0.5% |
Trans-Neptunian object | 1 | 0.5% |
Transcription (biology) | 1 | 0.5% |
Transcriptome | 1 | 0.5% |
Transfusion medicine | 1 | 0.5% |
Transhumanism | 1 | 0.5% |
Transitional justice | 1 | 0.5% |
Transmission (mechanics) | 1 | 0.5% |
Transmission of COVID-19 | 1 | 0.5% |
Transplant rejection | 1 | 0.5% |
Trastuzumab | 1 | 0.5% |
Trimethoprim/sulfamethoxazole | 1 | 0.5% |
Tropical disease | 1 | 0.5% |
Trust (social science) | 1 | 0.5% |
Trustee | 1 | 0.5% |
Tuberculosis diagnosis | 1 | 0.5% |
Tumour heterogeneity | 1 | 0.5% |
Tympanostomy tube | 1 | 0.5% |
Type three secretion system | 1 | 0.5% |
Tyrosine kinase | 1 | 0.5% |
U.S. Route 60 in Arizona | 1 | 0.5% |
Ulipristal acetate | 1 | 0.5% |
Ultracold atom | 1 | 0.5% |
Ultrashort pulse | 1 | 0.5% |
Umbilical cord | 1 | 0.5% |
Unfolded protein response | 1 | 0.5% |
United States congressional committee | 1 | 0.5% |
United States federal budget | 1 | 0.5% |
Universe | 1 | 0.5% |
University | 1 | 0.5% |
Unsupervised learning | 1 | 0.5% |
Urinary system | 1 | 0.5% |
Urinary tract infection | 1 | 0.5% |
Urination | 1 | 0.5% |
Urogynecology | 1 | 0.5% |
Urology | 1 | 0.5% |
Use case | 1 | 0.5% |
User interface | 1 | 0.5% |
Uterus | 1 | 0.5% |
Vaccine Adverse Event Reporting System | 1 | 0.5% |
Vaccine Information Statement | 1 | 0.5% |
Vaccine hesitancy | 1 | 0.5% |
Vaccines | 1 | 0.5% |
Vagina | 1 | 0.5% |
Valley Metro Rail | 1 | 0.5% |
Valproate | 1 | 0.5% |
Valsartan | 1 | 0.5% |
Value chain | 1 | 0.5% |
Vaporized hydrogen peroxide | 1 | 0.5% |
Varenicline | 1 | 0.5% |
Vehicular automation | 1 | 0.5% |
Ventilation (architecture) | 1 | 0.5% |
Ventricular escape beat | 1 | 0.5% |
Venture capital | 1 | 0.5% |
Verapamil | 1 | 0.5% |
Vertically transmitted infection | 1 | 0.5% |
Very low-density lipoprotein | 1 | 0.5% |
Veterinary medicine | 1 | 0.5% |
Vineyard | 1 | 0.5% |
Viral hemorrhagic fever | 1 | 0.5% |
Viral load | 1 | 0.5% |
Viral vector vaccine | 1 | 0.5% |
Virology | 1 | 0.5% |
Virtual assistant | 1 | 0.5% |
Visual impairment | 1 | 0.5% |
Vitamin | 1 | 0.5% |
Vitamin D | 1 | 0.5% |
Viticulture | 1 | 0.5% |
Volatile organic compound | 1 | 0.5% |
Volcano | 1 | 0.5% |
Volunteering | 1 | 0.5% |
WHO Framework Convention on Tobacco Control | 1 | 0.5% |
Waitangi Day | 1 | 0.5% |
Warfarin | 1 | 0.5% |
Wastewater treatment | 1 | 0.5% |
Water footprint | 1 | 0.5% |
Water pollution | 1 | 0.5% |
Weight loss | 1 | 0.5% |
Weight management | 1 | 0.5% |
West Nile fever | 1 | 0.5% |
Western African Ebola virus epidemic | 1 | 0.5% |
Wet market | 1 | 0.5% |
Whistleblower | 1 | 0.5% |
White people | 1 | 0.5% |
Whole blood | 1 | 0.5% |
Wi-Fi | 1 | 0.5% |
Wildlife trade | 1 | 0.5% |
Window | 1 | 0.5% |
Wood | 1 | 0.5% |
Working capital | 1 | 0.5% |
Working conditions | 1 | 0.5% |
Working poor | 1 | 0.5% |
Workplace | 1 | 0.5% |
World energy consumption | 1 | 0.5% |
X-linked agammaglobulinemia | 1 | 0.5% |
X-linked severe combined immunodeficiency | 1 | 0.5% |
Years of potential life lost | 1 | 0.5% |
Youth | 1 | 0.5% |
Zanamivir | 1 | 0.5% |
Zika fever | 1 | 0.5% |
Zygosity | 1 | 0.5% |
abs | rel | |
---|---|---|
Health | 89 | 93.7% |
Health sciences | 80 | 84.2% |
Health care | 77 | 81.1% |
Medicine | 74 | 77.9% |
Clinical medicine | 58 | 61.1% |
Medical specialties | 51 | 53.7% |
Diseases and disorders | 34 | 35.8% |
Public health | 34 | 35.8% |
Disease | 31 | 32.6% |
Risk | 30 | 31.6% |
Preventive healthcare | 29 | 30.5% |
COVID-19 pandemic | 28 | 29.5% |
Epidemiology | 25 | 26.3% |
Branches of science | 24 | 25.3% |
Cancer | 21 | 22.1% |
Clinical trial | 21 | 22.1% |
Medical diagnosis | 21 | 22.1% |
Research | 21 | 22.1% |
Hospital | 20 | 21.1% |
Infection | 20 | 21.1% |
Social programs | 20 | 21.1% |
Technology | 20 | 21.1% |
Artificial intelligence | 19 | 20.0% |
Patient | 19 | 20.0% |
Health economics | 18 | 18.9% |
Screening (medicine) | 17 | 17.9% |
Health professional | 16 | 16.8% |
Public services | 16 | 16.8% |
Evidence-based medicine | 15 | 15.8% |
Systematic review | 15 | 15.8% |
COVID-19 | 14 | 14.7% |
Causes of death | 14 | 14.7% |
Health system | 14 | 14.7% |
Therapy | 14 | 14.7% |
Chronic condition | 13 | 13.7% |
Nursing | 13 | 13.7% |
Life sciences | 12 | 12.6% |
Tuberculosis | 12 | 12.6% |
HIV/AIDS | 11 | 11.6% |
Human activities | 11 | 11.6% |
Digital health | 10 | 10.5% |
Emergency department | 10 | 10.5% |
Health informatics | 10 | 10.5% |
Machine learning | 10 | 10.5% |
Pandemic | 10 | 10.5% |
Primary care | 10 | 10.5% |
Science | 10 | 10.5% |
Telehealth | 10 | 10.5% |
Vaccine | 10 | 10.5% |
Adherence (medicine) | 9 | 9.5% |
Breast cancer | 9 | 9.5% |
Electronic health record | 9 | 9.5% |
Health policy | 9 | 9.5% |
Immunology | 9 | 9.5% |
Infectious diseases | 9 | 9.5% |
Lung cancer | 9 | 9.5% |
Neoplasms | 9 | 9.5% |
Prostate cancer | 9 | 9.5% |
Randomized controlled trial | 9 | 9.5% |
Education | 8 | 8.4% |
Governance | 8 | 8.4% |
Health equity | 8 | 8.4% |
Innovation | 8 | 8.4% |
Public sphere | 8 | 8.4% |
Antimicrobial resistance | 7 | 7.4% |
Caregiver | 7 | 7.4% |
Cervical cancer | 7 | 7.4% |
General practitioner | 7 | 7.4% |
Medicaid | 7 | 7.4% |
Physician | 7 | 7.4% |
Quality-adjusted life year | 7 | 7.4% |
Sensitivity and specificity | 7 | 7.4% |
Sustainability | 7 | 7.4% |
Cancer screening | 6 | 6.3% |
Cardiovascular disease | 6 | 6.3% |
Clinical endpoint | 6 | 6.3% |
Creative Commons license | 6 | 6.3% |
Diabetes | 6 | 6.3% |
Evaluation | 6 | 6.3% |
Heart | 6 | 6.3% |
Human papillomavirus infection | 6 | 6.3% |
Insurance | 6 | 6.3% |
Intensive care medicine | 6 | 6.3% |
Intensive care unit | 6 | 6.3% |
Medical guideline | 6 | 6.3% |
Medical humanities | 6 | 6.3% |
Medical imaging | 6 | 6.3% |
Medical treatments | 6 | 6.3% |
Medication | 6 | 6.3% |
Meta-analysis | 6 | 6.3% |
Pharmacology | 6 | 6.3% |
Physical therapy | 6 | 6.3% |
Policy | 6 | 6.3% |
Social work | 6 | 6.3% |
Type 2 diabetes | 6 | 6.3% |
Algorithm | 5 | 5.3% |
Biomarker | 5 | 5.3% |
CT scan | 5 | 5.3% |
Chemotherapy | 5 | 5.3% |
DNA sequencing | 5 | 5.3% |
Data | 5 | 5.3% |
EHealth | 5 | 5.3% |
Employment | 5 | 5.3% |
Health data | 5 | 5.3% |
Health insurance | 5 | 5.3% |
Health technology | 5 | 5.3% |
Hypertension | 5 | 5.3% |
Informed consent | 5 | 5.3% |
Isolation (health care) | 5 | 5.3% |
Mammography | 5 | 5.3% |
Management of HIV/AIDS | 5 | 5.3% |
Medical test | 5 | 5.3% |
Mental health | 5 | 5.3% |
Non-communicable disease | 5 | 5.3% |
Pneumonia | 5 | 5.3% |
Pregnancy | 5 | 5.3% |
Privacy | 5 | 5.3% |
Psychological resilience | 5 | 5.3% |
Shared decision-making in medicine | 5 | 5.3% |
Stroke | 5 | 5.3% |
Surgery | 5 | 5.3% |
Virus | 5 | 5.3% |
COVID-19 vaccine | 4 | 4.2% |
CRISPR | 4 | 4.2% |
Childbirth | 4 | 4.2% |
Climate resilience | 4 | 4.2% |
Cohort study | 4 | 4.2% |
Colorectal cancer | 4 | 4.2% |
Comorbidity | 4 | 4.2% |
DNA | 4 | 4.2% |
Database | 4 | 4.2% |
Dependent and independent variables | 4 | 4.2% |
Drugs | 4 | 4.2% |
Expert | 4 | 4.2% |
Gene | 4 | 4.2% |
Genetics | 4 | 4.2% |
Influenza | 4 | 4.2% |
Information | 4 | 4.2% |
Lung cancer screening | 4 | 4.2% |
Managed care | 4 | 4.2% |
Mathematical optimization | 4 | 4.2% |
Medical device | 4 | 4.2% |
Medical prescription | 4 | 4.2% |
Medicare (United States) | 4 | 4.2% |
Microbiology | 4 | 4.2% |
Multidrug-resistant tuberculosis | 4 | 4.2% |
Personalized medicine | 4 | 4.2% |
Pharmacist | 4 | 4.2% |
Pharmacy | 4 | 4.2% |
Placebo | 4 | 4.2% |
Prostate cancer screening | 4 | 4.2% |
Prostate-specific antigen | 4 | 4.2% |
Pyrazinamide | 4 | 4.2% |
Radiation therapy | 4 | 4.2% |
Radiology | 4 | 4.2% |
Regression analysis | 4 | 4.2% |
Remote patient monitoring | 4 | 4.2% |
Risk assessment | 4 | 4.2% |
Safety | 4 | 4.2% |
Severe acute respiratory syndrome coronavirus 2 | 4 | 4.2% |
Social determinants of health | 4 | 4.2% |
Statistical significance | 4 | 4.2% |
Tuberculosis management | 4 | 4.2% |
Vaccination | 4 | 4.2% |
Accountable care organization | 3 | 3.2% |
Agriculture | 3 | 3.2% |
Antibiotic | 3 | 3.2% |
Asthma | 3 | 3.2% |
Audit | 3 | 3.2% |
Avian influenza | 3 | 3.2% |
Behavior | 3 | 3.2% |
Best practice | 3 | 3.2% |
Biology | 3 | 3.2% |
Bootstrapping (statistics) | 3 | 3.2% |
Breast cancer screening | 3 | 3.2% |
Cancer immunotherapy | 3 | 3.2% |
Cardiology | 3 | 3.2% |
Cas9 | 3 | 3.2% |
Chest radiograph | 3 | 3.2% |
Collaboration | 3 | 3.2% |
Computing | 3 | 3.2% |
Copyright | 3 | 3.2% |
Cost-effectiveness analysis | 3 | 3.2% |
Decision tree learning | 3 | 3.2% |
Deep learning | 3 | 3.2% |
Disease surveillance | 3 | 3.2% |
Econometrics | 3 | 3.2% |
Emergency | 3 | 3.2% |
Emergency management | 3 | 3.2% |
Ethics | 3 | 3.2% |
Experiment | 3 | 3.2% |
Extensively drug-resistant tuberculosis | 3 | 3.2% |
Fecal occult blood | 3 | 3.2% |
Fee-for-service | 3 | 3.2% |
Food | 3 | 3.2% |
General Data Protection Regulation | 3 | 3.2% |
Genetic engineering | 3 | 3.2% |
Genome | 3 | 3.2% |
Genome editing | 3 | 3.2% |
Guido Imbens | 3 | 3.2% |
HIV | 3 | 3.2% |
Health human resources | 3 | 3.2% |
Hospital readmission | 3 | 3.2% |
Immunotherapy | 3 | 3.2% |
Infection prevention and control | 3 | 3.2% |
Leadership | 3 | 3.2% |
Lymphoma | 3 | 3.2% |
MEDLINE | 3 | 3.2% |
MHealth | 3 | 3.2% |
Medical error | 3 | 3.2% |
Mental disorder | 3 | 3.2% |
National Lung Screening Trial | 3 | 3.2% |
Obesity | 3 | 3.2% |
Occupational safety and health | 3 | 3.2% |
Oregon Medicaid health experiment | 3 | 3.2% |
Organization | 3 | 3.2% |
Overdiagnosis | 3 | 3.2% |
Patient safety | 3 | 3.2% |
Pay for performance (healthcare) | 3 | 3.2% |
Percentile | 3 | 3.2% |
Personal protective equipment | 3 | 3.2% |
Phases of clinical research | 3 | 3.2% |
Point of care | 3 | 3.2% |
Poverty | 3 | 3.2% |
Pre-exposure prophylaxis | 3 | 3.2% |
Preterm birth | 3 | 3.2% |
Psychiatry | 3 | 3.2% |
Public Health Emergency of International Concern | 3 | 3.2% |
Random forest | 3 | 3.2% |
Respiratory disease | 3 | 3.2% |
Rifampicin | 3 | 3.2% |
Risk management | 3 | 3.2% |
Scientific Advice Mechanism | 3 | 3.2% |
Self-care | 3 | 3.2% |
Service industries | 3 | 3.2% |
Services sector of the economy | 3 | 3.2% |
Shortness of breath | 3 | 3.2% |
Social distancing | 3 | 3.2% |
Social media | 3 | 3.2% |
Software testing | 3 | 3.2% |
Statin | 3 | 3.2% |
Statistical classification | 3 | 3.2% |
Statistics | 3 | 3.2% |
Stomach cancer | 3 | 3.2% |
Supplemental Nutrition Assistance Program | 3 | 3.2% |
Sustainable Development Goals | 3 | 3.2% |
Synthetic biology | 3 | 3.2% |
Transmission (medicine) | 3 | 3.2% |
Adjuvant therapy | 2 | 2.1% |
Adolescence | 2 | 2.1% |
Adverse event | 2 | 2.1% |
Air pollution | 2 | 2.1% |
Airborne diseases | 2 | 2.1% |
Ambulance | 2 | 2.1% |
Animal diseases | 2 | 2.1% |
Animal viral diseases | 2 | 2.1% |
Anticoagulant | 2 | 2.1% |
Artificial intelligence in healthcare | 2 | 2.1% |
Atezolizumab | 2 | 2.1% |
Attention | 2 | 2.1% |
Autonomy | 2 | 2.1% |
Average treatment effect | 2 | 2.1% |
BCG vaccine | 2 | 2.1% |
Bacteria | 2 | 2.1% |
Bias | 2 | 2.1% |
Big data | 2 | 2.1% |
Biopsy | 2 | 2.1% |
Biotechnology | 2 | 2.1% |
Bladder cancer | 2 | 2.1% |
Bone fracture | 2 | 2.1% |
Breast imaging | 2 | 2.1% |
Breastfeeding | 2 | 2.1% |
Business | 2 | 2.1% |
Business continuity planning | 2 | 2.1% |
COVID-19 testing | 2 | 2.1% |
CRISPR gene editing | 2 | 2.1% |
Cerebral palsy | 2 | 2.1% |
Cerebrovascular disease | 2 | 2.1% |
Cervical intraepithelial neoplasia | 2 | 2.1% |
Cervical screening | 2 | 2.1% |
Chemicals in medicine | 2 | 2.1% |
Cholesterol | 2 | 2.1% |
Chronic myelogenous leukemia | 2 | 2.1% |
Chronic obstructive pulmonary disease | 2 | 2.1% |
Cirrhosis | 2 | 2.1% |
Clinical decision support system | 2 | 2.1% |
Cloud computing | 2 | 2.1% |
Cognition | 2 | 2.1% |
Colonoscopy | 2 | 2.1% |
Conflict of interest | 2 | 2.1% |
Contract | 2 | 2.1% |
Coronary artery disease | 2 | 2.1% |
Coronavirus disease 2019 | 2 | 2.1% |
Cystic fibrosis | 2 | 2.1% |
Cytopathology | 2 | 2.1% |
Data analysis | 2 | 2.1% |
Dense breast tissue | 2 | 2.1% |
Diabetes management | 2 | 2.1% |
Digital data | 2 | 2.1% |
Dose (biochemistry) | 2 | 2.1% |
Duchenne muscular dystrophy | 2 | 2.1% |
Emergency medical technician | 2 | 2.1% |
Environmental social science | 2 | 2.1% |
Epidermal growth factor receptor | 2 | 2.1% |
Exercise | 2 | 2.1% |
Fake news | 2 | 2.1% |
Foot | 2 | 2.1% |
Gardasil | 2 | 2.1% |
Gene therapy | 2 | 2.1% |
Genomics | 2 | 2.1% |
Global catastrophic risk | 2 | 2.1% |
HPV vaccine | 2 | 2.1% |
Health Insurance Portability and Accountability Act | 2 | 2.1% |
Health care in the United States | 2 | 2.1% |
Health literacy | 2 | 2.1% |
Health promotion | 2 | 2.1% |
Healthcare in the Netherlands | 2 | 2.1% |
Healthy diet | 2 | 2.1% |
Heart failure | 2 | 2.1% |
Hematopoietic stem cell transplantation | 2 | 2.1% |
Hemodialysis | 2 | 2.1% |
Hepatitis | 2 | 2.1% |
Human diseases and disorders | 2 | 2.1% |
Human reproduction | 2 | 2.1% |
Hypercholesterolemia | 2 | 2.1% |
Immersion (virtual reality) | 2 | 2.1% |
Immunization | 2 | 2.1% |
Immunodeficiency | 2 | 2.1% |
Incremental cost-effectiveness ratio | 2 | 2.1% |
Infant | 2 | 2.1% |
Influenza pandemic | 2 | 2.1% |
Information privacy | 2 | 2.1% |
Infrastructure | 2 | 2.1% |
Injection (medicine) | 2 | 2.1% |
Insulin (medication) | 2 | 2.1% |
Intention-to-treat analysis | 2 | 2.1% |
International Classification of Diseases | 2 | 2.1% |
Internet access | 2 | 2.1% |
Internet of things | 2 | 2.1% |
Interoperability | 2 | 2.1% |
Intramuscular injection | 2 | 2.1% |
Isoniazid | 2 | 2.1% |
Judgment (law) | 2 | 2.1% |
Learning | 2 | 2.1% |
Lentiviruses | 2 | 2.1% |
Leukemia | 2 | 2.1% |
Local average treatment effect | 2 | 2.1% |
Loss function | 2 | 2.1% |
Major depressive disorder | 2 | 2.1% |
Malaria | 2 | 2.1% |
Mantoux test | 2 | 2.1% |
Maternal health | 2 | 2.1% |
Maternal–fetal medicine | 2 | 2.1% |
Measles | 2 | 2.1% |
Median | 2 | 2.1% |
Medical education | 2 | 2.1% |
Medical privacy | 2 | 2.1% |
Medical statistics | 2 | 2.1% |
Medical tests | 2 | 2.1% |
Men who have sex with men | 2 | 2.1% |
Middle East respiratory syndrome | 2 | 2.1% |
Middle East respiratory syndrome–related coronavirus | 2 | 2.1% |
Midwife | 2 | 2.1% |
Midwifery | 2 | 2.1% |
Misinformation | 2 | 2.1% |
Mobile app | 2 | 2.1% |
Mobility aid | 2 | 2.1% |
Multiple myeloma | 2 | 2.1% |
Mutation | 2 | 2.1% |
Mycobacterium tuberculosis | 2 | 2.1% |
Neonatal intensive care unit | 2 | 2.1% |
Neurology | 2 | 2.1% |
Nivolumab | 2 | 2.1% |
Non-alcoholic fatty liver disease | 2 | 2.1% |
Non-small-cell lung carcinoma | 2 | 2.1% |
Orthopedic surgery | 2 | 2.1% |
Orthotics | 2 | 2.1% |
Osimertinib | 2 | 2.1% |
Osteoporosis | 2 | 2.1% |
Ovarian cancer | 2 | 2.1% |
Palliative care | 2 | 2.1% |
Pap test | 2 | 2.1% |
Paramedic | 2 | 2.1% |
Patent | 2 | 2.1% |
Pathology | 2 | 2.1% |
Patient-reported outcome | 2 | 2.1% |
Pediatrics | 2 | 2.1% |
Pembrolizumab | 2 | 2.1% |
Pharmaceutical industry | 2 | 2.1% |
Pharmaceutical sciences | 2 | 2.1% |
Pharmacokinetics | 2 | 2.1% |
Photonics | 2 | 2.1% |
Physical examination | 2 | 2.1% |
Pneumothorax | 2 | 2.1% |
Population health | 2 | 2.1% |
Postpartum period | 2 | 2.1% |
Precision medicine | 2 | 2.1% |
Prediction | 2 | 2.1% |
Programmed cell death protein 1 | 2 | 2.1% |
Protein | 2 | 2.1% |
Ptosis (eyelid) | 2 | 2.1% |
Pulmonary embolism | 2 | 2.1% |
Radiography | 2 | 2.1% |
Reason | 2 | 2.1% |
Regulation | 2 | 2.1% |
Rheumatology | 2 | 2.1% |
Robot-assisted surgery | 2 | 2.1% |
Sepsis | 2 | 2.1% |
Severe acute respiratory syndrome | 2 | 2.1% |
Sexually transmitted diseases and infections | 2 | 2.1% |
Sexually transmitted infection | 2 | 2.1% |
Signs and symptoms | 2 | 2.1% |
Simulation | 2 | 2.1% |
Single-photon emission computed tomography | 2 | 2.1% |
Smoking cessation | 2 | 2.1% |
Stichting | 2 | 2.1% |
Stress (biology) | 2 | 2.1% |
Surveillance | 2 | 2.1% |
Survival analysis | 2 | 2.1% |
Symptoms of COVID-19 | 2 | 2.1% |
Technology roadmap | 2 | 2.1% |
Thrombosis | 2 | 2.1% |
Tobacco smoking | 2 | 2.1% |
Transport | 2 | 2.1% |
Treatment as prevention | 2 | 2.1% |
Triage | 2 | 2.1% |
Type 1 diabetes | 2 | 2.1% |
Unemployment | 2 | 2.1% |
Unmanned aerial vehicle | 2 | 2.1% |
Vaccination schedule | 2 | 2.1% |
Viral diseases | 2 | 2.1% |
Viral respiratory tract infections | 2 | 2.1% |
Virtual reality | 2 | 2.1% |
Wearable technology | 2 | 2.1% |
Zoonosis | 2 | 2.1% |
ABC (medicine) | 1 | 1.1% |
ABVD | 1 | 1.1% |
Ab initio quantum chemistry methods | 1 | 1.1% |
Abaloparatide | 1 | 1.1% |
Abdominal obesity | 1 | 1.1% |
Academic degree | 1 | 1.1% |
Accountability | 1 | 1.1% |
Acinetobacter | 1 | 1.1% |
Acromegaly | 1 | 1.1% |
Active ageing | 1 | 1.1% |
Active surveillance of prostate cancer | 1 | 1.1% |
Acute lymphoblastic leukemia | 1 | 1.1% |
Acute myeloid leukemia | 1 | 1.1% |
Acute respiratory distress syndrome | 1 | 1.1% |
Adaptive clinical trial | 1 | 1.1% |
Adipose tissue | 1 | 1.1% |
Administrative divisions of Cambodia | 1 | 1.1% |
Adverse effect | 1 | 1.1% |
Ageing | 1 | 1.1% |
Aircraft | 1 | 1.1% |
Alagille syndrome | 1 | 1.1% |
Allergy | 1 | 1.1% |
Alzheimer's disease | 1 | 1.1% |
Amoxicillin | 1 | 1.1% |
Amyloidosis | 1 | 1.1% |
Anakinra | 1 | 1.1% |
Analysis | 1 | 1.1% |
Analytics | 1 | 1.1% |
Anaplastic lymphoma kinase | 1 | 1.1% |
Anatomical Therapeutic Chemical Classification System | 1 | 1.1% |
Anatomical terms of motion | 1 | 1.1% |
Anatomy | 1 | 1.1% |
Ancient DNA | 1 | 1.1% |
Anesthesia | 1 | 1.1% |
Anesthesiology | 1 | 1.1% |
Angiography | 1 | 1.1% |
Angiology | 1 | 1.1% |
Angiotensin II receptor blocker | 1 | 1.1% |
Animal bite | 1 | 1.1% |
Animal husbandry | 1 | 1.1% |
Animal welfare | 1 | 1.1% |
Anosmia | 1 | 1.1% |
Anticonvulsant | 1 | 1.1% |
Antineoplastic and immunomodulating drugs | 1 | 1.1% |
Antineoplastic drugs | 1 | 1.1% |
Antipsychotic | 1 | 1.1% |
Aortic insufficiency | 1 | 1.1% |
Aortic valve | 1 | 1.1% |
Apixaban | 1 | 1.1% |
Application software | 1 | 1.1% |
Applied mathematics | 1 | 1.1% |
Arab world | 1 | 1.1% |
Artificial cardiac pacemaker | 1 | 1.1% |
Artificial neural network | 1 | 1.1% |
Ascending cholangitis | 1 | 1.1% |
Assessment of kidney function | 1 | 1.1% |
Assisted reproductive technology | 1 | 1.1% |
Association for Molecular Pathology v. Myriad Genetics, Inc. | 1 | 1.1% |
Atelectasis | 1 | 1.1% |
Atherosclerosis | 1 | 1.1% |
Atrial septal defect | 1 | 1.1% |
Atrophic vaginitis | 1 | 1.1% |
Attention deficit hyperactivity disorder | 1 | 1.1% |
Attenuated vaccine | 1 | 1.1% |
Atypical pneumonias | 1 | 1.1% |
Augmented reality | 1 | 1.1% |
Autism spectrum | 1 | 1.1% |
Automation | 1 | 1.1% |
Bachelor of Medicine, Bachelor of Surgery | 1 | 1.1% |
Bacteriophage | 1 | 1.1% |
Barrett's esophagus | 1 | 1.1% |
Bayh–Dole Act | 1 | 1.1% |
Bedaquiline | 1 | 1.1% |
Benjamin List | 1 | 1.1% |
Bevacizumab | 1 | 1.1% |
Biobased economy | 1 | 1.1% |
Bioethics | 1 | 1.1% |
Biofuel | 1 | 1.1% |
Bioinformatics | 1 | 1.1% |
Biological globalization | 1 | 1.1% |
Biopharmaceutical | 1 | 1.1% |
Biosensor | 1 | 1.1% |
Biosimilar | 1 | 1.1% |
Birth control | 1 | 1.1% |
Birth defect | 1 | 1.1% |
Birth weight | 1 | 1.1% |
Bisphosphonate | 1 | 1.1% |
Blastoma | 1 | 1.1% |
Blinded experiment | 1 | 1.1% |
Blockchain | 1 | 1.1% |
Blood | 1 | 1.1% |
Blood pressure | 1 | 1.1% |
Blood sugar level | 1 | 1.1% |
Body fluids | 1 | 1.1% |
Body mass index | 1 | 1.1% |
Bone | 1 | 1.1% |
Bone density | 1 | 1.1% |
Bone resorption | 1 | 1.1% |
Booster dose | 1 | 1.1% |
Bortezomib | 1 | 1.1% |
Brain | 1 | 1.1% |
Brain–computer interface | 1 | 1.1% |
Breast milk | 1 | 1.1% |
Breathing | 1 | 1.1% |
Brentuximab vedotin | 1 | 1.1% |
Bundled payment | 1 | 1.1% |
COVID-19 misinformation | 1 | 1.1% |
COVID-19 pandemic in France | 1 | 1.1% |
Canakinumab | 1 | 1.1% |
Cancer registry | 1 | 1.1% |
Cancer research | 1 | 1.1% |
Cancer staging | 1 | 1.1% |
Cancer treatments | 1 | 1.1% |
Capacity building | 1 | 1.1% |
Car | 1 | 1.1% |
Carbon neutrality | 1 | 1.1% |
Cardiac amyloidosis | 1 | 1.1% |
Cardiac catheterization | 1 | 1.1% |
Cardiac muscle | 1 | 1.1% |
Cardiothoracic surgery | 1 | 1.1% |
Cardiovascular system | 1 | 1.1% |
Carfilzomib | 1 | 1.1% |
Cas12a | 1 | 1.1% |
Cataplexy | 1 | 1.1% |
Cataract | 1 | 1.1% |
Cattle | 1 | 1.1% |
Causality | 1 | 1.1% |
Cefiderocol | 1 | 1.1% |
Cell (biology) | 1 | 1.1% |
Cerebral cortex | 1 | 1.1% |
Certified Nurse‐Midwife | 1 | 1.1% |
Checkpoint inhibitor | 1 | 1.1% |
Chemistry | 1 | 1.1% |
Chickenpox | 1 | 1.1% |
Chikungunya | 1 | 1.1% |
Child | 1 | 1.1% |
Child development | 1 | 1.1% |
Childhood | 1 | 1.1% |
Childhood obesity | 1 | 1.1% |
Chimeric antigen receptor T cell | 1 | 1.1% |
Chloroplast | 1 | 1.1% |
Chronic lymphocytic leukemia | 1 | 1.1% |
Circulating tumor DNA | 1 | 1.1% |
Circulatory system | 1 | 1.1% |
Climate change | 1 | 1.1% |
Clinic | 1 | 1.1% |
Cloth face mask | 1 | 1.1% |
Cochrane Library | 1 | 1.1% |
Cogeneration | 1 | 1.1% |
Cognitive behavioral therapy | 1 | 1.1% |
Cognitive bias | 1 | 1.1% |
Cognitive science | 1 | 1.1% |
Communication | 1 | 1.1% |
Community | 1 | 1.1% |
Competence (human resources) | 1 | 1.1% |
Computational chemistry | 1 | 1.1% |
Computed tomography angiography | 1 | 1.1% |
Computer | 1 | 1.1% |
Computer network | 1 | 1.1% |
Computer science | 1 | 1.1% |
Computer-aided diagnosis | 1 | 1.1% |
Condom | 1 | 1.1% |
Confounding | 1 | 1.1% |
Congenital heart defect | 1 | 1.1% |
Congenital pulmonary airway malformation | 1 | 1.1% |
Conspiracy theory | 1 | 1.1% |
Continuous positive airway pressure | 1 | 1.1% |
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine | 1 | 1.1% |
Convulsion | 1 | 1.1% |
Coronavirus-associated diseases | 1 | 1.1% |
Corporate social responsibility | 1 | 1.1% |
Corps | 1 | 1.1% |
Cost–benefit analysis | 1 | 1.1% |
Cost–utility analysis | 1 | 1.1% |
Cough | 1 | 1.1% |
Credential | 1 | 1.1% |
Crisis | 1 | 1.1% |
Crisis management | 1 | 1.1% |
Crowdsourcing | 1 | 1.1% |
Current Procedural Terminology | 1 | 1.1% |
Cushing's disease | 1 | 1.1% |
Cyclophosphamide | 1 | 1.1% |
DICOM | 1 | 1.1% |
DNA repair | 1 | 1.1% |
DPT vaccine | 1 | 1.1% |
Dairy cattle | 1 | 1.1% |
Daratumumab | 1 | 1.1% |
Dasatinib | 1 | 1.1% |
Data mining | 1 | 1.1% |
Deep brain stimulation | 1 | 1.1% |
Deep vein thrombosis | 1 | 1.1% |
Deepfake | 1 | 1.1% |
Deferasirox | 1 | 1.1% |
Deferiprone | 1 | 1.1% |
Dementia | 1 | 1.1% |
Demographic and Health Surveys | 1 | 1.1% |
Dengue fever | 1 | 1.1% |
Denosumab | 1 | 1.1% |
Dentistry | 1 | 1.1% |
Dermatology | 1 | 1.1% |
Determinants of health | 1 | 1.1% |
Developing country | 1 | 1.1% |
Dexamethasone | 1 | 1.1% |
Diabetic retinopathy | 1 | 1.1% |
Diagnosis of HIV/AIDS | 1 | 1.1% |
Diet (nutrition) | 1 | 1.1% |
Dietary supplement | 1 | 1.1% |
Dieting | 1 | 1.1% |
Difference in differences | 1 | 1.1% |
Diffuse large B-cell lymphoma | 1 | 1.1% |
Digital divide | 1 | 1.1% |
Digital electronics | 1 | 1.1% |
Digital library | 1 | 1.1% |
Dignity | 1 | 1.1% |
Disability | 1 | 1.1% |
Disasters | 1 | 1.1% |
Disease burden | 1 | 1.1% |
Disease outbreak | 1 | 1.1% |
Disease outbreaks | 1 | 1.1% |
Disinformation | 1 | 1.1% |
Docking (molecular) | 1 | 1.1% |
Doctor of Philosophy | 1 | 1.1% |
Doctor–patient relationship | 1 | 1.1% |
Dog | 1 | 1.1% |
Dosimetry | 1 | 1.1% |
Dravet syndrome | 1 | 1.1% |
Drug design | 1 | 1.1% |
Drug development | 1 | 1.1% |
Drug discovery | 1 | 1.1% |
Drug overdose | 1 | 1.1% |
Drug withdrawal | 1 | 1.1% |
Drug-induced QT prolongation | 1 | 1.1% |
Dual-energy X-ray absorptiometry | 1 | 1.1% |
Dyspareunia | 1 | 1.1% |
ECTS grading scale | 1 | 1.1% |
EQ-5D | 1 | 1.1% |
Ebola | 1 | 1.1% |
Echinocandin | 1 | 1.1% |
Echo chamber (media) | 1 | 1.1% |
Echocardiography | 1 | 1.1% |
Economics | 1 | 1.1% |
Economy | 1 | 1.1% |
Ecosystem | 1 | 1.1% |
Electric vehicle | 1 | 1.1% |
Electrocardiography | 1 | 1.1% |
Electroconvulsive therapy | 1 | 1.1% |
Electrocorticography | 1 | 1.1% |
Electroencephalography | 1 | 1.1% |
Electronic cigarette | 1 | 1.1% |
Electrophysiology | 1 | 1.1% |
Embryonic stem cell | 1 | 1.1% |
Emergency medicine | 1 | 1.1% |
Emerging technologies | 1 | 1.1% |
Emphysema | 1 | 1.1% |
Empowerment | 1 | 1.1% |
End-of-life care | 1 | 1.1% |
Endoscopy | 1 | 1.1% |
Energy development | 1 | 1.1% |
Engineer | 1 | 1.1% |
Enterovirus-associated diseases | 1 | 1.1% |
Entrepreneurship | 1 | 1.1% |
Epidemic | 1 | 1.1% |
Epidemics | 1 | 1.1% |
Epidemiology of HIV/AIDS | 1 | 1.1% |
Epilepsy | 1 | 1.1% |
Eradication of infectious diseases | 1 | 1.1% |
Erlotinib | 1 | 1.1% |
Esophageal cancer | 1 | 1.1% |
Esophagus | 1 | 1.1% |
Estradiol (medication) | 1 | 1.1% |
Ethology | 1 | 1.1% |
Eugenics | 1 | 1.1% |
Europe | 1 | 1.1% |
European Patent Convention | 1 | 1.1% |
Everolimus | 1 | 1.1% |
Excessive daytime sleepiness | 1 | 1.1% |
Exoplanet | 1 | 1.1% |
Expanded Program on Immunization | 1 | 1.1% |
Familial hypercholesterolemia | 1 | 1.1% |
Fat | 1 | 1.1% |
Fatigue | 1 | 1.1% |
Fatty liver disease | 1 | 1.1% |
Feminism | 1 | 1.1% |
Financial crisis of 2007–2008 | 1 | 1.1% |
Flooring | 1 | 1.1% |
Food choice | 1 | 1.1% |
Food marketing | 1 | 1.1% |
Food system | 1 | 1.1% |
Forecasting | 1 | 1.1% |
Frailty syndrome | 1 | 1.1% |
Functional magnetic resonance imaging | 1 | 1.1% |
Functional near-infrared spectroscopy | 1 | 1.1% |
Futures studies | 1 | 1.1% |
GISAID | 1 | 1.1% |
Gait analysis | 1 | 1.1% |
Gastroesophageal reflux disease | 1 | 1.1% |
Gene expression | 1 | 1.1% |
GeneXpert MTB/RIF | 1 | 1.1% |
General practice | 1 | 1.1% |
Generic drug | 1 | 1.1% |
Genetic code | 1 | 1.1% |
Genetic disorder | 1 | 1.1% |
Genetic testing | 1 | 1.1% |
Genetically modified organism | 1 | 1.1% |
Genome-wide association study | 1 | 1.1% |
Geographic information system | 1 | 1.1% |
Geriatrics | 1 | 1.1% |
Germline | 1 | 1.1% |
Global Influenza Surveillance and Response System | 1 | 1.1% |
Global health | 1 | 1.1% |
Glomerular filtration rate | 1 | 1.1% |
Glycogen storage disease type II | 1 | 1.1% |
Goal | 1 | 1.1% |
Goldwater–Nichols Act | 1 | 1.1% |
Gout | 1 | 1.1% |
Green building | 1 | 1.1% |
Guide RNA | 1 | 1.1% |
Gynaecologic disorders | 1 | 1.1% |
HER2/neu | 1 | 1.1% |
HERG | 1 | 1.1% |
HIV-positive people | 1 | 1.1% |
Hans Kluge | 1 | 1.1% |
Haptic technology | 1 | 1.1% |
Hartree–Fock method | 1 | 1.1% |
Hazard ratio | 1 | 1.1% |
He Jiankui | 1 | 1.1% |
Health Information Technology for Economic and Clinical Health Act | 1 | 1.1% |
Health care in France | 1 | 1.1% |
Health care management | 1 | 1.1% |
Health care quality | 1 | 1.1% |
Health disasters | 1 | 1.1% |
Health in All Policies | 1 | 1.1% |
Health insurance in the United States | 1 | 1.1% |
Health law | 1 | 1.1% |
Helicobacter pylori | 1 | 1.1% |
Hematology | 1 | 1.1% |
Hemophagocytic lymphohistiocytosis | 1 | 1.1% |
Hemosiderosis | 1 | 1.1% |
Hepatitis C | 1 | 1.1% |
Herbivore | 1 | 1.1% |
Hierarchy of evidence | 1 | 1.1% |
Hip fracture | 1 | 1.1% |
Hip replacement | 1 | 1.1% |
Hives | 1 | 1.1% |
Human development | 1 | 1.1% |
Human gender and sexuality | 1 | 1.1% |
Human germline engineering | 1 | 1.1% |
Human microbiome | 1 | 1.1% |
Human resource management | 1 | 1.1% |
Hydrops fetalis | 1 | 1.1% |
Hydroxychloroquine | 1 | 1.1% |
Hypersomnia | 1 | 1.1% |
Hypoglycemia | 1 | 1.1% |
Hypopnea | 1 | 1.1% |
Hypoxia (medical) | 1 | 1.1% |
Ibandronic acid | 1 | 1.1% |
Ibrutinib | 1 | 1.1% |
Idiopathic hypersomnia | 1 | 1.1% |
Imaging biomarker | 1 | 1.1% |
Immigration | 1 | 1.1% |
Immune system | 1 | 1.1% |
Immunosuppressive drug | 1 | 1.1% |
Impact evaluation | 1 | 1.1% |
Improving Access to Psychological Therapies | 1 | 1.1% |
In vitro fertilisation | 1 | 1.1% |
Incentive | 1 | 1.1% |
Indication (medicine) | 1 | 1.1% |
Industrial espionage | 1 | 1.1% |
Industrial policy | 1 | 1.1% |
Infant mortality | 1 | 1.1% |
Inferior vena cava filter | 1 | 1.1% |
Influenza A virus subtype H1N1 | 1 | 1.1% |
Influenza A virus subtype H7N9 | 1 | 1.1% |
Influenza vaccine | 1 | 1.1% |
Influenza-like illness | 1 | 1.1% |
Infodemic | 1 | 1.1% |
Information governance | 1 | 1.1% |
Information system | 1 | 1.1% |
Insect | 1 | 1.1% |
Insomnia | 1 | 1.1% |
Insulin | 1 | 1.1% |
Intellectual property | 1 | 1.1% |
International law | 1 | 1.1% |
Internet | 1 | 1.1% |
Interventional radiology | 1 | 1.1% |
Intrauterine growth restriction | 1 | 1.1% |
Intravenous therapy | 1 | 1.1% |
Ionizing radiation | 1 | 1.1% |
Iron overload | 1 | 1.1% |
Jennifer Doudna | 1 | 1.1% |
Jože Plečnik | 1 | 1.1% |
Juvenile idiopathic arthritis | 1 | 1.1% |
Kangaroo care | 1 | 1.1% |
Knee replacement | 1 | 1.1% |
Lab-on-a-chip | 1 | 1.1% |
Latent tuberculosis | 1 | 1.1% |
Law | 1 | 1.1% |
Law of Canada | 1 | 1.1% |
Lenalidomide | 1 | 1.1% |
Lennox–Gastaut syndrome | 1 | 1.1% |
Levofloxacin | 1 | 1.1% |
License | 1 | 1.1% |
Licensure | 1 | 1.1% |
Life | 1 | 1.1% |
Life-cycle assessment | 1 | 1.1% |
Light-water reactor | 1 | 1.1% |
Lipid disorders | 1 | 1.1% |
Lipids | 1 | 1.1% |
Lisinopril | 1 | 1.1% |
Liver | 1 | 1.1% |
Liver disease | 1 | 1.1% |
Liver function tests | 1 | 1.1% |
Ljubljana | 1 | 1.1% |
Long QT syndrome | 1 | 1.1% |
Long-term effects of alcohol | 1 | 1.1% |
Low birth weight | 1 | 1.1% |
Low-carbon economy | 1 | 1.1% |
Low-molecular-weight heparin | 1 | 1.1% |
Lung | 1 | 1.1% |
Lupus | 1 | 1.1% |
Lysosome | 1 | 1.1% |
László Lovász | 1 | 1.1% |
Maghreb | 1 | 1.1% |
Magnetic resonance imaging | 1 | 1.1% |
Magnetoencephalography | 1 | 1.1% |
Male genital disorders | 1 | 1.1% |
Malnutrition | 1 | 1.1% |
Management | 1 | 1.1% |
Mandibular advancement splint | 1 | 1.1% |
Maternal death | 1 | 1.1% |
Mechanical ventilation | 1 | 1.1% |
Mechanics | 1 | 1.1% |
Media (communication) | 1 | 1.1% |
Medical assistant | 1 | 1.1% |
Medical home | 1 | 1.1% |
Medical license | 1 | 1.1% |
Medical record | 1 | 1.1% |
Medical research | 1 | 1.1% |
Medical school | 1 | 1.1% |
Medical ultrasound | 1 | 1.1% |
Medicinal chemistry | 1 | 1.1% |
Medium-chain acyl-coenzyme A dehydrogenase deficiency | 1 | 1.1% |
Membrane-active molecules | 1 | 1.1% |
Menopause | 1 | 1.1% |
Mental states | 1 | 1.1% |
Metabolic disorders | 1 | 1.1% |
Metabolism | 1 | 1.1% |
Methylnaltrexone | 1 | 1.1% |
Methylphenidate | 1 | 1.1% |
Microplastics | 1 | 1.1% |
Migraine | 1 | 1.1% |
Minimally invasive procedure | 1 | 1.1% |
Mitochondrial DNA | 1 | 1.1% |
Mobile device | 1 | 1.1% |
Mobile phone | 1 | 1.1% |
Modafinil | 1 | 1.1% |
Molecule | 1 | 1.1% |
Money | 1 | 1.1% |
Monitoring (medicine) | 1 | 1.1% |
Mosquito-borne disease | 1 | 1.1% |
Motherhood | 1 | 1.1% |
Multilateralism | 1 | 1.1% |
Mycobacteria | 1 | 1.1% |
Mycoplasma | 1 | 1.1% |
Myelodysplastic syndrome | 1 | 1.1% |
Myocardial infarction | 1 | 1.1% |
Naldemedine | 1 | 1.1% |
Narcolepsy | 1 | 1.1% |
National Health Interview Survey | 1 | 1.1% |
National TB Elimination Program (India) | 1 | 1.1% |
Natural language processing | 1 | 1.1% |
Neonatal hypoglycemia | 1 | 1.1% |
Neonatology | 1 | 1.1% |
Neuroendocrine tumor | 1 | 1.1% |
Neurological disorder | 1 | 1.1% |
Neuromarketing | 1 | 1.1% |
Neuroprosthetics | 1 | 1.1% |
Neuroscience | 1 | 1.1% |
Neurosurgery | 1 | 1.1% |
Neurotechnology | 1 | 1.1% |
News | 1 | 1.1% |
Nilotinib | 1 | 1.1% |
Niraparib | 1 | 1.1% |
Nobel Prize in Chemistry | 1 | 1.1% |
Nuclear medicine | 1 | 1.1% |
Nuclear pharmacy | 1 | 1.1% |
Nuclear power | 1 | 1.1% |
Nuclear proliferation | 1 | 1.1% |
Nuclear reactor | 1 | 1.1% |
Nucleic acid | 1 | 1.1% |
Nucleic acid thermodynamics | 1 | 1.1% |
Nudge theory | 1 | 1.1% |
Null hypothesis | 1 | 1.1% |
Nurse practitioner | 1 | 1.1% |
Nursing in the United Kingdom | 1 | 1.1% |
Nutrition | 1 | 1.1% |
Obesity and the environment | 1 | 1.1% |
Obeticholic acid | 1 | 1.1% |
Obstetrics | 1 | 1.1% |
Obstructive sleep apnea | 1 | 1.1% |
Octreotide | 1 | 1.1% |
Odor | 1 | 1.1% |
Off-target genome editing | 1 | 1.1% |
Olaparib | 1 | 1.1% |
Olfaction | 1 | 1.1% |
Olive oil | 1 | 1.1% |
Omacetaxine mepesuccinate | 1 | 1.1% |
Omalizumab | 1 | 1.1% |
Onboarding | 1 | 1.1% |
Ongoing events | 1 | 1.1% |
Online community | 1 | 1.1% |
Operationalization | 1 | 1.1% |
Opioid | 1 | 1.1% |
Oregon Health Plan | 1 | 1.1% |
Organ donation | 1 | 1.1% |
Organic farming | 1 | 1.1% |
Organism | 1 | 1.1% |
Organocatalysis | 1 | 1.1% |
Organoid | 1 | 1.1% |
Orphan drug | 1 | 1.1% |
Orthomyxoviridae | 1 | 1.1% |
Osilodrostat | 1 | 1.1% |
Ospemifene | 1 | 1.1% |
Outcomes research | 1 | 1.1% |
PD-1 and PD-L1 inhibitors | 1 | 1.1% |
PD-L1 | 1 | 1.1% |
Palbociclib | 1 | 1.1% |
Pandemics | 1 | 1.1% |
Parkinson's disease | 1 | 1.1% |
Patient safety organization | 1 | 1.1% |
Patient-centered outcomes | 1 | 1.1% |
Peer review | 1 | 1.1% |
Periodic limb movement disorder | 1 | 1.1% |
Personal data | 1 | 1.1% |
Pertuzumab | 1 | 1.1% |
Pest (organism) | 1 | 1.1% |
Phage therapy | 1 | 1.1% |
Pharmacodynamics | 1 | 1.1% |
Pharmacogenomics | 1 | 1.1% |
Physical and logical qubits | 1 | 1.1% |
Physical sciences | 1 | 1.1% |
Physics | 1 | 1.1% |
Physiology | 1 | 1.1% |
Picture archiving and communication system | 1 | 1.1% |
Pitolisant | 1 | 1.1% |
Placebo-controlled study | 1 | 1.1% |
Plant | 1 | 1.1% |
Plant breeding | 1 | 1.1% |
Pleural effusion | 1 | 1.1% |
Point-of-care testing | 1 | 1.1% |
Polio | 1 | 1.1% |
Polio eradication | 1 | 1.1% |
Polio vaccine | 1 | 1.1% |
Poliovirus | 1 | 1.1% |
Politics | 1 | 1.1% |
Positron emission tomography | 1 | 1.1% |
Post-exposure prophylaxis | 1 | 1.1% |
Precision agriculture | 1 | 1.1% |
Prediabetes | 1 | 1.1% |
Preferred Reporting Items for Systematic Reviews and Meta-Analyses | 1 | 1.1% |
Pressure ulcer | 1 | 1.1% |
Pretomanid | 1 | 1.1% |
Prevention of HIV/AIDS | 1 | 1.1% |
Preventive medicine | 1 | 1.1% |
Price | 1 | 1.1% |
Primary biliary cholangitis | 1 | 1.1% |
Primary sclerosing cholangitis | 1 | 1.1% |
Probability | 1 | 1.1% |
Problem solving | 1 | 1.1% |
Profession | 1 | 1.1% |
Professionalization | 1 | 1.1% |
Programmer | 1 | 1.1% |
Progressive familial intrahepatic cholestasis | 1 | 1.1% |
Propensity score matching | 1 | 1.1% |
Propfan | 1 | 1.1% |
Prosthesis | 1 | 1.1% |
Protected health information | 1 | 1.1% |
Protein folding | 1 | 1.1% |
Provinces and territories of Canada | 1 | 1.1% |
Psychiatric and mental health nursing | 1 | 1.1% |
Public health surveillance | 1 | 1.1% |
Pulmonary fibrosis | 1 | 1.1% |
Pulmonary sequestration | 1 | 1.1% |
QT interval | 1 | 1.1% |
Quality of life (healthcare) | 1 | 1.1% |
Quantitative research | 1 | 1.1% |
Quantum algorithm | 1 | 1.1% |
Quantum annealing | 1 | 1.1% |
Quantum chemistry | 1 | 1.1% |
Quantum computing | 1 | 1.1% |
Quantum entanglement | 1 | 1.1% |
Quantum error correction | 1 | 1.1% |
Quantum machine learning | 1 | 1.1% |
Quantum mechanics | 1 | 1.1% |
Quantum memory | 1 | 1.1% |
Quantum simulator | 1 | 1.1% |
Quantum superposition | 1 | 1.1% |
Quantum supremacy | 1 | 1.1% |
Quarantine | 1 | 1.1% |
Qubit | 1 | 1.1% |
RNA | 1 | 1.1% |
Rabies | 1 | 1.1% |
Rabies vaccine | 1 | 1.1% |
Rabies virus | 1 | 1.1% |
Race (human categorization) | 1 | 1.1% |
Radiation protection | 1 | 1.1% |
Radiobiology | 1 | 1.1% |
Radiographer | 1 | 1.1% |
Radionuclide | 1 | 1.1% |
Radiopharmaceutical | 1 | 1.1% |
Radiosurgery | 1 | 1.1% |
Raloxifene | 1 | 1.1% |
Rare disease | 1 | 1.1% |
Real world evidence | 1 | 1.1% |
Receiver operating characteristic | 1 | 1.1% |
Record linkage | 1 | 1.1% |
Recovery model | 1 | 1.1% |
Redlining | 1 | 1.1% |
Refrigerator | 1 | 1.1% |
Refugee children | 1 | 1.1% |
Regional policy of the European Union | 1 | 1.1% |
Regulatory T cell | 1 | 1.1% |
Regulatory compliance | 1 | 1.1% |
Reinforcement learning | 1 | 1.1% |
Relative risk | 1 | 1.1% |
Remote work | 1 | 1.1% |
Renewable energy | 1 | 1.1% |
Research and development | 1 | 1.1% |
Response rate (survey) | 1 | 1.1% |
Retina | 1 | 1.1% |
Retinopathy | 1 | 1.1% |
Ribociclib | 1 | 1.1% |
Rifapentine | 1 | 1.1% |
Rivaroxaban | 1 | 1.1% |
Robotics | 1 | 1.1% |
Romosozumab | 1 | 1.1% |
Rubella | 1 | 1.1% |
SARS-CoV-2 | 1 | 1.1% |
SOFA score | 1 | 1.1% |
Safe sex | 1 | 1.1% |
Sampling (statistics) | 1 | 1.1% |
Sarcoma | 1 | 1.1% |
Satellite | 1 | 1.1% |
Schengen Area | 1 | 1.1% |
Science, technology, engineering, and mathematics | 1 | 1.1% |
Scientometrics | 1 | 1.1% |
Scintigraphy | 1 | 1.1% |
Sclerostin | 1 | 1.1% |
Seizure | 1 | 1.1% |
Septic shock | 1 | 1.1% |
Sequence motif | 1 | 1.1% |
Serum free light-chain measurement | 1 | 1.1% |
Sexual health | 1 | 1.1% |
Sexual intercourse | 1 | 1.1% |
Sleep | 1 | 1.1% |
Sleep apnea | 1 | 1.1% |
Sleep disorder | 1 | 1.1% |
Sláintecare | 1 | 1.1% |
Small Business Innovation Research | 1 | 1.1% |
Small modular reactor | 1 | 1.1% |
Social exclusion | 1 | 1.1% |
Social policy | 1 | 1.1% |
Societal collapse | 1 | 1.1% |
Socioeconomic status | 1 | 1.1% |
Space weather | 1 | 1.1% |
Spastic cerebral palsy | 1 | 1.1% |
Spectroscopy | 1 | 1.1% |
Spinal fusion | 1 | 1.1% |
Spinal muscular atrophy | 1 | 1.1% |
Spirometry | 1 | 1.1% |
Standardization | 1 | 1.1% |
Stargardt disease | 1 | 1.1% |
Stimulant | 1 | 1.1% |
Strategic planning | 1 | 1.1% |
Strategy | 1 | 1.1% |
Streptococcus pneumoniae | 1 | 1.1% |
Strontium ranelate | 1 | 1.1% |
Study heterogeneity | 1 | 1.1% |
Subcutaneous injection | 1 | 1.1% |
Subsidy | 1 | 1.1% |
Sudden unexpected death in epilepsy | 1 | 1.1% |
Supercritical water reactor | 1 | 1.1% |
Superficial thrombophlebitis | 1 | 1.1% |
Superficial vein thrombosis | 1 | 1.1% |
Supply chain | 1 | 1.1% |
Surgical mask | 1 | 1.1% |
Surrogacy | 1 | 1.1% |
Sustainable Development Goal 3 | 1 | 1.1% |
Sustainable development | 1 | 1.1% |
Syphilis | 1 | 1.1% |
System | 1 | 1.1% |
Systemic inflammatory response syndrome | 1 | 1.1% |
T cell | 1 | 1.1% |
Tafamidis | 1 | 1.1% |
Tank | 1 | 1.1% |
Technetium-99m | 1 | 1.1% |
Telepharmacy | 1 | 1.1% |
Telepsychiatry | 1 | 1.1% |
Teleradiology | 1 | 1.1% |
Telmisartan | 1 | 1.1% |
Temporary Assistance for Needy Families | 1 | 1.1% |
Teriparatide | 1 | 1.1% |
Tetanus vaccine | 1 | 1.1% |
The New England Journal of Medicine | 1 | 1.1% |
Theoretical physics | 1 | 1.1% |
Thermosphere | 1 | 1.1% |
Thoracic diaphragm | 1 | 1.1% |
Thrombophilia | 1 | 1.1% |
Thrombosis prevention | 1 | 1.1% |
Tissues (biology) | 1 | 1.1% |
Tobacco control | 1 | 1.1% |
Tocilizumab | 1 | 1.1% |
Torsades de pointes | 1 | 1.1% |
Training | 1 | 1.1% |
Transcranial direct-current stimulation | 1 | 1.1% |
Transcranial magnetic stimulation | 1 | 1.1% |
Transcription (biology) | 1 | 1.1% |
Transcription activator-like effector nuclease | 1 | 1.1% |
Transcutaneous electrical nerve stimulation | 1 | 1.1% |
Transfection | 1 | 1.1% |
Transthyretin | 1 | 1.1% |
Trapped ion quantum computer | 1 | 1.1% |
Trastuzumab | 1 | 1.1% |
Traumatic brain injury | 1 | 1.1% |
Treatment and management of COVID-19 | 1 | 1.1% |
Treatment of cancer | 1 | 1.1% |
Treaty | 1 | 1.1% |
Treaty on the Non-Proliferation of Nuclear Weapons | 1 | 1.1% |
Truenat | 1 | 1.1% |
Trust (social science) | 1 | 1.1% |
Tuberculosis diagnosis | 1 | 1.1% |
Tyrosine kinase | 1 | 1.1% |
Ultracold atom | 1 | 1.1% |
Universal health care | 1 | 1.1% |
Ursodeoxycholic acid | 1 | 1.1% |
Vaccine adverse event | 1 | 1.1% |
Vaccine hesitancy | 1 | 1.1% |
Valproate | 1 | 1.1% |
Vein | 1 | 1.1% |
Venous thrombosis | 1 | 1.1% |
Venture capital | 1 | 1.1% |
Vertically transmitted infection | 1 | 1.1% |
Veteran | 1 | 1.1% |
Vienna Convention on the Law of Treaties | 1 | 1.1% |
Viral infections of the central nervous system | 1 | 1.1% |
Virology | 1 | 1.1% |
Visual impairment | 1 | 1.1% |
Warfarin | 1 | 1.1% |
Watson (computer) | 1 | 1.1% |
Wave function collapse | 1 | 1.1% |
Weakness | 1 | 1.1% |
Wearable computer | 1 | 1.1% |
Weight loss | 1 | 1.1% |
Western African Ebola virus epidemic | 1 | 1.1% |
Whole genome sequencing | 1 | 1.1% |
Xenobiology | 1 | 1.1% |
Zero-energy building | 1 | 1.1% |
Zika fever | 1 | 1.1% |
Zinc finger nuclease | 1 | 1.1% |
Zoledronic acid | 1 | 1.1% |
abs | rel | |
---|---|---|
Health | 10 | 90.9% |
Health sciences | 9 | 81.8% |
Medicine | 9 | 81.8% |
Health care | 8 | 72.7% |
Clinical medicine | 5 | 45.5% |
Medical specialties | 5 | 45.5% |
Health policy | 4 | 36.4% |
Medicare (United States) | 4 | 36.4% |
Risk | 4 | 36.4% |
Disease | 3 | 27.3% |
Diseases and disorders | 3 | 27.3% |
Health economics | 3 | 27.3% |
Hospital | 3 | 27.3% |
Adverse effect | 2 | 18.2% |
Affordable Care Act | 2 | 18.2% |
Andrea Palm | 2 | 18.2% |
COVID-19 | 2 | 18.2% |
COVID-19 pandemic | 2 | 18.2% |
Cancer | 2 | 18.2% |
Cardiovascular disease | 2 | 18.2% |
Caregiver | 2 | 18.2% |
Chronic condition | 2 | 18.2% |
Evidence-based medicine | 2 | 18.2% |
Government | 2 | 18.2% |
Health care in the United States | 2 | 18.2% |
Health equity | 2 | 18.2% |
Health insurance | 2 | 18.2% |
Human activities | 2 | 18.2% |
Insurance | 2 | 18.2% |
Medicaid | 2 | 18.2% |
Medicare Part D | 2 | 18.2% |
Medication | 2 | 18.2% |
Mental health | 2 | 18.2% |
Myocardial infarction | 2 | 18.2% |
Nursing | 2 | 18.2% |
Politics | 2 | 18.2% |
Pregnancy | 2 | 18.2% |
Preterm birth | 2 | 18.2% |
Preventive healthcare | 2 | 18.2% |
Psychotherapy | 2 | 18.2% |
Public health insurance option | 2 | 18.2% |
Public services | 2 | 18.2% |
Services sector of the economy | 2 | 18.2% |
Social programs | 2 | 18.2% |
Surgery | 2 | 18.2% |
Technology | 2 | 18.2% |
Telehealth | 2 | 18.2% |
Trump administration family separation policy | 2 | 18.2% |
3D computer graphics | 1 | 9.1% |
3D printing | 1 | 9.1% |
3D printing processes | 1 | 9.1% |
3D scanning | 1 | 9.1% |
Aboriginal Australians | 1 | 9.1% |
Abortion | 1 | 9.1% |
Accountable care organization | 1 | 9.1% |
Aciclovir | 1 | 9.1% |
Acute coronary syndrome | 1 | 9.1% |
Adherence (medicine) | 1 | 9.1% |
Ageing | 1 | 9.1% |
Alpha-Linolenic acid | 1 | 9.1% |
Anatomical terms of motion | 1 | 9.1% |
Angiology | 1 | 9.1% |
Attention | 1 | 9.1% |
Audit | 1 | 9.1% |
Audit committee | 1 | 9.1% |
Augmented reality | 1 | 9.1% |
Australians | 1 | 9.1% |
Bacterial vaginosis | 1 | 9.1% |
Bevacizumab | 1 | 9.1% |
Birth control | 1 | 9.1% |
Birth weight | 1 | 9.1% |
Blood pressure | 1 | 9.1% |
Brain–computer interface | 1 | 9.1% |
Breastfeeding | 1 | 9.1% |
C-reactive protein | 1 | 9.1% |
CAD/CAM dentistry | 1 | 9.1% |
CT scan | 1 | 9.1% |
Caesarean section | 1 | 9.1% |
Cancer immunotherapy | 1 | 9.1% |
Cardiology | 1 | 9.1% |
Cardiovascular system | 1 | 9.1% |
Census in Australia | 1 | 9.1% |
Ceritinib | 1 | 9.1% |
Cervical cancer | 1 | 9.1% |
Cervical screening | 1 | 9.1% |
Chancroid | 1 | 9.1% |
Chemotherapy | 1 | 9.1% |
Childbirth | 1 | 9.1% |
Chlamydia infection | 1 | 9.1% |
Cholesterol | 1 | 9.1% |
Clinical commissioning group | 1 | 9.1% |
Clinical psychology | 1 | 9.1% |
Clinical trial | 1 | 9.1% |
Cognition | 1 | 9.1% |
Cognitive science | 1 | 9.1% |
Combined oral contraceptive pill | 1 | 9.1% |
Condom | 1 | 9.1% |
Contrast (vision) | 1 | 9.1% |
Coronary artery disease | 1 | 9.1% |
Crizotinib | 1 | 9.1% |
DICOM | 1 | 9.1% |
Decision-making | 1 | 9.1% |
Dementia | 1 | 9.1% |
Dental implant | 1 | 9.1% |
Dentistry | 1 | 9.1% |
Diabetes | 1 | 9.1% |
Diabetic retinopathy | 1 | 9.1% |
Diagnosis of HIV/AIDS | 1 | 9.1% |
Dietary supplement | 1 | 9.1% |
Disability | 1 | 9.1% |
Docetaxel | 1 | 9.1% |
Docosahexaenoic acid | 1 | 9.1% |
Domestic violence | 1 | 9.1% |
Dose (biochemistry) | 1 | 9.1% |
Driving | 1 | 9.1% |
Echocardiography | 1 | 9.1% |
Economics of service industries | 1 | 9.1% |
Efavirenz | 1 | 9.1% |
Eicosanoid | 1 | 9.1% |
Eicosapentaenoic acid | 1 | 9.1% |
Emergency contraception | 1 | 9.1% |
Epidemiology | 1 | 9.1% |
Epidermal growth factor receptor | 1 | 9.1% |
Erlotinib | 1 | 9.1% |
Essential fatty acid | 1 | 9.1% |
Ethics | 1 | 9.1% |
Evaluation | 1 | 9.1% |
Executive functions | 1 | 9.1% |
Family planning | 1 | 9.1% |
Fat | 1 | 9.1% |
Fee-for-service | 1 | 9.1% |
Female condom | 1 | 9.1% |
Fertility | 1 | 9.1% |
Fish oil | 1 | 9.1% |
Food | 1 | 9.1% |
Fused filament fabrication | 1 | 9.1% |
General practitioner | 1 | 9.1% |
Genital herpes | 1 | 9.1% |
Genital wart | 1 | 9.1% |
Gonorrhea | 1 | 9.1% |
Group A streptococcal infection | 1 | 9.1% |
HIV | 1 | 9.1% |
HIV and pregnancy | 1 | 9.1% |
HIV/AIDS | 1 | 9.1% |
Hazard ratio | 1 | 9.1% |
Healthcare | 1 | 9.1% |
Hearing aid | 1 | 9.1% |
Heart | 1 | 9.1% |
Heart arrhythmia | 1 | 9.1% |
Herpes simplex | 1 | 9.1% |
High-density lipoprotein | 1 | 9.1% |
Hormonal contraception | 1 | 9.1% |
Hospital readmission | 1 | 9.1% |
Human | 1 | 9.1% |
Human enhancement | 1 | 9.1% |
Human papillomavirus infection | 1 | 9.1% |
Human reproduction | 1 | 9.1% |
Human sexual activity | 1 | 9.1% |
Human sexuality | 1 | 9.1% |
Hyperlipidemia | 1 | 9.1% |
Hypertension | 1 | 9.1% |
Immersion (virtual reality) | 1 | 9.1% |
Indigenous Australians | 1 | 9.1% |
Infection | 1 | 9.1% |
Infection prevention and control | 1 | 9.1% |
Infectious diseases | 1 | 9.1% |
Infertility | 1 | 9.1% |
Internal audit | 1 | 9.1% |
International humanitarian law | 1 | 9.1% |
Intrauterine device | 1 | 9.1% |
James Palmer (mayor) | 1 | 9.1% |
Lamivudine | 1 | 9.1% |
Lipids | 1 | 9.1% |
Low-density lipoprotein | 1 | 9.1% |
Lung cancer | 1 | 9.1% |
Lutein | 1 | 9.1% |
Magnetic resonance imaging | 1 | 9.1% |
Major depressive disorder | 1 | 9.1% |
Malaria | 1 | 9.1% |
Management | 1 | 9.1% |
Management of HIV/AIDS | 1 | 9.1% |
Maryland hospital payment system | 1 | 9.1% |
Maternal death | 1 | 9.1% |
Medical abortion | 1 | 9.1% |
Medical history | 1 | 9.1% |
Medical humanities | 1 | 9.1% |
Medical imaging | 1 | 9.1% |
Medical treatments | 1 | 9.1% |
Medroxyprogesterone acetate | 1 | 9.1% |
Memory | 1 | 9.1% |
Metastasis | 1 | 9.1% |
Mifepristone | 1 | 9.1% |
Miscarriage | 1 | 9.1% |
Misoprostol | 1 | 9.1% |
Motor skill | 1 | 9.1% |
NHS foundation trust | 1 | 9.1% |
Neoplasms | 1 | 9.1% |
Neuroenhancement | 1 | 9.1% |
Nevirapine | 1 | 9.1% |
Nivolumab | 1 | 9.1% |
Non-small-cell lung carcinoma | 1 | 9.1% |
Nutrient | 1 | 9.1% |
Nutrients | 1 | 9.1% |
Nutrition | 1 | 9.1% |
Obstetrics | 1 | 9.1% |
Occupational therapist | 1 | 9.1% |
Occupational therapy | 1 | 9.1% |
Old age | 1 | 9.1% |
Omega-3 acid ethyl esters | 1 | 9.1% |
Omega-3 fatty acid | 1 | 9.1% |
Organic compounds | 1 | 9.1% |
Osteoarthritis | 1 | 9.1% |
PD-L1 | 1 | 9.1% |
Pain | 1 | 9.1% |
Palpitations | 1 | 9.1% |
Patient | 1 | 9.1% |
Pelvic inflammatory disease | 1 | 9.1% |
Pembrolizumab | 1 | 9.1% |
Pemetrexed | 1 | 9.1% |
Perception | 1 | 9.1% |
Percutaneous coronary intervention | 1 | 9.1% |
Performance appraisal | 1 | 9.1% |
Peterborough | 1 | 9.1% |
Pharmacy | 1 | 9.1% |
Physical therapy | 1 | 9.1% |
Physician | 1 | 9.1% |
Postpartum period | 1 | 9.1% |
Powder bed and inkjet head 3D printing | 1 | 9.1% |
Prenatal development | 1 | 9.1% |
Privacy | 1 | 9.1% |
Problem solving | 1 | 9.1% |
Programmed cell death protein 1 | 1 | 9.1% |
Prosthesis | 1 | 9.1% |
Public health | 1 | 9.1% |
RTT | 1 | 9.1% |
Randomized controlled trial | 1 | 9.1% |
Rape | 1 | 9.1% |
Reperfusion therapy | 1 | 9.1% |
Reproductive health | 1 | 9.1% |
Rheumatic fever | 1 | 9.1% |
Robotics | 1 | 9.1% |
Safe sex | 1 | 9.1% |
Safety | 1 | 9.1% |
Screening (medicine) | 1 | 9.1% |
Selective laser sintering | 1 | 9.1% |
Sensitivity and specificity | 1 | 9.1% |
Service industries | 1 | 9.1% |
Sexual health | 1 | 9.1% |
Sexual intercourse | 1 | 9.1% |
Sexually transmitted infection | 1 | 9.1% |
Shortness of breath | 1 | 9.1% |
Simulation | 1 | 9.1% |
Sintering | 1 | 9.1% |
Snellen chart | 1 | 9.1% |
Solid | 1 | 9.1% |
Spermicide | 1 | 9.1% |
Stavudine | 1 | 9.1% |
Stereolithography | 1 | 9.1% |
Sterilization (medicine) | 1 | 9.1% |
Survey methodology | 1 | 9.1% |
Syncope (medicine) | 1 | 9.1% |
Syphilis | 1 | 9.1% |
Systematic review | 1 | 9.1% |
Test (assessment) | 1 | 9.1% |
Therapy | 1 | 9.1% |
Tissue engineering | 1 | 9.1% |
Traffic | 1 | 9.1% |
Traffic collision | 1 | 9.1% |
Transcranial direct-current stimulation | 1 | 9.1% |
Transmission (medicine) | 1 | 9.1% |
Traumatic brain injury | 1 | 9.1% |
Unintended pregnancy | 1 | 9.1% |
Unmanned aerial vehicle | 1 | 9.1% |
Urology | 1 | 9.1% |
Vacuum aspiration | 1 | 9.1% |
Vagina | 1 | 9.1% |
Vaginal discharge | 1 | 9.1% |
Vaginitis | 1 | 9.1% |
Vertically transmitted infection | 1 | 9.1% |
Violence | 1 | 9.1% |
Virtual reality | 1 | 9.1% |
Visual acuity | 1 | 9.1% |
Visual impairment | 1 | 9.1% |
Visual perception | 1 | 9.1% |
War | 1 | 9.1% |
Wart | 1 | 9.1% |
Woman | 1 | 9.1% |
Women's health | 1 | 9.1% |
Working memory | 1 | 9.1% |
Zidovudine | 1 | 9.1% |